Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.9081123650715014,1.8615133319972024,0.0,1.0,0.66,4/15,2.19%,ITGB5;FHDC1;PHACTR1;PDLIM1
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.9081123650715014,1.8615133319972024,0.0,1.0,0.66,4/15,2.19%,ITGB5;FHDC1;PHACTR1;PDLIM1
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.9066725727602353,1.8574245476729956,0.0,1.0,0.69,2/24,0.16%,CPA1;ACE2
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.8176626223766017,1.799435825057172,0.0,1.0,0.87,2/35,0.39%,CPA1;CYP4Z1
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.7758142819619777,1.794154107016398,0.0,1.0,0.9,8/28,11.34%,NRG1;EGFR;EREG;BTC;NRG2;ERBB4;PTPN12;PIK3R1
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),-0.9105595102101903,-1.7850589238005858,0.0,0.15582107094439304,0.15,1/13,0.11%,NPY
prerank,PanglaoDB_Augmented_2021__Podocytes,0.6284710522449705,1.7709804405259884,0.0,1.0,0.94,34/165,11.95%,PLEKHH2;LRIG3;ITGB5;CDH13;LAMB2;PROS1;NFIB;WWTR1;GOLIM4;EGFR;SRGAP1;RASSF8;IQGAP2;KITLG;KANK1;UNC13B;THSD7A;FAT4;ADGRL2;DDAH1;MYO1D;TRIB2;PTPRO;HTRA1;MID1;GNG12;CAP2;AMOTL2;DACH1;EHD4;NEBL;PARD3B;ETF1;RASAL2
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.8746215048444191,1.7649827288980444,0.0,1.0,0.97,1/15,0.10%,NRG1
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.9287981446303278,1.7563558732646594,0.0,1.0,0.97,1/10,0.16%,ACE2
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.9287981446303278,1.7563558732646594,0.0,1.0,0.97,1/10,0.16%,ACE2
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.7505852113817919,1.752300100629042,0.03571428571428571,1.0,0.97,6/39,9.21%,NRG1;EPHA3;MCTP1;RAB7A;PXK;PRKD1
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.7739295366267679,-1.7391136597947616,0.0,0.20502772492683297,0.3,12/42,10.44%,CD44;HCK;B2M;TRIM22;STAT1;IRF1;CIITA;HLA-DPB1;IFNGR2;TRIM5;TRIM25;HLA-A
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.6135983219604839,1.738480046190631,0.0,1.0,0.98,34/128,12.86%,GPC4;IGSF11;CDH13;CDH6;PTPRT;NTNG1;CDH20;CDH26;IL1RAPL1;CNTN6;SDK1;NECTIN3;AMIGO1;DSCAM;UNC5D;TGFB2;DSCAML1;FAT4;ACVR1;CNTN4;CDHR3;LRRC4C;FGFRL1;NLGN1;BSG;CLDN12;DCHS1;ROBO2;LRFN4;GRID2;ADGRL1;PTPRS;PTPRM;TENM4
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.6601087502392724,1.733459375467814,0.0,1.0,0.98,18/80,10.33%,EPHA3;ROR2;ALK;TOX;COBL;BMP7;VLDLR;MDK;PLPPR5;LRRC7;APOE;FUT9;RETREG3;PRKD1;ZNF804A;FZD1;LTK;STYXL1
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),0.9389122780357277,1.7282243127024508,0.0,1.0,0.98,2/9,3.27%,MYRFL;KLK6
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.7742412427812174,1.728008801045226,0.0,0.9941236704716894,0.98,14/33,12.12%,UBASH3B;PTPRT;DUSP5;DUSP2;PTPN9;PTPRB;PTPRO;PTPN6;DUSP8;DUSP4;DUSP10;PTPN12;PTPN13;PTPRS
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.7655864899855181,1.7251899425846424,0.0,0.9556494709902631,0.98,7/27,7.17%,ACE2;KCNJ16;BCL2;KCNJ6;KCNJ3;KCNJ2;PRKCB
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.9432157310121669,1.7248076869035385,0.0,0.8959213790533718,0.98,1/12,0.01%,CPA1
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),0.9016081834690514,1.7222195141822059,0.0,0.8646839063719386,0.98,1/8,0.61%,CCNH
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),0.8897741314521939,1.7194886336696973,0.0,0.8318494258847063,0.98,2/11,0.42%,ITGB5;KIT
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.609014358539657,1.7132089173671978,0.0,0.8360789749788019,0.98,48/105,18.94%,LRRTM3;GRIA4;TNR;CACNG3;CTNNA2;OLFM3;ADGRA1;CNTNAP5;GRIA2;GRM5;SPHKAP;KCTD16;UNC79;GRIN2A;LSAMP;GRIA1;TMEM196;NRXN1;FUT9;CSRNP3;PAK5;RBFOX1;MMD2;KCNC2;SLC6A1;NOL4;ST8SIA3;TMEM132B;ELAVL3;PPFIA2;NXPH1;NTRK3;MAGI2;FRRS1L;BRINP2;DLG2;GRIN2B;SLC1A2;KCNC1;MEIS2;SNAP91;GRIN1;BSN;SLC1A6;CELF4;SRRM4;CLVS2;CACNA1B
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.800847562525494,-1.7106125173182838,0.0,0.24603326991219956,0.5,4/40,3.45%,SERF1A;CALB1;HSPG2;B2M
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),0.9005945042712675,1.7079608720677726,0.022727272727272728,0.832066618946295,0.98,3/11,3.11%,CYP4Z1;GLYATL2;ABHD1
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.7217086923443906,-1.696017145319568,0.0,0.27268687415268783,0.63,15/63,10.66%,CD44;HCK;GBP6;B2M;TRIM22;STAT1;IRF1;CIITA;HLA-DPB1;IFNGR2;EPRS1;TRIM5;TRIM25;HLA-A;CCL5
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.7276628870553581,1.6946507546055474,0.029411764705882353,0.9016614813953586,1.0,11/51,10.22%,KIT;NRK;PHACTR1;EFS;NRP1;THSD7A;MCU;FGF10;CASS4;RALA;AUTS2
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.7508314071810309,1.6909268563135953,0.0,0.8849630018550328,1.0,10/24,13.36%,NRP1;MIEN1;TGFB3;PLPPR5;NLGN1;RALA;PIK3R1;GPM6A;RIPOR2;FNBP1L
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),0.9245952540665839,1.6844666353290638,0.0,0.8974795031908559,1.0,3/9,3.47%,PLEKHH2;F2RL1;SEMA5A
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.6941582341347304,1.6720358857412185,0.0,0.9551064883362914,1.0,13/48,13.94%,NRG1;EGFR;TGFBR1;ZSWIM5;EREG;BTC;NRG2;PKHD1;IGBP1;ERBB4;PDPN;ZSWIM6;ACTN4
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.6552907076835985,1.668929722025181,0.03333333333333333,0.939316552758793,1.0,19/93,7.13%,FBXL7;RNF150;FLRT2;SEMA6D;WWTR1;PCDH18;ZNF462;PDE10A;RASSF8;NTM;SLC16A2;CACNA2D1;LAMA4;FIGN;GUCY1A2;ADGRL2;IL17RD;PPFIBP1;RBMS3
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.7208642664603665,-1.6616309675461445,0.0,0.48714587442615515,0.9,18/52,10.84%,MS4A6A;HCK;SIGLEC1;HLA-DMA;PTPRC;CD74;AHR;FGL2;CD300LF;CIITA;HLA-DPB1;MYO1F;NCKAP1L;CLDN1;TAGAP;IGSF6;SPI1;WDFY4
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.7112051863596898,1.6609809315869564,0.02857142857142857,0.9703517705439595,1.0,9/38,5.81%,ACE2;KCNJ16;STAC;AMIGO1;KCNJ6;KCNJ3;KCNN2;KCNJ2;KCNN3
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),0.9101010985405557,1.6594989492319294,0.023255813953488372,0.9108146175623109,1.0,1/7,1.40%,F2RL1
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),0.9101010985405557,1.6594989492319294,0.023255813953488372,0.9108146175623109,1.0,1/7,1.40%,F2RL1
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.5971099265766646,1.6579557990193614,0.0,0.8883945160569358,1.0,13/162,3.41%,CPA1;KIT;PID1;COL15A1;HS3ST3A1;STK32B;SGCD;KDR;SPRED1;EXT1;COBL;UNC13B;LRRC66
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.7926071921765909,1.6562629348091726,0.0,0.8692066324779619,1.0,6/17,12.63%,NEDD1;PCM1;CEP83;PIBF1;HOOK3;CCDC14
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),0.7899058293826245,1.6518073765542929,0.0,0.8689123709106483,1.0,5/16,8.31%,PNP;ADA;POLD3;APRT;HPRT1
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.7655953585861146,1.6503623462714978,0.03333333333333333,0.8515325470911819,1.0,2/18,2.66%,PTPRK;TRIP6
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.8301389506887393,1.6502247265601597,0.03333333333333333,0.8261234269882771,1.0,2/9,6.10%,SLC22A2;SLC22A3
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.7877013762404688,1.648017532721266,0.02702702702702703,0.8186900815649205,1.0,3/22,4.99%,ZC3H12C;ZC3H12B;NYNRIN
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.6442462817283533,1.6466223783004221,0.0,0.8068411962217793,1.0,41/110,14.13%,ETV1;UNC5C;RIMBP2;PTPRT;NFIB;SEMA6D;FGF14;MAPK4;PLCXD3;THSD7A;TOX3;ADGRA1;ESRRG;SERTM1;RGS7BP;PDZRN4;GUCY1A2;GRIA2;PTGFR;ADGRL2;MEIS1;CNTN4;PCDH19;TMEM196;NRXN1;RCAN2;PXK;NOVA1;CSRNP3;CNTN1;ERBB4;PAK5;SLC6A1;PCDH17;NOL4;ST8SIA3;PPFIA2;RNF180;FGF12;KALRN;RAPGEF4
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.8170635846321946,1.6465173209719723,0.020833333333333332,0.785876894515099,1.0,6/15,12.63%,NEDD1;PCM1;CEP83;PIBF1;HOOK3;CCDC14
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.8198838333428259,1.6453553060610417,0.044444444444444446,0.7744987174597993,1.0,5/14,12.12%,GPC4;NTNG1;LRRC4C;LRFN4;PTPRS
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.7503698971856885,1.6431293284252,0.0,0.76783462878488,1.0,7/20,14.80%,IRS1;PPP1R3B;ENPP1;IGF1;IRS2;GCK;AKT2
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.8866263638688656,1.641681454917339,0.024390243902439025,0.7588391428737369,1.0,4/6,10.20%,RUNX1;CBFB;HMGB1;TWSG1
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),0.7346860709836346,1.6414996087563112,0.021739130434782608,0.7421486914485748,1.0,4/23,4.30%,PER2;IFI16;LEF1;HEY1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.8391571369523985,-1.6402763197308317,0.016129032258064516,0.6478876107687921,0.99,3/14,4.11%,CD44;CD74;ING2
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),0.7562098002789495,1.633326357067861,0.0,0.776809525643083,1.0,3/20,8.31%,PNP;FHIT;HPRT1
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),0.9254805319042221,1.632943250342052,0.025,0.7614168187695148,1.0,4/14,2.70%,FLRT2;LAMB2;NTNG1;LAMB3
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.8208489243973105,1.6309817780630078,0.0,0.7398385470662223,1.0,3/17,2.73%,GPC4;MDGA1;IL1RAPL1
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.8208489243973105,1.6309817780630078,0.0,0.7398385470662223,1.0,3/17,2.73%,GPC4;MDGA1;IL1RAPL1
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.8397735669415036,1.627745119577877,0.05128205128205128,0.7480129041114696,1.0,4/14,7.40%,TRPC7;TRPC3;SLC30A10;TRPC5
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.5406917382979342,1.6237165776841838,0.0,0.7603645790922529,1.0,47/133,16.11%,NTNG1;CDH20;GRIA4;RAB3C;TNR;VWC2L;ZNF536;CACNG3;CTNNA2;PCBP3;OLFM3;NRL;CNTNAP5;GRIA2;GRM5;SPHKAP;UNC79;CNTN4;LSAMP;HCN1;GRIA1;LIN7A;TMEM196;NRXN1;SVOP;AP3B2;CADM2;PCSK2;PAK5;RBFOX1;MMD2;ADGRB3;SEZ6L;SGIP1;ST8SIA3;ELAVL3;PPFIA2;SAG;NTRK3;MAGI2;PAK3;FRRS1L;CNTNAP2;SLC1A2;KCNC1;QPCT;NCAM1
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.60606097057925,1.6206990243698527,0.05,0.7647044219510094,1.0,34/109,16.73%,EPHA3;ROR2;TOX;IL1RAPL1;AMIGO1;FBXW8;MDK;PLPPR5;LRRC7;APOE;GRIP1;FUT9;RETREG3;PRKD1;CHODL;ZNF804A;FZD1;LTK;ROBO2;STYXL1;ARSB;DVL2;TIAM2;NGF;NTRK3;MAGI2;EP300;WNT5A;TIAM1;MAP6;MAP3K13;RAPGEF1;PROM2;RAP1A
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.6813707468704163,1.6196496033071952,0.02702702702702703,0.7561033456556486,1.0,3/30,3.73%,RUNX1;CBFB;LATS1
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),0.9278413430132919,1.6174629547279844,0.0,0.7571616077669607,1.0,1/8,0.42%,KIT
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.5970785375519867,1.6171839605954166,0.05263157894736842,0.7443640606767794,1.0,38/114,11.58%,RNF150;RIMBP2;ZNF385D;PENK;SEMA6D;SGCD;FGF14;GRIA4;PCDH18;RAB3C;ZNF536;NTM;CACNA2D1;OLFM3;PDZRN3;CNGA3;UNC5D;PDZRN4;GRIA2;KCTD16;RAB27A;CNTN4;PDGFRA;LSAMP;FGF10;GRIA1;TMEM196;NRXN1;CADM2;NOVA1;CSRNP3;ANGPT1;PCSK2;RBFOX1;ROBO2;ADGRB3;SGIP1;ST8SIA3
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.8743596471970525,-1.616693490882824,0.0,0.8904061196822459,1.0,2/16,3.46%,CD44;CD74
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.9044561806284848,1.616238828089828,0.0,0.7359011969122882,1.0,2/7,2.31%,ACE2;BCL2
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),0.810596128437111,1.6113386570119734,0.02631578947368421,0.7568342838436873,1.0,2/12,6.10%,SLC22A2;SLC22A3
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),0.93917899097139,1.6082180022193897,0.019230769230769232,0.7634541013957375,1.0,3/8,2.70%,LAMB2;NTNG1;LAMB3
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.7131930448781741,1.5991170356310311,0.03571428571428571,0.8178525396934347,1.0,6/18,18.50%,VCAN;CHSY3;CHST12;CHSY1;CHST11;CHST9
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),0.879792270112429,1.5981851317669096,0.0,0.8108014437343836,1.0,2/9,5.96%,SPX;DDAH1
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.7448279139014452,1.5972993816465058,0.02702702702702703,0.8019078109656933,1.0,4/21,4.36%,PID1;ACADVL;LEPR;COX10
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.7540253604854298,1.597063499422804,0.0,0.7889823742553583,1.0,8/23,11.06%,PID1;IRS1;KANK1;ENPP1;PRKCD;PRKCB;PTPRE;PIP4K2A
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.6489965603201349,1.595476625212975,0.0,0.7868380362244282,1.0,11/57,9.21%,CDH13;ITGA4;KDR;NRP1;TGFBR1;VASH2;SEMA5A;MDK;HMGB1;APLN;PRKD1
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.9515848520245066,-1.5906347351852939,0.0,1.0,1.0,3/8,3.12%,ENPP2;CYP1B1;PDXDC1
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),0.8138129304822465,1.5891834603960462,0.023809523809523808,0.8185601555061437,1.0,1/14,0.61%,PID1
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),0.7104450895651468,1.583926090711945,0.058823529411764705,0.8437950442720845,1.0,8/40,6.65%,CCL28;KIT;LEF1;NRP1;SEMA5A;ACKR2;PDGFRA;PRKCD
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),0.7243058891741948,1.5824650886437672,0.05263157894736842,0.8410712296472428,1.0,4/15,8.77%,SMPD4;GDE1;PLA2G4C;LYPLA2
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),0.8369482469671353,1.5796117137755286,0.02857142857142857,0.8457918191931418,1.0,3/17,3.28%,RUNX1;IFIH1;CBFB
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),0.86188728044439,1.5796054828194528,0.025,0.8323665522218221,1.0,2/9,5.07%,NRG1;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),0.8954174790527545,1.5772730952875897,0.05,0.8338177380053539,1.0,2/7,5.72%,PID1;ENPP1
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),0.9396020599769686,1.5756593541406403,0.0,0.8320164974705437,1.0,3/5,3.71%,NRP1;SEMA5A;DSCAM
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.803082834246218,-1.5753167435455127,0.0,1.0,1.0,3/26,3.46%,CD44;CDKN2D;CD74
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),0.8560645320495907,1.5728188601897228,0.02857142857142857,0.8399448036348305,1.0,4/11,7.17%,RUNX1;GFI1B;CBFB;PRKCB
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),-0.8853845542047412,-1.5703653834817095,0.0,1.0,1.0,3/11,3.46%,PTGIS;PTGES;CD74
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.8609347067985027,1.569042048379911,0.024390243902439025,0.8558054964091909,1.0,3/8,6.57%,EFS;MCU;CASS4
prerank,GO_Biological_Process_2021__regulation of meiotic nuclear division (GO:0040020),-0.9469680171358706,-1.568371004300428,0.0,1.0,1.0,1/6,0.12%,WEE2
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),-0.7838943156747599,-1.5653927621407084,0.016129032258064516,1.0,1.0,5/23,8.59%,CSRP3;SCN4B;ATP1B1;KCNQ1;TTN
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.6683619574330776,1.5637449980611144,0.03225806451612903,0.8867226140919681,1.0,17/35,17.09%,HOMER2;GRIA4;GRIK4;GRIN3A;PLCB1;GRIA2;GRM5;GRIN2A;GRIK1;GRM8;GNAQ;GRID2;GRIK2;GRIN2C;GRIN2B;HOMER1;GRIN1
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),0.84001720594847,1.563306632214189,0.0,0.8761379240956187,1.0,2/8,2.30%,F11;KLKB1
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.9516001190909993,1.5626529641657987,0.038461538461538464,0.8708821218102176,1.0,2/5,1.51%,RUNX1;LEF1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.8297862267487125,-1.562639094980336,0.0,1.0,1.0,1/19,0.02%,CD44
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.7379771882245951,1.5587699005028093,0.05,0.8890843861991359,1.0,2/15,2.67%,RUNX1;MELTF
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.8119068526776902,-1.5586468134227285,0.03278688524590164,1.0,1.0,4/18,9.89%,CD44;TGFB1;CEMIP;HAS3
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.8454933467611181,-1.5583789190613206,0.03389830508474576,1.0,1.0,3/15,7.26%,CD44;TGFB1;CEMIP
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.8465191863307114,-1.557628360945397,0.05084745762711865,1.0,1.0,3/10,4.11%,CD44;CD74;ING2
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.8465191863307114,-1.557628360945397,0.05084745762711865,1.0,1.0,3/10,4.11%,CD44;CD74;ING2
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),0.9581166018200444,1.5571323708707752,0.0,0.8886816103337485,1.0,1/6,0.05%,PLEKHH2
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.7200700075514436,-1.5562490537335831,0.0,0.9896004856468471,1.0,2/40,2.87%,CD44;CDKN2D
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.6677281139295748,1.55531594675323,0.0,0.8888254139590012,1.0,9/30,12.86%,IL1RAPL1;NECTIN3;AMIGO1;FAT4;NLGN1;DCHS1;GRID2;ADGRL1;TENM4
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.6715375797064755,1.5527042987546806,0.0,0.8951289178827102,1.0,6/25,15.08%,VCAN;CHSY3;ARSB;CHST12;CHSY1;CHST11
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),0.8040489694146802,1.5498694873051404,0.03125,0.9064769618465822,1.0,2/8,6.17%,HTR1F;HTR1E
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.8443922834963379,1.5492735710943049,0.05555555555555555,0.8983219339446151,1.0,3/12,4.99%,ZC3H12C;ZC3H12B;NYNRIN
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.9183314217909144,1.548171417978519,0.0,0.8956252066966598,1.0,2/6,5.75%,PMEPA1;GREM1
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),0.8285666762791615,1.5479744133589564,0.047619047619047616,0.885312333352693,1.0,4/10,12.78%,BRCA2;MACROH2A2;LRWD1;RUVBL2
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.5313467803524149,1.5475461864046014,0.06451612903225806,0.8778998535000311,1.0,36/151,14.37%,EPHA3;ROR2;MYLIP;TOX;NTNG1;IL1RAPL1;KANK1;CTNNA2;MDK;MINAR1;PLPPR5;LZTS3;CSMD3;LRRC7;PTPN9;APOE;PTPRO;LRRC4C;FUT9;KNDC1;RETREG3;PRKD1;ZNF804A;FZD1;LTK;STYXL1;MARK1;ARSB;SPOCK1;PTPRS;PPFIA2;SIPA1L1;NTRK3;MAGI2;PAK3;EP300
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.8732509671904901,-1.5466957402470414,0.0,1.0,1.0,6/11,8.59%,MYLK;ACTC1;ZFPM1;NOTCH1;TBX1;TTN
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.9313798065129458,1.5446348987337246,0.0,0.8885911132247531,1.0,2/8,3.10%,KIT;COBL
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),0.8641411217766986,1.543490391315029,0.04878048780487805,0.8846997375379556,1.0,2/10,3.21%,DGKB;GAL3ST1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.7820660371790915,1.5432397935877444,0.06382978723404255,0.8754999338722881,1.0,5/12,12.15%,ITGA4;MDK;HMGB1;APLN;FGFR1
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),0.8276263979607165,1.5421656522031049,0.027777777777777776,0.8718600513267685,1.0,1/10,0.72%,IMMP2L
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.7410681884024408,-1.5415322380334024,0.04838709677419355,1.0,1.0,4/22,5.92%,NES;ATP5IF1;NOTCH1;IFIT1
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by hormone (GO:0001990),0.8859575986531807,1.539454518534717,0.022222222222222223,0.8814935542478367,1.0,2/9,2.00%,ACE2;OXTR
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),0.7620023382839579,1.5393317908587216,0.027777777777777776,0.8717362928423479,1.0,4/16,10.92%,PNP;HPRT1;RRM2;NMNAT3
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),0.8398147252581651,1.5392619628435815,0.023255813953488372,0.862054414449832,1.0,1/11,0.33%,PNP
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.8884233512887878,-1.5383891887255303,0.0,1.0,1.0,2/12,3.46%,CD44;CD74
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.7690659653364593,1.5379741240098328,0.045454545454545456,0.8633798668946515,1.0,5/12,14.80%,IRS1;IGF1;IRS2;GCK;AKT2
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),0.9615175924337408,1.5376807897971003,0.0,0.8553457661838471,1.0,1/5,0.58%,UBASH3B
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.7744768363561223,1.5372794955333144,0.045454545454545456,0.8486635853717412,1.0,5/11,14.80%,IRS1;IGF1;IRS2;GCK;AKT2
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.7228971959723404,-1.5371193296224612,0.0,1.0,1.0,13/39,10.84%,C3AR1;MS4A6A;HCK;SIGLEC1;SLC7A7;FGL2;CD300LF;MYO1F;AQP9;CD14;IGSF6;SPI1;WDFY4
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.7540749053047532,1.5359520376250835,0.03571428571428571,0.848356098565447,1.0,8/22,11.06%,PID1;IRS1;KANK1;ENPP1;PRKCD;PRKCB;PTPRE;PIP4K2A
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.7089939590923123,1.5316323651777741,0.05555555555555555,0.8712544527729412,1.0,8/27,14.40%,MCTP1;EPHB2;APOE;NSMF;SHISA9;GRIK2;PPFIA3;ZDHHC2
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.7776604772459901,1.5311887983693462,0.02857142857142857,0.864617248654827,1.0,5/16,5.94%,PDGFD;RGS14;NRP1;PDGFC;PDGFRA
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.5598557036566539,1.530804779603613,0.04,0.8585431537767364,1.0,42/127,15.71%,LRRTM3;CDH20;GRIA4;KCNIP1;TNR;ZEB2;EGFR;GRIN3A;CTNNA2;ADGRA1;RGS7BP;GRIA2;GRM5;SPHKAP;NTSR2;GRIN2A;LSAMP;SLCO1C1;GRIA1;PTCH1;LRRC4C;NRXN1;CADM2;RBFOX1;MMD2;SLC6A1;SLC4A4;DPP6;ADGRB3;ADCY2;ST8SIA3;PMP2;ELAVL3;PPFIA2;NTRK3;RAPGEF4;GPM6B;MAGI2;DLG2;GRIN2B;FAM181B;SLC1A2
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),-0.8652314560126779,-1.5300944265146237,0.0,1.0,1.0,2/9,3.46%,CD4;CD74
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),-0.9439745167714069,-1.5280303519212408,0.0,1.0,1.0,1/6,0.82%,SIGLEC1
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.7327831499757891,1.5270254797082294,0.05,0.8793546316960211,1.0,2/17,1.51%,EPHA3;MCTP1
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.8738659071509454,1.526652682515813,0.0,0.8731161075865584,1.0,3/8,10.10%,NPNT;BMP7;ROBO2
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),0.8489159982132288,1.5251459176977917,0.058823529411764705,0.8770527318278537,1.0,3/9,7.17%,PID1;ENPP1;PRKCB
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.7016507217207533,-1.5242174792281986,0.016129032258064516,1.0,1.0,9/38,7.88%,MS4A6A;HCK;PTPRC;DRD3;FGL2;CD300LF;AQP9;TUBB;CD14
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.6969093441778464,1.5235453361147213,0.08823529411764706,0.8830577281376287,1.0,6/27,11.34%,PID1;IRS1;ENPP1;IGF1;IRS2;PIK3R1
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.6391209306539324,1.520488051369225,0.027777777777777776,0.8997111763525214,1.0,8/50,7.13%,NRG1;TGFBR1;TGFB2;EREG;CFLAR;PDGFRA;FGF10;IGF1
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),-0.8997615814453305,-1.5203921544764063,0.03076923076923077,1.0,1.0,2/10,3.56%,TICRR;GMNN
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.7996811270891206,-1.519834444892149,0.015625,1.0,1.0,2/20,3.27%,CD44;ITGA5
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.6859344930141813,1.5197337572932914,0.03333333333333333,0.8982578498674317,1.0,11/36,12.78%,ALK;COBL;BMP7;VLDLR;CSMD3;KNDC1;ADGRB3;MARK1;NSMF;HECW2;NEDD4L
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.6907153479708764,1.519254089511915,0.03571428571428571,0.8931847464773539,1.0,3/25,3.73%,RUNX1;CBFB;LATS1
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.6965087035355477,1.5188006236540934,0.05,0.8885991773235746,1.0,6/21,4.98%,HS3ST5;HS3ST3B1;SULF2;EXT1;HS3ST4;HS6ST3
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.7375234830320803,-1.518605312409741,0.04477611940298507,1.0,1.0,1/31,0.02%,CD44
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.7993773987510635,-1.5177684187199336,0.0196078431372549,1.0,1.0,4/16,9.90%,MYLK;RCSD1;YBX3;LRRC8D
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,-0.6776468677007037,-1.5176416192313973,0.02631578947368421,1.0,1.0,14/58,12.59%,EPHA1;TMEM184A;TNK1;DENND1C;SLC14A1;TMCO4;SYTL1;CAPN1;TMC4;SYNGR2;ZBTB7B;TRIM25;TMEM79;TJP3
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),0.8733807637799489,1.514360392798436,0.0,0.9122108586725238,1.0,1/7,0.58%,UBASH3B
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),0.7998805838393834,1.5143483125403674,0.05555555555555555,0.9039870437191654,1.0,3/11,1.42%,ALK;TYSND1;CIDEA
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.9513584778722098,1.5135963415294216,0.0,0.9013094376966296,1.0,3/6,4.75%,SPRED1;SPRED2;SPRED3
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),0.804092882037261,1.5133933542680407,0.05405405405405406,0.8938425311781655,1.0,4/11,8.31%,PNP;ADA;APRT;HPRT1
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.8618688770516046,-1.5117426773295601,0.017543859649122806,1.0,1.0,1/14,0.02%,CD44
prerank,GO_Biological_Process_2021__nucleoside transport (GO:0015858),-0.9919934792478196,-1.5107404646956413,0.0,1.0,1.0,1/5,0.05%,SLC28A2
prerank,GO_Biological_Process_2021__pyrimidine nucleoside transport (GO:0015864),-0.9919934792478196,-1.5107404646956413,0.0,1.0,1.0,1/5,0.05%,SLC28A2
prerank,GO_Biological_Process_2021__uridine transport (GO:0015862),-0.9919934792478196,-1.5107404646956413,0.0,1.0,1.0,1/5,0.05%,SLC28A2
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),0.8841192551286665,1.510309045659743,0.07142857142857142,0.9049574300119201,1.0,2/6,3.30%,UNC13C;UNC13B
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.8434698114277802,1.5094978004044797,0.0,0.9021022470210126,1.0,5/12,5.85%,EPHA3;SEMA5A;AMIGO1;EPHB2;CNTN4
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),-0.8272830093058694,-1.5092135027495912,0.045454545454545456,1.0,1.0,4/17,10.02%,NES;CYP1B1;LAMA1;EFEMP1
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),0.7361924017564276,1.5091151464943875,0.0,0.8970073443613151,1.0,6/15,15.95%,NTNG1;SPRY3;GRIP1;DVL2;WNT5A;MAP3K13
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),0.8680264020949708,1.5083123623200294,0.0,0.8857922844538261,1.0,2/11,6.90%,PER2;PGM2
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),0.8680264020949708,1.5083123623200294,0.0,0.8857922844538261,1.0,2/11,6.90%,PER2;PGM2
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.8226038217415563,1.5063521636372623,0.022222222222222223,0.8906089541685669,1.0,4/11,8.22%,C5AR1;EREG;ZBTB1;TFCP2
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),0.9205710996669916,1.5054839133136977,0.046511627906976744,0.8884747597989021,1.0,3/5,5.75%,TGFBR1;TGFB2;ACVR1
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.7845209503812732,1.5052902779415551,0.0,0.8816500650507515,1.0,1/12,0.53%,CDH13
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),0.791138638531345,1.5042907800952259,0.023809523809523808,0.8800891479849324,1.0,3/13,6.24%,NRG1;SGK1;FGF10
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,-0.6835112765504768,-1.5014995617355513,0.015384615384615385,1.0,1.0,14/48,10.84%,C3AR1;MS4A6A;HCK;SIGLEC1;KLHDC4;FGL2;CD300LF;MYO1F;AQP9;CD14;TRIM25;IGSF6;SPI1;WDFY4
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.6760701770866651,1.5006893224214675,0.05405405405405406,0.8994059112153815,1.0,8/35,13.12%,EPHA3;CDK2AP2;TRIM36;EFNA5;IGBP1;BICD1;MAP10;KLHL42
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.7858862804597522,-1.4999841889157521,0.03278688524590164,1.0,1.0,4/21,4.11%,CD44;CDKN2D;CD74;ING2
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),-0.834453556697629,-1.4999663014391234,0.05084745762711865,1.0,1.0,1/10,0.50%,CD4
prerank,PanglaoDB_Augmented_2021__Neutrophils,-0.6555065402709969,-1.4997718880867916,0.028985507246376812,1.0,1.0,13/51,11.42%,NR1I3;HCK;MYLK;DOCK8;ELANE;CD300LF;MYO1F;AQP9;CD14;TAGAP;IGSF6;SPI1;ARG2
prerank,GO_Biological_Process_2021__regulation of striated muscle cell differentiation (GO:0051153),0.8878859504653442,1.4975953944114513,0.046511627906976744,0.9126602236275349,1.0,2/6,3.97%,NRG1;HDAC9
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.9028291220369575,-1.4971065395773315,0.0,1.0,1.0,3/10,2.78%,CD44;ENPP2;RREB1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.6408460883194661,-1.4966779533030887,0.028985507246376812,1.0,1.0,5/59,8.48%,CD44;TERF2IP;TGFB1;PINK1;CALCR
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),0.9004030283494626,1.4965536324746576,0.043478260869565216,0.912099477615299,1.0,1/7,1.33%,PTPRT
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),0.8294473996988186,1.4954712038406095,0.06976744186046512,0.9129839187222463,1.0,3/11,6.63%,PID1;IRS1;AKR1C3
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.7697592559994331,1.4951919916361012,0.08333333333333333,0.9083780399386058,1.0,3/16,5.75%,KDR;NRP1;GREM1
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),0.866882635118294,1.4937543281992403,0.02127659574468085,0.9140569996960277,1.0,3/7,4.90%,PNP;SLC2A9;SLC16A9
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.6524960111060242,1.4933249820438599,0.03225806451612903,0.9104876740516549,1.0,3/28,2.70%,PTPRK;TRIP6;LAMB3
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),0.8380010298074333,1.493193099952316,0.02702702702702703,0.9045200879670882,1.0,1/7,0.52%,NPNT
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.870916533518425,-1.491350651105008,0.03636363636363636,1.0,1.0,2/8,3.79%,ARR3;DRD3
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.8128522278551146,-1.4906812452263665,0.01639344262295082,1.0,1.0,2/18,1.29%,TERF2IP;SHCBP1L
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.5686633422581762,1.4901186273731102,0.1111111111111111,0.9194153114471733,1.0,29/106,11.58%,ETV1;UNC5B;RIMBP2;PTPRT;SEMA6D;KCNIP1;RAB3C;LCORL;MAPK4;KCNB2;TOX3;ADGRA1;LEPR;RGS7BP;UNC5D;GRIA2;CNTN4;TMEM196;NRXN1;RCAN2;CSRNP3;PCSK2;CNTN1;POU3F1;SLC6A1;RBP4;PCDH17;NOL4;ST8SIA3
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.7343330128107705,1.4893568721824177,0.15789473684210525,0.9183062768525938,1.0,2/21,7.19%,EPHA3;EFNA5
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),0.6951647638048296,1.4887351662681465,0.08108108108108109,0.916589470794152,1.0,4/22,8.31%,PNP;ADA;APRT;HPRT1
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),0.9238557807709679,1.4885771474048801,0.021739130434782608,0.9103492038589064,1.0,2/6,5.75%,UBASH3B;GREM1
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),0.961398252965203,1.4874821722389446,0.030303030303030304,0.9122108586725239,1.0,1/5,0.81%,CA2
prerank,PanglaoDB_Augmented_2021__Basophils,-0.6380767076469265,-1.4871230843876793,0.0,1.0,1.0,14/81,8.30%,CD44;C3AR1;MS4A6A;HCK;CD4;SIGLEC1;IL3RA;P2RY1;FGL2;CD300LF;MYO1F;AQP9;CD14;RNF39
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),0.8313139507801672,1.487028646707818,0.10810810810810811,0.9080366795201161,1.0,2/9,5.83%,PDE3A;PDE4D
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.7124002528550606,1.4863293158414381,0.08571428571428572,0.9048363965813728,1.0,8/19,23.01%,TEX15;FOS;GATAD2A;DMAP1;DNMT1;DNMT3B;EHMT2;BEND3
prerank,GO_Biological_Process_2021__thiamine-containing compound metabolic process (GO:0042723),-0.9375048402110724,-1.4860435229606672,0.038461538461538464,1.0,1.0,1/5,0.28%,SLC19A3
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),0.7972700992204456,1.486010111623317,0.05405405405405406,0.9006829192497392,1.0,1/9,0.42%,KIT
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),0.824075638590046,1.4857091994388592,0.09523809523809523,0.8954985986663095,1.0,3/8,4.75%,SPRED1;SPRED2;SPRED3
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.6429849392575431,-1.4854229301125936,0.0,1.0,1.0,15/78,10.83%,CD44;C3AR1;MS4A6A;HCK;PTPRC;FGL2;CD300LF;IFIT1;MYO1F;AQP9;CD14;IFIT3;TAGAP;IGSF6;SPI1
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.7536337431997571,1.4849311176079265,0.029411764705882353,0.8940456207941966,1.0,6/11,17.42%,LRRTM3;C5AR1;NLGN1;FZD1;WNT5A;NLGN4Y
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),0.7734072580018466,1.4841691066091185,0.02127659574468085,0.8934963287040544,1.0,3/12,4.58%,SLC2A9;SLC2A11;SLC2A14
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.8272084651508572,1.4839345032199964,0.04878048780487805,0.8887734581458631,1.0,4/8,14.24%,GALNT3;GALNTL6;GALNT13;GALNT16
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.8690470783225509,1.4836958560116968,0.0,0.883058723294841,1.0,3/7,6.65%,CA2;SLC30A10;PRKCD
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),0.847255461737506,1.4825770029426484,0.0,0.8831772567630937,1.0,3/14,1.79%,CDH13;F2RL1;KDR
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.8769041075231979,1.4818692353879463,0.02564102564102564,0.8812965177894613,1.0,1/6,0.42%,KIT
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.7375304156929949,-1.4816860754338,0.043478260869565216,1.0,1.0,3/24,4.99%,KCNE2;CAV3;ATP1B1
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),0.8370577476893817,1.4815894954839721,0.043478260869565216,0.8773655370524244,1.0,2/9,7.35%,SLC22A2;SLC6A4
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),0.7740695368567105,1.481434516772041,0.08823529411764706,0.8714285643742148,1.0,3/8,13.52%,RNF2;PCGF1;PCGF6
prerank,GO_Biological_Process_2021__L-arginine transmembrane transport (GO:1903400),0.8475567737462811,1.481069573743213,0.05263157894736842,0.8674380604050255,1.0,3/6,7.55%,SLC22A2;SLC7A2;SLC7A1
prerank,"GO_Biological_Process_2021__CD4-positive, alpha-beta T cell activation (GO:0035710)",0.9182006164720584,1.4805146011674084,0.03225806451612903,0.8640586948054129,1.0,2/5,7.04%,CDH26;HMGB1
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.7826379240207485,-1.4803907993695469,0.0,1.0,1.0,2/23,1.77%,ENPP2;CYP1B1
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.7141698535232656,-1.4798326790482128,0.0,1.0,1.0,1/30,0.02%,CD44
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),-0.7390327812529092,-1.4796303955712478,0.0,1.0,1.0,1/30,0.04%,SERF1A
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.6536151232206413,1.4793281767871624,0.02857142857142857,0.8645813379832843,1.0,12/29,18.53%,HS3ST3B1;EXT1;B3GAT2;IGF1;EXT2;CHST8;CHST12;CHST11;B3GAT3;GAL3ST4;CHST9;B3GAT1
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.5728840326645175,1.4775785255009326,0.0,0.8707467287328637,1.0,13/72,11.23%,MYRFL;TYSND1;RCE1;KLKB1;PRSS12;KLK6;ADAMTS3;HGFAC;PTCH1;PCSK2;ADAM19;SRGN;CASP2
prerank,GO_Biological_Process_2021__ammonium transmembrane transport (GO:0072488),-0.9002253089894867,-1.4775357850752837,0.0,1.0,1.0,1/6,0.59%,SLC12A7
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.8399054962073738,-1.4767948808457745,0.0,1.0,1.0,2/13,5.85%,CD44;RAC1
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.6772185434740412,-1.4758999831878956,0.015625,1.0,1.0,7/32,11.18%,H1-2;H1-0;NCAPH2;NCAPG;TTN;GPER1;SMC2
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.7012610364369446,1.4750932439003064,0.0967741935483871,0.8856952057369039,1.0,6/29,9.51%,CDH13;CDH6;CDH20;CDHR3;NLGN1;DCHS1
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.7006255056526238,1.474559876611074,0.0625,0.8830021365968026,1.0,6/34,11.97%,EPHA3;CDK2AP2;TRIM36;EFNA5;MAPRE1;BICD1
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.636777029065421,1.4740243212709954,0.07142857142857142,0.8807922459276385,1.0,9/24,18.53%,VCAN;CHSY3;B3GAT2;CHST12;CHSY1;CHST11;B3GAT3;CHST9;B3GAT1
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.5385573789507294,1.4734275458094817,0.043478260869565216,0.8781691706520914,1.0,29/105,15.71%,UNC13C;GRIA4;CATSPER2;TNR;FGF13;CACNG3;CTNNA2;KCNJ6;CNTNAP5;GRIA2;HCN1;PRKCB;NRXN1;SVOP;AP3B2;PCSK2;XKR4;KCNC2;DPP6;ADCY2;SEZ6L;C4ORF50;ST8SIA3;PMP2;CACNB2;NR3C1;FRRS1L;OTUD7A;SLC1A2
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),0.6424853335479632,1.4733160215531793,0.027777777777777776,0.8726758513806355,1.0,8/29,13.12%,TPD52L1;BCL2;TGFBR1;CRADD;SGMS1;STYXL1;NR4A2;TRAF1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),0.8575055596992086,1.4731849637949501,0.05405405405405406,0.8675186488180983,1.0,4/7,9.59%,PTPRT;PTPRB;PTPRO;DUSP10
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.652875657032969,-1.4728146357243335,0.014084507042253521,1.0,1.0,8/70,4.89%,CD44;TUBB1;TRIM58;GYPB;DOCK2;RGS10;TMC8;GMFG
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.7975613346481885,-1.4727617957165444,0.017241379310344827,1.0,1.0,2/15,3.12%,ENPP2;PDXDC1
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.5430041511924615,1.4714924337197126,0.0,0.8738980026082779,1.0,23/195,10.56%,CPA1;TYSND1;KLKB1;TMPRSS7;CAPN13;VASH2;ADAMTS3;DESI2;VASH1;DPP3;HGFAC;PTCH1;HTRA1;CTSC;THOP1;PCSK2;PM20D2;ADAM19;TASP1;USP25;MMP17;MALT1;SRGN
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.7730282091725547,1.4703757498096552,0.0,0.8703726162822802,1.0,5/11,16.90%,MELTF;KANK1;EFNA5;ACTN4;RCC2
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.7730282091725547,1.4703757498096552,0.0,0.8703726162822802,1.0,5/11,16.90%,MELTF;KANK1;EFNA5;ACTN4;RCC2
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.5156485641827799,1.4695721207991048,0.0,0.8717533275922766,1.0,36/126,14.30%,EPHA3;FEZF2;LRRTM3;GRIA4;RAB3C;BCL2;ZNF536;MAPK4;CTNNA2;SLC35F1;OLFM3;ADGRA1;GRIA2;UNC79;LSAMP;LRRC4C;NRXN1;CADM2;SOX5;FUT9;EPHA7;NOVA1;CSRNP3;PAK5;RBFOX1;MMD2;ROBO2;ADGRB3;NOL4;ST8SIA3;ELAVL3;PPFIA2;NXPH1;NTRK3;GPM6B;PAK3
prerank,GO_Biological_Process_2021__N-acylethanolamine metabolic process (GO:0070291),0.8810717704604533,1.4680856288815467,0.02040816326530612,0.870846089781567,1.0,1/5,6.12%,GDE1
prerank,GO_Biological_Process_2021__ethanolamine-containing compound metabolic process (GO:0042439),0.8810717704604533,1.4680856288815467,0.02040816326530612,0.870846089781567,1.0,1/5,6.12%,GDE1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.7316397029235864,1.4680806579089378,0.06521739130434782,0.865263743052198,1.0,6/16,15.84%,ITGA4;MDK;HMGB1;APLN;FGFR1;MEF2C
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),0.9188022274333686,1.4678549530318237,0.0,0.8609975647870873,1.0,2/7,1.51%,RUNX1;LEF1
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.7657736403197962,-1.4671604071736102,0.03333333333333333,1.0,1.0,3/15,3.46%,PTGIS;PTGES;CD74
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.6215161238738842,-1.4666051771701099,0.0,1.0,1.0,38/85,24.44%,SRP68;RPL36;RPL15;RPL38;RPS21;RPS7;RPL37A;RPL9;SRP9;RPL28;RPLP2;SRP14;RPL5;RPL35A;RPS20;RPLP1;RPL8;RPL4;RPL22;RPL27A;RPL24;RPS15;RPL34;RPL3;RPS24;RPS4X;RPS3;RPS29;RPL13A;RPS8;RPS27A;RPL27;RPL37;RPL7A;RPL35;RPL23;RPL32;RPS13
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.7223261478290115,-1.4641708912807476,0.015873015873015872,1.0,1.0,9/41,8.47%,CD44;ADAMTS4;MMP15;ELANE;KIF9;CAPN1;TIMP2;BMP1;MMP19
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.7441883568663914,-1.4639098673758428,0.01694915254237288,1.0,1.0,2/18,3.45%,SLC28A2;B2M
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.6259052155014079,-1.463774434504781,0.0136986301369863,1.0,1.0,39/88,24.44%,SRP68;RPL36;RPL15;RPL38;RPS21;SEC62;RPS7;RPL37A;RPL9;SRP9;RPL28;RPLP2;SRP14;RPL5;RPL35A;RPS20;RPLP1;RPL8;RPL4;RPL22;RPL27A;RPL24;RPS15;RPL34;RPL3;RPS24;RPS4X;RPS3;RPS29;RPL13A;RPS8;RPS27A;RPL27;RPL37;RPL7A;RPL35;RPL23;RPL32;RPS13
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),-0.7918962427899031,-1.463137393503017,0.0,1.0,1.0,2/15,3.68%,WEE2;NODAL
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.8533258458172969,-1.4629617145183822,0.0,1.0,1.0,1/9,0.12%,WEE2
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),0.7895730619246867,1.4629145921614417,0.10256410256410256,0.8849105156146029,1.0,1/8,0.52%,NPNT
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),-0.8215488600748262,-1.462611830365989,0.037037037037037035,1.0,1.0,3/13,8.59%,CSRP3;CAV3;TTN
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.5788590922087411,1.4619409172649653,0.03571428571428571,0.8859837719901152,1.0,9/77,5.53%,GPC4;TRPC7;NPNT;GEM;KCNIP1;SPRED2;PDZRN3;WWC1;FAM222A
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.9128869523044999,1.4615199688087641,0.0,0.8837857167371033,1.0,1/5,0.72%,IMMP2L
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.706469303402077,1.4610289751205876,0.025,0.8812912004637479,1.0,5/24,5.52%,LHFPL2;TACR1;PDE3A;PLCB1;ANKRD31
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.8950837547399979,1.460890892982561,0.0,0.8764946663223826,1.0,2/7,2.17%,KIT;NFATC1
prerank,MSigDB_Hallmark_2020__UV Response Dn,0.5520931330276967,1.4603772007676956,0.06666666666666667,0.8752747134747407,1.0,30/131,14.36%,RUNX1;KIT;IRS1;NFIB;BCKDHB;NRP1;LTBP1;GRK5;ATXN1;VLDLR;PTGFR;MGMT;SYNJ2;MT1E;ADGRL2;DDAH1;SFMBT1;SLC7A1;RASA2;FHL2;TOGARAM1;CAP2;PRKCE;PTPRM;CELF2;FYN;SIPA1L1;KALRN;MAGI2;NR3C1
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.6864419938080746,-1.4598370350053174,0.017543859649122806,1.0,1.0,1/28,0.36%,RAB6C
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.8352488667756192,1.4589365946805215,0.045454545454545456,0.8790756733008825,1.0,3/7,9.72%,PNP;HPRT1;PRTFDC1
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.5879276812394524,1.457294658576176,0.030303030303030304,0.8852789190355255,1.0,10/58,11.34%,NRG1;EGFR;SLC30A10;EREG;BTC;SHC3;NRG2;ERBB4;PTPN12;PIK3R1
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),0.8424529216686376,1.4570530456648574,0.08108108108108109,0.8823010189862732,1.0,1/6,0.76%,ADARB2
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.568903715092512,1.456751185087017,0.09090909090909091,0.8790466486694596,1.0,24/92,16.96%,ITGB5;PDE3A;PTPRK;TGFBR1;PARD3;WWOX;TGFB2;TGFB3;FOS;ACVR1;SOX5;SMAD2;TGFBR3L;TWSG1;CILP;LIMS1;GCNT2;MAPK7;SIRT1;NR3C1;WNT5A;MEF2C;GDF10;PXN
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),0.8679340829864359,1.45549948250143,0.023255813953488372,0.8815711231984041,1.0,2/6,5.83%,LEF1;PDE4D
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),0.691610614557183,1.4548327937088374,0.07894736842105263,0.8825235230352524,1.0,5/19,11.17%,EGFR;FOS;MT1E;AKR1C3;MAPK8
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),-0.7870025504965217,-1.4547391609635538,0.0625,1.0,1.0,6/12,18.59%,LRRC19;NOTCH1;OCIAD2;LPCAT3;CCN3;UBAP2L
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),-0.9350860698062706,-1.4538774960074303,0.0,1.0,1.0,2/7,2.78%,ENPP2;RREB1
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.6489537503022353,-1.4516907870096831,0.0,1.0,1.0,22/72,15.08%,HCK;CD4;DOCK8;PTPRC;CLEC4C;ARHGAP9;IL3RA;CD37;GMFG;CARD6;CD300LF;MYO1F;BLNK;NCKAP1L;TAGAP;SPI1;WDFY4;CD83;GPR183;SERPINF1;SLA;WAS
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),-0.7972179656739624,-1.4513832360839245,0.03225806451612903,1.0,1.0,2/12,5.56%,TICRR;CDC6
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.5952160814125165,1.4509196635720953,0.06666666666666667,0.9053117849514711,1.0,9/37,5.75%,PMEPA1;TGFBR1;BMP6;BMP7;BMP3;TGFB2;TGFB3;GREM1;ACVR1
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),-0.9595862416937069,-1.4505147632021502,0.0,1.0,1.0,1/6,0.50%,CD4
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),-0.9595862416937069,-1.4505147632021502,0.0,1.0,1.0,1/6,0.50%,CD4
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),0.8466330490091863,1.4505109723116811,0.0,0.9028372633829064,1.0,4/9,3.92%,ALK;COBL;BMP7;VLDLR
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),0.6345072957284542,1.4502662588212456,0.029411764705882353,0.89880044986978,1.0,3/22,6.08%,RUNX1;CBFB;MACROH2A2
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),-0.653713364849867,-1.4498495142285062,0.015873015873015872,1.0,1.0,4/39,7.59%,TICRR;TERF2IP;TOM1L1;SUB1
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.6749456790270293,-1.449587402394358,0.031746031746031744,1.0,1.0,6/27,10.66%,CD4;TNFSF18;FGL1;IL4I1;HLA-DPB1;CCL5
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.6365010842344525,1.449384778091866,0.05128205128205128,0.8980493688764516,1.0,8/28,16.80%,MICU1;CACNA2D1;MCU;SLC35G1;SLC8A1;MCUR1;MAIP1;MCUB
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),0.7307312907397512,1.44924556108187,0.13513513513513514,0.8935622130395634,1.0,2/10,3.99%,CD247;TGM1
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.6785257553251948,1.449153594822403,0.05128205128205128,0.8889774065985787,1.0,3/23,10.52%,PRELID2;PITPNC1;SCARB1
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),-0.8786132973923242,-1.4480464302165459,0.041666666666666664,1.0,1.0,3/7,8.59%,CSRP3;CAV3;TTN
prerank,GO_Biological_Process_2021__negative regulation of lens fiber cell differentiation (GO:1902747),0.9513618705269613,1.4478446159176945,0.023255813953488372,0.8928115693078971,1.0,3/5,4.75%,SPRED1;SPRED2;SPRED3
prerank,GO_Biological_Process_2021__alkaloid metabolic process (GO:0009820),0.9434309969647385,1.4471027900220854,0.06666666666666667,0.8924057964463005,1.0,1/5,0.56%,CYP1A2
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.7357412437527562,-1.446160792921411,0.014925373134328358,1.0,1.0,4/29,8.12%,ENPP2;RREB1;RAC1;BRK1
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),0.8132087305499357,1.446049759041405,0.11363636363636363,0.8942009171610117,1.0,1/8,1.79%,KDR
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),0.9141580227070398,1.4459541099465496,0.0,0.8897877984593445,1.0,1/5,1.59%,RAB7B
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.7183010738015221,1.445763861850874,0.1388888888888889,0.8867268727794502,1.0,3/18,5.75%,KDR;NRP1;GREM1
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.7793163063054571,-1.444482410519175,0.037037037037037035,1.0,1.0,1/16,0.12%,WEE2
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.791828903895186,1.4439780075829698,0.10810810810810811,0.893059470479399,1.0,3/9,14.24%,GALNT3;GALNT13;GALNT16
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),0.6053476857622163,1.4435535748467445,0.08108108108108109,0.8913030430734363,1.0,4/33,2.93%,TRPC7;TRPC3;MELTF;SLC30A10
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.6575943913104961,-1.4427088620694772,0.03076923076923077,1.0,1.0,4/38,4.14%,ARR3;CAV3;DRD3;LDLRAP1
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.7765067919760581,-1.442523702616786,0.0,1.0,1.0,3/17,9.27%,PINK1;HSPA5;SKP1
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.7963650921953399,1.4424403524761655,0.10256410256410256,0.8922718235102829,1.0,2/10,2.45%,SGK1;SGK2
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.7882501314536606,1.4421845772159554,0.07142857142857142,0.8891931157324174,1.0,2/10,1.42%,ALK;CIDEA
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),0.8608537579849942,1.441963227855633,0.0392156862745098,0.8855137223453511,1.0,2/8,1.77%,CYP1A2;ALLC
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.8673922960009214,-1.4412404924621343,0.03278688524590164,1.0,1.0,2/8,5.95%,NOTCH1;TGFB1
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),0.8063753279276812,1.4411226741262577,0.027777777777777776,0.8858674421701529,1.0,2/10,4.30%,IFI16;CSF1R
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.7347580871361609,1.439199420411768,0.11904761904761904,0.8945798924965004,1.0,2/14,8.59%,PNP;SAMHD1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),0.667163608378733,1.4389622022486492,0.07692307692307693,0.8915544121767478,1.0,6/19,16.80%,MICU1;MCU;SLC8A3;MCUR1;MAIP1;MCUB
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.772942523444392,-1.4379543829977328,0.07936507936507936,1.0,1.0,2/13,12.06%,DDX20;PRPF19
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.7409300656197657,-1.4379260445303432,0.07936507936507936,1.0,1.0,4/23,3.46%,CD44;HIC1;MSX1;CD74
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.6894098169735438,-1.4377977340031776,0.046153846153846156,1.0,1.0,10/37,11.38%,ALPL;CYP19A1;CYP1B1;CDKN2D;DRD3;TGFB1;IGFBP5;IL18;CCL5;ABCB4
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.6054974529165054,-1.4375341245611601,0.0,1.0,1.0,39/87,24.44%,RPL36;RPL15;RPL38;RPS21;RPS7;RPL37A;RPL9;RPL28;RPL5;RPL22L1;RPL26L1;RPL35A;RPS20;EIF3I;RPLP1;RPL8;RPL4;EIF4A2;RPL22;RPL27A;ZC3H15;RPL24;RPS15;RPL34;RPL3;RPS24;RPS4X;RPS3;RPS29;RPL13A;RPS8;RPS27A;RPL27;RPL37;RPL7A;RPL35;RPL23;RPL32;RPS13
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.733271740994564,1.4371746139703891,0.029411764705882353,0.8997308764034592,1.0,4/19,7.13%,NRG1;MAML1;GREM1;IGF1
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),0.8482124629304765,1.4368646856703853,0.07894736842105263,0.8978761166076699,1.0,1/6,5.95%,ZNHIT6
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.6421466086621802,-1.4365425532619134,0.015384615384615385,1.0,1.0,15/51,17.08%,ENPP2;ELANE;PDXDC1;IL4I1;TST;GNPDA1;ERAP2;LIPC;CLPX;LVRN;PLA2G7;PLA2G10;SIAH1;ERAP1;NAALADL1
prerank,GO_Biological_Process_2021__G protein-coupled receptor internalization (GO:0002031),-0.8779935458104267,-1.4363321051133853,0.03571428571428571,1.0,1.0,2/6,3.79%,ARR3;DRD3
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),-0.9460870810921677,-1.435600746406421,0.03225806451612903,1.0,1.0,1/5,2.29%,PTPRC
prerank,GO_Biological_Process_2021__negative regulation of delayed rectifier potassium channel activity (GO:1902260),-0.8797157060709456,-1.435270291023086,0.03389830508474576,1.0,1.0,1/7,0.68%,KCNE2
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.8797157060709456,-1.435270291023086,0.03389830508474576,1.0,1.0,1/7,0.68%,KCNE2
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),-0.8833743310518767,-1.4349815526885386,0.03225806451612903,1.0,1.0,2/8,3.38%,BTN2A2;PDCD1LG2
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.8209206560575699,1.4349073838720503,0.061224489795918366,0.9068208319084903,1.0,2/14,1.34%,PID1;IRS1
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.6398503365948133,1.4349007149942867,0.07142857142857142,0.9021656795740466,1.0,3/18,4.30%,IFI16;BATF3;CSF1R
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),-0.8605481152366488,-1.433688289650143,0.058823529411764705,1.0,1.0,1/6,8.35%,RNF213
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),0.9139644853394286,1.4330356193440752,0.0,0.9099826604241009,1.0,2/6,3.12%,KIT;S100A13
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.6103430150300538,-1.4329696331864004,0.0,1.0,1.0,42/97,24.44%,CHMP4B;SRP68;RPL36;RPL15;RPL38;RPS21;SEC62;RPS7;RPL37A;RPL9;SRP9;RPL28;RPLP2;SRP14;RPL5;MAN1A1;RPL35A;RPS20;RPLP1;RPL8;RPL4;RPL22;SGTB;RPL27A;RPL24;RPS15;RPL34;RPL3;RPS24;RPS4X;RPS3;RPS29;RPL13A;RPS8;RPS27A;RPL27;RPL37;RPL7A;RPL35;RPL23;RPL32;RPS13
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),0.7025900395905824,1.432011894006154,0.037037037037037035,0.9137558402446497,1.0,3/26,1.40%,ACE2;PER2;F2RL1
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.7173312104264785,-1.4313853590985692,0.016129032258064516,1.0,1.0,9/41,8.47%,CD44;ADAMTS4;MMP15;ELANE;KIF9;CAPN1;TIMP2;BMP1;MMP19
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),-0.796684170795803,-1.4311525863843548,0.16,1.0,1.0,2/11,4.51%,LRPAP1;RIN3
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),0.7658201581526468,1.4302959748944193,0.0975609756097561,0.9212327243077465,1.0,2/10,2.67%,RUNX1;MELTF
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),0.952360573946354,1.4302527356206707,0.022727272727272728,0.9169979710503972,1.0,1/6,0.58%,UBASH3B
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.7880152950687831,-1.4299964807309349,0.046875,1.0,1.0,1/14,0.02%,CD44
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),0.7858437976274786,1.4289040036484588,0.0975609756097561,0.9208765310790576,1.0,4/9,13.79%,MTHFS;MTHFD2L;MTHFD2;MTHFD1L
prerank,GO_Biological_Process_2021__hepoxilin metabolic process (GO:0051121),-0.87958891493064,-1.4288897907049523,0.017241379310344827,1.0,1.0,3/6,10.35%,ALOX12;ALOXE3;GSTP1
prerank,GO_Biological_Process_2021__hepoxilin biosynthetic process (GO:0051122),-0.87958891493064,-1.4288897907049523,0.017241379310344827,1.0,1.0,3/6,10.35%,ALOX12;ALOXE3;GSTP1
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),0.9179670050282642,1.428382622472263,0.0,0.9143063897190077,1.0,2/5,3.12%,KIT;S100A13
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),0.9179670050282642,1.428382622472263,0.0,0.9143063897190077,1.0,2/5,3.12%,KIT;S100A13
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),-0.8421352256163954,-1.4280408198151264,0.017857142857142856,1.0,1.0,2/9,5.69%,F11R;KCNQ1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.7591851059535814,-1.427269494400516,0.05172413793103448,1.0,1.0,4/15,5.69%,KCNE2;SCN4B;CAV3;KCNQ1
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),0.6942907738912423,1.4270009944147353,0.075,0.9180099134169419,1.0,5/18,11.17%,EGFR;FOS;MT1E;AKR1C3;MAPK8
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),-0.7357042220730599,-1.426984635847263,0.029411764705882353,1.0,1.0,5/20,9.94%,RAB6C;ATF5;CHMP4B;CHMP2B;CHMP2A
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),0.8416574988463916,1.42602605150456,0.09523809523809523,0.9156300365727816,1.0,2/9,3.92%,MYLIP;VLDLR
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),0.8416574988463916,1.42602605150456,0.09523809523809523,0.9156300365727816,1.0,2/9,3.92%,MYLIP;VLDLR
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),-0.947274390141458,-1.42601956485413,0.04838709677419355,1.0,1.0,1/5,0.50%,CD4
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),-0.947274390141458,-1.42601956485413,0.04838709677419355,1.0,1.0,1/5,0.50%,CD4
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),0.7083931904196008,1.4258328875027582,0.11627906976744186,0.9125960286339618,1.0,3/13,3.56%,ALK;CIDEA;SLC22A13
prerank,GO_Biological_Process_2021__endoderm development (GO:0007492),0.8509182236956553,1.4239907005156136,0.02564102564102564,0.9206430598871439,1.0,3/7,8.33%,DUSP5;DUSP2;DUSP4
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.6795937486635654,1.422976345961669,0.047619047619047616,0.9225725569278285,1.0,6/26,9.82%,RUNX1;NFIB;SULF2;FGFR3;SOX5;EIF2AK3
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.6233706394462444,-1.422717124263413,0.056338028169014086,1.0,1.0,7/67,5.36%,CD44;TUBB1;NR1I3;GYPB;UROD;GMFG;CD300LF
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),0.6459676317301737,1.4226454069961965,0.11764705882352941,0.9198653325906497,1.0,3/35,2.36%,ALK;CIDEA;EGFR
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.7774913611359905,1.4225815128022739,0.09302325581395349,0.9157363112664275,1.0,1/12,0.10%,NRG1
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.640984835343838,1.4225099322254748,0.08571428571428572,0.9118349476043895,1.0,11/45,11.11%,GPC4;MDGA1;IL1RAPL1;LHFPL4;CLSTN2;EPHB2;NRXN1;NLGN1;ROBO2;LRFN4;GRID2
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.6338261823288655,1.4221240563810225,0.06666666666666667,0.9092803111429539,1.0,14/33,18.94%,GRIK4;BTBD9;GRIK1;LRRC4C;NLGN1;PXK;CEL;GRID2;NGF;GRIK2;NRG3;NLGN4Y;CACNA1A;CACNA1B
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),-0.8417814697891951,-1.4214173435983828,0.03508771929824561,1.0,1.0,3/7,12.33%,CAV3;NOTCH1;MLIP
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.661591623927889,1.4213527818645617,0.05,0.909914817735729,1.0,2/14,7.11%,NXF5;IWS1
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),0.8639283663237254,1.4205292590500551,0.02631578947368421,0.9103580268675018,1.0,2/9,0.60%,CLEC2A;KLRD1
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),0.7130743251370097,1.4200311437148772,0.06666666666666667,0.9088300232798695,1.0,5/14,9.70%,DSCAML1;GREM1;ACVR1;PTCH1;FBXL15
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.6158825599423693,-1.4196947085478429,0.04054054054054054,1.0,1.0,8/59,10.86%,PRLR;CYP19A1;LIPH;LIPI;ACSL5;ACSM4;LIPC;ACSM6
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.6075175397167453,-1.4193671887292456,0.029850746268656716,1.0,1.0,7/63,9.58%,CD44;CDKN2D;NODAL;CARD8;BCAP31;REST;GPER1
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),0.8622326036659484,1.4190273181517368,0.025,0.911231960366772,1.0,2/8,5.46%,RAB7B;RAB7A
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),-0.6801981743545258,-1.4184685139905089,0.058823529411764705,1.0,1.0,4/30,10.94%,ROPN1B;ODAD4;ATP6V1D;FSIP2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.7385711016482381,-1.4184068660781655,0.0625,1.0,1.0,4/18,5.69%,KCNE2;SCN4B;CAV3;KCNQ1
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),0.701532837211398,1.4180997939838866,0.1,0.9128807064325637,1.0,2/16,5.93%,UBASH3B;LRRC17
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.7026865332472945,1.4177956934348679,0.05128205128205128,0.910877394294398,1.0,2/15,2.92%,NFATC1;HRH1
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.5488269102051213,1.4174439897712285,0.15,0.9091339569666841,1.0,37/109,15.95%,PTPRT;LRRTM3;KCNIP1;ZNF536;MAPK4;OLFM3;ADGRA1;RGS7BP;GRIA2;HS6ST3;GRM5;SPHKAP;KCTD16;NTSR2;UBE2QL1;BRINP1;TMEM196;CADM2;PAK5;RBFOX1;PARM1;MMD2;KCNC2;SLC6A1;SYN2;ADGRB3;SEMA3C;ST8SIA3;ELAVL3;PPFIA2;SPTBN4;NXPH1;BRINP2;GABBR2;MAP6;PVALB;KCNC1
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),0.6792455929149621,1.417441894654243,0.0967741935483871,0.9049443995613076,1.0,3/24,5.65%,PLEKHH2;FGF13;NAV3
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),-0.8546648840026668,-1.4166088236212584,0.06666666666666667,1.0,1.0,2/7,9.11%,ALDH1A1;GNPDA1
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),0.788304702423954,1.4160906185403404,0.08888888888888889,0.9091621854227009,1.0,4/8,16.70%,SLC16A2;SLCO1C1;SLC22A9;SLC16A10
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.5281199911650586,1.415847623586467,0.0,0.9072124430085649,1.0,42/150,14.40%,RIMBP2;FILIP1;TOX;KCNIP1;ZNF536;LIX1;MAPK4;CACNA2D1;FSTL5;OLFM3;ADGRA1;RGS7BP;GUCY1A2;GRIA2;KCTD16;LSAMP;TSHZ1;SHC3;BRINP1;LRRC4C;EFNA5;TMEM196;NRXN1;TAFA1;CADM2;IGF2BP3;RGMB;NOVA1;CSRNP3;CNTN1;PAK5;RBFOX1;PCDH17;ADGRB3;ST8SIA3;GCNT2;ELAVL3;PPFIA2;HIVEP3;KALRN;DCLK2;ZDHHC2
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),-0.9270660792491855,-1.4158169421790456,0.0196078431372549,1.0,1.0,1/5,0.77%,MYLK
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),-0.8402253738615117,-1.4155442782248302,0.03125,1.0,1.0,2/9,5.56%,TICRR;CDC6
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.573987513588224,1.4143288427011298,0.0967741935483871,0.9134547825707137,1.0,12/63,8.48%,ROR2;KIT;PDGFD;UNC5B;F2RL1;KDR;TGFB2;PDGFC;PDGFRA;IGF1;PTPN6;IRS2
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.617215705174094,-1.4134160532177438,0.028169014084507043,1.0,1.0,8/71,7.33%,CD44;ENPP2;PTPRC;ITGA5;AGT;CD74;TGFB1;IL15
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.6593731536914237,-1.4127632249153868,0.03278688524590164,1.0,1.0,11/27,23.73%,B2M;TAPBPL;BCAP31;ERAP2;HLA-A;ERAP1;CALR;HLA-C;SEC23A;CANX;HLA-F
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.821302848540024,-1.4114259560464888,0.07142857142857142,1.0,1.0,1/7,4.61%,MEOX1
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication initiation (GO:0030174),-0.9681710766438298,-1.4105128880900775,0.017543859649122806,1.0,1.0,1/5,0.26%,TICRR
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.7260710261222367,-1.4103571653954003,0.04918032786885246,1.0,1.0,8/26,19.47%,CENPK;CENPO;CENPU;ITGB3BP;OIP5;CENPL;KNL1;CENPI
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.7260710261222367,-1.4103571653954003,0.04918032786885246,1.0,1.0,8/26,19.47%,CENPK;CENPO;CENPU;ITGB3BP;OIP5;CENPL;KNL1;CENPI
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.69108255243949,1.410050669990335,0.12195121951219512,0.9377433280846249,1.0,10/15,21.23%,IRS1;PRKCD;IRS2;PLIN5;PNPLA2;ABCD2;AKT2;PPARA;ABCD1;APOA1
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.5191151773547892,1.40881679639181,0.043478260869565216,0.9416199732281825,1.0,25/124,13.24%,RUNX1;EPHA3;ALK;TRPS1;TGFBR1;KLK6;CBFB;HEY1;MDK;GREM1;PRKCB;NLGN1;BIN1;LTK;MOSMO;ANP32B;CDK5RAP2;NGF;SMOC1;FGFR1;BCL6;PDCD2;ZFHX3;MEGF10;ID2
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.7399341377793462,1.407818394265816,0.0975609756097561,0.9433580968321943,1.0,3/12,16.12%,VCAN;CHST12;B3GAT3
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.8111620901957933,1.4073196968141621,0.043478260869565216,0.9375790082660834,1.0,2/8,7.13%,LMCD1;IGF1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.8111620901957933,1.4073196968141621,0.043478260869565216,0.9375790082660834,1.0,2/8,7.13%,LMCD1;IGF1
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.6362881972221135,1.4063035765843008,0.05714285714285714,0.939830896681635,1.0,5/16,10.54%,CNTN4;NRXN1;NCAM2;NLGN1;CEL
prerank,GO_Biological_Process_2021__neurotransmitter reuptake (GO:0098810),0.8410995925273679,1.4061263811301175,0.11764705882352941,0.9370110531940171,1.0,3/8,7.35%,SLC22A2;SLC22A3;SLC6A4
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),0.6055735613232048,1.4059149450181412,0.15789473684210525,0.9340444769690718,1.0,6/25,6.69%,F11;IFI16;KLKB1;PRSS12;GRIN2A;HGFAC
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),0.9014685952751682,1.4058136435170312,0.07692307692307693,0.9306485578746385,1.0,2/5,3.45%,FRMPD4;CTNNA2
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.8832062437758678,-1.4057465486712262,0.01694915254237288,1.0,1.0,2/7,5.92%,STAT1;IFIT1
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),0.8821073374140382,1.4044306622501157,0.06976744186046512,0.9350444596691093,1.0,4/7,7.00%,MDGA1;SOX13;MDGA2;ZC4H2
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),-0.7710003285585009,-1.4039495107820152,0.017543859649122806,1.0,1.0,4/14,8.66%,KCNE2;ATP1B1;KCNQ1;ATP1A1
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.7956746174978209,-1.40375763471618,0.01639344262295082,1.0,1.0,5/15,10.32%,TGFB1;IL15;ZBTB7B;NCKAP1L;IL18
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.7234471276859813,-1.4036670269612952,0.03389830508474576,1.0,1.0,8/28,19.47%,CENPK;CENPO;CENPU;ITGB3BP;OIP5;CENPL;KNL1;CENPI
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.687934360397694,1.4035527465514022,0.11428571428571428,0.9370329228540891,1.0,2/18,3.28%,RUNX1;CBFB
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),0.8974179235799962,1.4031449094502737,0.08571428571428572,0.9357463481912299,1.0,1/6,1.16%,PKD1L1
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),-0.7754606351404236,-1.4031113890997453,0.05357142857142857,1.0,1.0,4/12,8.66%,KCNE2;ATP1B1;KCNQ1;ATP1A1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.6972801764918339,1.4030938699533864,0.08571428571428572,0.932177705793682,1.0,4/22,5.07%,NRG1;PKP2;TGFBR1;TGFB2
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.6696104510482394,1.4030707005690772,0.06666666666666667,0.9285281835559824,1.0,2/16,4.20%,PID1;LEPR
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.5314052152996938,1.4029166979348233,0.034482758620689655,0.9252978959154853,1.0,28/109,10.86%,FBXL7;PDGFD;DOK5;SEMA6D;KCNIP1;EFS;ZNF536;NTM;MAPK4;CACNA2D1;SLC35F1;ADGRA1;PDZRN3;RGS7BP;GUCY1A2;GRIA2;SHC3;BRINP1;LRRC4C;PCDH19;NLGN1;RCAN2;NOVA1;CSRNP3;SLC6A1;PCDH17;ADGRB3;MARK1
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.6403170671453207,-1.402650877572754,0.08620689655172414,1.0,1.0,14/42,14.94%,GNLY;CD4;PTPRC;ARHGAP9;CD37;GMFG;MYO1F;NCKAP1L;CD6;TAGAP;GBP5;GPR183;CD5;SLA
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),0.5515904355998141,1.4024540075233953,0.06666666666666667,0.9244693823181231,1.0,8/62,6.29%,FRMPD1;EGFR;NECTIN3;PARD3;ZDHHC14;ZDHHC11B;RAB3IP;REEP1
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),0.6813571716796715,1.402344165063467,0.11363636363636363,0.9211735090621332,1.0,3/20,9.88%,RAB32;BLOC1S4;KIF13A
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),-0.7133186749657827,-1.402137433091107,0.09615384615384616,1.0,1.0,6/19,13.97%,CSRP3;MYPN;TTN;SIX4;CASQ1;TPM1
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.529340464624994,1.4019222540868694,0.034482758620689655,0.9199312506937019,1.0,28/61,15.86%,ALK;BMP7;HEY1;VWC2;CNTN4;BRINP1;ZC4H2;NLGN1;ZEB1;KCTD11;BIN1;MMD2;LTK;MOSMO;CDK5RAP2;TCF4;DTX1;NGF;FGFR1;DISP3;ZFHX3;ID2;BRINP2;NRCAM;TIAM1;SIN3A;MEF2C;BEND6
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),0.8876798134454542,1.4016795976754737,0.09090909090909091,0.917281725968193,1.0,3/6,8.22%,C5AR1;ZBTB1;TFCP2
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),-0.8666275077465866,-1.4015071249106197,0.1,1.0,1.0,1/7,0.39%,C4BPB
prerank,"GO_Biological_Process_2021__negative regulation of complement activation, classical pathway (GO:0045959)",-0.8666275077465866,-1.4015071249106197,0.1,1.0,1.0,1/7,0.39%,C4BPB
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",-0.8666275077465866,-1.4015071249106197,0.1,1.0,1.0,1/7,0.39%,C4BPB
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.8226632603665747,1.4011549029838661,0.1111111111111111,0.9132382449389601,1.0,3/8,14.75%,HOMER2;FHL2;CHP1
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.8226632603665747,1.4011549029838661,0.1111111111111111,0.9132382449389601,1.0,3/8,14.75%,HOMER2;FHL2;CHP1
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.849653809807946,1.4007355339719607,0.10256410256410256,0.9123724072307303,1.0,3/6,13.69%,RORA;NLGN1;BTRC
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),0.8131733982871843,1.4002123534021913,0.04878048780487805,0.9123181145054072,1.0,2/7,10.24%,CDK2AP2;PRDM15
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),-0.876506865224425,-1.399644771805982,0.017543859649122806,1.0,1.0,2/7,4.27%,HCK;KIF9
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),-0.828584205340861,-1.399521021531863,0.07692307692307693,1.0,1.0,3/6,16.58%,DRD3;NOTCH1;DAAM2
prerank,GO_Biological_Process_2021__medium-chain fatty acid catabolic process (GO:0051793),0.9629101977337233,1.3981045900352864,0.020833333333333332,0.9201152618975552,1.0,2/5,3.11%,GLYATL2;ABHD1
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.7239498364689376,1.3978557562284688,0.06818181818181818,0.9179022033884399,1.0,1/9,0.71%,RFWD3
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.7078439139499784,1.397809400994933,0.07142857142857142,0.9145946849582535,1.0,3/17,8.17%,NRG1;ACVR1;MYH11
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.5936629828228882,1.3974188928021496,0.11764705882352941,0.9129494909467526,1.0,11/30,17.09%,INSYN2A;GABRG3;GRIN2A;GABRA3;GRID2;DRD4;GRIN2C;GRIN2B;MEF2C;GABRA5;GRIN1
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),0.8646095769621254,1.3962957871233257,0.09523809523809523,0.9161518618061898,1.0,3/7,5.75%,LEPR;MDK;GREM1
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),0.8242151020291926,1.396214093227703,0.10256410256410256,0.9129958938348927,1.0,2/7,8.31%,PNP;HPRT1
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.6685334265188992,1.3960537738045768,0.075,0.9101779316160535,1.0,9/18,16.12%,HS3ST5;HS3ST3B1;EXT1;HS6ST3;EXT2;HS6ST2;HS2ST1;NDST1;B3GAT3
prerank,GO_Biological_Process_2021__vascular wound healing (GO:0061042),0.8956986273733744,1.3958864601666177,0.06521739130434782,0.9082131218416881,1.0,1/5,1.79%,KDR
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.6039921278427025,1.395857409315815,0.08823529411764706,0.9048159520517658,1.0,8/33,4.59%,CDH13;F2RL1;HSPB1;KDR;NRP1;SEMA5A;DSCAM;MDK
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.804917636397702,1.3957356171783288,0.024390243902439025,0.9018061950106464,1.0,2/11,1.98%,KDR;NRP1
prerank,GO_Biological_Process_2021__purine nucleobase transport (GO:0006863),-0.9052507320490069,-1.3955731883426088,0.04838709677419355,1.0,1.0,1/6,0.05%,SLC28A2
prerank,MSigDB_Hallmark_2020__Apical Surface,0.5896218517089589,1.3945265607120045,0.058823529411764705,0.9050280960058111,1.0,7/34,7.33%,MDGA1;NTNG1;HSPB1;SULF2;CROCC;EFNA5;PKHD1
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),-0.9209769892991412,-1.3938885533579906,0.05555555555555555,1.0,1.0,1/5,0.77%,MYLK
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.8131554894703107,1.393624549703529,0.0851063829787234,0.9068449124450384,1.0,3/8,9.21%,HSPB1;KDR;PRKD1
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.7616712925859915,1.3924162230637827,0.13333333333333333,0.9093092951153624,1.0,8/14,17.80%,PER2;HDAC9;HDAC1;SIRT2;SIRT1;SMARCAD1;HDAC3;SIRT7
prerank,GO_Biological_Process_2021__heparin metabolic process (GO:0030202),0.8005537122486566,1.3920889621367547,0.09090909090909091,0.9080529214623434,1.0,2/5,9.03%,SLC10A7;ANGPT1
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.6950637159752149,-1.3920651921612233,0.05084745762711865,1.0,1.0,7/33,12.43%,ARIH2;ATP5IF1;LMAN1;PINK1;UBL5;TOMM7;BAG4
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.5782419230921109,1.391414681966549,0.06060606060606061,0.9089782177558549,1.0,7/37,5.81%,KCNJ16;AMIGO1;KCNJ6;KCNJ3;KCNN2;KCNJ2;KCNN3
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.8129766574555731,1.3908139801819657,0.08333333333333333,0.9088397540100276,1.0,5/14,5.07%,NRG1;TGFBR1;BMP7;HEY1;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),0.7915464528512477,1.3902065164954898,0.12195121951219512,0.9082011406124249,1.0,2/7,11.79%,MELTF;PDPN
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.780125728404797,1.3897095993154627,0.15384615384615385,0.9078170680013042,1.0,2/7,6.73%,NRP1;APOE
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),-0.8070522357481915,-1.3891205158596478,0.11666666666666667,1.0,1.0,3/10,9.11%,ACOT4;IL4I1;GNPDA1
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.5568514858993201,-1.3890829652385537,0.014285714285714285,1.0,1.0,30/97,15.47%,C3AR1;MS4A6A;HCK;SIGLEC1;PTPRC;SLC7A7;SLCO2B1;CD74;AHR;FGL2;CD300LF;MYO1F;AQP9;FMNL1;CD14;SCIMP;TAGAP;IGSF6;CCL5;CPM;SPI1;WDFY4;CD83;GPR132;TLR2;NCEH1;F13A1;SLA;STAB1;ADGRE1
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),-0.7422984768423706,-1.3889636752735057,0.14925373134328357,1.0,1.0,6/16,16.47%,ALOX12;ALOXE3;CLDN1;TMEM79;STMN1;HRNR
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),-0.7422984768423706,-1.3889636752735057,0.14925373134328357,1.0,1.0,6/16,16.47%,ALOX12;ALOXE3;CLDN1;TMEM79;STMN1;HRNR
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.7384843607302451,1.3886701299207873,0.11363636363636363,0.9106689537314743,1.0,6/10,22.93%,MDK;FUT9;NFAT5;ITGB2;RELA;TRAF6
prerank,GO_Biological_Process_2021__megakaryocyte development (GO:0035855),0.9444785748058888,1.387965167861056,0.0,0.9114676124541594,1.0,1/5,0.42%,KIT
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.7838231188006701,1.387640656367617,0.125,0.9099895659971851,1.0,3/9,12.78%,ZNHIT6;NAF1;RUVBL2
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.7148048240201149,1.387484857693661,0.0625,0.9075883346447493,1.0,5/20,9.35%,SLC22A2;SLC16A2;SLC7A2;SLC7A1;SLC6A13
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),-0.8721821869349907,-1.3873292145968803,0.03508771929824561,1.0,1.0,2/7,3.46%,CD4;CD74
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.7017962249656471,1.3867428184695259,0.13043478260869565,0.9080466307999586,1.0,4/15,10.43%,RUNX1;TGFBR1;ERBB4;RBP4
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.667472948054199,1.386138471292031,0.09090909090909091,0.9077693825816089,1.0,5/18,8.02%,RUNX1;CBFB;CD22;PRKCB;ELF2
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.7010807917184769,1.386035094963227,0.1282051282051282,0.9016015024298641,1.0,2/13,5.24%,RUNX1;TGFB3
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.7010807917184769,1.386035094963227,0.1282051282051282,0.9016015024298641,1.0,2/13,5.24%,RUNX1;TGFB3
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198),0.894941515840999,1.3860268150187658,0.06060606060606061,0.8983105027308473,1.0,2/5,6.17%,HTR1F;HTR1E
prerank,GO_Biological_Process_2021__L-arginine import across plasma membrane (GO:0097638),0.8772980661113263,1.3857601357362352,0.02857142857142857,0.8973038810136688,1.0,3/5,7.55%,SLC22A2;SLC7A2;SLC7A1
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),-0.8103434315314823,-1.3848484276028439,0.03333333333333333,1.0,1.0,2/10,5.69%,KCNE2;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),0.841431913561042,1.3842872175319323,0.11904761904761904,0.9018622480909447,1.0,2/7,3.20%,STAC;CACNA2D1
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.6075133625216259,1.3841272845763934,0.030303030303030304,0.8994179486712556,1.0,5/31,9.08%,LRRTM3;APOE;IGF1;SLC2A13;BIN1
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.5166515657363205,1.3840170945057755,0.058823529411764705,0.8967061277065571,1.0,29/118,14.44%,LRRTM3;KCNIP1;VCAN;TNR;ZNF536;LHFPL3;NTM;MAPK4;SLC35F1;ADGRA1;GRIA2;PDGFRA;SLCO1C1;SHC3;BRINP1;LRRC4C;ETV5;MMD2;SLC6A1;ADGRB3;ST8SIA3;PMP2;ELAVL3;MEGF10;FYN;NXPH1;NYAP1;EPN2;BRINP2
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),0.6945263002883296,1.3839373018246128,0.12195121951219512,0.894108804230295,1.0,1/13,0.42%,KIT
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),0.737931792705,1.3837859665111718,0.08333333333333333,0.8918135972363681,1.0,2/10,8.83%,DGKB;DGKH
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),0.7319149658069032,1.3836958248664653,0.1,0.889299734991579,1.0,7/9,19.36%,IRS1;IRS2;PLIN5;ABCD2;AKT2;PPARA;ABCD1
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),0.782441681056627,1.3831975925983921,0.10416666666666667,0.8889602633024534,1.0,2/7,10.87%,LRRC55;NOS1AP
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.7121065550524606,1.3830945941331694,0.12195121951219512,0.886287815837744,1.0,4/15,7.72%,CACNG3;CACNG4;NRXN1;NLGN1
prerank,GO_Biological_Process_2021__response to vitamin (GO:0033273),-0.9137118337617883,-1.3826456196339185,0.03389830508474576,1.0,1.0,2/5,2.87%,ALPL;CDKN2D
prerank,GO_Biological_Process_2021__immunoglobulin mediated immune response (GO:0016064),-0.8845714510105882,-1.3826192508083985,0.10714285714285714,1.0,1.0,2/5,7.28%,CD74;CD27
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),0.9161628656227607,1.38257438278166,0.11627906976744186,0.8862873153929016,1.0,2/5,2.14%,F2RL1;TLR1
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.6436415443036895,-1.3820261368768834,0.07462686567164178,1.0,1.0,10/41,7.53%,TMEM184A;FUT2;SMIM22;LIPH;GGH;B3GNT3;TMC4;KLF5;CBLC;GPX2
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.5723552219504116,1.381568208398502,0.05,0.889208490299287,1.0,8/45,7.72%,ACE2;KDR;NRP1;IL1RAPL1;CLSTN2;EPHB2;NRXN1;NLGN1
prerank,GO_Biological_Process_2021__regulation of inflammatory response to wounding (GO:0106014),0.8528899157455188,1.381274663967437,0.20454545454545456,0.8879961428698693,1.0,2/5,4.59%,SIGLEC10;MDK
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.7642576805943669,1.3806541573845421,0.09375,0.889002667215131,1.0,5/6,23.29%,SLC30A10;PRKCD;NFKB1;RELA;ROCK2
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),-0.8757808834995926,-1.3805557636823065,0.08196721311475409,1.0,1.0,1/6,0.62%,MCM2
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),-0.8757808834995926,-1.3805557636823065,0.08196721311475409,1.0,1.0,1/6,0.62%,MCM2
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),0.8486369955931304,1.379456676123121,0.06666666666666667,0.894544803310908,1.0,2/7,11.72%,ARL13B;BBIP1
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.6663785166010108,1.3776597099275298,0.125,0.9018770414264091,1.0,5/18,14.80%,IRS1;IGF1;IRS2;PIK3R1;AKT2
prerank,PanglaoDB_Augmented_2021__Microglia,-0.5914989474679284,-1.377633314223241,0.030303030303030304,1.0,1.0,19/79,11.70%,C3AR1;MS4A6A;HCK;CD4;SIGLEC1;PTPRC;SLCO2B1;P2RY12;IL21R;FGL2;CD300LF;MYO1F;AQP9;CD14;TAGAP;IGSF6;SPI1;WDFY4;MAFB
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),-0.689473514061258,-1.3775940439427938,0.1206896551724138,1.0,1.0,6/18,22.95%,GADD45B;AGER;SPI1;GADD45A;RELL2;PJA2
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.8227433074978363,1.3770404042219369,0.06666666666666667,0.9030522981034341,1.0,3/6,12.78%,MACROH2A2;LRWD1;RUVBL2
prerank,GO_Biological_Process_2021__serotonin uptake (GO:0051610),0.8835562800381611,1.3769281904107393,0.05,0.8974145813517939,1.0,3/5,7.35%,SLC22A2;SLC22A3;SLC6A4
prerank,GO_Biological_Process_2021__serotonin transport (GO:0006837),0.8835562800381611,1.3769281904107393,0.05,0.8974145813517939,1.0,3/5,7.35%,SLC22A2;SLC22A3;SLC6A4
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.8116670101719429,1.3762593541502846,0.024390243902439025,0.8984127112304184,1.0,1/6,0.71%,RFWD3
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.7532123443786105,1.3758258253181335,0.1590909090909091,0.8973368786616566,1.0,3/8,13.88%,LEPR;SGIP1;CFAP20
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.5477746606302397,1.3743258761374733,0.037037037037037035,0.9024035843451168,1.0,17/72,14.87%,NTNG1;VASH2;CTNNA2;SEMA5A;AMIGO1;PARD3;EPHB2;DSCAML1;CNTN4;RYK;MTR;SLITRK5;SVBP;DHFR;SPTBN4;PAK3;NRCAM
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.6105698800336239,1.3740880689259258,0.07317073170731707,0.9006073937383332,1.0,5/27,10.50%,ARL13B;PCM1;RPGRIP1L;TOGARAM1;PIBF1
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),-0.6535067346072957,-1.3737819095171289,0.078125,1.0,1.0,7/22,24.33%,NCAPH2;NCAPG;TTN;SMC2;SET;NCAPG2;NCAPD3
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),0.8702294767450054,1.3736012839548126,0.09090909090909091,0.9004246140334103,1.0,2/5,7.72%,NRXN1;NLGN1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),0.6384775962099841,1.3729665387658485,0.07692307692307693,0.90068632887394,1.0,8/17,20.87%,IFI16;EPHA7;NGF;FYN;GRIN2B;GRIN1;AIM2;PCID2
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.7617311182917905,1.3729289459514902,0.09090909090909091,0.8977656794577096,1.0,4/8,7.04%,RUNX1;SH3RF1;CBFB;HMGB1
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),0.7512874562496685,1.3727825698180678,0.10810810810810811,0.8955251484680409,1.0,2/11,7.04%,XRCC4;HMGB1
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",0.8650492149093216,1.3726106006463599,0.07692307692307693,0.8845839012384417,1.0,1/6,0.51%,ELOVL6
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",0.8650492149093216,1.3726106006463599,0.07692307692307693,0.8845839012384417,1.0,1/6,0.51%,ELOVL6
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",0.8650492149093216,1.3726106006463599,0.07692307692307693,0.8845839012384417,1.0,1/6,0.51%,ELOVL6
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",0.8650492149093216,1.3726106006463599,0.07692307692307693,0.8845839012384417,1.0,1/6,0.51%,ELOVL6
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),0.8311434207740112,1.3722047160435007,0.075,0.8839829763823253,1.0,3/7,1.79%,CDH13;F2RL1;KDR
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),-0.8945165706194692,-1.3716547920346722,0.03636363636363636,1.0,1.0,2/6,7.28%,CD74;CD27
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.8010763442575646,-1.3712282883398936,0.03225806451612903,1.0,1.0,1/12,1.08%,TERF2IP
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.5797038977326782,-1.3701118886186578,0.045454545454545456,1.0,1.0,19/51,16.85%,SIGLEC1;CLIC6;STEAP4;SLCO2B1;IFI27;CRLF1;ALDH1A1;CD14;ADGRF5;AGER;CTSH;DUOXA1;NRN1;TNFAIP2;TFCP2L1;WFDC2;C1QA;SFTPD;CXCL17
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.7820828002010942,1.3700399205105107,0.1951219512195122,0.8925771812507642,1.0,3/8,13.57%,LEPR;GCK;SIRT1
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),0.7793747807031591,1.3700007485879446,0.1,0.8898034160808981,1.0,2/6,9.82%,SULF2;EIF2AK3
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),-0.8430717055612633,-1.3698538226738073,0.0847457627118644,1.0,1.0,1/8,0.09%,ENPP2
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.7258066491240016,1.369853131944215,0.05,0.8874337028307607,1.0,8/12,19.36%,IRS1;IRS2;PLIN5;ABCD2;MLYCD;AKT2;PPARA;ABCD1
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.6985891001373666,-1.3693954922393436,0.06451612903225806,1.0,1.0,8/32,19.47%,CENPK;CENPO;CENPU;ITGB3BP;OIP5;CENPL;KNL1;CENPI
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.6859138566413426,1.3686300359876908,0.1282051282051282,0.891873042807038,1.0,5/14,12.15%,HSPB1;KDR;SEMA5A;PRKD1;FGFR1
prerank,GO_Biological_Process_2021__response to alkaloid (GO:0043279),-0.871587105944452,-1.3679703880161778,0.10526315789473684,1.0,1.0,1/6,3.79%,DRD3
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.7732490381837707,-1.3676698520044472,0.14705882352941177,1.0,1.0,4/12,12.52%,TNFSF18;RAC1;NCKAP1L;RHOH
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),0.7855300516888315,1.3675846725028027,0.04878048780487805,0.8947076531209642,1.0,1/10,1.33%,NTNG1
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.6458051629498022,1.3672653146274816,0.15,0.8940006000233609,1.0,2/18,3.94%,IL1RAPL1;FBXW8
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),-0.7504009313437263,-1.3672637574711224,0.08620689655172414,1.0,1.0,4/10,21.79%,WNT8A;RIPPLY2;SHH;MESP1
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),-0.8257889173506137,-1.3672273671699748,0.07462686567164178,1.0,1.0,2/9,10.32%,CD74;IL18
prerank,GO_Biological_Process_2021__intestinal epithelial cell differentiation (GO:0060575),-0.9066163337760602,-1.3663610603399197,0.0392156862745098,1.0,1.0,1/5,0.11%,NPY
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5730962658873457,1.3659968984803412,0.08,0.8979522752136816,1.0,6/33,6.65%,ACE2;PID1;F2RL1;RAB27A;AKR1C3;PRKCD
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),0.8503462426594727,1.3658333683384611,0.10256410256410256,0.8958475755858415,1.0,1/5,3.71%,DSCAM
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.827541553549446,1.3652518674967482,0.07317073170731707,0.896699070338415,1.0,3/6,12.15%,FGFR3;PLIN5;FGFR1
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.6734982649716915,1.3650382714289855,0.14634146341463414,0.8946957397508374,1.0,5/20,9.59%,DUSP5;DUSP2;DUSP8;DUSP4;DUSP10
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.8374009148469943,1.3646844727740666,0.0975609756097561,0.8933317694728911,1.0,2/6,2.14%,F2RL1;TLR1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),0.7531111207317398,1.3641889132558163,0.14583333333333334,0.893350451599103,1.0,3/10,3.28%,RUNX1;PNP;CBFB
prerank,GO_Biological_Process_2021__regulation of keratinocyte apoptotic process (GO:1902172),-0.9073333843852038,-1.364101471077694,0.04838709677419355,1.0,1.0,1/5,2.85%,SFRP4
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),0.8988162974440947,1.3639140776713312,0.08108108108108109,0.8922069626816159,1.0,1/5,5.96%,DDAH1
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),-0.8489687772961582,-1.3637797105210194,0.08928571428571429,1.0,1.0,1/7,0.09%,ENPP2
prerank,GO_Biological_Process_2021__skeletal muscle thin filament assembly (GO:0030240),-0.8513385013747983,-1.3633071815638549,0.10344827586206896,1.0,1.0,2/5,8.59%,ACTC1;TTN
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.7821911463723367,-1.3632501023923107,0.06451612903225806,1.0,1.0,2/13,6.88%,WFS1;HSPA5
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.6430424047016633,1.3629321555440645,0.08108108108108109,0.8949181539593668,1.0,6/23,14.80%,IRS1;IGF1;IRS2;PIK3R1;BRAF;AKT2
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.6330890296944598,-1.3624943680936978,0.12121212121212122,1.0,1.0,8/32,12.88%,TERF2IP;H1-2;H1-0;PPP4C;RAD51AP1;FIGNL1;MRE11;ALYREF
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.7111188138438929,1.3623928632001838,0.08108108108108109,0.894478007441548,1.0,8/14,19.36%,TYSND1;IRS1;IRS2;PLIN5;ABCD2;AKT2;PPARA;ABCD1
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.6304934555518531,1.3615425923256559,0.05714285714285714,0.896712729167362,1.0,8/24,11.60%,TEAD2;WWTR1;LATS1;WWC1;FAT4;DCHS1;AMOTL2;DVL2
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid transport (GO:0015812),0.8725119132369447,1.3612082773398315,0.17142857142857143,0.8956959900271947,1.0,3/5,10.08%,SLC6A11;SLC6A13;SLC6A1
prerank,GO_Biological_Process_2021__medium-chain fatty acid biosynthetic process (GO:0051792),0.8703879220290313,1.3605867366725037,0.08888888888888889,0.8960745716516708,1.0,1/5,3.11%,ABHD1
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.726644927439146,1.3594876370872129,0.1794871794871795,0.8993014460743458,1.0,2/10,12.39%,VCAN;CHST12
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),0.8064119235034178,1.3588229128008946,0.13953488372093023,0.9003565831615147,1.0,3/7,9.66%,MN1;GREM1;NELL1
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),0.7672782144006983,1.3585339650088033,0.05714285714285714,0.8993006872476553,1.0,4/8,21.06%,APOE;NRCAM;SIN3A;ABL1
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.5554811684110978,-1.358401576632185,0.0379746835443038,1.0,1.0,13/116,5.03%,CD44;OLFML1;CALB1;ALPL;LAMA2;HSPG2;SFRP4;TIMP3;ITGA5;LRP4;ANGPTL2;OSMR;COL6A1
prerank,GO_Biological_Process_2021__phospholipase C-activating dopamine receptor signaling pathway (GO:0060158),-0.8484475449663746,-1.3582078282491643,0.11320754716981132,1.0,1.0,1/6,3.79%,DRD3
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),0.7480552403327889,1.3573115195684724,0.14285714285714285,0.9030120937111202,1.0,2/8,8.75%,ACADVL;PLIN5
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),0.7541848198975997,1.3572987766507936,0.125,0.8974951933919605,1.0,3/10,5.23%,ALKBH3;ALKBH2;MGMT
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),0.7541848198975997,1.3572987766507936,0.125,0.8974951933919605,1.0,3/10,5.23%,ALKBH3;ALKBH2;MGMT
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.8351838429605452,-1.357056213727025,0.03333333333333333,1.0,1.0,1/7,0.02%,CD44
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),0.608744167645561,1.3569792668337892,0.07407407407407407,0.8967408498072186,1.0,7/30,16.82%,KIT;S100A13;BORCS6;PIP4P1;PLEKHM1;MAP6;BORCS5
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.7361693265989959,1.3566812603723737,0.21052631578947367,0.8960309718826136,1.0,2/9,11.56%,VCAN;ARSB
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),0.7987670188031535,1.3565159606522879,0.21428571428571427,0.894411622405743,1.0,1/5,1.56%,ALKBH3
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.7988623301637847,-1.356515497207768,0.078125,1.0,1.0,3/10,9.24%,PINK1;NONO;REST
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),0.7726722283920323,1.3562578343915086,0.15151515151515152,0.8930793847368387,1.0,4/8,13.10%,RAB7B;HMGB1;PTPRS;GRAMD4
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),-0.8310259482864116,-1.3561711204102815,0.1346153846153846,1.0,1.0,3/5,16.58%,DRD3;NOTCH1;DAAM2
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),0.5975784838023471,1.356154400653099,0.10810810810810811,0.8909259386368317,1.0,3/50,1.98%,EPHA3;KDR;NRP1
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),-0.7618318991783862,-1.3558633879820559,0.11475409836065574,1.0,1.0,2/10,5.73%,ALOX12;ALOXE3
prerank,GO_Biological_Process_2021__glandular epithelial cell development (GO:0002068),0.8809956560768092,1.3557964151461661,0.14,0.8902422070048818,1.0,1/5,3.13%,BMP6
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.6348957013288847,1.3553751567497971,0.0625,0.8899943635774874,1.0,3/21,3.71%,NRP1;SEMA5A;DSCAM
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),-0.736230863546226,-1.35503664314523,0.06666666666666667,1.0,1.0,5/15,10.22%,LIPH;LIPI;FABP3;LIPC;PNPLA1
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.6920991572698079,1.3549799716090165,0.10526315789473684,0.8902567492038287,1.0,4/18,8.26%,LMCD1;HOMER2;IGF1;FHL2
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),0.6826871481505492,1.3548413261125207,0.1111111111111111,0.8880595104467629,1.0,5/22,13.46%,PNP;ENPP3;FHIT;NMNAT3;AK5
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.7726907611844995,-1.3546416733706648,0.08928571428571429,1.0,1.0,4/13,8.35%,SFRP4;GPC3;RSPO3;RNF213
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.7698318683663274,-1.354589901388287,0.05263157894736842,1.0,1.0,5/14,11.45%,ELANE;CD6;SIGIRR;ITIH4;LBP
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.8864994303715266,-1.3545195051092296,0.07692307692307693,1.0,1.0,2/5,5.98%,ATP5IF1;PINK1
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.5610647769143524,1.3543270046799323,0.08571428571428572,0.8875481002760044,1.0,19/62,19.88%,LRRTM3;FGF13;SDK1;DSCAM;NRXN1;NLGN1;SHANK2;RYK;FZD1;GRID2;GPM6A;GABRB3;NRCAM;WNT5A;DNER;NLGN4Y;PTEN;FARP1;CDH1
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),-0.7756647993783969,-1.3542271740319998,0.08196721311475409,1.0,1.0,4/15,10.24%,PTGES;TRPA1;ALOXE3;SCN9A
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.6612994712054405,-1.353609154112787,0.109375,1.0,1.0,10/33,19.59%,CENPK;CENPO;CENPU;HAT1;ITGB3BP;OIP5;CENPL;KNL1;CENPI;H3-3A
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.6536552354595152,-1.3533652095543591,0.08771929824561403,1.0,1.0,9/32,16.37%,CD44;NODAL;AGER;CCL5;FLOT1;RNASE10;PLAUR;CXCL13;PODXL
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.5436724538889852,1.35309143695071,0.09375,0.891926578099151,1.0,8/47,5.82%,RUNX1;KIT;IFI16;F2RL1;LEF1;BATF3;CSF1R;TNFRSF11A
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.6043228004404309,1.3528560389462971,0.0967741935483871,0.8907493484324539,1.0,10/48,5.85%,IGSF11;CDH13;PTPRT;CNTN6;SDK1;NECTIN3;AMIGO1;DSCAM;DSCAML1;CNTN4
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),-0.8288497167939682,-1.3522075896826078,0.13114754098360656,1.0,1.0,2/5,15.36%,TRIM25;OAS3
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),-0.7441836049000843,-1.3520413504570012,0.17543859649122806,1.0,1.0,2/10,6.05%,STAT1;TBX1
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),0.7915996263956926,1.351743074603699,0.14285714285714285,0.8938201325699544,1.0,1/8,2.21%,SULF2
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.7180020979338612,-1.3509839796010152,0.13846153846153847,1.0,1.0,5/15,16.98%,ALOX12;ALOXE3;GSTP1;FADS2;ELOVL2
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.4803619951019502,1.3504578104365932,0.0,0.8969496824865572,1.0,34/123,12.79%,FEZF2;LRRTM3;CDH20;GRIA4;RAB3C;OXTR;CACNG3;KCNB2;CTNNA2;OLFM3;ADGRA1;KCND2;GRIA2;GRM5;SPHKAP;GRIN2A;GRIA1;BRINP1;TMEM196;NRXN1;NGB;CADM2;PAK5;POU3F1;RBFOX1;MMD2;KCNC2;SLC6A1;ADGRB3;SEZ6L;ST8SIA3;DAB1;ELAVL3;NR4A2
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),0.7469535882471645,1.3502332022535135,0.125,0.895384784430623,1.0,2/9,0.98%,NRG1;SPX
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.5233371564498185,1.3501143917745546,0.06666666666666667,0.8935233383587047,1.0,12/69,6.65%,RUNX1;KIT;IFI16;TOX;KDR;KITLG;SELPLG;CSF1R;TGFB2;MEIS1;JAG1;TET2
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),-0.6907945233080648,-1.3497943539170931,0.07272727272727272,1.0,1.0,4/17,10.26%,CSRP3;ACTC1;TTN;PDGFRB
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.5938158581706151,1.3497041353097052,0.12121212121212122,0.8930826276343615,1.0,5/35,2.92%,KIT;CDH13;NRP1;ZEB2;KANK1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),-0.7871506034290551,-1.3496776688054717,0.078125,1.0,1.0,4/10,10.32%,TGFB1;IL15;ZBTB7B;IL18
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),-0.7722224512895475,-1.3496568558942528,0.12280701754385964,1.0,1.0,4/8,13.58%,AMBP;SLCO2B1;BLVRB;ABCC2
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),-0.7722224512895475,-1.3496568558942528,0.12280701754385964,1.0,1.0,4/8,13.58%,AMBP;SLCO2B1;BLVRB;ABCC2
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.77081578010601,1.3490936663909416,0.15,0.8940122330455293,1.0,2/9,12.39%,VCAN;CHST12
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.5620481144393227,1.3477116965534992,0.12903225806451613,0.8991035099557178,1.0,11/57,8.77%,TPD52L1;TNFRSF19;F2RL1;RASSF2;SH3RF1;TRAF3;PLCB1;SH3RF3;RASGRP1;HMGB1;ANKRD6
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),-0.7692548252097525,-1.3474555277420286,0.08823529411764706,1.0,1.0,3/11,9.10%,TCP1;CCT6A;CCT8
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),-0.7692548252097525,-1.3474555277420286,0.08823529411764706,1.0,1.0,3/11,9.10%,TCP1;CCT6A;CCT8
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),-0.746338528576278,-1.3473082900217368,0.15254237288135594,1.0,1.0,2/11,5.56%,GMNN;CDC6
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.579723259191778,-1.3471345461162099,0.0547945205479452,1.0,1.0,14/64,10.83%,GNLY;HCK;PDE6B;ARHGAP9;IL21R;SPON2;GMFG;ALOX12;CD300LF;TGFB1;MYO1F;AQP9;TAGAP;SPI1
prerank,PanglaoDB_Augmented_2021__Clara Cells,-0.6192834293433893,-1.3469836709396,0.1,1.0,1.0,17/41,16.85%,DUOX1;SMIM22;STEAP4;FOXM1;AHR;VWA2;B3GNT3;TMC4;ALDH1A1;DUOXA1;SYT2;TFCP2L1;MUC4;WFDC2;CYP2B7P;SFTPD;CXCL17
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),-0.8278766367562707,-1.3468053108778353,0.10714285714285714,1.0,1.0,1/5,3.27%,ITGA5
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.49003080976813124,1.34680433279232,0.045454545454545456,0.9019744552480826,1.0,31/140,10.71%,LUZP2;LRRTM3;CDH20;KCNIP1;NTM;SLC16A2;MAPK4;ADGRA1;FGFR3;RGS7BP;GRIA2;GRM5;SPHKAP;NTSR2;SLC6A11;GRIN2A;SLCO1C1;APOE;BRINP1;HTRA1;NRXN1;CADM2;SRR;RCAN2;RBFOX1;BYSL;MMD2;SLC6A1;SLC4A4;LCAT;ADGRB3
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),0.7853774015204221,1.3467781324156,0.19444444444444445,0.8995182468074272,1.0,5/6,21.41%,LIN28B;PNPT1;NFKB1;ZSWIM8;RELA
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),-0.8569619125156809,-1.3465125674583809,0.0625,1.0,1.0,3/6,8.33%,SERINC1;TLCD2;PEX16
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),0.830072365367339,1.3463968366482968,0.1,0.8992543849696824,1.0,3/6,14.18%,IGF1;SIRT1;LRP6
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),-0.704972173927124,-1.3455963504521922,0.08620689655172414,1.0,1.0,3/18,9.24%,KCNE2;KCNQ1;REST
prerank,GO_Biological_Process_2021__regulation of sarcomere organization (GO:0060297),-0.8496705387697443,-1.3455648916918528,0.07142857142857142,1.0,1.0,1/5,2.84%,CAV3
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),0.7990047490468499,1.3453542176137019,0.05714285714285714,0.9018380176276845,1.0,1/7,2.21%,SULF2
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),-0.6945422208902498,-1.3450507686103854,0.125,1.0,1.0,1/20,0.09%,ENPP2
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.5078921069564994,1.344851076717617,0.11428571428571428,0.9022037972675204,1.0,13/39,14.85%,NRP1;MIEN1;TGFB3;PLPPR5;PRKCD;NLGN1;RALA;PIK3R1;GPM6A;SRGAP2C;RIPOR2;FNBP1L;MYO10
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),0.7557483577008649,1.3447317945292667,0.21875,0.9002962678653724,1.0,3/10,8.01%,F2RL1;SEMA5A;CRACD
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.6902246208685765,1.3441960157721897,0.15384615384615385,0.9005901017020517,1.0,6/17,21.78%,CYSLTR2;ADCY2;CREB1;ADCY9;ADCY8;PRKACB
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.6037644229206345,1.3441940724544017,0.1388888888888889,0.8980316070949437,1.0,7/27,12.12%,FGF13;FGFR3;WWC1;PTCH1;SLC6A4;DUSP10;PTPRS
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.7061569002924797,1.3438580091525747,0.14285714285714285,0.897185774921827,1.0,6/11,22.93%,MDK;NFAT5;ITGB2;ST3GAL4;RELA;TRAF6
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.722402280698783,1.343722138309139,0.08333333333333333,0.8954612242618701,1.0,3/12,11.97%,PCM1;SAXO2;BICD1
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.7218481282463338,1.3436826713156007,0.18604651162790697,0.8931590503968281,1.0,5/13,19.87%,PLCB1;RIPOR2;RANBP3L;MEF2C;AKIRIN1
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),-0.7084069045183001,-1.3436614077889755,0.03278688524590164,1.0,1.0,3/19,7.48%,WFS1;MYO5B;RAB11A
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.7401585887676577,-1.3433524516865343,0.078125,1.0,1.0,5/12,17.57%,GNLY;CXCL14;ROMO1;CXCL13;PGLYRP1
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.7835463002817207,1.34323640830014,0.1509433962264151,0.8928099054182527,1.0,1/9,2.32%,SLC25A37
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.6604670136146059,1.3431382592321954,0.12195121951219512,0.8908200798337044,1.0,5/13,20.57%,APBA1;DYNC1I2;BAG3;BORCS5;DYNC1I1
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),-0.8038794060101303,-1.3426028862614439,0.11864406779661017,1.0,1.0,1/8,0.98%,HENMT1
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),0.809749543217626,1.342440697602486,0.06,0.8923358734835695,1.0,2/6,9.58%,FHIT;MACROD2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-17 production (GO:0032700),-0.8580310965028609,-1.3421389629260045,0.06779661016949153,1.0,1.0,1/5,7.73%,NCKAP1L
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell differentiation (GO:0046637),0.7725518614945148,1.3421063409855338,0.12244897959183673,0.8918104407428001,1.0,2/6,2.26%,PNP;SH3RF1
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.6703144953063633,1.34208166079897,0.08333333333333333,0.8893693883621127,1.0,9/21,17.87%,GRIN3A;APOE;NLGN1;FOXO6;PTPRS;PPFIA2;SRGAP2C;MEF2C;DLG5
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.6361542869163117,1.34185406566519,0.1111111111111111,0.8883858026090546,1.0,8/21,17.09%,INSYN2A;GRIN2A;GRID2;DRD4;GRIN2C;GRIN2B;MEF2C;GRIN1
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.7229475086490017,1.3410271255744064,0.06896551724137931,0.8884811704559737,1.0,8/17,23.01%,TEX15;FOS;GATAD2A;DMAP1;DNMT1;DNMT3B;EHMT2;BEND3
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.7229475086490017,1.3410271255744064,0.06896551724137931,0.8884811704559737,1.0,8/17,23.01%,TEX15;FOS;GATAD2A;DMAP1;DNMT1;DNMT3B;EHMT2;BEND3
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.5566854205622748,1.3404108383400821,0.09375,0.8891907808810626,1.0,13/57,8.13%,EPHA3;LEF1;WWTR1;SPRED1;SPRED2;TGFBR1;MDK;SPRED3;TGFB2;TGFB3;GREM1;IL17RD;SMAD2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway (GO:0038033),0.8851690498165834,1.3399244139495705,0.10204081632653061,0.8890396317731708,1.0,3/5,9.21%,HSPB1;KDR;PRKD1
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),-0.7887272767264301,-1.3396859458142183,0.08928571428571429,1.0,1.0,6/10,18.40%,B3GNT3;B3GNT9;B3GALT1;B3GNT4;B3GALNT1;B4GAT1
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),-0.7787213642410268,-1.339619448949817,0.1,1.0,1.0,4/10,16.47%,C4BPB;A2M;C4BPA;SERPING1
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),-0.8445121322099537,-1.3395544669628856,0.15625,1.0,1.0,3/7,12.52%,RAC1;NCKAP1L;RHOH
prerank,GO_Biological_Process_2021__peptidyl-lysine oxidation (GO:0018057),-0.8854119070949258,-1.3392023667572177,0.11864406779661017,1.0,1.0,1/5,1.30%,LOXL4
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.6571929081738831,-1.3387404853968325,0.07692307692307693,1.0,1.0,3/18,9.59%,CGAS;STAT1;TRAF3IP2
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.5530142467387197,-1.3387183044593836,0.057971014492753624,1.0,1.0,4/78,5.98%,CD44;TERF2IP;TGFB1;PINK1
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.552742070527809,1.3379977269431031,0.045454545454545456,0.895761154663675,1.0,32/127,13.69%,UBASH3B;PTPN3;PTPRT;EYA4;PTPRK;DUSP5;CDC14B;DUSP2;PTPN9;PTPRB;PTPRO;PTPN6;DUSP8;DUSP4;DUSP12;SSH1;DUSP10;PTPN12;PTPRE;PPEF1;TAB1;EYA2;EYA3;PTPN13;PTPRS;CTDSP2;CTTNBP2NL;PTPRM;PPP2R5E;PPP2R3B;PPP2R1B;BTRC
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.5817265072328989,-1.33780969296394,0.0625,1.0,1.0,19/67,17.57%,GNLY;ELANE;GBP6;RARRES2;SERPINE1;LYG1;HLA-A;ADGRB1;LBP;TLR2;STAB1;OAS3;WFDC2;ROMO1;CXCL13;ADAM17;SFTPD;RAB1A;PGLYRP1
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.7508590047864752,1.3374219082902812,0.20512820512820512,0.8963386027820366,1.0,1/8,0.62%,TAS2R7
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),-0.8054536257860205,-1.3373524280144418,0.125,1.0,1.0,1/9,0.64%,ACOT4
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.6344980792101705,1.33730218396168,0.07692307692307693,0.8945757263891808,1.0,7/22,13.44%,PDE3A;GLP1R;EPHA5;PDE4D;CAP2;ADCY2;MAPK7
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.6213001574843537,1.3372212885820038,0.12195121951219512,0.8926105092120806,1.0,4/22,5.31%,NRP1;EGFR;DSCAM;EREG
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.6683849006429828,1.336927408489994,0.1282051282051282,0.8916420887317996,1.0,1/16,0.10%,NRG1
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),0.8474726647650486,1.3366319865570895,0.14634146341463414,0.8905735121595367,1.0,1/6,12.77%,SRM
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.5930826598588989,-1.3360181233873114,0.06060606060606061,1.0,1.0,15/51,14.94%,CD44;GNLY;ITK;PTPRC;ARHGAP9;GMFG;MYO1F;THEMIS;CD6;TAGAP;TCF7;GBP5;STYK1;CD5;SLA
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.7929635649707416,1.335896892603102,0.15,0.8918577669333251,1.0,1/5,14.73%,SORL1
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.6234803283510084,1.335886962763148,0.1111111111111111,0.8894667273436915,1.0,6/20,17.09%,CACNA2D1;GRIN2A;SLC8A1;GRIN2C;GRIN2B;GRIN1
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.6097446190868568,1.3358335102801255,0.05714285714285714,0.8873672245153998,1.0,9/30,17.80%,IRS1;RORA;RUBCNL;IRS2;MLYCD;SIRT1;AKT2;FOXK1;SIRT7
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),0.8228788877124371,1.3358312964296066,0.13157894736842105,0.885000911916692,1.0,1/7,1.42%,CIDEA
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.826371343103057,-1.3358054697650765,0.07462686567164178,1.0,1.0,3/7,11.83%,ATP5IF1;PINK1;DNAJA1
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),0.7442087672473247,1.335642407855077,0.1320754716981132,0.8833403554326222,1.0,2/8,10.82%,SPX;SLC27A2
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.6902929658401389,1.3356008852568422,0.15384615384615385,0.8811355437067565,1.0,6/18,9.21%,PTPRK;TGM1;MDK;FGF10;CASK;PRKD1
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),0.7300488512814409,1.3349135612943852,0.17391304347826086,0.8821830560306582,1.0,3/10,9.03%,PDE3A;DDAH1;ANGPT1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),-0.88596692836228,-1.334866839362638,0.109375,1.0,1.0,2/5,9.24%,PINK1;REST
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.7151225290666362,-1.3344528298768157,0.13114754098360656,1.0,1.0,4/15,8.77%,HSF2BP;ING2;TDRD9;BTBD18
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),0.6031929411185548,1.3343032873474918,0.1,0.8832250405850404,1.0,3/40,0.59%,RUNX1;KIT;IFI16
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.6710542951450384,1.3339666504835,0.12195121951219512,0.8827526207928359,1.0,3/23,3.45%,MDGA1;IL1RAPL1;CTNNA2
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.6573970474193289,-1.3339589490860606,0.125,1.0,1.0,3/26,4.07%,B2M;TMC8;CP
prerank,GO_Biological_Process_2021__estrogen biosynthetic process (GO:0006703),-0.8978561818969415,-1.333477681418917,0.06666666666666667,1.0,1.0,2/5,1.28%,CYP19A1;HSD17B2
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),0.7998134000255868,1.3332309367839754,0.17307692307692307,0.8843691024310751,1.0,1/5,1.31%,TOX
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.736229358815073,1.333155162120099,0.1794871794871795,0.8825998255637824,1.0,4/10,5.85%,SEMA5A;AMIGO1;EPHB2;CNTN4
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.5955407596743988,-1.333047334114807,0.1111111111111111,1.0,1.0,6/45,9.27%,FRRS1;B2M;CP;ATP6AP1;NUBP1;SKP1
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.632888039314787,1.3329695488057214,0.06060606060606061,0.8809078377855891,1.0,3/26,7.55%,SLC22A2;SLC7A2;SLC7A1
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),-0.6838331095194693,-1.3327643714778423,0.08620689655172414,1.0,1.0,4/22,8.66%,KCNE2;ATP1B1;KCNQ1;ATP1A1
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),0.8412671993703082,1.3326281337709516,0.11627906976744186,0.880276691335811,1.0,2/5,10.87%,EGFR;NOS1AP
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),0.8273535762369626,1.3325169624247006,0.14634146341463414,0.8783964376033643,1.0,3/7,14.93%,SLC16A2;SIRT2;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.670239270233232,1.3323997194792474,0.12195121951219512,0.8766272078568007,1.0,4/15,18.54%,SHLD1;PNKP;KMT5B;SETMAR
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.48443036471535617,1.332205956128147,0.06896551724137931,0.8753048748738864,1.0,15/72,13.36%,F2RL1;NRP1;CROCC;MIEN1;TGFB3;PLPPR5;WASF2;NLGN1;RALA;CEP120;AUTS2;PIK3R1;GPM6A;RIPOR2;FNBP1L
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),0.5734400264276244,1.3321223523210504,0.09375,0.873351213477969,1.0,5/27,7.33%,NPNT;KDR;NRP1;FGF10;PKHD1
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.6613140590842915,1.3318788165766438,0.12195121951219512,0.8724796034986124,1.0,7/17,13.81%,UNC13C;GRIK4;UNC13B;GRIA2;GRIK1;GRID2;GRIK2
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),0.7931003274593412,1.331810687172379,0.2,0.8705432051646617,1.0,3/6,13.57%,PER2;CTBP2;SIRT1
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),0.6972950977048089,1.3317592245537249,0.11363636363636363,0.86865004054008,1.0,5/11,13.79%,MTHFS;MTHFD2L;MTHFD2;DHFR;MTHFD1L
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.5787210188158003,1.3314342143810247,0.14705882352941177,0.868162776028898,1.0,10/42,16.04%,CDH13;KDR;NRP1;SEMA5A;GREM1;ANGPT1;NAXE;YJEFN3;RECK;PARVA
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),-0.8240320875324758,-1.3311185968584198,0.08928571428571429,1.0,1.0,3/7,13.18%,MSMP;CCL5;MSN
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),-0.7247417839301951,-1.3308013286896387,0.1016949152542373,1.0,1.0,1/13,0.68%,KCNE2
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),0.7775140436690424,1.3307516043919159,0.20833333333333334,0.8692696350454457,1.0,2/5,11.17%,CAP2;MAPK8
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),0.8518876494516107,1.3304497778002315,0.06666666666666667,0.8684855956136017,1.0,1/5,6.08%,MACROH2A2
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by integrin (GO:0033631),0.890383802083022,1.3301822534195782,0.02564102564102564,0.8676395432994106,1.0,2/5,1.17%,NPNT;ITGA4
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.7288397891408754,1.329653706134233,0.15217391304347827,0.8680811775224568,1.0,5/11,19.91%,PDE4D;ADCY2;PTHLH;ADCY9;ADCY8
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),-0.7542214477063893,-1.3294236351794135,0.11475409836065574,1.0,1.0,4/13,10.26%,CSRP3;ACTC1;TTN;PDGFRB
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),-0.8623151462558589,-1.3292364218568422,0.08333333333333333,1.0,1.0,3/6,11.84%,ALDH1A1;ALDH2;ADH5
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),0.7288362525669889,1.3282796963182562,0.11428571428571428,0.8741008620219733,1.0,2/9,4.07%,PPP1R3B;RUBCNL
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),-0.7384426168994442,-1.3282284912785922,0.09230769230769231,1.0,1.0,8/13,20.91%,CYP19A1;HSD17B10;UGT2B7;SHH;HSD17B11;HSD17B6;SPP1;SRD5A1
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),0.7965775619375773,1.3279178461000465,0.15,0.8738691890563887,1.0,1/8,0.83%,RGS14
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),-0.8479984565691041,-1.3278894986866157,0.1016949152542373,1.0,1.0,2/6,11.58%,CASP8;FADD
prerank,GO_Biological_Process_2021__regulation of extracellular exosome assembly (GO:1903551),0.8268094826406255,1.3266229325792969,0.11764705882352941,0.8780478598121064,1.0,2/5,12.52%,SDC4;TSG101
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),0.7578538391429119,1.3266118949074674,0.2,0.8737335641706262,1.0,1/7,4.88%,EEFSEC
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),0.7578538391429119,1.3266118949074674,0.2,0.8737335641706262,1.0,1/7,4.88%,EEFSEC
prerank,GO_Biological_Process_2021__purine deoxyribonucleotide catabolic process (GO:0009155),0.8139114411599238,1.3264626759681568,0.21875,0.8723381025898229,1.0,2/6,8.59%,PNP;SAMHD1
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.7633019141275695,1.326452539641939,0.09090909090909091,0.8702058283493899,1.0,6/11,11.34%,IRS1;PLCB1;IGF1;EIF2AK3;GIGYF1;PIK3R1
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.5687996999320061,-1.3263465025547045,0.09090909090909091,1.0,1.0,15/63,16.78%,HCK;PDCD1LG2;TGFB1;SERPINE1;CD14;CD6;DAB2IP;IL18;GSTP1;CCL5;LBP;STAP1;ADAM9;CXCL13;LYN
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),-0.7389914075902922,-1.3257435065290504,0.13114754098360656,1.0,1.0,1/13,4.16%,YBX3
prerank,GO_Biological_Process_2021__norepinephrine transport (GO:0015874),0.8330573043359177,1.3251331262055273,0.10256410256410256,0.8722795120900686,1.0,2/5,6.10%,SLC22A2;SLC22A3
prerank,GO_Biological_Process_2021__catecholamine uptake (GO:0090493),0.8330573043359177,1.3251331262055273,0.10256410256410256,0.8722795120900686,1.0,2/5,6.10%,SLC22A2;SLC22A3
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.5334894835580543,-1.3247798618862558,0.0958904109589041,1.0,1.0,18/106,8.72%,CD44;C3AR1;MS4A6A;HCK;SIGLEC1;PTPRC;MGST1;IL3RA;ABCB1;FGL2;CD300LF;NOTCH1;FLT3;ALDH1A1;PROCR;FCGRT;CD14;TAF7
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),-0.7611707130961932,-1.324536337401055,0.12698412698412698,1.0,1.0,1/9,0.62%,MCM2
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",-0.8088134388369065,-1.3241558042339883,0.09259259259259259,1.0,1.0,2/7,9.60%,HSPA5;SEC62
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),-0.7789887914446096,-1.3240811390145686,0.11666666666666667,1.0,1.0,2/10,4.01%,CHAC2;CHAC1
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),0.8604931115557112,1.3237207222968732,0.13157894736842105,0.8740766665812997,1.0,1/5,3.16%,RAB32
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),0.8604931115557112,1.3237207222968732,0.13157894736842105,0.8740766665812997,1.0,1/5,3.16%,RAB32
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.6486047110564742,1.3236946326929155,0.125,0.8719662619663832,1.0,8/17,22.35%,PARD3;LRRC7;PARD3B;DLG2;DLG3;MTCL1;CLIC4;MARK2
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),-0.7729993022727506,-1.3236757427157737,0.1111111111111111,1.0,1.0,2/9,2.72%,PTGIS;PTGES
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),-0.7043829378778463,-1.3232760501826408,0.09523809523809523,1.0,1.0,3/18,5.85%,LRPAP1;RIN3;RAC1
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.595918412102542,-1.3226873839512834,0.10294117647058823,1.0,1.0,13/45,14.12%,TIMP3;AGT;TIMP2;SERPINE1;SERPINI2;SERPINA10;PSMB8;A2ML1;KNG1;APH1B;PSMA3;TIMP4;SERPINF1
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.8750006684409477,1.3223771397196573,0.16666666666666666,0.8756969346753632,1.0,2/5,3.58%,LHFPL2;PLCB1
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.714688447067948,-1.3221910129118246,0.1346153846153846,1.0,1.0,7/14,21.15%,ATP5F1E;ATP5F1C;ATP5MC3;ATP5PD;ATP5F1A;ATP5ME;ATP5PB
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.5434518529127529,1.3215157634840655,0.058823529411764705,0.877343426199919,1.0,21/56,21.42%,GRIA4;CACNG3;GRIA2;GRIN2A;LRRC7;GRIA1;CACNG4;NLGN1;DLGAP1;DLGAP4;SHISA9;DLG2;GRIN2B;MEF2C;GRIN1;DLG3;CNIH2;DLGAP3;DLGAP2;AKAP9;RELN
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.6514073431797344,-1.3213039195122143,0.07936507936507936,1.0,1.0,15/34,16.85%,FUT2;DUOX1;CP;IL20RA;VWA2;CLCA4;TMC4;CBLC;DUOXA1;ZNF750;MUC4;WFDC2;CYP2B7P;EXPH5;CXCL17
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.6508249356227672,-1.320901866221813,0.07246376811594203,1.0,1.0,5/31,7.01%,MCM2;POLE3;GMNN;CDC6;RPA3
prerank,GO_Biological_Process_2021__ornithine transport (GO:0015822),0.7701738230658239,1.3208280190176762,0.1956521739130435,0.8786014214047839,1.0,2/5,7.55%,SLC7A2;SLC7A1
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),-0.7793999507207512,-1.3206976282708378,0.11864406779661017,1.0,1.0,2/9,4.01%,CHAC2;CHAC1
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.7572669447883844,-1.3199763873930486,0.1016949152542373,1.0,1.0,4/11,17.09%,CHMP4B;HSPA5;SEC62;SGTB
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.724767376067557,1.3199259439373283,0.14285714285714285,0.8804226508720424,1.0,3/11,9.96%,ELOVL6;HACD2;TECR
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),0.6117635863327296,1.3198133899626268,0.1,0.8788903928559142,1.0,5/30,8.86%,TENT5A;ELAVL1;NAF1;TENT5C;TRDMT1
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),-0.8374420140891276,-1.3197284120701265,0.12903225806451613,1.0,1.0,2/7,3.50%,ODAD4;CCDC39
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.5342972156221258,1.319332753530219,0.0967741935483871,0.8795374676683114,1.0,8/68,3.58%,FRMPD1;GNG4;RGS14;KCTD8;CAMKMT;KLK6;GRK5;PLCB1
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.7633690487786854,1.3191948132022802,0.14634146341463414,0.8782031354387082,1.0,5/8,19.28%,HDAC9;SIRT2;SIRT1;HDAC10;SIRT3
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.6814640377328881,1.318896322557119,0.13793103448275862,0.8774077589477584,1.0,2/9,3.18%,NPNT;BMP7
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.6991495537287682,-1.318781920997901,0.15873015873015872,1.0,1.0,4/23,7.59%,TERF2IP;H1-2;H1-0;SUB1
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.7280223498971733,-1.3187709576858169,0.1323529411764706,1.0,1.0,7/14,21.83%,DUOX1;PRDX4;NOX1;PRDX1;PRDX3;MAOB;ACOX1
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),0.6896088027283376,1.318674749390763,0.12195121951219512,0.8763036892098748,1.0,3/13,9.66%,MN1;GREM1;NELL1
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.7301622933473418,1.3184945211248995,0.23076923076923078,0.874955493801927,1.0,3/8,15.37%,RUBCNL;PIP4K2A;PLEKHM1
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",0.8105443184774113,1.3184869437195723,0.1956521739130435,0.8728672945327101,1.0,3/6,4.98%,HS3ST5;HS3ST3B1;HS6ST3
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),-0.7971357370992351,-1.3179814510484078,0.19230769230769232,1.0,1.0,1/7,8.35%,RNF213
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.5176941401783971,1.3178831103121027,0.07317073170731707,0.874171045314275,1.0,8/35,13.16%,IFI16;LEF1;HMGB1;IGF1;TFAP4;MAPK8;NGF;SIRT2
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),0.705018568327614,1.317313798191712,0.13157894736842105,0.8750042942977572,1.0,1/11,0.42%,KIT
prerank,GO_Biological_Process_2021__positive regulation of membrane depolarization (GO:1904181),0.7488438202293578,1.3172531432462873,0.16666666666666666,0.8731469881166423,1.0,1/6,1.79%,KDR
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.5390011566987091,-1.3164955836428147,0.0625,1.0,1.0,51/142,24.83%,RPL36;RPL15;RPL38;RPS21;RPS7;WARS1;RPL37A;ASMT;RPL9;RPL28;MRPS14;RPLP2;GGTA1;PCSK5;RPL5;EEF1A1;RPL35A;RSL24D1;RPS20;RPLP1;RPL8;RPL4;RHD;RPL22;RPL27A;MRPS18C;COPS5;RPL24;RPS15;MRPL51;MRPL43;RPL34;RPL3;RPS24;RPS4X;RPS3;RPS6KB2;RPS29;FURIN;RPL13A;RPS8;RPS27A;RPL27;RPL37;RPL7A;RPL35;RPL23;RPL32;RPS13;MRPL27;MRPL42
prerank,GO_Biological_Process_2021__sensory perception of bitter taste (GO:0050913),0.7864267952983803,1.3163947264753688,0.15,0.8733005167897941,1.0,1/7,0.62%,TAS2R7
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),0.7864267952983803,1.3163947264753688,0.15,0.8733005167897941,1.0,1/7,0.62%,TAS2R7
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),0.8139222932523056,1.3162695993333726,0.11904761904761904,0.8717976179420905,1.0,4/6,13.52%,LHFPL4;APOE;NLGN1;GPHN
prerank,GO_Biological_Process_2021__type B pancreatic cell differentiation (GO:0003309),0.8567392027928507,1.3159768896002695,0.2391304347826087,0.8713418544073832,1.0,1/5,3.13%,BMP6
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.6123585960310085,-1.3156659061476743,0.08823529411764706,1.0,1.0,19/38,24.27%,STAT1;IRF1;IFIT1;IFI27;PSMB8;ISG20;IFIT3;HLA-A;IFI6;IFIT5;OAS3;XAF1;IRF3;HLA-C;STAT2;ISG15;IFIT2;HLA-F;GBP2
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.6123585960310085,-1.3156659061476743,0.08823529411764706,1.0,1.0,19/38,24.27%,STAT1;IRF1;IFIT1;IFI27;PSMB8;ISG20;IFIT3;HLA-A;IFI6;IFIT5;OAS3;XAF1;IRF3;HLA-C;STAT2;ISG15;IFIT2;HLA-F;GBP2
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),-0.8356593464969111,-1.3156011320810714,0.12962962962962962,1.0,1.0,1/5,4.15%,P2RY12
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.5156329730496721,1.315235833973123,0.08,0.872505728959143,1.0,16/90,9.52%,LRIG3;KIT;LAMB2;WWTR1;EGFR;KITLG;CACNA2D1;FIGN;TSPAN12;ADGRL2;PKDCC;DDAH1;MID1;GNG12;CAP2;AMOTL2
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.5471435613013491,1.3152075078739878,0.12903225806451613,0.8706194022991371,1.0,15/77,8.77%,TPD52L1;TNFRSF19;F2RL1;RASSF2;SH3RF1;TRAF3;PLCB1;TGFB2;SH3RF3;SEMA4C;RASGRP1;HMGB1;MID1;KLHDC10;ANKRD6
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.7501350919843,-1.3151151646450492,0.1,1.0,1.0,3/10,12.33%,CAV3;NOTCH1;MLIP
prerank,GO_Biological_Process_2021__striated muscle hypertrophy (GO:0014897),-0.8722174367176068,-1.3149264257897348,0.07936507936507936,1.0,1.0,3/5,11.98%,CSRP3;TTN;HTR2B
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),-0.7555118265692372,-1.3145421531660808,0.14285714285714285,1.0,1.0,3/10,11.42%,CGAS;B2M;ARG2
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),-0.7529258110075067,-1.3144666042362443,0.16981132075471697,1.0,1.0,3/10,16.21%,HLA-A;WFDC2;SFTPD
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.877310511236866,1.3143060049111557,0.16326530612244897,0.8710249929935883,1.0,3/5,11.22%,MTR;KCNC2;FOXO1
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.877310511236866,1.3143060049111557,0.16326530612244897,0.8710249929935883,1.0,3/5,11.22%,MTR;KCNC2;FOXO1
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),-0.6872885889168785,-1.3141701007100515,0.16666666666666666,1.0,1.0,4/18,8.15%,TRPV6;WFS1;TMC8;FAM20A
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),-0.8299531533341505,-1.3141148474845115,0.15254237288135594,1.0,1.0,1/6,0.77%,MYLK
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.664358918904475,-1.313801415352114,0.07547169811320754,1.0,1.0,3/28,8.64%,EPN1;ITGA5;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.8309822286463981,-1.3126040464628663,0.08196721311475409,1.0,1.0,2/7,10.72%,PINK1;TOMM7
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-0.8562508992736257,-1.3123435479533156,0.09836065573770492,1.0,1.0,3/6,10.72%,ATP5IF1;PINK1;TOMM7
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),0.5277993856191212,1.3122118095956659,0.06060606060606061,0.8786190037177617,1.0,10/48,13.03%,MCTP1;RAB3C;DNAJC1;SNCAIP;RALA;ARFIP1;MCTP2;VAMP3;VAMP8;SYT1
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),-0.8186481884039964,-1.312066399385867,0.18,1.0,1.0,1/5,2.84%,CAV3
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),0.630949486689881,1.3119271750084356,0.13157894736842105,0.8779727857693058,1.0,6/13,25.88%,PRKCD;SPHK2;SMPD3;SIRT3;NSMAF;SAMD8
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),-0.8283948885444632,-1.3118273769485103,0.07142857142857142,1.0,1.0,3/8,11.98%,CSRP3;TTN;HTR2B
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.6345717015620739,-1.3114857017840384,0.10606060606060606,1.0,1.0,13/30,23.61%,NDUFB9;NDUFA2;NDUFB3;NDUFC1;NDUFB2;NDUFS2;NDUFB4;NDUFAB1;NDUFA1;NDUFB11;NDUFS5;NDUFB10;NDUFA3
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),-0.6822495274824114,-1.3109685412327512,0.13114754098360656,1.0,1.0,3/19,10.68%,GNPDA1;NANS;GFPT2
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),-0.7666910755063163,-1.3096261724012421,0.21311475409836064,1.0,1.0,3/7,17.98%,OSMR;PTGER3;IL6ST
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),-0.7620800809364954,-1.3095941882732611,0.19642857142857142,1.0,1.0,3/9,16.01%,STAT1;TBX1;SHH
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.473420028189286,1.3094377669965604,0.07407407407407407,0.8871709565143076,1.0,33/135,12.67%,GDAP1;LRRTM3;PPP1R1C;GRIA4;RAB3C;ZNF536;FGF13;MAPK4;OLFM3;ADGRA1;RGS7BP;GRIA2;GRM5;SPHKAP;KCTD16;LSAMP;BRINP1;TMEM196;NRXN1;CADM2;DGKH;NOVA1;CSRNP3;PAK5;RBFOX1;PARM1;MMD2;SLC6A1;ADGRB3;ST8SIA3;GCNT2;ELAVL3;PPFIA2
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),0.7840057773449343,1.3093897581774046,0.25,0.8854871040899515,1.0,2/6,14.65%,SRM;HDAC10
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),0.784433548339676,1.3078365961064338,0.21568627450980393,0.8913004094326742,1.0,2/5,14.25%,SLC25A37;ABCB10
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),-0.6913267770116034,-1.307783588148012,0.15384615384615385,1.0,1.0,2/18,1.28%,CYP19A1;HSD17B2
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),-0.7877501985720182,-1.3074211247301875,0.2,1.0,1.0,2/7,12.89%,SOD2;PRDX1
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.462474343681754,1.3073587665742123,0.029411764705882353,0.8911092575512001,1.0,28/118,14.87%,GPC4;UNC13C;NTNG1;C5AR1;UNC13B;SDK1;DSCAM;PDZRN3;GRM5;ZC4H2;LRRC4C;PPFIBP1;NRXN1;NLGN1;SHANK2;SLC8A3;RYK;SLC6A1;LRFN4;GPM6A;PTPRS;PPFIA2;CACNB2;ARHGAP39;GPHN;PPFIA3;PAK3;NRCAM
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),0.6378889684443346,1.3071491625243752,0.15384615384615385,0.8899945432194009,1.0,1/15,1.19%,GDAP1
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.5269028052483699,1.306430599422216,0.13043478260869565,0.891473384161932,1.0,40/100,22.25%,MCTP1;GRIK4;CLSTN2;BTBD9;GRM5;GRIK1;SNCAIP;LRRC4C;NLGN1;SLC8A3;SYN3;PXK;DLGAP1;GRM8;CEL;MCTP2;GRID2;NGF;DLGAP4;SYT1;GRIK2;NRG3;MEF2C;HOMER1;KCTD13;NLGN4Y;TMEM108;CACNA1A;OPHN1;PTEN;CACNA1B;HCRT;DLGAP3;DLGAP2;ITGB1;AKAP9;RELN;RIMS2;UNC13A;GRM7
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.8370240121528572,1.3061402325581004,0.11904761904761904,0.8909566128277621,1.0,3/7,5.07%,NRG1;TGFBR1;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),-0.7570480147961147,-1.3059848233590756,0.13846153846153847,1.0,1.0,3/9,11.42%,CGAS;B2M;ARG2
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.5711946280567886,1.3057733926654476,0.10344827586206896,0.8905902766325582,1.0,18/46,16.12%,GPC4;HS3ST5;HS3ST3A1;HS3ST3B1;EXT1;SDC4;B3GAT2;CLN6;GLB1;HS3ST2;EXT2;GCNT2;HS3ST1;HS6ST2;HS2ST1;GUSB;NDST1;B3GAT3
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),-0.8272353771410834,-1.3057374129495138,0.15,1.0,1.0,1/6,2.29%,PTPRC
prerank,GO_Biological_Process_2021__positive regulation of macrophage proliferation (GO:0120041),0.8551689672279811,1.3054933419836756,0.1836734693877551,0.8877692684385381,1.0,2/5,10.58%,CSF1R;IL34
prerank,GO_Biological_Process_2021__regulation of macrophage proliferation (GO:0120040),0.8551689672279811,1.3054933419836756,0.1836734693877551,0.8877692684385381,1.0,2/5,10.58%,CSF1R;IL34
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.7400817829674948,-1.3054906217809168,0.08620689655172414,1.0,1.0,7/14,11.45%,HCK;TGFB1;CD14;CD6;IL18;CCL5;LBP
prerank,GO_Biological_Process_2021__regulation of leukocyte tethering or rolling (GO:1903236),0.84731747166563,1.3045125402708102,0.20408163265306123,0.8902954413970956,1.0,2/5,8.54%,CCL28;FUT9
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.6295278171061809,-1.3045086822558731,0.12903225806451613,1.0,1.0,4/21,16.89%,TERF2IP;TDG;EXOSC6;MPG
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.7229208927571903,-1.3043474752392057,0.125,1.0,1.0,7/19,19.68%,ELANE;RARRES2;SERPINE1;ADGRB1;LBP;ROMO1;SLC11A1
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),0.7098064924387657,1.30425452757181,0.17391304347826086,0.8874654918802836,1.0,3/8,13.52%,CACNG3;CACNG4;GPHN
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),0.7098064924387657,1.30425452757181,0.17391304347826086,0.8874654918802836,1.0,3/8,13.52%,CACNG3;CACNG4;GPHN
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.7056755002027384,1.304215746217472,0.1702127659574468,0.8855633153314174,1.0,2/9,13.57%,LEPR;SIRT1
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),0.5481104632781612,1.3042107537161667,0.024390243902439025,0.8836113427774217,1.0,3/46,3.28%,RUNX1;RAB7B;CBFB
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),0.4786492476543349,1.3041540240874652,0.09090909090909091,0.8819007912383156,1.0,13/79,6.91%,TPD52L1;KIT;PDGFD;RGS14;EGFR;BMP7;PDGFC;SPRY3;TRIB2;PRKCD;APOE;RASGRP1;PIK3R6
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),0.7994625963370434,1.3041512214261994,0.13513513513513514,0.8799656705088211,1.0,3/6,19.07%,PUSL1;RPUSD4;PUS10
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.6476720934615583,1.3037923883054423,0.17073170731707318,0.8796318994342194,1.0,4/15,5.96%,RUNX1;CBFB;MDK;SOX12
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.5318451721757826,1.3037919634288964,0.1724137931034483,0.8776814961095316,1.0,13/56,12.84%,TPD52L1;KIT;PDGFD;EGFR;PDGFC;TNFRSF11A;RASGRP1;PIK3R6;IL34;DVL2;FGFR1;MAP3K10;MAP3K5
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),-0.5852654382032401,-1.3032813396893117,0.08955223880597014,1.0,1.0,13/68,11.98%,CSRP3;TRPV6;WFS1;GCM2;ELANE;CALCB;DRD3;ATP1B1;SLC24A1;FAM20A;SLC24A5;CCL5;HTR2B
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.6079386433051662,-1.303257915853826,0.15384615384615385,1.0,1.0,15/41,17.14%,TXNRD2;PRDX4;CDKN2D;MGST1;JUNB;SOD2;GLRX2;GLRX;NQO1;G6PD;IPCEF1;PRDX1;TXN;NDUFS2;NDUFB4
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.7299909402628465,-1.3031384473185248,0.15254237288135594,1.0,1.0,4/13,11.24%,IL4I1;CD27;NCKAP1L;INHBA
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.513162265480143,1.3031284459686674,0.17391304347826086,0.8784786619390583,1.0,13/85,11.51%,PER2;IRS1;GLP1R;EPHA5;ITPR2;MCU;EFNA5;IRS2;KCNC2;MYRIP;RBP4;KCNS3;GCK
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),0.8302812256782295,1.3030192165229388,0.13636363636363635,0.8752976061787269,1.0,1/5,3.30%,PEX7
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),0.8302812256782295,1.3030192165229388,0.13636363636363635,0.8752976061787269,1.0,1/5,3.30%,PEX7
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),-0.6238321354293643,-1.3026553271680525,0.11594202898550725,1.0,1.0,11/30,22.91%,PPP1R1B;FKBP1B;CALM3;PDGFRB;CRY2;PPP4R4;BOD1;CALM1;PPP1R11;HSP90B1;HSP90AB1
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),0.7433686885733798,1.3025790587363015,0.2708333333333333,0.8753214525196129,1.0,2/5,23.65%,FERMT2;PLEKHA7
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.5303525747979903,-1.3013677318318917,0.07246376811594203,1.0,1.0,26/95,15.47%,MS4A6A;HCK;HLA-DMA;GPR68;PTPRC;PDCD1LG2;CD74;FGL2;CD300LF;FLT3;HLA-DPB1;MYO1F;AQP9;CD14;SCIMP;TAGAP;IGSF6;HLA-A;SPI1;WDFY4;CD83;GPR132;HLA-DMB;SLA;PLAC8;ADGRE1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),0.5394129318028124,1.3011716151114037,0.08333333333333333,0.8804892404668064,1.0,4/48,3.18%,NRK;NYAP2;SGK1;BMP7
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),0.8008796859132525,1.3010173653398434,0.22727272727272727,0.8792184246780221,1.0,2/6,1.98%,PHACTR1;NRP1
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),0.8203415515976435,1.3009427031080858,0.2608695652173913,0.8777255323870873,1.0,1/7,0.98%,SPX
prerank,GO_Biological_Process_2021__dopamine uptake (GO:0090494),0.8199274572110381,1.3007388770978359,0.1388888888888889,0.8770624913200001,1.0,2/6,6.10%,SLC22A2;SLC22A3
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.6274022684019714,1.300628210496199,0.17142857142857143,0.8759207310340299,1.0,2/19,5.04%,RNF126;DNAJB12
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.6907957010304488,1.3003760446124086,0.17391304347826086,0.8713429115329836,1.0,4/11,15.47%,CDC23;ESPL1;NSMCE2;ANAPC7
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.6907957010304488,1.3003760446124086,0.17391304347826086,0.8713429115329836,1.0,4/11,15.47%,CDC23;ESPL1;NSMCE2;ANAPC7
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.6907957010304488,1.3003760446124086,0.17391304347826086,0.8713429115329836,1.0,4/11,15.47%,CDC23;ESPL1;NSMCE2;ANAPC7
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.6242129115531827,1.3001587758651774,0.0967741935483871,0.8704760884758683,1.0,3/20,2.00%,ACE2;PER2;OXTR
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),0.6824913883130405,1.2998873692963653,0.23684210526315788,0.869781143157003,1.0,1/13,0.33%,PNP
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.7676585122893169,-1.2989006461364232,0.14545454545454545,1.0,1.0,2/11,10.68%,GNPDA1;GFPT2
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.649111773642854,-1.2987359964023268,0.1746031746031746,1.0,1.0,5/24,10.22%,LIPH;LIPI;FABP3;LIPC;PNPLA1
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),0.6918747123190196,1.2986539761734306,0.16279069767441862,0.873675403024126,1.0,2/11,4.30%,PER2;HEY1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.6192396650614609,1.2985342200163719,0.18518518518518517,0.8724742951133414,1.0,4/23,8.00%,RUNX1;CBFB;MDK;ZBTB1
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),-0.8495051402474685,-1.29828851591168,0.14285714285714285,1.0,1.0,1/5,1.76%,DOCK2
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.4568974816280253,1.2981084726265706,0.043478260869565216,0.8726705833576588,1.0,30/158,16.65%,SGK1;STK32B;GALNT3;SGK2;TGFBR1;LATS1;NEK6;PRKCD;PRKCB;GALNT13;STK38;SBK1;PRKD1;CLSPN;EIF2AK3;MAST4;MARK1;MAPK8;PRKCE;MAP3K10;DMPK;GALNT16;MAPK12;AKT2;MAST2;RPS6KA6;DYRK3;MAP3K13;SGK3;ATM
prerank,GO_Biological_Process_2021__glyceraldehyde-3-phosphate metabolic process (GO:0019682),-0.7814663301590362,-1.2979362791105515,0.1935483870967742,1.0,1.0,4/7,16.43%,ALDOB;ALDH1A1;GLYCTK;KHK
prerank,GO_Biological_Process_2021__regulation of glial cell migration (GO:1903975),-0.8678010086322094,-1.2975761818220104,0.09433962264150944,1.0,1.0,2/5,13.19%,P2RY12;GPR183
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.49235261425861143,1.2975613775217922,0.08,0.8731716793720397,1.0,22/113,8.96%,FBXL7;PENK;DOK5;SEMA6D;EFS;PCDH18;VCAN;NTM;SLC16A2;VAT1L;MAPK4;CACNA2D1;PDZRN3;RGS7BP;GUCY1A2;TGFB2;ADGRL2;BRINP1;PCDH19;GFRA1;RCAN2;CSRNP3
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta clearance (GO:1900222),-0.855086535890915,-1.297555948490967,0.15789473684210525,1.0,1.0,1/5,3.11%,LRPAP1
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),0.760464217386843,1.2975146330650438,0.1282051282051282,0.8715911350264677,1.0,2/8,4.30%,F2RL1;CSF1R
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.6102772047102186,-1.2972903562641853,0.13043478260869565,1.0,1.0,4/23,10.81%,CGAS;STAT1;TRAF3IP2;IFNLR1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.5174456470563303,1.297277439094301,0.1,0.8708196713939647,1.0,18/89,12.15%,ROR2;KIT;PDGFD;UNC5B;F2RL1;KDR;EGFR;TGFB2;PDGFC;PDGFRA;IGF1;PTPN6;IRS2;PIP4K2A;IER3;PIK3R1;PTPN13;FGFR1
prerank,GO_Biological_Process_2021__low-density lipoprotein particle remodeling (GO:0034374),-0.8126307684503618,-1.297233473777372,0.12903225806451613,1.0,1.0,4/6,14.98%,AGT;LIPC;PLA2G7;PLA2G10
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),-0.8805612271951332,-1.2971890789109115,0.1016949152542373,1.0,1.0,2/5,7.73%,CD27;NCKAP1L
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),-0.6008607571697482,-1.2971142762640344,0.11940298507462686,1.0,1.0,2/36,7.73%,HCK;NCKAP1L
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.797457060161719,-1.297042423927307,0.12121212121212122,1.0,1.0,2/9,2.63%,EPAS1;COPS9
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.4800431886677284,1.2969572928713018,0.08,0.8708521460123714,1.0,19/119,9.36%,NRG1;KIT;IRS1;EGFR;KITLG;FGFR4;TGFBR1;SEMA5A;FGFR3;EREG;BTC;PDGFRA;FGF10;CASS4;AKR1C3;NRG2;IRS2;ANGPT1;ERBB4
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),-0.685055475606155,-1.2966887803510947,0.1076923076923077,1.0,1.0,6/19,16.76%,FKBP1B;FKBP4;PPID;PPWD1;PPIC;FKBP5
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.6273265766002821,1.296235182259544,0.2,0.8716559089906769,1.0,1/27,0.10%,NRG1
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),0.7075916164083338,1.2960264871319127,0.1111111111111111,0.8708067130076407,1.0,3/13,4.89%,ITGA4;SELPLG;JAM2
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),0.6538389372239287,1.2959503944362636,0.15625,0.8692477848475261,1.0,7/17,13.79%,MTHFS;MTHFD2L;SLC19A1;PM20D2;MTHFD2;DHFR;MTHFD1L
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),0.7203646721159075,1.2958924657818467,0.13157894736842105,0.867750161359073,1.0,1/8,2.53%,FGGY
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),0.7120895249425818,1.2958607075545894,0.1111111111111111,0.8661495376865438,1.0,3/12,4.89%,ITGA4;SELPLG;JAM2
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),0.6510376007698553,1.2956960147764007,0.18181818181818182,0.8653189675512825,1.0,2/11,1.98%,KDR;NRP1
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),-0.7721587117131816,-1.2956224858275296,0.12857142857142856,1.0,1.0,1/7,10.46%,TRUB1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell differentiation (GO:0051152),0.8394883819687774,1.295328329220711,0.20930232558139536,0.8648455408989221,1.0,2/5,5.47%,KIT;OLFM2
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),-0.7401827141118427,-1.2949459838700745,0.10344827586206896,1.0,1.0,4/12,11.72%,PDE6B;CACNA2D4;RP1;CNGB1
prerank,GO_Biological_Process_2021__depurination (GO:0045007),-0.7801404640307374,-1.2948190116142198,0.16363636363636364,1.0,1.0,1/8,1.08%,TERF2IP
prerank,PanglaoDB_Augmented_2021__Platelets,-0.52600082286144,-1.2947159129804988,0.09722222222222222,1.0,1.0,21/110,11.88%,TUBB1;C3AR1;HCK;CDKN2D;P2RY12;GMFG;ALOX12;FGL2;CD300LF;F11R;SERPINE1;MYO1F;AQP9;ALDH2;SLC26A4;THEMIS2;HLA-A;CCL5;SPI1;NOX5;PREX1
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.7752585159029888,1.2944572534607153,0.18604651162790697,0.866437420942706,1.0,5/8,14.93%,RYK;FZD1;NR4A2;LRP6;WNT5A
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.6347408760349053,1.2943221622548131,0.13513513513513514,0.8652863202935274,1.0,7/15,21.38%,GRIN2A;GRID2;GRIN2C;GRIN2B;MEF2C;GRIN1;ARRB2
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),0.6418924254744626,1.2936652505993926,0.16,0.8663840238933321,1.0,5/19,10.08%,SLC22A2;SLC16A2;SLC7A1;SLC6A13;SLC6A1
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.533207911258726,-1.2936114194133856,0.09859154929577464,1.0,1.0,32/101,17.30%,SLC28A2;NR1I3;ANKS4B;CDHR5;DEGS2;SOX10;SLC51A;SPON2;ALDOB;NKD2;TMC4;KLF5;RBP2;GPX2;TREH;GBA3;PLIN2;ACSL5;UGT2B7;CA1;ABCG5;TMEM45B;PDZK1;ABCC2;TRPM6;ASPN;SLC23A1;NR5A2;A1CF;KHK;VIL1;HNF4A
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.7768854845759432,-1.2929310688468525,0.1111111111111111,1.0,1.0,2/8,8.28%,TBX1;GLI3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.5872585821278932,1.2928717989293534,0.14285714285714285,0.868664324336604,1.0,8/45,12.13%,EPHA3;STAC;EGFR;EPHB2;PTPN9;PIK3R1;ZDHHC5;PRKCE
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.549003567676172,1.2927415269282403,0.09302325581395349,0.8676503813672397,1.0,10/30,19.21%,CLSTN2;NMB;PTPN23;VAMP3;ECE1;SYT1;GRIK2;HOMER1;KCTD13;HCRT
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),0.8122105578993617,1.2927329019487819,0.1590909090909091,0.8659151499982157,1.0,3/6,12.62%,HRH1;GABRB1;GABRB3
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.6938488649920863,1.2915086504068432,0.25,0.8699520605165011,1.0,6/8,30.59%,NR1H3;PPARA;NR1H2;ABCA1;PPARG;TTC39B
prerank,PanglaoDB_Augmented_2021__Stromal Cells,0.5420050332168661,1.2909272194603214,0.21739130434782608,0.8711894668759566,1.0,15/85,7.22%,ABI3BP;KIT;ADAMTS2;PRRX1;SVEP1;ITGA4;COL15A1;SGCD;PCDH18;FNDC1;TLR1;LAMA4;PDGFRA;SSC5D;HTRA1
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.7013912174421296,1.290801772306597,0.15789473684210525,0.8683192056128204,1.0,4/8,21.51%,NFATC1;NFAT5;PPP3CA;NFATC3
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.7013912174421296,1.290801772306597,0.15789473684210525,0.8683192056128204,1.0,4/8,21.51%,NFATC1;NFAT5;PPP3CA;NFATC3
prerank,GO_Biological_Process_2021__nucleoside triphosphate catabolic process (GO:0009143),0.8067516765336502,1.29076786847572,0.13636363636363635,0.8666269108076635,1.0,2/5,6.02%,ENPP1;ENPP3
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),0.7586441520542562,1.2907197858064243,0.1951219512195122,0.8650476728749948,1.0,3/5,21.41%,RC3H1;NFKB1;RELA
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.5289274997940153,-1.2905112406123591,0.0641025641025641,1.0,1.0,40/104,24.44%,RPL36;RPL15;RPL38;RPS21;NCBP2;RPS7;NCBP1;RPL37A;RPL9;RPL28;RPLP2;RNPS1;RPL5;RPL35A;RPS20;RPLP1;RPL8;RPL4;RPL22;RPL27A;RPL24;RPS15;UPF3B;RPL34;RPL3;RPS24;RPS4X;RPS3;RPS29;RPL13A;RPS8;RPS27A;DHX34;RPL27;RPL37;RPL7A;RPL35;RPL23;RPL32;RPS13
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.7528700144614013,1.2901658676862084,0.2608695652173913,0.8654084025960329,1.0,3/5,22.18%,ASH1L;SETMAR;SETD2
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.625096028666682,1.2899722280545718,0.17647058823529413,0.8648160725351771,1.0,6/21,8.06%,TRPS1;TGFBR1;MDK;GREM1;PKDCC;SOX5
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),-0.6054444896437146,-1.2895117877577837,0.11764705882352941,1.0,1.0,6/30,10.35%,CHAC2;CHAC1;GSTM5;GLRX2;G6PD;GSTP1
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.7900827660871981,-1.2893798428977197,0.1111111111111111,1.0,1.0,6/9,18.40%,B3GNT3;B3GNT9;B3GALT1;B3GNT4;B3GALNT1;B4GAT1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),-0.7646061540236587,-1.2891947888048816,0.13043478260869565,1.0,1.0,3/10,9.10%,TCP1;CCT6A;CCT8
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),-0.7991936588138182,-1.2891578595284392,0.10714285714285714,1.0,1.0,3/7,11.45%,SIGIRR;ITIH4;LBP
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.6094391153108965,-1.2889346662799284,0.06349206349206349,1.0,1.0,14/47,14.94%,GNLY;CD4;ITK;PTPRC;SP140;HLA-DPB1;CD6;TAGAP;CCL5;CNGB1;GBP5;GPR183;CD5;SLA
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.7022871571529342,1.2888706209200487,0.175,0.8681830991836736,1.0,5/15,21.78%,CYSLTR2;ADCY2;ADCY9;ADCY8;PRKACB
prerank,GO_Biological_Process_2021__regulation of microglial cell migration (GO:1904139),-0.8357694946635914,-1.2886216841527156,0.16071428571428573,1.0,1.0,1/5,4.15%,P2RY12
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.7052020876881535,1.2883969149652044,0.125,0.8685353084694151,1.0,4/12,11.34%,ALG8;MPDU1;ALG12;ALG13
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.6514206272546459,-1.2879193243116847,0.13793103448275862,1.0,1.0,12/34,23.33%,CENPK;CENPO;CENPU;ITGB3BP;OIP5;CENPL;KNL1;CENPI;VPS72;SPTY2D1;ACTR6;ANP32E
prerank,GO_Biological_Process_2021__GDP-mannose metabolic process (GO:0019673),0.7868382164465539,1.287273483306641,0.19230769230769232,0.872012626709132,1.0,1/6,3.96%,GMDS
prerank,GO_Biological_Process_2021__protein sialylation (GO:1990743),0.7862624297449201,1.287105577605685,0.1956521739130435,0.8706776019856232,1.0,5/5,21.39%,ST3GAL1;ST8SIA3;ST3GAL2;ST6GALNAC2;ST3GAL4
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.7011442968666618,1.2868191474483663,0.16666666666666666,0.8700544704533203,1.0,3/12,9.96%,ELOVL6;HACD2;TECR
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.812128828691327,1.2867842436476364,0.22727272727272727,0.8685459129038303,1.0,2/5,6.36%,TGFB2;JAG1
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.8061382178891137,1.2862727394727023,0.19444444444444445,0.8687114322975397,1.0,2/6,5.23%,XRCC4;MGMT
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),0.7722340404141758,1.286146034716169,0.15,0.8675237113899634,1.0,1/7,4.86%,XRCC4
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.5934129956266506,-1.285923830966743,0.11764705882352941,1.0,1.0,22/45,30.26%,PSMB6;PSMB8;NQO1;PSMA3;PSMC3;PSMC6;PSMA5;AZIN1;PSMA7;BCKDK;PSMD12;PSME1;PSMB2;PSMD2;PSMA8;PSMA1;PPM1K;PSMC1;PSMD4;PSMD8;PSMB4;PSMC4
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.6762607899507835,1.285464887092164,0.20408163265306123,0.8689626147753006,1.0,4/12,14.80%,IRS1;IRS2;SIRT1;AKT2
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.7373131117543906,1.2853536434686712,0.1282051282051282,0.8676495784420002,1.0,7/10,25.72%,MAPK7;MEF2C;HDAC3;NFE2L2;MTSS1;SREBF2;KLF2
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),-0.8419097346628002,-1.2852645121115671,0.10526315789473684,1.0,1.0,3/6,8.60%,IL21R;STAT1;STAT4
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),-0.8419097346628002,-1.2852645121115671,0.10526315789473684,1.0,1.0,3/6,8.60%,IL21R;STAT1;STAT4
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),-0.8159559842753398,-1.2850524185097028,0.0847457627118644,1.0,1.0,2/5,7.92%,NOTCH1;PRKCH
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.5989060779219312,-1.2847541860873373,0.1323529411764706,1.0,1.0,10/36,16.47%,TIMP3;AGT;TIMP2;SERPINE1;SERPINI2;SERPINA10;KNG1;TIMP4;SERPINF1;SERPING1
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),-0.7898409742100346,-1.284690967267543,0.15384615384615385,1.0,1.0,3/8,19.42%,CCDC39;DNAH7;DNAI3
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.5428637706809634,-1.284646221845112,0.07228915662650602,1.0,1.0,17/90,10.98%,CD44;ENPP2;TNFSF18;PTPRC;ITGA5;AGT;CD74;DOK7;CTF1;TGFB1;FLT3;CRLF1;IL15;IL18;STAP2;CCL5;TEC
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.6541309901567344,-1.2836662019088185,0.1746031746031746,1.0,1.0,5/17,8.59%,ACTC1;ZFPM1;NOTCH1;TGFB1;TTN
prerank,GO_Biological_Process_2021__pteridine-containing compound biosynthetic process (GO:0042559),0.8167721449334348,1.2834824305294454,0.12195121951219512,0.8739952223596557,1.0,3/5,13.00%,MTHFS;GCH1;DHFR
prerank,GO_Biological_Process_2021__double-strand break repair via synthesis-dependent strand annealing (GO:0045003),-0.8708404676053073,-1.283296773935375,0.07272727272727272,1.0,1.0,2/5,6.90%,RAD54L;FANCM
prerank,GO_Biological_Process_2021__regulation of glomerular filtration (GO:0003093),0.7429637177341126,1.2831711185356967,0.2564102564102564,0.8733225485163855,1.0,2/6,6.90%,F2RL1;PTPRO
prerank,GO_Biological_Process_2021__heart process (GO:0003015),0.6621389627791661,1.2825913051990157,0.17142857142857143,0.8744038134853057,1.0,3/11,3.46%,NOX4;SGCD;SGCZ
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),-0.8113067354561417,-1.282448015894834,0.13333333333333333,1.0,1.0,3/6,13.58%,PRDX4;DAB2IP;TLR2
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.6787769653880267,-1.282281940652654,0.1896551724137931,1.0,1.0,7/15,27.67%,PTPRC;YAP1;NANOG;KDM1A;GJA1;SOX11;FBLN1
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.699521391183867,1.2820329720040657,0.14285714285714285,0.8752751865419965,1.0,3/9,23.14%,PIK3R1;WDR81;RBL2
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.6448343894972142,1.2819337472817343,0.18604651162790697,0.873911342024659,1.0,1/15,1.08%,INTS11
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.743255148468254,-1.2819159386701735,0.14545454545454545,1.0,1.0,2/8,11.48%,AGT;SIX4
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.743255148468254,-1.2819159386701735,0.14545454545454545,1.0,1.0,2/8,11.48%,AGT;SIX4
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.6981568329866872,1.2817415575489695,0.1111111111111111,0.872988095958903,1.0,2/11,3.30%,UNC13C;UNC13B
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle contraction (GO:0045987),0.7198499216058631,1.281621960922052,0.21739130434782608,0.8717107407174552,1.0,1/8,0.98%,SPX
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.8011444074392873,-1.280833166301091,0.13114754098360656,1.0,1.0,1/9,0.14%,EPN1
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),0.5749197020191475,1.2806958304439184,0.20588235294117646,0.8745952305891587,1.0,8/26,13.44%,ITGA4;KDR;SEMA5A;AKR1C3;ANGPT1;PAK4;ANO6;MAPK7
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.5951589005739162,1.2804825572582212,0.11428571428571428,0.873650606136562,1.0,12/29,17.50%,GRIA4;GRIA2;EPHB2;GRIN2A;LRRC7;GRIA1;NLGN1;DLG2;GRIN2B;MEF2C;GRIN1;DLG3
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),-0.8077161732253997,-1.2802228261783015,0.1320754716981132,1.0,1.0,1/7,1.08%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.4946535650501377,1.2799481408057956,0.11538461538461539,0.8743354370551267,1.0,5/62,4.65%,IFI16;TYSND1;HSPB1;WDR24;OSBPL7
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),0.5929736274821651,1.2798851173888939,0.08823529411764706,0.8730146944838711,1.0,5/29,8.97%,PLEKHH2;KANK1;IQCJ-SCHIP1;PRKCD;SSH1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),-0.8662415544273282,-1.2796944930395673,0.09433962264150944,1.0,1.0,3/5,5.95%,AGT;NOTCH1;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.6830209612597921,-1.2791335968241988,0.15151515151515152,1.0,1.0,7/19,21.42%,PPP1R1B;FKBP1B;NCKAP1L;CRY2;PPP4R4;BOD1;PPP1R11
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.6192367268817832,1.2786743119363588,0.17142857142857143,0.8770888428101808,1.0,2/14,5.24%,RUNX1;TGFB3
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.6515757164499585,-1.278619610138596,0.171875,1.0,1.0,5/21,10.35%,PTGIS;PTGES;CD74;PTGR1;GSTP1
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.6611610635981935,1.2785280744278065,0.21875,0.8760961984316128,1.0,2/17,7.15%,ATP6V0D2;CLN6
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),-0.6852210375462559,-1.2779677200988693,0.15873015873015872,1.0,1.0,10/19,19.42%,DNAH3;CCDC39;DNAH8;TEKT3;DRC1;CFAP54;DNAH17;DNAH7;RSPH9;DNAI3
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.5161568079574061,1.2777704595354666,0.14634146341463414,0.8782077515062008,1.0,8/37,8.59%,MDGA1;ADA;B4GALNT2;JAG1;EFNA5;PKHD1;FUT9;EPHA7
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),-0.8253194762342551,-1.2773348996668954,0.17391304347826086,1.0,1.0,1/5,6.65%,BEX4
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.8311820701828607,-1.276678820475189,0.18840579710144928,1.0,1.0,1/5,4.16%,YBX3
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),-0.8053807001216845,-1.2765119784426926,0.1267605633802817,1.0,1.0,1/7,2.83%,GOT1
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.6264421743682473,1.2764290102786993,0.17073170731707318,0.8817199717251688,1.0,5/11,20.27%,NRXN1;NLGN1;BSN;PCLO;NPHS1
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.44775302139604384,1.2763881312759389,0.1,0.8801466344356723,1.0,14/124,7.72%,ETV1;RUNX1;ALK;EPHA5;GPRIN2;TGFB2;BTG2;LRP12;BLOC1S4;CNTN4;FRY;APOE;HMGB1;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.7126149051880921,-1.2757058386057596,0.16363636363636364,1.0,1.0,1/14,1.08%,TERF2IP
prerank,GO_Biological_Process_2021__catecholamine biosynthetic process (GO:0042423),0.7377772799374681,1.2752403091221833,0.10638297872340426,0.882814613144423,1.0,2/7,5.07%,GCH1;TGFB2
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.5097932827415106,-1.2751115459393099,0.0821917808219178,1.0,1.0,32/151,13.17%,F8;MYLK;ELK3;HSPG2;EPAS1;NOSTRIN;CYP1B1;SEMA3D;CD82;RASIP1;TIMP3;APOLD1;ANGPTL2;RND1;MEOX1;CASZ1;TBX1;CHST1;USHBP1;IFI27;PROCR;PRKCH;NOTCH4;ADGRF5;PDGFRB;PCDH12;RGS5;A2M;SPARCL1;PLSCR4;EMCN;SRPX
prerank,GO_Biological_Process_2021__fructose catabolic process (GO:0006001),-0.8344952607965119,-1.2745315463560862,0.16666666666666666,1.0,1.0,4/5,16.43%,ALDOB;ALDH1A1;GLYCTK;KHK
prerank,GO_Biological_Process_2021__fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),-0.8344952607965119,-1.2745315463560862,0.16666666666666666,1.0,1.0,4/5,16.43%,ALDOB;ALDH1A1;GLYCTK;KHK
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.74335209518701,-1.2740903591279382,0.09433962264150944,1.0,1.0,4/7,16.65%,B2M;ERAP2;HLA-A;ERAP1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),-0.8009490343249847,-1.2740813996171865,0.07547169811320754,1.0,1.0,1/6,4.99%,ATP1B1
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),-0.8357654876453098,-1.2738451883831432,0.15873015873015872,1.0,1.0,2/6,7.62%,CAPN1;CASP8
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.48113981057601435,1.2736817073027693,0.06666666666666667,0.8877485000275629,1.0,18/164,7.01%,RUNX1;FRMPD1;GNG4;UBASH3B;RGS14;DOK5;KCTD8;WWTR1;RORA;CBFB;SEMA5A;GRK5;PLCB1;TSPAN12;ACVR1;AKR1C3;KIF26A;PTCH1
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.6690219126890455,1.2733805943300518,0.17073170731707318,0.8873709625482995,1.0,7/12,20.89%,WWC1;SHANK2;MAP2K3;VGLL4;DLG5;CIT;MARK3
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),-0.8017406094027542,-1.273222696771375,0.19672131147540983,1.0,1.0,2/6,12.89%,SOD2;PRDX1
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),-0.7094434539469098,-1.2729032614934075,0.19298245614035087,1.0,1.0,1/18,0.09%,ENPP2
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),0.8791413440611998,1.272881004609564,0.08571428571428572,0.8875181255137019,1.0,1/5,2.46%,CROCC
prerank,PanglaoDB_Augmented_2021__Pinealocytes,0.47376336217998855,1.27284517441109,0.043478260869565216,0.8859487358056158,1.0,15/77,7.86%,SV2C;UNC13C;CATSPER2;TNR;PDE10A;PMEPA1;SLC2A11;GABRG3;KCNJ6;MGAT4C;RNFT2;HCN1;SAMD7;SVOP;AP3B2
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),-0.8436857959504613,-1.272616083956409,0.12962962962962962,1.0,1.0,1/5,5.69%,KCNQ1
prerank,GO_Biological_Process_2021__regulation of coagulation (GO:0050818),0.7849604593709091,1.272087364355087,0.16666666666666666,0.8874384386193217,1.0,3/7,5.06%,HS3ST5;F2RL1;EPHB2
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.5807385114280907,1.2715267428178347,0.2,0.8881296811975187,1.0,12/31,15.84%,BMP6;BMP7;TGFB2;TGFB3;ACVR1;PKDCC;NELL1;ANO6;SLC8A1;GPM6B;WNT5A;MEF2C
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.5923792832634712,1.2714599885170936,0.1891891891891892,0.8867411599890678,1.0,8/26,13.16%,NTNG1;PHACTR1;CTNNA2;MDK;ZNF609;NEXMIF;NSMF;SRGAP2C
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.6669527308699721,1.2712833497203702,0.17073170731707318,0.8857281137765386,1.0,3/16,6.91%,KLRD1;RASGRP1;PIK3R6
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.7340120332846192,1.2711105024139635,0.2702702702702703,0.8830987924550503,1.0,2/7,13.16%,NRP1;SIRT2
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.7340120332846192,1.2711105024139635,0.2702702702702703,0.8830987924550503,1.0,2/7,13.16%,NRP1;SIRT2
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),-0.8067538020851971,-1.2708551172542049,0.06666666666666667,1.0,1.0,1/5,5.83%,NOTCH1
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),0.7591554121473989,1.2700243534532933,0.15,0.8855586931487583,1.0,6/10,20.56%,MICU1;MCU;MCUR1;MAIP1;MCUB;SLC25A23
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),0.642921518017862,1.2697994668507715,0.18604651162790697,0.8851433775008499,1.0,2/13,5.04%,ATF3;GSTO2
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.4635568571555941,1.2697980775439766,0.0,0.8834826957419365,1.0,24/115,15.99%,RUNX1;ALK;ATOH8;EPHA5;IL1RAPL1;TGFBR1;TGFB2;FUT9;ERCC2;RYK;FZD1;SPOCK1;NR4A2;TENM4;ATP8A2;NRBP2;ID2;LRP6;ADNP2;WNT5A;PBX4;MEF2C;PBX1;DDIT4
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),0.6315160965482123,1.269606463355715,0.23255813953488372,0.8827067674971605,1.0,6/16,17.08%,LEF1;TFAP4;RRP1B;EP300;SMARCB1;SMARCA4
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.6817464781003049,1.2696039439676141,0.17142857142857143,0.881056848305577,1.0,2/13,3.97%,KDR;HDAC9
prerank,GO_Biological_Process_2021__tachykinin receptor signaling pathway (GO:0007217),0.8388893309006868,1.2694897568000358,0.16216216216216217,0.8800452145887352,1.0,2/6,3.55%,TACR1;GRK5
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),-0.7092337494810007,-1.2684558557008474,0.16981132075471697,1.0,1.0,3/10,7.62%,CD4;IL15;CASP8
prerank,GO_Biological_Process_2021__regulation of bile acid metabolic process (GO:1904251),0.711532735816045,1.2683807366191284,0.2682926829268293,0.8830414664904443,1.0,2/5,13.57%,FGFR4;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),-0.6908371995406152,-1.268310217432341,0.16666666666666666,1.0,1.0,1/12,1.08%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),0.6426026337319375,1.2682766629063513,0.23076923076923078,0.8819087932397218,1.0,2/15,2.36%,CDH13;EGFR
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),0.7530867891454751,1.2676714272297485,0.3,0.8828837510242394,1.0,2/7,12.78%,ZNHIT6;RUVBL2
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.5213063214663024,1.2675907240627355,0.13793103448275862,0.8815383718637202,1.0,9/47,10.20%,HIVEP1;BMP6;BMP7;TGFB2;TGFB3;ACVR1;SMAD2;RGMB;RGMA
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.6310508251365664,-1.2671734974544304,0.14516129032258066,1.0,1.0,6/29,8.59%,CSRP3;SCN4B;ACTC1;ATP1B1;KCNQ1;TTN
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),-0.7093691723639319,-1.266877811852391,0.14285714285714285,1.0,1.0,2/8,20.09%,IL4I1;PCBD1
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),0.7116275536286745,1.2666702935746312,0.23529411764705882,0.8837388957744271,1.0,6/13,14.88%,FHDC1;VTI1A;PRMT5;STX6;TMED5;TRIP11
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),-0.7921422457835106,-1.2660150443088851,0.16923076923076924,1.0,1.0,1/6,9.11%,GNPDA1
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.6021845393238026,1.2655166707999204,0.16216216216216217,0.8876383890477658,1.0,4/23,6.90%,KIT;CDH13;ARFIP2;PTPRO
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.7585462755704075,-1.2653028339825345,0.14814814814814814,1.0,1.0,4/7,23.73%,B2M;HLA-A;HLA-C;HLA-F
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.5251784077785369,1.2652815948115768,0.03571428571428571,0.8873236537147916,1.0,5/53,6.73%,EPHA3;CDH13;MCTP1;CD22;APOE
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),0.6601375934589933,1.2648050426910002,0.2702702702702703,0.8877526841267085,1.0,2/12,7.11%,SRPK3;IWS1
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.6825941569100203,-1.264642067286515,0.18518518518518517,1.0,1.0,7/15,21.15%,ATP5F1E;ATP5F1C;ATP5MC3;ATP5PD;ATP5F1A;ATP5ME;ATP5PB
prerank,GO_Biological_Process_2021__regulation of flagellated sperm motility (GO:1901317),0.7774116247205333,1.2645921684730712,0.2391304347826087,0.8870324043033975,1.0,1/6,0.44%,TACR1
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.43445724859468204,1.264526952506158,0.15,0.8856703438937733,1.0,55/257,16.11%,NRG1;KIT;NRK;PTPN3;IRS1;RCE1;KDR;DUSP5;EGFR;FGF13;KITLG;SPRED1;FGFR4;PDE6D;FGFR3;EREG;BTC;LRRC7;MAP3K20;PDGFRA;FGF10;IL17RD;SHC3;RASGRP1;IGF1;NRG2;RASA2;PSPN;GFRA1;IRS2;ANGPT1;ERBB4;MAPK8;PIK3R1;RASAL2;FGFR1;PRKG2;ABHD17A;MAP3K5;SPTB;SPTBN4;FYN;BTRC;NRTN;MBP;MAPK12;DLG2;BRAF;RASGRF1;IL2RA;FRS2;GRIN2B;MEF2C;PSMD13;NCAM1
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.6265148704212635,1.264425573069574,0.15,0.8844562060124693,1.0,6/25,7.73%,NRP1;EPHB2;EREG;BTC;GREM1;HDAC1
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.5932533457327502,-1.264233882063094,0.0958904109589041,1.0,1.0,6/46,10.85%,ENPP2;RREB1;RAB11A;DAB2IP;DOCK1;CTSH
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.6463015610375935,-1.2641092734845862,0.171875,1.0,1.0,3/17,9.82%,FKBP1B;ATP1B1;CALM3
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),0.7734217964058546,1.2638035881624707,0.21621621621621623,0.8858861083974852,1.0,1/7,2.32%,PPP1R3B
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.6677883977315511,1.2635794867693213,0.2,0.8853881089899854,1.0,1/11,3.10%,COBL
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.5236210916713007,1.2635446696864987,0.10256410256410256,0.8839204751594071,1.0,15/47,15.99%,MDGA1;NRP1;SH3RF1;FGF13;LRP12;AUTS2;MARK1;SPOCK1;GPM6A;FGFR1;NR4A2;NRCAM;DNER;MEF2C;DDIT4
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),-0.7322355801982352,-1.2633719537646189,0.2,1.0,1.0,4/9,18.32%,ATP6AP1;SLC26A4;CLCN3;LACC1
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",0.7652510535557566,1.263066300822647,0.2682926829268293,0.8841137235907774,1.0,2/5,10.79%,NLGN1;ZDHHC3
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.6201662915234651,-1.2630595723905866,0.14285714285714285,1.0,1.0,12/38,23.76%,WIPI1;BNIP3;PINK1;MAP1LC3B2;MAP1LC3B;ULK1;GABARAPL2;FUNDC1;ATG3;CTSK;GABARAPL1;ATG14
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),0.6512116815574588,1.2625858251064426,0.10526315789473684,0.8842354480222407,1.0,3/15,16.45%,KCNB2;CHRM3;CHRM2
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.7661841582026947,1.2625263395787574,0.2619047619047619,0.8812784894318232,1.0,2/6,15.47%,CDC23;ANAPC7
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.7661841582026947,1.2625263395787574,0.2619047619047619,0.8812784894318232,1.0,2/6,15.47%,CDC23;ANAPC7
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.6245075782312384,-1.2624324108306506,0.18309859154929578,1.0,1.0,5/28,8.91%,MYLK;DUOX1;RREB1;SERPINE1;CLDN1
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),0.5533311770385899,1.2623819406752208,0.20512820512820512,0.8803480495291875,1.0,4/37,5.06%,CD38;BCL2;SHLD1;EPHB2
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),0.5888963158279615,1.2621466665357735,0.12121212121212122,0.8798897185361052,1.0,3/16,9.35%,CDH13;CD22;RGN
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.5383906253817394,1.2621379257683787,0.14814814814814814,0.8783100242478896,1.0,14/51,18.49%,PER2;GLP1R;ITPR2;CHD7;KCNC2;KCNS3;GCK;RAPGEF4;EIPR1;RAP1A;KCNA5;RFX3;CACNA1A;ENSA
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),0.7593440307038269,1.2620557231016132,0.05263157894736842,0.8771563656139612,1.0,4/11,13.61%,LTBP1;GREM1;CHRDL1;GREM2
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),0.7219209174793741,1.2620126072088576,0.2,0.8757503991027863,1.0,1/8,0.76%,ADARB2
prerank,GO_Biological_Process_2021__urea cycle (GO:0000050),-0.7448896851820935,-1.2619305071461229,0.1694915254237288,1.0,1.0,4/7,24.77%,ARG2;SLC25A15;ARG1;CPS1
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.6137110436697293,-1.2615143286272275,0.14492753623188406,1.0,1.0,16/33,27.35%,ENO4;ALDOB;MANBA;PGAM1;HKDC1;ENO2;PKLR;NEU1;MAN2B2;PGK1;ENOSF1;HK3;LDHA;DERA;PKM;GAPDH
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.5880178470908811,-1.261466758561123,0.1323529411764706,1.0,1.0,20/43,30.26%,PSMB6;PSMB8;NQO1;PSMA3;PSMC3;PSMC6;PSMA5;AZIN1;PSMA7;PSMD12;PSME1;PSMB2;PSMD2;PSMA8;PSMA1;PSMC1;PSMD4;PSMD8;PSMB4;PSMC4
prerank,PanglaoDB_Augmented_2021__Eosinophils,-0.5537530432901456,-1.2613118011584914,0.15254237288135594,1.0,1.0,11/53,10.83%,C3AR1;HCK;PTPRC;ARHGAP9;GMFG;CD300LF;MYO1F;NCKAP1L;TAGAP;CCL5;SPI1
prerank,PanglaoDB_Augmented_2021__Principal Cells,0.4766743917370398,1.2611107707855733,0.1111111111111111,0.8779564101019638,1.0,10/71,6.03%,ACE2;NPNT;PHACTR1;TMEM229A;PELI2;SLC2A9;CAPN13;COBL;BTC;NR3C2
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.7328850368437306,1.2607768953556981,0.16216216216216217,0.8778780944983963,1.0,3/10,7.35%,LATS1;WWC1;SLC6A4
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.6398250940975072,-1.2606530618341134,0.12280701754385964,1.0,1.0,11/34,22.65%,WIPI1;BNIP3;PINK1;MAP1LC3B2;MAP1LC3B;ULK1;GABARAPL2;FUNDC1;ATG3;CTSK;GABARAPL1
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),-0.6784196816049533,-1.2602701683219966,0.1694915254237288,1.0,1.0,4/12,18.41%,SLC13A4;SLC26A4;SLC25A11;RACGAP1
prerank,GO_Biological_Process_2021__vesicle localization (GO:0051648),-0.8116949184037919,-1.2602405251860431,0.16666666666666666,1.0,1.0,1/5,7.48%,RAB11A
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.6645370471840197,1.2600498795712058,0.1935483870967742,0.8790290147792759,1.0,2/15,8.87%,LRRTM3;SLC2A13
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.830883417835294,1.2599900027071134,0.16216216216216217,0.8777454446008824,1.0,2/7,6.82%,AKR1C3;H6PD
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),-0.6557916294644018,-1.2593879795173517,0.18461538461538463,1.0,1.0,5/19,12.77%,DNASE2;H1-0;GPER1;DNASE2B;BLCAP
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),0.4643882987893051,1.2593697560525927,0.02857142857142857,0.8788694131541739,1.0,14/89,7.33%,CDH13;KDR;NRP1;EGFR;C5AR1;TGFBR1;BMP6;VASH2;SEMA5A;TGM1;MDK;FGF10;IGF1;PKHD1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),-0.7711623699911215,-1.2591133966673953,0.16923076923076924,1.0,1.0,1/11,0.28%,SLC19A3
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),-0.746304149809173,-1.259009490815054,0.140625,1.0,1.0,4/12,16.14%,CHAC1;SERPINE1;CTSZ;GAS1
prerank,GO_Biological_Process_2021__regulation of osteoclast development (GO:2001204),-0.7818382464250635,-1.258895170950794,0.18867924528301888,1.0,1.0,3/5,19.91%,ATP6AP1;SIGLEC15;NOTCH2
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.551063984043225,1.2588086531653693,0.08571428571428572,0.8793666548103324,1.0,8/33,18.68%,SRPK3;IWS1;KHDRBS3;KHDRBS2;PAPOLA;SLTM;QKI;SON
prerank,GO_Biological_Process_2021__adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),-0.7929683272595713,-1.258190726043825,0.2222222222222222,1.0,1.0,1/6,3.79%,DRD3
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.6817862996321283,1.2581170025821746,0.275,0.880737051408381,1.0,2/14,3.28%,RUNX1;CBFB
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),0.8018124265744653,1.2579154415080422,0.2682926829268293,0.879781291487164,1.0,2/6,6.20%,SLC16A2;SLCO1C1
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),-0.7635826950457307,-1.2578345604689913,0.1746031746031746,1.0,1.0,3/6,16.93%,SOX10;PLP1;CNTNAP1
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),0.6256136279647534,1.2574991514068965,0.24390243902439024,0.8798154428665479,1.0,5/14,13.89%,TIMELESS;MTR;KCNC2;FOXO1;SPIDR
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),-0.781142686484976,-1.2573502165490025,0.16923076923076924,1.0,1.0,2/6,5.95%,EID2;TGFB1
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),-0.7618527028848324,-1.2572035260130558,0.10909090909090909,1.0,1.0,1/7,6.59%,CHMP2B
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),0.6930724419492595,1.2569213012551719,0.24489795918367346,0.8808342863305364,1.0,2/9,9.64%,NXF5;RBFOX1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.5743646672615791,-1.2568251908883725,0.18461538461538463,1.0,1.0,3/37,6.13%,CD44;CDKN2D;CARD8
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),0.7920283298076801,1.2567998856607052,0.21052631578947367,0.8797004867168263,1.0,6/7,18.71%,GRIN3A;NLGN1;PTPRS;SRGAP2C;NGEF;PTEN
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),-0.8064062033181221,-1.256662591017796,0.1111111111111111,1.0,1.0,2/8,15.38%,GMNN;DDX11
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.5085992611123447,1.256656704264596,0.11764705882352941,0.8787075927097703,1.0,17/97,5.94%,FBXL7;LAMB2;PRRX1;SVEP1;SEMA6D;EFS;PCDH18;BMP7;CACNA2D1;LAMA4;PDZRN3;GUCY1A2;ALDH1A2;FAT4;ADGRL2;PKDCC;PDGFRA
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.49050141687217036,-1.2566436301904513,0.0821917808219178,1.0,1.0,16/98,13.60%,ACOT4;LIPH;BAAT;ACOX2;ACOT12;LIPI;ALOX12;ALOXE3;ACSBG1;ACSL5;ACSM4;LIPC;ACSM6;ACOT1;ACOT2;FASN
prerank,GO_Biological_Process_2021__endothelium development (GO:0003158),0.7420694233103674,1.2566203534750204,0.2682926829268293,0.8773764330254138,1.0,2/7,6.36%,KDR;JAG1
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),-0.7472749944306865,-1.2566080390592023,0.12857142857142856,1.0,1.0,2/8,13.62%,DRD3;VPS35
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),-0.6320895120507124,-1.2565419563567812,0.1791044776119403,1.0,1.0,10/23,25.03%,HSD17B10;IL4I1;ALDH4A1;ACMSD;DAO;SARDH;FAH;GSTZ1;IDO1;KMO
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.7214041562275619,-1.2563080976637602,0.29508196721311475,1.0,1.0,1/11,1.05%,DOCK8
prerank,GO_Biological_Process_2021__antifungal innate immune response (GO:0061760),-0.8359830775577426,-1.256304945199944,0.1896551724137931,1.0,1.0,2/5,15.04%,RARRES2;PLCG2
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),-0.8300582002597482,-1.25627686843674,0.22727272727272727,1.0,1.0,2/5,6.89%,PINK1;NONO
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.7127096754729001,1.2558984914582347,0.21052631578947367,0.8790519598456841,1.0,3/9,13.01%,PEX7;PLA2G4C;CHPT1
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.5169322367381854,1.2555938494024268,0.15384615384615385,0.8789508062097253,1.0,9/50,10.20%,HIVEP1;BMP6;BMP7;TGFB2;TGFB3;ACVR1;SMAD2;RGMB;RGMA
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),0.7571647702768074,1.2553248251609594,0.2702702702702703,0.8786007045505027,1.0,2/5,4.06%,ALKBH3;ALKBH2
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),0.7771131132666468,1.2551891045986143,0.2894736842105263,0.8775052173728302,1.0,1/5,7.17%,PRKCB
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),-0.8478119895619408,-1.2548119958825386,0.1774193548387097,1.0,1.0,2/5,5.62%,TIMP3;TIMP2
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.5153625756195497,-1.254627682226838,0.09523809523809523,1.0,1.0,33/131,14.12%,OLFML1;LAMA2;EPAS1;CYP1B1;STEAP4;PXMP2;PTGES;TIMP3;AGT;ANGPTL2;ACOX2;FBLN5;ECM2;COL6A1;AOX1;TBX1;RARRES2;RSPO3;F10;ADGRF5;BCAT2;NQO1;PDGFRB;ACTA2;LBP;ADRB1;MEST;PLSCR4;HSD11B1;EPSTI1;TLR2;SRPX2;SERPINF1
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.6479153819962453,-1.2546125424033296,0.15492957746478872,1.0,1.0,6/24,13.54%,ENO4;ALDOB;PGAM1;HKDC1;ENO2;PKLR
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.6785416956545295,1.2544171508410367,0.21428571428571427,0.8791463204923661,1.0,1/14,0.10%,NRG1
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),0.7478589122472736,1.2542729877306502,0.2702702702702703,0.8782791398810719,1.0,2/8,6.63%,PTGFR;AKR1C3
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),0.5349750001417267,1.2535953918974123,0.15625,0.879845716437856,1.0,5/30,5.83%,RUNX1;PNP;HOMER2;NAV3;PDE4D
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.6177968824413711,1.2534199012232887,0.15151515151515152,0.8792050027269589,1.0,3/19,6.73%,RORA;ACADVL;APOE
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.48932540258448426,1.2531265757508057,0.12121212121212122,0.8784992058428016,1.0,13/61,17.32%,EPM2A;WDR24;MINAR1;PKHD1;TTI1;FAM83D;GNA12;TELO2;SIRT1;DYRK3;DDIT4;WDR59;HDAC3
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),-0.7537761844700566,-1.2530156105042756,0.2037037037037037,1.0,1.0,1/9,1.89%,ZNF703
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),0.7181495128291635,1.2526544186400455,0.24242424242424243,0.8790497324650126,1.0,2/10,7.17%,NEK6;PRKCB
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.6016508483793628,1.2526098008245703,0.21428571428571427,0.8776983968790816,1.0,2/19,5.06%,ACE2;EPHB2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.559150531049259,1.2525004140624816,0.16666666666666666,0.8766194614224584,1.0,10/45,13.42%,EPHA3;STAC;EGFR;EPHB2;PTPN9;GNAI1;PIK3R1;ZDHHC5;PRKCE;NUMA1
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.6473849214337037,-1.2520795337745187,0.136986301369863,1.0,1.0,8/29,13.03%,LRPAP1;B2M;LDLRAP1;RAC1;SERPINE1;PIK3CB;HIP1R;FLOT1
prerank,GO_Biological_Process_2021__mesonephros development (GO:0001823),0.7846551055530522,1.2520775534030846,0.3333333333333333,0.8766134727834227,1.0,2/5,6.24%,BMP7;FGF10
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.6616207430417721,-1.2520120635225978,0.2,1.0,1.0,6/18,17.52%,ENC1;PSMB6;PSMB8;PSMA3;PSMA5;PSMA7
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),-0.7557413451101361,-1.251972972169807,0.25,1.0,1.0,3/8,12.80%,CHAC2;CHAC1;ALDH4A1
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),0.7520797630157666,1.2519356026763528,0.2631578947368421,0.8757402148835687,1.0,2/11,6.36%,KLRD1;JAG1
prerank,GO_Biological_Process_2021__lymphoid progenitor cell differentiation (GO:0002320),-0.8117318691624709,-1.2518334330096823,0.16666666666666666,1.0,1.0,3/5,16.01%,FLT3;SPI1;SHH
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.45063447799765427,1.2515326833599116,0.09090909090909091,0.875802345452204,1.0,28/139,15.99%,RUNX1;MDGA1;PER2;ATOH8;NRP1;SH3RF1;FGF13;IL1RAPL1;HEY1;TGFB2;LRP12;TAFA1;FUT9;RYK;FZD1;AUTS2;MARK1;SPOCK1;GPM6A;FGFR1;NR4A2;NRBP2;ADNP2;NRCAM;WNT5A;DNER;MEF2C;DDIT4
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),0.7073082727022215,1.2514725146547336,0.21739130434782608,0.8745788363686864,1.0,2/9,5.72%,KIT;ENPP1
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.626813712418156,1.251039689353667,0.16666666666666666,0.8748861019764155,1.0,3/13,12.60%,TBC1D16;VAMP3;ECE1
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.7006906679249506,-1.2503237850316675,0.16129032258064516,1.0,1.0,3/11,5.86%,ZNF703;ALOX12;ADAMTS18
prerank,GO_Biological_Process_2021__response to cGMP (GO:0070305),0.8251152733335977,1.2502294553529916,0.2558139534883721,0.8747257617485865,1.0,1/5,1.45%,PDE3A
prerank,GO_Biological_Process_2021__cellular response to cGMP (GO:0071321),0.8251152733335977,1.2502294553529916,0.2558139534883721,0.8747257617485865,1.0,1/5,1.45%,PDE3A
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),0.703864637055386,1.2499647650358297,0.2,0.8747010299278815,1.0,2/10,8.31%,ADA;HPRT1
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),-0.8184885326306385,-1.2497754723650132,0.16,1.0,1.0,3/6,8.83%,ALDH1A1;GAD1;BCAT2
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.6234268227299824,-1.2496141335114341,0.16176470588235295,1.0,1.0,11/21,29.40%,SOX10;ARTN;GFRA3;ADGRB1;GPC1;SERPINI1;ADGRG6;UGT8;BDNF;ADGRB2;NTF3
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),-0.7867325367934968,-1.249201309408248,0.18461538461538463,1.0,1.0,2/5,3.46%,CD4;CD74
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),-0.7867325367934968,-1.249201309408248,0.18461538461538463,1.0,1.0,2/5,3.46%,CD4;CD74
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.5411316983569474,1.2491432787181336,0.1,0.8766102421692838,1.0,7/29,5.75%,TGFBR1;BMP6;BMP7;BMP3;TGFB2;TGFB3;ACVR1
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.8239073780652487,1.2491004933940921,0.275,0.8752660995093557,1.0,4/7,8.89%,NFIB;NRP1;EPHB2;RYK
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.5555102841998656,-1.2490918058802767,0.16417910447761194,1.0,1.0,24/52,26.80%,NDUFB9;COX4I1;NDUFA2;NDUFB3;UQCRB;NDUFC1;CYCS;NDUFB2;NDUFS2;NDUFB4;NDUFAB1;COX7A2L;COX6C;NDUFA1;NDUFB11;NDUFS5;COX6B1;NDUFB10;NDUFA3;COX7C;NDUFB6;COX7B;UQCR10;UQCRH
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.6416256636554867,1.2489488424664297,0.20454545454545456,0.8745616277947791,1.0,3/14,4.59%,RUNX1;LEPR;MDK
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.8038210497050085,-1.2487470139574184,0.21428571428571427,1.0,1.0,2/8,7.73%,ZBTB7B;NCKAP1L
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),0.7457934184496733,1.248631676159008,0.18181818181818182,0.8741437660323307,1.0,1/8,2.13%,TMOD4
prerank,GO_Biological_Process_2021__regulation of monocyte chemotactic protein-1 production (GO:0071637),-0.7894099692330548,-1.2485771217936819,0.18181818181818182,1.0,1.0,4/6,17.96%,GSTP1;APOD;OAS3;TWIST1
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.5544893542399886,-1.2485485865066104,0.1724137931034483,1.0,1.0,5/42,9.27%,FRRS1;CP;ATP6AP1;NUBP1;SKP1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),-0.7842310640703025,-1.248451627963802,0.25,1.0,1.0,2/7,5.69%,KCNE2;KCNQ1
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.6452101630610317,-1.2480880932320686,0.18032786885245902,1.0,1.0,7/20,17.08%,CHAC2;CHAC1;ERAP2;CTSH;LVRN;ERAP1;NAALADL1
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,-0.5949930642000757,-1.2477729542166098,0.13333333333333333,1.0,1.0,8/35,10.83%,HCK;PTPRC;CD300LF;MYO1F;AQP9;TAGAP;IGSF6;SPI1
prerank,GO_Biological_Process_2021__terpenoid metabolic process (GO:0006721),0.9105629762392216,1.247705002311766,0.11904761904761904,0.8763685463982888,1.0,1/5,0.56%,CYP1A2
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),-0.6944368136061875,-1.2475494240339124,0.16901408450704225,1.0,1.0,1/15,0.29%,C3AR1
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),0.7667671583086555,1.2471297369555125,0.22727272727272727,0.8771476175926364,1.0,5/7,22.55%,NLGN1;SGIP1;CFAP20;MEF2C;NPAS2
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.7251793412165615,1.247073420182019,0.18,0.8759008199621865,1.0,4/9,14.80%,IRS1;IRS2;PRKCE;AKT2
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.6344225437020768,1.2469885980468267,0.13157894736842105,0.874701616936156,1.0,6/17,13.66%,MOB3B;IQCJ-SCHIP1;WWC1;SHANK2;MAP2K3;VGLL4
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.7161587374864239,-1.2467156174280265,0.25,1.0,1.0,4/10,16.91%,PRLR;STAT5A;LYN;STAT6
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.49102124316424517,1.24665763789949,0.13636363636363635,0.8745038303095213,1.0,16/101,10.20%,ITGB5;PTPRK;HIVEP1;TGFBR1;BMP6;BMP7;PARD3;TGFB2;TGFB3;FOS;ACVR1;SMAD2;RGMB;TGFBR3L;RGMA;TWSG1
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),-0.7012378786892826,-1.2465635124910164,0.24242424242424243,1.0,1.0,2/13,2.99%,CYP1B1;RDH10
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),-0.6973114636696485,-1.2461195021621636,0.21212121212121213,1.0,1.0,3/13,11.27%,MYLK;SMTN;ACTA2
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.5377611495531422,1.2455630333667815,0.13157894736842105,0.8774238902366732,1.0,13/30,24.34%,IL1RAPL1;FBXW8;KNDC1;ADGRB3;NSMF;HECW2;NEDD4L;GORASP1;NEDD4;PTPRD;RAP2A;CAPRIN1;CUX1
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),-0.7916984634660948,-1.245497225342825,0.1746031746031746,1.0,1.0,1/6,2.30%,NDP
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),-0.6845743432707829,-1.2454814171040514,0.23809523809523808,1.0,1.0,1/17,0.98%,HENMT1
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.5451160206848302,1.245162286401769,0.16129032258064516,0.8773519125687858,1.0,16/42,25.53%,PRR5L;BTG2;MEX3D;KHSRP;RC3H1;PNPT1;CELF1;NANOS3;FTO;ZFP36L2;TNRC6B;ROCK2;ZC3HAV1;AGO2;ZFP36;POLR2G
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),0.7046575462932361,1.2451105957935433,0.3170731707317073,0.8761366733437523,1.0,2/6,15.66%,DACH1;CREB1
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),0.7568157706659615,1.2450028983613972,0.28205128205128205,0.8749039116307101,1.0,1/7,5.04%,DNAJB12
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.504779603595989,-1.2445361191738722,0.08974358974358974,1.0,1.0,17/94,18.93%,TICRR;MCM2;POLE3;CDC6;RFC5;RPA3;BRCA1;MRE11;DONSON;RMI1;POLE2;CHEK1;CDK2AP1;RBBP8;KAT5;SET;RAD9B
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.5081946882938151,-1.2443822881624504,0.1095890410958904,1.0,1.0,23/124,15.51%,CD4;BTN2A2;ITK;PTPRC;HHLA2;TXK;PSMB6;FYB1;HLA-DPB1;PSMB8;THEMIS;PIK3CB;SKP1;THEMIS2;PSMA3;HLA-A;TEC;PSMC3;PSMC6;PSMA5;PLCG2;WAS;EIF2B5
prerank,GO_Biological_Process_2021__response to morphine (GO:0043278),-0.7673184041674134,-1.2443027163529639,0.1509433962264151,1.0,1.0,1/5,3.79%,DRD3
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by integrin (GO:0033634),-0.7502684446663623,-1.2440472543656529,0.25,1.0,1.0,4/5,18.87%,CCL5;CXCL13;PODXL;SKAP1
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.46594741569835624,-1.2437558345651007,0.08450704225352113,1.0,1.0,65/180,27.70%,HSD17B10;ATP1B1;COX4I1;ATP6AP1;SLC25A3;ATP6V1E1;ETFB;ATP6V1D;ATP5F1E;NDUFA2;RETSAT;MDH1;SLC25A5;NDUFB3;UQCRB;ATP5F1C;NDUFC1;TOMM22;CYCS;CYB5R3;ATP6V1C1;SLC25A4;SLC25A11;VDAC1;LDHB;NDUFB2;NDUFS2;ATP5MC3;SUPV3L1;NDUFB4;NDUFAB1;ISCU;COX7A2L;COX6C;COX7A2;HSPA9;PRDX3;IDH3A;ATP5PD;NDUFA1;PDHX;VDAC3;MAOB;ATP5F1A;DECR1;ATP5ME;ATP5PB;COX6B1;NDUFA3;COX7C;ATP6V0B;TIMM17A;LDHA;ATP6V1G1;IDH3B;VDAC2;BAX;NDUFB6;COX7B;UQCR10;DLST;UQCRH;ALDH6A1;OXA1L;MRPL34
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),-0.7483030634254603,-1.243643580573645,0.15789473684210525,1.0,1.0,1/11,1.08%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),0.5950419839332294,1.2434250100357969,0.1956521739130435,0.8792233184272704,1.0,3/27,4.30%,PER2;HDAC9;HEY1
prerank,GO_Biological_Process_2021__negative regulation of lipase activity (GO:0060192),0.7514252911638513,1.2433852622423816,0.2631578947368421,0.8779036581039502,1.0,2/6,8.75%,HDAC9;PLIN5
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.6692192852922773,1.2431394440294379,0.23333333333333334,0.8774456798011226,1.0,3/22,5.47%,NRG1;CTNNA2;OLFM2
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.6530935804779923,-1.2427549495048573,0.15517241379310345,1.0,1.0,4/15,10.38%,H1-2;H1-0;CHAF1A;HAT1
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),-0.7860278654950374,-1.2425627763325424,0.12307692307692308,1.0,1.0,2/8,3.79%,DUOX1;TPO
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),0.8010626364844577,1.242495699310203,0.2765957446808511,0.8769187664353574,1.0,1/5,1.31%,TOX
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),0.8010626364844577,1.242495699310203,0.2765957446808511,0.8769187664353574,1.0,1/5,1.31%,TOX
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.5775513984731278,1.2424477571242218,0.16666666666666666,0.8755901889427898,1.0,10/26,15.84%,BMP6;BMP7;TGFB3;ACVR1;PKDCC;NELL1;ANO6;SLC8A1;GPM6B;MEF2C
prerank,GO_Biological_Process_2021__long-chain fatty acid catabolic process (GO:0042758),0.8284377236855404,1.2423313415345114,0.2857142857142857,0.8745214744556619,1.0,1/5,0.57%,GLYATL2
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.7158583533055629,1.2420737991264212,0.32432432432432434,0.8746042166545398,1.0,3/6,17.82%,ERCC8;UVRAG;ZBTB7A
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),0.7317877468956345,1.2420085621422146,0.2222222222222222,0.8734556928294334,1.0,4/7,21.51%,NFATC1;DNMT1;PDGFB;NFATC3
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.5709875015736158,1.2418678023073177,0.1794871794871795,0.872501610144015,1.0,10/29,15.84%,BMP6;BMP7;TGFB3;ACVR1;PKDCC;NELL1;ANO6;SLC8A1;GPM6B;MEF2C
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),-0.7130438546600802,-1.24181182855057,0.21311475409836064,1.0,1.0,2/6,20.09%,IL4I1;PCBD1
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),0.732987820120096,1.2415074120550251,0.16666666666666666,0.8724602973681251,1.0,2/10,14.65%,SRM;HDAC10
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),0.6979811519162067,1.241323491715393,0.18421052631578946,0.8719122173586278,1.0,4/8,5.75%,TGFBR1;TGFB2;TGFB3;ACVR1
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),-0.7706391400996977,-1.241285314496837,0.14925373134328357,1.0,1.0,3/11,19.17%,GMNN;DDX11;ZNF304
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),-0.5791631263506413,-1.2412594130954113,0.19402985074626866,1.0,1.0,3/34,5.99%,HENMT1;TDRD1;TDRD9
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.6249578766349033,1.24092116700586,0.24390243902439024,0.8720195989261107,1.0,4/14,15.77%,RORA;MLYCD;SIRT1;FOXK1
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.5462764946284488,1.2407624696136643,0.16666666666666666,0.8711161068578743,1.0,4/32,5.61%,LEF1;NFATC1;PLCB1;GNAO1
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),-0.7992039029785696,-1.2403894803227196,0.18032786885245902,1.0,1.0,2/5,5.95%,STAT1;TGFB1
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),-0.7992039029785696,-1.2403894803227196,0.18032786885245902,1.0,1.0,2/5,5.95%,STAT1;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of systemic arterial blood pressure (GO:0003085),-0.773542388503334,-1.2402317521110962,0.23880597014925373,1.0,1.0,2/5,12.08%,SOD2;ADRB1
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),-0.7087501093728485,-1.240212431698128,0.20967741935483872,1.0,1.0,4/13,16.42%,SHCBP1L;MRE11;DDX11;GNL3
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.7360094692121469,1.2400064635110615,0.2391304347826087,0.8724435097184129,1.0,4/6,23.50%,CFLAR;AKIRIN1;PPP3CA;LARGE1
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),-0.7494961684092629,-1.23992220216925,0.171875,1.0,1.0,3/8,18.43%,PRDX4;PRDX1;PRDX3
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.6636442761938907,1.2398783079432525,0.23076923076923078,0.8713743661264753,1.0,2/16,2.93%,SLC39A11;SLC30A10
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),-0.7768564465068539,-1.2396807345948269,0.19298245614035087,1.0,1.0,1/7,2.33%,HSD17B10
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),-0.6292596189001094,-1.2396721574805911,0.18181818181818182,1.0,1.0,2/22,1.05%,PRLR;CYP19A1
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.7358050402203739,-1.2395503086588815,0.11475409836065574,1.0,1.0,2/9,9.82%,FKBP1B;CALM3
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.7358050402203739,-1.2395503086588815,0.11475409836065574,1.0,1.0,2/9,9.82%,FKBP1B;CALM3
prerank,GO_Biological_Process_2021__acid secretion (GO:0046717),-0.819780690372817,-1.2392914087871016,0.14285714285714285,1.0,1.0,3/5,11.38%,SLC51A;DRD3;ABCB4
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.5496998613480487,-1.2390686208872757,0.16176470588235295,1.0,1.0,24/53,26.80%,NDUFB9;COX4I1;NDUFA2;NDUFB3;UQCRB;NDUFC1;CYCS;NDUFB2;NDUFS2;NDUFB4;NDUFAB1;COX7A2L;COX6C;NDUFA1;NDUFB11;NDUFS5;COX6B1;NDUFB10;NDUFA3;COX7C;NDUFB6;COX7B;UQCR10;UQCRH
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.6322113527515475,1.2389112164482456,0.1891891891891892,0.8737655916614059,1.0,8/15,28.96%,BTG2;TNRC6B;AGO2;ZFP36;POLR2G;TNRC6A;TENT4B;TOB1
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.6260444853143746,-1.2388394470971607,0.189873417721519,1.0,1.0,8/26,12.99%,ACOT4;BAAT;ACOT12;ACOT13;ACSM4;ACSM6;ACOT1;ACOT2
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.6260444853143746,-1.2388394470971607,0.189873417721519,1.0,1.0,8/26,12.99%,ACOT4;BAAT;ACOT12;ACOT13;ACSM4;ACSM6;ACOT1;ACOT2
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),-0.6414158490552513,-1.238380326905815,0.14516129032258066,1.0,1.0,5/27,9.94%,RAB6C;CHMP4B;CHMP2B;C10ORF90;CHMP2A
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),-0.7843089653821133,-1.238239199732253,0.2631578947368421,1.0,1.0,4/5,19.73%,HLA-DMA;TAPBPL;HLA-DMB;CALR
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.4294374187704926,1.2380770180849083,0.09090909090909091,0.8756471214342855,1.0,36/152,16.13%,POU6F2;NKAIN3;KCTD8;MAPK4;SLC35F1;OLFM3;ADGRA1;CDK14;GRIA2;TOX2;PLPPR5;GALNTL6;BRINP1;TMEM196;GRIP1;MTUS2;PAK5;RBFOX1;NELL1;MMD2;FBLL1;ADGRB3;DTX1;ST8SIA3;NGF;ELAVL3;FGF12;GPHN;NXPH1;GALNT14;NYAP1;MAP6;CPNE4;DNER;KCNC1;YDJC
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),-0.6257401958779448,-1.2377679557694532,0.19696969696969696,1.0,1.0,5/21,15.07%,LMAN1;UFM1;BAG4;APOD;RAB23
prerank,GO_Biological_Process_2021__cerebellar granule cell differentiation (GO:0021707),0.7719986665616159,1.2372165420082148,0.2,0.8777732280417776,1.0,4/5,20.35%,KNDC1;GRID2;OPHN1;PROX1
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.5738309389108192,1.2370854097760329,0.19444444444444445,0.8768066520890737,1.0,4/26,6.90%,KIT;CDH13;ARFIP2;PTPRO
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),0.8093669954160635,1.2369319207164646,0.25,0.875905615917506,1.0,1/6,0.22%,FBXL7
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),0.6019407364691245,1.2368173575489256,0.23333333333333334,0.8749866698394756,1.0,6/14,21.96%,UNC13B;PARD3;TENM4;HCRT;MYRF;RIMS2
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.631431118466416,-1.2367668083465169,0.25,1.0,1.0,5/26,14.97%,ARIH2;PINK1;UBL5;TOMM7;PDCD5
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.6826386616497802,1.2367663251429772,0.19444444444444445,0.8737801373289953,1.0,2/16,2.93%,SLC39A11;SLC30A10
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.5473517397186011,-1.2366665986960714,0.13846153846153847,1.0,1.0,21/56,13.72%,C4BPB;PRLR;ANKS4B;UPB1;HSD17B2;TPO;ALDOB;SPTLC3;LECT2;SERPINA10;ITIH2;ABCC6;ASGR1;UGT2B7;KNG1;LIPC;TSHR;ABCG5;TMEM45B;PDZK1;FMO5
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.4579423565288653,1.2366157297357776,0.13793103448275862,0.8729089281955359,1.0,19/135,9.92%,LRIG3;KIT;TEAD2;ITGA4;LEF1;ADGRA3;KITLG;FRAS1;PARD3;ADGRL2;IL17RD;PRDM5;MID1;GNG12;SMAD2;PRTG;AMOTL2;FZD1;CDK8
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),-0.6716953686921892,-1.2362085400871334,0.21212121212121213,1.0,1.0,5/15,20.14%,SOX10;PLP1;EIF2B5;CNTNAP1;EIF2B2
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.7506338256282954,-1.2354897206236115,0.20588235294117646,1.0,1.0,2/9,10.44%,IL18;HLA-A
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.4546773084727484,-1.2352005180976209,0.023529411764705882,1.0,1.0,81/394,16.15%,CD44;HCK;CD4;PRLR;TNFSF18;DUOX1;PLP2;B2M;IL3RA;IL21R;OSMR;TCP1;IL20RA;JUNB;TRIM22;STAT1;CD300LF;IRF1;CTF1;CIITA;IFIT1;TGFB1;IL7;PSMB6;NDN;SOD2;FLT3;IFI27;CRLF1;HLA-DPB1;CD27;IL15;IFNGR2;PSMB8;TOLLIP;STAT5A;STAT4;PIK3CB;TRIM5;ISG20;IFIT3;TRIM25;SKP1;TRAF3IP2;CA1;IL18BP;IL18;PSMA3;HLA-A;TMSB4X;CCL5;IFNLR1;SPI1;TEC;PELI3;IL18R1;TXLNA;LBP;PSMC3;BAG4;INPPL1;TXNDC17;MSN;LTBR;IFI6;IFIT5;YAP1;CDKN1B;PSMC6;PSMA5;PTPRZ1;F13A1;SLA;RBX1;OAS3;XAF1;CXCL13;NANOG;OPRD1;NFKBIA;ADAM17
prerank,GO_Biological_Process_2021__establishment of centrosome localization (GO:0051660),0.777872171971561,1.2351740475990387,0.24390243902439024,0.8776668193531788,1.0,3/6,11.44%,PARD3;PKHD1;PARD3B
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.595995567520308,-1.2351664124497213,0.1724137931034483,1.0,1.0,5/46,3.46%,CD44;CD4;ITK;PTPRC;CD74
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),-0.7750497540138501,-1.2351035509053847,0.23636363636363636,1.0,1.0,3/7,11.84%,ALDH1A1;ALDH2;ADH5
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),0.5497170622164339,1.2346711920981943,0.21212121212121213,0.8780106960743419,1.0,5/26,6.63%,LHFPL2;KIT;KITLG;TGFB2;AKR1C3
prerank,GO_Biological_Process_2021__sequestering of BMP from receptor via BMP binding (GO:0038098),0.7210754867733935,1.2345245688391524,0.22727272727272727,0.8772400264774832,1.0,3/7,13.61%,GREM1;CHRDL1;GREM2
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),-0.5947789366889912,-1.2344872542475023,0.20833333333333334,1.0,1.0,3/39,1.95%,MYLK;SCN4B;WFS1
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),0.48003298247577236,1.2344298423755167,0.14285714285714285,0.8762865086751518,1.0,6/66,6.73%,PLEKHH2;FGF13;KANK1;NAV3;PRKCD;APOE
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.7804280152960505,1.2344261689215321,0.3157894736842105,0.8749454623955233,1.0,1/6,5.39%,NBDY
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),-0.7229698274232386,-1.2343014874137033,0.18032786885245902,1.0,1.0,1/10,1.30%,LOXL4
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),-0.6164211863822079,-1.2340606953688031,0.14492753623188406,1.0,1.0,10/32,18.42%,ZFPM1;STAT1;NCKAP1L;ZNF16;SPI1;INHBA;MAFB;LYN;FAM210B;HSPA9
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.5700765009240539,1.2340408572904513,0.1724137931034483,0.8751272811332381,1.0,7/20,14.21%,RAB7A;STX8;PTPN23;WDR81;SNF8;HOOK3;RILP
prerank,GO_Biological_Process_2021__cellular triglyceride homeostasis (GO:0035356),0.7449925761642581,1.2340132006599835,0.2608695652173913,0.8737717847536187,1.0,3/5,25.41%,SIRT1;FITM2;NR1H4
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.5061922222245364,1.2335798758765042,0.18518518518518517,0.8740980793563787,1.0,11/69,10.20%,ITGB5;PTPRK;TGFBR1;PARD3;TGFB2;TGFB3;FOS;ACVR1;SMAD2;TGFBR3L;TWSG1
prerank,GO_Biological_Process_2021__positive regulation of cilium movement (GO:0003353),0.7794763526345458,1.2334414526550856,0.25,0.8705301526970182,1.0,1/5,0.44%,TACR1
prerank,GO_Biological_Process_2021__positive regulation of cilium-dependent cell motility (GO:2000155),0.7794763526345458,1.2334414526550856,0.25,0.8705301526970182,1.0,1/5,0.44%,TACR1
prerank,GO_Biological_Process_2021__positive regulation of flagellated sperm motility (GO:1902093),0.7794763526345458,1.2334414526550856,0.25,0.8705301526970182,1.0,1/5,0.44%,TACR1
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.5022901798539694,1.232630167720938,0.125,0.8722622440683004,1.0,8/47,10.37%,IFI16;CARD18;F2RL1;HSPB1;IGF1;SERPINB1;STMP1;MALT1
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),0.7053400209247962,1.232207763812546,0.21428571428571427,0.8724259614095478,1.0,7/9,25.88%,SMPD4;SGMS1;SMPD3;SGMS2;SMPDL3A;ABCA2;SAMD8
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.6318780938982713,1.2320464737921792,0.2571428571428571,0.8715960939362488,1.0,8/13,30.59%,SCARB1;NR1H3;PPARA;SREBF2;NR1H2;ABCA1;PPARG;TTC39B
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),-0.7281072870583306,-1.2314702204257313,0.16393442622950818,1.0,1.0,2/11,1.99%,DOCK8;TNFSF18
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),-0.6775920360617679,-1.2314151088426128,0.25862068965517243,1.0,1.0,3/15,5.69%,KCNE2;CAV3;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of cAMP-mediated signaling (GO:0043950),-0.8264367417599566,-1.2311197014553021,0.1320754716981132,1.0,1.0,1/6,2.31%,CGAS
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),0.6110815759173063,1.2309097278828884,0.22727272727272727,0.8742695241558649,1.0,3/11,25.05%,PARP10;PARP6;PARP3
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.5682656138974943,1.2308596606873001,0.24242424242424243,0.8732373316209336,1.0,9/37,9.66%,NPNT;WWTR1;BMP6;BMP7;ACVR1;ZHX3;IGF1;PRKD1;NELL1
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),0.6184952821838454,1.2306817706391115,0.25,0.8726723075226311,1.0,3/15,8.98%,KIT;ALAS1;LYAR
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),0.7376767069869608,1.2306277440401938,0.2571428571428571,0.8715249250333431,1.0,4/6,25.72%,MAPK7;NFE2L2;SREBF2;KLF2
prerank,GO_Biological_Process_2021__positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),-0.7985857240456542,-1.2305656760846908,0.21212121212121213,1.0,1.0,2/5,12.31%,PTGIS;GPS2
prerank,GO_Biological_Process_2021__mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),-0.8223114084240115,-1.2293673618684804,0.18032786885245902,1.0,1.0,1/5,10.82%,SLBP
prerank,GO_Biological_Process_2021__lipoxin metabolic process (GO:2001300),-0.8100814080367493,-1.228803287484565,0.23728813559322035,1.0,1.0,2/5,5.46%,ALOX12;PTGR1
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),-0.6843566376526612,-1.2287917914780921,0.22666666666666666,1.0,1.0,1/12,4.66%,LMAN1
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell proliferation (GO:1902033),0.7164655902317987,1.2281700083916565,0.23076923076923078,0.8793704633415663,1.0,2/6,21.02%,PDCD2;THPO
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),-0.7680251939270138,-1.227888883700498,0.22950819672131148,1.0,1.0,1/7,7.44%,ZBTB7B
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),-0.8141760785925027,-1.2278635618240958,0.2553191489361702,1.0,1.0,1/5,0.85%,PRLR
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),0.6233038901433418,1.2276269089063903,0.3125,0.8800234493295335,1.0,4/15,14.01%,METTL8;TRMT61A;ZC3H13;TRMT61B
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),-0.8340579051556155,-1.2273507878575785,0.2,1.0,1.0,4/5,16.03%,SLC25A5;SLC25A4;TSC2;VDAC1
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),0.6911540080815224,1.2272627701294068,0.23076923076923078,0.8788411965832745,1.0,2/11,7.86%,BLOC1S4;AP3B2
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),0.6911540080815224,1.2272627701294068,0.23076923076923078,0.8788411965832745,1.0,2/11,7.86%,BLOC1S4;AP3B2
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),-0.706275917512434,-1.2271571395770362,0.2857142857142857,1.0,1.0,1/8,0.62%,MCM2
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),-0.5739682623999951,-1.2270475837362604,0.23333333333333334,1.0,1.0,6/37,8.59%,CSRP3;SCN4B;RCSD1;ATP1B1;KCNQ1;TTN
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.5905995561266516,1.2268954310810236,0.23076923076923078,0.8791122350537312,1.0,3/20,10.97%,DGKB;DGKH;PNPLA2
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),0.7333192205081627,1.2267278421599095,0.30434782608695654,0.8785043581190806,1.0,2/6,14.37%,GCK;EP300
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),0.7173104736659258,1.2266170397535625,0.18421052631578946,0.8775197467251917,1.0,3/9,12.15%,FGFR3;RASGRP1;FGFR1
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.7001577605231867,-1.2260722815709715,0.22950819672131148,1.0,1.0,1/14,1.08%,TERF2IP
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),0.6852063021748669,1.2258901857989921,0.2571428571428571,0.8790847718744922,1.0,2/10,9.49%,PRMT5;PRMT8
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.5740502369663674,1.2258642242734255,0.20930232558139536,0.8778440297199223,1.0,11/23,23.78%,CLSTN2;NMB;PTPN23;SYT1;GRIK2;HOMER1;KCTD13;HCRT;ANK3;RIMS2;EDN1
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.7453753895492933,-1.225623720310426,0.16363636363636364,1.0,1.0,4/10,14.98%,AGT;PRKCH;IL18;PLA2G10
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),-0.7016213888645763,-1.2252768151796767,0.2222222222222222,1.0,1.0,2/13,5.15%,HSD17B10;RPP38
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),0.7444035058160068,1.2249193729610024,0.2,0.8798996717019315,1.0,4/8,7.77%,SPRED1;SPRED2;SPRED3;ZEB1
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.5727831939756046,1.2247847406885373,0.1388888888888889,0.8789981446040518,1.0,11/23,20.56%,MICU1;MCU;CACNA1I;CACNB2;SLC8A1;MCUR1;MAIP1;MCUB;CACNA1A;CACNA1B;SLC25A23
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.38657032624666454,1.2246532126386638,0.0,0.8782180022654554,1.0,43/394,11.22%,CD38;MYRFL;RUNX1;CREB5;TEAD2;ATOH8;NFIB;LEF1;ZNF496;NFATC1;EGFR;KDM8;RORA;FANK1;TGFBR1;BMP7;PLCB1;ESRRG;HEY1;TGFB3;FOS;BRCA2;ACVR1;ARID1B;APOE;ARID1A;IGF1;MED30;HDAC1;ELF2;SMAD2;RGMB;WBP2NL;ERBB4;TFAP4;POU3F1;FZD1;TASP1;RYBP;FLI1;CDK5RAP2;TCF4;FOXO1
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.621350336848348,1.2244587125019633,0.25,0.8775389481134557,1.0,3/14,7.13%,NRG1;JAG1;IGF1
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),-0.7042009712332797,-1.2242891907824678,0.1774193548387097,1.0,1.0,2/14,5.56%,TICRR;CDC6
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.4735921526171147,1.2240111043984871,0.15789473684210525,0.8779659859361034,1.0,11/68,9.21%,CDH13;ATOH8;KDR;NRP1;TGFBR1;VASH2;SEMA5A;VASH1;APOE;ANGPT1;PRKD1
prerank,"GO_Biological_Process_2021__fructose 1,6-bisphosphate metabolic process (GO:0030388)",-0.8163228969214185,-1.2237409915884985,0.16901408450704225,1.0,1.0,1/5,4.79%,ALDOB
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.5902340263564076,-1.223736426930416,0.18461538461538463,1.0,1.0,6/35,10.22%,LIPH;CAV3;LIPI;FABP3;LIPC;PNPLA1
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),-0.6713179268407604,-1.2236745512168483,0.2153846153846154,1.0,1.0,2/20,0.86%,GNLY;ITK
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),0.7299706056522638,1.2233217286124112,0.2777777777777778,0.8792578811710607,1.0,2/9,2.31%,KDR;BCL2
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),0.6874204467393413,1.2230282476626917,0.37777777777777777,0.8792879285222012,1.0,3/7,26.84%,MTR;MSRA;MTHFR
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.5747649718447833,-1.2227551680595852,0.1864406779661017,1.0,1.0,5/47,4.74%,TERF2IP;POLQ;CGAS;H1-2;H1-0
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),0.6926139664659818,1.222475369762155,0.24324324324324326,0.8797300288295155,1.0,4/8,15.95%,GRIP1;DVL2;WNT5A;MAP3K13
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),-0.7885782660738487,-1.222409015702993,0.16666666666666666,1.0,1.0,2/6,8.39%,STAT1;STAT5A
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),-0.7885782660738487,-1.222409015702993,0.16666666666666666,1.0,1.0,2/6,8.39%,STAT1;STAT5A
prerank,PanglaoDB_Augmented_2021__Schwann Cells,-0.4902001007448057,-1.222128801041666,0.08333333333333333,1.0,1.0,24/125,15.25%,NPY;PPP1R1B;SCN4B;CD82;SOX10;LRP4;AGT;CHST1;TST;CTHRC1;SCN7A;MPZ;DAB2IP;IGFBP5;GFRA3;CNP;PLP1;STMN1;SPARCL1;NRN1;APOD;NDRG4;CNTN2;PRX
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.5666330918268095,-1.2219750845214155,0.16176470588235295,1.0,1.0,13/39,18.77%,TERF2IP;FOXM1;PPP4C;RAD51AP1;FIGNL1;OTUB1;SLF1;DEK;WAS;DDX11;CHEK1;TWIST1;KDM1A
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),-0.746229217598473,-1.221778336936929,0.25396825396825395,1.0,1.0,2/9,4.82%,NODAL;PLAC1
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.43043878770553756,1.22167435896764,0.07692307692307693,0.8815425451639847,1.0,27/148,16.65%,SGK1;STK32B;SGK2;TGFBR1;LATS1;NEK6;PRKCD;PRKCB;STK38;SBK1;PRKD1;CLSPN;EIF2AK3;MAST4;MARK1;MAPK8;PRKCE;MAP3K10;DMPK;MAPK12;AKT2;MAST2;RPS6KA6;DYRK3;MAP3K13;SGK3;ATM
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",-0.6765411646276185,-1.2214763285851993,0.22,1.0,1.0,3/15,16.89%,TERF2IP;TDG;MPG
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.7374326597251124,-1.2212305061273871,0.22857142857142856,1.0,1.0,1/8,1.95%,WFS1
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.722779471153973,-1.2199192387407733,0.22807017543859648,1.0,1.0,2/8,17.31%,RSPO3;PLEKHA4
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.6193040664274263,-1.2198693618034264,0.1875,1.0,1.0,9/26,17.57%,GBP6;RARRES2;LYG1;HLA-A;LBP;TLR2;ROMO1;ADAM17;PGLYRP1
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.551035549151898,1.2198614699974486,0.14285714285714285,0.8867346995564444,1.0,11/33,16.15%,PID1;IRS1;KANK1;ENPP1;PRKCD;PRKCB;PTPRE;PIP4K2A;SIRT1;SORL1;SNX5
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),-0.7960367365123491,-1.219840199549794,0.21428571428571427,1.0,1.0,1/5,6.87%,SERPINE1
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),0.6154408251143744,1.2197631486258353,0.3,0.8857764767538278,1.0,3/15,4.58%,SLC2A9;SLC2A11;SLC2A14
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),-0.6273233803763116,-1.219705946791791,0.25,1.0,1.0,6/21,11.58%,BTN2A2;PDCD1LG2;HHLA2;AGER;IL18;FADD
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.6871001152872095,1.2196200316507464,0.21428571428571427,0.8847430894464565,1.0,1/10,0.30%,CLEC2A
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),-0.6536972620541152,-1.219588974827573,0.2,1.0,1.0,4/17,9.94%,CD4;CD74;CHMP2B;CHMP2A
prerank,GO_Biological_Process_2021__mitochondrial ribosome assembly (GO:0061668),-0.8094416201835779,-1.2188900338847752,0.21311475409836064,1.0,1.0,1/6,4.69%,MPV17L2
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),0.649969500917782,1.2188358761175013,0.2391304347826087,0.8865372752488557,1.0,1/9,0.44%,NOX4
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),0.5737045814242934,1.218657925666195,0.2,0.8858753895330227,1.0,3/17,7.13%,KDR;FGF10;IGF1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.5479218699295895,-1.2183373356964313,0.19402985074626866,1.0,1.0,6/42,8.34%,TERF2IP;POLQ;CGAS;PPP4C;RAD51AP1;FIGNL1
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.6675502584750586,1.2183083038777214,0.1935483870967742,0.8861476912818802,1.0,6/15,14.09%,KIT;PDGFRA;RASGRP1;BICD1;FGFR1;NTRK3
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.6560445623279869,1.2178411842042647,0.1568627450980392,0.8869233807875542,1.0,2/10,10.82%,SPX;SLC27A2
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",0.7815813695747622,1.2178270996810092,0.2708333333333333,0.8856442422832497,1.0,2/6,3.28%,RUNX1;CBFB
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.7336254407146227,1.2169138886215844,0.2857142857142857,0.8875397892433984,1.0,3/6,24.05%,MEGF10;AKIRIN1;THBS4
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.6539419845513671,1.2167721938857095,0.1794871794871795,0.8856079215430208,1.0,7/14,13.44%,UNC5B;EYA4;BCL2;HSPA1A;EYA2;EYA3;MAPK7
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.6539419845513671,1.2167721938857095,0.1794871794871795,0.8856079215430208,1.0,7/14,13.44%,UNC5B;EYA4;BCL2;HSPA1A;EYA2;EYA3;MAPK7
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.4994483155307562,1.216488242740702,0.20930232558139536,0.8855509717921389,1.0,7/37,11.70%,RFWD3;SMYD2;RADX;PRKCD;CASP9;IER3;NSMCE1
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),0.4972391514474097,1.2161506688467165,0.1388888888888889,0.8857824994084127,1.0,8/57,8.43%,EPHA3;CCL28;CDH13;UTRN;JAG1;EFNA5;PKHD1;CASK
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),0.6869673270251365,1.2161182965203163,0.3055555555555556,0.8845547289155892,1.0,2/8,10.70%,BMP6;SCAP
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.5204397408219628,-1.2159822141009105,0.11688311688311688,1.0,1.0,28/66,30.51%,EPAS1;NOTCH1;BACH1;PSMB6;PSMB8;PSMA3;PSMC3;HIF3A;PSMC6;PSMA5;RBX1;PSMA7;PSMD12;PSME1;RPS27A;PSMB2;UBC;PSMD2;PSMA8;CUL2;PSMA1;PSMC1;LIMD1;PSMD4;PSMD8;PSMB4;PSMC4;UBB
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),0.6786252946265049,1.2155870980826018,0.2682926829268293,0.8853236352540877,1.0,1/9,0.42%,KIT
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),0.6855647667337232,1.2148075474790743,0.24324324324324326,0.8857464255082707,1.0,5/8,22.77%,PRKCD;SPHK2;SMPD3;SIRT3;NSMAF
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),0.6855647667337232,1.2148075474790743,0.24324324324324326,0.8857464255082707,1.0,5/8,22.77%,PRKCD;SPHK2;SMPD3;SIRT3;NSMAF
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),0.651007591426974,1.2146793295711664,0.2619047619047619,0.8847548572998034,1.0,3/10,2.65%,KIT;KDR;KITLG
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),0.7399113845463886,1.2146270062060378,0.3076923076923077,0.8824760187954611,1.0,2/6,8.91%,IWS1;TPR
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),0.7399113845463886,1.2146270062060378,0.3076923076923077,0.8824760187954611,1.0,2/6,8.91%,IWS1;TPR
prerank,GO_Biological_Process_2021__negative regulation of organ growth (GO:0046621),0.753913149186094,1.2139497264459098,0.3191489361702128,0.8834121984945241,1.0,2/5,7.35%,WWC1;SLC6A4
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6213509034208192,1.21315108920959,0.23076923076923078,0.8847819357854274,1.0,9/19,13.53%,UNC5B;EYA4;BCL2;HSPA1A;EYA2;EYA3;FGFR1;MAPK7;PPP2R1B
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.5309704872035953,1.2127109803513103,0.16666666666666666,0.8850869809810984,1.0,16/61,17.43%,FLRT2;GALNT3;SPRED1;FGFR4;SPRED2;FGFR3;FGF10;FGFRL1;FIBP;TRIM71;FGFR1;FRS2;RBFOX2;FGF17;TIAL1;HNRNPH1
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.6397653185790497,-1.212562793605303,0.16923076923076924,1.0,1.0,9/21,15.31%,BIK;MOAP1;BNIP3;PINK1;CIDEB;GPER1;HRK;PDCD5;PLAUR
prerank,GO_Biological_Process_2021__AV node cell action potential (GO:0086016),-0.7550078022979494,-1.2123615487048873,0.15789473684210525,1.0,1.0,2/6,13.00%,SCN4B;CACNA1G
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),-0.6122334058612587,-1.2118943203791548,0.2328767123287671,1.0,1.0,2/28,4.66%,SHCBP1L;LMAN1
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.629450488321379,1.211881508777708,0.19444444444444445,0.8869042418592575,1.0,3/12,8.13%,TGFBR1;ACVR1;SMAD2
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),-0.8278295646172347,-1.2115577845080936,0.1774193548387097,1.0,1.0,3/6,12.43%,LMAN1;DNAJA1;BAG4
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),0.5849568877034558,1.2112593427027225,0.23255813953488372,0.8880929856595876,1.0,7/14,28.39%,MLYCD;NR1H3;PPARA;APOA1;ELOVL5;NR1H2;PPARG
prerank,GO_Biological_Process_2021__succinyl-CoA metabolic process (GO:0006104),-0.7912324373787312,-1.21125287613471,0.23809523809523808,1.0,1.0,1/5,0.64%,ACOT4
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.6859537211262441,1.2102730198020595,0.23529411764705882,0.890108085747897,1.0,3/8,23.16%,LARP1;RPTOR;SMG1
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.499980672263679,1.2102384985796961,0.15,0.8889347929970647,1.0,12/44,16.00%,MYLIP;KANK1;MINAR1;SPRY3;PTPN9;APOE;PTPRO;SPOCK1;PTPRS;FYN;GRIN2B;RTN4R
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.5075865666938936,1.2101529799910582,0.20588235294117646,0.8878401047488053,1.0,7/41,5.81%,KCNJ16;AMIGO1;KCNJ6;KCNJ3;KCNN2;KCNJ2;KCNN3
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.4832103076348218,-1.210151889859204,0.17567567567567569,1.0,1.0,31/147,16.78%,TRIM58;HCK;TNK1;B2M;CD74;TRIML2;TRIM22;CIITA;IFIT1;RARRES2;IFI27;CORO1A;RNF39;AGER;TRIM5;TRIM25;SIGLEC15;IFNLR1;LBP;SERINC3;TRIM32;MASP2;IFI6;TLR2;STYK1;SLA;PLCG2;WFDC2;SFTPD;CFD;LYN
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.46411653422775684,-1.2100718487534057,0.10526315789473684,1.0,1.0,32/174,19.94%,RAD54L;MCM2;POLQ;TPX2;ATF5;CDKN3;SUV39H1;GINS2;CDC6;TGFB1;DDX39A;CHAF1A;FANCC;KIF20B;SMC2;STMN1;CDC25A;HMGB3;PLK4;CDKN1B;ILF3;H2AZ2;CDK4;PDS5B;KNL1;CHEK1;SQLE;KIF11;RACGAP1;KATNA1;NOTCH2;H2AZ1
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),-0.6397147182207008,-1.2099392397724968,0.3114754098360656,1.0,1.0,3/13,13.48%,GPR68;MCOLN1;HVCN1
prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.47204843380148737,-1.2097409878768888,0.14457831325301204,1.0,1.0,71/186,30.60%,MCM2;POLE3;PRDX4;TCP1;SLC25A3;EIF1AX;SNRPD2;EPRS1;NCBP2;PCBP1;NCBP1;RNPS1;VBP1;XPOT;PSMC6;DEK;CDK4;PCNA;VDAC1;GNL3;CBX3;RPL22;EIF2S2;NDUFAB1;PSMA7;COPS5;C1QBP;RRM1;PRDX3;SET;VDAC3;SRPK1;RPL34;H2AZ1;USP1;HSPD1;RPS3;HDDC2;ERH;IFRD1;CCT7;EIF3J;PGK1;PSMB2;CANX;HSP90AB1;NOP56;CCT2;EIF4H;LDHA;SSB;KPNA2;RAN;APEX1;PWP1;PSMA1;IMPDH2;RPS5;PA2G4;MCM4;ACP1;DHX15;RPL18;PSMD8;DDX18;CTPS1;RAD23B;PSMC4;AIMP2;SNRPB2;CYC1
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.6672463544330038,1.2085760433665005,0.23076923076923078,0.8918748282084987,1.0,3/16,6.10%,SLC22A2;SLC25A26;SLC22A3
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),-0.7338635493206782,-1.2083114896719822,0.18333333333333332,1.0,1.0,1/9,1.08%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),-0.7338635493206782,-1.2083114896719822,0.18333333333333332,1.0,1.0,1/9,1.08%,TERF2IP
prerank,GO_Biological_Process_2021__neuroblast proliferation (GO:0007405),-0.734160977583002,-1.2079421314171603,0.23728813559322035,1.0,1.0,3/6,18.41%,ARTN;SHH;RACGAP1
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),0.7598104142564396,1.2077142110816532,0.3333333333333333,0.8943041501415421,1.0,1/5,1.44%,DOCK10
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),-0.7082325042621382,-1.2073721165144478,0.273972602739726,1.0,1.0,3/11,9.10%,TCP1;CCT6A;CCT8
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),-0.8406527551638545,-1.2064019274592943,0.16666666666666666,1.0,1.0,1/5,9.45%,NCBP2
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),-0.8406527551638545,-1.2064019274592943,0.16666666666666666,1.0,1.0,1/5,9.45%,NCBP2
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.6374124864882643,-1.2061696447551302,0.27692307692307694,1.0,1.0,4/14,8.66%,KCNE2;ATP1B1;KCNQ1;ATP1A1
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),0.6887944579828361,1.206086226179114,0.22580645161290322,0.8987673571017754,1.0,2/6,21.23%,APOE;APOA1
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.4426522600283399,1.2058343584347475,0.12903225806451613,0.8984127112304185,1.0,17/124,10.11%,PLEKHH2;KCNIP1;ZNF536;MAPK4;SLC35F1;TOX3;ADGRA1;GRIA2;PLPPR5;POU3F4;APOE;CACNG4;PCDH19;CSRNP3;PAK5;RHBDL3;PHF21B
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.5533570905408558,1.2057326721189956,0.32432432432432434,0.8975549944879573,1.0,7/26,17.36%,RORA;ACADVL;APOE;MLYCD;SIRT1;FOXK1;PPARA
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),0.7317685266942517,1.2055776426575397,0.20930232558139536,0.8969420932269323,1.0,2/7,12.17%,IGF1;SELENON
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081),0.7729513198523819,1.20537599775136,0.2391304347826087,0.8963495596605036,1.0,1/5,0.16%,ACE2
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),0.6837042575052681,1.205239042579539,0.2558139534883721,0.8955170467489875,1.0,3/8,25.41%,PRMT5;PRMT6;NR1H4
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.6755916916571092,-1.2050942642671745,0.21818181818181817,1.0,1.0,4/11,8.64%,TNFSF18;IL15;NCKAP1L;PIK3CB
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.4500479442619909,1.2047178013130952,0.15625,0.8958749702795279,1.0,35/135,15.50%,PTPN3;PTPRT;PTPRK;DUSP5;CDC14B;DUSP2;PLPPR5;PTPN9;PTPRB;PTPRO;PTPN6;DUSP8;SGPP2;DUSP4;DUSP12;SSH1;DUSP10;PTPN12;PTPRE;PPEF1;PNKP;TAB1;PTPN13;PTPRS;CTDSP2;CTTNBP2NL;PTPRM;PPP2R5E;PSPH;PPP2R3B;PPP2R1B;BTRC;PPM1H;PPM1E;THNSL2
prerank,PanglaoDB_Augmented_2021__T Cells Naive,-0.5564445603145123,-1.2044931688447873,0.23809523809523808,1.0,1.0,12/37,15.08%,GNLY;CD4;PTPRC;ARHGAP9;CD37;GMFG;CD6;TAGAP;GBP5;CD5;SLA;WAS
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.5796420148762834,-1.204367730603319,0.23880597014925373,1.0,1.0,2/28,0.39%,C3AR1;C4BPB
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),0.5979533805292117,1.2038699760202605,0.2,0.8976221582909901,1.0,1/15,1.91%,FARS2
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),-0.691276373355215,-1.203852803038719,0.25,1.0,1.0,2/11,4.48%,MCM2;GINS2
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),-0.6720724150650992,-1.2035536807052214,0.21052631578947367,1.0,1.0,2/15,2.29%,CCNE1;PTPRC
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.581989589967561,-1.2031065004837207,0.2463768115942029,1.0,1.0,2/27,0.39%,C3AR1;C4BPB
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),0.7513960605503052,1.2030500696945998,0.34210526315789475,0.8993088503832636,1.0,1/5,5.75%,ACVR1
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.5877984387803065,-1.2029699529325462,0.16666666666666666,1.0,1.0,4/27,5.95%,ZNF703;EID2;SFRP4;TGFB1
prerank,GO_Biological_Process_2021__regulation of adherens junction organization (GO:1903391),0.7725324285720966,1.2027637863373972,0.25,0.8988095846596044,1.0,2/5,11.02%,BMP6;PTPN23
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.6801093913377175,-1.202689659593576,0.26153846153846155,1.0,1.0,4/13,16.15%,DOCK8;CCL5;CXCL13;ADAM17
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),-0.6289260794084008,-1.2024947158278063,0.2647058823529412,1.0,1.0,6/14,25.03%,IL4I1;ACMSD;FAH;GSTZ1;IDO1;KMO
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.4884963938977181,1.202413254853689,0.17142857142857143,0.8987178166310505,1.0,13/67,7.93%,CDH13;CDH6;F2RL1;CDH20;PKP2;SDK1;NECTIN3;CSF1R;TGFB2;TGFB3;CDHR3;PKHD1;CADM2
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),0.7044928604136048,1.2023997977328653,0.2653061224489796,0.8974835101964814,1.0,1/8,0.60%,KLRD1
prerank,GO_Biological_Process_2021__positive regulation of blood pressure (GO:0045777),0.7634229728279471,1.2022605232875403,0.29411764705882354,0.8969705319779951,1.0,4/6,13.24%,SPX;GLP1R;TAC3;ID2
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),-0.6944635539718266,-1.202258755610136,0.21212121212121213,1.0,1.0,2/16,7.90%,MCM2;RECQL
prerank,GO_Biological_Process_2021__regulation of cell adhesion molecule production (GO:0060353),-0.7913851573708994,-1.202201986054711,0.2962962962962963,1.0,1.0,3/5,13.03%,NOTCH1;NOTCH4;FLOT1
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),-0.7213943455865068,-1.2020313584991202,0.2903225806451613,1.0,1.0,1/8,2.33%,HSD17B10
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.5403857697884216,-1.2018842874260995,0.15,1.0,1.0,14/44,23.63%,POLE3;H1-2;H1-0;CHAF1A;NAP1L2;H2BC18;DAXX;CHAF1B;H3-3A;M1AP;GRWD1;SPTY2D1;H2BC5;PAF1
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),0.7583227649630421,1.2011805428732714,0.2692307692307692,0.8986653533666822,1.0,2/5,13.45%,DPY19L1;DPM3
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),0.7583227649630421,1.2011805428732714,0.2692307692307692,0.8986653533666822,1.0,2/5,13.45%,DPY19L1;DPM3
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),0.4804433820718701,1.2010546572797494,0.22580645161290322,0.8979879206309349,1.0,12/55,11.08%,MCTP1;HRH1;ACKR2;MCU;DDAH1;APOE;RCAN2;LAT2;EIF2AK3;CHRM3;MCTP2;GUCY1A1
prerank,GO_Biological_Process_2021__metanephric mesenchyme development (GO:0072075),-0.779229946956407,-1.2009500990212305,0.25862068965517243,1.0,1.0,3/6,16.01%,STAT1;SIX4;SHH
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.716232269354501,1.2008004979873665,0.3103448275862069,0.8980445022396881,1.0,2/6,7.72%,PHACTR1;NLGN1
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),-0.6940052296484642,-1.2003943641371828,0.23636363636363636,1.0,1.0,1/8,0.77%,MYLK
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),-0.7532208917800672,-1.2003652220724499,0.27586206896551724,1.0,1.0,1/7,1.76%,DOCK2
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),-0.5730107893295161,-1.20028381284618,0.1694915254237288,1.0,1.0,3/26,11.17%,CALB1;AGER;SCGN
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.5979687921247745,-1.1999085539045442,0.22807017543859648,1.0,1.0,6/31,12.96%,TMC8;SERPINE1;CASP8;BRCA1;FADD;TMBIM1
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.5692133884190015,-1.1997754902984674,0.2463768115942029,1.0,1.0,2/29,0.39%,C3AR1;C4BPB
prerank,GO_Biological_Process_2021__cellular response to indole-3-methanol (GO:0071681),-0.777107509181497,-1.1997114027609035,0.27450980392156865,1.0,1.0,2/5,10.39%,CTNNA1;BRCA1
prerank,GO_Biological_Process_2021__response to indole-3-methanol (GO:0071680),-0.777107509181497,-1.1997114027609035,0.27450980392156865,1.0,1.0,2/5,10.39%,CTNNA1;BRCA1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.6652294481393167,-1.1996620587043694,0.16981132075471697,1.0,1.0,4/11,16.65%,B2M;ERAP2;HLA-A;ERAP1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),0.7186797817932785,1.1996276639682875,0.2564102564102564,0.8984320093387291,1.0,3/5,17.81%,APOE;SCAP;ERLIN2
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),0.7186797817932785,1.1996276639682875,0.2564102564102564,0.8984320093387291,1.0,3/5,17.81%,APOE;SCAP;ERLIN2
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),0.7186797817932785,1.1996276639682875,0.2564102564102564,0.8984320093387291,1.0,3/5,17.81%,APOE;SCAP;ERLIN2
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.5011748396934265,1.1995831099358325,0.1951219512195122,0.8973410208525827,1.0,6/41,3.07%,GPC4;HS3ST5;HS3ST3A1;HS3ST3B1;EXT1;SDC4
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.5876059568765051,1.1994281379952718,0.21951219512195122,0.8966529289051662,1.0,3/20,5.06%,CD38;BCL2;EPHB2
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell differentiation (GO:0051150),0.7183726254134302,1.1993417742226704,0.275,0.8956763562401588,1.0,2/7,5.47%,EREG;OLFM2
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.7511036693670339,-1.1991784779704815,0.2542372881355932,1.0,1.0,2/7,9.08%,PIK3CB;DAB2IP
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.568074711098244,1.1987495561945263,0.2413793103448276,0.8968412022418801,1.0,1/18,0.18%,RUNX1
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),-0.8221856063702686,-1.1987273274606698,0.25806451612903225,1.0,1.0,3/5,12.96%,IL15;IL18;TMBIM1
prerank,GO_Biological_Process_2021__L-ornithine transmembrane transport (GO:1903352),0.7282414760607265,1.1987003799099996,0.2926829268292683,0.8957946831007781,1.0,2/5,7.55%,SLC7A2;SLC7A1
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.6277918455558125,1.198600023461154,0.23404255319148937,0.8950583303412334,1.0,1/15,1.08%,INTS11
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),0.7338638294851584,1.198582877091692,0.30357142857142855,0.8939088837874044,1.0,2/5,19.09%,LYPLA2;ABHD12
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.7495917436554266,1.1983437610546774,0.3170731707317073,0.8937539545176006,1.0,2/6,12.40%,MALT1;RC3H1
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),0.4996403512868779,1.1980562554985272,0.19444444444444445,0.8937794474791406,1.0,9/39,12.15%,LEF1;TGFBR1;BMP7;HEY1;TGFB2;TGFBR3L;FAM83D;LIMS1;FGFR1
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),-0.7539792652208535,-1.198037563981499,0.26153846153846155,1.0,1.0,3/10,11.58%,AMBP;GPER1;FADD
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),-0.7271113183865303,-1.1977393744225362,0.2631578947368421,1.0,1.0,2/6,22.13%,CELSR1;FUZ
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.627266299855856,1.1972670962145362,0.21621621621621623,0.8952428379713049,1.0,4/13,19.72%,SHLD1;KMT5B;SLC15A4;TP53BP1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.6394444765355997,1.1972473553184864,0.29411764705882354,0.8940815204737981,1.0,4/16,4.75%,SPRED1;SPRED2;PARD3;SPRED3
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),0.7472776879685809,1.1969548217295778,0.3023255813953488,0.8939092810206346,1.0,3/5,7.04%,RUNX1;CBFB;HMGB1
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.5603881688595255,-1.1964731417096512,0.2835820895522388,1.0,1.0,14/46,19.12%,ENO4;SLC16A8;SDS;ALDOB;PGAM1;HKDC1;ENO2;PKLR;VDAC1;LDHB;SLC16A1;PDHX;SLC16A3;PCK2
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.7108493289645781,-1.1961163253595701,0.2463768115942029,1.0,1.0,5/8,24.52%,ARG2;AZIN1;HNF4A;AZIN2;ARG1
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),-0.742542060936685,-1.1958949465607476,0.22413793103448276,1.0,1.0,3/8,15.75%,C17ORF99;GPR183;EXOSC6
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.4719877324369657,1.1958212379821085,0.2,0.8972102170012607,1.0,10/116,5.86%,FBXL7;TPD52L1;CCNH;NEDD1;KDM8;PCM1;PLCB1;LATS1;CDK14;TAF2
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.4871158071551324,1.195593035163353,0.14285714285714285,0.8966766388765915,1.0,9/75,2.36%,LRIG3;TEAD2;LAMB2;PRRX1;SVEP1;WWTR1;PCDH18;FNDC1;EGFR
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),0.6302373571475501,1.1948522769004366,0.27586206896551724,0.898411661143094,1.0,3/12,10.50%,F2RL1;HMGB1;PIBF1
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),-0.6135160206090651,-1.1945553127660535,0.25,1.0,1.0,3/20,5.33%,BTN2A2;PDCD1LG2;IL4I1
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.5037489579434905,-1.1943218657397225,0.21311475409836064,1.0,1.0,22/72,15.65%,DOCK8;PTPRC;STAG3;RCSD1;CD74;TMC8;SP140;ARHGAP9;CD37;GMFG;ADAM28;P2RY14;MYO1F;NCKAP1L;TAGAP;MAP4K1;WDFY4;ABCB4;RHOH;GPR18;WAS;STAP1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),-0.5606767947265937,-1.19429226624287,0.1791044776119403,1.0,1.0,7/31,10.91%,TPX2;CHMP4B;CHMP2B;GPSM2;CHMP2A;BORA;DCTN1
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.7606172108148176,1.194049714047314,0.21951219512195122,0.90015976349053,1.0,6/8,22.32%,RYK;FZD1;LRP6;WNT5A;WNT3;CTNNB1
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),0.7203789594818714,1.1939753015892836,0.3111111111111111,0.8991792749772021,1.0,1/5,3.30%,UNC13B
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),-0.6481036675770282,-1.1938007338314898,0.24193548387096775,1.0,1.0,2/12,7.99%,UPB1;DPYS
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.7688919373715118,-1.1934787818093635,0.23333333333333334,1.0,1.0,2/8,10.17%,MSX1;RPS7
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.7806850811443318,1.1931568729708204,0.325,0.9009748956500908,1.0,3/6,12.53%,NRP1;ROBO2;PTPRM
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),-0.7333173039978318,-1.1930590654953808,0.25,1.0,1.0,2/8,16.14%,CHAC1;GAS1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.5698040567910404,1.1926967222777871,0.2,0.9013275333247961,1.0,7/19,16.80%,MICU1;MCU;SLC8A3;MCUR1;PDZD8;MAIP1;MCUB
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),0.5814118041024541,1.1923583832116276,0.24324324324324326,0.9011650401117273,1.0,2/13,3.81%,SLC22A13;ACADVL
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),0.7078614519775202,1.192341137404772,0.275,0.8987902724788344,1.0,3/6,21.53%,DPH5;DPH1;DPH3
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),0.7078614519775202,1.192341137404772,0.275,0.8987902724788344,1.0,3/6,21.53%,DPH5;DPH1;DPH3
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.48273528369169016,1.1923001311214918,0.11428571428571428,0.8976253733983562,1.0,5/53,7.73%,RUNX1;CBFB;MEIS1;PRKCB;HDAC1
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.6107583147634736,1.19189277702556,0.2558139534883721,0.8977685487314296,1.0,2/21,3.28%,RUNX1;CBFB
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),-0.689291596382135,-1.1917893601275198,0.23214285714285715,1.0,1.0,2/10,7.02%,ATP1B1;GLRX
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.6291573625430277,1.1916806918021912,0.2926829268292683,0.8974358604017468,1.0,3/10,8.02%,RUNX1;CBFB;ELF2
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),-0.7485139237609862,-1.1916009651034316,0.24074074074074073,1.0,1.0,1/7,4.99%,ATP1B1
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),0.6595859188974986,1.1913099799223783,0.175,0.897596491532426,1.0,2/9,6.36%,KDR;JAG1
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),0.7004324842481591,1.1912196494172689,0.23255813953488372,0.8966326716944236,1.0,4/9,20.35%,KNDC1;GRID2;OPHN1;PROX1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),-0.6073341232596746,-1.1908697966396038,0.25,1.0,1.0,4/17,8.59%,CSRP3;CAV3;PKD2L2;TTN
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),-0.6953972480927331,-1.1903358485886084,0.25925925925925924,1.0,1.0,2/11,7.44%,ING2;ZBTB7B
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),-0.7514111165403339,-1.1901760061381497,0.21568627450980393,1.0,1.0,1/7,4.70%,BNIP3
prerank,GO_Biological_Process_2021__sulfation (GO:0051923),0.7965389082508,1.1899001354171184,0.2647058823529412,0.9003719367420498,1.0,1/5,0.88%,HS3ST5
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.5390912445336254,-1.1896987621950943,0.1746031746031746,1.0,1.0,9/47,9.36%,AMBP;FOXM1;FGL1;TOM1L1;MYO5B;CBLC;HNF4G;CLDN1;UGT2B7
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),0.6333453096739351,1.1896795072960324,0.23255813953488372,0.900072569020833,1.0,1/9,2.10%,ZEB2
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),-0.5743722283894976,-1.1896759443032572,0.17391304347826086,1.0,1.0,8/29,20.07%,TRPV6;REST;SYT2;SYT4;CACNA1G;DOC2A;SYT9;CACNA1H
prerank,GO_Biological_Process_2021__detection of light stimulus involved in visual perception (GO:0050908),-0.7425828595306223,-1.1893546452052475,0.14545454545454545,1.0,1.0,2/7,11.72%,CACNA2D4;CNGB1
prerank,GO_Biological_Process_2021__detection of light stimulus involved in sensory perception (GO:0050962),-0.7425828595306223,-1.1893546452052475,0.14545454545454545,1.0,1.0,2/7,11.72%,CACNA2D4;CNGB1
prerank,GO_Biological_Process_2021__negative regulation of plasminogen activation (GO:0010757),-0.7866436127760084,-1.1893033866626013,0.2459016393442623,1.0,1.0,2/5,9.97%,SERPINE1;CTSZ
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),0.774747955106798,1.1885494145523219,0.3157894736842105,0.9026252105315354,1.0,2/5,12.83%,CROT;CPT1A
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),0.5802312850641438,1.187967697521572,0.23076923076923078,0.9034765532467051,1.0,5/25,7.13%,ITGA4;CACNA2D1;GRM5;GRIN2A;IGF1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),-0.7047694738951845,-1.1879545488158239,0.27419354838709675,1.0,1.0,1/6,6.89%,NONO
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),-0.72681732284168,-1.187603881631957,0.26666666666666666,1.0,1.0,3/9,21.57%,PTPRC;STAP1;GRN
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),-0.7577097108425745,-1.1871849883447365,0.24528301886792453,1.0,1.0,2/6,15.45%,B2M;ATP2A3
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),-0.6690459444759576,-1.1864537474559662,0.21875,1.0,1.0,1/11,4.13%,WIPI1
prerank,GO_Biological_Process_2021__phasic smooth muscle contraction (GO:0014821),-0.7576448187942005,-1.1861217052924449,0.2833333333333333,1.0,1.0,2/6,11.98%,PTGER3;HTR2B
prerank,GO_Biological_Process_2021__regulation of angiotensin levels in blood (GO:0002002),0.6915286213461982,1.1861076387987617,0.3191489361702128,0.9079424923552061,1.0,1/8,0.16%,ACE2
prerank,GO_Biological_Process_2021__angiotensin maturation (GO:0002003),0.6915286213461982,1.1861076387987617,0.3191489361702128,0.9079424923552061,1.0,1/8,0.16%,ACE2
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),-0.7506292022698463,-1.186039394678886,0.2962962962962963,1.0,1.0,1/6,2.33%,HSD17B10
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.6740743088439984,-1.1858558186198387,0.25925925925925924,1.0,1.0,3/11,7.92%,SFRP4;ETV4;PRKCH
prerank,GO_Biological_Process_2021__cobalamin transport (GO:0015889),-0.7476825253758143,-1.1857059494905189,0.2708333333333333,1.0,1.0,3/6,17.98%,AMN;CBLIF;TCN2
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),-0.7399781059578265,-1.1856612098897414,0.2777777777777778,1.0,1.0,1/5,6.55%,TST
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),-0.5600998362455891,-1.1855075016106902,0.25,1.0,1.0,10/36,17.44%,SLC7A11;SLC7A7;ABCB1;SLC38A11;SLC38A8;SLC36A1;SLC23A1;SLC38A4;SLC25A11;SLC16A1
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.6301521209851701,-1.1853520305691203,0.3064516129032258,1.0,1.0,1/14,0.29%,C3AR1
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.4474688230106118,1.1852110023211087,0.14285714285714285,0.9096358594910717,1.0,6/64,9.21%,EPHA3;MCTP1;BMP6;HSPA1A;CRACD;PRKD1
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),0.5591970099800749,1.185057455116589,0.21428571428571427,0.9088573978015944,1.0,2/25,0.56%,ELOVL6;CYP1A2
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),0.7314258376911329,1.1848533833840285,0.3137254901960784,0.9081851230968717,1.0,2/5,19.54%,AK5;AK3
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.5678855881710094,1.1848240658992566,0.2682926829268293,0.9071507224504042,1.0,10/23,26.15%,CACNG3;CACNG4;NLGN1;SHISA9;MEF2C;CNIH2;RELN;CACNG2;SHANK1;NLGN3
prerank,GO_Biological_Process_2021__negative regulation of fibroblast migration (GO:0010764),-0.7571665806074357,-1.1845038711942228,0.30357142857142855,1.0,1.0,1/6,5.85%,RAC1
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),-0.6540151426604248,-1.1844569411610855,0.27419354838709675,1.0,1.0,3/12,6.05%,HESX1;GCM2;TBX1
prerank,GO_Biological_Process_2021__dopamine transport (GO:0015872),0.7631922962447117,1.1843918415346733,0.225,0.907468954379671,1.0,2/5,6.10%,SLC22A2;SLC22A3
prerank,GO_Biological_Process_2021__negative regulation of cytosolic calcium ion concentration (GO:0051481),-0.7676956278049515,-1.1841184467687136,0.26666666666666666,1.0,1.0,1/6,3.79%,DRD3
prerank,GO_Biological_Process_2021__tongue development (GO:0043586),-0.7826537339132618,-1.1839382675810306,0.18867924528301888,1.0,1.0,2/5,11.48%,TBX1;SIX4
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.5967674343096845,1.183872306425848,0.2894736842105263,0.9081147242749227,1.0,5/15,13.44%,KDR;SEMA5A;ANGPT1;PAK4;MAPK7
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.41847298738928007,1.1837435728583958,0.16666666666666666,0.9073779534610138,1.0,48/331,10.16%,NRG1;EPHA3;ATP6V0D2;ROR2;KIT;ALK;UBASH3B;FLRT2;PDGFD;RGS14;GALNT3;PTPRT;IRS1;EFS;KDR;EPHA5;NRP1;SULF2;EGFR;SPRED1;FGFR4;SPRED2;PLCB1;FGFR3;CSF1R;MPZL1;EPHB2;PDGFC;PDGFRA;FGF10;CNKSR1;CASS4;SHC3;IGF1;EFNA5;FGFRL1;WASF2;ARPC3;IRS2;EPHA7;RYK;ANGPT1;PRKD1;ERBB4;EIF2AK3;FRK;LTK;FIBP
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),-0.6665210449113304,-1.1836680139009277,0.25806451612903225,1.0,1.0,2/11,7.99%,UPB1;DPYS
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.5843625167247563,-1.1835907860305408,0.1896551724137931,1.0,1.0,7/26,16.29%,CD74;CD300LF;IL7;TXK;FADD;ADAM17;C1QTNF4
prerank,GO_Biological_Process_2021__tubulin complex assembly (GO:0007021),-0.7795193533159924,-1.1834298754556813,0.2641509433962264,1.0,1.0,2/6,13.16%,TCP1;VBP1
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),-0.6947929440821429,-1.1833048921769334,0.32142857142857145,1.0,1.0,2/10,0.59%,CA12;SLC12A7
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),-0.6947929440821429,-1.1833048921769334,0.32142857142857145,1.0,1.0,2/10,0.59%,CA12;SLC12A7
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.45157367385733027,1.1830738807478787,0.19047619047619047,0.9086082118572829,1.0,38/119,13.22%,RIMBP2;PTPRT;GRIA4;KCNIP1;RAB3C;MAPK4;KCNB2;ADGRA1;SERTM1;UNC5D;GRIA2;UBE2QL1;UNC79;CNTN4;LSAMP;LRRC4C;EFNA5;TMEM196;NRXN1;SVOP;EDARADD;CADM2;NOVA1;CSRNP3;PCSK2;CNTN1;PAK5;RBFOX1;ROBO2;DPP6;PCDH17;ADGRB3;SEZ6L;NOL4;ST8SIA3;GABRB3;ELAVL3;FGF12
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.4966079375195391,-1.1829022475353594,0.2,1.0,1.0,18/83,17.35%,PTER;SOX10;MEOX1;STAT1;TGFB1;TBX1;TST;WNT7B;TOLLIP;PPP2R3A;RCN3;NDRG4;KANK2;PCNA;SHH;VDAC1;VIL1;SNAI2
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.5590588146721386,-1.1821408616221194,0.2465753424657534,1.0,1.0,14/50,16.00%,CD4;TMEM184A;ERVFRD-1;PTGES;TMEM40;B3GNT3;KLF5;SERPINE1;IL18;INHBA;LTBR;PLAUR;GPRC5A;CDCP1
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.571763559024502,-1.1820269370218328,0.16923076923076924,1.0,1.0,6/45,7.26%,CD44;HSPG2;PRELP;GPC3;TGFB1;CEMIP
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),-0.5957289992804671,-1.1820188036535164,0.20588235294117646,1.0,1.0,1/26,0.82%,SIGLEC1
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.6235193593857251,1.1819565299265873,0.2857142857142857,0.9110402540605267,1.0,4/12,12.74%,PRR5L;KHSRP;RC3H1;PNPT1
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.45162733517857073,1.181901779887555,0.10526315789473684,0.9100102746184326,1.0,22/127,14.87%,NRK;NYAP2;SGK1;NTNG1;DOCK10;BMP7;CTNNA2;PARD3;EPHB2;DSCAML1;CNTN4;MYO16;NLGN1;RYK;SLITRK5;GPM6A;NGF;SPTBN4;NYAP1;PAK3;CNTNAP2;NRCAM
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),-0.7275454586469544,-1.1817931523320462,0.2698412698412698,1.0,1.0,2/6,20.65%,DOLK;DOLPP1
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),-0.7275454586469544,-1.1817931523320462,0.2698412698412698,1.0,1.0,2/6,20.65%,DOLK;DOLPP1
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.5603317382734345,-1.1817178323224853,0.22727272727272727,1.0,1.0,10/34,15.31%,BIK;MOAP1;BNIP3;PINK1;CIDEB;GPER1;GHITM;HRK;PDCD5;PLAUR
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),0.7112932382286737,1.1816048370969192,0.25,0.9100303433506453,1.0,1/7,8.54%,FUT9
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.5785280107094856,-1.1814229306130555,0.234375,1.0,1.0,4/34,7.33%,HCK;DOCK2;PTPRC;IL15
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.5199853988061299,1.1813184900100537,0.2,0.9097760101399769,1.0,17/38,25.34%,PLPPR5;SYNJ2;MTMR8;SGPP2;MTMR9;PIP4P1;PLPPR4;PLPP1;PTEN;MTMR6;MTM1;MTMR3;MTMR11;INPP5J;MTMR10;PLPP3;MTMR12
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),0.6547591033158066,1.181195546258849,0.2619047619047619,0.9077301829137648,1.0,2/13,6.89%,KLRD1;RASGRP1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.6547591033158066,1.181195546258849,0.2619047619047619,0.9077301829137648,1.0,2/13,6.89%,KLRD1;RASGRP1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.7420250041991311,1.181112852003096,0.3333333333333333,0.9068991646630283,1.0,1/5,10.01%,CHRM3
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),0.7079740511048096,1.1808931287434339,0.24324324324324326,0.9064796909740577,1.0,3/7,24.60%,IGF1;FKTN;ABCA2
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),0.6962022270178302,1.1802000951395009,0.28,0.9065286798810912,1.0,1/6,2.10%,ZEB2
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),0.6962022270178302,1.1802000951395009,0.28,0.9065286798810912,1.0,1/6,2.10%,ZEB2
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.4728863596788154,1.180119610954735,0.21875,0.9056356006671921,1.0,12/59,11.76%,UNC5B;EYA4;SH3RF1;BCL2;TGFBR1;ACVR1;CFLAR;IGF1;HSPA1A;ZMYND11;EYA2;EYA3
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),0.6879362646701317,1.1799601236815538,0.3333333333333333,0.9049654338835885,1.0,1/9,1.31%,TOX
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.6234965483354895,-1.17992915415002,0.21666666666666667,1.0,1.0,4/11,26.14%,HSPA5;KDELR3;KDELR1;GPAA1
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),-0.6031488228059975,-1.1798860247941587,0.25806451612903225,1.0,1.0,4/17,10.91%,TPX2;GPSM2;BORA;DCTN1
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),0.6244840086390485,1.1798272380289407,0.20930232558139536,0.9041614409153355,1.0,1/11,0.33%,PNP
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.5339760976460819,1.179640969872051,0.2903225806451613,0.9034272327791835,1.0,7/28,12.96%,SPX;APOE;SLC27A2;ABCD2;SLC25A20;CPT1A;SLC27A6
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),0.6795243925829662,1.1791220991089948,0.3333333333333333,0.9041316148251,1.0,1/9,2.38%,KDM8
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.6192271049691883,1.1791070195840054,0.2,0.9029942204631382,1.0,6/12,17.36%,CIDEA;PLIN5;PNPLA2;OSBPL11;FITM2;PPARA
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.7365638591701638,-1.1787923586015445,0.38,1.0,1.0,2/9,4.74%,H1-2;H1-0
prerank,GO_Biological_Process_2021__response to fructose (GO:0009750),-0.7715862018147768,-1.1785160975081845,0.27419354838709675,1.0,1.0,2/5,19.63%,KHK;GCKR
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),0.744983388295347,1.1784650973273574,0.2857142857142857,0.9040007923599472,1.0,2/6,8.76%,SDF4;ERCC2
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.49627488276684006,1.178456908607326,0.12903225806451613,0.9028496693513367,1.0,13/60,15.48%,GALNT3;TGFBR1;GALNTL6;ACVR1;PRKCD;GALNT13;SBK1;PRKD1;MAPK8;MAP3K10;CDC42BPB;GALNT16;DYRK3
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),0.7832437331671198,1.1781187126089487,0.3,0.9030803426124467,1.0,2/6,12.22%,IRS2;BCL6
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.5135805000151796,-1.178083731379708,0.2222222222222222,1.0,1.0,8/55,8.91%,BTN2A2;PRLR;TMEM184A;B3GNT3;KLF5;MYO5B;CBLC;CLDN1
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.5831376618783343,-1.1776066049856098,0.25,1.0,1.0,4/22,12.77%,CEMIP;GPER1;CALM3;CASQ1
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.6261157898316614,1.1769689119346818,0.2222222222222222,0.9058629996044419,1.0,5/12,10.10%,NFATC1;HEY1;TGFB2;JAG1;ROBO2
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),-0.6023785752192246,-1.1768925005242568,0.2,1.0,1.0,4/21,5.73%,FUT2;CYP1B1;SERINC1;ALOXE3
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),0.5779850761892578,1.1764946287372335,0.21951219512195122,0.9062736892669333,1.0,7/13,31.71%,ELP4;ADAT2;DPH3;ALKBH8;CTU1;ALKBH1;TRMT9B
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.6945515147763511,-1.1764485210492455,0.2631578947368421,1.0,1.0,3/6,23.73%,HLA-A;HLA-C;HLA-F
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.6945515147763511,-1.1764485210492455,0.2631578947368421,1.0,1.0,3/6,23.73%,HLA-A;HLA-C;HLA-F
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),-0.6081407962786971,-1.176169990325269,0.2753623188405797,1.0,1.0,7/22,9.16%,CD4;CD74;TRIML2;TRIM22;CIITA;TRIM5;TRIM25
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",-0.7840186288546849,-1.1757273736273648,0.2692307692307692,1.0,1.0,2/5,7.73%,ZBTB7B;NCKAP1L
prerank,GO_Biological_Process_2021__alpha-amino acid biosynthetic process (GO:1901607),-0.7593924809544759,-1.1755044556711645,0.23214285714285715,1.0,1.0,1/6,3.99%,SDS
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),-0.4957531667761959,-1.1754521933184308,0.2112676056338028,1.0,1.0,13/60,11.72%,ARR3;CRYBG3;WFS1;RDH10;CRYBB1;RABGGTB;CABP4;SLC24A1;RDH12;GPR179;CRYBA1;EFEMP1;CNGB1
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),-0.779033001777895,-1.1753391461792104,0.3333333333333333,1.0,1.0,1/6,2.00%,POLE3
prerank,PanglaoDB_Augmented_2021__Interneurons,0.40566363235965774,1.175252186246355,0.21052631578947367,0.9092293395237228,1.0,47/274,10.75%,ETV1;TMEM132D;TACR1;GNG4;PTPN3;NTNG1;LRRTM3;GRIA4;RAB3C;RORA;CALN1;SRGAP1;MAPK4;CTNNA2;PCBP3;SLC35F1;OLFM3;ADGRA1;VLDLR;TIMELESS;RGS7BP;GRIA2;GRM5;PLPPR5;ADGRL2;PRKCD;BRINP1;PTPRO;PRKCB;TMEM196;NRXN1;KCNQ5;CADM2;CACNA1I;CASK;CSRNP3;PCSK2;PAK5;RBFOX1;DLGAP1;PARM1;MMD2;KCNC2;RGMA;POU2F2;ADGRB3;NMB
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.653906641522546,-1.1752244943227776,0.2727272727272727,1.0,1.0,4/14,2.33%,CYP19A1;HSD17B2;CYP1B1;HSD17B10
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),-0.7703181771687173,-1.1751210975243531,0.25806451612903225,1.0,1.0,3/6,13.58%,CD14;LBP;TLR2
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),-0.7703181771687173,-1.1751210975243531,0.25806451612903225,1.0,1.0,3/6,13.58%,CD14;LBP;TLR2
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.45815100204688325,1.1748206385330942,0.23333333333333334,0.9093837243406759,1.0,8/42,8.06%,NRG1;TGFBR1;COBL;MDK;TGFB3;FGF10;ZBTB1;ARID5B
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.6832526356979076,-1.1741450089713865,0.22388059701492538,1.0,1.0,4/11,14.23%,SERPINE1;IGFBP5;TPM1;NDRG4
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),-0.577482146690402,-1.1741289759308509,0.23809523809523808,1.0,1.0,5/29,9.24%,OMG;LRP4;B2M;NOTCH1;REST
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.7014072711365916,1.1740245369056488,0.275,0.9109912360959104,1.0,2/9,1.98%,UNC5C;NRP1
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.5459999549676586,1.1732258797249668,0.2727272727272727,0.9126113170703314,1.0,6/19,16.73%,NGF;MAGI2;FRS2;DDIT4;RAPGEF1;RAP1A
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.43953450797931015,-1.1731980863558884,0.14814814814814814,1.0,1.0,60/363,16.88%,CD44;C3AR1;DOCK2;PTPRC;ELANE;PRDX4;CLEC4C;OSCAR;MGST1;B2M;ARHGAP9;GGH;GM2A;GMFG;FGL2;CAPN1;TIMP2;RAC1;ATP6AP2;MANBA;NCKAP1L;TUBB;CD14;PGAM1;TOLLIP;ATP6V1D;CCT8;CYSTM1;CTSZ;SLCO4C1;GSTP1;CTSH;PDAP1;PSMC3;TMEM30A;SVIP;HEBP2;AGL;TMBIM1;RAB31;SRP14;HVCN1;TLR2;CYB5R3;PKP1;PSAP;EEF2;PSMA5;EEF1A1;NEU1;PLAC8;PLAUR;LAMTOR2;OSTF1;LAMP1;ADAM17;CFD;HRNR;BRI3;DNASE1L1
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),0.6870736138085468,1.173171943624633,0.3829787234042553,0.9117609190820205,1.0,1/6,0.57%,GLYATL2
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),-0.6608388890778296,-1.1730640975916289,0.2647058823529412,1.0,1.0,1/9,3.92%,DGAT2L6
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),-0.7513616825407101,-1.1727936676881479,0.3333333333333333,1.0,1.0,2/8,2.78%,ZNF703;RREB1
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.5641126156672325,1.1727219164317246,0.17647058823529413,0.912194215526042,1.0,9/23,18.55%,SULF2;HS3ST4;IGF1;CHST8;CHST12;CHST11;GAL3ST4;CHST9;HPSE
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.48012281686920477,-1.1727133541144088,0.21621621621621623,1.0,1.0,26/125,11.69%,CD4;ITK;HLA-DMA;PTPRC;ELANE;B2M;CD74;CCND2;STAT1;TGFB1;IL7;FYB1;IL15;IFNGR2;GCNT1;STAT4;IL18;IGSF6;BRCA1;HLA-A;CCL5;MAP4K1;SPI1;WARS1;INHBA;RPL9
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.7192250101448747,1.1725625099719825,0.3170731707317073,0.9116290915432684,1.0,1/6,6.20%,LIN28B
prerank,GO_Biological_Process_2021__regulation of guanyl-nucleotide exchange factor activity (GO:1905097),-0.7729159304430313,-1.1725079691849822,0.2711864406779661,1.0,1.0,3/5,21.29%,PBXIP1;STMN1;MET
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),0.5683174868343416,1.1724346709875824,0.21428571428571427,0.9108827991876504,1.0,3/14,6.97%,UBASH3B;ACVR1;KIF26A
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.4967994881626078,1.1723281107935233,0.1794871794871795,0.9101218261717471,1.0,5/32,6.73%,RUNX1;ZBTB20;TGFB3;RAB27A;APOE
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.5059197012689732,-1.1721303802562129,0.22535211267605634,1.0,1.0,22/77,13.99%,B2M;CD74;IRF1;IL7;IFI27;PROCR;IL15;CASP8;PSMB8;LPAR6;TRIM5;ISG20;IFIT3;TRIM25;PSMA3;WARS1;IFI44;CNP;CMPK2;CMTR1;EPSTI1;TMEM140
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),-0.6927347040481062,-1.1717979789798838,0.23076923076923078,1.0,1.0,2/7,20.54%,CALM3;CALM1
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),-0.5075006577243717,-1.1717076445548438,0.22058823529411764,1.0,1.0,14/61,11.72%,ARR3;CRYBG3;WFS1;RDH10;CRYBB1;RABGGTB;CABP4;SLC24A1;CACNA2D4;RDH12;GPR179;CRYBA1;EFEMP1;CNGB1
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.530228891754821,-1.1714854757349582,0.22857142857142856,1.0,1.0,8/50,5.87%,C3AR1;MS4A6A;HCK;PTPRC;FGL2;CARD6;IRF1;CIITA
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),-0.4857840663207147,-1.171482551844843,0.26153846153846155,1.0,1.0,17/79,19.68%,ALPL;CYP19A1;HSD17B2;CDKN2D;WNT8A;TGFB1;CD6;CTSH;LBP;ADAM17;HNRNPA0;PRDX3;ESR1;PCK2;NOS1;SPP1;SLC11A1
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),-0.712377450179257,-1.1712240269759153,0.3442622950819672,1.0,1.0,3/7,15.28%,CCDC39;DRC1;DNAH11
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.6380187414805842,-1.1711308542602787,0.27941176470588236,1.0,1.0,5/16,19.23%,ODAD4;CCDC39;ROPN1L;CABYR;SPAG17
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373),-0.7791241182112301,-1.1710250688936763,0.2641509433962264,1.0,1.0,1/5,2.84%,CAV3
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.7165141811189655,-1.1705644328894371,0.3050847457627119,1.0,1.0,1/5,5.07%,STAT1
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),0.6005428250115579,1.1703508456063667,0.3055555555555556,0.9145095771162418,1.0,6/13,11.75%,COQ6;PDSS2;COQ2;COQ9;UBIAD1;COQ7
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),0.6005428250115579,1.1703508456063667,0.3055555555555556,0.9145095771162418,1.0,6/13,11.75%,COQ6;PDSS2;COQ2;COQ9;UBIAD1;COQ7
prerank,GO_Biological_Process_2021__regulation of barbed-end actin filament capping (GO:2000812),0.6935504897310498,1.1703225394180827,0.325,0.9134330857871673,1.0,1/5,8.01%,CRACD
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.42530709059914057,1.1701317988550086,0.16666666666666666,0.9130521381262724,1.0,41/162,14.48%,NRG1;HOMER2;ZNF536;INSYN2A;MAPK4;LINGO2;CLSTN2;SLC35F1;OLFM3;GRIA2;PLPPR5;BRINP1;PCDH19;GALNT13;NLGN1;CADM2;RGMB;GNL3L;FUT9;EPHA7;NOVA1;CSRNP3;PAK5;DACH1;PHF21B;SLITRK5;ADGRB3;GRID2;MAPK8;NOL4;ST8SIA3;CIB2;TRIM44;ELAVL3;PPFIA2;MEGF10;SYT1;RIPOR2;AATF;GPM6B;CNTNAP2
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.6317772176584723,1.1700699310569702,0.2972972972972973,0.9121449593870861,1.0,7/13,28.96%,BTG2;TNRC6B;AGO2;ZFP36;POLR2G;TNRC6A;TOB1
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),0.4945310565065769,1.1692985609471933,0.23333333333333334,0.9135436342777272,1.0,12/67,12.13%,EPHA3;PID1;STAC;EGFR;EPHB2;PTPN9;NUMB;STX8;PIK3R1;ZDHHC5;VAMP8;PRKCE
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.6166567103111198,-1.1686506494679132,0.3076923076923077,1.0,1.0,4/21,13.97%,ACTC1;MYBPC2;TTN;TPM1
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.6166567103111198,-1.1686506494679132,0.3076923076923077,1.0,1.0,4/21,13.97%,ACTC1;MYBPC2;TTN;TPM1
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.6173063565525307,-1.1686421766638937,0.26666666666666666,1.0,1.0,3/26,11.01%,TERF2IP;GAR1;MRE11
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.4599005153239952,1.1681273221117077,0.19230769230769232,0.9163027430863134,1.0,10/115,5.86%,FBXL7;TPD52L1;CCNH;NEDD1;KDM8;PCM1;PLCB1;LATS1;CDK14;TAF2
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.6446694532480646,1.1679394461876276,0.3125,0.9156903243443226,1.0,2/9,12.77%,SLC22A3;SRM
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.3730526561265212,1.1678987992165397,0.11764705882352941,0.9147024319073528,1.0,61/419,10.99%,NRG1;ROR2;KIT;CDH13;PDGFD;UNC5B;TNFRSF19;IRS1;F2RL1;PELI2;KDR;BCL2L11;BCL2;EGFR;KITLG;TRIP6;FGFR4;TGFBR1;S100A13;SEMA5A;FGFR3;IQCJ-SCHIP1;WDR24;LGALS1;TGFB2;PDGFC;WWC1;EREG;CCDC22;BTC;CFLAR;NEK6;TICAM1;PDGFRA;NR3C2;FGF10;CASS4;AKR1C3;HMGB1;IGF1;PRKCB;PTPN6;NRG2;NLGN1;EEF1D;REL;IRS2;RYK;PELI1;ANGPT1;PRKD1;ERBB4;MID2;TAB3;STYXL1;SPHK2;MALT1;DDX60;NOS1AP;GPR89A;LIMS1
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),0.5885741397489821,1.1678694268653969,0.3055555555555556,0.9135860509217789,1.0,6/14,11.75%,COQ6;PDSS2;COQ2;COQ9;UBIAD1;COQ7
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),-0.7254935152541211,-1.16713406538205,0.2727272727272727,1.0,1.0,1/7,1.08%,TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.6400811762438271,-1.1667614113911486,0.2878787878787879,1.0,1.0,3/17,13.49%,PTPRC;LBP;HLA-DMB
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),0.663781163177224,1.1666572116621512,0.3333333333333333,0.9167073273252384,1.0,3/9,19.36%,APOE;SIRT1;ABCD1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.5740500312600159,-1.1662775676165549,0.265625,1.0,1.0,5/24,12.96%,SERPINE1;CASP8;BRCA1;FADD;TMBIM1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.7122394086298592,1.1661937517385323,0.35555555555555557,0.9170119684550109,1.0,2/5,21.09%,MTMR9;MTMR3
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),-0.7195467129565514,-1.165905253167452,0.2903225806451613,1.0,1.0,2/9,9.89%,PTPRC;SIGIRR
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.41518054371833835,1.1658177795845686,0.2222222222222222,0.9174463259643865,1.0,23/117,10.05%,EPHA3;ROR2;KIT;ALK;PTPRT;EFS;KDR;EPHA5;EGFR;FGFR4;FGFR3;CSF1R;MPZL1;EPHB2;PDGFRA;CNKSR1;CASS4;SHC3;EPHA7;RYK;ERBB4;FRK;LTK
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),-0.7477808628736343,-1.165797873426672,0.2413793103448276,1.0,1.0,1/5,15.51%,EIF2B5
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.5188571863751599,1.1657612567394087,0.3,0.91651128129198,1.0,7/35,10.37%,IFI16;F2RL1;HSPB1;S100A13;HMGB1;STMP1;MALT1
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),-0.5214521056494772,-1.16546073371488,0.24615384615384617,1.0,1.0,7/53,14.98%,ENPP2;LIPC;LPCAT4;PLA2G7;LPCAT3;PCYT1A;PLA2G10
prerank,GO_Biological_Process_2021__heart trabecula formation (GO:0060347),0.7340013496897992,1.1653240546078725,0.35,0.9169939867704322,1.0,2/5,10.43%,HEY1;RBP4
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.5923197415775642,-1.1652733316952235,0.2692307692307692,1.0,1.0,8/31,12.99%,ACOT4;BAAT;ACOT12;ACOT13;ACSM4;ACSM6;ACOT1;ACOT2
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.518231241253413,1.1651222231183727,0.21428571428571427,0.9164193127586688,1.0,2/24,4.95%,MSH4;POLD3
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),0.7471363687857786,1.1650570610122686,0.32432432432432434,0.9155052689964969,1.0,3/5,25.20%,ENPP3;CTPS2;PRPS1
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),-0.6271425971291651,-1.165018781590052,0.3235294117647059,1.0,1.0,3/14,11.56%,DNASE2;H1-0;DNASE2B
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),0.7317309306262475,1.164936350122088,0.2571428571428571,0.9147555833493467,1.0,1/6,7.66%,LETM2
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.5334278143988627,-1.1647505010951453,0.23943661971830985,1.0,1.0,26/57,30.51%,MCM2;GMNN;CDC6;PSMB6;PSMB8;PSMA3;PSMC3;PSMC6;PSMA5;PSMA7;PSMD12;PSME1;RPS27A;PSMB2;UBC;PSMD2;PSMA8;PSMA1;PSMC1;MCM4;PSMD4;PSMD8;ORC4;PSMB4;PSMC4;UBB
prerank,"GO_Biological_Process_2021__regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",-0.7691901872532099,-1.1646807233555674,0.24528301886792453,1.0,1.0,2/6,17.31%,RSPO3;PLEKHA4
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),-0.6845346745720134,-1.164392177582605,0.25757575757575757,1.0,1.0,4/12,16.78%,ZNF703;CCL5;PLAUR;LYN
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.6972455040398666,-1.164326651572133,0.2807017543859649,1.0,1.0,1/9,1.08%,TERF2IP
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.6496499080813449,1.1641641147615265,0.35135135135135137,0.9162741226570279,1.0,3/8,20.39%,HMGB1;ERCC3;TOP3B
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),-0.6468489733903092,-1.1641007241492254,0.2982456140350877,1.0,1.0,1/13,2.00%,POLE3
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.6122267187377635,-1.163920700387525,0.2786885245901639,1.0,1.0,3/27,11.01%,TERF2IP;GAR1;MRE11
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),0.6823157405791878,1.1638468895354082,0.2777777777777778,0.9160588945527801,1.0,5/8,29.43%,DPH5;DPH1;DPH3;CPEB2;DPH2
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.438853410235529,-1.163818288526555,0.17721518987341772,1.0,1.0,59/358,16.88%,CD44;C3AR1;DOCK2;PTPRC;ELANE;PRDX4;CLEC4C;OSCAR;MGST1;B2M;ARHGAP9;GGH;GM2A;GMFG;FGL2;CAPN1;TIMP2;RAC1;ATP6AP2;MANBA;NCKAP1L;TUBB;CD14;PGAM1;TOLLIP;ATP6V1D;CCT8;CYSTM1;CTSZ;SLCO4C1;GSTP1;CTSH;PDAP1;PSMC3;TMEM30A;SVIP;HEBP2;AGL;TMBIM1;RAB31;SRP14;HVCN1;TLR2;CYB5R3;PKP1;PSAP;EEF2;PSMA5;EEF1A1;NEU1;PLAC8;PLAUR;LAMTOR2;OSTF1;LAMP1;CFD;HRNR;BRI3;DNASE1L1
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.675241520513699,1.1635043121807525,0.3076923076923077,0.9158603480345346,1.0,2/8,5.46%,IL1RAPL1;RAB7A
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),-0.555997128098616,-1.1634591666879535,0.24561403508771928,1.0,1.0,8/23,18.40%,PRELP;B3GNT3;CHST1;B3GNT4;OGN;ACAN;B4GALT3;B4GAT1
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),0.6170875261083998,1.1634304008699279,0.2894736842105263,0.9150655496552862,1.0,2/10,5.75%,PLCB1;GREM1
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.644155809377846,1.162981453459819,0.3488372093023256,0.9152069953441305,1.0,2/9,5.01%,NRP1;ZSWIM5
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),-0.760015322962817,-1.1625498069358575,0.29310344827586204,1.0,1.0,1/5,10.32%,IL18
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell differentiation (GO:0045630),-0.760015322962817,-1.1625498069358575,0.29310344827586204,1.0,1.0,1/5,10.32%,IL18
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),-0.6418316976316145,-1.1623908232500035,0.3333333333333333,1.0,1.0,2/13,11.86%,KIF14;STMN1
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.6842596464365934,-1.1622921121669945,0.3230769230769231,1.0,1.0,2/12,12.18%,PAICS;RFK
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.5450326574519291,1.1622436409976151,0.2,0.9167477804034877,1.0,3/28,5.06%,STAC;LRRC55;EPHB2
prerank,GO_Biological_Process_2021__regulation of microvillus organization (GO:0032530),-0.751916791656214,-1.1621770878323125,0.2708333333333333,1.0,1.0,1/7,1.32%,CDHR5
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.35582640967767243,1.1620534298046394,0.0,0.9162279929805761,1.0,101/904,11.34%,CD38;MYRFL;ETV1;RUNX1;CREB5;CDH13;ZNF300;IFI16;PID1;MAML3;TEAD2;E2F5;ATOH8;SSBP3;F2RL1;NFIB;LEF1;ZNF496;WWTR1;ZEB2;NFIA;NFATC1;ZNF462;EGFR;KDM8;RORA;ATF3;HIVEP1;FANK1;ZGLP1;TGFBR1;ZBED3;BMP6;BMP7;SERTAD2;ZNF827;PLCB1;GABPB2;MRTFA;TOX3;ESRRG;HEY1;MAML1;CREB3L4;NRL;WWOX;TGFB3;TOX2;FOS;BRCA2;GREM1;ACVR1;MEIS1;ZNF407;SOX12;ARID1B;JAG1;TET2;NFIX;APOE;ARID1A;HMGB1;IGF1;MED30;HDAC1;ZNF263;BCL11B;TET1;ELF2;REL;ASF1A;SMAD2;TFCP2;RGMB;WBP2NL;CSRNP3;LYAR;PRKD1;ZBTB17;ERBB4;ATF6;ETV5;TFAP4;POU3F1;EIF2AK3;FZD1;CDK8;TASP1;RGMA;AUTS2;PRDM15;RYBP;FLI1;POU2F2;CDK5RAP2;TCF4;ZNF609;MRTFB;H1-4;FOXO1;PIK3R1
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.6116946611087036,-1.1620456968707005,0.2698412698412698,1.0,1.0,5/20,20.62%,TERF2IP;POLR2J;POLR2K;DAXX;POLR2B
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.6116946611087036,-1.1620456968707005,0.2698412698412698,1.0,1.0,5/20,20.62%,TERF2IP;POLR2J;POLR2K;DAXX;POLR2B
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),-0.7403906921471068,-1.1620433335001037,0.3387096774193548,1.0,1.0,2/5,23.76%,GPS2;ATG14
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),-0.7719823501975271,-1.1619474658289883,0.38181818181818183,1.0,1.0,1/5,6.22%,SLU7
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.43862430930102875,-1.1619274368090633,0.1518987341772152,1.0,1.0,59/360,16.88%,CD44;C3AR1;DOCK2;PTPRC;ELANE;PRDX4;CLEC4C;OSCAR;MGST1;B2M;ARHGAP9;GGH;GM2A;GMFG;FGL2;CAPN1;TIMP2;RAC1;ATP6AP2;MANBA;NCKAP1L;TUBB;CD14;PGAM1;TOLLIP;ATP6V1D;CCT8;CYSTM1;CTSZ;SLCO4C1;GSTP1;CTSH;PDAP1;PSMC3;TMEM30A;SVIP;HEBP2;AGL;TMBIM1;RAB31;SRP14;HVCN1;TLR2;CYB5R3;PKP1;PSAP;EEF2;PSMA5;EEF1A1;NEU1;PLAC8;PLAUR;LAMTOR2;OSTF1;LAMP1;CFD;HRNR;BRI3;DNASE1L1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.6146088860152816,1.1617393072515183,0.30434782608695654,0.9160625582869045,1.0,3/13,7.95%,SULF2;SPRY3;APLN
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),-0.734867823773976,-1.1617174933763494,0.32075471698113206,1.0,1.0,4/9,16.85%,P2RY12;CCL5;SFTPD;CXCL17
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.5381610733830204,1.161505301879634,0.2391304347826087,0.9157532694925314,1.0,3/28,1.98%,HSPB1;KDR;NRP1
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.5232117442803654,-1.161457809358095,0.2698412698412698,1.0,1.0,1/53,0.09%,ENPP2
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),-0.6321244109089899,-1.161119099993461,0.23809523809523808,1.0,1.0,2/15,7.99%,UPB1;DPYS
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.6392611009305413,-1.1607885597267733,0.27419354838709675,1.0,1.0,7/17,23.65%,EIF3I;EIF4A2;EIF2S2;RBM4;MCTS1;EIF5;EIF4H
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.43293658342415553,-1.1605362340111758,0.16049382716049382,1.0,1.0,28/286,11.24%,CD44;ENPP2;CD4;TERF2IP;PTPRC;ITGA5;AGT;CD74;NODAL;P2RY1;CCND2;SPDYA;RAC1;TGFB1;PINK1;TBX1;TOM1L1;RARRES2;CEMIP;IL15;FAM20A;CALCR;AGER;GPER1;CALM3;TEC;MRE11;INHBA
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),-0.7065176834297995,-1.1604884733090806,0.26153846153846155,1.0,1.0,4/7,28.50%,MMUT;PCK2;PCCB;MMAA
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.4425388688248348,1.1602709289873716,0.125,0.9191589020678184,1.0,33/100,14.30%,GRIA4;KCNIP1;RAB3C;NTM;MAPK4;CTNNA2;SLC35F1;UNC5D;GUCY1A2;GRIA2;LSAMP;GRIA1;BRINP1;NRXN1;NOVA1;CSRNP3;CNTN1;RBFOX1;ROBO2;RGMA;PCDH17;ADGRB3;GRID2;ST8SIA3;TMEM132B;GABRB3;ELAVL3;DENND2A;SEMA5B;NTRK3;GPM6B;MAGI2;PAK3
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),0.446232542001095,1.1598615351534884,0.18518518518518517,0.9193902219598853,1.0,17/81,10.05%,EPHA3;ROR2;KIT;ALK;KDR;EPHA5;EGFR;FGFR4;FGFR3;CSF1R;EPHB2;PDGFRA;IRS2;EPHA7;RYK;ERBB4;LTK
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.5234790294622267,1.1596402855268944,0.22580645161290322,0.9191897827838666,1.0,6/44,4.78%,TPD52L1;BCL2L11;BCL2;TGFBR1;CRADD;WWOX
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),0.6960347242383871,1.1595004509610898,0.26666666666666666,0.9184315656996664,1.0,3/7,25.56%,VCL;ROCK2;IKBKB
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),-0.7197022111718507,-1.159262817196393,0.2982456140350877,1.0,1.0,1/7,12.23%,LGSN
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.5399950852917772,1.1591376940071363,0.19047619047619047,0.9185195471118239,1.0,5/16,21.42%,EPHA5;PRKD1;CRTC3;ADCY8;RELN
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),0.6190004711827181,1.1590203446535903,0.35714285714285715,0.917795823113376,1.0,5/13,22.97%,HDAC1;SIRT1;AURKC;SIRT7;CHD1
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.560008691321037,1.1587353555026747,0.25,0.9177572278306547,1.0,2/18,7.92%,GDAP1;PLD6
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.5336407930907417,-1.1585919181193396,0.28125,1.0,1.0,11/49,14.35%,CCNE1;CDKN2D;CDKN3;CCND2;CCNG2;CDC6;CAMK2N1;CDC25A;CDK5R1;GADD45A;CDKN1B
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),-0.6520187963782507,-1.1585363614752204,0.3442622950819672,1.0,1.0,3/13,20.15%,F11R;TJP3;ACTG1
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),-0.7426306680295309,-1.1585210361226224,0.42105263157894735,1.0,1.0,3/5,17.65%,CAV3;FLOT1;EMP2
prerank,GO_Biological_Process_2021__complement receptor mediated signaling pathway (GO:0002430),-0.7140030117522767,-1.1580369155279342,0.3488372093023256,1.0,1.0,1/7,0.29%,C3AR1
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.625630064680842,1.157946013950027,0.3023255813953488,0.9194488637456867,1.0,5/11,8.13%,LEF1;TGFB2;TGFB3;CHD7;SMAD2
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.6445450674877725,-1.1576057051723168,0.3333333333333333,1.0,1.0,2/12,5.24%,DEGS2;SPTLC3
prerank,GO_Biological_Process_2021__meiotic sister chromatid cohesion (GO:0051177),0.7339359197581615,1.1568087543989358,0.35,0.9219290591655072,1.0,1/5,1.53%,HORMAD1
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),-0.7068594482689221,-1.156694995616025,0.3448275862068966,1.0,1.0,1/9,4.15%,P2RY12
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.5641867591457352,1.1564852893710724,0.24324324324324326,0.9219014166573803,1.0,3/18,10.07%,CROCC;CEP135;CEP120
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.46037962261448206,1.1564778816718342,0.22580645161290322,0.9207984192872809,1.0,13/65,14.98%,GLYATL2;ABHD1;ACADVL;EHHADH;CROT;CEL;SLC27A2;AIG1;ABCD2;PEX2;ACOT8;NUDT7;ECHDC1
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.6757374293372514,-1.1563007134501595,0.30357142857142855,1.0,1.0,3/12,12.08%,DRD3;ADRA1D;ADRB1
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.4466301328706555,1.1562384210159171,0.20689655172413793,0.920282542634111,1.0,14/93,5.94%,EPHA3;ROR2;KIT;ALK;RASSF2;KDR;EPHA5;EGFR;FGFR4;FGFR3;CSF1R;EPHB2;EREG;PDGFRA
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),-0.7078651167755263,-1.1561944756409117,0.3384615384615385,1.0,1.0,3/9,10.66%,CD4;THEMIS2;CCL5
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.4791913859259094,-1.1557632122747843,0.25,1.0,1.0,47/117,30.51%,MCM2;POLE3;GMNN;GINS2;CDC6;RFC5;PSMB6;RPA3;RECQL;PSMB8;MGME1;PSMA3;PSMC3;GINS1;PSMC6;PSMA5;POLE2;PSMA7;CDK2AP1;PSMD12;PSME1;PURA;GINS4;RPS27A;PSMB2;BLM;TWNK;UBC;PSMD2;MCMDC2;PSMA8;RECQL4;CDC7;PSMA1;PSMC1;MCM4;DBF4;PSMD4;PSMD8;RPA1;ORC4;PSMB4;HELB;DDX23;POLD1;PSMC4;UBB
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.5900788490044083,-1.155690780448658,0.28125,1.0,1.0,13/22,34.46%,RFC5;RPA3;PCNA;UFD1;RPS27A;UBC;RCHY1;RPA1;POLD1;UBB;RFC1;RPA2;UBA52
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),0.5281187309017439,1.1555476804473053,0.1794871794871795,0.9212035980264385,1.0,3/26,5.94%,UBASH3B;HSPB1;PDGFRA
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),-0.691547402016058,-1.1555331310955406,0.34328358208955223,1.0,1.0,1/7,2.84%,CAV3
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),-0.6290951200575874,-1.1555097182599299,0.3559322033898305,1.0,1.0,4/7,33.46%,KDELR3;KDELR1;GPAA1;RER1
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.476222370963877,-1.154529459928498,0.18461538461538463,1.0,1.0,23/94,24.74%,MEP1B;PEBP1;CDKN3;ZC2HC1C;GAD1;GSG1;CCT6B;ZPBP;HSPA4L;RPL39L;NEFH;VDAC3;NOS1;ACRV1;HSPA1L;CLGN;DDX4;PSMG1;CCNB2;SCG5;SHE;TALDO1;PCSK4
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.4698756829887455,1.1542160571199647,0.20588235294117646,0.9249745621709649,1.0,12/70,9.66%,NPNT;WWTR1;BMP6;BMP7;CRIM1;GREM1;ACVR1;ZHX3;PTCH1;IGF1;PRKD1;NELL1
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.7362077905154065,-1.1537363450798366,0.2923076923076923,1.0,1.0,4/8,16.41%,BCAP31;SVIP;HERPUD1;USP14
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),-0.5342037818488006,-1.1535651402520366,0.2465753424657534,1.0,1.0,8/45,13.33%,PRLR;CYP19A1;HSD17B10;BAAT;ACOX2;HSD11B2;DHCR7;HSD11B1
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),-0.6949404197411762,-1.1535204484128376,0.27419354838709675,1.0,1.0,1/9,2.44%,STEAP4
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),-0.6949404197411762,-1.1535204484128376,0.27419354838709675,1.0,1.0,1/9,2.44%,STEAP4
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),-0.6813882003390141,-1.1534159930468195,0.3389830508474576,1.0,1.0,3/11,15.93%,DRD3;GRM3;AKAP5
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),-0.6813882003390141,-1.1534159930468195,0.3389830508474576,1.0,1.0,3/11,15.93%,DRD3;GRM3;AKAP5
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.6820335324451176,-1.153237358138201,0.2631578947368421,1.0,1.0,3/12,10.26%,PTPRC;CALM3;PDGFRB
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.4792923421846919,1.1530932677400307,0.2972972972972973,0.927603236515549,1.0,17/64,16.51%,RGS14;CACNG3;CLSTN2;EPHB2;GRIN2A;CACNG4;NRXN1;NLGN1;SHANK2;SLC8A3;ZDHHC3;SYT1;GRIK2;GRIN2C;ZDHHC2;GRIN2B;KCTD13
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.5576715251209221,1.153051469741804,0.2571428571428571,0.9267358084125445,1.0,5/18,17.28%,LIN28B;MEX3D;CELF1;ZC3H18;FTO
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),-0.5564243574341874,-1.1529045239529807,0.3333333333333333,1.0,1.0,5/29,8.66%,KCNE2;SCN4B;ATP1B1;KCNQ1;ATP1A1
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.4470547377307112,1.1527754328035615,0.24242424242424243,0.9265299000341303,1.0,25/64,24.43%,RGS14;IL1RAPL1;AMIGO1;FBXW8;NUMB;CHODL;ROBO2;TIAM2;NGF;TIAM1;MAP6;PLXNA2;ROBO1;PLXNC1;NUMBL;PTPRD;DISC1;CTNNB1;NEURL1;PLXNA1;SMARCD3;CAPRIN1;VEGFA;CUX1;MME
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.5585762769231816,1.1522805830979208,0.24324324324324326,0.9262761978052149,1.0,4/9,16.15%,IRS1;SIRT1;SORL1;SNX5
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.5585762769231816,1.1522805830979208,0.24324324324324326,0.9262761978052149,1.0,4/9,16.15%,IRS1;SIRT1;SORL1;SNX5
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.6014820213732128,1.1522489592402436,0.30952380952380953,0.9252267982097481,1.0,6/18,15.43%,RGS14;GRIN2A;SHANK2;SLC8A3;GRIN2C;GRIN2B
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.42806728206309996,-1.1512930132170194,0.1125,1.0,1.0,37/246,18.43%,TICRR;RAD54L;MCM2;TERF2IP;POLQ;POLE3;GMNN;DNASE2;CDC6;RFC5;BACH1;GLRX2;RPA3;RAD51AP1;INIP;RECQL;FANCC;XRCC1;BRCA1;MRE11;NUDT1;TDG;HMGB3;GADD45A;POLE2;UHRF1;PCNA;PDS5B;PARG;SUPV3L1;DNASE1L1;MPG;CHEK1;RAD51C;NUDT15;RBBP8;KAT5
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.49157509414970213,1.1506432700686589,0.2571428571428571,0.9290862907959622,1.0,7/40,7.72%,RGS14;IL1RAPL1;CLSTN2;EPHB2;NUMB;NRXN1;NLGN1
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.4025454679514236,1.1505607397334727,0.14285714285714285,0.9282233195963564,1.0,29/220,8.59%,KLHL17;POU6F2;TBX6;MDGA1;NFIB;PCDH18;VCAN;CNTN6;KLK6;AMIGO1;ATXN1;AFF2;PDGFC;DSCAML1;SYNJ2;ADGRL2;MEIS1;GRIN2A;CNTN4;SOX12;MACROH2A2;CHD7;SMG9;GRIK1;PTCH1;JHY;PSPN;SLC8A3;EPHA7
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.5141667468732003,-1.1498985191611613,0.2608695652173913,1.0,1.0,15/50,17.65%,PTGES;KLRG2;ALOXE3;TOM1L1;CELSR1;WNT7B;SEMA3F;SIX4;PPIC;IGSF3;YAP1;SH2D4A;CRABP2;SHROOM3;EMP2
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),-0.6264256951743069,-1.1498460918092603,0.3620689655172414,1.0,1.0,5/12,16.15%,PTPRC;GLI3;FADD;SHH;ADAM17
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.5611660326945364,1.149218048830452,0.3333333333333333,0.9313529457273745,1.0,3/16,8.06%,TRPS1;MDK;SOX5
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),0.6291191803142081,1.1488507368255234,0.27906976744186046,0.9315324779866151,1.0,3/9,25.54%,LRP6;VEGFA;SHROOM2
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.42078154342951163,1.1486755241574615,0.1,0.9310895491332885,1.0,22/135,7.17%,UBASH3B;PID1;HSPB1;RASSF2;WWTR1;SAMSN1;PMEPA1;SPRED1;SPRED2;ZBED3;DNAJC3;CEP85;PARD3;PRR5L;SPRED3;EPHB2;ENPP1;GREM1;PDE4D;TRIB2;PRKCD;PTPN6
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),-0.6837147132691692,-1.1485761621274277,0.3333333333333333,1.0,1.0,4/7,19.02%,MANBA;GBA3;NEU1;MAN2B2
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.710494928691961,-1.148523948995108,0.3125,1.0,1.0,2/8,6.87%,CYP1B1;SERPINE1
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),0.5969733469125985,1.1485238617076308,0.3,0.9305389501629644,1.0,2/11,4.14%,F2RL1;BATF3
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.6706163637370042,-1.1482982344858126,0.359375,1.0,1.0,3/11,13.68%,DOCK8;CCL5;APOD
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),-0.505229550291456,-1.148131874730863,0.26153846153846155,1.0,1.0,11/75,11.98%,CSRP3;GCM2;ELANE;CALCB;DRD3;ATP1B1;SLC24A1;ATP1A1;SLC24A5;CCL5;HTR2B
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.5422648293921084,1.1480485081046725,0.29411764705882354,0.9310601136604,1.0,4/17,14.73%,APOE;IGF1;BIN1;SORL1
prerank,GO_Biological_Process_2021__scaRNA localization to Cajal body (GO:0090666),-0.7785810748669453,-1.1478679123332771,0.3148148148148148,1.0,1.0,1/5,4.80%,TCP1
prerank,GO_Biological_Process_2021__RNA localization to Cajal body (GO:0090670),-0.7785810748669453,-1.1478679123332771,0.3148148148148148,1.0,1.0,1/5,4.80%,TCP1
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),-0.7828395821684595,-1.1476904851408438,0.3018867924528302,1.0,1.0,2/5,8.10%,ALDH1A1;GAD1
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.46393475297637604,1.1475500219976842,0.2,0.9315800377678296,1.0,8/48,11.50%,HTR1F;HTR1E;GRM8;CHRM3;CHRM5;ADCY2;GNAI1;DRD4
prerank,GO_Biological_Process_2021__endothelial cell morphogenesis (GO:0001886),0.7314454635665287,1.147495927985762,0.35714285714285715,0.9307367561586285,1.0,2/5,11.17%,COL15A1;COL22A1
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),-0.6810281667111037,-1.1472679787552837,0.3283582089552239,1.0,1.0,4/12,20.46%,CHMP4B;PINK1;PHF23;NUPR1
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),-0.6778248150109973,-1.147050796418673,0.38333333333333336,1.0,1.0,4/12,11.34%,FIP1L1;CSTF2T;NCBP2;NCBP1
prerank,GO_Biological_Process_2021__cilium movement involved in cell motility (GO:0060294),-0.7240156441191029,-1.1469658480506697,0.31666666666666665,1.0,1.0,5/6,24.32%,TEKT3;CFAP54;RSPH9;DNAI3;TEKT5
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),0.755947449803375,1.1466188775636077,0.3469387755102041,0.9325388925507542,1.0,1/5,1.40%,F2RL1
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.6470766916236617,-1.1465771812448238,0.35294117647058826,1.0,1.0,4/17,11.34%,B2M;IL18;HLA-A;IL18R1
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.6024760415618164,-1.146198341694097,0.32786885245901637,1.0,1.0,1/16,0.46%,HCK
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.6984525716737033,-1.1460243149346945,0.29508196721311475,1.0,1.0,3/7,26.16%,MCTS1;MTIF2;GFM2
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.7877798188056935,-1.1456901765064436,0.3090909090909091,1.0,1.0,1/5,6.88%,HSPA5
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),-0.6480977021584978,-1.14559421127868,0.3076923076923077,1.0,1.0,2/9,9.24%,PINK1;REST
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),-0.505099798050315,-1.1454551878512809,0.2753623188405797,1.0,1.0,7/68,10.51%,FANCI;WFS1;PINK1;FANCM;UBE3A;BRCA1;TSPYL5
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),0.5385398946791773,1.1452677339310406,0.34285714285714286,0.9356491810060529,1.0,1/19,0.44%,NOX4
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.6552201529830529,1.1450040232077459,0.3125,0.9355751773688701,1.0,3/11,10.79%,NLGN1;SYN3;ZDHHC3
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),-0.5564814667207834,-1.1447460021234073,0.2631578947368421,1.0,1.0,11/24,23.50%,SLC13A4;MGST1;SLC26A4;LRRC8D;SLC36A1;SLC25A11;RACGAP1;SLC25A19;SLC27A1;ABCG2;SLC26A8
prerank,GO_Biological_Process_2021__multi-ciliated epithelial cell differentiation (GO:1903251),-0.7590469919920294,-1.1446343553053648,0.36363636363636365,1.0,1.0,2/5,13.76%,PLK4;DEUP1
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),-0.6543006230463505,-1.1445197176724415,0.3582089552238806,1.0,1.0,1/12,1.20%,PATL2
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.5439769282533361,1.1444854028808107,0.2777777777777778,0.9362099217899132,1.0,7/27,11.11%,IL1RAPL1;CLSTN2;EPHB2;NRXN1;NLGN1;VSTM5;GRID2
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),-0.6764634669418903,-1.144316847995463,0.30357142857142855,1.0,1.0,3/12,21.39%,GNPDA1;GFPT2;NANP
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),-0.5894145947357837,-1.1440926842792263,0.3157894736842105,1.0,1.0,5/22,16.00%,ATP1A1;NOX5;HVCN1;SLC36A1;ATP12A
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.4642843588700165,1.1440699714753868,0.23529411764705882,0.9362431299028575,1.0,11/40,14.12%,NRG1;SEMA6D;SEMA5A;SEMA4C;ERBB4;SEMA3C;RADIL;PHACTR4;TCOF1;SEMA5B;NRTN
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.4144231165400618,1.144059328469307,0.2222222222222222,0.9351698044753667,1.0,20/155,9.36%,NRG1;KIT;IRS1;EGFR;KITLG;FGFR4;TGFBR1;SEMA5A;FGFR3;EREG;BTC;PDGFRA;FGF10;CASS4;AKR1C3;NRG2;PKHD1;IRS2;ANGPT1;ERBB4
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),-0.6904902860129316,-1.1439016390887033,0.3018867924528302,1.0,1.0,3/8,15.29%,YBX3;CASP8;SLC25A4
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.39299242521339106,1.1438727564039013,0.16666666666666666,0.9348357754768869,1.0,55/367,13.69%,CD38;NRG1;PER2;IFI16;SOX13;ATOH8;LEF1;PHC2;PTPRK;KDM8;BMP7;ID3;PLCB1;ARID5A;ATXN1;KCTD1;HDAC9;SAMD13;HEY1;TIMELESS;HIC2;EREG;PRICKLE1;ZHX3;FOXN3;SFMBT1;SAMD7;PRDM5;HDAC1;ZEB1;ARID5B;SMAD2;NACC2;FOXP2;DAP;SUV39H2;DACH1;TFAP4;SCMH1;GATAD2A;LIMS1;FOXO1;ZMYND11;TLE2;MAP3K10;BCL6;CTBP2;POU2F1;SIRT2;ID2;WWP1;PCGF6;SIRT1;VGLL4;BTRC
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.4229482189735399,1.143823910804216,0.22580645161290322,0.9338892814315649,1.0,36/127,16.87%,POU6F2;PROS1;NTNG1;EGFR;MAPK4;SLC35F1;VLDLR;IGDCC3;UNC5D;GRM5;PLPPR5;TSHZ1;EPHA7;CSRNP3;ERBB4;PAK5;RHBDL3;PHF21B;FBLL1;GRID2;NOL4;DAB1;ELAVL3;PHF1;MAPK7;SIRT1;SEMA5B;NYAP1;PPM1E;DPYSL5;PBX1;KCNC1;NCAM1;KIF5C;SNAP91;PRR36
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.5182700543612552,-1.1438166744191935,0.23880597014925373,1.0,1.0,22/51,32.22%,RPL5;RPL26L1;RPL35A;RSL24D1;WDR12;RPL24;RRP15;EIF6;RPF2;RPL3;TRAF7;SURF6;RPL7A;LAS1L;NSA2;MAK16;ZNF622;NIP7;MRPL20;MRTO4;SNU13;RPL11
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.660435732527651,1.1436864045853878,0.3333333333333333,0.9332819035194837,1.0,2/11,7.35%,CTNNA2;SLC6A4
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.5258998914256032,-1.143681274222923,0.2786885245901639,1.0,1.0,15/56,10.84%,C3AR1;MS4A6A;HCK;CD4;SIGLEC1;FGL2;CD300LF;STARD5;MYO1F;AQP9;CD14;G6PD;IGSF6;SPI1;WDFY4
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.7069005319746685,1.1435921127677893,0.3142857142857143,0.9324159315146836,1.0,3/6,28.68%,BICD1;PARD6A;MARK4
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),0.5491711654086562,1.1434566091816944,0.3023255813953488,0.9318728143769542,1.0,6/13,31.71%,ELP4;DPH3;ALKBH8;ELP1;CTU1;TRMT9B
prerank,GO_Biological_Process_2021__regulation of skeletal muscle satellite cell proliferation (GO:0014842),0.68889614902451,1.1432671012589797,0.3409090909090909,0.9314072665047425,1.0,2/6,9.03%,CFLAR;ANGPT1
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),0.7153909998204957,1.1426782411433105,0.34146341463414637,0.9320249625367557,1.0,6/7,27.33%,DISP3;NR1H3;PPARA;ITGAV;PRKN;NR1H2
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.6544646011589539,-1.1425707639980052,0.3064516129032258,1.0,1.0,4/12,29.87%,BRCA1;METTL3;YTHDC1;RLIM
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,-0.5226921745555864,-1.1421502016717944,0.26666666666666666,1.0,1.0,18/59,17.26%,CCDC60;TEX26;ANKUB1;TMEM212;DNAH3;CCDC39;ECT2L;C11ORF16;CFAP126;ATP5MK;ARMC3;CFAP77;DRC1;EFHB;APOBEC4;FAM81B;CXCL17;SNTN
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),-0.7536123827701467,-1.142070412470673,0.37037037037037035,1.0,1.0,3/6,16.21%,RCN3;CTSH;SFTPD
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),-0.7536123827701467,-1.142070412470673,0.37037037037037035,1.0,1.0,3/6,16.21%,RCN3;CTSH;SFTPD
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),0.5711497854863157,1.1416996854127366,0.2702702702702703,0.9341027013756462,1.0,2/14,2.90%,MELTF;FGFR4
prerank,GO_Biological_Process_2021__regulation of bile acid biosynthetic process (GO:0070857),0.6784693377728148,1.1413516430613093,0.34210526315789475,0.9343660715594362,1.0,3/7,20.35%,FGFR4;SIRT1;PROX1
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.5372078783306347,1.1412633390626004,0.2777777777777778,0.9335504566817628,1.0,12/24,25.34%,SYNJ2;MTMR8;MTMR9;PIP4P1;PTEN;MTMR6;MTM1;MTMR3;MTMR11;INPP5J;MTMR10;MTMR12
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.5602710362050662,-1.14112269591284,0.28125,1.0,1.0,5/29,10.39%,BTN2A2;LRPAP1;RIN3;PINK1;BRCA1
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.5604696140855261,-1.1410229755330763,0.29508196721311475,1.0,1.0,5/30,13.18%,RIN3;PEX11B;RAC1;VAV3;MSN
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.4324052278985528,-1.140995292320485,0.16049382716049382,1.0,1.0,37/282,15.20%,SERF1A;CALB1;LOXL4;HSPG2;COL9A1;CYP1B1;ACTC1;B2M;RND1;FBLN5;COL6A1;RAC1;MYO5B;MYO1F;CORO1A;BMP1;FIGNL1;P4HA3;KIF14;COL19A1;APH1B;HIP1R;BFSP1;DCTN1;COL13A1;STMN1;MFGE8;RHOH;INPPL1;TUBGCP4;TPM1;TLL1;ARHGAP12;COL10A1;NEFL;SIAH1;MARCKSL1
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),0.6664518362238622,1.1407900300004594,0.2727272727272727,0.9338897097791766,1.0,6/9,19.64%,TGFB2;PTCH1;MYH3;LRP6;FBXW4;MBNL1
prerank,GO_Biological_Process_2021__interleukin-18-mediated signaling pathway (GO:0035655),-0.7283348874187637,-1.1407762150159917,0.29411764705882354,1.0,1.0,3/6,11.34%,IL18BP;IL18;IL18R1
prerank,GO_Biological_Process_2021__cellular response to interleukin-18 (GO:0071351),-0.7283348874187637,-1.1407762150159917,0.29411764705882354,1.0,1.0,3/6,11.34%,IL18BP;IL18;IL18R1
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),-0.6680836127617795,-1.1404048343840703,0.3333333333333333,1.0,1.0,2/9,4.29%,SDS;BAAT
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.6783943159862007,-1.140316628292811,0.38095238095238093,1.0,1.0,4/11,11.34%,FIP1L1;CSTF2T;NCBP2;NCBP1
prerank,MSigDB_Hallmark_2020__heme Metabolism,-0.4460971849314861,-1.1402881402455558,0.2191780821917808,1.0,1.0,5/166,1.50%,TRIM58;GYPB;GYPE;SLC7A11;UROD
prerank,GO_Biological_Process_2021__regulation of mast cell chemotaxis (GO:0060753),-0.7634103366515981,-1.1396144615828558,0.27586206896551724,1.0,1.0,1/5,4.51%,RIN3
prerank,GO_Biological_Process_2021__regulation of respiratory burst (GO:0060263),-0.7444941701804768,-1.1394402557436638,0.3137254901960784,1.0,1.0,1/5,5.85%,RAC1
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),-0.747563399829377,-1.1391505772480577,0.3898305084745763,1.0,1.0,2/5,20.50%,CHDH;SARDH
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),0.6824414800423274,1.139040429675574,0.3488372093023256,0.9380921900116047,1.0,4/7,14.80%,PRKCB;IRS2;CTTNBP2NL;AKT2
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),-0.6928934640111725,-1.1387179152439566,0.3,1.0,1.0,2/7,20.10%,PEX16;PEX1
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),-0.667295558316402,-1.1387014429787619,0.35,1.0,1.0,1/15,0.98%,HENMT1
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.6768902989632908,1.13858023973459,0.4,0.9385010571379988,1.0,2/5,17.36%,PNPLA2;PPARA
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.4777413991502225,1.1384231131959759,0.2564102564102564,0.9379716691328815,1.0,6/35,6.57%,NOX4;CSF1R;GRM5;EREG;BTC;CASS4
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),0.617339238142661,1.1382806181891336,0.2765957446808511,0.9373529060105432,1.0,2/9,5.31%,NFATC1;EREG
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),-0.7278060317577233,-1.1380377974665845,0.26865671641791045,1.0,1.0,2/7,14.34%,UBE3A;YAP1
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.4792919157782236,1.1375101749217569,0.21621621621621623,0.9388471744201375,1.0,12/37,13.87%,ST6GAL2;ST3GAL3;B4GALNT2;GLA;MPDU1;FUT9;ST6GALNAC4;ABO;ST8SIA3;NEU3;ST3GAL2;ST8SIA4
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),0.6363019501653321,1.1374348140266919,0.3409090909090909,0.9379425869402805,1.0,4/7,14.70%,CIDEA;PLIN5;OSBPL11;FITM2
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),0.534627850377412,1.137319582748629,0.3333333333333333,0.9372959048851122,1.0,2/23,0.55%,ACE2;PER2
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.5263887630671931,-1.1372909265769664,0.25333333333333335,1.0,1.0,21/47,30.79%,MCM2;RECQL;MRE11;DDX1;RBX1;DDX11;SUPV3L1;PURA;RPS27A;BLM;TWNK;UBC;CETN2;RAD50;MCMDC2;RECQL4;MCM4;RPA1;RAD23B;UBB;PIF1
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),-0.5321158471650287,-1.1369800094803553,0.2727272727272727,1.0,1.0,9/34,17.19%,BNIP3;F11R;IRF1;CASP8;FADD;LTBR;GADD45A;PIEZO2;CHEK1
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),-0.7456492250161697,-1.1369021371107209,0.3230769230769231,1.0,1.0,1/6,6.00%,IL7
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte proliferation (GO:0010838),0.7041374941258971,1.1368636853171095,0.40540540540540543,0.9376878302568035,1.0,3/7,6.24%,TGM1;MDK;FGF10
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),0.5852393575749413,1.13676735475123,0.27906976744186046,0.9367726915360566,1.0,2/15,3.67%,C5AR1;OR3A2
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.5819126062559756,-1.1366667788313156,0.23333333333333334,1.0,1.0,5/24,9.58%,CYP19A1;ZNF703;TGFB1;SSTR1;GPER1
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.39340227299956937,1.1365529562916346,0.17391304347826086,0.9362495567894408,1.0,44/190,15.86%,NPNT;LEF1;KDR;WWTR1;KITLG;TGFBR1;BMP6;BMP7;CTNNA2;PLCB1;MDK;VWC2;TGFB2;TGFB3;ACVR1;PKDCC;ZHX3;BRINP1;ZC4H2;IGF1;ZEB1;SOX5;SMAD2;KCTD11;PRKD1;NELL1;MMD2;TCF4;RIN2;PDPN;GCNT2;NGF;FGFR1;ID2;RIPOR2;MAPK12;BRINP2;NRCAM;RANBP3L;TIAM1;SIN3A;CREB1;MEF2C;BEND6
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.5312592410380533,1.136020094714296,0.25,0.9368959735344666,1.0,2/18,0.33%,RUNX1;PNP
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.6388847546001442,1.1359881338386115,0.3333333333333333,0.9359848959766183,1.0,3/12,24.97%,DESI2;ATG10;ATG7
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.6346794423914914,1.1356117975410291,0.34146341463414637,0.9361519103696632,1.0,5/10,10.10%,NFATC1;HEY1;TGFB2;JAG1;ROBO2
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),0.5108766910684308,1.1355713864666577,0.3333333333333333,0.9352437723516549,1.0,4/22,14.01%,METTL8;TRMT61A;ZC3H13;TRMT61B
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),-0.7008794952652452,-1.1355106386087157,0.4107142857142857,1.0,1.0,4/10,16.78%,CD74;GPER1;PLA2G10;LYN
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.4906458265281853,-1.135332341568605,0.3013698630136986,1.0,1.0,6/65,10.51%,FANCI;WFS1;PINK1;UBE3A;BRCA1;TSPYL5
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.4188176286304559,1.1352801608300849,0.15384615384615385,0.9352174189035095,1.0,11/88,7.04%,TPD52L1;TNFRSF19;F2RL1;RASSF2;SH3RF1;EGFR;TRAF3;PLCB1;SH3RF3;RASGRP1;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),0.6127362954076608,1.1352795691874285,0.35714285714285715,0.9341485989961912,1.0,4/14,19.38%,TPR;ANP32B;BAG3;EMD
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),0.6071249641791907,1.1349730872135748,0.35714285714285715,0.9339004123572032,1.0,3/10,14.93%,FGF13;GABRB3;WNT5A
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),0.6491481679026059,1.1345959520963382,0.3783783783783784,0.9340985699418614,1.0,2/13,4.59%,F2RL1;MDK
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.5496444649464567,1.1341249368768458,0.30303030303030304,0.934786073707358,1.0,2/21,4.01%,UNC13B;ZBTB20
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),-0.6758588048341817,-1.133660315631968,0.36363636363636365,1.0,1.0,3/8,25.31%,NOTCH1;CPE;SFRP2
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),-0.6660467494404567,-1.1329730377143747,0.31343283582089554,1.0,1.0,7/11,27.09%,RAC1;NTN1;SEMA3A;RHOH;CHN1;SLIT1;NTN5
prerank,GO_Biological_Process_2021__regulation of system process (GO:0044057),0.6770193427422165,1.1329198903122173,0.40476190476190477,0.9377699602547022,1.0,3/5,23.29%,MTG2;HTR2C;ROCK2
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.6837542193763283,-1.1329144858441782,0.3090909090909091,1.0,1.0,4/9,22.65%,MAP1LC3B2;MAP1LC3B;GABARAPL2;GABARAPL1
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.6837542193763283,-1.1329144858441782,0.3090909090909091,1.0,1.0,4/9,22.65%,MAP1LC3B2;MAP1LC3B;GABARAPL2;GABARAPL1
prerank,GO_Biological_Process_2021__regulation of complement-dependent cytotoxicity (GO:1903659),0.6575132424393377,1.1328509241025306,0.34146341463414637,0.936867207368786,1.0,3/6,23.93%,TGFB2;CFH;CR1L
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.5311762628893681,1.1327542942046884,0.275,0.9360700465278632,1.0,9/22,26.18%,EIF4EBP1;MEIS2;TTL;PPP1R10;PKN2;HSF1;SMOC2;CUL3;PRKCA
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.537580442099625,1.132591590322257,0.3333333333333333,0.9354519937663346,1.0,2/21,7.92%,GDAP1;PLD6
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.5421551991251884,-1.1317345701798578,0.26229508196721313,1.0,1.0,8/32,13.97%,CSRP3;ACTC1;MYPN;TTN;PDGFRB;SIX4;CASQ1;TPM1
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.469632267023998,1.131649240859974,0.3181818181818182,0.937565627402493,1.0,12/86,5.06%,GPC4;FREM1;NPNT;TNFRSF19;RIMBP2;PTPRT;CAPN13;COBL;BMP7;TOX3;PDZRN3;EPHB2
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.6481906957676817,-1.131460976095847,0.3275862068965517,1.0,1.0,1/10,0.62%,MCM2
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.5416678838213808,1.1311259723733813,0.19444444444444445,0.9383182508947125,1.0,6/17,24.20%,ZBED3;MARK1;TRAK2;MTM1;MARK2;TRAK1
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.5171554160233998,1.130600956752296,0.2571428571428571,0.9389071990562734,1.0,4/28,6.42%,CD38;BCL2;EPHB2;CD22
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.5695349122448684,-1.1304688995668166,0.3492063492063492,1.0,1.0,3/23,16.42%,TERF2IP;MRE11;GNL3
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.4898986642513877,-1.1304492531743,0.3026315789473684,1.0,1.0,6/65,8.05%,PTER;ZNF703;OVOL3;TBX1;TST;TOLLIP
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.43587468691107384,1.1303364603869226,0.25925925925925924,0.9387446927429081,1.0,14/107,9.52%,FBXL7;SEMA6D;EFS;PCDH18;NTM;CACNA2D1;FIGN;PDZRN3;ADGRL2;IL17RD;GFRA1;CSRNP3;CAP2;AMOTL2
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),0.703104120808363,1.1301275691439385,0.3409090909090909,0.9382446425599086,1.0,2/6,5.90%,KIT;TICAM1
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.5647221404485895,1.1299304069321068,0.2702702702702703,0.9377750690297879,1.0,1/21,0.96%,GFI1B
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.6056885164922254,1.1296040699767187,0.26666666666666666,0.9377902889856132,1.0,2/10,8.06%,TGFB2;SOX5
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),-0.6903185357332327,-1.1293793760961517,0.390625,1.0,1.0,5/6,28.76%,FURIN;FN1;HSP90AB1;CDH3;CD24
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),0.6271757912208629,1.1292785618438475,0.3783783783783784,0.9367236917514904,1.0,3/12,9.51%,AASS;OGDH;HYKK
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),0.6271757912208629,1.1292785618438475,0.3783783783783784,0.9367236917514904,1.0,3/12,9.51%,AASS;OGDH;HYKK
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.6030582480181494,-1.1290990168913597,0.34545454545454546,1.0,1.0,7/14,18.87%,P2RY12;NCKAP1L;CCL5;ADAM9;CXCL13;PODXL;SKAP1
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.5384619662608866,-1.1289199245805093,0.3125,1.0,1.0,16/30,35.88%,NSDHL;G6PD;DHCR7;SQLE;FAXDC2;PRKAG2;HMGCR;ACAA2;ACAT2;DHCR24;PMVK;ARV1;INSIG2;ACLY;IDI1;MSMO1
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.5077084661118172,1.1285684703755257,0.3225806451612903,0.9381279320755517,1.0,7/42,9.51%,CDH13;CDH6;CDH20;NECTIN3;CDHR3;CADM2;DCHS1
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),0.53110843106684,1.1282057164539319,0.32608695652173914,0.9383032121408725,1.0,5/27,13.16%,PER2;HEY1;ELAPOR2;TENM4;SIRT2
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),-0.6987577634630067,-1.1281966400939323,0.373134328358209,1.0,1.0,6/10,27.96%,COPS2;COPS5;COPS8;COPS7B;GPS1;COPS7A
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),-0.6643669493585469,-1.1281467524872493,0.38095238095238093,1.0,1.0,3/13,15.93%,DRD3;GRM3;AKAP5
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.5750525217423748,-1.1281194637896699,0.3333333333333333,1.0,1.0,6/34,9.22%,DUOX1;AHR;STAT1;KCNQ1;AQP9;IGFBP5
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.5253449410045226,-1.1281057128408225,0.3076923076923077,1.0,1.0,8/44,16.89%,POLQ;RFC5;RPA3;XRCC1;TDG;PCNA;PARG;MPG
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.5101308990249919,1.1280076682605071,0.25,0.9380116451833959,1.0,7/36,15.95%,TNFRSF19;TAB3;MAPK8;TAB1;MAP3K10;MAP3K5;MAP3K13
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),-0.5036653351300115,-1.1277524048872867,0.296875,1.0,1.0,6/54,10.91%,HCK;CAV3;RAC1;PINK1;NCKAP1L;DCTN1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.49801403854521914,1.1276347270267044,0.2631578947368421,0.9381721030621984,1.0,7/46,8.48%,CD38;PNP;BCL2;EPHB2;FGF10;SLC7A1;IRS2
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell apoptotic process (GO:0010664),0.7267298205436205,1.1275394697839733,0.41025641025641024,0.9374595520822099,1.0,4/5,18.26%,BMP7;MDK;BAG3;PPP1R10
prerank,GO_Biological_Process_2021__mitochondrial respirasome assembly (GO:0097250),-0.7293798405967702,-1.1275188179846787,0.3333333333333333,1.0,1.0,4/6,26.89%,HIGD1C;COX7A2L;COX7A2;RAB5IF
prerank,GO_Biological_Process_2021__regulation of dopamine uptake involved in synaptic transmission (GO:0051584),-0.6713570950171992,-1.127424119590219,0.3333333333333333,1.0,1.0,1/7,3.79%,DRD3
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.6325985305163832,-1.1274186487928235,0.3194444444444444,1.0,1.0,6/12,23.44%,TCP1;CCT6A;CCT8;GNL3;CCT7;CCT2
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),-0.6998079871471381,-1.1273991503504153,0.39622641509433965,1.0,1.0,2/7,11.58%,NCKAP1L;FADD
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.6775227779089608,-1.127259192773979,0.36363636363636365,1.0,1.0,2/11,7.63%,STAT1;IFNGR2
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.6498191229907067,-1.1271407584976258,0.3582089552238806,1.0,1.0,5/13,32.58%,PAICS;AMPD2;AMPD3;IMPDH2;ADSS2
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),0.6060582113160696,1.1270861582107876,0.3404255319148936,0.9378527151075773,1.0,5/9,23.46%,LAMB3;LAMA3;CD151;LAMC1;DST
prerank,GO_Biological_Process_2021__intracellular pH elevation (GO:0051454),0.6449973383390857,1.1266052391289434,0.29411764705882354,0.9384626792792466,1.0,2/6,2.84%,BCL2;SLC26A3
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),-0.6817557798448697,-1.1264277414493475,0.3559322033898305,1.0,1.0,3/8,16.00%,ATP1B1;ATP1A1;ATP12A
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.42435037237123463,1.1263174864628256,0.21212121212121213,0.9382160434883272,1.0,20/120,8.59%,KLHL17;MDGA1;NFIB;PCDH18;CTNNA2;AMIGO1;ATXN1;AFF2;DSCAML1;SYNJ2;ADGRL2;MEIS1;GRIN2A;CNTN4;MACROH2A2;SMG9;PTCH1;SLC6A4;JHY;EPHA7
prerank,GO_Biological_Process_2021__regulation of interleukin-18 production (GO:0032661),-0.7362271567318492,-1.1260525770905934,0.3230769230769231,1.0,1.0,4/5,25.80%,GBP5;TLR2;NLRP9;NLRP12
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.5145534931324591,-1.1258524934707688,0.296875,1.0,1.0,6/39,15.37%,MARVELD2;CTNNA1;F11R;CLDN1;CLDN20;CLDN10
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.610879014273917,-1.1256406349998713,0.359375,1.0,1.0,3/18,7.63%,STAT1;TXK;IFNGR2
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),-0.6901367610694016,-1.1254626828043288,0.32727272727272727,1.0,1.0,4/10,22.79%,F11R;TJP3;RAB1A;RAB1B
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.5913544310168266,-1.1252394236362295,0.30158730158730157,1.0,1.0,4/17,17.67%,DOCK8;CCL5;CXCL13;ACKR3
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),0.6696227748742355,1.125218364529502,0.4222222222222222,0.9407934655775961,1.0,4/8,19.55%,CHRM3;CHRM5;CHRM2;HRH4
prerank,GO_Biological_Process_2021__desmosome organization (GO:0002934),0.6825897062481149,1.1251481913833008,0.4634146341463415,0.9400241055605413,1.0,1/5,2.71%,PKP2
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),-0.6543640476574504,-1.1250782474097174,0.375,1.0,1.0,4/8,31.54%,NGLY1;AGA;OGA;PARK7
prerank,GO_Biological_Process_2021__cellular response to UV-A (GO:0071492),-0.7295314859357971,-1.1250655370516098,0.38636363636363635,1.0,1.0,3/6,17.56%,PPID;OPN1SW;OPN3
prerank,GO_Biological_Process_2021__indolalkylamine catabolic process (GO:0046218),-0.681603638440155,-1.1249831667165704,0.36666666666666664,1.0,1.0,5/9,29.29%,IL4I1;ACMSD;IDO1;KMO;TDO2
prerank,GO_Biological_Process_2021__tryptophan metabolic process (GO:0006568),-0.681603638440155,-1.1249831667165704,0.36666666666666664,1.0,1.0,5/9,29.29%,IL4I1;ACMSD;IDO1;KMO;TDO2
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),-0.5382305305340852,-1.1246953996701112,0.2857142857142857,1.0,1.0,8/28,23.84%,POLR3K;TBP;POLR2K;GTF3C6;GTF3C3;GTF3C4;POLR3G;SNAPC2
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),0.5610855348933649,1.1246838256756764,0.35,0.9404700357324455,1.0,4/15,11.49%,ARL13B;ALDH1A2;PTCH1;TRIM71
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.6000659718794503,-1.1244830467370348,0.390625,1.0,1.0,4/18,10.25%,TCP1;CCT6A;CCT8;DCP2
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.6632359751784668,1.1244642769921518,0.3170731707317073,0.9402511323380944,1.0,4/7,20.37%,COMMD1;NEDD4L;NEDD4;WNK2
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.5308727702363347,1.12429834354554,0.2972972972972973,0.9396290801199818,1.0,8/30,13.80%,NYAP2;IRS1;IGF1;MYO16;LTK;PIK3R1;SIRT2;NYAP1
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.4432510366347874,-1.1242338958265916,0.15714285714285714,1.0,1.0,18/110,12.13%,CD44;C3AR1;SIGLEC1;HSPG2;GPR68;NOX1;F11R;RAC1;CIITA;TGFB1;BLNK;PTGER3;CD14;TRAF3IP2;IL18;CCL5;TBXA2R;TAC4
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),0.6181559849920119,1.1238980078910508,0.29411764705882354,0.9398291763826092,1.0,2/13,3.58%,ZBED3;PLCB1
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),-0.6792535434861595,-1.1237238723102838,0.2982456140350877,1.0,1.0,6/8,28.63%,BNIP3;HEBP2;RNF122;BAX;ARL6IP5;PIP5KL1
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),-0.47992934637906826,-1.1236385245383205,0.2647058823529412,1.0,1.0,9/48,19.96%,ELANE;CDKN2D;SLC24A1;CRY2;TRIM32;OPN1SW;OPN3;TYR;USP1
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),-0.690528868387661,-1.1235768597598277,0.36065573770491804,1.0,1.0,1/7,1.45%,POLQ
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),0.43793068542375024,1.1235137291101267,0.2,0.9399281454063927,1.0,6/61,5.82%,NPNT;PID1;AFF3;GCH1;SMPD4;TNFRSF11A
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.6535404864356621,1.1234414896553206,0.425531914893617,0.9391360933417995,1.0,5/7,21.93%,PIK3R1;SOCS2;PXN;JAK2;STAT3
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.4611493760371056,-1.1233588752906725,0.2631578947368421,1.0,1.0,29/131,17.11%,SLC28A2;C3AR1;NDP;CD82;ITGA5;OSMR;AHR;GPC3;IRF1;KCNA3;SERPINE1;IL15;IFNGR2;AQP9;CD14;IL18;CCL5;INHBA;IL18R1;GPR132;GPR183;TLR2;PLAUR;STAB1;ADGRE1;NFKBIA;NAMPT;LYN;TNFSF9
prerank,GO_Biological_Process_2021__photoreceptor cell outer segment organization (GO:0035845),-0.7350387458347563,-1.1233358019696444,0.3389830508474576,1.0,1.0,2/5,10.73%,PCARE;RP1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.6047294139727872,-1.122711915220562,0.3548387096774194,1.0,1.0,6/11,33.11%,UQCRB;CYCS;UQCR10;UQCRH;CYC1;UQCRC1
prerank,GO_Biological_Process_2021__positive regulation of neutrophil extravasation (GO:2000391),0.7265412859433557,1.122506221650659,0.3269230769230769,0.9401807374289295,1.0,2/5,13.33%,MDK;RIPOR2
prerank,GO_Biological_Process_2021__regulation of neutrophil extravasation (GO:2000389),0.7265412859433557,1.122506221650659,0.3269230769230769,0.9401807374289295,1.0,2/5,13.33%,MDK;RIPOR2
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.4363375437127301,1.1224661887095961,0.3103448275862069,0.9393194168431217,1.0,13/52,14.52%,PTPRK;EGFR;FOS;PDGFRA;AKR1C3;PRKCD;AGAP3;ERCC6L2;MAPK8;MAP3K5;MAPK7;SIRT1;FER
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.6264769089186962,1.1221132822983202,0.36585365853658536,0.9394756210471488,1.0,1/10,3.71%,DSCAM
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.561479009434652,1.1217615848307467,0.36,0.939617193680887,1.0,7/22,14.70%,PNP;PDE4D;HPRT1;PRTFDC1;MLYCD;NUDT7;FITM2
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),0.5051869689098268,1.1214945098460776,0.2727272727272727,0.9395015355897804,1.0,6/42,7.13%,ITGA4;CACNA2D1;TIMELESS;GRM5;GRIN2A;IGF1
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),0.6795285383971355,1.121307746916194,0.3333333333333333,0.9390154290742798,1.0,2/5,28.25%,SLC15A4;XIAP
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),-0.5531680880405095,-1.1211769622876713,0.373134328358209,1.0,1.0,5/29,8.66%,KCNE2;SCN4B;CAV3;KCNQ1;ATP1A1
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),0.6567068737794177,1.1202809156623195,0.32608695652173914,0.9410227644819621,1.0,3/8,12.12%,FGF13;NGF;PTPRS
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.6830223893583358,-1.120235813398929,0.35,1.0,1.0,3/9,25.39%,CHDH;SARDH;LRTOMT
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.4304683729265526,-1.1200665782470973,0.2289156626506024,1.0,1.0,40/153,18.36%,CD44;CA12;PRLR;WFS1;PTGES;NXT1;ACOX2;GINS2;PLAC1;CDC6;FKBP4;TST;PTGER3;CALCR;ETFB;ISG20;GPER1;CKB;PRSS23;HSPA4L;DHCR7;MYOF;MEST;TJP3;BLVRB;RAB31;PDZK1;PLK4;CXCL14;IMPA2;FKBP5;SCUBE2;MOCS2;CPE;SLC16A1;OPN3;EMP2;IL6ST;COX6C;RBBP8
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.651749915857564,-1.1200285551034004,0.3620689655172414,1.0,1.0,3/15,15.47%,CAMLG;EMC1;EMC3
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),-0.5583585347142359,-1.1199537978653484,0.36666666666666664,1.0,1.0,7/19,26.77%,SERINC1;LPCAT4;LPCAT3;PLA2G10;SLC27A1;PLA2G4A;OSBPL10
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),-0.6867392217819023,-1.1198966341336154,0.3442622950819672,1.0,1.0,4/8,26.67%,ATP6AP1;NDUFS2;ATP6V1G1;ATP6V1A
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),0.647318337029126,1.11969139666687,0.34285714285714286,0.9416172817055263,1.0,2/10,5.46%,RAB7B;RAB7A
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001270),-0.6889348604324835,-1.1195852068676844,0.4074074074074074,1.0,1.0,3/5,30.12%,RPS3;RNF34;RFPL1
prerank,GO_Biological_Process_2021__arachidonic acid secretion (GO:0050482),-0.6871051848685148,-1.119493739244307,0.3333333333333333,1.0,1.0,1/6,3.79%,DRD3
prerank,GO_Biological_Process_2021__arachidonate transport (GO:1903963),-0.6871051848685148,-1.119493739244307,0.3333333333333333,1.0,1.0,1/6,3.79%,DRD3
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),0.6129274935298411,1.1194252839509944,0.3617021276595745,0.9412157248907919,1.0,1/11,0.56%,CYP1A2
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),-0.610315883776507,-1.1193441373266035,0.3333333333333333,1.0,1.0,3/13,11.45%,CD14;SCIMP;LBP
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.5855851127846832,-1.119194577134717,0.32142857142857145,1.0,1.0,2/17,2.31%,POLQ;CGAS
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.49135132847191265,1.1190132320332948,0.2631578947368421,0.9414254547999445,1.0,5/23,6.13%,SEMA6D;NRP1;SEMA5A;DSCAM;SEMA4C
prerank,GO_Biological_Process_2021__phospholipid homeostasis (GO:0055091),-0.6678135971275867,-1.1185488053751502,0.4032258064516129,1.0,1.0,7/10,27.76%,FABP3;TLCD2;RCN3;HNF4A;ANGPTL3;LIPG;ABCB11
prerank,GO_Biological_Process_2021__iron import into cell (GO:0033212),-0.7276796460290138,-1.1185014084502527,0.3508771929824561,1.0,1.0,1/6,11.12%,NOX5
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),-0.5020730329996103,-1.1184633149765741,0.27419354838709675,1.0,1.0,6/27,10.54%,SLC13A4;SLC22A25;SLCO2B1;SLC26A4;LRRC8D;SLC17A8
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.7443327861895355,1.117991262174552,0.34210526315789475,0.942707597472554,1.0,2/5,21.94%,PHLDB2;DAG1
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.7443327861895355,1.117991262174552,0.34210526315789475,0.942707597472554,1.0,2/5,21.94%,PHLDB2;DAG1
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),0.6750243721408937,1.1178470722799148,0.3902439024390244,0.9422217045115874,1.0,2/7,10.50%,TICAM1;PIBF1
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),0.701795369724774,1.1176533983826356,0.32608695652173914,0.9418782059355177,1.0,2/6,11.50%,INSYN2A;DRD4
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.4519132868788393,1.1176156701516906,0.18181818181818182,0.9409565839202759,1.0,2/40,4.66%,PID1;MARCHF5
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),-0.6015317503352036,-1.117607419198226,0.3793103448275862,1.0,1.0,5/19,16.07%,AGT;PRKCH;IL18;PLA2G10;NFKBIA
prerank,GO_Biological_Process_2021__regulation of glial cell differentiation (GO:0045685),0.6624496877074505,1.1175658346709907,0.3541666666666667,0.9400651636489963,1.0,2/5,21.90%,TNFRSF21;EPHA4
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),0.6173719508489866,1.1172718812002018,0.3673469387755102,0.9399646098939118,1.0,1/10,0.56%,CYP1A2
prerank,GO_Biological_Process_2021__positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),0.7477134364669453,1.1171630249027709,0.36585365853658536,0.9391746970745072,1.0,2/5,16.90%,SIRT2;RCC2
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),0.5610543472845455,1.1169008705450356,0.3333333333333333,0.9389769162301211,1.0,3/9,17.70%,ALDH1A2;CYP2C8;ALDH1A3
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),0.7094861047673016,1.1168398754447608,0.3235294117647059,0.9380633862405059,1.0,1/6,5.07%,TGFB2
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),0.6235640978640102,1.116665312836904,0.375,0.9375305664982029,1.0,3/10,6.85%,SERTAD2;ARID1B;ARID1A
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell migration (GO:0090521),0.6972597442747897,1.1162143606358292,0.4,0.9380077894070264,1.0,1/5,2.92%,KANK1
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),0.5781063395913427,1.116175575603512,0.30952380952380953,0.9371402362894604,1.0,6/12,33.52%,WDR35;TTC21A;DYNC2I2;IFT43;TTC21B;IFT122
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.5823557309840066,1.116148539896027,0.3902439024390244,0.936148703400411,1.0,2/15,1.59%,F2RL1;RAB7B
prerank,GO_Biological_Process_2021__cranial nerve development (GO:0021545),0.7598879600769916,1.116012908844617,0.35135135135135137,0.9356621223643194,1.0,1/5,6.55%,CHD7
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.6960559871769518,-1.1157666892240212,0.3333333333333333,1.0,1.0,5/10,24.54%,B2M;TLR2;PGK1;RPS27A;UBC
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.6542206048779383,-1.1155485763543764,0.4117647058823529,1.0,1.0,2/10,5.41%,FOXM1;RPS27L
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.5059953296334245,1.1154940251012448,0.23333333333333334,0.9363764935336559,1.0,8/27,15.10%,PLCB1;LATS1;FGFR3;APOE;IGF1;MBD5;NRCAM;SIN3A
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),-0.6745560595761931,-1.115244154569005,0.3877551020408163,1.0,1.0,2/11,6.05%,MSX1;TBX1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),-0.5519041739896582,-1.1148361164660443,0.296875,1.0,1.0,8/25,21.25%,CAV3;ATP1B1;KCNQ1;CALM3;HCN4;NOS1;CALM1;PLN
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.47254579171085886,1.114644950463404,0.26666666666666666,0.9382461510178298,1.0,13/44,17.80%,PER2;TBL1Y;HDAC9;PRDM5;HDAC1;SIRT2;SIRT1;SMARCAD1;HDAC10;SIN3A;HDAC3;HDAC5;SIRT7
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),0.5763959959728879,1.1145983797156522,0.29411764705882354,0.9373829776053677,1.0,2/13,2.90%,RUNX1;FGFR4
prerank,GO_Biological_Process_2021__adrenal gland development (GO:0030325),0.6429439463077408,1.114559073593565,0.3902439024390244,0.9364660155184591,1.0,1/6,4.59%,MDK
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),0.5886375950879379,1.1139867716154246,0.2777777777777778,0.9371209115144341,1.0,2/11,2.94%,SLC2A9;SLC2A11
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.4848018791155588,1.1131024462543575,0.20833333333333334,0.9387181268919749,1.0,13/102,7.22%,FBXL7;ADAMTS2;LAMB2;PRRX1;SVEP1;PCDH18;FNDC1;LAMA4;COLEC11;PDZRN3;PDGFRA;FGF10;HTRA1
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.6361727226359588,1.1127397718317082,0.3469387755102041,0.9389810587955731,1.0,4/7,16.12%,EXT1;EXT2;HS2ST1;NDST1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),0.5821505862658751,1.1127254527612291,0.34,0.938010901631487,1.0,5/14,19.21%,MCTP1;SNCAIP;MCTP2;MEF2C;HCRT
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),0.6738057624532898,1.112598830899021,0.3902439024390244,0.9365189771455579,1.0,1/8,9.50%,SLC25A33
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),0.6738057624532898,1.112598830899021,0.3902439024390244,0.9365189771455579,1.0,1/8,9.50%,SLC25A33
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.41492299624613604,1.1123108452319759,0.21739130434782608,0.9364380084450765,1.0,9/94,7.33%,EPHA3;CDK2AP2;EPHA5;IQGAP2;TRIM36;IQCJ-SCHIP1;PRKCD;EFNA5;PEAK3
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.4124754970438078,1.1122675231538417,0.1891891891891892,0.9355711790745082,1.0,11/79,9.84%,ATP6V0D2;CYP4Z1;KCNJ16;PTPRT;ESRRG;PDZD2;JAG1;SCNN1B;CCDC30;ERBB4;FRK
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),0.7252804478496678,1.1120711127403689,0.3958333333333333,0.9351332215361766,1.0,4/6,24.25%,SPHK2;WNT5A;ADRA1A;VEGFA
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),-0.6687786846939056,-1.1120349703733508,0.3050847457627119,1.0,1.0,2/7,10.40%,WNT7B;BFSP1
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,-0.45463503943911093,-1.111919045268617,0.323943661971831,1.0,1.0,17/99,15.29%,CSRP3;LAMA2;ACTC1;TRIM54;CAV3;PDE1A;NOTCH1;C14ORF180;FABP3;TTN;MYOM1;CTNNA3;CKB;CASQ1;TPM1;NEXN;SLC25A4
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),0.7416862056146017,1.1118408970503717,0.4594594594594595,0.9348475589669318,1.0,2/5,13.25%,MAML1;ATP11A
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.5594894616669404,1.1115877143918786,0.45454545454545453,0.9336601039118205,1.0,6/14,28.96%,NANOS3;ZFP36L2;TNRC6B;AGO2;ZFP36;TOB1
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.5594894616669404,1.1115877143918786,0.45454545454545453,0.9336601039118205,1.0,6/14,28.96%,NANOS3;ZFP36L2;TNRC6B;AGO2;ZFP36;TOB1
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.5131292195585113,1.1115092881811772,0.3103448275862069,0.9329379354763462,1.0,6/38,11.55%,C5AR1;PTCHD1;GRM5;CHD7;SOBP;MAGT1
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),-0.6842808043674525,-1.111432413731145,0.35384615384615387,1.0,1.0,2/10,10.25%,PATL2;DCP2
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.6358428866479646,-1.1113922153790934,0.40816326530612246,1.0,1.0,2/8,23.76%,MAP1LC3B;ATG14
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),-0.563856383481486,-1.111266439223383,0.3492063492063492,1.0,1.0,3/22,11.45%,DRD3;SLC24A1;GRIK3
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),0.48410571305124417,1.1104877340313062,0.23684210526315788,0.9347934558648375,1.0,3/32,5.94%,UBASH3B;HSPB1;PDGFRA
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),-0.6465021684382886,-1.1104658193197599,0.3492063492063492,1.0,1.0,1/7,6.55%,TST
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.6181786202617856,1.110465453343685,0.29411764705882354,0.9338662845191615,1.0,3/10,5.75%,TGFBR1;TGFB2;ACVR1
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),-0.6518649236131315,-1.1103834969275423,0.3508771929824561,1.0,1.0,4/9,20.46%,PINK1;IFNLR1;ISCU;NUPR1
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),0.578614734703478,1.1099597725126145,0.25806451612903225,0.9344452291747203,1.0,2/16,3.81%,TYSND1;ACADVL
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.5199811028706789,-1.1096308769851324,0.35064935064935066,1.0,1.0,8/43,13.14%,UPB1;HSD17B10;B2M;TRPA1;SOD2;ACOT13;GBP5;MCOLN1
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.6469979769061749,1.109482557104365,0.3673469387755102,0.9351595595196314,1.0,3/9,19.91%,ADCY2;ADCY9;ADCY8
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),-0.6908496216414794,-1.109317953732476,0.34545454545454546,1.0,1.0,1/8,3.50%,CCDC39
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.41656993218854266,1.1089331371535756,0.28125,0.9357768744231215,1.0,20/82,14.24%,GALNT3;GXYLT2;ST3GAL3;TMTC2;GALNT12;C1GALT1C1;GALNT7;GALNTL6;GALNT10;TET2;GALNT18;GALNT13;TET1;CRPPA;ST3GAL1;ST6GALNAC4;ST3GAL2;DPM3;GALNT14;GALNT16
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),0.49127938148301986,1.108874097783662,0.3,0.9349479733208468,1.0,10/34,13.94%,MELTF;KANK1;JAG1;PTPRO;EFNA5;CASK;NEXMIF;GCNT2;SPOCK1;ACTN4
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),0.6954450935074457,1.1088599261778416,0.391304347826087,0.9340663360298818,1.0,4/6,25.04%,FER;MMP24;PLEKHA7;CDH2
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),-0.6715587625682468,-1.1088030364123487,0.3220338983050847,1.0,1.0,1/10,2.29%,PTPRC
prerank,GO_Biological_Process_2021__citrulline metabolic process (GO:0000052),0.6984038540610451,1.1087473715212803,0.4146341463414634,0.9334858032440093,1.0,1/6,5.96%,DDAH1
prerank,GO_Biological_Process_2021__carbohydrate transport (GO:0008643),-0.6576270868241504,-1.1081353133658143,0.3384615384615385,1.0,1.0,2/8,15.61%,AQP9;SLC23A1
prerank,GO_Biological_Process_2021__regulation of plasma membrane organization (GO:1903729),-0.7295229437840001,-1.1079571263081889,0.3770491803278688,1.0,1.0,3/5,26.61%,NOX5;SYTL4;RAB3A
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.5647032395232177,1.1079372162905425,0.3783783783783784,0.9347273698124072,1.0,3/19,5.22%,EPHB2;TGFB2;SPRY3
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",0.6607565148673301,1.1075132384481907,0.29411764705882354,0.9350161301393368,1.0,3/7,24.67%,DCP1B;DCP1A;ZFP36
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),-0.6435721207945736,-1.107338522932949,0.34545454545454546,1.0,1.0,2/11,9.03%,ABCB1;MLC1
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.6768049444507022,-1.1072148029099786,0.3684210526315789,1.0,1.0,5/9,21.15%,ATP5F1C;ATP5MC3;ATP5PD;ATP5F1A;ATP5PB
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),0.5487404092489808,1.1069489421855163,0.2564102564102564,0.9358467071438515,1.0,5/14,24.67%,KHSRP;TRIM71;RC3H1;ZFP36L2;ZFP36
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),-0.543477299397314,-1.1069385994064609,0.3611111111111111,1.0,1.0,4/25,8.28%,NPY;CCDC39;RARRES2;GLI3
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.44733014217401146,1.1069029929249785,0.3103448275862069,0.935049996001331,1.0,15/90,7.33%,ACE2;SLC22A2;SLC12A3;KCNJ16;PTPN3;COBL;ESRRG;PDZD2;GSTO2;JAG1;SLC16A7;ABCA13;BAZ2B;COBLL1;PKHD1
prerank,GO_Biological_Process_2021__hyaluronan biosynthetic process (GO:0030213),-0.7449219610070621,-1.1065608452396372,0.3870967741935484,1.0,1.0,2/5,9.89%,CEMIP;HAS3
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.5307451944169365,-1.1065194793895614,0.32,1.0,1.0,13/42,21.09%,MPV17L2;RPS27L;RPL5;RSL24D1;ERAL1;C1QBP;RPL24;EIF6;RPS15;RPF2;RPL3;TRAF7;SBDS
prerank,GO_Biological_Process_2021__fructose metabolic process (GO:0006000),-0.7654896479498882,-1.106397198996752,0.390625,1.0,1.0,3/5,22.01%,ALDOB;KHK;AKR1B1
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),-0.6078266875313483,-1.106274693252749,0.3188405797101449,1.0,1.0,1/16,2.83%,GOT1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),0.7017010085555383,1.1062492098441714,0.391304347826087,0.9358382160266587,1.0,2/5,11.22%,TRPC3;FOXO1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),-0.7393005699678157,-1.1062084297537176,0.3898305084745763,1.0,1.0,1/5,6.48%,SOD2
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",-0.7139709924220313,-1.1059634298997663,0.36,1.0,1.0,2/7,8.71%,ABT1;RPS21
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),0.6272485594447608,1.1057124640020193,0.3103448275862069,0.9365977642600348,1.0,3/10,13.57%,FGFR4;AKR1C3;SIRT1
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.5624637732438428,1.1057048677032801,0.2903225806451613,0.9356271966286773,1.0,4/18,14.74%,MACROH2A2;LRWD1;RUVBL2;LEMD2
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),-0.4644536962218919,-1.105653361989505,0.28378378378378377,1.0,1.0,16/77,19.73%,CSRP3;GCM2;ELANE;CALCB;DRD3;ATP1B1;SLC24A1;SLC24A5;CCL5;HTR2B;SLC30A8;ATP2A3;SLC24A4;TMEM203;SLC11A1;CALR
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),-0.6661081470945542,-1.1056037511189019,0.3548387096774194,1.0,1.0,1/9,2.83%,GOT1
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),0.7103581264683139,1.1055712285000379,0.3191489361702128,0.9350228752654733,1.0,1/5,16.12%,B3GAT3
prerank,GO_Biological_Process_2021__cellular response to interleukin-4 (GO:0071353),0.6444476665513396,1.1054501038211952,0.32653061224489793,0.9344332800929845,1.0,1/5,1.51%,LEF1
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.4616675053116809,1.104483491719043,0.32142857142857145,0.9362815938452876,1.0,26/88,22.02%,CDH6;CDH20;PKP2;SDK1;DSCAM;CDHR3;NRXN1;NLGN1;SHANK2;RYK;DCHS1;LIMS1;GPM6A;PKP4;NRCAM;DNER;OPHN1;PTEN;FARP1;FERMT2;CDH10;CDH1;PARD6B;MYO9A;CDH11;CDH18
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),0.6659021019414862,1.1043798707477783,0.4358974358974359,0.9358398499549597,1.0,4/6,31.18%,ELAVL4;METTL16;TENT4B;LARP4B
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.6863153518325084,1.1039903156459572,0.4,0.936057313372726,1.0,2/12,5.07%,LTBP1;TGFB2
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),-0.6828465000175835,-1.1035713069178246,0.43636363636363634,1.0,1.0,2/6,15.28%,CCDC39;DNAH11
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.5819985407109549,-1.1035382225316583,0.36666666666666664,1.0,1.0,2/16,11.01%,TERF2IP;MRE11
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),0.5711539313711578,1.1032401034095263,0.3076923076923077,0.9375358828054509,1.0,3/12,6.97%,UBASH3B;ACVR1;KIF26A
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),0.709037982681811,1.1026310563434014,0.42105263157894735,0.9383410609587195,1.0,2/7,8.43%,PTPRK;CASK
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),-0.7008903257359563,-1.1018479065006568,0.34545454545454546,1.0,1.0,3/9,16.03%,SLC25A5;SLC25A4;VDAC1
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),-0.7555056362866246,-1.1017472376360307,0.3387096774193548,1.0,1.0,3/5,23.17%,FLOT1;EMP2;RFTN1
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.5814221858959852,1.1016518846115495,0.3333333333333333,0.9400955012764909,1.0,3/12,5.07%,TGFBR1;HEY1;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.5049480066709472,-1.1015952085106766,0.3064516129032258,1.0,1.0,12/40,13.49%,DOCK8;PTPRC;PDCD1LG2;IL7;HLA-DPB1;IL15;NCKAP1L;CD6;HLA-A;CCL5;RHOH;HLA-DMB
prerank,GO_Biological_Process_2021__regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),-0.7097018887292845,-1.1015116142008663,0.41379310344827586,1.0,1.0,1/5,5.69%,KCNQ1
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),-0.604853728217573,-1.101413091970791,0.3389830508474576,1.0,1.0,2/14,9.11%,CHST1;GNPDA1
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),0.5964455158024864,1.1009754273335388,0.3953488372093023,0.9411506076796912,1.0,3/10,13.84%,UPP2;MACROD2;NT5C3A
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.5321957358074659,1.1008190599058618,0.2777777777777778,0.9405729310842909,1.0,5/17,9.36%,NRG1;OXTR;TGFB3;APLN;ERBB4
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.5321224136998796,-1.1008126985154265,0.34375,1.0,1.0,4/34,6.87%,SFRP4;B2M;LDLRAP1;SERPINE1
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),0.6629992283404167,1.1007524675692766,0.4423076923076923,0.9398762699601332,1.0,1/6,4.59%,MDK
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.4834871843750999,1.1005714534707671,0.39473684210526316,0.9396478777731142,1.0,10/32,11.85%,LEF1;WWTR1;TGFBR1;MDK;TGFB2;TGFB3;JAG1;SMAD2;PDPN;GCNT2
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),-0.6704802546332965,-1.1005608483912834,0.4,1.0,1.0,3/7,19.01%,PSMC3;PSMC6;ESR1
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.6174657158374363,1.1003888124265637,0.35714285714285715,0.939300030096439,1.0,2/14,5.06%,DOCK10;EPHB2
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),0.5419535363265173,1.1001401980587404,0.36666666666666664,0.9391525597954362,1.0,3/25,7.87%,TENT5A;ELAVL1;TENT5C
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),-0.6068637252792859,-1.1000905339205929,0.373134328358209,1.0,1.0,4/16,8.77%,HENMT1;TDRD1;TDRD9;BTBD18
prerank,GO_Biological_Process_2021__negative regulation of catecholamine secretion (GO:0033604),-0.7331107673363106,-1.0992263520498016,0.39285714285714285,1.0,1.0,1/6,12.25%,SYT4
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3674535147631077,1.0992129154525505,0.2,0.941385649108785,1.0,71/436,15.12%,CD38;NRG1;PER2;IFI16;SOX13;ATOH8;LEF1;PHC2;PTPRK;KDM8;BMP7;ID3;PLCB1;ARID5A;ATXN1;SAMD4A;KCTD1;HDAC9;SAMD13;HEY1;TIMELESS;HIC2;BTG2;EREG;PRICKLE1;ENPP1;ZHX3;FOXN3;SFMBT1;SAMD7;PRDM5;HDAC1;ZEB1;ARID5B;SMAD2;NACC2;IGF2BP3;FOXP2;DAP;SUV39H2;DACH1;TFAP4;EIF2AK3;SCMH1;GATAD2A;LIMS1;FOXO1;ZMYND11;TLE2;TRIM71;MAP3K10;BCL6;CTBP2;DHFR;LSM14A;POU2F1;SIRT2;ID2;WWP1;PCGF6;SIRT1;VGLL4;BTRC;NR3C1;SPINDOC;DMAP1;HDAC10;TERF1;WNT5A;SIN3A;CREB3L1
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.6431366579073536,-1.0991481607423979,0.4461538461538462,1.0,1.0,4/13,25.49%,ZWILCH;KNL1;BOD1;CHAMP1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),0.5592106355614935,1.0991293135704028,0.3939393939393939,0.940797982130559,1.0,4/21,11.34%,KDR;NRP1;LIMS1;PIK3R1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.5021115291601619,1.0984904132330309,0.3103448275862069,0.9416712617311943,1.0,3/31,1.75%,IFI16;F2RL1;HSPB1
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),-0.7232313931053304,-1.0983344025981159,0.38596491228070173,1.0,1.0,2/7,12.95%,PTGIS;BOK
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.45951185594962474,-1.0982927013235455,0.3382352941176471,1.0,1.0,23/81,25.18%,HLA-DMA;CD74;HLA-DPB1;HLA-A;DCTN1;HLA-DMB;KIF11;RACGAP1;KIF3A;ARF1;AP1M2;KIF22;DYNLL1;SEC23A;CANX;KIF5A;HLA-F;KLC1;CLTC;SPTBN2;CLTA;KIF4A;LGMN
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.446221290806181,1.0982439816889307,0.2916666666666667,0.941468951465581,1.0,12/57,13.57%,TOX;EYA4;EGFR;FGFR4;FGF10;ERCC8;HMGB1;BABAM2;EYA2;EYA3;BRCC3;SIRT1
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),0.4910974357268906,1.0979708269924182,0.2972972972972973,0.9414127306727114,1.0,3/15,5.24%,CATSPER2;TGFB2;TGFB3
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),0.679239071842965,1.0979555337882856,0.3611111111111111,0.9404702117417699,1.0,1/5,2.13%,CDH26
prerank,GO_Biological_Process_2021__ventricular compact myocardium morphogenesis (GO:0003223),0.6532237971630551,1.0979187467544556,0.4523809523809524,0.9396221209282006,1.0,1/6,3.05%,TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of steroid metabolic process (GO:0045940),-0.7483268861672032,-1.097892182374287,0.4482758620689655,1.0,1.0,2/5,4.14%,AGT;LDLRAP1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),0.5054195242727222,1.097339002583016,0.38235294117647056,0.9405053711943825,1.0,3/17,6.71%,PID1;PKDCC;NUMB
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),-0.6897902185365324,-1.0969435109732768,0.43548387096774194,1.0,1.0,2/7,10.25%,PATL2;DCP2
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),-0.5369046996835423,-1.0967467553094388,0.34328358208955223,1.0,1.0,9/32,20.46%,CAV3;TCHP;CHMP4B;PINK1;BRCA1;YAP1;PHF23;MDM1;NUPR1
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),-0.6714247060878293,-1.0967459356801035,0.40625,1.0,1.0,3/9,21.83%,ALOX12;PLA2G7;ACOX1
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.4186237631403611,1.0966001251711173,0.2,0.941584681435157,1.0,34/122,12.67%,PENK;LRRTM3;GRIA4;KCNIP1;RAB3C;PRSS12;PDE10A;ZNF536;OLFM3;ATXN1;ADGRA1;RGS7BP;GRIA2;GRM5;SPHKAP;LSAMP;GABRB1;BRINP1;LRRC4C;TMEM196;NRXN1;CADM2;CSRNP3;PAK5;RBFOX1;MMD2;KCNC2;SLC6A1;ADGRB3;MRTFB;ST8SIA3;SPOCK1;ELAVL3;PPFIA2
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),0.5658318580659611,1.0965096677186057,0.3902439024390244,0.9408961546328024,1.0,2/18,5.71%,SLC30A10;MT1E
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),0.7047158080506042,1.0962505751955793,0.43478260869565216,0.9407487106436931,1.0,2/6,11.17%,PRKD1;MAPK8
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),-0.6372474643345669,-1.0959622886920748,0.3770491803278688,1.0,1.0,1/15,4.13%,WIPI1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),0.6347045813008677,1.0958061782437851,0.4418604651162791,0.9411012616781969,1.0,6/10,27.33%,ABCD2;NR1H3;ABCD1;APOA1;ELOVL5;NR1H2
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),-0.529827094673463,-1.0956011303879485,0.3382352941176471,1.0,1.0,14/28,35.88%,NSDHL;G6PD;DHCR7;SQLE;HMGCR;ACAA2;ACAT2;DHCR24;PMVK;ARV1;INSIG2;ACLY;IDI1;MSMO1
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),-0.6468385681853338,-1.0955717511022747,0.4166666666666667,1.0,1.0,2/10,4.15%,RASIP1;P2RY12
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),-0.7338837849956182,-1.0955468907142667,0.4166666666666667,1.0,1.0,3/5,11.58%,CASP8;SPI1;FADD
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.6300756716387932,1.0955115766214296,0.38636363636363635,0.9409144981627235,1.0,1/12,0.33%,PNP
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),-0.5180169495918101,-1.0952643712416297,0.35135135135135137,1.0,1.0,3/32,1.95%,SLC12A7;TRPV6;WFS1
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),-0.601550090487358,-1.0951902440282617,0.42,1.0,1.0,4/10,26.54%,NCBP2;NCBP1;PAF1;NUDT21
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.5507526667348578,-1.0951706749418353,0.3220338983050847,1.0,1.0,2/22,2.29%,C17ORF99;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.5511007898362513,1.0948524364377623,0.3157894736842105,0.9421323197252265,1.0,4/21,5.75%,PDGFD;RASSF2;PDGFC;GREM1
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.6502574066122149,-1.094784967343643,0.46296296296296297,1.0,1.0,4/9,20.46%,YBX3;CASP8;SLC25A4;NUPR1
prerank,GO_Biological_Process_2021__action potential (GO:0001508),-0.49283250269833934,-1.0947470403260942,0.32786885245901637,1.0,1.0,6/39,13.00%,KCNE2;KCNQ1;SCN7A;GPER1;SCN9A;CACNA1G
prerank,GO_Biological_Process_2021__kidney epithelium development (GO:0072073),-0.7229209281391847,-1.0946924041277852,0.43333333333333335,1.0,1.0,3/5,21.00%,WNT7B;KANK2;FGF1
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.5097298063216782,1.0945897438945347,0.32432432432432434,0.9419317844645706,1.0,11/27,19.64%,AFF3;TGFB2;MAP3K20;PTCH1;HDAC1;MYH3;ECE1;LRP6;FBXW4;CREBBP;MBNL1
prerank,GO_Biological_Process_2021__catecholamine catabolic process (GO:0042424),-0.7137172403659426,-1.0944939264354436,0.44642857142857145,1.0,1.0,3/5,25.53%,MAOB;LRTOMT;MAOA
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.536404193919778,1.0944710545016416,0.3333333333333333,0.9412732548734476,1.0,4/19,14.73%,APOE;IGF1;BIN1;SORL1
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),-0.6116728145033943,-1.0944310062892277,0.35,1.0,1.0,2/12,10.44%,B2M;HLA-A
prerank,GO_Biological_Process_2021__T cell mediated cytotoxicity (GO:0001913),-0.7128649876369528,-1.09441017698276,0.4406779661016949,1.0,1.0,3/5,17.65%,HLA-A;CTSH;EMP2
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),-0.6522937330907608,-1.0943120133431443,0.42105263157894735,1.0,1.0,5/10,29.29%,IL4I1;ACMSD;IDO1;KMO;TDO2
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.5998817417103794,-1.0942677398367253,0.375,1.0,1.0,7/19,20.65%,PTPRC;PRKCH;KCNN4;STAP1;TESPA1;NFAM1;RPS3
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),0.5581916471950812,1.0942371580371024,0.32432432432432434,0.941034733050831,1.0,4/13,12.36%,COL15A1;PKHD1;COL22A1;SIPA1L3
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.4270317482568446,1.093598452548646,0.25925925925925924,0.941920778170484,1.0,25/81,16.59%,GPC4;HS3ST5;HS3ST3A1;HS3ST3B1;VCAN;CHSY3;EXT1;SDC4;ST3GAL3;SLC10A7;ANGPT1;HS3ST2;ST3GAL1;EXT2;GCNT2;CHST12;HS3ST1;ST3GAL2;HS6ST2;CHSY1;HS2ST1;CHST11;NDST1;B3GAT3;ABCC5
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.42708507074168783,-1.0935721627024897,0.25675675675675674,1.0,1.0,21/151,11.34%,CD44;CCNE1;GADD45B;ETV4;GPR83;IL3RA;AHR;COCH;CCND2;COL6A1;ABCB1;FGL2;CDC6;SYNGR2;PRKCH;PLIN2;AGER;CTSZ;SCN9A;CD83;IL18R1
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.4177619921218462,-1.0935448087757684,0.21333333333333335,1.0,1.0,25/174,14.30%,CD44;POLR3K;BIK;SPAG4;GOT1;ALDOB;GPC3;B3GNT3;NSDHL;FKBP4;CHST1;HSPA5;GLRX;PGAM1;ARTN;ISG20;GNPDA1;G6PD;MDH1;STMN1;ENO2;AGL;GPC1;TGFA;TXN
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),0.5463790833013414,1.0935191063645426,0.28205128205128205,0.9411336621646458,1.0,2/11,4.30%,F2RL1;CSF1R
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),-0.43673431487912606,-1.093327887453222,0.3466666666666667,1.0,1.0,9/142,6.53%,STK16;EPHA1;HCK;ITK;TNK1;MAK;PINK1;TXK;FLT3
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),-0.5408718088621038,-1.0932110877037766,0.29850746268656714,1.0,1.0,14/27,35.88%,NSDHL;G6PD;DHCR7;SQLE;HMGCR;ACAA2;ACAT2;DHCR24;PMVK;ARV1;INSIG2;ACLY;IDI1;MSMO1
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),-0.6182510809560453,-1.093180168131992,0.3448275862068966,1.0,1.0,4/9,24.28%,IL4I1;PCBD1;FAH;GSTZ1
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.5269056499886511,1.093146083849039,0.3548387096774194,0.941339513719224,1.0,3/22,5.83%,PDE3A;PEX5L;PDE4D
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),0.5543140903040034,1.0928349575978382,0.35714285714285715,0.9413885745663493,1.0,6/16,25.99%,NAF1;TERF1;ATM;SMG6;TERF2;TNKS
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),0.5060684501538603,1.0928180443191173,0.3333333333333333,0.9405132192655603,1.0,2/24,2.31%,CD38;BCL2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),0.6230593096256415,1.0927997329683128,0.38095238095238093,0.9395745833181894,1.0,2/10,10.36%,F2RL1;SPHK2
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.38809858201255765,1.0926928195327494,0.25925925925925924,0.9389496415688073,1.0,50/218,14.93%,EPHA3;UNC5C;UNC5B;NTNG1;DOK5;SEMA6D;EPHA5;NRP1;TNR;CNTN6;CTNNA2;SEMA5A;DSCAM;VLDLR;PARD3;UNC5D;EPHB2;DSCAML1;CNTN4;SEMA4C;DOK6;SHC3;PTPRO;EFNA5;NRXN1;BSG;PSPN;GFRA1;IRS2;EPHA7;LYPLA2;RYK;ROBO2;AUTS2;SLITRK5;PIK3R1;SEMA3C;DOK1;DAB1;SPTB;SPTBN4;FYN;MAPK7;SEMA5B;NRTN;EPHA8;PAK3;LAMA3;NRCAM;WNT5A
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.45088636777313695,1.0926206821830844,0.3157894736842105,0.9382870057282027,1.0,10/42,13.57%,EYA4;EGFR;FGF10;ERCC8;RADX;BABAM2;EYA2;EYA3;BRCC3;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.5948145453106777,-1.092390571319825,0.3770491803278688,1.0,1.0,4/16,10.85%,PINK1;APH1B;RCN3;CTSH
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),-0.6283415054200258,-1.092302948063496,0.43636363636363634,1.0,1.0,3/10,16.00%,ATP1B1;ATP1A1;ATP12A
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),-0.5651919098141618,-1.0918675915231406,0.32727272727272727,1.0,1.0,3/25,13.32%,AMN;RAB31;PREPL
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),0.5375114916930718,1.0918329281509558,0.3870967741935484,0.9397133353071284,1.0,3/14,7.49%,CCDC22;COMMD1;COX19
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),-0.6645909759681213,-1.0917438376781938,0.3333333333333333,1.0,1.0,3/8,14.68%,PRELP;OGN;ACAN
prerank,GO_Biological_Process_2021__prostaglandin transport (GO:0015732),0.6749048168685692,1.0916363683563055,0.35135135135135137,0.9394269196505268,1.0,2/5,13.36%,ABCC4;SLCO3A1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.5868135302540181,-1.0916266055622765,0.36764705882352944,1.0,1.0,4/20,13.58%,IRF1;GPS2;FLOT1;TLR2
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.43536286535987023,-1.0915276086320918,0.2876712328767123,1.0,1.0,50/178,23.33%,MCM2;CCNE1;PRDX4;CDCA3;SPC24;CDKN3;SUV39H1;DDX39A;RPA3;RAD51AP1;TUBB;ATAD2;BRCA1;SLBP;MRE11;PSMC3IP;PAICS;STMN1;DONSON;GINS1;CDC25A;HMGB3;PLK4;CBX5;DIAPH3;CDKN1B;ILF3;DEK;CDK4;PCNA;PDS5B;NAA38;CHEK1;MMS22L;RAD51C;PMS2;BUB1B;RACGAP1;H2AZ1;USP1;EXOSC8;KIF22;RAD1;DEPDC1;SPC25;GINS4;CCP110;CCNB2;NOP56;ANP32E
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.6337255637517633,-1.091244429552829,0.42424242424242425,1.0,1.0,2/10,11.38%,CYP19A1;ABCB4
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.41905717716219215,1.0905504174450125,0.2571428571428571,0.9420139741147542,1.0,23/107,15.84%,PID1;VASH2;MARCHF5;TSPAN12;LZTS3;VASH1;LRRC4C;EFNA5;KNDC1;FMNL2;INF2;ADGRB3;NSMF;BCL6;RC3H1;HECW2;PPFIA2;NEDD4L;SIPA1L1;PAK3;FITM2;PDZD8;MEF2C
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.5571932882201256,-1.0901528923925499,0.390625,1.0,1.0,3/21,5.95%,ZNF703;EID2;TGFB1
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),0.604906357038273,1.0898118866545625,0.3111111111111111,0.9434065049590431,1.0,1/11,0.71%,RFWD3
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),0.6450040291594819,1.0893477037433719,0.38461538461538464,0.9437888786279863,1.0,4/8,27.62%,ROBO1;EDN1;HIF1A;SLIT2
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),-0.6656254174744809,-1.089327384943775,0.41379310344827586,1.0,1.0,3/8,21.51%,TMSB4X;TMSB10;TWF2
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),0.4438910932621753,1.0891439735615462,0.16666666666666666,0.9434350493088393,1.0,9/70,8.91%,NRG1;BCL2L11;SDC4;BMP7;RAB7A;STX18;GNL3L;FAF1;TPR
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),0.4113145914656454,1.0891414994248798,0.28125,0.9425147689274215,1.0,17/82,20.43%,SORCS1;CCDC22;BLOC1S4;ACBD3;CLVS1;AP4E1;COMMD1;EXOC6B;VAMP8;KLHL20;AP4B1;SORL1;GOPC;CLVS2;EXOC2;AP1S3;AP1S2
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),-0.5916204021289206,-1.0890402894506652,0.42028985507246375,1.0,1.0,4/14,16.91%,PRLR;STAT5A;LYN;STAT6
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),0.5000300462437685,1.0888586283563906,0.358974358974359,0.9423045455262462,1.0,5/34,4.57%,CCL28;CDH13;KDR;NRP1;UTRN
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),0.48524207424903404,1.087858340588447,0.2608695652173913,0.9441273040309575,1.0,6/27,9.59%,PNP;LEF1;MDK;SOX12;ZBTB1;DUSP10
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.6931791032128063,-1.0876647458610968,0.417910447761194,1.0,1.0,2/7,23.36%,DDX11;BLM
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),-0.5612053752857926,-1.0876111261730257,0.38333333333333336,1.0,1.0,5/19,20.54%,CAV3;CALM3;HCN4;NOS1;CALM1
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),-0.6098537693224333,-1.0875453992799156,0.45161290322580644,1.0,1.0,2/10,7.44%,ING2;ZBTB7B
prerank,PanglaoDB_Augmented_2021__Merkel Cells,0.4738954541206968,1.0874024640083966,0.2727272727272727,0.944699856287685,1.0,4/35,4.59%,ACE2;SLC26A3;TOX3;MDK
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.44082788213136753,-1.0869432244006585,0.325,1.0,1.0,23/116,15.26%,CD44;ALPL;ADAMTS4;NOTUM;PRELP;HHIP;ALX4;RFLNA;LECT2;BMP1;PHEX;ETS2;COL19A1;TEAD4;XYLT1;COL13A1;PRDX1;MEPE;PCSK5;TLL1;COL10A1;ACAN;SOX6
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.4193446941893624,-1.086719375079466,0.2804878048780488,1.0,1.0,79/276,24.83%,TICRR;MCM2;POLE3;CDC6;RFC5;RPA3;GCNT1;RPL36;RPL15;RPL38;RPS21;RPS7;BRCA1;MRE11;WARS1;INHBA;RPL37A;ASMT;RPL9;GTPBP2;RPL28;MRPS14;RPLP2;RNPS1;DONSON;POLR2J;RPL5;EEF2;POLR2K;RMI1;EEF1A1;RPL35A;POLE2;RSL24D1;RPS20;RPLP1;RPL8;RPL4;RPL22;CHEK1;CREBL2;RPL27A;MRPS18C;COPS5;RPL24;RBBP8;KAT5;SET;RPS15;RAD9B;MRPL51;GTPBP1;EEF2K;MRPL43;RPL34;RPL3;RPS24;RPS4X;POLR2B;RPS3;RPS6KB2;RPS29;RPL13A;GRWD1;RAD1;RPS8;RPS27A;RPL27;RPL37;RPL7A;RPL35;BLM;RPL23;RPL32;RPS13;MRPL27;RAD50;RMI2;MRPL42
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),-0.6899865686534699,-1.0865458193164412,0.45,1.0,1.0,2/7,21.59%,SLC36A1;SLC38A5
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),0.42029033141994115,1.086463191624967,0.375,0.9465680192328008,1.0,15/96,11.51%,PER2;GLP1R;ITPR2;BMP6;UNC13B;DNAJC1;TGFB2;TGFB3;APOE;IGF1;KCNC2;ARFIP1;KCNS3;DRD4;GCK
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),0.4573300868726916,1.0862412103289925,0.35,0.946213544082266,1.0,11/42,20.38%,GRM5;MEX3D;TRIM71;GCNT2;RC3H1;TDRD7;TCOF1;NANOS3;LARP1;FOXO3;GEMIN5
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),-0.5316730589637294,-1.0861978262134941,0.34782608695652173,1.0,1.0,4/41,2.84%,CD4;MYLK;WFS1;CAV3
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),0.676800442470715,1.0861778256156127,0.4423076923076923,0.9454625397830057,1.0,2/6,24.56%,CRYZ;ACAA1
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),0.58049012008683,1.0860357387043504,0.36666666666666664,0.9449178295384837,1.0,1/9,4.60%,DBF4B
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),-0.6418600447948253,-1.0860078614469304,0.41379310344827586,1.0,1.0,2/7,8.77%,TTN;MYOM1
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.4520184006829745,-1.0859872329435332,0.2948717948717949,1.0,1.0,7/79,7.70%,CD44;SIGLEC1;FBLN5;ECM2;VWA2;RAC1;STRC
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.5018566061318896,-1.0855869484514942,0.2727272727272727,1.0,1.0,7/37,17.19%,TICRR;CDC6;BRCA1;MRE11;DONSON;ABRAXAS1;CHEK1
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),0.6658352708353419,1.0855739808398437,0.358974358974359,0.9456530484303908,1.0,1/6,6.20%,SLCO1C1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),-0.6940428772638225,-1.0853876228873502,0.47368421052631576,1.0,1.0,1/6,3.51%,ATF5
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.6933605956915759,-1.0853108971676404,0.38235294117647056,1.0,1.0,4/7,24.54%,B2M;TLR2;RPS27A;UBC
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.6933605956915759,-1.0853108971676404,0.38235294117647056,1.0,1.0,4/7,24.54%,B2M;TLR2;RPS27A;UBC
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.5817152874212894,1.0851725953828204,0.4146341463414634,0.9458502310938789,1.0,2/14,6.53%,CEPT1;CHKA
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.5759640680780315,-1.0851655989794093,0.36363636363636365,1.0,1.0,5/21,13.26%,AGT;GPER1;INHBA;FADD;LTBR
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.6079112246669526,-1.0851313598105463,0.3157894736842105,1.0,1.0,4/13,18.87%,RASIP1;KIF14;CXCL13;SKAP1
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),0.6785233415297476,1.085131134603818,0.4418604651162791,0.9449748893736903,1.0,1/5,4.36%,COX10
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),-0.6149267848751615,-1.084907723000993,0.42105263157894735,1.0,1.0,2/11,7.44%,ING2;ZBTB7B
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.45950595031606184,1.084613476196996,0.4,0.9454656241102922,1.0,9/51,16.26%,PRELID2;ATP11C;PITPNC1;APOE;SCARB1;ATP8A2;ATP11A;ABCC1;TRIAP1
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.41918442242299503,-1.0845029289444024,0.2972972972972973,1.0,1.0,20/159,7.80%,CD44;MYLK;LAMA2;MSX1;FBLN2;SFRP4;GADD45B;TIMP3;ITGA5;RGS4;FBLN5;ECM2;LAMA1;TGFB1;CTHRC1;PCOLCE2;SERPINE1;CRLF1;IL15;BMP1
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),0.6717880760684838,1.0843672984886632,0.4090909090909091,0.9452420380683882,1.0,3/5,19.30%,PRIMPOL;SIRT7;DDX21
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),0.5866289505950131,1.0843592236884558,0.3783783783783784,0.9443444024524922,1.0,2/16,1.98%,KDR;NRP1
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),0.6828057571029734,1.0839380783693204,0.40540540540540543,0.9446436098986368,1.0,4/7,6.36%,TGFBR1;TGFB2;ACVR1;JAG1
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),-0.5043870814635781,-1.083797645218612,0.3333333333333333,1.0,1.0,15/38,22.37%,HSPA5;ZNF430;G6PD;CALM3;CKB;CNP;PLP1;SUDS3;YWHAH;MAOB;CALM1;ATP5PB;COX6B1;RAD1;DYNLL1
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.4532953158216424,1.0836651177037475,0.27586206896551724,0.9445357909382099,1.0,9/59,10.23%,CDK2AP2;GFI1B;EGFR;PLCB1;FGF10;PTPN6;MYO16;LSM10;UBE2E2
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),-0.5116690158400153,-1.082962518256525,0.38095238095238093,1.0,1.0,8/27,18.40%,PRELP;B3GNT3;CHST1;B3GNT4;OGN;ACAN;B4GALT3;B4GAT1
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.47071869705051816,1.0825496620904678,0.35,0.9469025332811019,1.0,14/36,15.86%,VWC2;BRINP1;ZC4H2;ZEB1;KCTD11;MMD2;TCF4;NGF;FGFR1;BRINP2;NRCAM;SIN3A;MEF2C;BEND6
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),-0.6449184197521722,-1.082488285067625,0.4262295081967213,1.0,1.0,3/12,8.10%,ACOT4;GOT1;GAD1
prerank,GO_Biological_Process_2021__peptidyl-glutamine methylation (GO:0018364),0.7014437939699131,1.0824560056272887,0.42857142857142855,0.9462096013484508,1.0,3/5,18.42%,FBLL1;SIRT7;CREBBP
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),-0.7139562726912244,-1.0824106405726128,0.3392857142857143,1.0,1.0,1/5,5.65%,ATP6AP1
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),-0.6048269120169225,-1.0820231771106374,0.42857142857142855,1.0,1.0,5/11,30.89%,APOLD1;CEACAM1;PRKX;CD24;MAFF
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.550784082403766,-1.0819335060954645,0.3114754098360656,1.0,1.0,8/35,13.58%,GBP6;CD74;STAT1;CIITA;EPRS1;CCL5;GBP5;TLR2
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.5136927655316813,1.081893449464234,0.36363636363636365,0.947088391711315,1.0,5/21,9.21%,KIT;IRS1;FGFR3;PDGFRA;PRKD1
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),0.6307071359629449,1.0818210451600894,0.4523809523809524,0.9463713207864741,1.0,3/8,8.13%,RORA;TGFBR1;SMAD2
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.38997045079513515,1.081518041660727,0.2857142857142857,0.9464519452201734,1.0,19/109,13.53%,RIMBP2;MAPK4;LHFPL4;KCNB2;OLFM3;KCNJ6;ADGRA1;GRIA2;HS6ST3;TMEM196;NRXN1;CSRNP3;PAK5;PHF21B;NOL4;ST8SIA3;ELAVL3;NR4A2;NXPH1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.4244243504147309,-1.0810750091394672,0.32051282051282054,1.0,1.0,45/160,23.78%,PATL2;RPL36;RPL15;RPL38;RPS21;NCBP2;RPS7;DCP2;NCBP1;RPL37A;RPL9;RPL28;RPLP2;RNPS1;RPL5;RPL35A;EXOSC6;RPS20;RPLP1;CNOT11;RPL8;RPL4;RPL22;CSDE1;RPL27A;RPL24;RPS15;UPF3B;RPL34;RPL3;RPS24;RPS4X;RPS3;RPS29;EXOSC8;RPL13A;RPS8;RPS27A;DHX34;RPL27;RPL37;RPL7A;RPL35;RPL23;RPL32
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),0.5102042608310945,1.0810430876789017,0.34146341463414637,0.9467091984551005,1.0,6/28,12.23%,ARL13B;PTCHD1;PTCH1;KIAA0586;MAP3K10;DISP3
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),0.6500348270116231,1.0810381092499415,0.42105263157894735,0.9458179631878552,1.0,1/7,8.05%,SLC35G1
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.5994973301580714,1.0809494451431974,0.38636363636363635,0.9451679102810988,1.0,1/10,0.58%,UBASH3B
prerank,GO_Biological_Process_2021__positive regulation of cholesterol storage (GO:0010886),0.6290320698435952,1.0807906235921656,0.3404255319148936,0.9446953861449202,1.0,2/5,24.06%,SCARB1;SREBF2
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),0.6250125362859291,1.0805235110903386,0.425,0.9446262941771999,1.0,1/8,2.42%,C5AR1
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),0.4260586927207832,1.0804979254955231,0.32142857142857145,0.9437907717162496,1.0,12/90,8.81%,NRG1;RUNX1;BCL2L11;FRMPD4;TGFBR1;BMP7;TGFB2;TGFB3;APOE;NRXN1;GNL3L;FAF1
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),-0.5819606494164303,-1.0804959379918313,0.375,1.0,1.0,5/18,9.24%,CAV3;B2M;NOTCH1;RFLNA;REST
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),-0.7488312812122766,-1.0802391830949447,0.38461538461538464,1.0,1.0,1/6,7.73%,NCKAP1L
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.4772433632040911,1.0801245138051432,0.21875,0.9441997558359919,1.0,5/35,4.75%,SPRED1;SPRED2;BMP7;PARD3;SPRED3
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),-0.7349731234233747,-1.0797884610428474,0.30357142857142855,1.0,1.0,1/7,9.08%,DAB2IP
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.3654407781257504,1.079755127151731,0.2,0.9441940525349592,1.0,65/559,8.57%,NRG1;ACE2;RUNX1;TBX6;ROR2;KIT;NOX4;ALK;CDH13;PDGFD;SGK1;CHRNA10;IRS1;LEF1;KDR;WWTR1;RNF126;PTPRK;BCL2;EGFR;SGK2;KITLG;MELTF;FGFR4;TGFBR1;S100A13;BMP6;GRK5;SMYD2;FGFR3;CSF1R;TIMELESS;DBF4B;MINAR1;ALDH1A2;TGFB2;PTGFR;PDGFC;TGFB3;BTG2;EREG;BTC;GREM1;MEIS1;TNFRSF11A;PDGFRA;DDAH1;ADAMTS8;FGF10;JAG1;AKR1C3;CDCA7;IGF1;PTPN6;PKHD1;MYO16;HDAC1;HSPA1A;TET1;NACC2;SHANK2;P3H3;BRICD5;IRS2;P3H2
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),0.606052969619809,1.0797057077572707,0.3783783783783784,0.9434490684344826,1.0,4/7,18.75%,ENPP3;SPHK2;FER;BLK
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.5997492653799545,-1.0793330895957072,0.39655172413793105,1.0,1.0,2/12,8.71%,ABT1;RPS21
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),-0.581409103625277,-1.079220863388131,0.3684210526315789,1.0,1.0,4/16,12.77%,CEMIP;CALCR;GPER1;CASQ1
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),-0.6094914401141651,-1.0790558853139158,0.42857142857142855,1.0,1.0,2/9,5.85%,NOX1;RAC1
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),0.6239407169759458,1.079002790747683,0.475,0.945021407054309,1.0,2/7,19.19%,PDSS2;PDSS1
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),0.7089703193361736,1.0786902842698562,0.5,0.9449273874124104,1.0,2/5,13.42%,TPR;NUMA1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion import (GO:0090281),-0.7158718337389915,-1.0785623086916538,0.509090909090909,1.0,1.0,2/5,21.25%,VDAC1;PLN
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.5816115755764489,1.07854343170117,0.3684210526315789,0.9445336841948608,1.0,3/11,14.52%,ENPP3;RC3H1;FER
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),0.613690035440334,1.0782797732066105,0.38636363636363635,0.94436541767554,1.0,4/9,7.01%,TGFBR1;BMP7;TGFB2;PTCH1
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.5701379095628969,1.078150409315943,0.37209302325581395,0.9438981832369379,1.0,4/9,12.54%,PCM1;NUMB;CEP120;HOOK3
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.5436345540884484,-1.0777957757118755,0.375,1.0,1.0,6/27,14.54%,KCNE2;CAV3;ATP5IF1;DAB2IP;PSMC3;PSMC6
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),-0.6726413196108076,-1.0777172431977933,0.49122807017543857,1.0,1.0,2/7,10.66%,DOCK8;CCL5
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),0.7527821581217338,1.0776089959670867,0.40476190476190477,0.9446652329806627,1.0,2/5,7.98%,JAM2;BCL11B
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.5028838545992951,-1.0772231394315037,0.31343283582089554,1.0,1.0,4/27,9.94%,CHMP4B;CHMP2B;RAB11A;CHMP2A
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),-0.653061178649446,-1.077132942986258,0.4426229508196721,1.0,1.0,3/7,15.07%,UFM1;APOD;RAB23
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),-0.653061178649446,-1.077132942986258,0.4426229508196721,1.0,1.0,3/7,15.07%,UFM1;APOD;RAB23
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.5933258356675951,1.0768466084605732,0.4583333333333333,0.9459784676175171,1.0,1/11,0.61%,PID1
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),-0.6237968249786381,-1.076825538650842,0.39655172413793105,1.0,1.0,2/11,4.52%,P2RY12;P2RY1
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.5113265744746966,1.0767608919950928,0.425,0.9453245107532889,1.0,3/14,9.99%,HOMER2;GRM5;GRM8
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.6542672771135736,-1.0765280290634507,0.44,1.0,1.0,2/9,5.41%,FOXM1;RPS27L
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.4197495896575757,1.0764728089570255,0.3055555555555556,0.9454295953753745,1.0,1/44,0.25%,GPC4
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),0.6024133568141897,1.0764219354760447,0.3939393939393939,0.9446781186220112,1.0,2/7,18.55%,PKDCC;CSK
prerank,"GO_Biological_Process_2021__phototransduction, visible light (GO:0007603)",-0.6363128978163377,-1.0764031906941338,0.423728813559322,1.0,1.0,3/11,11.72%,PDE6B;RP1;CNGB1
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),-0.6895313687188271,-1.0763844789863675,0.42857142857142855,1.0,1.0,3/8,19.28%,CCDC39;BBOF1;RSPH9
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.44967881414852673,1.0762600559844029,0.2647058823529412,0.9442380524736809,1.0,22/80,16.02%,STAC;FGF14;GRIA4;FGF13;CACNG3;GRIA2;PDE4D;GRIN2A;LRRC7;GRIA1;CACNG4;NLGN1;SELENON;SHISA9;CACNB2;JSRP1;FGF12;DLG2;KCNS2;GRIN2B;MEF2C;HOMER1
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),0.502280765079341,1.0762484503309926,0.3793103448275862,0.9433652626589633,1.0,2/23,6.90%,PER2;PGM2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.5314725045174452,1.0761567928863034,0.375,0.9427045170061162,1.0,2/27,0.96%,CDK2AP2;GFI1B
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),0.6583743123448742,1.0755884909501916,0.3684210526315789,0.9436770640848521,1.0,3/6,25.31%,APOE;ABCA2;PTPN1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),-0.670094479505237,-1.0754605464389206,0.35,1.0,1.0,1/7,6.80%,ATP6AP2
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.44460104137045503,1.0752666691677673,0.25925925925925924,0.9438448736902671,1.0,12/55,11.51%,F2RL1;BMP6;UNC13B;MCU;TGFB2;TGFB3;IGF1;IRS2;MYRIP;RBP4;PTPN23;GCK
prerank,GO_Biological_Process_2021__regulation of dopamine metabolic process (GO:0042053),0.6803209751353373,1.074844391386171,0.5,0.9440864085636377,1.0,5/6,28.65%,HPRT1;DRD4;ITGB2;PRKN;ITGAM
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),0.570299686503097,1.0747552365528559,0.3783783783783784,0.94343980994996,1.0,1/14,3.62%,ARID5A
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.472877131055898,-1.0746989691534299,0.3548387096774194,1.0,1.0,18/61,23.63%,POLE3;H1-2;H1-0;CHAF1A;NAP1L2;H2BC18;DAXX;CHAF1B;SET;SMARCE1;H3-3A;VPS72;GRWD1;SPTY2D1;ACTR6;H2BC5;ANP32E;PAF1
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),-0.5798772937103082,-1.074565475750935,0.41935483870967744,1.0,1.0,3/10,16.93%,SOX10;PLP1;CNTNAP1
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.40092065824534767,1.0745152575710306,0.25,0.9430777289376244,1.0,8/88,6.91%,TPD52L1;KIT;PDGFD;EGFR;CSF1R;PDGFC;RASGRP1;PIK3R6
prerank,GO_Biological_Process_2021__protein localization to microtubule plus-end (GO:1904825),0.6875536793022152,1.0743723614613858,0.4634146341463415,0.9417163311902335,1.0,2/5,19.24%,MAPRE1;GAS2L1
prerank,GO_Biological_Process_2021__protein localization to microtubule end (GO:1905725),0.6875536793022152,1.0743723614613858,0.4634146341463415,0.9417163311902335,1.0,2/5,19.24%,MAPRE1;GAS2L1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.660605570982446,-1.074230930725844,0.3559322033898305,1.0,1.0,2/9,9.08%,PIK3CB;DAB2IP
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.48741736527393864,-1.0736536682722677,0.37142857142857144,1.0,1.0,19/60,22.90%,EPN1;HSPG2;STAT1;SERPINE1;PIK3CB;DAB2IP;AMOT;ADGRB1;SERPINF1;STAB1;CD160;ADAMTS9;RGCC;GHRL;CNMD;FOXO4;SPARC;PGK1;SPINK5
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),-0.5075595882015996,-1.0736347646991218,0.38028169014084506,1.0,1.0,10/33,22.69%,CHAF1A;HAT1;NAP1L2;H2BC18;DAXX;CHAF1B;H3-3A;GRWD1;SPTY2D1;H2BC5
prerank,GO_Biological_Process_2021__contact inhibition (GO:0060242),-0.6866247272445966,-1.0735853787444647,0.39285714285714285,1.0,1.0,2/6,24.73%,YAP1;SMO
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.6915933427941808,1.0734973125002183,0.4888888888888889,0.9434694642376453,1.0,4/8,18.71%,NRXN1;NLGN1;TMEM108;PTEN
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.5435664239233614,-1.0727946922601437,0.4032258064516129,1.0,1.0,8/25,12.30%,GNLY;ITK;PTPRC;CD27;THEMIS;CD6;TAGAP;GBP5
prerank,GO_Biological_Process_2021__protein localization to nucleolus (GO:1902570),-0.6673074570048114,-1.0727602264637806,0.4262295081967213,1.0,1.0,2/5,25.97%,RPF2;RAN
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.5475775569528065,1.072752088842255,0.4444444444444444,0.9449370674441088,1.0,5/15,22.41%,CPSF7;KCNC2;GRIN2B;GRIN1;FARSA
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),-0.5713678349628066,-1.0725719624889813,0.4,1.0,1.0,8/18,28.92%,CD74;LBP;PLA2G10;HSPD1;PJA2;IL31RA;CD200;TNIP2
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),-0.7328493620700061,-1.0724796890538328,0.5272727272727272,1.0,1.0,1/5,11.46%,PSMC3
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),0.5909354496683128,1.0724516054745656,0.40625,0.9449920955505017,1.0,2/7,16.81%,MX1;SNAP91
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),-0.7120361071977898,-1.0724175542174397,0.41818181818181815,1.0,1.0,2/6,19.27%,NOTCH1;RGCC
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.5687036629604459,-1.0722928581142406,0.3392857142857143,1.0,1.0,3/19,8.54%,C3AR1;DRD3;LPAR6
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.4555240888001151,1.0720064997507277,0.3142857142857143,0.9454634430078609,1.0,13/42,15.84%,LEF1;TGFBR1;BMP7;TGFB2;TGFBR3L;FAM83D;LIMS1;FGFR1;LRP6;RANBP3L;WNT5A;FBXL17;MEF2C
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.45437076579189495,-1.071914565045212,0.3055555555555556,1.0,1.0,22/64,14.94%,GNLY;ITK;DOCK2;PTPRC;ARHGAP9;SPON2;AHR;GMFG;TGFB1;TXK;MYO1F;CD27;THEMIS;CD6;TAGAP;CCL5;IL18R1;GBP5;HSD11B1;STYK1;CD5;SLA
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.500859632666247,1.071192096244766,0.35714285714285715,0.9470841108149342,1.0,4/16,11.34%,ALG8;MPDU1;ALG12;ALG13
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),-0.6731855306899148,-1.0709683754950947,0.41379310344827586,1.0,1.0,2/8,17.71%,STRC;PDZD7
prerank,GO_Biological_Process_2021__regulation of sensory perception (GO:0051931),0.6002052748646342,1.070925626560643,0.45652173913043476,0.947014722444176,1.0,1/7,0.98%,SPX
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.5600686719670797,1.0707857446453315,0.4444444444444444,0.9464813589996774,1.0,1/10,0.18%,RUNX1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.6384201397714833,-1.0701947288404294,0.3484848484848485,1.0,1.0,3/10,10.35%,TGFB1;TAF7;GSTP1
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.6327258550672639,-1.0699159797437625,0.3770491803278688,1.0,1.0,6/15,10.85%,PINK1;PSMB8;A2ML1;RCN3;PSMA3;CTSH
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),-0.5522201888590617,-1.0698046057437924,0.41509433962264153,1.0,1.0,2/16,2.92%,IHO1;RNF212B
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),-0.6804500676285627,-1.069599262034954,0.4426229508196721,1.0,1.0,3/7,20.65%,OTUB1;TWIST1;RPS3
prerank,GO_Biological_Process_2021__regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547),0.6923368898842409,1.06951564105966,0.42857142857142855,0.9490482661408538,1.0,1/5,5.56%,TSPAN12
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.4615377397070786,1.069417589845932,0.3333333333333333,0.9486480931583207,1.0,5/33,7.01%,UNC5C;NRP1;VLDLR;HEY1;PTCH1
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.394470508134107,1.0692518293031297,0.3548387096774194,0.948321742463766,1.0,13/106,8.81%,IRS1;KDR;SLC25A37;EGFR;FGFR4;SAMD4A;PRR16;TGFB2;ELAVL1;EREG;IGF1;IRS2;FAF1
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),-0.5286234796614233,-1.0690622291328984,0.34375,1.0,1.0,5/28,22.94%,DRD3;SYT2;SYT4;SYT9;SYT13
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),0.6285351894095395,1.0689114339556374,0.41025641025641024,0.9482880254854362,1.0,2/8,10.36%,LEF1;SPHK2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.5637046661636385,-1.0685227019779504,0.36231884057971014,1.0,1.0,13/23,32.17%,COPS2;RBX1;COPS5;COPS8;COPS7B;RPS27A;UBC;CETN2;GPS1;COPS7A;RAD23B;UBB;XPC
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.6482010017477904,-1.0684787581383732,0.4444444444444444,1.0,1.0,3/8,8.02%,H1-2;H1-0;ATAD2
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.6482010017477904,-1.0684787581383732,0.4444444444444444,1.0,1.0,3/8,8.02%,H1-2;H1-0;ATAD2
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.6482010017477904,-1.0684787581383732,0.4444444444444444,1.0,1.0,3/8,8.02%,H1-2;H1-0;ATAD2
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.43909569697804385,-1.068380131351359,0.3150684931506849,1.0,1.0,26/110,25.97%,CENPK;SPC24;CENPO;ERCC6L;WDR62;CENPU;GPSM2;ZWILCH;ITGB3BP;CENPL;STMN1;NUP85;SKA2;KNL1;BUB1B;KIF11;CENPI;SBDS;DYNLL1;SPC25;NDEL1;EFHC2;KIF4A;DSN1;CENPH;RAN
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.39939285006143826,1.0683693830852172,0.3076923076923077,0.9489594384402082,1.0,14/89,8.13%,CIDEA;VWC2L;PMEPA1;SPRED1;SPRED2;TGFBR1;VWC2;CRIM1;SPRED3;GREM1;ACVR1;IL17RD;HSPA1A;SMAD2
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),-0.6805101679462733,-1.067944752952827,0.5084745762711864,1.0,1.0,1/8,5.98%,PINK1
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),-0.5536636428139691,-1.0678737243585317,0.45454545454545453,1.0,1.0,6/24,16.76%,FKBP1B;FKBP4;PPID;PPWD1;PPIC;FKBP5
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),-0.6285806189778825,-1.067789356269047,0.4375,1.0,1.0,1/8,9.22%,IGFBP5
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.5013464794929968,1.0677509525334081,0.36666666666666664,0.9497874849104787,1.0,3/27,6.31%,IFI16;GREM1;FHIT
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),0.5782795718888455,1.0673940551142522,0.425,0.9500315722463768,1.0,3/9,13.57%,LEPR;GCK;SIRT1
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),0.5330285095083751,1.0673238414359527,0.37209302325581395,0.9493902700153628,1.0,2/18,0.57%,CYP1A2;GLYATL2
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),0.4735469060089229,1.0672677055613795,0.3333333333333333,0.9486653818350876,1.0,5/30,12.18%,IFI16;TRAFD1;SAMHD1;LYAR;FAM3A
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.4830725200740224,1.0670169549573971,0.3235294117647059,0.9485105347040608,1.0,12/23,22.65%,SMYD2;PRMT5;SUV39H2;PRMT8;FBLL1;SIRT7;CREBBP;NSD1;SMYD3;SETD6;PRMT6;EHMT2
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.6792567842161459,1.0667352342400935,0.42857142857142855,0.9484405955323377,1.0,5/8,28.06%,MAPK7;NFE2L2;SREBF2;KLF2;ABCA1
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.45940179864150027,1.0664946686868735,0.17857142857142858,0.9483466310695607,1.0,15/79,8.17%,ABI3BP;ADAMTS2;PRRX1;SVEP1;COL15A1;SGCD;PCDH18;FNDC1;CACNA2D1;LAMA4;FAT4;PDGFRA;SSC5D;RBMS3;MYH11
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),-0.6709494552258073,-1.0659660617842945,0.42105263157894735,1.0,1.0,2/5,24.43%,SLC39A6;SLC39A12
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),-0.5253631597416917,-1.0655908657322932,0.3492063492063492,1.0,1.0,7/24,20.07%,SCN4B;SCN7A;SCN9A;CACNA1G;HCN4;YWHAH;CACNA1H
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),-0.7218648864978432,-1.0651984414955522,0.4444444444444444,1.0,1.0,1/7,6.48%,SOD2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.4173745225455645,1.0651734437217633,0.3142857142857143,0.9512090795088942,1.0,13/86,14.80%,EPHA3;STAC;BCL2;EGFR;EPHB2;PTPN9;MAPK8;PIK3R1;ZDHHC5;PRKCE;FYN;CHP1;AKT2
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.45863311994308964,1.0651318864825887,0.2894736842105263,0.9504496963057899,1.0,11/32,19.70%,EPHA3;BRINP1;LTK;BRINP2;ADNP2;WNT5A;CREB1;ATM;WNT3;ABL2;SETX
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.3445188314486404,1.0650586897862226,0.23076923076923078,0.9497037607460328,1.0,79/752,9.61%,CD38;NRG1;RUNX1;TBX6;PER2;IFI16;SOX13;TRPS1;ATOH8;GFI1B;LEF1;PHC2;ZNF239;PTPRK;ZEB2;KDM8;ZNF536;ATF3;HIVEP1;ZGLP1;BMP6;BMP7;CBFB;ID3;PLCB1;ARID5A;SMYD2;ATXN1;KCTD1;HDAC9;ZNF205;BATF3;SAMD13;HEY1;TIMELESS;WWOX;E2F6;HIC2;ZMYM5;WWC1;EREG;PRICKLE1;ZBTB5;ZHX3;RITA1;MACROH2A2;ZNF596;AASS;MXI1;ZNF608;NFIX;PTCH1;HMGB1;FOXN3;SFMBT1;SAMD7;PRDM5;ZNF846;RNF2;HDAC1;PCGF1;ZEB1;ZNF263;ZBTB1;ARID5B;SMAD2;ZNF778;NACC2;FHL2;FOXP2;TPR;LYAR;IGBP1;DAP;SUV39H2;ZNF202;DACH1;ETV5;TFAP4
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),-0.5913599207945094,-1.0650575933886155,0.4153846153846154,1.0,1.0,5/11,21.05%,TAF7;BRCA1;SPI1;SET;CTBP1
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.4340501226742725,1.065009779364244,0.2972972972972973,0.9489471698653377,1.0,15/45,14.65%,EYA4;EGFR;TIMELESS;MGMT;FGF10;ERCC8;HMGB1;BABAM2;FAM168A;EYA2;EYA3;BRCC3;SIRT1;SPIDR;HDAC10
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.37592178083396927,1.0650097092228565,0.36,0.9480717573470117,1.0,21/136,9.48%,ROR2;KIT;NRK;PELI2;KDR;EGFR;SPRED1;FGFR3;WWC1;SPRY3;GREM1;FGF10;RASGRP1;HMGB1;IGF1;PTPN6;PKHD1;EPHA7;RYK;FAM83D;PAK5
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),-0.5413073628964489,-1.064553226184818,0.38596491228070173,1.0,1.0,3/21,9.94%,CHMP4B;CHMP2B;CHMP2A
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.5860505972458981,1.0642116008901341,0.4,0.9492637948016185,1.0,3/15,11.34%,BCL2L11;RNFT1;PIK3R1
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.561148736092818,-1.0641744304813447,0.36666666666666664,1.0,1.0,4/19,10.91%,CHMP4B;GPER1;CHMP2A;DCTN1
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.528508486921689,1.064120637557119,0.40625,0.9487136925594197,1.0,8/17,19.31%,NRP1;TGFB2;ACVR1;ROBO2;SEMA3C;PARVA;ZFPM2;ROBO1
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.4454388047049745,1.0634744649624774,0.28205128205128205,0.9497231175342181,1.0,5/42,6.71%,PER2;RGS14;PCM1;HEY1;NUMB
prerank,GO_Biological_Process_2021__negative regulation of trophoblast cell migration (GO:1901164),-0.6917614910674311,-1.063230409044913,0.42,1.0,1.0,3/5,24.52%,NODAL;CALR;GJA1
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),0.5530931603290541,1.0632002859318221,0.36585365853658536,0.9496527066794869,1.0,5/13,16.93%,SDC4;RAB7A;SNF8;TSG101;SMPD3
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),0.41513080413826786,1.0629724724431182,0.27586206896551724,0.9494268598593473,1.0,12/52,10.87%,KCNJ16;KCNIP1;AMIGO1;KCNJ6;KCNJ3;KCNN2;KCNIP4;KCNJ2;KCNN3;BIN1;DPP6;NOS1AP
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.3808619993512441,1.0627244898828527,0.2,0.9492133830184146,1.0,30/182,8.89%,EPHA3;UNC5C;UNC5B;DOK5;NFIB;SEMA6D;EPHA5;NRP1;TNR;CNTN6;SEMA5A;DSCAM;VLDLR;UNC5D;EPHB2;DSCAML1;CNTN4;SEMA4C;DOK6;SHC3;PTPRO;EFNA5;NRXN1;BSG;PSPN;GFRA1;IRS2;EPHA7;LYPLA2;RYK
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),0.43987981727445524,1.0626417860812594,0.325,0.9485344572219954,1.0,2/31,1.98%,CDH13;NRP1
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.4249403032231244,-1.0625144253401755,0.3333333333333333,1.0,1.0,42/150,24.67%,RPL36;RPL15;RPL38;RPS7;RPL37A;RPL9;RPL28;RPLP2;NOB1;RPL5;RPL35A;DIS3L;EMG1;EXOSC6;DDX54;RPLP1;RPL8;RPL4;RPL22;RPL27A;WDR12;RPL24;RPS15;KRR1;RPL34;RPL3;RPS24;SBDS;UTP11;EXOSC8;RPL13A;RPL27;RPL37;RPL7A;LAS1L;NOP56;RPL35;WDR55;RPL23;RPL32;IMP4;UTP15
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),0.6157667106831421,1.0624506806866811,0.45454545454545453,0.9482625201593069,1.0,4/7,21.23%,PLIN5;PNPLA2;SORL1;APOA1
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.5945141496466286,1.0624340339906282,0.425,0.9473949423732508,1.0,2/12,15.48%,AFF2;DYRK3
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.4568018528281739,1.0622479209630071,0.3793103448275862,0.9471602796616226,1.0,14/64,13.80%,NYAP2;IRS1;PLCB1;CSF1R;PDGFRA;IGF1;MYO16;IRS2;LTK;PIK3R1;NGF;FGFR1;SIRT2;NYAP1
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.45445081009711463,1.0622114381939824,0.3793103448275862,0.9464262039912911,1.0,5/32,7.95%,ATOH8;NFIB;TGFB2;FOS;APLN
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.4060843381645767,-1.062102456961172,0.3048780487804878,1.0,1.0,26/232,8.53%,CD44;MMP26;LAMA2;LOXL4;HSPG2;ADAMTS4;COL9A1;CYP1B1;MMP15;ELANE;ITGA5;KIF9;FBLN5;ECM2;LAMA1;COL6A1;F11R;CAPN1;TIMP2;ADAMTS18;TGFB1;SERPINE1;BMP1;P4HA3;MMP19;COL19A1
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),-0.7422178988326847,-1.0613556216092757,0.4666666666666667,1.0,1.0,5/5,25.80%,CIITA;TAF7;HSPH1;NLRC5;NLRP12
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),0.5087393694625723,1.061170525909828,0.3673469387755102,0.9484281980301426,1.0,3/20,5.93%,VASH2;TSPAN12;VASH1
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),-0.6453818048456499,-1.060817028311161,0.46,1.0,1.0,3/7,20.09%,CTBS;GNPDA1;CHIT1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.4873659010949414,-1.0607419998615226,0.35294117647058826,1.0,1.0,9/45,17.66%,ARIH2;PINK1;CASP8;UBL5;TOMM7;NMT1;YWHAG;YWHAB;YWHAH
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.40898436379560693,1.0604956803371768,0.3333333333333333,0.9493930436919925,1.0,23/146,14.80%,IRS1;ZEB2;SLC25A37;EGFR;FGFR4;SAMD4A;ZNF205;PRR16;ELAVL1;EREG;DDAH1;IGF1;IRS2;PLIN5;FAF1;SCARB1;NOS1AP;GCK;EIF3E;SIRT1;ABCB10;CHP1;AKT2
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.4982108662777646,-1.0604684996480607,0.3793103448275862,1.0,1.0,6/20,10.26%,RASIP1;RASA1;NOTCH1;TGFB1;WNT7B;PDGFRB
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),-0.6633560307325308,-1.0599728429341566,0.42857142857142855,1.0,1.0,2/8,12.95%,HSPA5;BOK
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.6491550730350157,1.0598588629724528,0.475,0.95048668510004,1.0,2/5,22.41%,SNX18;SPIRE2
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),0.6060640753461443,1.059710992101731,0.375,0.950036838643476,1.0,3/9,4.15%,PID1;PTPRT;SELPLG
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.5677181522989156,1.059560493866911,0.35,0.9495996569838288,1.0,4/8,26.83%,VAMP3;ECE1;SNCA;SCRIB
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.5117724093790987,1.0594578585629848,0.38461538461538464,0.9490093997340637,1.0,5/23,9.21%,KIT;IRS1;FGFR3;PDGFRA;PRKD1
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),0.41101167518126613,1.0593243865961068,0.2571428571428571,0.9485148168799993,1.0,6/49,8.98%,IFI16;EREG;PTPN6;TRAFD1;SAMHD1;LYAR
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),-0.6128564781156517,-1.0592766594719507,0.38181818181818183,1.0,1.0,2/11,14.34%,TCHP;YAP1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5402753069686014,1.0591419727285856,0.35135135135135137,0.9481865362357649,1.0,3/18,7.04%,F2RL1;TLR1;HMGB1
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.45193293913333665,1.059098662048478,0.3333333333333333,0.9474221033855174,1.0,3/61,3.28%,RUNX1;KITLG;CBFB
prerank,GO_Biological_Process_2021__cochlea morphogenesis (GO:0090103),0.629702827675823,1.0587859820566659,0.4888888888888889,0.947460997736159,1.0,2/6,5.41%,MYO3A;POU3F4
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.3607227579328614,1.0585481633716567,0.25,0.9471816908675644,1.0,54/243,18.66%,KIT;CDH13;FHDC1;NRP1;ARL13B;PCM1;PDE6D;CDC14B;DNAH5;CFAP70;ARFIP2;TTC39C;CNGA4;RAB3IP;PTPRO;UBXN10;PKHD1;CEP83;KIAA0586;VSTM5;PIBF1;CFAP43;EHD4;PTPN23;ABCC4;SCLT1;TMEM250;RFX2;BBIP1;WDR35;SNAP29;EXOC7;ANO6;FNBP1L;CFAP44;CFAP20;RILP;ABLIM1;TTC36;BBS9;POC1B;PARVA;MACIR;IFT74;B9D1;RAP1A;RFX3;AIF1L;VCL;RILPL1;SPAG16;RPGR;RAB11FIP3;OPHN1
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),-0.43313883987547047,-1.058539032375674,0.35714285714285715,1.0,1.0,7/98,5.73%,ENPP2;DEGS2;PDXDC1;SERINC1;GM2A;SPTLC3;ALOXE3
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.6418824932428209,-1.057845165020809,0.4696969696969697,1.0,1.0,3/10,32.58%,PAICS;IMPDH2;ADSS2
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),-0.49629923155720884,-1.0578133617945815,0.4166666666666667,1.0,1.0,8/29,23.05%,GADD45B;AGER;DAB2IP;SPI1;GADD45A;RELL2;PJA2;PER1
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),-0.641552270404293,-1.0577307361675676,0.42592592592592593,1.0,1.0,1/9,1.05%,CYP19A1
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),-0.6450593297573826,-1.0572823553121886,0.4838709677419355,1.0,1.0,1/8,1.41%,CHRNB1
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.6564214654984646,1.0572470736643835,0.4583333333333333,0.950234359427618,1.0,3/6,11.22%,DNAJC3;EIF2AK3;FOXO1
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.508393622050927,-1.0569791686617227,0.38235294117647056,1.0,1.0,10/40,11.17%,SLC28A2;ANKS4B;HSD17B2;PBLD;ALDOB;GBA3;ABCC6;SLC18A2;LIPC;SCGN
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.5330442963422796,-1.056856238030745,0.43137254901960786,1.0,1.0,3/29,4.51%,SFRP4;LRPAP1;RIN3
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),0.5561762884038637,1.0562296201998074,0.4090909090909091,0.9520700979716624,1.0,3/19,2.70%,LAMB2;NTNG1;LAMB3
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.5418567051278704,-1.056030963825633,0.3728813559322034,1.0,1.0,8/21,14.35%,SOD2;IGFBP5;GPER1;OGN;APOD;TPM1;NDRG4;CDKN1B
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),-0.43038560655329533,-1.0560134554997815,0.3611111111111111,1.0,1.0,21/121,17.72%,CSRP3;ROPN1B;MSX1;ARL1;RAB11A;TOLLIP;ATP6V1D;OTOF;FSIP2;SIX4;TMEM30A;DNAJA1;GBP5;VPS35;RIPOR1;DDX1;LAMP1;GABARAPL2;CCDC47;LAMP2;TRAM2
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),0.6236658772224394,1.055811248858198,0.425,0.9523984296716226,1.0,4/8,21.87%,SLC22A3;SLC25A48;SLC25A29;SLC22A1
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.6105538513202862,-1.0556849840312184,0.37037037037037035,1.0,1.0,4/11,24.52%,NODAL;C1QBP;CALR;GJA1
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),0.44242724760629165,1.0555428298489729,0.35294117647058826,0.9521978623358265,1.0,5/28,13.02%,PID1;ZBTB20;IGF1;SLC4A4;PFKFB3
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),0.5846036165243336,1.055535585636882,0.4,0.9513759873482028,1.0,2/7,15.38%,WARS2;EARS2
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.6688619676768404,1.0553486389914382,0.4375,0.9510829478068604,1.0,2/8,4.97%,GRIN3A;GRIA2
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),-0.6013757315733368,-1.0550401858178535,0.42592592592592593,1.0,1.0,2/10,5.69%,KCNE2;KCNQ1
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.3362617995901408,1.0548555522358076,0.3333333333333333,0.9518090761546247,1.0,183/1686,10.57%,CD38;MYRFL;NRG1;ETV1;RUNX1;CREB5;POU6F2;TBX6;KIT;ZNF300;PER2;IFI16;CCNH;TEAD2;SOX13;RGS14;E2F5;TRPS1;PRRX1;ATOH8;GFI1B;ZNF485;TOX;NFIB;LEF1;ZNF496;PHC2;WWTR1;TBL1Y;ZNF239;PTPRK;ZNF18;ZNF273;ZNF117;ZEB2;LCORL;NFIA;NFATC1;EGFR;KDM8;RORA;ZNF707;ZNF132;DACH2;ZNF536;BACH2;ATF3;HIVEP1;FANK1;ZGLP1;ARID3B;ZNF354B;OR7D2;TGFBR1;BMP7;ZNF347;CBFB;ID3;PLCB1;ARID5A;ATXN1;TOX3;KCTD1;ESRRG;HDAC9;ZBTB20;ZNF205;ZNF534;BATF3;SAMD13;HEY1;GTF2H2C;TIMELESS;ZNF442;CDK14;CREB3L4;TSFM;NRL;ZNF771;ZNF264;E2F6;HIC2;ZNF165;SPIN2B;ZNF572;ZNF606;WWC1;TGFB3;HDX;TOX2;EREG;POU3F4;PRICKLE1;ZNF628;FOS;BRCA2;ZBTB5;ACVR1;MEIS1;SOX12;ZHX3;NR3C2;ZNF596;ARID1B;MXI1;ZNF608;CHD7;NFIX;TSHZ1;APOE;ARID1A;BAZ2B;ELP4;PRMT5;ZNF600;HMGB1;IGF1;FOXN3;PRKCB;SFMBT1;ZNF518A;MED30;SAMD7;PRDM5;ZBTB39;ZFHX4;ZNF846;HDAC1;PCGF1;ZNF33B;ZEB1;ZNF263;ZFP62;BCL11B;ZBTB1;ELF2;SOX5;ARID5B;REL;FOXO6;SMAD2;ZNF778;TFCP2;NACC2;MED12L;RGMB;FOXP2;ZNF782;WBP2NL;CSRNP3;DAP;ZNF441;ZNF48;ZNF444;RRM2;ZNF429;SUV39H2;ZNF276;ZBTB17;ERBB4;ATF6;ZNF678;ZNF202;DACH1;ETV5;TFAP4;POU3F1;ZNF780B;ZNF83;ZNF99;FZD1;TASP1;ZNF334;PRDM15;RYBP;ZNF155;BRD3;SCMH1;SMARCAL1;GATAD2A;FLI1;ATXN1L;POU2F2
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.4841438450576818,-1.0548065848968766,0.38095238095238093,1.0,1.0,6/36,6.05%,CYP1B1;RASIP1;LAMA1;RASA1;TGFB1;TBX1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.5545435151249446,-1.0547263729301237,0.4393939393939394,1.0,1.0,1/14,1.19%,C17ORF99
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.44064497998560437,1.0546514570676726,0.29411764705882354,0.9516448520629456,1.0,3/37,8.13%,NOX4;DDAH1;SRR
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),-0.5471309251426226,-1.0545748756436109,0.36065573770491804,1.0,1.0,5/23,22.94%,DRD3;SYT2;SYT4;SYT9;SYT13
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.4163357371144543,-1.054573703621595,0.352112676056338,1.0,1.0,18/97,11.04%,EMILIN2;TMEM184A;MSX1;LIPH;ITGA5;PRG4;B3GNT3;TMC4;KLF5;MYO5B;CBLC;GPX2;AGER;CLDN1;CRYBA1;BRCA1;STAP2;KIF20B
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.3566812456621762,1.0544290419855624,0.16666666666666666,0.9513991099105632,1.0,37/321,7.13%,ROR2;KIT;CDH13;PDGFD;SGK1;PTPRT;NTNG1;F2RL1;DOCK10;PHACTR1;SEMA6D;LEF1;MCTP1;KDR;PTPRK;EGFR;SRGAP1;TRIP6;KANK1;TGFBR1;CTNNA2;SEMA5A;MIEN1;CSF1R;MDK;PRR5L;EPHB2;PDGFC;NAV3;ACVR1;PDGFRA;SEMA4C;FGF10;JAG1;CASS4;NUMB;IGF1
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),-0.5363991177146953,-1.0543883810538135,0.4142857142857143,1.0,1.0,7/24,21.42%,PPP1R1B;FKBP1B;CRY2;SH2D4A;PPP4R4;BOD1;PPP1R11
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),-0.6743681943784516,-1.0542385571940085,0.38461538461538464,1.0,1.0,1/5,6.55%,TST
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.5280964814637713,1.0541892893637868,0.37142857142857144,0.9511070999710156,1.0,8/19,23.58%,LIN28B;KHSRP;TRIM71;XPO5;TARBP2;DIS3L2;DGCR8;AGO2
prerank,GO_Biological_Process_2021__sensory perception of taste (GO:0050909),-0.6619834066721056,-1.053798768859689,0.4666666666666667,1.0,1.0,1/7,4.94%,TAS1R1
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.40899656277673485,-1.053738520242511,0.3614457831325301,1.0,1.0,60/193,24.83%,NARS1;PPA1;RPL36;EPRS1;RPL15;RPL38;RPS21;IARS2;RPS7;WARS1;RPL37A;ASMT;RPL9;GTPBP2;RPL28;MRPS14;RPLP2;RPL5;EEF2;RPL22L1;EEF1A1;RPL26L1;RPL35A;RSL24D1;RPS20;RPLP1;RPL8;RPL4;RPL22;RPL27A;MRPS18C;COPS5;ZC3H15;RPL24;RPS15;MRPL51;GTPBP1;EEF2K;MRPL43;RPL34;RPL3;RPS24;MRPL16;RPS4X;RPS3;RPS6KB2;RPS29;MRPS34;RPL13A;RPS8;RPS27A;RPL27;RPL37;RPL7A;RPL35;RPL23;RPL32;RPS13;MRPL27;MRPL42
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.4440405672711853,-1.0532619999899318,0.34782608695652173,1.0,1.0,19/55,14.94%,GNLY;CD4;ITK;PTPRC;TMC8;ARHGAP15;ARHGAP9;GMFG;CD27;THEMIS;CD6;TAGAP;SEPTIN1;TCF7;GBP5;RHOH;EPSTI1;CD5;SLA
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),0.6184197844852543,1.052663536927774,0.4222222222222222,0.9548055874743321,1.0,6/8,28.86%,NRXN1;SHANK1;TPP1;PCDH15;CLN3;MYO7A
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),-0.6167698185889433,-1.052170345361604,0.48214285714285715,1.0,1.0,3/11,8.39%,CD4;IL15;STAT5A
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),-0.6167698185889433,-1.052170345361604,0.48214285714285715,1.0,1.0,3/11,8.39%,CD4;IL15;STAT5A
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),-0.5097026111848137,-1.052153172985722,0.4117647058823529,1.0,1.0,7/23,32.01%,SLC36A1;SLC6A7;SLC38A5;CTNS;SLC7A5;SLC38A2;SLC38A3
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),0.647880757076192,1.0520928297951835,0.4411764705882353,0.9554202332329512,1.0,3/7,18.11%,REL;PTPRS;YY1
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.4382381882257008,-1.0520625767256895,0.3783783783783784,1.0,1.0,22/78,28.11%,RAB6C;ARCN1;RAB1A;KDELR3;KIF11;ARF3;RACGAP1;KIF3A;ARF4;KIF22;RAB1B;KIF5A;RAB6D;KLC1;KIF4A;KDELR1;KIF1C;TMED10;NAPA;COPB1;ERGIC3;RAB6B
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),0.43763433421093423,1.0520282955956435,0.28,0.9547178117448424,1.0,2/58,3.28%,RUNX1;CBFB
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.4948641575672083,-1.0520059572609453,0.36507936507936506,1.0,1.0,1/39,0.02%,CD44
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.5138994293969862,1.0516841692376016,0.3611111111111111,0.954819483219192,1.0,3/19,6.55%,TGFBR1;TGFB3;CHD7
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.43616904216476193,-1.0513066833594082,0.32098765432098764,1.0,1.0,8/77,10.85%,ENPP2;RREB1;AGT;RAC1;RAB11A;PIK3CB;DOCK1;CTSH
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),0.4636929888284001,1.05116375944344,0.34210526315789475,0.9552580972307544,1.0,7/19,21.23%,OSBPL6;ABCA13;NAXE;YJEFN3;NR1H3;NFKB1;APOA1
prerank,GO_Biological_Process_2021__venous blood vessel morphogenesis (GO:0048845),-0.6868046487959126,-1.0511006941252103,0.41818181818181815,1.0,1.0,2/5,15.34%,NOTCH1;CCBE1
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.3641199867070318,1.0510996767651388,0.29411764705882354,0.9546041567901036,1.0,30/206,10.58%,EPHA3;ROR2;KIT;ALK;PELI2;KDR;EPHA5;NRP1;EGFR;FGFR4;DSCAM;ZBTB20;FGFR3;LEPR;CSF1R;EPHB2;EREG;PDGFRA;FGF10;RASGRP1;IGF1;EFNA5;EPHA7;RYK;KNDC1;ANGPT1;ERBB4;LTK;SLC4A4;IL34
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),0.6129346062453143,1.0508861720392697,0.42857142857142855,0.9542066746951147,1.0,2/9,10.58%,CSF1R;IL34
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.5733289376745767,-1.0507662428588325,0.35,1.0,1.0,2/14,9.82%,FKBP1B;CALM3
prerank,GO_Biological_Process_2021__tyrosine metabolic process (GO:0006570),-0.624725465564764,-1.0506793644460206,0.4807692307692308,1.0,1.0,4/9,24.28%,IL4I1;TYR;FAH;GSTZ1
prerank,MSigDB_Hallmark_2020__Adipogenesis,-0.3974941430487912,-1.0504353717989814,0.32894736842105265,1.0,1.0,21/180,14.78%,ENPP2;MYLK;RREB1;CCNG2;NKIRAS1;TST;CD302;MRAP;PTGER3;ALDH2;PLIN2;STAT5A;ETFB;GHITM;RETSAT;NMT1;DHCR7;SPARCL1;GADD45A;LPCAT3;YWHAG
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),0.557359653080431,1.0497888668998971,0.3783783783783784,0.9562794081617748,1.0,2/12,3.18%,SOX13;BMP7
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.5227369408431612,1.0492751094177615,0.425,0.9570858411042363,1.0,5/19,16.27%,SULF2;SPRY3;APLN;CREB3L1;FGFBP3
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.5705535580027615,1.0492712102192092,0.4782608695652174,0.9562474270212798,1.0,1/13,0.61%,PID1
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),0.545518362856323,1.0491437005616933,0.4,0.9558614606688324,1.0,1/9,0.98%,SPX
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.7106177695375454,-1.0490838433034562,0.5423728813559322,1.0,1.0,1/5,11.29%,UFM1
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.7106177695375454,-1.0490838433034562,0.5423728813559322,1.0,1.0,1/5,11.29%,UFM1
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.7106177695375454,-1.0490838433034562,0.5423728813559322,1.0,1.0,1/5,11.29%,UFM1
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.44709892977994725,-1.0490489279965882,0.38571428571428573,1.0,1.0,12/88,13.97%,CSRP3;LAMA2;ACTC1;TRIM54;CAV3;ANGPTL2;FABP3;TTN;DOCK1;SIX4;CASQ1;TPM1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),-0.7026334875468775,-1.0488875119501757,0.4909090909090909,1.0,1.0,1/5,5.83%,NOTCH1
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),-0.686929534525481,-1.0486882081135487,0.3793103448275862,1.0,1.0,2/5,5.33%,AHR;IL4I1
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),-0.67750076045533,-1.0485595108669055,0.5357142857142857,1.0,1.0,1/5,2.33%,HSD17B10
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),-0.5453000822160738,-1.0482685041698363,0.43103448275862066,1.0,1.0,6/12,18.87%,AHR;IL4I1;IRF1;FADD;IL6ST;SKAP1
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.3951229013909615,1.048263489627775,0.25,0.9574170528212774,1.0,15/85,14.80%,IRS1;CYSLTR2;SLC30A10;HDAC9;ENPP1;PRKCD;IRS2;SLC25A33;ADCY2;FOXO1;PIK3R1;GCK;NR4A2;FER;AKT2
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.5369654205650853,1.047972969163209,0.47058823529411764,0.9573423841363928,1.0,5/13,21.89%,RAB27A;NLGN1;KIF5C;SYNDIG1;TMEM230
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),0.5160706718089809,1.0478719947414326,0.4,0.9567604231106017,1.0,5/13,19.65%,SLC25A33;PNPT1;EARS2;TFB2M;FOXO3
prerank,GO_Biological_Process_2021__xenobiotic transport across blood-brain barrier (GO:1990962),0.6129120050251232,1.0477836554686242,0.4,0.9562140577286103,1.0,1/6,0.43%,SLC22A2
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),0.5429340726872195,1.0474654575024647,0.47619047619047616,0.9562787936422162,1.0,2/12,7.69%,IQGAP2;ARPC3
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),-0.6216781153866762,-1.0473832516019705,0.4166666666666667,1.0,1.0,1/9,4.70%,BNIP3
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),0.6450261900625045,1.0471661485620403,0.48717948717948717,0.955580520811981,1.0,1/5,5.72%,ENPP1
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),0.6450261900625045,1.0471661485620403,0.48717948717948717,0.955580520811981,1.0,1/5,5.72%,ENPP1
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.6201417720522797,-1.046122234919617,0.45901639344262296,1.0,1.0,3/12,16.56%,NOTCH1;TBXA2R;MMRN2
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.46170039634804283,1.0461046153727265,0.3333333333333333,0.9576434372473154,1.0,10/43,11.22%,F2RL1;EGFR;TGFB2;GREM1;SEMA4C;RASGRP1;MID1;KLHDC10;IGBP1;FOXO1
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),0.46010955419257843,1.045996981487975,0.38235294117647056,0.9571216422703976,1.0,6/33,15.47%,CDC14B;CDC26;ANAPC16;CDC23;SIRT2;ANAPC7
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),-0.5997046137284624,-1.045785860914583,0.48148148148148145,1.0,1.0,5/10,20.76%,MSMP;CCL5;GPR183;CXCL13;PIK3CD
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.5697358125651747,-1.0455965689513673,0.43548387096774194,1.0,1.0,3/15,9.10%,TCP1;CCT6A;CCT8
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),0.625859019149867,1.0455024563000852,0.375,0.9576437502892832,1.0,2/11,13.57%,POLD3;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),-0.6546883150279654,-1.0453024786407366,0.43636363636363634,1.0,1.0,1/6,1.47%,PTGIS
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),-0.6546883150279654,-1.0453024786407366,0.43636363636363634,1.0,1.0,1/6,1.47%,PTGIS
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),-0.5774695954884863,-1.0447115762083203,0.4393939393939394,1.0,1.0,5/14,24.09%,LPCAT4;PLA2G10;SLC27A1;GPAM;PLA2G4A
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),0.649729200089479,1.0446350310071104,0.4186046511627907,0.9595734510836406,1.0,2/7,10.36%,PRKD1;SPHK2
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.6591613524588743,-1.0444074330123156,0.44642857142857145,1.0,1.0,3/7,24.09%,LPCAT4;PLA2G10;PLA2G4A
prerank,GO_Biological_Process_2021__positive regulation of meiotic nuclear division (GO:0045836),-0.6330583242845109,-1.0443891747283474,0.45614035087719296,1.0,1.0,1/6,7.03%,RAD51AP1
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.6095595816630428,-1.0442946353722968,0.46153846153846156,1.0,1.0,1/12,5.38%,F11R
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.5463137734254419,-1.044186238047328,0.4647887323943662,1.0,1.0,10/22,28.61%,ALDOB;PGAM1;ENO2;PKLR;ADPGK;PGK1;HK3;PKM;GAPDH;GAPDHS
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.39392320214310733,1.044129844013167,0.2962962962962963,0.9602869909708048,1.0,14/62,14.37%,ZEB2;TGFBR1;BMP6;BMP7;BMP3;TGFB2;TGFB3;ACVR1;SMAD2;FBXL15;TWSG1;ELAPOR2;NUMA1;EP300
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.3957131361382896,1.0440631558171065,0.32,0.9596732582365379,1.0,4/77,4.07%,ELOVL6;RORA;FGFR4;RUBCNL
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),0.5134073198200262,1.043996476997196,0.35555555555555557,0.959037758892348,1.0,3/18,8.25%,SLC22A2;SLC22A3;ABCC11
prerank,GO_Biological_Process_2021__tyrosine catabolic process (GO:0006572),-0.6628238115314916,-1.0438651058611348,0.4444444444444444,1.0,1.0,3/5,24.28%,IL4I1;FAH;GSTZ1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.5175274365196253,1.0435551829177836,0.2903225806451613,0.9593733240076946,1.0,3/20,5.94%,KIT;FGFR3;PDGFRA
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.6776776782912564,1.043435192579629,0.5,0.9588076063215003,1.0,2/5,12.12%,FGF13;PTPRS
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.40373405567893017,-1.0431361204919107,0.273972602739726,1.0,1.0,31/135,25.97%,TPX2;CENPK;SPC24;CENPO;ERCC6L;RAB11A;WDR62;CENPU;GPSM2;ZWILCH;ITGB3BP;CENPL;STMN1;NUP85;SKA2;ABRAXAS1;KNL1;MZT1;BUB1B;KIF11;CENPI;SBDS;DYNLL1;SPC25;NDEL1;EFHC2;KIF4A;DSN1;GOLGA2;CENPH;RAN
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),0.5689863591197367,1.043131787801435,0.3870967741935484,0.9588352223656638,1.0,1/8,4.60%,DBF4B
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.5219281288555999,1.043065669740917,0.41935483870967744,0.9582026750155765,1.0,6/14,18.13%,ST3GAL1;ST6GALNAC4;ST8SIA3;ST3GAL2;ST8SIA4;ST8SIA2
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),0.5438916166022455,1.042995967095693,0.32432432432432434,0.9575143747651608,1.0,1/13,0.81%,CA2
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.3694522371193517,1.0429947006087483,0.2857142857142857,0.956679575833369,1.0,23/170,7.13%,ROR2;KIT;CDH13;PDGFD;F2RL1;SEMA6D;LEF1;KDR;EGFR;TRIP6;TGFBR1;SEMA5A;MIEN1;CSF1R;MDK;EPHB2;PDGFC;ACVR1;PDGFRA;SEMA4C;CASS4;NUMB;IGF1
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),0.6637087278707268,1.042891177823562,0.4878048780487805,0.9560959654374314,1.0,2/7,11.62%,PGM2;GALE
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.6146310238938044,-1.0422754446439009,0.49019607843137253,1.0,1.0,3/10,8.02%,H1-2;H1-0;ATAD2
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),0.504104158881708,1.0413451214207998,0.35,0.9596984486919427,1.0,5/28,7.13%,ITGA4;CACNA2D1;GRM5;GRIN2A;IGF1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),0.4477265879478015,1.0408122913063826,0.37142857142857144,0.9605410364643041,1.0,11/43,14.93%,F2RL1;RAB7B;TLR1;IFIH1;EREG;HMGB1;SPHK2;POU2F2;TMEM106A;MBP;WNT5A
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.6967087487666205,1.0408023165425229,0.48936170212765956,0.9589299911913424,1.0,2/5,14.48%,NRXN1;CNTNAP2
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.6967087487666205,1.0408023165425229,0.48936170212765956,0.9589299911913424,1.0,2/5,14.48%,NRXN1;CNTNAP2
prerank,GO_Biological_Process_2021__positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),0.6589675331683056,1.0405506207795205,0.46511627906976744,0.9587086343208793,1.0,3/5,31.18%,ELAVL4;TENT4B;LARP4B
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.5619790270085968,1.0405505817978988,0.4339622641509434,0.957889156807339,1.0,3/12,7.01%,RORA;OSBPL7;PTCH1
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.5428907646928534,1.040389756208077,0.40540540540540543,0.9573757327265265,1.0,4/15,9.03%,NRP1;SEMA5A;FGF10;ANGPT1
prerank,GO_Biological_Process_2021__macrophage chemotaxis (GO:0048246),-0.6740887674519522,-1.0402126445749904,0.48148148148148145,1.0,1.0,3/7,16.85%,CCL5;SFTPD;CXCL17
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.6116571408805074,1.0393299925488613,0.4358974358974359,0.9596927189880042,1.0,4/12,8.13%,HEY1;TGFB2;ACVR1;SMAD2
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),0.5588823326469794,1.0392082275960761,0.3902439024390244,0.9592799928667759,1.0,5/14,6.55%,MYO3A;EPHB2;POU3F4;TTC39C;CHD7
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),-0.6434154928465103,-1.0389126767056935,0.5161290322580645,1.0,1.0,2/7,18.09%,RP1;RP1L1
prerank,GO_Biological_Process_2021__regulation of low-density lipoprotein particle clearance (GO:0010988),-0.6969511276654089,-1.0389103282599073,0.4918032786885246,1.0,1.0,1/5,4.14%,LDLRAP1
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.6739404779203495,1.0387099358108778,0.46808510638297873,0.9596894870063429,1.0,2/5,25.60%,PXN;NCK1
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.4193682269762372,1.038698662962028,0.3,0.9588951861125375,1.0,11/65,13.17%,CA2;KCNJ16;NKAIN3;KCNJ6;KCNJ3;KCNJ2;PXK;VAMP3;NEDD4L;SYT1;SPTBN4
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.6793025305228361,-1.0386632118585712,0.5094339622641509,1.0,1.0,4/9,23.65%,EIF2S2;MCTS1;EIF5;EIF4H
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.3883567208869226,1.038387385198014,0.34782608695652173,0.9589448139936778,1.0,19/124,10.05%,EPHA3;ROR2;KIT;ALK;KDR;EPHA5;EGFR;FGFR4;FGFR3;CSF1R;EPHB2;GREM1;PDGFRA;NAF1;EPHA7;RYK;ERBB4;PARM1;LTK
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.5438266579387874,-1.0382265845746685,0.4153846153846154,1.0,1.0,5/20,21.72%,ABT1;RPS21;ERI2;WDR12;EXOSC8
prerank,GO_Biological_Process_2021__protein geranylgeranylation (GO:0018344),-0.6826064470819316,-1.038012149127825,0.43636363636363634,1.0,1.0,1/5,3.41%,RABGGTB
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.5296798494631573,1.037807052568246,0.41379310344827586,0.9597014965837266,1.0,4/30,8.23%,CDK2AP2;GFI1B;MYO16;NACC2
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),-0.6853303848743195,-1.037653786249094,0.5263157894736842,1.0,1.0,1/6,5.73%,ALOXE3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),-0.6242687963601796,-1.0374754778665731,0.40350877192982454,1.0,1.0,1/10,1.93%,TMEM35A
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),0.5956334207475247,1.0373993377334938,0.41304347826086957,0.9602101514573579,1.0,3/9,11.01%,KDR;HEY1;RIN2
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.6829173286057363,-1.0373088415025338,0.43103448275862066,1.0,1.0,3/6,25.15%,SPI1;METTL3;TRPV4
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.5934304547146343,1.0370139408075425,0.4146341463414634,0.9603257515252425,1.0,4/8,12.78%,COMMD1;PRKCE;HECW2;NEDD4L
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),-0.6581476667398736,-1.0369041266482928,0.5172413793103449,1.0,1.0,3/6,24.63%,CD300LF;LYN;CD226
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),-0.5157501003557665,-1.0366967967901997,0.43243243243243246,1.0,1.0,5/30,12.31%,AMBP;PINK1;GSTP1;DNAJA1;GPS2
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),-0.4932241713001282,-1.036636101636561,0.36666666666666664,1.0,1.0,1/24,1.83%,FIP1L1
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),-0.4932241713001282,-1.036636101636561,0.36666666666666664,1.0,1.0,1/24,1.83%,FIP1L1
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),0.5232953918430123,1.0363426779166771,0.3783783783783784,0.9613367944586682,1.0,3/15,8.81%,EGFR;EREG;FAF1
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),0.6667821542451681,1.0360820551978245,0.475,0.9611268376421739,1.0,2/6,16.97%,MTR;CTH
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.41685935427133425,1.035965774421894,0.375,0.9606154804430542,1.0,19/70,19.70%,AFF2;PTBP3;PTBP2;KHDRBS3;HSPA1A;FASTK;U2AF2;PIK3R1;KHDRBS2;RRP1B;CELF1;HNRNPL;HNRNPH1;QKI;SRRM4;SON;PTBP1;MBNL1;SETX
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.44194222567757174,-1.0358739802896852,0.40298507462686567,1.0,1.0,21/77,25.18%,HLA-DMA;CD74;HLA-DPB1;DCTN1;HLA-DMB;KIF11;RACGAP1;KIF3A;ARF1;AP1M2;KIF22;DYNLL1;SEC23A;CANX;KIF5A;KLC1;CLTC;SPTBN2;CLTA;KIF4A;LGMN
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),0.6292685377730216,1.035823651051425,0.4666666666666667,0.9601943335129675,1.0,3/6,21.90%,PTPRS;RTN4R;EPHA4
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),-0.652504032749067,-1.03563696683312,0.5614035087719298,1.0,1.0,3/5,28.28%,CRY2;PER1;LMO3
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),-0.5305812264881533,-1.03559952770666,0.47368421052631576,1.0,1.0,6/18,23.01%,SCN7A;GPER1;SCN9A;CACNA1G;CACNA1H;SCN11A
prerank,GO_Biological_Process_2021__positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568),0.6295690192471559,1.0354657098800866,0.40476190476190477,0.9603875525050576,1.0,1/5,7.13%,IGF1
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),-0.6391326753220004,-1.0352326885240937,0.41509433962264153,1.0,1.0,1/6,4.70%,BNIP3
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),-0.5957487663753974,-1.0350142486235052,0.48333333333333334,1.0,1.0,3/13,7.46%,TRPV6;SLC24A1;TRPV3
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),-0.5957487663753974,-1.0350142486235052,0.48333333333333334,1.0,1.0,3/13,7.46%,TRPV6;SLC24A1;TRPV3
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),0.6134159809563042,1.0343766987349312,0.5,0.9624755386401935,1.0,1/7,0.42%,KIT
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),-0.6833584424185446,-1.0341640172068647,0.4909090909090909,1.0,1.0,3/6,20.76%,MSN;GPR183;PIK3CD
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.4992102333925273,1.0340787843543933,0.34375,0.9626219251725463,1.0,2/14,13.33%,KANK1;RIPOR2
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),-0.6238434282768863,-1.0339769108322139,0.41509433962264153,1.0,1.0,1/10,11.36%,SESN3
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),0.6213508408035904,1.0338467186482152,0.45454545454545453,0.9624675896444053,1.0,1/6,4.60%,DBF4B
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.5111029353585409,1.033814880036251,0.4358974358974359,0.9618131580452461,1.0,10/21,26.96%,APOE;NLGN1;FOXO6;DLG5;RELN;NEURL1;CAPRIN1;SHANK1;PSEN1;LLPH
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5496107910173312,1.0337995230488486,0.45,0.9610376364567857,1.0,1/11,1.47%,NFIB
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.4348159701896436,1.033700906358561,0.4,0.9605298397847348,1.0,12/29,28.86%,CLVS1;CLN6;ARSB;HOOK3;CLVS2;VPS18;TFEB;TPP1;ZKSCAN3;CLN3;ABCA1;MYO7A
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.42786757786144447,1.0336652743401447,0.4594594594594595,0.9597678211283024,1.0,8/42,14.74%,VWC2L;VWC2;CRIM1;GREM1;CHRDL1;GREM2;SORL1;LEMD2
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.6728097017038048,-1.0336597004151962,0.5517241379310345,1.0,1.0,1/6,5.62%,TIMP2
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.5446729549594155,-1.033638130262291,0.390625,1.0,1.0,3/19,8.91%,MYLK;DUOX1;CLDN1
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.5624349393181577,1.03352330225256,0.48717948717948717,0.9593395367815404,1.0,6/16,16.00%,SIGLEC10;MDK;CASK;PTPRS;CRK;RTN4R
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),0.5906917895848494,1.0335112550035273,0.48936170212765956,0.9585355368213992,1.0,5/6,21.39%,ST3GAL1;ST8SIA3;ST3GAL2;ST6GALNAC2;ST3GAL4
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),-0.42915674046711705,-1.0334376961225302,0.47297297297297297,1.0,1.0,15/89,16.91%,C4BPB;WFS1;AGT;GPC3;TGFB1;DAB2IP;IL18;INHBA;TRIM32;CDKN1B;C4BPA;PLA2G10;UHRF1;NFKBIA;RAB1A
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.5383064401290877,-1.033225917913214,0.43478260869565216,1.0,1.0,5/17,16.15%,TGFB1;APH1B;MBTPS2;ADAM9;ADAM17
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.5339267388819178,-1.0330074860742184,0.5,1.0,1.0,4/21,13.18%,CAV3;RAC1;VAV3;MSN
prerank,GO_Biological_Process_2021__rhodopsin mediated signaling pathway (GO:0016056),-0.6842916043836398,-1.0328047814981636,0.4827586206896552,1.0,1.0,2/7,11.72%,PDE6B;CNGB1
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),-0.5155630477522225,-1.0325251679341152,0.4444444444444444,1.0,1.0,8/34,22.94%,TRPV6;SYT2;SYT4;PREPL;DOC2A;SYT9;SEPTIN5;SYT13
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.45075717017234124,1.0323056128509809,0.4,0.9609742041130828,1.0,9/28,25.26%,SHLD1;PNKP;KMT5B;SIRT7;SETMAR;HSF1;HMGA2;PARP3;USP51
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),-0.48809702525604554,-1.0322484684895494,0.4788732394366197,1.0,1.0,17/57,21.70%,ACOT4;HINT1;BAAT;ACOT12;ACOT13;ACSM4;ACSM6;ACOT1;ACOT2;RAB23;TPST2;ACSM3;ACOT6;GTPBP1;SULT2A1;GMPR2;AK4
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),0.36034726311550586,1.032201518880505,0.391304347826087,0.9603912431745659,1.0,16/138,8.41%,SLC22A2;SLC12A3;KCNJ16;SGK1;FGF13;KCNB2;KCNJ6;CNGA3;KCNJ3;KCNN2;KCNJ2;SLC22A3;KCNK7;SLC7A1;SCNN1B;SLC8A3
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.4376905008100259,-1.031949335394126,0.4358974358974359,1.0,1.0,12/96,15.38%,NES;LRPAP1;B2M;TMC8;ZFPM1;LDLRAP1;IFIT1;CTSZ;HIP1R;FLOT1;EFHB;DDX11
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.3976705370553325,1.0319155980415662,0.39473684210526316,0.9603504123402421,1.0,19/69,14.33%,SLC12A3;SGK1;FGF13;SLC12A1;SLC6A11;HCN1;SLC6A4;SCNN1B;SLC8A3;SLC6A13;SLC6A1;SLC4A4;SLC24A3;NEDD4L;SLC38A7;ANO6;SLC6A2;SLC8A1;SCNN1D
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.36331939352879145,1.0319147993124664,0.4230769230769231,0.9595372451833072,1.0,22/80,17.94%,TRPC7;TRPC3;MICU1;CACNA2D1;MCU;GRIN2A;TRPC5;SLC35G1;SLC8A3;SLC24A3;ANO6;TRPC1;SLC8A1;GRIN2C;TRPV2;MCUR1;GRIN2B;MAIP1;MCUB;GRIN1;CACNA1A;ITGAV
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),0.5485523704253067,1.031570958500165,0.32432432432432434,0.9597728316518962,1.0,2/21,3.92%,MYLIP;VLDLR
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),0.5101990624055779,1.0315416695578687,0.3783783783783784,0.9590276217368667,1.0,1/16,1.34%,IRS1
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),-0.5291333831408666,-1.0315275169214337,0.4153846153846154,1.0,1.0,4/21,9.94%,CHMP4B;CHMP2B;GPSM2;CHMP2A
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.4465735997630475,-1.0314028633935561,0.4142857142857143,1.0,1.0,17/70,23.63%,FIP1L1;CSTF2T;SLU7;DDX39A;NCBP2;SLBP;NCBP1;RNPS1;ALYREF;CDC40;UPF3B;THOC5;CLP1;DHX38;SRSF5;CPSF4;PAF1
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.464751447285363,-1.0313482786198325,0.4927536231884058,1.0,1.0,5/57,4.29%,PRLR;CYP19A1;CYP1B1;HSD17B10;BAAT
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),-0.6307339941545183,-1.0311165591150961,0.5,1.0,1.0,1/8,5.08%,NOX1
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),-0.6071632274379788,-1.0310765085906066,0.5,1.0,1.0,3/9,11.58%,TGFB1;CASP8;FADD
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),-0.6178214666333794,-1.0309558478977772,0.4918032786885246,1.0,1.0,2/11,15.08%,ELANE;WAS
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),-0.6722038143627913,-1.0307068153075316,0.5901639344262295,1.0,1.0,4/7,24.42%,TGFB1;ACMSD;HSP90AB1;CLTC
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),0.47538657640094195,1.0306797435860815,0.3611111111111111,0.9605289772725768,1.0,2/23,1.40%,KIT;F2RL1
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),-0.6943196826235207,-1.0304146581449953,0.5161290322580645,1.0,1.0,2/6,14.16%,BCAP31;HERPUD1
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),-0.566580448715633,-1.0300373182355838,0.48333333333333334,1.0,1.0,7/19,28.29%,TPX2;TUBGCP4;TUBGCP2;NDEL1;GOLGA2;TUBG2;TUBGCP5
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.3175947455286796,1.0298979038536134,0.3333333333333333,0.9619618161726384,1.0,178/1645,10.45%,ETV1;RUNX1;CREB5;POU6F2;TBX6;KIT;CDH13;ZNF300;PER2;IFI16;CCNH;PID1;MAML3;TEAD2;SOX13;E2F5;TRPS1;PRRX1;ATOH8;GFI1B;ZNF485;SSBP3;TOX;F2RL1;NFIB;LEF1;ZNF496;WWTR1;TBL1Y;ZNF239;ZNF18;ZEB2;LCORL;NFIA;NFATC1;ZNF462;EGFR;RORA;ZNF707;ZNF132;DACH2;ZNF536;BACH2;ATF3;HIVEP1;ZGLP1;ARID3B;ZNF354B;ZBED3;BMP6;ZNF347;CBFB;ID3;ZNF827;GABPB2;ARID5A;SMYD2;ATXN1;MRTFA;TOX3;KCTD1;ESRRG;HDAC9;ZBTB20;ZNF205;ZNF534;BATF3;HEY1;CSF1R;GTF2H2C;ZNF442;MAML1;CREB3L4;NRL;ZNF771;ZNF264;WWOX;E2F6;HIC2;ZNF165;ZMYM5;ZNF572;ZNF606;WWC1;TGFB3;HDX;TOX2;POU3F4;FOS;ZBTB5;GREM1;ACVR1;MEIS1;ZNF407;SOX12;ZHX3;NR3C2;RITA1;MACROH2A2;ZNF596;ARID1B;AASS;JAG1;MXI1;ZNF608;TET2;NFIX;TSHZ1;APOE;ARID1A;BAZ2B;ELP4;PTCH1;ZNF600;HMGB1;IGF1;PRKCB;ZNF518A;MED30;PRDM5;ZBTB39;ZFHX4;ZNF846;RNF2;HDAC1;PCGF1;ZNF33B;ZEB1;ZNF263;ZFP62;BCL11B;TET1;ZBTB1;ELF2;SOX5;ARID5B;REL;FOXO6;SMAD2;ZNF778;TFCP2;NACC2;FHL2;MED12L;FOXP2;ZNF782;TPR;CSRNP3;LYAR;IGBP1;ZNF441;ZNF48;ZNF444;ZNF429;SUV39H2;PRKD1;ZNF276;ZBTB17;ATF6;ZNF202;DACH1;ETV5;TFAP4;POU3F1;ZNF780B;ZNF83;ZNF99;FRK;CDK8;ZNF334;RGMA;AUTS2;PRDM15;ZNF155;BRD3;SMARCAL1;GATAD2A;FLI1
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.6179377261348684,1.0295188015120469,0.4583333333333333,0.96065149301473,1.0,4/8,17.02%,HSPB1;DLG2;KIF5C;RAB27B
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.6179377261348684,1.0295188015120469,0.4583333333333333,0.96065149301473,1.0,4/8,17.02%,HSPB1;DLG2;KIF5C;RAB27B
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.6179377261348684,1.0295188015120469,0.4583333333333333,0.96065149301473,1.0,4/8,17.02%,HSPB1;DLG2;KIF5C;RAB27B
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.6492121667570181,1.0292517511726402,0.47619047619047616,0.9608409149014074,1.0,3/5,27.62%,ROBO1;MYO9B;SLIT2
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.42921448824015385,1.0292043422357515,0.36363636363636365,0.9600991910251643,1.0,2/49,1.19%,IMMP2L;GDAP1
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),-0.6161591647177475,-1.0288969289762662,0.41379310344827586,1.0,1.0,3/7,34.58%,RIPOR1;CDC42;PDCD10
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),-0.620351326149374,-1.028808375000534,0.47619047619047616,1.0,1.0,1/7,4.51%,RIN3
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),0.5982667153606113,1.0287134475556292,0.46511627906976744,0.9607592523384707,1.0,1/7,0.61%,PID1
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),0.5743379803641455,1.0284642062584863,0.4166666666666667,0.9604998730871517,1.0,3/9,7.94%,SPX;PDE4D;RNLS
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),0.5467011165168765,1.0279732172216662,0.4090909090909091,0.9609291011546154,1.0,3/11,9.03%,PDE3A;BMP6;ANGPT1
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),-0.5332766379480431,-1.0279619445541002,0.4117647058823529,1.0,1.0,2/21,2.77%,TRIM54;TPX2
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),-0.6239440382424802,-1.027895567240066,0.4696969696969697,1.0,1.0,2/8,12.31%,PTGIS;GPS2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),-0.5459616053129209,-1.027884336781285,0.4225352112676056,1.0,1.0,4/24,10.66%,MYLK;WFS1;PDGFRB;CCL5
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),-0.4425203684689809,-1.0276352592540707,0.4714285714285714,1.0,1.0,9/63,9.43%,SLC12A7;KCNE2;TRPV6;ATP1B1;SLC5A2;SLC24A1;TRPV3;ATP1A1;SLC9A6
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),-0.46686330753916255,-1.0276165640669634,0.42424242424242425,1.0,1.0,6/50,14.84%,C4BPB;GPC3;DAB2IP;TRIM32;CDKN1B;C4BPA
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.43192970709301504,-1.0276155819970403,0.4155844155844156,1.0,1.0,16/119,9.22%,PRLR;HSPG2;TMEM184A;EPAS1;VASN;EPHX1;TIMP3;AGT;ACOX2;DOCK6;COL6A1;RARRES2;AARD;F10;DAB2IP;IGFBP5
prerank,GO_Biological_Process_2021__positive regulation of muscle contraction (GO:0045933),0.5562287756473496,1.027611745968155,0.4897959183673469,0.9614012671438934,1.0,2/7,25.85%,F2R;MYOCD
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),-0.42409300007554873,-1.0271488981769525,0.38461538461538464,1.0,1.0,22/82,25.97%,CENPK;NCAPH2;CHMP4B;CHMP2B;NCAPG;RAB11A;KIF14;TTN;CHMP2A;SMC2;PDS5B;EML3;SET;BOD1;VPS4A;KIF22;PSRC1;ANKRD53;NCAPG2;NCAPD3;DSN1;RAN
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),-0.6424022225729793,-1.0268528505208567,0.4528301886792453,1.0,1.0,5/7,28.63%,HEBP2;RNF122;BAX;ARL6IP5;PIP5KL1
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.3760068560265466,1.0268465200095642,0.3333333333333333,0.9626687145371715,1.0,25/181,16.02%,FBXL7;RNF150;MYLIP;RNF126;FEM1A;RNF217;CDC26;RNF130;PTTG1;RBBP6;RNF128;ANAPC16;KCTD21;UBE2D4;CDC23;WDR81;KLHL25;RC3H1;NEDD4L;BTRC;RNF19B;UBE2R2;ANAPC7;FBXO45;PSMD13
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),0.5698158953587282,1.026678986359448,0.5,0.9623105424777826,1.0,4/9,25.99%,PARP10;ZC3HAV1;PARP3;TNKS
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),-0.5600831256645875,-1.0266624001017122,0.45,1.0,1.0,3/11,8.66%,ATP1B1;KCNQ1;ATP1A1
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),-0.6767473722152515,-1.0263731864426968,0.47540983606557374,1.0,1.0,2/5,28.28%,YAP1;LMO3
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),-0.6423027291255594,-1.0262036468782973,0.4528301886792453,1.0,1.0,2/10,12.18%,AGT;RFK
prerank,GO_Biological_Process_2021__negative regulation of fibrinolysis (GO:0051918),-0.6991191361654457,-1.026169075133211,0.4745762711864407,1.0,1.0,1/5,6.87%,SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.3831801240021702,1.026069904124766,0.391304347826087,0.963150524596008,1.0,13/72,13.64%,ATOH8;HSPB1;KDR;NRP1;SEMA5A;HMGB1;ANGPT1;PRKD1;SCARB1;RIN2;FGFR1;SIRT1;MAP2K3
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),-0.4270520785914135,-1.0260598527777318,0.43478260869565216,1.0,1.0,16/108,11.98%,CALB1;CSRP3;WFS1;GCM2;ELANE;CAV3;CALCB;DRD3;FKBP1B;ATP1B1;SLC24A1;GPER1;SLC24A5;CCL5;SCGN;HTR2B
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.5164155021924227,1.025945072402287,0.42857142857142855,0.9626837704807817,1.0,9/19,23.29%,SLC8A3;DLGAP1;DLGAP4;TMEM108;DLGAP3;DLGAP2;HTR2C;AKAP9;ROCK2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.43676022868787623,1.0257807215991617,0.3548387096774194,0.962369956882624,1.0,11/49,7.17%,EPHA3;KIT;KDR;EGFR;FGFR4;FGFR3;CSF1R;EPHB2;PKDCC;PDGFRA;PTPN6
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.39683498895612496,-1.025748661182885,0.4235294117647059,1.0,1.0,22/204,15.59%,EPN1;CD4;CHRNB1;SPAG4;CAV3;LDLRAP1;MTCH1;CHMP4B;CHMP2B;SYNGR2;TLCD2;CHMP2A;OTOF;HIP1R;SYT2;MYOF;LRP2;TGFA;ATP10B;LPCAT3;CNTN2;MYADM
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),-0.5756580238736351,-1.0251470317908775,0.47619047619047616,1.0,1.0,2/9,5.65%,MC4R;ATP6AP1
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.4364451163146593,-1.0249534256904635,0.3880597014925373,1.0,1.0,9/57,7.88%,CD44;IL3RA;OSMR;STAT1;IRF1;TGFB1;IL7;IFNGR2;CD14
prerank,GO_Biological_Process_2021__cell migration involved in heart development (GO:0060973),-0.6547421215288527,-1.0249375017097697,0.5416666666666666,1.0,1.0,3/5,17.35%,NOTCH1;PDGFRB;SNAI2
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.585610470095387,-1.0248611896467363,0.4426229508196721,1.0,1.0,3/12,10.26%,MYLK;TBX1;PDGFRB
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",-0.6732928587854474,-1.024740453185426,0.4666666666666667,1.0,1.0,4/6,24.36%,ITGA5;ADAM17;WNT7A;PLET1
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),-0.6120525083748389,-1.0243961878528294,0.4426229508196721,1.0,1.0,4/12,9.91%,TBP;TAF7;POLR1E;TAF7L
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),0.5598411800864314,1.0243720374802414,0.5,0.9652168253532452,1.0,5/10,18.53%,B3GAT2;CLN6;B3GAT3;CHST9;B3GAT1
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.46709865827420394,-1.0243375733855984,0.4057971014492754,1.0,1.0,11/40,23.43%,CHMP4B;CHMP2B;RAB11A;KIF14;CHMP2A;EML3;BOD1;VPS4A;KIF22;PSRC1;ANKRD53
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.5418322379462123,1.0240769793211386,0.4594594594594595,0.9652811966024313,1.0,4/15,8.35%,TGFB2;SEMA4C;MID1;KLHDC10
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.4051143532835107,1.0240272328740323,0.3548387096774194,0.9646082330481396,1.0,15/40,24.54%,AMIGO1;CHODL;ROBO2;TIAM2;NGF;TIAM1;MAP6;MAP3K13;PLXNA2;ROBO1;PLXNC1;LIMK1;PLXNA1;GOLGA4;L1CAM
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.45843160911028635,1.0239726289133178,0.3,0.9639797185893508,1.0,4/25,9.96%,ELOVL6;HACD2;SLC25A1;TECR
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),-0.5746863681189158,-1.0236954076965685,0.4098360655737705,1.0,1.0,2/12,4.44%,TNFSF18;AHR
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),0.4100288259788651,1.0232096350226365,0.375,0.9654411980525841,1.0,8/56,6.57%,CCL28;NPNT;CDH13;NRP1;RSU1;UTRN;MDK;CASS4
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.513713409218188,1.0231648415406556,0.4,0.9647589625526637,1.0,7/12,28.58%,XRCC4;BRCC3;ATM;NIPBL;XRCC6;IKBIP;LIG4
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.4394750377831943,1.0229693846489147,0.39473684210526316,0.9644344440784028,1.0,9/22,19.86%,RNF126;UBAP1L;PTPN23;SNF8;TSG101;VPS25;MVB12B;UBAP1;NEDD4
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.6092420561728877,1.0226608087482467,0.43902439024390244,0.9645747202485889,1.0,2/9,5.90%,F2RL1;TICAM1
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.43538913489953524,1.022592329566522,0.41379310344827586,0.9639488349993146,1.0,7/46,6.36%,MAML3;GMDS;HEY1;MAML1;MDK;WWC1;JAG1
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,0.4142144453625225,1.0220448281078398,0.37142857142857144,0.9645851061295697,1.0,6/49,7.73%,WWTR1;PMEPA1;TGFBR1;ID3;ACVR1;HDAC1
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),-0.4795587033131484,-1.0217339677230444,0.4305555555555556,1.0,1.0,5/34,8.45%,WFS1;LRP4;AGT;STAT1;REN
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),-0.6837457845727316,-1.0214998147193028,0.5510204081632653,1.0,1.0,2/5,29.88%,KDM1A;CTR9
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.5346353912150101,-1.0212906324272404,0.4594594594594595,1.0,1.0,9/21,28.61%,ALDOB;PGAM1;ENO2;PKLR;PGK1;HK3;PKM;GAPDH;GAPDHS
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.5346353912150101,-1.0212906324272404,0.4594594594594595,1.0,1.0,9/21,28.61%,ALDOB;PGAM1;ENO2;PKLR;PGK1;HK3;PKM;GAPDH;GAPDHS
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.3285231559306042,1.0211981308455662,0.5,0.9661680771134843,1.0,58/684,8.22%,ETV1;RUNX1;CDH13;ZNF300;IFI16;PID1;MAML3;E2F5;ATOH8;SSBP3;F2RL1;NFIB;LEF1;WWTR1;ZEB2;NFIA;NFATC1;ZNF462;EGFR;RORA;ATF3;HIVEP1;ZGLP1;ZBED3;BMP6;ZNF827;GABPB2;MRTFA;TOX3;HEY1;MAML1;CREB3L4;NRL;WWOX;TGFB2;WWC1;TGFB3;TOX2;FOS;GREM1;ACVR1;MEIS1;ZNF407;SOX12;JAG1;TET2;NFIX;HMGB1;IGF1;MED30;HDAC1;ZNF263;APLN;BCL11B;TET1;REL;SMAD2;TFCP2
prerank,GO_Biological_Process_2021__auditory receptor cell stereocilium organization (GO:0060088),-0.7079221936925819,-1.0210587017551493,0.5081967213114754,1.0,1.0,2/5,17.71%,STRC;PDZD7
prerank,GO_Biological_Process_2021__auditory receptor cell morphogenesis (GO:0002093),-0.7079221936925819,-1.0210587017551493,0.5081967213114754,1.0,1.0,2/5,17.71%,STRC;PDZD7
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.6144600984369839,-1.0208108640118048,0.4745762711864407,1.0,1.0,4/9,21.05%,TAF7;BRCA1;SET;CTBP1
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.40794545289965983,1.0206859106051676,0.3448275862068966,0.9668875529383619,1.0,13/95,6.79%,LRIG3;NPNT;MAPK4;COBL;BMP7;SLC7A2;TOX3;FGFR3;WWC1;FAM222A;TSPAN12;DDAH1;CACNG4
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.45351924450116665,-1.0206244203645398,0.44594594594594594,1.0,1.0,13/48,22.91%,KCNE2;PINK1;UCHL5;DAB2IP;PSMC3;TMF1;PSMC6;GABARAPL2;USP14;NUDT15;NUPR1;PSME1;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),0.49572061646567434,1.0205870531149395,0.45714285714285713,0.9662510729074143,1.0,6/17,13.00%,GCH1;APOE;S100A1;SCARB1;NOS1AP;DHFR
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),-0.5601543770891273,-1.0204387805735946,0.48333333333333334,1.0,1.0,2/20,4.17%,POLE3;SUV39H1
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),0.5777665484387353,1.0203462677092576,0.4418604651162791,0.966195778762377,1.0,4/12,23.96%,TET2;WDR82;BEND3;TET3
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.5075486858748162,-1.0199165863963686,0.43283582089552236,1.0,1.0,6/27,17.19%,TICRR;BRCA1;MRE11;DONSON;ABRAXAS1;CHEK1
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),-0.6193190071497933,-1.0197462910905921,0.5079365079365079,1.0,1.0,1/7,4.52%,P2RY1
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),-0.5138654938905898,-1.0195573396633049,0.4918032786885246,1.0,1.0,5/19,12.20%,CHMP2B;TRIM5;TRIM25;CHMP2A;TRIM32
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.6355438189199646,-1.0193246941043899,0.5384615384615384,1.0,1.0,3/9,25.49%,ZWILCH;KNL1;CHAMP1
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.4344290135639651,-1.0192974398236214,0.4430379746835443,1.0,1.0,19/126,14.56%,MMP26;HCK;PTGIS;ELANE;PTGES;CASP12;AGT;LRRC19;SERPINE1;IL15;GPER1;IL18;TMSB4X;CCL5;GPS2;TLR2;VPS35;PLA2G7;LPCAT3
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",0.66979490520668,1.0192037311840003,0.5294117647058824,0.968384069115373,1.0,1/5,10.20%,TWSG1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.5448173201591996,1.0191539261911984,0.4523809523809524,0.9677479289395,1.0,2/13,5.90%,KIT;TICAM1
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),-0.5368870802842671,-1.0183889418446417,0.532258064516129,1.0,1.0,7/17,17.71%,WNT7B;DACT2;BFSP1;ACTA2;TMEM79;EXPH5;PDZD7
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.40055271471039144,-1.0182926601797002,0.4050632911392405,1.0,1.0,17/152,13.60%,CD44;CA12;WFS1;PTGES;NXT1;FKBP4;CELSR1;CALCR;PRSS23;ZNF185;DHCR7;MYOF;TJP3;BLVRB;RAB31;PDZK1;FASN
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),-0.6270069067684021,-1.0182525317537898,0.5,1.0,1.0,3/7,11.77%,F8;F10;A2M
prerank,GO_Biological_Process_2021__enzyme-directed rRNA pseudouridine synthesis (GO:0000455),0.6421674981024343,1.0178071527687893,0.5675675675675675,0.9705850662287884,1.0,2/6,18.33%,RPUSD1;RPUSD4
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.45428892521705916,1.0177661105330773,0.4090909090909091,0.9698946231480361,1.0,1/26,0.61%,CCNH
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.4171591454219368,1.0177359889286879,0.3225806451612903,0.9692267121309555,1.0,15/66,16.47%,MAML3;EGFR;HEY1;MAML1;TGFB2;RITA1;JAG1;RFNG;DTX1;JAG2;YJEFN3;EP300;EPN2;BEND6;BMP2K
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),-0.5508163893824438,-1.0175928074058438,0.45588235294117646,1.0,1.0,3/16,9.10%,TCP1;CCT6A;CCT8
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.4451023360619024,1.0175794435275138,0.45714285714285713,0.9688912989945879,1.0,15/46,21.38%,PER2;MINAR1;HSPA1A;GNL3L;IVNS1ABP;U2AF2;BAG2;SVBP;CHP1;SIRT7;NXN;LIMK1;N4BP1;ABL1;ARRB2
prerank,GO_Biological_Process_2021__glomerular epithelial cell differentiation (GO:0072311),0.5841133991861867,1.0174064582499203,0.4594594594594595,0.9678485702234759,1.0,1/5,6.90%,PTPRO
prerank,GO_Biological_Process_2021__renal filtration cell differentiation (GO:0061318),0.5841133991861867,1.0174064582499203,0.4594594594594595,0.9678485702234759,1.0,1/5,6.90%,PTPRO
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),-0.4684604024506161,-1.0173057673582802,0.4,1.0,1.0,7/44,11.34%,BTN2A2;NOTCH1;ALDH1A1;IL15;ACOT13;GSTP1;IL18R1
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),0.5860380402276465,1.0170866408435928,0.4634146341463415,0.9679949947692736,1.0,4/10,19.17%,GCH1;PRKG2;DHFR;GCHFR
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.41634788881479357,1.0169138265409727,0.3548387096774194,0.9676829966266082,1.0,13/79,9.52%,FBXL7;WWTR1;PCDH18;ZNF462;SLC16A2;MDK;ADGRL2;IL17RD;EFNA5;MID1;GNG12;P3H2;AMOTL2
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.40414504529107476,1.0167295613792606,0.32,0.9673182746913029,1.0,21/105,9.07%,RIMBP2;PTPRT;SEMA6D;GLP1R;FGF14;KCNIP1;RAB3C;CACNA2D1;KCNB2;TOX3;PDZRN3;CNGA3;RGS7BP;POU3F4;CNTN4;PKDCC;DDAH1;TMEM196;RCAN2;CSRNP3;PCSK2
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),0.5142726632895429,1.0165871928423003,0.4418604651162791,0.9669541482203816,1.0,5/17,16.93%,SDC4;RAB7A;SNF8;TSG101;SMPD3
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),0.6079506464794582,1.0164348643929897,0.45714285714285713,0.966537469004326,1.0,2/6,16.81%,MX1;SNAP91
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.5352806698463539,1.0162903457148524,0.4358974358974359,0.9662701585985123,1.0,5/18,18.71%,RASSF2;PDE4D;GPD1L;DDIT4;PTEN
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.5179335651595334,-1.0162559469826902,0.4576271186440678,1.0,1.0,1/20,0.64%,CSRP3
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),-0.6488252703971574,-1.0162359128537026,0.5084745762711864,1.0,1.0,3/9,9.91%,TBP;TAF7;TAF7L
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),-0.43535814193942696,-1.0161397506453471,0.39436619718309857,1.0,1.0,6/65,14.85%,HCK;KIF9;C10ORF90;ODAD3;MSN;TBC1D13
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.45069550758262056,1.0161204256470089,0.39473684210526316,0.966109403940064,1.0,16/37,22.17%,JHY;TOGARAM1;CDK5RAP2;CFAP46;NUMA1;RSPH6A;CHP1;TPPP3;SPAST;ZNF207;SPAG16;MTCL1;GAS2L1;RSPH1;NAV1;AAAS
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),-0.6792762508246983,-1.0160284898296017,0.47540983606557374,1.0,1.0,1/5,19.68%,SLC11A1
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),-0.6792762508246983,-1.0160284898296017,0.47540983606557374,1.0,1.0,1/5,19.68%,SLC11A1
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.5429944862881484,1.0157771848915516,0.375,0.9663730470498254,1.0,4/12,12.54%,PCM1;BICD1;CCDC120;HOOK3
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),0.5749979281786127,1.015762462523186,0.3958333333333333,0.9640515986812673,1.0,1/9,0.56%,CYP1A2
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),0.5749979281786127,1.015762462523186,0.3958333333333333,0.9640515986812673,1.0,1/9,0.56%,CYP1A2
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),0.5749979281786127,1.015762462523186,0.3958333333333333,0.9640515986812673,1.0,1/9,0.56%,CYP1A2
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),0.6017098179808857,1.0156161096584448,0.5116279069767442,0.9636713461117142,1.0,3/7,21.90%,PTPRS;RTN4R;EPHA4
prerank,GO_Biological_Process_2021__positive regulation of epidermis development (GO:0045684),-0.6900702077711063,-1.015592930377983,0.5573770491803278,1.0,1.0,2/5,11.49%,SFRP4;TMEM79
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),-0.5246699928448667,-1.0155382286045527,0.4406779661016949,1.0,1.0,2/17,5.48%,RND1;MTCH1
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.43177587370897264,1.015512263687959,0.4482758620689655,0.963249468072435,1.0,10/54,8.13%,CIDEA;LTBP1;PMEPA1;SPRED1;SPRED2;TGFBR1;SPRED3;IL17RD;HSPA1A;SMAD2
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.43765838047977035,1.015227402511927,0.42857142857142855,0.9632397969320996,1.0,13/54,22.96%,LEF1;CBFB;CSF1R;MED30;CDK8;MED15;MED27;NFKB1;PTEN;SETX;RELA;CTNNB1;TNRC6B
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.49361887434106155,1.0151639495752702,0.4375,0.9625659102330875,1.0,6/16,17.94%,CIDEA;PLIN5;SCARB1;OSBPL11;FITM2;NFKB1
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),-0.5212904087072066,-1.015143361585284,0.41379310344827586,1.0,1.0,6/19,18.33%,AGT;GPER1;HIP1R;PLAUR;SHKBP1;BCAR3
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),-0.5933838947883212,-1.0147424493104822,0.47619047619047616,1.0,1.0,3/8,20.02%,SLC5A2;SLC2A1;SLC27A1
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.4997719524751261,-1.0142710641634403,0.5,1.0,1.0,5/35,12.52%,RND1;RAC1;NCKAP1L;FMNL1;RHOH
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.5699806052993355,1.014191207324705,0.5116279069767442,0.9643161237954514,1.0,2/9,3.13%,BCL2;BMP6
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),-0.6341897639342093,-1.014147052840531,0.5230769230769231,1.0,1.0,1/9,2.06%,ACTC1
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),0.43050099644153317,1.0141008034927121,0.5333333333333333,0.9638319301118274,1.0,4/36,3.46%,ACE2;HTR7;SGCD;SGCZ
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),-0.46803068706577416,-1.014070767906015,0.453125,1.0,1.0,13/51,21.57%,AGT;OSMR;SERPINE1;IL15;IL18;LBP;TLR2;PLA2G7;NFKBIA;SNX4;IL6ST;NUPR1;GRN
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),0.5448798984250858,1.0140612896823638,0.4634146341463415,0.9632117863065959,1.0,4/10,21.98%,RGN;CYP2C8;SLC35D1;PAH
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.4441779631743838,-1.0140434367853968,0.4492753623188406,1.0,1.0,19/81,18.77%,TICRR;ALPL;FANCI;DEPDC1B;ERCC6L;CDC6;ATAD5;CHAF1A;PAICS;TRIM32;GINS1;PLK4;NANOG;PHF6;CHEK1;BUB1B;KIF11;SET;KDM1A
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.5640069143001298,1.0139569188880206,0.3888888888888889,0.9626977361502059,1.0,1/10,0.61%,PID1
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.5589299886293261,1.0138098499840038,0.45714285714285713,0.9623210257910376,1.0,1/14,0.83%,RGS14
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.5282948343578959,-1.012696787584693,0.4482758620689655,1.0,1.0,3/17,10.35%,MGST1;GSTM5;GSTP1
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.5282948343578959,-1.012696787584693,0.4482758620689655,1.0,1.0,3/17,10.35%,MGST1;GSTM5;GSTP1
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),-0.6374556517642068,-1.012433579269085,0.5,1.0,1.0,2/8,15.46%,BRCA1;KANK2
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),0.5689121854794439,1.0123657601140341,0.42424242424242425,0.9656172685027878,1.0,3/12,13.17%,PRKD1;LIMS1;PHACTR4
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.4928602833617326,1.0123530419755127,0.41025641025641024,0.9648613923152478,1.0,2/17,7.69%,IQGAP2;ARPC3
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.45796592209050246,1.0122804877089462,0.3611111111111111,0.9642533890570565,1.0,5/31,10.94%,CA2;SLC26A3;GPR89B;SLC4A4;GPR89A
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.490194446311105,-1.0120951150658508,0.453125,1.0,1.0,3/25,2.85%,NOTUM;PTPRC;SFRP4
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.4410160638586411,1.0119295818664658,0.27586206896551724,0.9644627990797898,1.0,9/56,13.69%,TNFRSF19;MAP3K20;TAB3;MAPK8;TAB1;MAP3K10;MAP3K5;MAP2K3;BTRC
prerank,GO_Biological_Process_2021__acylglycerol acyl-chain remodeling (GO:0036155),-0.6468860493701772,-1.0118580965167374,0.46938775510204084,1.0,1.0,1/6,3.92%,DGAT2L6
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),0.6354036898574469,1.0116074958042316,0.475,0.9644417808028904,1.0,3/6,28.23%,MALT1;NFKBIZ;PRKCQ
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),-0.5452974102601637,-1.011535531831151,0.4666666666666667,1.0,1.0,4/14,12.52%,IL7;CD27;NCKAP1L;RHOH
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),-0.6650453955901426,-1.0113816878729662,0.5535714285714286,1.0,1.0,5/5,33.52%,HSP90AB1;CLU;HSP90AA1;EGR1;NAB2
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),-0.538131929172931,-1.0113290614376482,0.4153846153846154,1.0,1.0,4/19,18.07%,PTPRC;CBLC;GPRC5A;MVP
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),-0.47464683325573925,-1.0112557008059395,0.4745762711864407,1.0,1.0,4/46,5.59%,CYP19A1;CYP1B1;LDLRAP1;NSDHL
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.5699982892209857,1.0111439055388904,0.4318181818181818,0.9649328632778954,1.0,2/8,8.06%,PKDCC;SOX5
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.426638810649973,-1.0110042924386062,0.43243243243243246,1.0,1.0,19/89,19.35%,TNFSF18;STAT1;PSMB6;CD27;PSMB8;PSMA3;TMSB4X;PSMC3;BAG4;TXNDC17;LTBR;PSMC6;PSMA5;NFKBIA;ADAM17;TNFSF9;PSMA7;TNFRSF11B;PSMD12
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),0.4936479738146986,1.010915010933262,0.41025641025641024,0.9647339884701749,1.0,5/27,3.98%,ITGB5;ITGA4;DUSP5;LAMB3;DUSP2
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),-0.5361580740377719,-1.0108501519052318,0.5,1.0,1.0,4/23,11.24%,STAT1;NCKAP1L;ZNF16;INHBA
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),0.5900374623655906,1.0108004409670668,0.5208333333333334,0.9642641581568796,1.0,1/8,1.98%,NRP1
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),-0.620830787430324,-1.010781277975656,0.5,1.0,1.0,2/7,15.08%,BRK1;WAS
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),-0.5360012168418621,-1.0105804518996047,0.5,1.0,1.0,7/20,21.42%,PPP1R1B;FKBP1B;CRY2;YWHAB;PPP4R4;BOD1;PPP1R11
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),-0.646009378322746,-1.010083235830988,0.49056603773584906,1.0,1.0,2/6,8.39%,BAAT;STAT5A
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.42155399016727385,-1.0100303000557689,0.44776119402985076,1.0,1.0,21/105,13.33%,NR1I3;AMBP;EID2;FGL1;CP;AHR;BNIP3;ALDOB;TMEM97;GPC3;AQP9;ITIH2;ASGR1;UGT2B7;KNG1;LIPC;SLBP;LBP;MASP2;C3P1;HSD11B1
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),0.5437717525497441,1.0097661021894453,0.46511627906976744,0.9662658678407186,1.0,5/13,20.22%,P3H3;P3H2;EGLN3;ASPH;P3H1
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),-0.5408953162055056,-1.0096895765564529,0.45,1.0,1.0,6/14,24.78%,SLC30A8;RAB1A;LTBP4;GHRL;CAMK2G;CDK16
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.467894630964481,1.009180964803728,0.4,0.9669205929393744,1.0,7/28,11.44%,KIT;IRS1;FGFR3;PDGFRA;PRKD1;PIK3R1;WDR81
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),0.45796726852478836,1.0091178778860388,0.3333333333333333,0.9662940127307442,1.0,12/50,10.37%,KIT;ITGA4;BCL2;HDAC9;EPHB2;RABL3;CD22;RASGRP1;PRKCB;LAT2;TPD52;MALT1
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.4851590527761895,-1.0089958683801037,0.45588235294117646,1.0,1.0,8/32,26.16%,KIF9;UFM1;ULK1;MCTS1;KLC1;MTIF2;GOLGA2;GFM2
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.5593776593849998,-1.0086951754299314,0.4696969696969697,1.0,1.0,1/11,6.83%,IFI27
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),-0.6079131802468739,-1.0083543131746628,0.4423076923076923,1.0,1.0,1/8,4.70%,BNIP3
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),-0.5836102328925411,-1.0083093332380657,0.5,1.0,1.0,5/10,26.77%,LPCAT4;LPCAT3;PLA2G10;PLA2G4A;OSBPL10
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.5270062645338595,-1.0081035371132094,0.4861111111111111,1.0,1.0,9/24,26.94%,RECQL;MRE11;HMGB3;DDX1;DDX11;SUPV3L1;BLM;RAD50;RECQL4
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),0.6168996267726005,1.0080623577273453,0.5,0.9682789095116936,1.0,2/5,19.33%,HMGB1;SLC15A4
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),0.5382200906685033,1.0078486958398272,0.4090909090909091,0.9682030221098394,1.0,1/8,0.55%,PER2
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),0.5956298542331243,1.0073782575068013,0.43902439024390244,0.9670741370461458,1.0,2/8,10.54%,APOE;CEL
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),0.5956298542331243,1.0073782575068013,0.43902439024390244,0.9670741370461458,1.0,2/8,10.54%,APOE;CEL
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),0.5956298542331243,1.0073782575068013,0.43902439024390244,0.9670741370461458,1.0,2/8,10.54%,APOE;CEL
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.4545413090760164,-1.0073747906226964,0.3770491803278688,1.0,1.0,12/37,13.49%,PTPRC;PDCD1LG2;HHLA2;HLA-DPB1;IL15;NCKAP1L;AGER;CD6;IL18;CCL5;FADD;HLA-DMB
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),-0.41911322494275194,-1.0072803717783256,0.47297297297297297,1.0,1.0,12/89,11.01%,RAD54L;MCM2;POLQ;MORF4L1;GINS2;FANCM;RPA3;RAD51AP1;RECQL;XRCC1;BRCA1;MRE11
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.43256422621656243,1.0070556554718952,0.45714285714285713,0.9672584228672296,1.0,15/48,13.57%,EYA4;EGFR;SPRED1;SPRED2;SPRED3;FGF10;ERCC8;PRKCD;NACC2;BABAM2;EYA2;NSMCE1;EYA3;BRCC3;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.4265188308069325,1.006972599902691,0.4,0.9667385655088662,1.0,13/51,16.90%,EGFR;RAD51B;PLCB1;DBF4B;FGF10;LSM10;UBE2E2;CDC23;ESPL1;NSMCE2;ANAPC7;TFDP1;RCC2
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),0.6100078645585483,1.0069533188595927,0.4791666666666667,0.9660333678395512,1.0,1/6,2.32%,SLC25A37
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),0.40424089855515044,1.0069314751448675,0.48,0.965298285669247,1.0,15/67,13.45%,MCTP1;KDR;EGFR;ACKR2;MCU;PTGFR;GRM5;RCAN2;LAT2;EIF2AK3;CHRM3;MCTP2;ADGRL1;DMPK;SLC8A1
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.43076018893043594,-1.0068527790075514,0.43283582089552236,1.0,1.0,1/74,0.02%,CD44
prerank,GO_Biological_Process_2021__protein localization to non-motile cilium (GO:0097499),0.6157680099207353,1.0066558257239748,0.5263157894736842,0.965276871834377,1.0,4/6,16.09%,ARL13B;ZDHHC3;BBIP1;SPATA7
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.540326182206048,-1.0066507561527083,0.4827586206896552,1.0,1.0,2/18,16.03%,PINK1;VDAC1
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.35321329122311135,1.0064041352305042,0.4230769230769231,0.9652658098691546,1.0,13/88,13.64%,ITPR2;EGFR;PLCB1;CAB39L;PRKCB;ARPC3;SMAD2;ADCY2;MAPK8;NGF;PAK4;PPP2R1B;MAP2K3
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.42688098464196406,1.006260155676188,0.3939393939393939,0.9649867106791316,1.0,8/44,5.91%,KIT;TEAD2;KDR;KITLG;COBL;HEY1;TGFB2;PKDCC
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),-0.6041578531305706,-1.0061052668685744,0.5161290322580645,1.0,1.0,1/9,2.29%,PTPRC
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.5862086369280648,-1.0060002764993252,0.5,1.0,1.0,5/13,24.40%,IL4I1;NCKAP1L;SPINK5;PRDM1;METTL3
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.45399671018541354,1.0057142592324995,0.3333333333333333,0.9656042960581781,1.0,5/29,11.51%,MCU;IRS2;MYRIP;RBP4;GCK
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),-0.4674785892053671,-1.0054408195713336,0.5,1.0,1.0,7/41,8.98%,LAMA2;CAV3;CTF1;SMTN;TBX1;MKX;TEAD4
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),-0.565630431441786,-1.0054369015919908,0.4426229508196721,1.0,1.0,4/12,25.01%,PCARE;RP1;RP1L1;AHI1
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),-0.4699691272805007,-1.0054204736393488,0.42424242424242425,1.0,1.0,5/33,15.37%,MARVELD2;F11R;CLDN1;CLDN20;CLDN10
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),-0.6839839758488162,-1.0049732582639999,0.5932203389830508,1.0,1.0,1/5,5.85%,RAC1
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.5024113417930799,-1.0046762975939043,0.48484848484848486,1.0,1.0,4/21,15.80%,RFC5;RPA3;POLE2;PCNA
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),-0.5990236075880389,-1.0045164561759565,0.4915254237288136,1.0,1.0,1/11,8.77%,BTBD18
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),0.4025435870430295,1.0043763079105712,0.4117647058823529,0.9686295871354453,1.0,2/35,2.59%,IFI16;IFIH1
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),0.5618673114510543,1.004102607408837,0.5151515151515151,0.9686261992951284,1.0,1/12,3.99%,IDH2
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),-0.6474166825302696,-1.0040640431223493,0.5932203389830508,1.0,1.0,1/7,6.65%,BEX4
prerank,PanglaoDB_Augmented_2021__Osteoclasts,-0.42994744916935584,-1.0036062442992906,0.5384615384615384,1.0,1.0,28/89,19.53%,C3AR1;HCK;SIGLEC1;OSCAR;SLC7A7;FCGRT;AQP9;CD14;MMP19;AGER;CTSZ;RASSF4;MAFB;TLR2;PSAP;TNFAIP2;SERPINF1;F13A1;STAB1;C1QA;SERPING1;TCN2;SLC2A1;TNFRSF11B;CMKLR1;VWF;ESR1;SPP1
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),-0.6029719002567598,-1.0032916163405474,0.5333333333333333,1.0,1.0,2/7,24.50%,CCL5;IDO1
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.5940285448231865,1.0030245916327516,0.5263157894736842,0.9710174216887945,1.0,3/12,5.75%,HEY1;TGFB2;ACVR1
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.6249023152723945,1.0030182445240203,0.5319148936170213,0.970272776886353,1.0,2/5,18.77%,ACTN4;RALY
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.49098438835356945,-1.0029025424614222,0.4166666666666667,1.0,1.0,7/26,17.35%,CYP1B1;P2RY12;SERPINE1;NCKAP1L;ADAM9;LYN;SNAI2
prerank,GO_Biological_Process_2021__negative regulation of ruffle assembly (GO:1900028),0.6081870038918369,1.0028898995497382,0.5365853658536586,0.9697345265433694,1.0,1/6,2.92%,KANK1
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.47612365136890944,1.002887175148987,0.48717948717948717,0.9689818098298777,1.0,2/20,5.46%,ATP6V0D2;RAB7A
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.47552206701063093,1.0028759116335444,0.45454545454545453,0.9682405215889663,1.0,3/23,6.71%,RGS14;PDE3A;NUMB
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),0.42566397223273433,1.002590875788531,0.45454545454545453,0.9682579291610445,1.0,11/57,9.59%,ATOH8;NFIB;PTPRK;TGFB2;MCC;EREG;BRCA2;VASH1;APOE;CASK;DUSP10
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.5351569392760431,1.0024997114487486,0.43478260869565216,0.9677740946481815,1.0,3/13,5.94%,TGFBR1;DSCAML1;PDGFRA
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),-0.5818561824560151,-1.0021289103313287,0.5666666666666667,1.0,1.0,1/8,5.95%,TGFB1
prerank,GO_Biological_Process_2021__deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),0.6583092583856942,1.0020040378466923,0.5142857142857142,0.9681597913377719,1.0,2/5,23.69%,DCP1B;DCP1A
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.47921887946737135,-1.0019765473020044,0.4507042253521127,1.0,1.0,4/31,11.86%,TRIM54;TPX2;FKBP4;STMN1
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),-0.5681648187460859,-1.0019059678469564,0.4838709677419355,1.0,1.0,4/13,13.69%,CYP1B1;NQO1;ARG2;CYB5R3
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),-0.6388222134568573,-1.001883127699987,0.5483870967741935,1.0,1.0,2/6,29.48%,NAIF1;ACAA2
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),0.5735350551653344,1.0018716648286343,0.4878048780487805,0.9677584948158272,1.0,2/6,14.93%,ROBO2;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),-0.4913560707026521,-1.001789854304024,0.45588235294117646,1.0,1.0,5/34,12.31%,AMBP;FOXM1;PINK1;GSTP1;GPS2
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,0.4212211368960115,1.0017415599865291,0.3333333333333333,0.9673884413198259,1.0,11/83,7.22%,FBXL7;ADAMTS2;PRRX1;COL15A1;GEM;PCDH18;FNDC1;LAMA4;PDGFRA;SSC5D;HTRA1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),-0.522384222682703,-1.0016079654436056,0.43548387096774194,1.0,1.0,4/25,16.67%,FKBP4;STMN1;SKA2;MAP1A
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.5632443402824157,1.0015975544984914,0.5,0.9670291637946287,1.0,5/9,17.32%,HDAC9;HDAC1;SIRT2;SMARCAD1;HDAC3
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),-0.6013887701488935,-1.001536209017134,0.47368421052631576,1.0,1.0,6/9,31.01%,CHMP2B;CHMP2A;VPS4A;CHMP1A;CHMP5;VPS4B
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),-0.6013887701488935,-1.001536209017134,0.47368421052631576,1.0,1.0,6/9,31.01%,CHMP2B;CHMP2A;VPS4A;CHMP1A;CHMP5;VPS4B
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.5257482543178233,1.0013182443459252,0.4166666666666667,0.9670066812788104,1.0,4/12,13.89%,KIAA0586;CEP135;CEP120;SPIDR
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),0.500372384960089,1.0012509672189505,0.47619047619047616,0.9664548258043006,1.0,4/15,11.99%,KLKB1;MELTF;RHBDD1;BAG2
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.38883459818028776,-1.0011836743289932,0.4307692307692308,1.0,1.0,18/111,11.98%,CD44;CD4;PTPRC;CD74;NODAL;P2RY1;ATP6AP1;NOTCH1;TGFB1;PRXL2C;CALCR;SCIMP;AGER;GPER1;PDGFRB;CCL5;ROR1;HTR2B
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.390617574563925,1.0011656752633284,0.45454545454545453,0.9658936589537206,1.0,19/114,9.52%,LRIG3;ITGB5;LAMB2;EGFR;RORA;SLC16A2;UNC13B;SLC7A2;TSPAN12;ADGRL2;PKDCC;DDAH1;CHKA;GALNT18;GNG12;PLIN5;CLDN12;CAP2;AMOTL2
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.6355110184528181,-1.0009432028654646,0.5,1.0,1.0,3/9,21.72%,RPS21;ERI2;EXOSC8
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.456784531835245,-1.0008836406545398,0.45588235294117646,1.0,1.0,15/50,23.61%,NDUFB9;TMEM126B;NDUFA2;NDUFB3;NDUFC1;NDUFB2;NDUFS2;NDUFB4;DMAC1;NDUFAB1;NDUFA1;NDUFB11;NDUFS5;NDUFB10;NDUFA3
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.456784531835245,-1.0008836406545398,0.45588235294117646,1.0,1.0,15/50,23.61%,NDUFB9;TMEM126B;NDUFA2;NDUFB3;NDUFC1;NDUFB2;NDUFS2;NDUFB4;DMAC1;NDUFAB1;NDUFA1;NDUFB11;NDUFS5;NDUFB10;NDUFA3
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.4505407742395307,1.0008448979746614,0.4772727272727273,0.9659534351133712,1.0,6/32,4.35%,NRG1;SGCD;BMP7;SGCZ;HEY1;MAML1
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.5214335324886624,1.0006542367390876,0.5476190476190477,0.9657693472348244,1.0,5/14,13.45%,SLC12A3;SLC12A1;SCNN1B;NEDD4L;SLC8A1
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.43685575294284607,1.0005071939648236,0.5,0.9653115174684145,1.0,10/35,12.80%,LEF1;HEY1;MAML1;JAG1;NUMB;PTCH1;FZD1;GNAI1;DVL2;JAG2
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),-0.644281042975051,-1.0002110470257053,0.4827586206896552,1.0,1.0,3/6,15.77%,GOT1;CALCR;ADAM9
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.503819819414604,-1.0001133184270827,0.5081967213114754,1.0,1.0,6/23,24.42%,KIF14;STMN1;VIL1;CFL1;TWF2;CFL2
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),0.34106372262420265,0.9999127720401118,0.3870967741935484,0.966040933578958,1.0,27/190,7.43%,TPD52L1;ROR2;KIT;NPNT;PDGFD;F2RL1;PELI2;KDR;NRP1;EGFR;C5AR1;FGFR4;SLC30A10;FGFR3;CSF1R;TGFB2;PDGFC;WWC1;PDGFRA;SEMA4C;FGF10;APOE;RASGRP1;PIK3R6;HMGB1;IGF1;MID1
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.37839359787562443,0.9998928850189649,0.4074074074074074,0.9653302690386798,1.0,18/103,11.22%,NOX4;PTPRK;EGFR;PRR5L;GPX7;FOS;PDGFRA;AKR1C3;PRKCD;HSPA1A;VKORC1L1;AGAP3;EIF2S1;PRKD1;ETV5;ERCC6L2;MAPK8;FOXO1
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),-0.4824744312671923,-0.9997233158075309,0.4507042253521127,1.0,1.0,5/31,11.34%,FIP1L1;CSTF2T;NCBP2;SLBP;NCBP1
prerank,PanglaoDB_Augmented_2021__Leydig Cells,-0.40997810827437875,-0.9995169202662803,0.5,1.0,1.0,27/105,16.47%,PRLR;LAMA2;CYP19A1;EPAS1;TIMP3;ANGPTL2;ACSBG1;RARRES2;ALDH1A1;F10;ADGRF5;IGFBP5;ADAM21;HSD11B2;EFEMP1;INHBA;MAFB;DHCR7;SPARCL1;PLSCR4;YAP1;CXCL14;PLAUR;NR5A2;KIAA1217;CFD;SERPING1
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.38961477971203146,0.9995035469347768,0.4375,0.9655725106339423,1.0,20/79,14.48%,MYO3A;LEF1;BMP7;VASH2;FRAS1;TOX3;IGDCC3;UNC5D;LIN28B;IL17RD;EPHA7;PHF21B;CRABP1;GRID2;TRIM71;GABRB3;MEX3A;SEMA5B;EPHA8;CNTNAP2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),-0.6339886937393243,-0.998876505055254,0.5272727272727272,1.0,1.0,2/7,8.70%,PDCD1LG2;AGER
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),-0.6865886977436262,-0.9987919459013151,0.5645161290322581,1.0,1.0,1/5,3.11%,LRPAP1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.6036634273946235,-0.9987222022541884,0.5081967213114754,1.0,1.0,1/10,1.77%,CYP1B1
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.4668301737479309,0.9986774219854452,0.4411764705882353,0.967038616471397,1.0,3/22,4.59%,HORMAD1;DIAPH2;MDK
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),0.6842811768245974,0.9983206894237324,0.4666666666666667,0.9671376191199119,1.0,2/5,19.31%,ROBO2;ROBO1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.45178532139111705,0.9982316710117505,0.425,0.9666202461012083,1.0,2/19,1.51%,RUNX1;LEF1
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.40225663006495826,-0.9980508758400382,0.45454545454545453,1.0,1.0,45/163,24.67%,RPL36;RPL15;RPL38;RPS7;RPL37A;RPL9;RPL28;RPLP2;NOB1;RPL5;RPL35A;EMG1;EXOSC6;DDX54;RPLP1;NAT10;RPL8;RPL4;RPL22;RPL27A;WDR12;RPL24;RRP15;EIF6;RPS15;KRR1;RPL34;RPL3;RPS24;SBDS;UTP11;EXOSC8;RPL13A;RPL27;RPL37;RPL7A;LAS1L;NOP56;NSA2;RPL35;WDR55;RPL23;RPL32;IMP4;UTP15
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.42257930384636994,-0.9979561638193262,0.47761194029850745,1.0,1.0,11/88,7.62%,AMBP;C17ORF99;OSCAR;B2M;FGL1;AHR;IL4I1;CD300LF;IRF1;IL15;CASP8
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),0.5148200429986143,0.9977878698108033,0.47619047619047616,0.9670424331364958,1.0,4/12,25.99%,PARP10;PARP6;PARP3;TNKS
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.3560520248086036,0.997775241617325,0.3076923076923077,0.9663342937414842,1.0,27/153,12.16%,ETV1;CA2;PRRX1;GALNT3;F2RL1;CIDEA;ZNF277;NRP1;CAB39L;HDAC9;ALDH1A2;EPHB2;EREG;BTC;TRIB2;PTBP2;IL1RL2;GABRA3;LAT2;ETV5;CROT;RBP4;TPH1;GUCY1A1;ANKH;NGF;PRKG2
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.5029558273378893,0.9975326833444731,0.45,0.9664637705301551,1.0,2/12,9.91%,REEP1;ATL2
prerank,GO_Biological_Process_2021__T cell apoptotic process (GO:0070231),-0.6806681085797758,-0.9974985862779113,0.5882352941176471,1.0,1.0,1/5,8.28%,GLI3
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),0.5679915167069247,0.997349433982375,0.45652173913043476,0.9663110654818505,1.0,4/8,24.07%,OTUD3;OTUD7B;OTUD7A;OTUB2
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.49243916091638607,0.9973402929251464,0.38235294117647056,0.9655950683278768,1.0,6/24,14.93%,TGM1;EREG;JAG1;AKR1C3;CERS3;WNT5A
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),0.4869649822287867,0.9971780067990511,0.3888888888888889,0.9652421645437638,1.0,2/16,8.40%,KCNB2;TNNC2
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),-0.5797502901040587,-0.9968090549734581,0.4262295081967213,1.0,1.0,3/9,31.43%,TWIST1;RPS6KA4;AKAP8L
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.5381648053352559,-0.996586158067777,0.47540983606557374,1.0,1.0,3/12,8.66%,FKBP1B;ATP1B1;ATP1A1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),-0.5654108736096347,-0.9965573299807627,0.509090909090909,1.0,1.0,2/11,10.49%,ELANE;TMSB4X
prerank,GO_Biological_Process_2021__telencephalon cell migration (GO:0022029),0.6512771561054931,0.996395305027111,0.5833333333333334,0.9664170221546062,1.0,1/5,2.61%,FGF13
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),0.5540936701279814,0.9962806123916021,0.45652173913043476,0.9660238699259327,1.0,4/9,21.42%,MDK;FUT9;PPARA;MIA3
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),0.5938794130293352,0.9962519030536032,0.5277777777777778,0.9653905547224859,1.0,4/6,38.99%,JADE3;KAT7;JADE1;JADE2
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.5154741917362924,-0.9962196556737467,0.4927536231884058,1.0,1.0,4/22,19.78%,BTBD18;ALYREF;SUPT5H;THOC5
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),0.4881148572102469,0.9961807493943561,0.47058823529411764,0.9648785053919242,1.0,2/13,6.02%,ENPP1;ENPP3
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.5312214693994103,-0.9961417125781714,0.546875,1.0,1.0,2/16,9.22%,LDLRAP1;IGFBP5
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.6011543079018415,-0.9959104496332496,0.5357142857142857,1.0,1.0,1/7,8.83%,BCAT2
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.669059482807511,0.9958744193784373,0.5365853658536586,0.9647979565975349,1.0,1/7,1.40%,F2RL1
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.4532703662844347,0.9957870798122932,0.358974358974359,0.9642771400727265,1.0,7/27,18.42%,LEF1;HDAC1;TLE2;EP300;BCL9;SMARCA4;CREBBP
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.4440117683192453,0.9957022020082322,0.5,0.9637271193130477,1.0,15/41,16.47%,BMP6;BMP7;TGFB3;ENPP1;GREM1;ACVR1;PKDCC;NELL1;SRGN;ANKH;ANO6;SLC8A1;GPM6B;MEF2C;BMP2K
prerank,PanglaoDB_Augmented_2021__T Cells,-0.41505543012370727,-0.9955981248434029,0.4647887323943662,1.0,1.0,19/73,12.52%,GNLY;CD4;ITK;PTPRC;ARHGAP9;GMFG;JUNB;TXK;FMNL1;THEMIS;CD6;IFIT3;TAGAP;CCL5;IL18R1;SEPTIN1;TCF7;GBP5;RHOH
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),0.6080829680337106,0.9954921334139943,0.475,0.9634977356084068,1.0,3/8,22.49%,TSFM;MTG2;SHMT2
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.5288601164080675,-0.9952675214132244,0.46551724137931033,1.0,1.0,3/16,11.70%,ZFPM1;INHBA;MAFB
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.3635011513573454,0.9944713344390367,0.4,0.9654556128973941,1.0,28/149,11.76%,GNG4;PENK;LRRTM3;GRIA4;RAB3C;CTNNA2;PCBP3;OLFM3;ADGRA1;GRIA2;GRM5;HCN1;TSHZ1;BRINP1;TMEM196;NRXN1;CADM2;SHANK2;PAK5;RBFOX1;DLGAP1;MMD2;SLC6A1;ADGRB3;SEZ6L;GRID2;ST8SIA3;SLC24A3
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.4947040731058583,0.9944549476214863,0.45161290322580644,0.9648061708149749,1.0,2/23,7.19%,EPHA5;EFNA5
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),-0.5943338212970197,-0.9943367957795306,0.5087719298245614,1.0,1.0,2/9,7.92%,ETV4;PRKCH
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),-0.5371626751372565,-0.9942964545767202,0.43103448275862066,1.0,1.0,2/19,4.04%,UROD;ATP5IF1
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),0.6294626124084183,0.994067764918881,0.46511627906976744,0.9649354298897094,1.0,2/7,20.90%,BYSL;NVL
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.6122583354898564,-0.9938969047964169,0.5166666666666667,1.0,1.0,1/8,3.27%,ITGA5
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.46876134643128753,-0.9938029709150153,0.4264705882352941,1.0,1.0,6/39,11.05%,TARS3;NARS1;PPA1;EPRS1;IARS2;WARS1
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),-0.6178205228386546,-0.9937137336170315,0.6,1.0,1.0,2/7,15.45%,B2M;ATP2A3
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.5847632963926397,-0.9937054784386425,0.5362318840579711,1.0,1.0,2/10,11.57%,BCAP31;TMEM30A
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.5449806334506039,-0.9936778841652739,0.5492957746478874,1.0,1.0,3/18,12.25%,CPNE5;SYT2;SYT4
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),0.6012463089361134,0.9936708001893904,0.5128205128205128,0.964466613307164,1.0,3/8,19.05%,LYPLA2;ABHD17A;ABHD17C
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),0.6012463089361134,0.9936708001893904,0.5128205128205128,0.964466613307164,1.0,3/8,19.05%,LYPLA2;ABHD17A;ABHD17C
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.4643115281606495,0.9933767004207119,0.46875,0.9644764622871961,1.0,3/19,6.93%,RGS14;ADA;RPGRIP1L
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.5123550976810783,0.9931080944623529,0.4857142857142857,0.9644365953126616,1.0,3/16,9.96%,ELOVL6;HACD2;TECR
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),0.564964400600538,0.9930690426654146,0.48936170212765956,0.9638306303680935,1.0,1/11,3.80%,GAS2L3
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.50785789327027,-0.9928376175909756,0.5373134328358209,1.0,1.0,7/21,12.20%,DUOX1;P2RY12;TGFB1;RARRES2;PDGFRB;NTN1;TRIM32
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.4831493659144991,-0.9927782458144515,0.4032258064516129,1.0,1.0,3/23,11.58%,B2M;HLA-A;FADD
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),0.5111353950517568,0.9926693180952609,0.45454545454545453,0.9641883177832627,1.0,3/11,14.37%,SLC22A13;GCK;EP300
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.4557982148427085,-0.9926594828247642,0.5423728813559322,1.0,1.0,6/34,5.73%,PTGIS;CYP1B1;EPHX1;PTGES;ALOX12;ALOXE3
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),-0.5923852332493423,-0.9926473537499543,0.5,1.0,1.0,2/8,20.10%,PEX16;PEX1
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.4672001054787056,0.9924117188132605,0.45454545454545453,0.9641983485742566,1.0,10/21,23.68%,DPY19L1;TMTC2;CRPPA;DPM3;TMTC1;FKTN;DPM2;LARGE1;FKRP;DPM1
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),-0.44165691344113894,-0.9921680776491515,0.5230769230769231,1.0,1.0,7/64,11.95%,ROPN1B;CHMP4B;RASA1;SEPTIN14;NOX5;STMN1;SEPTIN1
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.3882460136967506,0.9920331476906398,0.4074074074074074,0.9645552123445311,1.0,6/107,2.65%,RUNX1;LRIG3;LAMB2;WWTR1;EGFR;KITLG
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.4693165770229932,0.9919635640397462,0.45,0.9640203160387271,1.0,3/15,5.21%,MAML3;MAML1;WWC1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.4067730459536813,0.9919222801624545,0.3333333333333333,0.963407072825595,1.0,10/77,7.33%,EPHA3;EPHA5;IQGAP2;CSF1R;MDK;PDGFRA;ESAM;PRKCD;EFNA5;PEAK3
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),-0.5842785596531253,-0.9917879182014903,0.5,1.0,1.0,1/8,5.69%,KCNQ1
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),-0.5842785596531253,-0.9917879182014903,0.5,1.0,1.0,1/8,5.69%,KCNQ1
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.5836580830413955,0.9916494213636651,0.47368421052631576,0.9633286793893778,1.0,3/12,5.75%,HEY1;TGFB2;ACVR1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.4108777716675882,0.9914162297849193,0.375,0.9630824465779156,1.0,14/62,13.45%,ALG8;GAL3ST1;MOGS;OSTC;MGAT4C;B4GALNT2;MPDU1;ALG12;ST3GAL1;DERL3;ALG13;MAGT1;UGGT2;DPM3
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),-0.5388832259042868,-0.9913898369919839,0.46551724137931033,1.0,1.0,2/17,4.04%,UROD;ATP5IF1
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),0.6214804396554885,0.9913784598800488,0.46153846153846156,0.9624614351946358,1.0,3/7,10.50%,FGGY;RPEL1;DCXR
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.4875550718731697,0.9911031241720183,0.47619047619047616,0.9624332603325414,1.0,1/19,0.59%,IFI16
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),-0.5467920033689365,-0.9908615633273586,0.4909090909090909,1.0,1.0,2/17,7.99%,UPB1;DPYS
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),-0.48108264388634403,-0.990633296732074,0.46875,1.0,1.0,2/25,3.43%,OMG;LRP4
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.542967175438774,0.990529830999752,0.47619047619047616,0.9630261491032227,1.0,2/10,7.50%,GCH1;NRXN1
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.46355555099464163,0.9905253381623197,0.4444444444444444,0.9623080882072227,1.0,2/29,3.58%,ZBED3;PLCB1
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.5425462606798117,0.9902572834268777,0.4666666666666667,0.9622899355923104,1.0,11/17,20.73%,LRRTM3;IL1RAPL1;NLGN1;FZD1;CEL;WNT5A;BSN;NLGN4Y;PTEN;PCLO;PTPRD
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.4740954890676036,0.9900805581984947,0.47368421052631576,0.9620259314399237,1.0,7/14,27.33%,PLIN5;SCARB1;PNPLA2;NR1H3;APOA1;LDLR;NR1H2
prerank,GO_Biological_Process_2021__positive regulation of activin receptor signaling pathway (GO:0032927),-0.6265588788581828,-0.989590518632581,0.5,1.0,1.0,1/5,3.68%,NODAL
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.4594823298444816,-0.9895250614880833,0.49206349206349204,1.0,1.0,8/33,10.66%,ELANE;LDLRAP1;STAT1;NOX1;IGFBP5;PDGFRB;IL18;CCL5
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.5758471844212245,-0.9894882576772509,0.532258064516129,1.0,1.0,2/10,15.47%,EMC1;EMC3
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),-0.6110689378267021,-0.989472291176788,0.5409836065573771,1.0,1.0,3/6,27.57%,ATPAF2;ATPAF1;OXA1L
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),-0.43419903680963373,-0.9893881254402422,0.417910447761194,1.0,1.0,14/52,24.46%,WIPI1;RAB19;MAP1LC3B2;MAP1LC3B;RAB23;ULK1;GABARAPL2;RAB1A;ATG16L2;ATG3;GABARAPL1;RAB1B;ATG14;TMEM41B
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.442761120792984,0.9893092200724279,0.4,0.9635411464859971,1.0,11/36,24.67%,MEX3D;KHSRP;TRIM71;RC3H1;CELF1;FTO;DCPS;ZFP36L2;DIS3L2;ROCK2;ZFP36
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.38722671647561924,-0.9892642672097497,0.43243243243243246,1.0,1.0,23/137,15.29%,C4BPB;UROD;POLE3;CCNE1;MSX1;EPHX1;GGH;JUNB;ABCB1;IRF1;FKBP4;SOD2;TST;GRINA;PDAP1;PSMC3;CNP;DNAJA1;ENO2;DNAJB1;SELENOW;ATP6V1C1;SLC25A4
prerank,PanglaoDB_Augmented_2021__Ionocytes,-0.4160734139072688,-0.9885636235303201,0.463768115942029,1.0,1.0,21/67,19.23%,FUT2;CCDC60;TEX26;DNAH3;IL20RA;VWA2;ATP1B1;MROH9;MYO5B;TFCP2L1;MUC4;WFDC2;APOBEC4;ATP12A;EXPH5;CXCL17;SNTN;SHROOM3;DNAH7;DNAH9;SPAG17
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.6092980816317691,-0.9881947874790422,0.5192307692307693,1.0,1.0,5/7,29.88%,NANOG;RTF1;PAF1;POU5F1;CTR9
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.42425396466936377,0.9877649836326323,0.42105263157894735,0.9665565890191031,1.0,7/23,19.79%,SYNJ2;NLGN1;CEL;SYT1;NLGN4Y;OPHN1;PIP5K1C
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),-0.5089648036255143,-0.9877296284446475,0.4852941176470588,1.0,1.0,4/23,8.28%,HHIP;GPC3;RFX4;GLI3
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.45583953279794465,0.9877094714849194,0.5333333333333333,0.9659759543552557,1.0,5/34,8.59%,PDGFD;RASSF2;PDGFC;ENPP1;EPHA7
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.41736214382683173,-0.9877083254867723,0.5,1.0,1.0,25/80,14.13%,MS4A6A;TEX26;CLIC6;ANKUB1;OMG;SLCO2B1;CD74;CP;ADAM28;FGL2;SOD2;CD302;ALDH1A1;HLA-DPB1;AQP9;ALDH2;CD14;FAM20A;L3MBTL4;CPM;RASSF4;HVCN1;HLA-DMB;FMO5;CLMN
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.34458495311990184,0.9875684932142189,0.47368421052631576,0.9655432768206466,1.0,50/371,10.10%,NRG1;POU6F2;TBX6;MYLIP;WWTR1;VCAN;ZEB2;FGF13;CNTN6;TGFBR1;KLK6;SDK1;SEMA5A;DSCAM;ATXN1;VLDLR;MDK;CRIM1;APBA1;ALDH1A2;EPHB2;PDGFC;DSCAML1;FAT4;NAV3;CNTN4;RITA1;LSAMP;JAG1;CHD7;GRIK1;ZC4H2;EFNA5;TRPC5;NRXN1;C3ORF70;NLGN1;PSPN;GFRA1;IGF2BP3;SHANK2;RYK;ERBB4;DCHS1;POU3F1;RBFOX1;NELL1;MTR;CHRM3;ROBO2
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),0.4229359547186136,0.9875010913993766,0.35,0.9650622590127987,1.0,5/36,16.46%,PCM1;DYNLRB2;WDR35;TRIP11;IFT74
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),-0.5870290751243097,-0.9874124460589866,0.5671641791044776,1.0,1.0,4/10,31.33%,ROMO1;TIMM8A;TIMM22;TIMM8B
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),-0.5227742486207959,-0.9873388251799602,0.4098360655737705,1.0,1.0,7/15,19.94%,ZNF703;SSTR1;GPER1;FAM210B;KAT5;ESR1;H2AZ1
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.5193414847823901,0.9871684677615268,0.5,0.9651400408339885,1.0,2/15,3.18%,SOX13;BMP7
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.3350844572466683,0.9871501949113262,0.4117647058823529,0.9644448116374811,1.0,42/332,8.48%,NRG1;TBX6;CDH13;PID1;PDGFD;TOX;IRS1;LEF1;KDR;WWTR1;BCL2;EGFR;C5AR1;KITLG;FGFR4;TGFBR1;S100A13;BMP6;GRK5;FGFR3;CSF1R;MDK;DBF4B;TGFB2;PTGFR;PDGFC;TGFB3;EREG;BTC;GREM1;MEIS1;TNFRSF11A;PDGFRA;FGF10;AKR1C3;IGF1;PTPN6;PKHD1;HDAC1;TET1;SHANK2;IRS2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.5246806414702996,-0.9871119002338983,0.4915254237288136,1.0,1.0,3/18,9.08%,ITGA5;TMEM204;DAB2IP
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.551975664800712,-0.9870946783349878,0.45901639344262296,1.0,1.0,4/15,18.73%,RPS27L;ABT1;ERAL1;RPS15
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.5397969889039409,-0.9869866459818263,0.5076923076923077,1.0,1.0,9/14,36.86%,CD160;CEACAM1;DUSP3;EZR;PTPN22;PHPT1;LAPTM5;PRNP;SLA2
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),-0.6443762520384618,-0.9868649081398171,0.5245901639344263,1.0,1.0,3/7,15.31%,F11R;CCL5;PLAUR
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),0.4168943636691265,0.9868138951653984,0.4074074074074074,0.9647282387259887,1.0,3/29,5.96%,MTHFS;DGLUCY;DDAH1
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.4508160699846331,0.9860869380546257,0.38235294117647056,0.9657048259255839,1.0,5/17,16.54%,RNF2;PCGF1;RYBP;PCGF6;RING1
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.41791700740153576,0.9858140110410972,0.4444444444444444,0.9657526089113553,1.0,12/41,21.41%,EGFR;LIN28B;HSPA1A;U2AF2;PIK3R1;PNPT1;ZC3H18;SIRT7;NFKB1;SETX;RIOK1;RELA
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),-0.6248621928603572,-0.9855164135615272,0.5245901639344263,1.0,1.0,4/6,37.41%,SLC38A5;SLC38A2;SLC38A3;SLC1A4
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),0.5244891430481239,0.9855019832871573,0.4857142857142857,0.9657613036480602,1.0,6/13,13.00%,GCH1;APOE;S100A1;SCARB1;NOS1AP;DHFR
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),0.6175058378725315,0.9854637376968323,0.5217391304347826,0.9651266910449262,1.0,1/5,9.32%,CEP135
prerank,GO_Biological_Process_2021__glycosylceramide metabolic process (GO:0006677),0.6397760007921988,0.9854207031844504,0.5319148936170213,0.9645222458381242,1.0,2/5,5.33%,GAL3ST1;GLA
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),-0.5463063760285447,-0.9851034047886559,0.5492957746478874,1.0,1.0,3/17,12.25%,CPNE5;SYT2;SYT4
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),-0.5919631440662256,-0.9849420807494217,0.5172413793103449,1.0,1.0,4/7,30.24%,EXOSC6;HSPD1;RNF168;RNF8
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),-0.5303272320069219,-0.9849184505326729,0.49206349206349204,1.0,1.0,3/21,5.95%,NOTUM;NOTCH1;TGFB1
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),-0.5109502680683284,-0.9848591057787549,0.5076923076923077,1.0,1.0,7/18,24.61%,BRCA1;MRE11;RBBP8;KAT5;RNF138;BLM;RAD50
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),-0.6579430731000175,-0.9847125107682912,0.5892857142857143,1.0,1.0,2/6,26.64%,PLCG2;AKT1
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.43858818429649504,0.9845481056721958,0.40476190476190477,0.9660208857460368,1.0,4/34,5.06%,DOCK10;PHACTR1;CTNNA2;EPHB2
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.4343893736724664,0.98428997758848,0.5526315789473685,0.9660488044466292,1.0,7/30,10.77%,PDE3A;GLP1R;EPHA5;PDE4D;APOE;CAP2;ADCY2
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.46899651518840835,0.9841820011132932,0.4117647058823529,0.965522766317964,1.0,2/19,8.87%,LRRTM3;SLC2A13
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.48030443002502216,-0.9841206745802837,0.48333333333333334,1.0,1.0,3/31,9.72%,POLQ;CGAS;OTUB1
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),-0.6462365640854332,-0.9840080060689259,0.5573770491803278,1.0,1.0,1/6,2.83%,GOT1
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),0.49566220405474803,0.9837503097126401,0.5526315789473685,0.9657646471074712,1.0,1/15,1.34%,IRS1
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),-0.49145428641111355,-0.9836006712822181,0.5084745762711864,1.0,1.0,4/24,12.59%,LAMA2;F11R;CLDN1;TJP3
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),0.4896017700645041,0.9833088479915653,0.47058823529411764,0.9662196411357858,1.0,3/19,6.73%,F2RL1;EPHB2;APOE
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),-0.6306054079721148,-0.9832755629004077,0.4745762711864407,1.0,1.0,2/6,21.59%,SFXN3;SLC38A5
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.40722920853374694,0.9831052739093614,0.4857142857142857,0.9660437103662936,1.0,5/65,2.19%,ITGB5;FHDC1;PHACTR1;TMOD4;PDLIM1
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),-0.5431192264418891,-0.9828988132635498,0.5555555555555556,1.0,1.0,5/14,18.32%,ATP1B1;ATP6AP1;ATP1A1;ATP12A;LACC1
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.5801347138779935,-0.9827353821948294,0.5636363636363636,1.0,1.0,3/10,15.77%,ADGRB1;FLOT1;ADAM9
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),0.33790209706834584,0.9827105324429448,0.4166666666666667,0.9665268870710173,1.0,32/163,9.59%,ROR2;NPNT;PDGFD;RGS14;F2RL1;KDR;NRP1;EGFR;C5AR1;SPRED1;FGFR4;SLC30A10;SPRED2;FGFR3;CSF1R;SPRED3;EPHB2;PDGFC;SPRY3;PDGFRA;FGF10;APOE;RASGRP1;HMGB1;PTPN6;PKHD1;DUSP4;EPHA7;FAM83D;ANGPT1;ERBB4;DUSP10
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.39209457242185175,0.98262351479606,0.4583333333333333,0.966031492968433,1.0,8/55,8.91%,PCM1;BMP6;UNC13B;PRR5L;TGFB2;TGFB3;IGF1;TPR
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),-0.5964922267658396,-0.9825356608395815,0.4838709677419355,1.0,1.0,3/8,21.57%,AGER;LYN;GRN
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),0.6219990015998277,0.98253297617751,0.5714285714285714,0.9655658579893015,1.0,1/5,3.99%,IDH2
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),0.5153898426520698,0.9823991790924389,0.5526315789473685,0.9651492505980298,1.0,1/13,0.61%,PID1
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),0.42360924282749557,0.9823900869387099,0.375,0.964472435982895,1.0,3/80,0.96%,FBXL7;CDK2AP2;GFI1B
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),-0.5991038611975592,-0.9822822209706576,0.576271186440678,1.0,1.0,3/6,16.94%,CHAF1A;HAT1;CHAF1B
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),-0.5991038611975592,-0.9822822209706576,0.576271186440678,1.0,1.0,3/6,16.94%,CHAF1A;HAT1;CHAF1B
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.4026181695953105,-0.9822163523626813,0.4935064935064935,1.0,1.0,17/167,8.53%,CD44;MMP26;LAMA2;HSPG2;ADAMTS4;COL9A1;MMP15;ITGA5;FBLN5;ECM2;LAMA1;COL6A1;F11R;ADAMTS18;SERPINE1;MMP19;COL19A1
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.4018687200900279,-0.9822029180126159,0.48717948717948717,1.0,1.0,17/167,8.53%,CD44;MMP26;LAMA2;HSPG2;ADAMTS4;COL9A1;MMP15;ITGA5;FBLN5;ECM2;LAMA1;COL6A1;F11R;ADAMTS18;SERPINE1;MMP19;COL19A1
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.4469179766689016,0.9821888518082523,0.48,0.964144132954621,1.0,10/30,21.23%,FGFR4;XRCC4;MAPK8;PHACTR4;NCSTN;B3GAT3;CHTOP;ABL2;ABL1;APOA1
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.4232391184224261,0.982111048267232,0.42857142857142855,0.9636812736231064,1.0,7/76,3.40%,FBXL7;LAMB2;PRRX1;SVEP1;PCDH18;NTM;LAMA4
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.42624125851071404,0.9820446781348668,0.47058823529411764,0.963170905268061,1.0,5/40,6.76%,EGFR;SLC30A10;EREG;BTC;SHC3
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.5344050519030544,0.9819465680502427,0.47058823529411764,0.9626998178232089,1.0,2/10,9.08%,PKP2;BIN1
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),0.6136182675961676,0.9819461286385158,0.5476190476190477,0.9619888135264414,1.0,3/6,16.59%,ABCC11;SLC25A33;ABCC5
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),0.514959538873136,0.9819347222205519,0.5,0.9612788586825104,1.0,1/14,1.51%,LEF1
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),-0.6316528400987517,-0.9819056517370135,0.546875,1.0,1.0,3/5,36.01%,TRAPPC11;RAB3A;TMEM167B
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.5544644899265803,0.9816404491456108,0.5,0.9613483862788516,1.0,2/11,6.63%,ITGA4;AKR1C3
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),-0.6115195174726928,-0.9813474556597825,0.5576923076923077,1.0,1.0,1/7,5.59%,PEX11B
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),-0.6463343500968466,-0.9813045970428476,0.5483870967741935,1.0,1.0,2/8,19.27%,TGFB1;RGCC
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.5318856961691008,0.9812704063153992,0.5151515151515151,0.9615522566287239,1.0,2/11,12.83%,CROT;CPT1A
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.5178870233751742,0.9812253023607835,0.475,0.9609689417034002,1.0,3/16,10.10%,NRP1;TGFBR1;ROBO2
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.3966443113593353,-0.9812047740679855,0.5362318840579711,1.0,1.0,18/126,10.39%,CD44;BIK;BCL2L2;GADD45B;TIMP3;CCND2;H1-0;IRF1;TIMP2;SOD2;CASP8;CD14;ISG20;BCAP31;PDGFRB;RETSAT;IL18;BRCA1
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),0.5708024213355164,0.9811741888259083,0.574468085106383,0.9603673070300704,1.0,2/5,7.04%,LGALS1;HMGB1
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),-0.5342266120380337,-0.9810747830597071,0.5333333333333333,1.0,1.0,2/19,1.39%,KCNE2;SCN4B
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),-0.6109475932562897,-0.9809782769053437,0.5357142857142857,1.0,1.0,2/8,5.95%,NOTCH1;TGFB1
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),-0.5761656807421668,-0.9808526799184428,0.5409836065573771,1.0,1.0,5/9,25.93%,BNIP3;VPS35;ATG3;DNM1L;BAX
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.43058546442124546,0.9807064849154403,0.43333333333333335,0.9610122232021369,1.0,8/36,14.38%,MAML3;MAML1;TGFB2;JAG1;ROBO2;JAG2;EP300;EPN2
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.4367753127209648,-0.980632317152021,0.46875,1.0,1.0,14/50,24.46%,WIPI1;RAB19;MAP1LC3B2;MAP1LC3B;RAB23;ULK1;GABARAPL2;RAB1A;ATG16L2;ATG3;GABARAPL1;RAB1B;ATG14;TMEM41B
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),0.5380896628136743,0.9806285592542205,0.5,0.9605359159174092,1.0,6/14,15.47%,NEK6;PTTG1;TPR;CDC23;HECW2;ANAPC7
prerank,GO_Biological_Process_2021__lens fiber cell differentiation (GO:0070306),-0.6256185764468952,-0.9805369882009574,0.515625,1.0,1.0,2/6,10.40%,WNT7B;BFSP1
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,0.39321035541604277,0.9800842660420197,0.28,0.9612276011623427,1.0,13/120,5.94%,FBXL7;ABI3BP;PRRX1;SVEP1;COL15A1;PDE3A;LEF1;PCDH18;LAMA4;CRIM1;FAT4;MAP3K20;PDGFRA
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),-0.6348293046759906,-0.98007194957262,0.5384615384615384,1.0,1.0,3/5,28.21%,MAFB;HSPA9;LDB1
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.6007748616280106,-0.9800351365875206,0.5094339622641509,1.0,1.0,3/7,15.78%,XRCC1;WARS1;HPF1
prerank,GO_Biological_Process_2021__SA node cell to atrial cardiac muscle cell signaling (GO:0086018),-0.6206657092222175,-0.9799143061977371,0.5094339622641509,1.0,1.0,2/5,16.85%,CACNA1G;HCN4
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.4306650370525925,0.9797576270984044,0.5135135135135135,0.9612107606817124,1.0,13/46,17.85%,IRS1;PLCB1;CSF1R;PDGFRA;IGF1;IRS2;PIK3R1;NGF;FGFR1;ADAP2;PLCB4;PLCL2;PIK3C2B
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),-0.522011675002046,-0.9796185368775822,0.5294117647058824,1.0,1.0,4/16,16.72%,CHMP4B;CHMP2B;CHMP2A;EML3
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),-0.664364891137529,-0.9793510408551475,0.5660377358490566,1.0,1.0,3/5,24.28%,IL4I1;FAH;GSTZ1
prerank,GO_Biological_Process_2021__L-phenylalanine catabolic process (GO:0006559),-0.664364891137529,-0.9793510408551475,0.5660377358490566,1.0,1.0,3/5,24.28%,IL4I1;FAH;GSTZ1
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),-0.5249649900503307,-0.979312135889952,0.546875,1.0,1.0,3/16,20.73%,WIPI1;ULK1;ATG3
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.5124835397892378,-0.9789988294838545,0.46875,1.0,1.0,9/22,17.35%,ELANE;CD74;IL7;AGER;SIGIRR;IL18;TLR2;ADAM17;SNAI2
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.5603101162709039,-0.9788542302134334,0.5342465753424658,1.0,1.0,3/14,5.07%,DUOX1;P2RY1;STAT1
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.48323070450874717,0.9787566380351711,0.47058823529411764,0.9632862592848332,1.0,2/16,13.33%,KANK1;RIPOR2
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.5655629401401909,0.9787491074729004,0.5714285714285714,0.9626187428566256,1.0,2/7,17.03%,FOXO1;RFX3
prerank,GO_Biological_Process_2021__response to catecholamine (GO:0071869),0.5998663281868606,0.9787289281651473,0.55,0.9612389749454132,1.0,3/5,39.61%,DRD1;NR4A3;GNG2
prerank,GO_Biological_Process_2021__cellular response to monoamine stimulus (GO:0071868),0.5998663281868606,0.9787289281651473,0.55,0.9612389749454132,1.0,3/5,39.61%,DRD1;NR4A3;GNG2
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.5344324780333326,-0.9783494497881261,0.5384615384615384,1.0,1.0,1/17,0.64%,CSRP3
prerank,GO_Biological_Process_2021__regulation of digestive system process (GO:0044058),0.6128968005732469,0.9782840440037498,0.5641025641025641,0.9616603842298449,1.0,2/6,6.24%,SGK1;FGF10
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.5234178069317053,-0.9781239207836181,0.5454545454545454,1.0,1.0,4/15,16.69%,CGAS;IFIT1;FLOT1;ZCCHC3
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),-0.49088531680876146,-0.9779833841099569,0.4461538461538462,1.0,1.0,2/25,2.77%,TRIM54;TPX2
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),0.41016937680241417,0.9778061895097885,0.4864864864864865,0.9623001160901887,1.0,6/33,10.35%,RFWD3;BRCA2;EME2;SAMHD1;PRIMPOL;SMARCAL1
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),-0.5020654805983384,-0.9777093643336783,0.5070422535211268,1.0,1.0,5/25,20.46%,CHMP4B;PINK1;TSC2;PHF23;NUPR1
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.5144055588843517,0.9775304048499636,0.475,0.9622635545884239,1.0,3/12,19.00%,SIRT1;PKIA;PKIG
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,-0.40769085955186224,-0.9772916929400317,0.48,1.0,1.0,16/95,11.27%,MYLK;LAMA2;HSPG2;CYP1B1;FBLN2;EPHX1;TIMP3;ANGPTL2;COL6A1;RARRES2;KCNMB1;ADGRF5;IGFBP5;EFEMP1;PDGFRB;ACTA2
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.3409754849062068,0.9772703572016792,0.4444444444444444,0.9622175412553742,1.0,29/150,14.61%,NRK;NYAP2;SGK1;DOCK10;BMP7;VASH2;GPRIN2;EPHB2;BTG2;LRP12;BLOC1S4;CNTN4;FRY;APOE;HMGB1;MYO16;NLGN1;RYK;GPM6A;NGF;SVBP;PTPRM;NYAP1;NRTN;GPM6B;EPHA8;PAK3;CNTNAP2;RASGRF1
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.4397543155176997,0.9763960077992028,0.5142857142857142,0.9636628184958169,1.0,3/28,5.46%,ATP6V0D2;RAB32;RAB7A
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.5686622597958941,-0.9762775019636512,0.49122807017543857,1.0,1.0,7/11,24.31%,PTGES;PTGR1;GSTP1;AKR1C2;HPGDS;ACOX1;PLAA
prerank,GO_Biological_Process_2021__pyridine-containing compound metabolic process (GO:0072524),-0.6466865185630006,-0.9761525561742629,0.6,1.0,1.0,1/5,5.10%,AOX1
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,-0.5045099750032005,-0.9761144417760846,0.5303030303030303,1.0,1.0,9/23,22.08%,IL20RA;MUCL1;DUOXA1;ZNF750;PKP1;EMP2;NUPR1;POSTN;SLC10A6
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.527902456602811,-0.9760453552265607,0.5735294117647058,1.0,1.0,4/12,16.69%,CGAS;IFIT1;FLOT1;ZCCHC3
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),0.4058147767820121,0.9759426351457208,0.46153846153846156,0.9641568583553323,1.0,4/71,6.36%,RUNX1;CBFB;PDGFRA;JAG1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),0.4538368212999223,0.9758891906058141,0.4444444444444444,0.9636258624660752,1.0,2/21,6.71%,PID1;NUMB
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.44725996338296803,0.9758500306388128,0.4482758620689655,0.9630292963265714,1.0,10/33,19.86%,PCM1;PRR5L;STX18;TPR;NUMA1;EIPR1;SORL1;B3GAT3;ICE1;NEDD4
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.5469439368944291,0.9758319842255672,0.5263157894736842,0.9623862441505869,1.0,4/11,22.41%,CPSF7;GRIN2B;GRIN1;FARSA
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.4928752801034335,0.9758024481078836,0.47619047619047616,0.9617251984647706,1.0,4/24,14.30%,DOCK10;EPHB2;FYN;PAK3
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.40982890259227284,-0.9757877619465536,0.5866666666666667,1.0,1.0,25/108,22.64%,PTGIS;EPAS1;SUV39H1;BNIP3;PINK1;BACH1;PSMB6;PSMB8;PSMA3;PSMC3;HIF3A;PSMC6;PSMA5;RBX1;OPRD1;TBL2;PSMA7;TWIST1;RGCC;PSMD12;PSME1;AK4;PGK1;RPS27A;PSMB2
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),-0.6064355494900169,-0.9756399407776796,0.5,1.0,1.0,2/5,13.03%,TGFB1;FLOT1
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.415053169836174,0.9756153550487111,0.5185185185185185,0.9615284994352983,1.0,8/31,14.18%,COBL;TGFB2;PRICKLE1;SEMA4C;DVL2;PHACTR4;MTHFD1L;LRP6
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.4054046311506973,0.9755256076129699,0.47368421052631576,0.9610674849994372,1.0,10/45,13.64%,HSPB1;KDR;VASH1;APOE;HMGB1;ANGPT1;PRKD1;FGFR1;SIRT1;MAP2K3
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.5397880364333807,0.9754387068614377,0.43243243243243246,0.9606826841131663,1.0,2/8,12.86%,PARD3;TENM4
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),-0.5276716195553997,-0.9753785749577436,0.5483870967741935,1.0,1.0,3/15,16.85%,SLC5A2;SLC9A6;HCN4
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),-0.6283416435019389,-0.975333065205487,0.5517241379310345,1.0,1.0,5/8,28.09%,CD300LF;GPER1;GRN;IL31RA;CD200
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),0.6169926125452635,0.9752674973099479,0.5294117647058824,0.9603833675534923,1.0,2/6,20.73%,FRS2;PTPRD
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.6125103210599269,0.9750848143206958,0.55,0.9601599202432265,1.0,2/7,25.71%,RAP1A;PRKN
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),-0.5787091585752717,-0.9750402503366561,0.5471698113207547,1.0,1.0,2/10,9.24%,NOTCH1;REST
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.49946575468880533,-0.9749401733693285,0.5,1.0,1.0,4/22,15.12%,ELANE;TGFB1;CLPX;SIAH1
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.44328393709298325,0.9749262954402887,0.5675675675675675,0.9599179506822231,1.0,5/26,10.10%,TGFBR1;HEY1;TGFB2;ACVR1;ROBO2
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.40734170357591254,0.9748191288536721,0.4857142857142857,0.9596198354831778,1.0,6/43,5.46%,HSPB1;SPRED1;SPRED2;SPRED3;GRM5;RABL3
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.42679370864869304,0.974715893544104,0.4482758620689655,0.9592751053468916,1.0,4/24,7.95%,ATOH8;TGFB2;FOS;APLN
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),-0.5679308664837663,-0.9746350543775444,0.5490196078431373,1.0,1.0,2/9,29.88%,SUPT5H;CTR9
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),-0.5665706658571692,-0.9744604616125508,0.5,1.0,1.0,2/9,24.77%,LGSN;CPS1
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),-0.641529093894606,-0.9744057013586245,0.5370370370370371,1.0,1.0,1/5,2.29%,PTPRC
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),-0.46345452559828726,-0.9743257087028708,0.4696969696969697,1.0,1.0,4/36,12.06%,DDX20;SNRPD2;GEMIN4;PRPF19
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),-0.390743429602791,-0.9741622973750913,0.5128205128205128,1.0,1.0,12/107,13.97%,NPY;ROPN1B;RAC1;CFAP126;RAB11A;AGER;PLP1;STMN1;CATIP;UNC5A;CDK5R1;TPM1
prerank,GO_Biological_Process_2021__myeloid leukocyte mediated immunity (GO:0002444),-0.6096805554254365,-0.9740250032034556,0.5454545454545454,1.0,1.0,2/6,30.39%,ADAM17;IRAK4
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.5551064719294212,0.9737002030529566,0.49056603773584906,0.9612532400251921,1.0,6/9,19.36%,SLC30A10;ABCD2;FYN;TRAP1;PPARA;ABCD1
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.38125323150971996,-0.973561264118258,0.5135135135135135,1.0,1.0,30/146,17.54%,F8;TIMP3;TGFB1;RARRES2;SERPINE1;SYNGR2;ANXA5;TTN;KNG1;OTOF;ITIH4;TMSB4X;CDC37L1;TMEM79;SYT2;A2M;GTPBP2;SYT4;RAB31;FAM3C;PSAP;STEAP2;MAGED2;F13A1;SYTL4;CFD;SERPING1;LYN;TUBA4A;LAMP2
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),0.546128802831084,0.9733022712770545,0.5,0.9616124931858633,1.0,2/11,3.30%,PEX5L;PEX7
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),-0.5892929100371445,-0.9732612718488672,0.5254237288135594,1.0,1.0,1/9,2.64%,OMG
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),-0.5841966584882048,-0.9731328711796091,0.5166666666666667,1.0,1.0,1/10,6.05%,TBX1
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),-0.5485800071365147,-0.9730000124224674,0.4745762711864407,1.0,1.0,4/14,13.69%,CYP1B1;NQO1;ARG2;CYB5R3
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.5599110138470208,-0.9728585780346491,0.5373134328358209,1.0,1.0,4/14,17.65%,CAV3;FLOT1;MYADM;EMP2
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.31018387663824276,0.9728018483160535,0.5384615384615384,0.9621308374247038,1.0,69/424,14.86%,EPHA3;KIT;NRK;ALK;CCNH;SGK1;STK32B;MYO3A;KDR;EGFR;SGK2;FGFR4;TGFBR1;GRK5;LATS1;FGFR3;CSF1R;MAML1;CDK14;EPHB2;TGFB2;ACVR1;NEK6;MAP3K20;PKDCC;PDGFRA;TRIB2;PRKCD;PRKCB;PTPN6;CDKL1;PEAK3;SMAD2;STK38;PXK;RYK;SBK1;PRKD1;CLSPN;ERBB4;PAK5;LMTK3;EIF2AK3;FRK;CDK8;LTK;FASTK;MAST4;MARK1;CCNA2;MAPK8;PRKCE;FGFR1;PRKG2;MAP3K10;MAP3K5;PAK4;NRBP2;DMPK;FYN;CDC42BPB;EPHA8;PAK3;MAPK12;BRAF;FER;CHEK2;AKT2;MAST2
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),0.5226006839664178,0.9726490240030476,0.5263157894736842,0.9618415841932239,1.0,2/10,3.18%,TGFBR1;BMP7
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),0.5442811173607276,0.9726146865097095,0.5,0.9612246137510434,1.0,2/12,13.57%,SLC30A10;SIRT1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.40776434750231727,0.972585803843103,0.5483870967741935,0.9606272673982054,1.0,22/66,18.66%,LAMB2;ITGA4;NTNG1;NRP1;ARL13B;LAMB3;PKHD1;MEGF9;PIK3R1;VAMP3;RADIL;TMEFF2;SIPA1L3;ITGA8;FER;MEF2C;PARVA;PXN;RILPL1;ITGAV;LAMB4;OPHN1
prerank,PanglaoDB_Augmented_2021__Myoblasts,0.3891062074276781,0.972100065981772,0.34615384615384615,0.961135468149357,1.0,15/87,9.52%,FBXL7;LAMB2;LMCD1;PRRX1;WWTR1;EGFR;FGFR4;CACNA2D1;PDZRN3;PKDCC;HTRA1;STK40;GNG12;CAP2;AMOTL2
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.5635093776688067,0.9719159793519158,0.5116279069767442,0.9608290499608134,1.0,4/10,12.73%,CACNA2D1;BIN1;NOS1AP;CACNB2
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),-0.5411716771552848,-0.9717888188731515,0.5384615384615384,1.0,1.0,2/15,11.71%,SYNGR2;STX19
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.4038703786284316,0.9716960248746277,0.4827586206896552,0.9607567798560288,1.0,9/33,19.79%,SYNJ2;NLGN1;CEL;SYT1;MX1;SNAP91;NLGN4Y;OPHN1;PIP5K1C
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),0.4517971995334268,0.9713072359807986,0.47058823529411764,0.9610676204836587,1.0,5/18,16.85%,APOE;PTCH1;EEPD1;SIRT1;NR1H3
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.4416062905336472,0.9712643461146798,0.45161290322580644,0.9604818610281893,1.0,9/42,13.64%,HSPB1;KDR;HDAC9;HMGB1;ANGPT1;PRKD1;FGFR1;SIRT1;MAP2K3
prerank,GO_Biological_Process_2021__skeletal myofibril assembly (GO:0014866),-0.5845006454001507,-0.9711366053538965,0.5178571428571429,1.0,1.0,2/7,8.59%,ACTC1;TTN
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.3913269400471618,0.9709780430634112,0.40540540540540543,0.9606711860148264,1.0,10/43,12.15%,SULF2;TGFBR1;BMP7;ALDH1A2;TGFB3;CHD7;PTCH1;RBP4;TRIM71;FGFR1
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.594933848230721,-0.9707933023319921,0.4918032786885246,1.0,1.0,3/8,17.96%,DAB2IP;TSC2;TWIST1
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.5378143874610481,0.9703592692700456,0.5142857142857142,0.9616339321722349,1.0,3/10,21.94%,TENM4;PHLDB2;DAG1
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.3875204094823549,0.9703069169117876,0.43243243243243246,0.9610397090877324,1.0,9/56,10.08%,SLC12A3;SLC37A4;SLC12A1;GABRG3;SLC20A2;GABRB1;GABRA3;ANO5;SLC6A1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),-0.588233747530183,-0.9701969725173538,0.53125,1.0,1.0,2/7,19.84%,CASP8;PRR7
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.47676683424533545,0.9701823064957106,0.5384615384615384,0.9605952672784398,1.0,5/16,25.23%,TPR;ZNF207;ATM;KLHL22;KNTC1
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),-0.36910770531987735,-0.9701284818648053,0.5394736842105263,1.0,1.0,35/235,15.12%,PNMA5;CYP1B1;PNMA2;SFRP4;GADD45B;MOAP1;DDX20;BNIP3;RASGRF2;MTCH1;VAV3;CASP8;TFPT;PXT1;DAB2IP;REST;PPID;GPER1;KNG1;APH1B;STK17A;FGD3;HIP1R;ITGB3BP;HRK;FADD;DNAJA1;PREX1;RNPS1;BOK;SUDS3;GADD45A;KLF11;PDCD5;SIAH1
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,0.4218635075546991,0.9700825103658688,0.4666666666666667,0.9601607615628762,1.0,10/71,6.11%,ADAMTS2;PRRX1;SVEP1;COL15A1;SGCD;PCDH18;LAMA4;FAT4;PDGFRA;SSC5D
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.47179938553365414,-0.9700759987559822,0.4852941176470588,1.0,1.0,6/35,17.82%,RAD54L;RECQL;MRE11;HMGB3;SUPV3L1;RAD51C
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),-0.5794595821341126,-0.9699938418042481,0.5517241379310345,1.0,1.0,5/7,35.63%,TXNIP;VPS4A;BLM;RFPL1;E2F7
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),0.5844468060402402,0.9698553158734161,0.5609756097560976,0.9599778405628652,1.0,2/6,6.93%,NRL;RPGRIP1L
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.49224507092159303,0.9694863511363738,0.45454545454545453,0.9602503104702459,1.0,3/11,8.13%,COBL;PTCH1;SMAD2
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.4102235675439292,0.9693591230089044,0.5161290322580645,0.9598633876552746,1.0,10/43,14.91%,NRP1;MELTF;KANK1;MDK;CASS4;EFNA5;LIMS1;PDPN;ACTN4;CRK
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),-0.6151982373848178,-0.9692953718111346,0.5625,1.0,1.0,2/7,16.78%,AGER;LYN
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.464644175203955,-0.9687006256634377,0.5396825396825397,1.0,1.0,7/41,15.65%,SLC7A11;SLC7A7;SLC38A11;SLC25A44;SLC38A8;SLC36A1;SLC38A4
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),-0.4744967470418936,-0.9686653764441225,0.4925373134328358,1.0,1.0,6/24,22.97%,MORF4L1;MORF4L2;TAF6;MSL3;KAT5;BRD8
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),0.5193040082879302,0.9685300262980949,0.4722222222222222,0.9613042198820171,1.0,3/7,13.57%,PRKCD;HMGB1;SIRT1
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),-0.39633333312972224,-0.968342452528578,0.582089552238806,1.0,1.0,13/87,12.60%,PRELP;CHAC2;MGST1;CHAC1;GSTM5;B3GNT3;CHST1;MAT2B;GSTP1;B3GNT4;OGN;SLC35B3;GGTA1
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),-0.6068868997494394,-0.9682246746169931,0.6140350877192983,1.0,1.0,1/7,6.87%,SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),-0.6068868997494394,-0.9682246746169931,0.6140350877192983,1.0,1.0,1/7,6.87%,SERPINE1
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),0.48808427783043995,0.9678421505955639,0.5263157894736842,0.9610330205992443,1.0,5/15,25.23%,TPR;ZNF207;ATM;KLHL22;KNTC1
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),0.48808427783043995,0.9678421505955639,0.5263157894736842,0.9610330205992443,1.0,5/15,25.23%,TPR;ZNF207;ATM;KLHL22;KNTC1
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),0.48808427783043995,0.9678421505955639,0.5263157894736842,0.9610330205992443,1.0,5/15,25.23%,TPR;ZNF207;ATM;KLHL22;KNTC1
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),-0.5077060424919474,-0.9677690028256385,0.45614035087719296,1.0,1.0,3/25,14.27%,ARL1;GBP5;RIPOR1
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),0.6265291000372553,0.9675337660286276,0.6190476190476191,0.9609798727430927,1.0,1/5,10.72%,MRI1
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.43136048255645776,0.9672963389801598,0.5294117647058824,0.9609730115636711,1.0,5/45,2.70%,LAMB2;ITGA4;NTNG1;NRP1;LAMB3
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),-0.5485401837858612,-0.9672686916223691,0.5692307692307692,1.0,1.0,3/16,17.95%,PDCD1LG2;INHBA;C1QBP
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.5449624394728841,-0.9668548839902317,0.5970149253731343,1.0,1.0,7/14,25.31%,CDKN2D;TRIM32;SNAI2;ACKR3;RPS3;TPT1;SFRP2
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB phosphorylation (GO:1903721),-0.658117469956652,-0.9668336232653623,0.6226415094339622,1.0,1.0,2/5,26.64%,PLCG2;AKT1
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.32559144497584697,0.9668094980845346,0.47368421052631576,0.9614371812069428,1.0,22/114,9.48%,RIMBP2;PTPRT;GLP1R;TMEM229A;GRIA4;KCNIP1;RAB3C;LHFPL4;KCNB2;AFP;OLFM3;TOX3;ADGRA1;CNGA3;UNC5D;GRIA2;UNC79;TMEM196;NRXN1;CSRNP3;PCSK2;PAK5
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.627314066605109,0.9667910521806286,0.6,0.9608024225222895,1.0,2/7,3.83%,MICU1;MCU
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),0.5354809832299581,0.9667262770726938,0.4594594594594595,0.9602884565520089,1.0,1/6,2.26%,SH3RF1
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),-0.5528044349904235,-0.9663021210539918,0.5517241379310345,1.0,1.0,3/11,10.07%,SLCO6A1;SLCO2B1;SLCO4C1
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.4230477779701441,0.9662982699017898,0.4864864864864865,0.960715261068902,1.0,13/67,9.52%,LRIG3;LAMB2;WWTR1;CA3;EGFR;LAMB3;SDC4;GNG12;MYH11;FHL2;FERMT1;PERP;AMOTL2
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),-0.4560580068172444,-0.966234383196953,0.47540983606557374,1.0,1.0,8/20,18.40%,B3GNT3;HAS3;B3GNT9;B3GALT1;B3GNT4;B3GALNT1;NDST4;B4GAT1
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),-0.5387988785732799,-0.9660763109182191,0.5757575757575758,1.0,1.0,3/12,20.15%,RAC1;WAS;ACTG1
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.38880145047241427,0.9659341545721486,0.42105263157894735,0.9609848991321877,1.0,9/56,16.65%,RFWD3;CRADD;BTG2;CASP2;EP300;CHEK2;TFDP1;TRIAP1;ATM
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.46228446104834475,0.9659154380639402,0.5882352941176471,0.9603338467677481,1.0,3/27,5.54%,ATP6V0D2;RAB7A;GPR89B
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.35583639392079425,0.9658862713495814,0.5925925925925926,0.9597113031230087,1.0,14/74,13.14%,UNC5B;BCL2;SLC30A10;TOX3;MDK;TGFB2;TGFB3;APOE;EPHA7;EGLN3;GRID2;NSMF;NGF;NRBP2
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),0.4565439337471312,0.9655209469563265,0.4,0.9598524171186085,1.0,3/26,14.45%,ARL13B;WDR81;DYNC1I2
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.438725128809099,-0.9654519160471215,0.5,1.0,1.0,8/58,13.14%,UPB1;HSD17B10;B2M;TRPA1;SOD2;ACOT13;GBP5;MCOLN1
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),0.4476685074086974,0.9654252674176054,0.5217391304347826,0.9594331302450005,1.0,7/24,15.47%,NEK6;CDC23;CDK5RAP2;ESPL1;HECW2;NSMCE2;ANAPC7
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),0.5923237904175956,0.9653973282120557,0.5294117647058824,0.9588584219988059,1.0,3/6,26.14%,CTTNBP2NL;WWP2;SNCA
prerank,GO_Biological_Process_2021__icosanoid secretion (GO:0032309),-0.5691642432969151,-0.9653506174679278,0.5344827586206896,1.0,1.0,1/9,3.79%,DRD3
prerank,MSigDB_Hallmark_2020__Myogenesis,-0.38217860802826503,-0.9653360398533513,0.5263157894736842,1.0,1.0,21/151,9.18%,CSRP3;MYLK;LAMA2;CHRNB1;PTGIS;ACTC1;CAV3;GADD45B;FKBP1B;CHRNG;ATP6AP1;CTF1;SMTN;NOTCH1;TGFB1;KLF5;SYNGR2;FABP3;MYOM1;TEAD4;NQO1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.4366500605745659,0.9650163223978263,0.5121951219512195,0.9590823746941913,1.0,10/21,32.16%,SAMD4A;SAMD4B;PNLDC1;CNOT4;ZFP36;PAN2;CNOT6;CNOT9;CNOT2;TNKS1BP1
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),0.456819503810237,0.9649980128528316,0.5945945945945946,0.9584445715718897,1.0,5/19,8.13%,GRIN3A;TGFBR1;GRIN2A;SDF4;SMAD2
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),-0.5828944245119634,-0.9649575887128581,0.543859649122807,1.0,1.0,1/7,5.69%,KCNQ1
prerank,GO_Biological_Process_2021__serine family amino acid catabolic process (GO:0009071),-0.6334104880532183,-0.9646249014431861,0.5471698113207547,1.0,1.0,1/7,3.99%,SDS
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter transport (GO:0051590),-0.6455641946090854,-0.9643865472090829,0.66,1.0,1.0,3/5,25.17%,GPER1;BAIAP3;STX1B
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.3982399943715775,-0.9642934875706429,0.5316455696202531,1.0,1.0,29/76,30.51%,EPAS1;BACH1;PSMB6;PSMB8;PSMA3;PSMC3;HIF3A;DNAJB1;PSMC6;PSMA5;RBX1;CHEK1;PSMA7;PSMD12;PSME1;RPS27A;PSMB2;UBC;PSMD2;PSMA8;CUL2;PSMA1;PSMC1;LIMD1;PSMD4;PSMD8;PSMB4;PSMC4;UBB
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),0.5867289582332893,0.9642697907281553,0.4883720930232558,0.9595201779768332,1.0,3/7,16.73%,KDR;RIN2;RAP1A
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),0.4874426942938419,0.9640415330868979,0.5,0.9592856244932648,1.0,3/17,7.13%,PER2;HEY1;IGF1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.47940651010866475,-0.96392013759592,0.484375,1.0,1.0,2/27,2.84%,TMEM35A;CAV3
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),0.5887331553818267,0.9638147009786436,0.5813953488372093,0.9590879800916251,1.0,1/6,5.06%,EPHB2
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),0.5063884585562667,0.9637838369725963,0.46875,0.9584702392235187,1.0,2/11,7.49%,CCDC22;COX19
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),-0.6401675822313665,-0.9637072660443522,0.625,1.0,1.0,3/5,21.05%,TAF7;SPI1;CTBP1
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),-0.6313127737141919,-0.9636394937723604,0.6111111111111112,1.0,1.0,1/6,14.91%,SLC6A7
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),-0.4436337114208899,-0.9635052173015313,0.5,1.0,1.0,8/26,22.29%,P2RY12;RAC1;NCKAP1L;RHOH;NEFH;CYFIP1;RHOU;KIF17
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),0.5472511633059922,0.9631738814924531,0.5428571428571428,0.9583050668273349,1.0,2/6,20.08%,PIK3R1;MAP4K4
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),0.5472511633059922,0.9631738814924531,0.5428571428571428,0.9583050668273349,1.0,2/6,20.08%,PIK3R1;MAP4K4
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.5485124068040075,0.9631255143121705,0.5,0.9570467969809037,1.0,3/8,24.06%,SCAP;ERLIN2;SREBF2
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.5485124068040075,0.9631255143121705,0.5,0.9570467969809037,1.0,3/8,24.06%,SCAP;ERLIN2;SREBF2
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.45656169891873555,-0.9628017771855198,0.5689655172413793,1.0,1.0,7/33,16.89%,RFC5;RPA3;XRCC1;TDG;PCNA;PARG;MPG
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),0.46313436296503996,0.962758749390695,0.4594594594594595,0.9574525831996786,1.0,4/24,11.01%,EGFR;UBE2J2;REEP1;CYB5A
prerank,GO_Biological_Process_2021__secretion (GO:0046903),0.48662362666473413,0.9621183989346497,0.5666666666666667,0.958221813395671,1.0,1/11,0.43%,SLC22A2
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.569812269544182,-0.9619902812638572,0.5666666666666667,1.0,1.0,1/9,5.92%,IFIT1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),0.447779357082342,0.9616028310014211,0.4722222222222222,0.9588717490707765,1.0,5/21,17.08%,LYAR;EIF2AK3;SMARCB1;UBTF;SMARCA4
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.4940123727872882,-0.9608845892545617,0.6101694915254238,1.0,1.0,3/31,11.01%,TERF2IP;GAR1;MRE11
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),-0.5544606492599202,-0.9608295979073741,0.5833333333333334,1.0,1.0,2/10,14.13%,DCTN1;CLMN
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),-0.5500791268093606,-0.9606636112856448,0.5967741935483871,1.0,1.0,3/11,17.19%,SERPINE1;ROMO1;CHEK1
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),-0.526729534167429,-0.9605719877355365,0.6031746031746031,1.0,1.0,2/11,16.76%,CLDN1;SUPV3L1
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),-0.6087145911849234,-0.9603138876682816,0.48,1.0,1.0,2/6,10.35%,FOXM1;GSTP1
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),-0.5340049038594372,-0.9602583628430716,0.6470588235294118,1.0,1.0,3/18,5.86%,ALOX12;F11R;ADAMTS18
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.3987474675566423,0.9597683547584688,0.4666666666666667,0.9629467943566115,1.0,12/43,19.28%,TBL1Y;HDAC9;PRDM5;HDAC1;SIRT2;SIRT1;HDAC10;SIN3A;HDAC3;HDAC5;SIRT7;SIRT3
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.46142520147055277,-0.9597191893082027,0.5522388059701493,1.0,1.0,10/50,11.58%,PDCD1LG2;ZFPM1;TXK;HLA-DPB1;CD14;IL18;HLA-A;INHBA;IL18R1;FADD
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.6285543289116259,-0.9596493492529744,0.5806451612903226,1.0,1.0,4/7,23.34%,AGBL5;AGBL2;AGBL3;FOLH1
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.4976776053320906,-0.9594880126472963,0.5254237288135594,1.0,1.0,5/20,18.79%,YBX3;CASP8;FLOT1;SLC25A4;SPATA2
prerank,GO_Biological_Process_2021__somite development (GO:0061053),-0.5567292754993376,-0.9594330342526031,0.5961538461538461,1.0,1.0,6/10,25.31%,MEOX1;PPP2R3A;SHH;SMO;SOX11;SFRP2
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.5055806099350355,-0.9593412637351395,0.515625,1.0,1.0,5/14,21.70%,PINK1;COX7A2L;COX7A2;NUPR1;AK4
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.4215889868530867,0.9593404176172879,0.4878048780487805,0.9633564192105394,1.0,10/26,17.94%,FGF10;RASGRP1;IGF1;IRS2;MMD2;NGF;RASGRF1;RAPGEF1;JAK2;ITGAV
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),0.5525607305199415,0.9592194887338562,0.5,0.9629668806836205,1.0,2/10,6.63%,SGK1;AKR1C3
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.43620551894200543,0.9591480176696264,0.5263157894736842,0.9625416098966268,1.0,2/27,4.01%,UNC13B;ZBTB20
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.5257695376055649,0.9585956166521656,0.5121951219512195,0.9632587800603875,1.0,4/15,21.78%,ADCY2;ADCY9;ADCY8;PRKACB
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),0.5577179649248711,0.9584916782247042,0.5208333333333334,0.9628520094885344,1.0,2/12,5.06%,NFIB;EPHB2
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.5707256841937995,0.9584554348005613,0.4666666666666667,0.9622648096578187,1.0,3/8,3.05%,NRP1;SPRED1;TGFBR1
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),0.42617566743933855,0.9584059659473475,0.3333333333333333,0.96166033795498,1.0,12/41,13.55%,GALNT3;GXYLT2;ST3GAL3;GALNT12;C1GALT1C1;GALNT7;GALNT10;GALNT13;ST3GAL1;ST6GALNAC4;ST3GAL2;GALNT14
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.4114417541013223,-0.958355697418367,0.5,1.0,1.0,17/64,20.12%,SLC19A3;AMN;AOX1;SLC52A2;CBLIF;RFK;CYB5R3;MMUT;SLC23A1;DHFR2;TCN2;SLC2A1;PDZD11;ALDH1L1;BTD;SLC25A19;SLC52A1
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.5585808881525174,0.9580365147273274,0.5306122448979592,0.9618248631713563,1.0,2/6,14.24%,ARFIP1;EIPR1
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),-0.5523233922985139,-0.9578097890440106,0.5925925925925926,1.0,1.0,3/13,9.94%,CHMP4B;CHMP2B;CHMP2A
prerank,PanglaoDB_Augmented_2021__Chondrocytes,0.4039552882967049,0.9577812235933574,0.43478260869565216,0.9619259440798325,1.0,11/109,4.00%,FBXL7;ADAMTS2;PRRX1;COL15A1;SGCD;EFS;PCDH18;FNDC1;LAMA4;SEMA5A;PDZRN3
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.38111296632472513,0.9576966448408689,0.4482758620689655,0.9614132093005668,1.0,6/74,5.16%,ELOVL6;PER2;OXTR;ESRRG;LEPR;PDGFC
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),-0.5228830837619202,-0.9576359565402028,0.5666666666666667,1.0,1.0,3/15,12.08%,DRD3;ADRA1D;ADRB1
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),-0.4557497570110747,-0.9575808606553751,0.5483870967741935,1.0,1.0,7/29,23.63%,ING2;ZBTB7B;BRCA1;KDM1A;NOS1;CTBP1;PAF1
prerank,GO_Biological_Process_2021__piRNA biosynthetic process (GO:1990511),0.6007821266617367,0.95754902037334,0.5555555555555556,0.9611086073202987,1.0,1/5,1.96%,TEX15
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),-0.644505929413647,-0.9574434033378594,0.578125,1.0,1.0,1/5,4.14%,LDLRAP1
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),-0.6145828066857477,-0.9574119645375073,0.5636363636363636,1.0,1.0,6/7,35.69%,LPCAT3;DGAT1;MTTP;ACSL3;SOAT1;MFSD2A
prerank,GO_Biological_Process_2021__L-alanine transport (GO:0015808),-0.6333567816446405,-0.9573531981780066,0.55,1.0,1.0,2/5,21.59%,SLC36A1;SLC38A5
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),-0.43476257281375597,-0.957244339384668,0.5616438356164384,1.0,1.0,5/53,5.98%,PTGIS;EPAS1;SUV39H1;BNIP3;PINK1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),-0.5693120271304278,-0.9568994904238854,0.5396825396825397,1.0,1.0,3/6,31.51%,PLN;ATP2A2;SLC8B1
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),0.5627322362372263,0.9567482711951495,0.5555555555555556,0.9623725425232577,1.0,1/8,2.22%,BCL2L11
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.37779902820381905,0.9564245888636774,0.575,0.9625630248373781,1.0,11/52,13.43%,ELOVL6;SGMS1;HACD2;SGPP2;SPTSSB;PRKD1;SPTLC1;SPHK2;ST3GAL2;CERS4;CERS3
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),-0.6505914119051642,-0.9562206056971919,0.6,1.0,1.0,2/5,23.89%,KDM6B;KDM7A
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.4524685682015044,0.9561280638165492,0.5625,0.9621967400932266,1.0,4/19,13.02%,ZBTB20;IGF1;SLC4A4;PFKFB3
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.4524685682015044,0.9561280638165492,0.5625,0.9621967400932266,1.0,4/19,13.02%,ZBTB20;IGF1;SLC4A4;PFKFB3
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.40838482096381934,0.9560983542181632,0.5348837209302325,0.9615511307327421,1.0,5/55,9.92%,LEF1;CBFB;CSF1R;MED30;CDK8
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),0.3949653500755813,0.955957157112967,0.6451612903225806,0.9613195420950045,1.0,4/67,0.57%,CYP4Z1;ELOVL6;CYP1A2;GLYATL2
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),-0.5931534845535078,-0.9555490104778371,0.6065573770491803,1.0,1.0,2/8,5.83%,ZFPM1;NOTCH1
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),-0.5726055243979304,-0.9552878447318092,0.5789473684210527,1.0,1.0,3/7,25.18%,CYP2R1;LRP2;LGMN
prerank,GO_Biological_Process_2021__phosphate ion homeostasis (GO:0055062),-0.6227346985252733,-0.9549066610940342,0.5384615384615384,1.0,1.0,2/5,2.85%,GCM2;SFRP4
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),-0.5180591308326017,-0.9548492024318302,0.5633802816901409,1.0,1.0,2/17,7.79%,NCKAP1L;FMNL1
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),-0.43814498892537923,-0.9544572093294014,0.5507246376811594,1.0,1.0,4/28,9.94%,CHMP4B;CHMP2B;RAB11A;CHMP2A
prerank,PanglaoDB_Augmented_2021__Plasma Cells,0.40098278738966586,0.9543380256032927,0.5172413793103449,0.9650462121259394,1.0,1/47,0.04%,CD38
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),-0.5308727719171138,-0.954211608635989,0.5714285714285714,1.0,1.0,2/20,12.82%,ENO4;ENO2
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),-0.4705368427757326,-0.954192579744217,0.5555555555555556,1.0,1.0,3/21,9.82%,DRD3;FKBP1B;CALM3
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,-0.37128090291124316,-0.9541901738835021,0.5125,1.0,1.0,53/181,22.49%,MCM2;SLC7A11;GOT1;PPA1;TMEM97;FGL2;DDX39A;CCT6A;HSPA5;GLRX;CORO1A;EPRS1;ATP6V1D;UCHL5;IGFBP5;G6PD;PSMA3;PDAP1;WARS1;UFM1;NMT1;DHCR7;PRDX1;FADS2;CDC25A;PSMC6;SLA;NIBAN1;SDF2L1;NAMPT;RAB1A;EIF2S2;TUBA4A;COPS5;SLC2A1;PLOD2;SQLE;HSPA9;ERO1A;SYTL2;PSMD12;CALR;CACYBP;HSPD1;NUPR1;SRD5A1;HSPA4;IFRD1;MLLT11;AK4;HSP90B1;PSMG1;PGK1
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),0.6116269282918037,0.9541217896085756,0.6097560975609756,0.9649650054694149,1.0,3/8,14.75%,PLCB1;IGF1;CHP1
prerank,GO_Biological_Process_2021__membrane depolarization during SA node cell action potential (GO:0086046),-0.6326890464944919,-0.9539545047917091,0.6,1.0,1.0,2/5,16.85%,CACNA1G;HCN4
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.4189669834217562,0.9539047341129783,0.5428571428571428,0.9646777712945415,1.0,2/40,2.30%,ACE2;ITPR2
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),-0.6438738343838697,-0.9538664452992809,0.6181818181818182,1.0,1.0,2/6,16.56%,LRRC8D;SLC25A18
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),-0.605507255680309,-0.9537585236264366,0.5967741935483871,1.0,1.0,1/7,3.44%,AGT
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),0.5665832184326774,0.9534583604054914,0.574468085106383,0.9650537066466809,1.0,1/7,2.22%,BCL2L11
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.3578872383279235,0.9533458161218256,0.5483870967741935,0.9645967510960941,1.0,6/84,5.16%,ELOVL6;PER2;OXTR;ESRRG;LEPR;PDGFC
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.3268924342444279,0.9530844608354706,0.5625,0.9645518523479001,1.0,62/539,9.84%,RUNX1;TBX6;PER2;IFI16;SOX13;TRPS1;GFI1B;NFIB;ZNF239;ZEB2;ZNF536;ATF3;HIVEP1;ZGLP1;BMP6;CBFB;ID3;ARID5A;SMYD2;ATXN1;KCTD1;HDAC9;ZNF205;BATF3;HEY1;WWOX;E2F6;ZMYM5;WWC1;ZBTB5;RITA1;MACROH2A2;ZNF596;AASS;MXI1;ZNF608;NFIX;PTCH1;HMGB1;PRDM5;ZNF846;RNF2;HDAC1;HSPA1A;PCGF1;ZEB1;ZNF263;ZBTB1;ARID5B;SMAD2;ZNF778;NACC2;FHL2;FOXP2;TPR;LYAR;IGBP1;SUV39H2;ZNF202;DACH1;ETV5;FRK
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.5472886834791341,-0.9530760216967038,0.5806451612903226,1.0,1.0,4/10,22.85%,STAT1;STAT4;IL6ST;CANX
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),0.5763816440804425,0.9528257473597016,0.5581395348837209,0.9644802012309885,1.0,3/5,29.29%,TPRKB;TRIT1;OSGEP
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.505705632908012,-0.9528006521494036,0.546875,1.0,1.0,6/20,20.16%,RPL5;RSL24D1;RPL24;RPF2;RPL3;TRAF7
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.482420218727047,0.9523140165537255,0.4666666666666667,0.964882036911943,1.0,3/21,9.96%,ELOVL6;HACD2;TECR
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),-0.5492429391079601,-0.9522695444619762,0.576271186440678,1.0,1.0,3/9,20.20%,LBP;STAP1;HSPD1
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),-0.5316809768135691,-0.9521972404865939,0.5614035087719298,1.0,1.0,6/15,24.87%,ABCB1;ABCC2;SLC23A1;GPLD1;ABCG2;BEST1
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.3293779264685471,0.9517928764166139,0.65,0.9655421686585152,1.0,18/97,13.70%,PID1;LEF1;IL1RAPL1;TGFBR1;CSF1R;ACVR1;PTPN9;PTPN6;IL1RL2;PTPN12;ROBO2;KHSRP;PTPN23;MAPK8;PTPN13;SOCS2;MAPK7;NFAT5
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),-0.5209020414992555,-0.9516388533026361,0.5172413793103449,1.0,1.0,4/12,13.97%,KCNQ1;ADRA1D;ADRB1;TPM1
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3488817029517976,0.951337024796924,0.5555555555555556,0.966049762974346,1.0,16/104,11.89%,HTR1F;RXFP2;GLP1R;GRK5;PTGFR;GNAO1;ADGRL2;HTR1E;WASF2;GNA12;GRM8;GNAQ;ADGRB3;ADCY2;GNAI1;ADGRL1
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.36577806296793264,0.9512741449263316,0.5882352941176471,0.9655761743933797,1.0,12/65,13.43%,ELOVL6;SMPD4;SGMS1;HACD2;SGPP2;SPTSSB;PRKD1;SPTLC1;SPHK2;ST8SIA3;CERS4;CERS3
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.4078634719835928,-0.9509744048012849,0.5633802816901409,1.0,1.0,22/63,30.26%,PSMB6;PSMB8;SKP1;PSMA3;PSMC3;PSMC6;PSMA5;PSMA7;PSMD12;COPS8;PSME1;PSMB2;PSMD2;CARD14;PSMA8;AKT1;PSMA1;PSMC1;PSMD4;PSMD8;PSMB4;PSMC4
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),-0.48455862968147867,-0.9509415084622085,0.5606060606060606,1.0,1.0,7/21,12.89%,DUOX1;NOX1;ALOX12;SOD2;NOX5;PREX1;PRDX1
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),-0.5912560322019867,-0.9508672634199525,0.5423728813559322,1.0,1.0,1/6,13.93%,LRP2
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.46039228450194336,-0.9507850333676636,0.5454545454545454,1.0,1.0,6/26,13.72%,CYP1B1;PTPRC;NOTCH1;CRLF3;CCL5;OCIAD2
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.4371899237489703,0.9505837746884543,0.45714285714285713,0.9665996830359105,1.0,3/34,9.97%,IFI16;EIF2AK3;KPTN
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),-0.5550531761603361,-0.9503528248800923,0.5614035087719298,1.0,1.0,1/7,10.52%,CKB
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.6101418818279295,0.9502302555952976,0.5555555555555556,0.9667850660741754,1.0,3/6,11.22%,MTR;KCNC2;FOXO1
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),-0.565590271419118,-0.9501930096120857,0.5714285714285714,1.0,1.0,4/12,24.63%,KCNN4;TESPA1;RPS3;CD226
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell proliferation (GO:0061469),0.5683554993588527,0.9500805906216377,0.5517241379310345,0.9666054895919045,1.0,1/6,8.30%,SGPP2
prerank,GO_Biological_Process_2021__fibrinolysis (GO:0042730),-0.6173910036140968,-0.9498766012079272,0.6206896551724138,1.0,1.0,3/7,15.31%,SERPINE1;CPB2;PLAUR
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),0.48574445421086254,0.9498642407943805,0.5405405405405406,0.9664528257317689,1.0,3/14,9.25%,IFI16;GRIN2A;PERP
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),0.5368858250532538,0.9498590294812377,0.47368421052631576,0.9657940303495387,1.0,3/8,18.58%,PRKCD;CCNA2;BAZ1B
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),-0.6145671530953682,-0.9498281322357784,0.5873015873015873,1.0,1.0,1/5,20.02%,SLC27A1
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.5004588722856907,0.9497821020834609,0.5128205128205128,0.9654113226276079,1.0,5/10,21.17%,DLGAP1;DLGAP4;DLGAP3;DLGAP2;AKAP9
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),0.5504218387538513,0.9496927587916938,0.6041666666666666,0.9649847806626323,1.0,3/8,18.99%,PDE4D;PDPN;PDE4B
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.3833692022115834,-0.9496703127746533,0.5217391304347826,1.0,1.0,23/96,17.54%,F8;TIMP3;TGFB1;RARRES2;SERPINE1;ANXA5;TTN;KNG1;ITIH4;TMSB4X;CDC37L1;A2M;GTPBP2;FAM3C;PSAP;MAGED2;F13A1;SYTL4;CFD;SERPING1;LYN;TUBA4A;LAMP2
prerank,GO_Biological_Process_2021__embryonic digestive tract morphogenesis (GO:0048557),0.5840879924908001,0.9496460736158656,0.5625,0.9644169786601088,1.0,2/6,13.24%,PDGFRA;ID2
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.518822952094465,0.949576814541805,0.55,0.963920820623301,1.0,4/12,19.17%,GCH1;PRKG2;MTHFD1L;GCHFR
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.5226269020375105,0.9495670138779486,0.46511627906976744,0.9632925420434524,1.0,4/9,16.73%,NGF;MAGI2;RAPGEF1;RAP1A
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.3669490825957464,0.9494692057252972,0.48148148148148145,0.9629305255600186,1.0,36/139,16.85%,WWTR1;EGFR;RORA;PKP2;SPRED1;SPRED2;TGFBR1;BMP7;HEY1;CRIM1;SPRED3;ENPP1;GREM1;MEIS1;CNTN4;IL17RD;JAG1;TRIB2;PTCH1;ANP32B;FOXO1;DTX1;DISP3;SIRT2;ID2;SIRT1;RANBP3L;WNT5A;ANKRD26;MEIS2;LRP3;BBS12;MYB;GDF10;PTHLH;NR1H3
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.42482060188862425,-0.9493723947784755,0.5492957746478874,1.0,1.0,6/58,5.92%,NES;LRPAP1;B2M;TMC8;ZFPM1;IFIT1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),0.3530016314712884,0.9492680616133503,0.5217391304347826,0.9628519111873157,1.0,27/144,18.11%,RUNX1;ATOH8;KDR;TGFB2;APOE;RBMS3;IGF1;HDAC1;APLN;TET1;REL;PARP10;CILP;ANKRD13D;PC;SLC24A3;ID2;SIRT1;CELF1;CREB3L1;CCDC3;MEF2C;LRP3;DNMT1;PDGFB;NFKB1;YY1
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),-0.5601035167930641,-0.9491965537570063,0.6164383561643836,1.0,1.0,1/9,11.06%,PHKA1
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),-0.4193959372405865,-0.9490679335068876,0.5,1.0,1.0,10/59,15.84%,PDCD1LG2;SERPINE1;CD14;DAB2IP;GSTP1;LBP;TLR2;STAP1;ADAM9;CXCL13
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.4349625975283361,0.9490384422809576,0.4838709677419355,0.9627822383823692,1.0,8/27,23.58%,LIN28B;SMAD2;TRIM71;SRRT;PUS10;TARBP2;DGCR8;AGO2
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.5004604506497832,-0.9489907670843097,0.5396825396825397,1.0,1.0,6/17,13.72%,PRLR;CYP1B1;NOTCH1;CRLF3;CCL5;OCIAD2
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),-0.5780086688959551,-0.9488637175056016,0.5686274509803921,1.0,1.0,3/9,16.00%,ATP1B1;ATP1A1;ATP12A
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),-0.5585007296645105,-0.9486901057578504,0.5714285714285714,1.0,1.0,3/11,15.04%,DOCK2;LBP;PLCG2
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",-0.6284814812405705,-0.9483907176918153,0.6363636363636364,1.0,1.0,1/8,2.78%,RREB1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.47344169738506,0.9480073463048734,0.6071428571428571,0.9644696282474626,1.0,2/16,6.71%,PID1;NUMB
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.5757077173363528,0.9479699107822886,0.6,0.9638960430240439,1.0,2/8,6.93%,NRL;RPGRIP1L
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),-0.6415792319362569,-0.9479560099041103,0.65625,1.0,1.0,1/5,9.01%,BCAP31
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.355435761101405,0.9478303018240293,0.6,0.9636141962528525,1.0,12/93,7.04%,TACR1;CHRNA10;TRPC3;F2RL1;GLP1R;C5AR1;CACNA2D1;ACKR2;GPR174;PTGFR;PDGFRA;HMGB1
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),-0.6365578439435362,-0.9476707787391798,0.625,1.0,1.0,1/6,11.08%,PAICS
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),-0.48505335732044486,-0.9476467083397774,0.5211267605633803,1.0,1.0,6/28,14.68%,PRELP;CHAC2;CHAC1;TST;OGN;ACAN
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),0.5663565695992109,0.9476161613569085,0.5454545454545454,0.9635441964743795,1.0,4/6,16.02%,APOE;FYN;GRIN2B;HOMER1
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),0.5492532903180223,0.947539929120775,0.5641025641025641,0.9630868658289894,1.0,1/7,17.56%,PHF14
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),-0.5741010193590353,-0.94685861709324,0.5769230769230769,1.0,1.0,2/10,5.95%,NOTCH1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.5260456857128151,-0.9468501849199168,0.5689655172413793,1.0,1.0,2/12,7.02%,ATP1B1;GLRX
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),0.4703161706222349,0.9466866342462674,0.5757575757575758,0.964504377849632,1.0,4/16,10.43%,SULF2;DSCAML1;PDGFRA;RBP4
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.2950435023882269,0.9464822769290132,0.7368421052631579,0.9643108137297313,1.0,53/347,14.86%,NRK;ALK;SGK1;DGKB;SGK2;FGGY;TGFBR1;GRK5;LATS1;MAML1;CDK14;EPHB2;TGFB2;ACVR1;NEK6;MAP3K20;TRIB2;PRKCD;PRKCB;CDKL1;PEAK3;STK38;EPHA7;DGKH;PXK;RYK;PRKD1;PAK5;LMTK3;EIF2AK3;FRK;CDK8;LTK;FASTK;SPHK2;MARK1;PNKP;MAPK8;PRKCE;FGFR1;PRKG2;PANK3;MAP3K5;PAK4;NRBP2;DMPK;FYN;CDC42BPB;PAK3;BRAF;FER;CHEK2;MAST2
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.4857094363599239,-0.9461800697669915,0.578125,1.0,1.0,12/32,23.46%,SLCO2B1;SLC51A;SLC16A8;STARD5;AQP9;ABCG5;ABCC2;SLC16A1;CEACAM1;GHRL;SLC10A6;SLCO1A2
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),-0.6108146258599603,-0.9459900248562535,0.6290322580645161,1.0,1.0,2/6,24.63%,CEACAM1;CD226
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),-0.4589361671800047,-0.9459852523166149,0.5857142857142857,1.0,1.0,8/42,13.62%,BTN2A2;CYP1B1;FOXM1;PINK1;STK17A;FLOT1;FASN;VPS35
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.47551058909046445,0.9456608201035741,0.5365853658536586,0.9656728648777414,1.0,3/13,9.21%,HSPB1;SEMA5A;PRKD1
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),0.6060867628450082,0.9453901181024871,0.6060606060606061,0.9656017137045699,1.0,1/5,1.59%,RAB7B
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),-0.4136744007238595,-0.9453118572247666,0.5857142857142857,1.0,1.0,16/61,23.32%,FIP1L1;CSTF2T;SLU7;DDX39A;NCBP2;NCBP1;RNPS1;ALYREF;CDC40;SUPV3L1;UPF3B;THOC5;CLP1;DHX38;SRSF5;CPSF4
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.3629378086342149,0.9449365960807126,0.4827586206896552,0.9661273908099359,1.0,28/106,19.93%,TNFRSF19;LEF1;EGFR;FGFR3;DDAH1;SLC19A1;SHC3;FMNL2;CAP2;AMOTL2;TBC1D16;ARHGAP39;KAZN;CDC42BPB;NYAP1;EPN2;NGEF;ARHGEF17;RBFOX2;MTCL1;MPDZ;FARP1;MEIS3;ID4;NCS1;FNDC4;ANTXR1;NAV2
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.5164040319833778,0.9443230688000178,0.5862068965517241,0.9671171477145222,1.0,2/6,21.76%,ATP10A;SH3GLB1
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.3962097061946306,0.9441691949439777,0.5161290322580645,0.9669049500259221,1.0,5/55,5.07%,BCL2;EGFR;TGFBR1;PLCB1;TGFB2
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),0.5071947262238041,0.9438835149958797,0.5319148936170213,0.966437650194494,1.0,2/11,8.42%,SYNJ2;INPP1
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),0.5071947262238041,0.9438835149958797,0.5319148936170213,0.966437650194494,1.0,2/11,8.42%,SYNJ2;INPP1
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),-0.6307161050107591,-0.9438280497253554,0.6190476190476191,1.0,1.0,2/6,15.08%,BRK1;WAS
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),-0.4211055792489616,-0.9438191928622172,0.5694444444444444,1.0,1.0,6/59,12.25%,HCK;ABITRAM;RASA1;NCKAP1L;HIP1R;KANK3
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),-0.5273629836140966,-0.9432585665055749,0.5970149253731343,1.0,1.0,4/18,15.80%,POLE3;GINS2;GINS1;PCNA
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.4415675661908229,0.9431112022711967,0.5,0.9674945100403956,1.0,8/33,18.98%,HSPB1;BLOC1S4;AP3B2;DLG2;SPAST;KIF5C;RAB27B;TRAK2
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.46913766640938653,-0.9428075038927591,0.5797101449275363,1.0,1.0,1/32,1.08%,TERF2IP
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.5348455580713856,0.9421499184855097,0.5348837209302325,0.9694414489052313,1.0,5/13,8.08%,CNTN6;DSCAM;DSCAML1;CNTN4;BSG
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),0.3842023944156515,0.942045775814292,0.48,0.9690886556054565,1.0,9/73,7.17%,CIDEA;HSPB1;TLR1;IFIH1;EPHB2;RASGRP1;HMGB1;IGF1;PTPN6
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.36725013631271397,-0.941798276715665,0.5844155844155844,1.0,1.0,39/184,21.88%,MCM2;BIK;TCHP;CASP12;AHR;BNIP3;IRF1;TBX1;GLRX2;BCL2L14;IFI27;CASP8;CD14;CIDEB;NOX5;KREMEN1;FADD;RFK;BOK;IFI6;TLR2;GADD45A;SIAH1;TSC2;PAK6;VDAC1;NFKBIA;RNF152;CHEK1;NSG1;FXR1;NOTCH2;IRF3;TRAF7;HSPD1;CDK5;TNFAIP1;AKAP1;CASP6
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),-0.5839467952756461,-0.9416744145231015,0.603448275862069,1.0,1.0,2/6,5.83%,ZFPM1;NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.50270456807546,-0.9414151030807613,0.5147058823529411,1.0,1.0,1/14,3.44%,AGT
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.5765061819834039,0.9413795639426902,0.5892857142857143,0.9702114438402486,1.0,5/9,28.22%,RAPGEF1;RAP1A;RAP2A;RAP2B;PLK2
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.45180340649756384,0.941202652127295,0.5263157894736842,0.9701377310424248,1.0,2/26,5.75%,TBX6;ACVR1
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.4435123814792127,0.9407882420240905,0.45454545454545453,0.9706132738957051,1.0,4/25,7.72%,ITGA4;LRRC7;NRXN1;NLGN1
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),0.4379370155771677,0.9403393593545493,0.4827586206896552,0.9709400948181519,1.0,3/17,5.24%,CATSPER2;TGFB2;TGFB3
prerank,GO_Biological_Process_2021__proton-transporting V-type ATPase complex assembly (GO:0070070),-0.6554079152185073,-0.9402341198306913,0.5645161290322581,1.0,1.0,1/5,4.79%,ALDOB
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),-0.6013337007992785,-0.9402102466948493,0.6226415094339622,1.0,1.0,1/5,3.46%,CD74
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),-0.5912235192390835,-0.9399367098347502,0.6166666666666667,1.0,1.0,5/5,40.90%,ATPAF1;OXA1L;ATP23;TMEM70;ATP5F1D
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.4733748748748272,0.9397305295335928,0.5128205128205128,0.971762671671653,1.0,2/12,17.20%,TET1;DNMT1
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),-0.543003582690033,-0.9392165336358143,0.5689655172413793,1.0,1.0,2/11,9.94%,CHMP4B;CHMP2A
prerank,GO_Biological_Process_2021__cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.5963170727195828,0.939159791988285,0.5714285714285714,0.9726015489348226,1.0,1/5,5.90%,TICAM1
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),0.6497720693269545,0.9390753557498904,0.6,0.9721613597818892,1.0,3/5,12.86%,MDK;IL34;TENM4
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.4623777085400903,-0.9386361930944895,0.5737704918032787,1.0,1.0,3/26,4.11%,CGAS;B2M;ING2
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.551489226770996,-0.9385335241685302,0.6166666666666667,1.0,1.0,2/9,19.84%,PLAUR;PRR7
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.4586145507836224,0.9384884385096236,0.4166666666666667,0.9728250983006971,1.0,9/19,19.36%,SLC30A10;RAB27A;SLC25A33;SPHK2;ABCD2;TRAP1;GRIN1;PPARA;ABCD1
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.36771148556222455,0.9384232393233776,0.5806451612903226,0.9723245732004437,1.0,11/94,10.77%,NRG1;NRK;TGFB2;PRKCD;IGF1;ANGPT1;CLSPN;PAK5;MALT1;PIBF1;ADCY2
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.37539852752554526,0.9381258916117555,0.5897435897435898,0.9723019030625363,1.0,9/42,13.23%,SLC12A3;SLC12A1;GABRG3;GABRB1;GABRA3;ANO5;SLC6A1;GABRB3;ANO6
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.4510858398369491,0.9380837865211218,0.5555555555555556,0.9717763809525374,1.0,2/26,1.62%,RXFP2;GLP1R
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),0.48307069767287447,0.9379880506638011,0.6388888888888888,0.9714681730955993,1.0,3/15,8.48%,CARD18;IGF1;SERPINB1
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),0.395216188663168,0.9379468208415787,0.5517241379310345,0.9709092678888601,1.0,10/35,22.81%,CAMKMT;PRMT5;PRMT8;ETF1;NSD1;LCMT1;PRMT6;SNRPB;EHMT2;ICMT
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),-0.5540743456370123,-0.9378928522190749,0.5714285714285714,1.0,1.0,2/6,18.03%,C1QBP;UFD1
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.34996207430433324,0.9378489406622238,0.5652173913043478,0.9704982077905102,1.0,25/155,11.02%,HS3ST5;SPX;CIDEA;NFIB;EGFR;SPRED1;SPRED2;LAMA4;HDAC9;HEY1;MDK;SPRED3;MCC;WWC1;BRCA2;IL17RD;PTPRO;PTCH1;SFMBT1;SLC6A4;NOVA1;DUSP10;TWSG1;SRGN;PTPN23
prerank,GO_Biological_Process_2021__regulation of growth hormone secretion (GO:0060123),0.5832445072106068,0.9378472149376129,0.6304347826086957,0.9698542142883267,1.0,1/5,6.55%,CHD7
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),0.6059035024728484,0.9375430262574506,0.5454545454545454,0.9699196888564487,1.0,3/5,26.59%,SFSWAP;PRPF39;SRSF12
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),0.590479896534916,0.9374840388896167,0.5405405405405406,0.9694323785964483,1.0,2/6,27.62%,ROBO1;SLIT2
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),-0.5377847246583158,-0.9373982252700288,0.6065573770491803,1.0,1.0,1/11,5.92%,IFIT1
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.49271474327862924,0.9373656809838907,0.5526315789473685,0.9691269477259326,1.0,4/14,17.80%,MACROH2A2;SMARCB1;SMARCA4;SIRT7
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),-0.48889744497941506,-0.9372974555076234,0.578125,1.0,1.0,5/20,15.28%,NOTCH1;TBX1;MMP21;ODAD3;DNAH11
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),0.5156487623480508,0.9371493233358118,0.5135135135135135,0.969089279897307,1.0,2/11,6.93%,NRL;RPGRIP1L
prerank,GO_Biological_Process_2021__regulation of morphogenesis of an epithelium (GO:1905330),-0.6123974475461391,-0.9370004990317152,0.5964912280701754,1.0,1.0,3/5,24.52%,FGF1;ADAMTS12;GJA1
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),0.40457518166253487,0.9365135196668246,0.5555555555555556,0.9701548647463654,1.0,4/27,11.74%,SHLD1;TIMELESS;ERCC2;KMT5B
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),0.5216212730913127,0.936461378557037,0.5106382978723404,0.9696083958474242,1.0,1/9,1.59%,RAB7B
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.40730614489916667,-0.9363893006615625,0.5492957746478874,1.0,1.0,18/86,20.77%,EIF5A2;YBX3;MPV17L2;RPS27L;CCL5;RCC1L;RPL5;EEF2;NIBAN1;EIF2B5;NAT10;C1QBP;EIF6;FASTKD3;FXR1;UPF3B;RPS4X;RPS6KB2
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.45932715571958194,0.9363665168289557,0.4444444444444444,0.9692261891862698,1.0,4/17,27.92%,STX18;AKAP9;MYO5A;STX5
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.4679902845997179,-0.9363622571325789,0.5454545454545454,1.0,1.0,4/22,8.60%,STAT1;IL15;STAT5A;STAT4
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.4039963885209503,-0.9363401945469731,0.581081081081081,1.0,1.0,12/97,13.14%,UPB1;POLQ;HSD17B10;STEAP4;B2M;TRPA1;SOD2;ACOT13;RNF213;CHMP2A;GBP5;MCOLN1
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.5588928670806592,0.9363244975811614,0.6111111111111112,0.9687068598018133,1.0,2/7,5.57%,EREG;BTC
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),0.5904091237693785,0.9360483682629569,0.6285714285714286,0.9686867853732258,1.0,3/6,24.86%,APOE;ROCK2;LDLR
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.5349987569496787,0.9357356836839469,0.5609756097560976,0.9688385447104679,1.0,1/12,5.96%,SOX12
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.44756992073802554,-0.9357348222570325,0.53125,1.0,1.0,4/26,12.08%,BNIP3;PINK1;GHITM;SLC25A5
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),-0.5953032494272292,-0.9355893897691397,0.6101694915254238,1.0,1.0,1/6,2.84%,CAV3
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.4130898440937395,-0.9355048378244128,0.53125,1.0,1.0,11/64,15.72%,DENND1C;SYTL1;JUNB;IRF1;ZBTB7B;ISG20;CTDSP1;SIGIRR;B3GALT4;RHBDF2;OSTF1
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.5129652012778577,-0.9354270556307893,0.5409836065573771,1.0,1.0,2/17,10.26%,CAV3;PDGFRB
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),0.4623490978690399,0.9353183708075683,0.5142857142857142,0.9692733993990084,1.0,6/13,23.26%,ENPP1;ENPP3;AK5;AK3;ITPA;SMPDL3A
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.5128325867636707,0.9350735091264807,0.43243243243243246,0.9692272544849717,1.0,4/12,20.87%,TPR;CDK5RAP2;LCMT1;PCID2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.4291396311831261,-0.9349673104397451,0.5076923076923077,1.0,1.0,12/55,17.67%,BCL2L2;CDKN2D;YBX3;PINK1;SOD2;DNAJA1;TRIM32;HERPUD1;PLAUR;SYVN1;SNAI2;ACKR3
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.45316870061259684,-0.9349655444118103,0.5606060606060606,1.0,1.0,3/31,9.10%,TCP1;CCT6A;CCT8
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.42966256547229,0.934861288458111,0.5789473684210527,0.9693440650841187,1.0,5/23,10.86%,NTNG1;IL1RAPL1;CTNNA2;ZNF804A;MARK1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),0.5692352130756939,0.9346976842744869,0.6136363636363636,0.9691522822353827,1.0,1/6,3.80%,ADAMTS3
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),0.4086900876054661,0.9345216828184163,0.48,0.9689008163904775,1.0,9/62,9.61%,PTPN3;PTPRK;BMP7;LATS1;BTG2;BRINP1;ZBTB17;HECA;TFAP4
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),0.5419095124534659,0.934253045527381,0.5652173913043478,0.9688807068761457,1.0,2/6,21.57%,CEP135;MAP4
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),-0.4001608405913596,-0.9341320367656542,0.5857142857142857,1.0,1.0,12/70,11.18%,CA12;SLCO6A1;SLC22A25;MGST1;SLCO2B1;SLC52A2;AQP9;ABCC6;LRRC8D;SLCO4C1;CA1;CYB5R2
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),0.46626158379211624,0.9340990727425832,0.4883720930232558,0.9685271383427266,1.0,4/17,19.91%,ADCY2;GUCY1A1;ADCY9;ADCY8
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),-0.5650743007937908,-0.934060973128157,0.6415094339622641,1.0,1.0,1/6,9.52%,G6PD
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),-0.4374943512049998,-0.9340172921334434,0.5178571428571429,1.0,1.0,13/38,17.98%,TNFSF18;PTPRC;PDCD1LG2;IL4I1;HLA-DPB1;IL15;NCKAP1L;CD6;CCL5;HLA-DMB;SFTPD;TNFSF9;IL6ST
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.46752770628998097,0.933956174779095,0.5897435897435898,0.9682509412127994,1.0,1/23,0.36%,TBX6
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.444143162063371,-0.9339109845820391,0.5901639344262295,1.0,1.0,11/39,19.94%,WEE2;TGFB1;TOM1L1;ZWILCH;CDKN1B;GAS1;CHEK1;BUB1B;NME6;RGCC;NABP1
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.3814582694898817,-0.9338730278095426,0.618421052631579,1.0,1.0,18/129,10.63%,KCNE2;RIBC2;ACTC1;PROP1;STAG3;PLAG1;PDE6B;CALCB;SOX10;CHRNG;SLC29A3;ZC2HC1C;SERPINA10;MYOT;KCNMB1;NRIP2;HSD11B2;EFHD1
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),-0.5757597124487814,-0.9335837436541531,0.5901639344262295,1.0,1.0,1/8,2.24%,SMIM22
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),-0.5015085357769862,-0.9335222710062968,0.5263157894736842,1.0,1.0,3/16,9.94%,CHMP4B;CHMP2B;CHMP2A
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle recycling (GO:1903421),-0.5998287781209322,-0.933497756790108,0.576271186440678,1.0,1.0,2/5,24.31%,CDK5;PLAA
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),0.3424011427070898,0.9334736333516332,0.6285714285714286,0.9687436791594375,1.0,6/75,5.06%,PID1;WWTR1;PPP1R8;ZBED3;PRR5L;EPHB2
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.4170008994431752,-0.9334086359900551,0.6,1.0,1.0,9/58,8.54%,C3AR1;AGT;TRHR;DRD3;P2RY12;P2RY1;PTGER3;ADRA1D;LPAR6
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.3745627637156516,-0.9333969328818306,0.5844155844155844,1.0,1.0,11/125,5.03%,CD44;NES;SCN4B;COL9A1;RDH10;TIMP3;LRP4;AGT;ANGPTL2;GSTM5;COL6A1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.5184194847490583,-0.9333689391455591,0.5555555555555556,1.0,1.0,2/11,13.97%,IGFBP5;TPM1
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),-0.3806066966987082,-0.9331977612968687,0.5769230769230769,1.0,1.0,22/140,16.01%,TRIM58;PTPRC;TRIML2;YBX3;AHR;ATP1B1;TRIM22;RASA1;TXK;RNF39;TRIM5;REST;PRDM6;PCBP1;CGGBP1;FLOT1;CAVIN4;ATXN7L3B;ANKRA2;CDK4;NANOG;SHH
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),0.5599672163542123,0.933147410371922,0.5192307692307693,0.9681409148727333,1.0,4/6,20.40%,JAG1;MAGI2;NPHS1;MYO1E
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),0.5599672163542123,0.933147410371922,0.5192307692307693,0.9681409148727333,1.0,4/6,20.40%,JAG1;MAGI2;NPHS1;MYO1E
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.4869380237886486,0.9327826554808204,0.4857142857142857,0.9683855925743328,1.0,3/14,7.13%,NRP1;MDK;IGF1
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),0.4357971599687801,0.9325874528853734,0.47058823529411764,0.9683233249370858,1.0,1/26,0.25%,GPC4
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),0.41216624878244257,0.932536190887934,0.5588235294117647,0.9678015008110912,1.0,4/32,5.46%,KIT;ITGA4;HDAC9;RABL3
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),-0.5534579298017459,-0.9325275593257647,0.6440677966101694,1.0,1.0,4/12,20.46%,WFS1;LPCAT3;MBTPS2;NUPR1
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),-0.5779999407011296,-0.9322114649993475,0.6779661016949152,1.0,1.0,2/9,5.86%,ALOX12;ADAMTS18
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.5348651755889267,-0.9321005317267017,0.5964912280701754,1.0,1.0,3/10,11.58%,CASP8;SCIMP;FADD
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),-0.5063574418012581,-0.9319148648005844,0.6166666666666667,1.0,1.0,7/13,38.06%,ETFB;ETFDH;NDUFA5;ETFA;ETFRF1;PPARGC1A;ENOX2
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.36320900182783594,0.9318644281500763,0.46153846153846156,0.9687519401495498,1.0,27/171,14.51%,FRMPD1;ITGA4;RAB3C;FGF13;PKP2;RAB32;KCNB2;KCNIP4;LRRC7;PTCH1;LIN7A;NRXN1;NLGN1;BSG;TSPAN17;DPP6;ZDHHC3;EHD4;RAB40A;ABHD17A;CACNB2;SPTBN4;LRP6;MAGI2;ZDHHC2;DLG2;BRAF
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.4583299617382712,0.9317896539173443,0.5405405405405406,0.9682985228745676,1.0,6/18,23.51%,PARD3;FERMT1;SIPA1L3;OPHN1;MYO9A;RAP2A
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),-0.5207331736081693,-0.9317737022242417,0.6774193548387096,1.0,1.0,3/18,15.93%,DRD3;GRM3;AKAP5
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),-0.46479605723679634,-0.9317446255978599,0.5671641791044776,1.0,1.0,5/23,22.39%,LMAN1;HERPUD1;SYVN1;UFD1;HSP90B1
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.4361207405457954,0.9317195568151874,0.45714285714285713,0.9678881725833055,1.0,2/16,8.06%,COBL;ARID5B
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.4850912243032154,-0.9315024729504575,0.5714285714285714,1.0,1.0,8/20,17.98%,CYP1B1;NODAL;NOX1;TGFB1;BRCA1;CCBE1;CXCL17;IL6ST
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),-0.5952278404054763,-0.9314364489327223,0.6507936507936508,1.0,1.0,2/7,19.20%,PRDX3;NOS1
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.5415348908710196,-0.9314085739993235,0.625,1.0,1.0,2/13,15.73%,UFM1;ULK1
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.36175075853798383,0.9311280409947632,0.5,0.9687602912422558,1.0,6/80,6.73%,ACE2;PID1;GREM1;SLCO1C1;AKR1C3;APOE
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.4448340856103784,-0.9310417596481564,0.5671641791044776,1.0,1.0,8/33,11.58%,ZFPM1;TXK;HLA-DPB1;CD14;IL18;HLA-A;IL18R1;FADD
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),-0.5106738991184622,-0.9308614756810986,0.578125,1.0,1.0,4/15,17.98%,STAT1;SPI1;YAP1;IL6ST
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.4338760381063961,0.9306133044586457,0.4482758620689655,0.9693937194189228,1.0,5/32,7.07%,ACE2;SLC26A3;CAPN13;GALNT12;REP15
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.4175568472878538,0.9304510083384044,0.5625,0.9691445506140242,1.0,13/31,23.99%,SOCS6;PI4K2A;PIP4K2A;PIK3R1;SOCS2;IP6K1;PIK3C2B;IP6K2;EFR3B;PI4K2B;SMG1;PI4KA;SOCS4
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,0.34397137683084456,0.9303370252075843,0.5925925925925926,0.9687177713279861,1.0,12/106,9.52%,LRIG3;NPNT;LAMB2;WWTR1;EGFR;SDC4;BTC;PXDC1;GNG12;SCNN1B;PERP;AMOTL2
prerank,GO_Biological_Process_2021__inner ear receptor cell development (GO:0060119),-0.6005213913242105,-0.9301311778562832,0.5961538461538461,1.0,1.0,2/7,25.39%,PDZD7;LRTOMT
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.3440806603181328,0.9301193203502902,0.5833333333333334,0.9685286385020138,1.0,21/115,13.87%,B3GALT9;ALG8;GAL3ST1;MOGS;ST3GAL3;MGAT4C;C1GALT1C1;GALNT7;GALNT10;TET2;GALNT18;TET1;ALG12;FUT9;ST3GAL1;MAGT1;ST8SIA3;GCNT2;ST3GAL2;DPM3;ST8SIA4
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.48776790227238537,-0.930111703967667,0.5652173913043478,1.0,1.0,8/19,17.98%,CYP1B1;NODAL;NOX1;TGFB1;BRCA1;CCBE1;CXCL17;IL6ST
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),0.49928169445400855,0.9300582907625098,0.5,0.9679928065423686,1.0,5/20,12.73%,STAC;CBARP;NOS1AP;DRD4;CACNB2
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),-0.5340448088267615,-0.9293277491936162,0.6029411764705882,1.0,1.0,3/17,12.80%,F11R;DAB2IP;GMIP
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),-0.4319534165252817,-0.9292722416099967,0.5909090909090909,1.0,1.0,7/28,23.01%,ATP5IF1;SCN7A;SCN9A;CACNA1G;YWHAH;CACNA1H;SCN11A
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.43759942179286876,-0.9292410590455863,0.47368421052631576,1.0,1.0,2/24,4.59%,CAV3;FKBP1B
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),0.5738396456296307,0.9291622430132959,0.6666666666666666,0.9694195956607468,1.0,3/7,19.36%,SLC27A2;ABCD2;ABCD1
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),0.37655498189255987,0.9291606427845558,0.5333333333333333,0.9687909188801627,1.0,8/72,12.56%,LRRTM3;SAMD4A;PRR16;ELAVL1;PRKCD;SLC2A13;SPHK2;EIF3E
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),-0.4625169825049618,-0.9290909769775522,0.5689655172413793,1.0,1.0,1/28,0.11%,NPY
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),0.5969798789005298,0.9289869754925472,0.6136363636363636,0.9686782394806387,1.0,1/6,5.90%,TICAM1
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),-0.47625749404014667,-0.9288777914896488,0.6,1.0,1.0,3/23,2.93%,IHO1;RNF212B;STAG3
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.34944493197567394,-0.9288082678356009,0.6666666666666666,1.0,1.0,44/306,12.67%,HCK;CD4;PRLR;DOCK8;PTGIS;DUOX1;GBP6;PLP2;LDLRAP1;YBX3;IL3RA;OSMR;IL20RA;JUNB;STAT1;IRF1;CTF1;IFIT1;TGFB1;IL7;NDN;FLT3;CRLF1;IFNGR2;EPRS1;STAT5A;STAT4;PIK3CB;DAB2IP;GPER1;SIGIRR;IL18BP;IL18;BRCA1;CCL5;IFNLR1;TEC;IL18R1;TXLNA;LBP;TCF7;GBP5;BAG4;INPPL1
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.3388847685740305,0.9284309190332727,0.6086956521739131,0.9694519212513271,1.0,28/121,15.18%,IRS1;ZBTB20;PRR5L;TICAM1;LIN28B;PRKCD;APOE;HMGB1;IGF1;IRS2;PLIN5;FAF1;PRKD1;ATF6;MID2;SLC4A4;KHSRP;PNPLA2;FOXO1;ABCD2;RC3H1;PNPT1;PFKFB3;VGLL4;DHRSX;ZC3H18;AKT2;TRIM8
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.49991985260842253,-0.9283662256204829,0.4838709677419355,1.0,1.0,2/11,6.83%,TGFB1;IFI27
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),-0.5788806572455893,-0.928330593013607,0.5555555555555556,1.0,1.0,3/6,18.87%,FADD;IL6ST;SKAP1
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),0.5036351022951113,0.9279010972958611,0.53125,0.9702752095842359,1.0,3/13,14.09%,SHISA9;GRIK2;PPFIA3
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),-0.5559738790489281,-0.9279010133848032,0.578125,1.0,1.0,3/14,15.91%,HSPA5;BCAP31;GABARAPL2
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),-0.5094971555125729,-0.9278554539272708,0.5645161290322581,1.0,1.0,7/11,35.53%,LAMP1;AP4M1;GAK;RBSN;ANKFY1;LAPTM5;AP1G1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),-0.5711409165355961,-0.9275715942927731,0.5970149253731343,1.0,1.0,1/8,2.84%,CAV3
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),-0.5124921661632706,-0.9274769698665727,0.576271186440678,1.0,1.0,3/13,13.97%,ABCB1;ABCB4;PSAP
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.39111352306729263,-0.927453164213504,0.6056338028169014,1.0,1.0,15/67,13.93%,MYLK;EPAS1;PLP2;BNIP3;B3GNT3;CAPN1;KLF5;CBLC;CLDN1;DUOXA1;MYOF;HEBP2;LTBR;SRPX2;PKP1
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.4282060296200643,-0.9274522459335938,0.547945205479452,1.0,1.0,8/39,19.04%,TCP1;SOD2;STAT4;CA1;MSN;HSPA9;ARF1;CFL1
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.4539645555624318,-0.9273176675681635,0.5303030303030303,1.0,1.0,9/30,20.73%,BIK;BNIP3;SOD2;BOK;IFI6;VPS35;NAIF1;HSPD1;ATG3
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.5191584656160331,0.927242353249724,0.5454545454545454,0.9713165927421203,1.0,2/11,5.05%,GMDS;B4GALNT2
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),-0.40409905170300275,-0.9268449829925971,0.5797101449275363,1.0,1.0,9/70,15.77%,C4BPB;GPC3;DAB2IP;TRIM32;MSN;VPS35;CDKN1B;C4BPA;ADAM9
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),0.5097400316644076,0.9266366094568331,0.5555555555555556,0.9723060869093859,1.0,3/7,28.14%,CHTOP;GTF2H2;MSH3
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.43682009324760385,-0.9266079243841814,0.5964912280701754,1.0,1.0,2/36,5.85%,EPHA1;RAC1
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),-0.4772247309088568,-0.9265868933773802,0.5714285714285714,1.0,1.0,3/21,4.38%,HSD17B10;BAAT;ACOX2
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),-0.5558137597394225,-0.9265867979114538,0.631578947368421,1.0,1.0,3/9,10.35%,PTGES;OSMR;GSTP1
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.3806969478522008,0.9264627654571844,0.5454545454545454,0.972157827338148,1.0,21/163,6.35%,CREB5;KIF6;PTPRT;LRRTM3;PEX5L;TNR;ITPR2;SGK2;MAPK4;KLK6;ADGRA1;VLDLR;FAM163B;DPY19L1;RGS7BP;GRIA2;GRM5;NTSR2;DSCAML1;SLCO1C1;MYO1D
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),-0.48809119816224716,-0.9262649866179182,0.6101694915254238,1.0,1.0,4/16,15.07%,CTNNA1;UFM1;APOD;RAB23
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.4125948158413908,-0.9258412250216346,0.5972222222222222,1.0,1.0,8/64,10.35%,EPHA1;RASIP1;ARHGAP15;ARHGAP9;ATP5IF1;VAV3;DAB2IP;FGD3
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),-0.5760856366556624,-0.9256294904623813,0.6140350877192983,1.0,1.0,1/7,7.99%,DPYS
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.5387199952490559,0.9254459185918695,0.6388888888888888,0.9740204425392308,1.0,3/8,19.00%,SIRT1;PKIA;PKIG
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.3933218791320039,-0.9254290909980261,0.620253164556962,1.0,1.0,19/77,15.36%,PTPRC;CGAS;BNIP3;STAT1;IRF1;IFIT1;IFI27;AGBL5;TRIM5;ISG20;IFIT3;IFNLR1;FADD;SERINC3;IFI6;TLR2;IFIT5;PLA2G10;OAS3
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.4354261126379777,0.9253180602393121,0.5714285714285714,0.9737451561344981,1.0,6/22,17.94%,ZBTB20;IGF1;SLC4A4;PFKFB3;PDGFB;NFKB1
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),-0.40911232732628244,-0.9242907920949048,0.5633802816901409,1.0,1.0,25/72,26.39%,HSD17B10;GOT1;SDS;IL4I1;GAD1;BCAT2;SLC25A44;ALDH4A1;ACMSD;AMDHD1;PIPOX;BCKDK;NOS1;DAO;SARDH;ABAT;ACAD8;FAH;DBT;GSTZ1;IDO1;ARG1;KMO;ASPA;DLST
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.47072943513932664,0.9242689158291827,0.47058823529411764,0.975360686560363,1.0,4/11,9.36%,SLC22A2;OXTR;APLN;ERBB4
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.5031390945503197,-0.9242643948463086,0.5806451612903226,1.0,1.0,5/14,23.14%,C10ORF90;BRCA1;PLK4;MDM1;CEP76
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.3805231621825203,-0.9240151886280064,0.6533333333333333,1.0,1.0,25/110,22.69%,MCM2;GMNN;CDC6;PSMB6;RPA3;CHAF1A;PSMB8;PSMA3;PSMC3;NAP1L2;H2BC18;PSMC6;PSMA5;RBX1;DAXX;CHAF1B;PSMA7;PSMD12;H3-3A;PSME1;GRWD1;SPTY2D1;RPS27A;PSMB2;H2BC5
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),-0.5697785357417777,-0.9239945496284409,0.7058823529411765,1.0,1.0,2/8,29.88%,SUPT5H;CTR9
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),-0.3852394858406669,-0.9235747535220235,0.6056338028169014,1.0,1.0,17/121,11.38%,CYP1B1;ZNF703;CTNNA1;P2RY12;AHR;P2RY1;KCNQ1;TGFB1;SSTR1;AQP9;ATP1A1;IGFBP5;GPER1;IL18;BRCA1;CCL5;ABCB4
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.5445746964075828,-0.9234893080474259,0.6129032258064516,1.0,1.0,2/10,8.81%,CIITA;TRIM5
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),-0.6059054735089767,-0.9232007931072945,0.6724137931034483,1.0,1.0,2/7,15.04%,RARRES2;PLCG2
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),0.5724350248098261,0.9231028990637572,0.631578947368421,0.9774359502609643,1.0,2/8,19.19%,PDSS2;PDSS1
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),-0.5996896491859305,-0.92301672649868,0.6206896551724138,1.0,1.0,2/6,16.92%,RNF26;HOOK2
prerank,GO_Biological_Process_2021__negative regulation of heart rate (GO:0010459),0.5395051057321828,0.9229672990204809,0.5897435897435898,0.9772009525039901,1.0,3/6,13.17%,SPX;RNLS;SPTBN4
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.46831103387166373,-0.9228711503290052,0.5689655172413793,1.0,1.0,6/22,21.74%,CCDC39;WNT7B;PCSK5;SHH;FGF1;FGF7
prerank,GO_Biological_Process_2021__bundle of His cell to Purkinje myocyte communication (GO:0086069),0.5737405679001877,0.9227482213563933,0.5681818181818182,0.9762960808706753,1.0,1/5,2.71%,PKP2
prerank,GO_Biological_Process_2021__bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073),0.5737405679001877,0.9227482213563933,0.5681818181818182,0.9762960808706753,1.0,1/5,2.71%,PKP2
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,0.36162628808582586,0.9227097769277407,0.5416666666666666,0.975777516929267,1.0,16/103,10.27%,LRIG3;LAMB2;SVEP1;WWTR1;DUSP5;EGFR;SDC4;FRAS1;COBLL1;HTRA1;PXDC1;GNG12;AMOTL2;FZD1;TWSG1;ST3GAL1
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.4642663234013885,-0.9226069778713534,0.578125,1.0,1.0,7/29,18.68%,TBPL2;TBP;TAF7;TBPL1;TAF6;TCEA2;TTF1
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.4119328793807699,-0.9225364865159371,0.6031746031746031,1.0,1.0,12/45,7.77%,GNLY;CD4;PTPRC;TMC8;ARHGAP9;CD37;GMFG;NOTCH1;MYO1F;CD27;NCKAP1L;CORO1A
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.4488167459243224,-0.9224403253777597,0.5901639344262295,1.0,1.0,6/32,17.72%,CAMLG;EMC1;OTOF;EMC3;CCDC47;TRAM2
prerank,GO_Biological_Process_2021__negative regulation of T cell differentiation (GO:0045581),-0.6025130939675857,-0.922351177620271,0.5818181818181818,1.0,1.0,2/5,8.28%,IRF1;GLI3
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.4146551038478632,-0.9219962080896612,0.5352112676056338,1.0,1.0,9/34,14.12%,TIMP3;AGT;TIMP2;SERPINE1;SERPINI2;SERPINA10;KNG1;TIMP4;SERPINF1
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),-0.5076502904750058,-0.9219211565235573,0.6029411764705882,1.0,1.0,8/17,32.63%,CCL5;EIF2B5;RPS6KB2;YTHDF1;POLR2D;DDX3X;UHMK1;BOLL
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),-0.4850398498258243,-0.9217583730840191,0.6507936507936508,1.0,1.0,9/20,28.64%,ZACN;HVCN1;SLC30A8;KHK;GLRA1;SLC30A4;MT1G;D2HGDH;SLC30A5
prerank,GO_Biological_Process_2021__diadenosine polyphosphate catabolic process (GO:0015961),0.5680266350506924,0.9216606582576479,0.5277777777777778,0.9774608435721569,1.0,2/5,19.34%,FHIT;NUDT10
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),-0.47499817788477394,-0.9212441750908946,0.5185185185185185,1.0,1.0,3/22,6.30%,ITK;P2RY12;TXK
prerank,GO_Biological_Process_2021__positive regulation of dopamine receptor signaling pathway (GO:0060161),-0.5973969550514064,-0.9210475462170099,0.6190476190476191,1.0,1.0,2/5,13.62%,DRD3;VPS35
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.3643055144474657,0.9210391545362138,0.6333333333333333,0.97838922208548,1.0,11/66,12.53%,ATOH8;KDR;NRP1;VASH1;APOE;ANGPT1;PRKD1;SCARB1;RIN2;SVBP;PTPRM
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),-0.5566824343269121,-0.9208790743451913,0.5535714285714286,1.0,1.0,4/9,22.39%,HSPA5;MBTPS2;CALR;HSP90B1
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),-0.3841445652607771,-0.9208214516957364,0.647887323943662,1.0,1.0,7/69,8.91%,MARVELD2;PPFIBP2;LRP4;TGFB1;WNT7B;MYOT;CLDN1
prerank,GO_Biological_Process_2021__collecting duct development (GO:0072044),-0.6076504412264183,-0.920675222085451,0.68,1.0,1.0,3/5,16.01%,WNT7B;DACT2;SHH
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),0.4696221827149597,0.9201936657503325,0.5135135135135135,0.9798848173622767,1.0,3/11,5.24%,TGFBR1;BMP6;TGFB3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),0.5706003342444974,0.9201916643396043,0.6153846153846154,0.9792650396483877,1.0,3/8,18.26%,MDK;LTK;PPP1R10
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),-0.5251681213049014,-0.9199464059492025,0.5409836065573771,1.0,1.0,2/11,14.27%,ARCN1;RIPOR1
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.5260551273507555,-0.9199268010696936,0.5538461538461539,1.0,1.0,4/14,9.89%,CARD8;SCIMP;TRIM5;SIGIRR
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",-0.4824065210620661,-0.9195630216331216,0.5806451612903226,1.0,1.0,4/21,16.88%,DNASE2;H1-0;DNASE2B;DNASE1L1
prerank,GO_Biological_Process_2021__positive regulation of cell activation (GO:0050867),-0.6038972916319728,-0.9193282035259768,0.6428571428571429,1.0,1.0,4/5,38.78%,RPS6KA1;PLA2G4A;SOX15;TTBK1
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),-0.6085171186829184,-0.9193086563957664,0.6379310344827587,1.0,1.0,3/6,26.70%,DDX1;SSB;DDX3X
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),-0.40604969649171047,-0.9191236083882053,0.576271186440678,1.0,1.0,2/57,4.66%,F8;LMAN1
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),-0.40604969649171047,-0.9191236083882053,0.576271186440678,1.0,1.0,2/57,4.66%,F8;LMAN1
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.40604969649171047,-0.9191236083882053,0.576271186440678,1.0,1.0,2/57,4.66%,F8;LMAN1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",0.41505636516129885,0.9190737783055797,0.4864864864864865,0.9811922655107325,1.0,4/25,12.44%,TXNL4A;SF3B4;KHSRP;SRRM1
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.3720877912401271,-0.9190165354433103,0.6623376623376623,1.0,1.0,15/118,14.24%,FOXM1;ARHGAP15;ARHGAP9;RASGRF2;DEPDC1B;RAC1;VAV3;ARHGAP22;TAGAP;FGD3;A2M;PREX1;RHOH;GMIP;ARHGAP12
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),-0.5523005083261294,-0.9189817935691055,0.6666666666666666,1.0,1.0,5/10,25.22%,STEAP4;STEAP2;ATOX1;CUTC;SLC31A1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3513072296539572,0.9188134237693285,0.5555555555555556,0.981239874994606,1.0,12/81,8.76%,CIDEA;ZEB2;PMEPA1;SPRED1;SPRED2;TGFBR1;LATS1;SPRED3;IL17RD;HSPA1A;SMAD2;TGFBR3L
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),0.5174961395307984,0.9186796000449308,0.6046511627906976,0.9807955083703593,1.0,3/10,12.54%,PCM1;CCDC120;HOOK3
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.5083676270764488,0.9183124038592817,0.5333333333333333,0.9809599616585212,1.0,3/9,16.15%,SNCAIP;HSPA1A;DNAJB2
prerank,GO_Biological_Process_2021__T-helper 1 type immune response (GO:0042088),0.5861298235122623,0.918154521084129,0.625,0.9807245140368098,1.0,2/5,7.04%,LEF1;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),-0.45381822988453496,-0.9180951352654191,0.6060606060606061,1.0,1.0,3/29,9.10%,TCP1;CCT6A;CCT8
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.43121841281384005,-0.9179983391062355,0.5,1.0,1.0,6/29,14.35%,LDLRAP1;SOD2;IGFBP5;GPER1;TPM1;CDKN1B
prerank,GO_Biological_Process_2021__elastic fiber assembly (GO:0048251),-0.6000195879504646,-0.9178211191059061,0.56,1.0,1.0,1/5,4.79%,FBLN5
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),-0.37715458088159837,-0.9177282426085496,0.6712328767123288,1.0,1.0,25/107,24.64%,WIPI1;LIX1L;CHMP4B;PINK1;CHMP2B;TOMM20;MAP1LC3B2;CHMP2A;TOMM7;TOMM22;MAP1LC3B;ULK1;GABARAPL2;VDAC1;LAMP2;PRKAB2;FUNDC1;ATG3;VPS4A;DYNLL1;GABARAPL1;ATG14;VPS37B;PLAA;VPS28
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),-0.4188716327430266,-0.9175292272862463,0.5735294117647058,1.0,1.0,5/36,15.37%,MARVELD2;F11R;CLDN1;CLDN20;CLDN10
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.38931477281932647,0.9174273703274017,0.47368421052631576,0.9819373208584121,1.0,2/36,2.31%,PID1;BCL2
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.3738260750067077,0.9173015883433939,0.5625,0.9816599687169605,1.0,12/38,14.78%,TRAF3;APOE;FAF1;FAM83D;SSH1;PM20D2;MAPK8;SNF8;NEDD4L;MAPK7;ZDHHC2;CHEK2
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.46074463569463386,-0.9172057419729862,0.578125,1.0,1.0,3/25,4.38%,HSD17B10;BAAT;ACOX2
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),-0.41759609874626913,-0.9170507155653177,0.5866666666666667,1.0,1.0,15/43,19.42%,ODAD4;CCDC39;TEKT3;ODAD3;ROPN1L;DNAH11;CABYR;DNHD1;CFAP54;DNAH17;DNAH7;DNAH9;SPAG17;RSPH9;DNAI3
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),0.49021699491496873,0.9167038049734306,0.5652173913043478,0.9827792114512083,1.0,2/12,8.42%,SYNJ2;INPP1
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),0.4899370668222471,0.9166047754939531,0.5882352941176471,0.9823521743557567,1.0,2/9,13.89%,TIMELESS;SPIDR
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),0.35420653510141137,0.9162362652495201,0.5,0.9825565095119201,1.0,25/131,12.39%,ITGB5;LAMB2;LMCD1;SVEP1;PDE3A;KDR;WWTR1;FNDC1;BMP6;LAMA4;GXYLT2;TAMALIN;TMTC2;HTRA1;PXDC1;GNG12;P3H3;AMOTL2;ATL2;FKBP7;SMOC1;TRIM47;PER3;FAM114A1;CHST12
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),-0.39481458041365874,-0.9161433714150747,0.7183098591549296,1.0,1.0,18/99,16.24%,ANKS4B;WFS1;CHAC1;RASGRF2;HSPA5;BCAP31;DAB2IP;RCN3;UFM1;ERLEC1;FLOT1;HERPUD1;MBTPS2;NIBAN1;SYVN1;ATP2A3;EIF2B5;CCDC47
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,0.4029049791367539,0.9159645159085062,0.6129032258064516,0.9824619613559612,1.0,3/33,1.93%,F11;RIMBP2;SLC39A11
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.43360582448300555,0.9158646736584598,0.5277777777777778,0.9820359410298364,1.0,3/25,7.17%,CIDEA;IGF1;PTPN6
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.42876897965323685,-0.915603460051597,0.5694444444444444,1.0,1.0,8/37,19.04%,TCP1;SOD2;STAT4;CA1;MSN;HSPA9;ARF1;CFL1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3632015118909993,0.9154317807210196,0.6285714285714286,0.9825714691775257,1.0,8/64,8.43%,SULF2;VWC2L;VWC2;CRIM1;SPRY3;GREM1;APLN;CASK
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),-0.3925289279787012,-0.9154009959009121,0.5921052631578947,1.0,1.0,10/69,17.05%,WFS1;LRPAP1;BNIP3;CHMP4B;PINK1;CHMP2A;HTR2B;VPS35;KANK2;CCN3
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.49048464089549715,0.9144792061485113,0.5555555555555556,0.9841577851733792,1.0,2/14,10.92%,ZBED3;ESPL1
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),-0.5202949185470387,-0.9144588865216109,0.5909090909090909,1.0,1.0,1/13,0.17%,CALB1
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),0.40188440420666466,0.9143806592864243,0.6551724137931034,0.9837645956865828,1.0,2/33,3.30%,UNC13C;UNC13B
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),0.5507636540843847,0.9142662482700019,0.6590909090909091,0.9834793991991599,1.0,1/6,12.17%,SELENON
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),0.4954023746077526,0.9138840969840094,0.59375,0.9838721737047561,1.0,2/9,6.65%,F2RL1;PRKCD
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),-0.5518149045137036,-0.9138773674019764,0.7166666666666667,1.0,1.0,1/10,1.68%,NOTUM
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),-0.37613785010857037,-0.9135330547449847,0.6619718309859155,1.0,1.0,13/110,17.67%,AMBP;HSPG2;AMN;LDLRAP1;ASGR1;HIP1R;RAB31;LRP2;WASF1;STAB1;SFTPD;HSPH1;ACKR3
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),-0.39619683136030737,-0.9132131138607336,0.609375,1.0,1.0,4/62,8.84%,HCK;NES;NCKAP1L;GPSM2
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.30235382346047884,0.9130141538846815,0.5263157894736842,0.9853958363074677,1.0,47/319,15.62%,FBXL7;RNF150;MYLIP;RNF126;FEM1A;RNF217;CDC26;RNF130;ERCC8;PTTG1;RBBP6;RNF128;ANAPC16;ZNRF1;UBE3D;FAF1;PELI1;AGAP3;KCTD21;UBE2D4;UBAP1L;CDC23;PTPN23;UBXN2A;WDR81;TRIM71;KLHL25;RC3H1;TSG101;RNF216;KCTD5;HECW2;NEDD4L;KLHL42;SIRT2;KLHL20;WWP1;SIRT1;BTRC;RNF19B;UBE2U;FBXL17;UBE2R2;ANAPC7;OTUD7B;OTUD7A;FBXO45
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.33668056814534664,0.9128826341985723,0.625,0.9850688832844937,1.0,24/103,18.86%,EYA4;TBL1Y;HDAC9;PRKCD;PRDM5;HDAC1;PRMT8;CCNA2;EYA2;EYA3;RUVBL2;SIRT2;SIRT1;EP300;UBE2U;HDAC10;SIN3A;AURKC;HDAC5;SIRT7;CREBBP;BAZ1B;NSD1;KAT6B
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.5072570937803195,0.9127603693806243,0.5957446808510638,0.9847423441261058,1.0,2/8,13.24%,PDGFRA;ID2
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),0.567874355466852,0.9126240582926871,0.574468085106383,0.9844162180469821,1.0,2/6,14.37%,FYN;FRRS1L
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.49781762656575695,-0.9125911649242616,0.6031746031746031,1.0,1.0,4/13,18.89%,MPV17L2;RCC1L;C1QBP;FASTKD3
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),0.3365665247101835,0.9120840138595135,0.6111111111111112,0.9850789935453534,1.0,28/198,10.40%,UBASH3B;PID1;RGS14;PTPRT;IRS1;NFATC1;SULF2;BCL2;EGFR;KANK1;HEY1;WWOX;SPRY3;ENPP1;ACVR1;RITA1;PRKCD;RPGRIP1L;KIF26A;PTCH1;PRKCB;APLN;PLIN5;KCTD21;PTPN12;PTPRE;MOSMO;CILP
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.5117788997293626,-0.9120577744850732,0.6086956521739131,1.0,1.0,3/13,12.18%,BCAP31;SVIP;ERLEC1
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),-0.38440242973179634,-0.9119164700809189,0.6229508196721312,1.0,1.0,19/60,28.62%,TPX2;CENPK;CHMP4B;RAB11A;CHMP2A;ABRAXAS1;MZT1;KIF11;CTDP1;NDEL1;NCAPG2;DSN1;GOLGA2;KLHDC8B;UBE2S;RAN;TUBG2;EPS8;STAG2
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),-0.49084054750365497,-0.9117148195383232,0.5833333333333334,1.0,1.0,4/13,16.58%,DRD3;NOTCH1;PTPRZ1;DAAM2
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),-0.45286720331016883,-0.9113518791428279,0.5757575757575758,1.0,1.0,8/31,16.01%,ODAD4;CCDC39;NOTCH1;TBX1;MMP21;ODAD3;DNAH11;SHH
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.4752052311984869,0.9111707816367828,0.5897435897435898,0.9867040998973923,1.0,3/13,15.99%,NGF;FRS2;DDIT4
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.4568332712260028,-0.9111462212024628,0.6060606060606061,1.0,1.0,2/26,5.85%,PTGIS;RAC1
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.3456353985845192,0.9111339704471999,0.6363636363636364,0.9862374938306712,1.0,24/117,10.71%,RIMBP2;SEMA6D;GRIA4;KCNIP1;RAB3C;MAPK4;CACNA2D1;ADGRA1;RGS7BP;UNC5D;GUCY1A2;GRIA2;KCTD16;LSAMP;SHC3;BRINP1;TMEM196;PLD2;NRXN1;CSRNP3;CNTN1;RBFOX1;PCDH17;ADGRB3
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.41797977010305354,0.9111137771600529,0.4722222222222222,0.9856481492508292,1.0,9/32,17.07%,TGM1;EREG;JAG1;AKR1C3;HDAC1;ERCC2;CERS3;WNT5A;ERCC3
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),0.538254728598207,0.9108400883938386,0.5686274509803921,0.9857579618609381,1.0,1/6,13.24%,PHF1
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),-0.6015222573521234,-0.9107646652518213,0.6491228070175439,1.0,1.0,1/5,10.00%,ORAI2
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),-0.5360162529134502,-0.9106287210640137,0.6231884057971014,1.0,1.0,2/10,9.82%,KCNMB1;CALM3
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.37787177760522184,-0.9105563049842232,0.6438356164383562,1.0,1.0,21/80,23.50%,SLC7A11;SLC7A7;SLCO2B1;SLC51A;SLC16A8;STARD5;LRRC8D;ABCC2;SLC36A1;SLC23A1;SLC38A4;SLC25A11;SLC16A1;SLC3A1;CEACAM1;SLC27A1;SLC38A5;SLC10A6;ABCG2;SLCO1A2;SLC26A8
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.32884856069570095,0.9105507424154043,0.7058823529411765,0.9858019444176238,1.0,49/255,14.46%,HTR1F;HTR7;RIMBP2;CHRNA10;UNC13C;PENK;GRIA4;GRIK4;HRH1;UNC13B;PTCHD1;GABRG3;KCND2;APBA1;GRIA2;GRM5;GRIN2A;HTR1E;GABRB1;GRIA1;APOE;NTSR1;GRIK1;LIN7A;NRXN1;NLGN1;GABRA3;HCRTR2;SYN3;NOVA1;DLGAP1;CHRM3;SLC6A1;SYN2;CEL;CHRM5;GRID2;HRH2;DRD4;GABRB3;CACNB2;SYT1;SLC6A2;GRIK2;GRIN2C;PPFIA3;LRP6;MBP;DLG2
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.42281072540346964,-0.9104891529119665,0.6461538461538462,1.0,1.0,22/53,30.26%,PSMB6;PSMB8;NQO1;PSMA3;PSMC3;PSMC6;PSMA5;AZIN1;PSMA7;PSMD12;PSME1;PSMB2;PSMD2;PSMA8;PRKAG2;PSMA1;PSMC1;PSMD4;PSMD8;PSMB4;PDK4;PSMC4
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.38578282325081975,-0.9104303846325267,0.6329113924050633,1.0,1.0,19/84,15.36%,PTPRC;CGAS;BNIP3;STAT1;IRF1;IFIT1;IFI27;AGBL5;TRIM5;ISG20;IFIT3;IFNLR1;FADD;SERINC3;IFI6;TLR2;IFIT5;PLA2G10;OAS3
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",-0.48931215870164735,-0.9101044198045942,0.6206896551724138,1.0,1.0,3/15,9.18%,CHRNB1;CHRNE;NQO1
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.4474342451003657,0.9099949601291216,0.6060606060606061,0.9866172625550694,1.0,5/22,10.10%,TGFBR1;HEY1;TGFB2;ACVR1;ROBO2
prerank,GO_Biological_Process_2021__cerebral cortex cell migration (GO:0021795),0.5747253946016662,0.9099601860694635,0.7045454545454546,0.9860701681502255,1.0,1/6,2.61%,FGF13
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.485250956035354,0.9099561685134243,0.5128205128205128,0.9854499982331499,1.0,1/12,0.45%,MSH4
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),0.4796209649898998,0.9096640439449926,0.6176470588235294,0.984915963183735,1.0,2/12,4.82%,HORMAD1;RAD21L1
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),0.4796209649898998,0.9096640439449926,0.6176470588235294,0.984915963183735,1.0,2/12,4.82%,HORMAD1;RAD21L1
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),-0.6031305226637999,-0.9095214061925005,0.6206896551724138,1.0,1.0,4/6,26.41%,NTN1;WAS;RHOU;CDC42
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),0.5185052676542047,0.9094815019205741,0.5675675675675675,0.9846494485168895,1.0,5/11,20.40%,JAG1;PTPRO;MAGI2;NPHS1;MYO1E
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),0.3062841519635335,0.9093439737340041,0.7619047619047619,0.9843505666571658,1.0,41/286,14.99%,FBXL7;MYLIP;PELI2;RNF126;BCL2;TRAF3;TRIM36;CBFB;FBXW8;MARCHF1;RNF217;MARCHF5;CDC26;UBE2QL1;UBE2J2;FBXO27;ERCC8;RBBP6;ZNRF1;UBE3D;THOP1;PELI1;UBE2D4;FBXL15;MARCHF8;UBE2E2;CDC23;TRIM71;RC3H1;RNF216;HECW2;NEDD4L;KLHL42;TRAF1;KLHL20;WWP1;BTRC;RNF19B;UBE2U;FBXL17;UBE2R2
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.5306803341218044,-0.9088961858680745,0.5818181818181818,1.0,1.0,4/11,23.48%,CAV3;NOS1;PLN;INPP5K
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),-0.5539690381859147,-0.9088595587962688,0.5636363636363636,1.0,1.0,3/9,15.29%,ABCC6;SLC25A5;SLC25A4
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.5520072676626132,0.9086700971951321,0.6097560975609756,0.985359303076421,1.0,4/7,32.00%,FYN;INSR;MTMR2;IGF1R
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.46912620681451206,-0.908399636380596,0.6,1.0,1.0,5/15,23.70%,C2ORF49;DDX1;CLP1;CPSF4;FAM98B
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.40497074477968487,-0.9080743554931178,0.6231884057971014,1.0,1.0,8/74,15.05%,KCNE2;ARIH2;NKD2;DAB2IP;DDA1;PSMC3;PSMC6;RBX1
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.538249017321523,-0.9079924082528894,0.6129032258064516,1.0,1.0,4/9,32.57%,BOD1;CHAMP1;NUF2;SEH1L
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),-0.4481479810214903,-0.9079575787921352,0.6029411764705882,1.0,1.0,4/34,9.16%,KCNE2;SCN4B;KCNQ1;CTNNA3
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.46568042160853346,-0.9075060535503668,0.6153846153846154,1.0,1.0,8/25,31.81%,POLR2J;POLR2K;SUPT5H;POLR2B;CTDP1;POLR2D;POLR2I;POLR2E
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),-0.5274432196197323,-0.9073119055896832,0.6545454545454545,1.0,1.0,3/7,14.96%,GM2A;GBA3;NEU1
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.4842285630617106,-0.9071785977385564,0.6268656716417911,1.0,1.0,4/26,11.34%,NCBP2;DCP2;SLBP;NCBP1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.41346957970280196,0.9070622639900863,0.55,0.988563201488911,1.0,7/28,13.45%,ALG8;OSTC;B4GALNT2;DERL3;MAGT1;UGGT2;DPM3
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),-0.5692519478355988,-0.906980642992885,0.6206896551724138,1.0,1.0,3/7,29.80%,CCL5;IDO1;JAK3
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),0.4739321912702886,0.9068158446008335,0.575,0.9872626749640923,1.0,2/10,14.77%,SMARCAL1;TERF1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),0.4739321912702886,0.9068158446008335,0.575,0.9872626749640923,1.0,2/10,14.77%,SMARCAL1;TERF1
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),0.4739321912702886,0.9068158446008335,0.575,0.9872626749640923,1.0,2/10,14.77%,SMARCAL1;TERF1
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.4146325649730548,-0.9066790320542768,0.576271186440678,1.0,1.0,2/41,5.85%,EPHA1;RAC1
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),0.5437948836527791,0.9066396758809118,0.627906976744186,0.986987714864242,1.0,4/6,23.54%,BSN;PCLO;ERC2;ERC1
prerank,GO_Biological_Process_2021__positive regulation of T-helper 1 type immune response (GO:0002827),-0.6215542768237503,-0.9066279364598352,0.6610169491525424,1.0,1.0,3/5,19.68%,IL18;IL18R1;SLC11A1
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),-0.40398131444226526,-0.9065235969281827,0.6571428571428571,1.0,1.0,7/59,10.27%,HCK;RAC1;VAV3;NCKAP1L;BRK1;PIK3CB;DOCK1
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.40398131444226526,-0.9065235969281827,0.6571428571428571,1.0,1.0,7/59,10.27%,HCK;RAC1;VAV3;NCKAP1L;BRK1;PIK3CB;DOCK1
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.3755640483814562,-0.9064978434921444,0.6216216216216216,1.0,1.0,18/90,19.29%,ACOT4;BAAT;ACOT12;ACOT13;ACSM4;CPM;ACSM6;ACOT1;PLAAT5;ACOT2;DHFR2;CPE;ST6GAL1;ACSM3;PDZD11;ACOT6;ALDH1L1;BTD
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),0.4456108114625658,0.906052178949876,0.5142857142857142,0.9878200909934757,1.0,6/18,13.79%,MTHFS;MTHFD2L;SLC19A1;MTHFD2;DHFR;MTHFD1L
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),-0.6061745465284429,-0.9060329365280552,0.6557377049180327,1.0,1.0,1/6,5.95%,TGFB1
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.4224099302284887,0.9057697598998192,0.6521739130434783,0.9871079145583626,1.0,8/28,14.18%,COBL;TGFB2;PRICKLE1;SEMA4C;DVL2;PHACTR4;MTHFD1L;LRP6
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.4224099302284887,0.9057697598998192,0.6521739130434783,0.9871079145583626,1.0,8/28,14.18%,COBL;TGFB2;PRICKLE1;SEMA4C;DVL2;PHACTR4;MTHFD1L;LRP6
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),-0.5542373642700953,-0.9057306351032295,0.6333333333333333,1.0,1.0,2/9,8.81%,CIITA;TRIM5
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.46004658465351667,0.9053965730875304,0.6,0.9874105710689691,1.0,7/24,12.53%,MCC;VASH1;APOE;DUSP10;PTPN23;SVBP;PTPRM
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.3959804082863938,-0.9048773941969496,0.5671641791044776,1.0,1.0,6/50,7.93%,FANCI;FAAP24;FANCM;RPA3;RAD51AP1;FANCC
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),-0.5482919475176897,-0.9046460817290434,0.6290322580645161,1.0,1.0,1/10,2.84%,CAV3
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),-0.5903047989623865,-0.9045716865665994,0.6774193548387096,1.0,1.0,5/5,40.99%,RAB3GAP2;TMEM33;RAB3GAP1;ATL3;LNPK
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.36876851736389943,0.9042289312460223,0.5416666666666666,0.9892474107605069,1.0,7/52,7.72%,MYLIP;KANK1;MINAR1;PTPN9;APOE;PTPRO;NLGN1
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.45684978581407687,0.9042058071393873,0.5384615384615384,0.9886720125710401,1.0,2/12,6.36%,PKP2;TCHH
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.2857642927690171,0.9041004823829198,0.9090909090909091,0.98829195277925,1.0,118/864,13.69%,FBXL7;NRK;B3GALT9;LAMB2;HS3ST5;PTPN3;SGK1;PTPRT;PENK;RCE1;PTPRK;DUSP5;CD247;VCAN;SGK2;LTBP1;SENP8;MELTF;TGFBR1;CDC14B;GRK5;DNAJC3;LATS1;AFP;FBXW8;DUSP2;TGM1;MAML1;FEM1A;CDK14;ST3GAL3;SOCS6;LGALS1;TGFB2;PTAR1;CCDC22;ACVR1;FBXO27;NEK6;MAP3K20;ERCC8;PTPN9;PTPRB;TRIB2;PRKCD;APOE;PTPRO;COMMD1;PRKCB;PTPN6;CDKL1;PEAK3;DUSP8;DUSP4;STK38;FUT9;DUSP12;PXK;RYK;PARP10;SSH1;PRKD1;PAK5;LMTK3;MACROD2;DUSP10;CHRDL1;FBXL15;PTPN12;EIF2AK3;PTPRE;FRK;CDK8;CHRM3;LTK;USP25;UBE2E2;ST3GAL1;FASTK;EGLN3;CEL;KTN1;PPEF1;RHBDD1;MARK1;PNPLA2;MAPK8;TAB1;ST8SIA3;KLHL25;PGGT1B;GCNT2;PTPN13;PTPRS;SOCS2;PRKCE;FGFR1;PRKG2;CTDSP2;CTTNBP2NL;PTPRM;PPP2R5E;ST3GAL2;MAP3K5;PAK4;KLHL42;NRBP2;SIRT2;DMPK;FYN;PPP2R3B;KLHL20;LOXL1;ASB9;CDC42BPB;PPP2R1B;SIRT1;BTRC
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),0.45716216221257866,0.9040847397300866,0.5454545454545454,0.9876854475745959,1.0,5/16,21.27%,FEM1A;SPTSSB;ATM;JMJD8;SMG6
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.5497641413997625,-0.9039063037220562,0.6451612903225806,1.0,1.0,3/11,11.58%,CASP8;INHBA;FADD
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),0.5584384899647097,0.9038075211336557,0.6190476190476191,0.9877519283594512,1.0,1/6,2.71%,PKP2
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),0.34645358561853346,0.903801247958,0.6206896551724138,0.9871627002990329,1.0,7/56,6.73%,UNC5B;BCL2;SLC30A10;TOX3;MDK;TGFB3;APOE
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),-0.5828448630092156,-0.903490751325274,0.631578947368421,1.0,1.0,2/7,15.04%,CD74;PLCG2
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),-0.4698119181914763,-0.9031738002464148,0.640625,1.0,1.0,4/22,8.77%,HSF2BP;ING2;TDRD9;BTBD18
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),0.392230650557171,0.9030748173229315,0.5333333333333333,0.988224385665037,1.0,9/62,10.57%,F2RL1;RAB7B;TLR1;IFIH1;EREG;HMGB1;PTPN6;SPHK2;POU2F2
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),-0.5478229885996178,-0.9029473071331859,0.6296296296296297,1.0,1.0,5/11,31.54%,HPF1;PARG;NNMT;AKAP8L;PARK7
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),0.4826089543461138,0.9026866428744466,0.6285714285714286,0.9884844270133186,1.0,2/12,7.17%,NEK6;PRKCB
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.39283918034815823,-0.902314915186234,0.6578947368421053,1.0,1.0,13/75,16.68%,CCNE1;CDKN2D;CDKN3;CCND2;CCNG2;SPDYA;CDC6;CDC25A;CDK5R1;GADD45A;CDKN1B;ADAM17;INCA1
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.4679652844199741,-0.9021546579462503,0.5901639344262295,1.0,1.0,5/16,23.70%,C2ORF49;DDX1;CLP1;CPSF4;FAM98B
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),-0.4945034712550594,-0.9017354122615909,0.6428571428571429,1.0,1.0,5/12,31.34%,CHST1;EXTL2;OGA;CHST2;PGM3
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),0.5479115453027366,0.9015892251782968,0.5476190476190477,0.9907073665359748,1.0,4/8,11.71%,MID1;FAM83D;MID2;MAPRE1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.5414139056085085,0.9011659041893724,0.6511627906976745,0.9911351031717621,1.0,1/7,0.60%,KLRD1
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),-0.4352855571243954,-0.9011305015854668,0.684931506849315,1.0,1.0,10/31,19.73%,DOCK2;PTPRC;CD300LF;IL15;NCKAP1L;RAB31;STAP1;SFTPD;SLC11A1;CALR
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.4492077024687728,0.9010507847207271,0.6176470588235294,0.9907634699876678,1.0,3/22,6.04%,EGFR;HEY1;RITA1
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.3473345538024497,-0.9007661249006421,0.6463414634146342,1.0,1.0,46/181,24.91%,RPL36;RPL15;RPL38;RPS7;RPL37A;RPL9;RPL28;RPLP2;NOB1;RPL5;RPL26L1;RPL35A;EMG1;EXOSC6;DDX54;RPLP1;RPL8;RPL4;RPL22;RPL27A;WDR12;RPL24;EIF6;RPS15;RPF2;KRR1;RPL34;RPL3;RPS24;SURF6;SBDS;UTP11;EXOSC8;RPL13A;RPL27;RPL37;RPL7A;LAS1L;NOP56;RPL35;WDR55;RPL23;RPL32;IMP4;UTP15;RBIS
prerank,GO_Biological_Process_2021__skeletal muscle contraction (GO:0003009),0.5107023202956161,0.9007411893207601,0.5581395348837209,0.9908196939831654,1.0,5/13,16.38%,STAC;TNNC2;MYH3;JSRP1;MYH14
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.44708945726476346,0.900704603064068,0.5952380952380952,0.9903197697269818,1.0,1/17,0.53%,CDH13
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),-0.5622313019686349,-0.9006784466060936,0.603448275862069,1.0,1.0,2/7,17.20%,MAP1LC3B;PEX5
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.29200173952520303,0.9005289710940164,1.0,0.9899976543025718,1.0,91/800,12.08%,ACE2;RUNX1;POU6F2;SLC22A2;IFI16;PID1;TEAD2;SOX13;FEZF2;ATOH8;LEF1;KDR;WWTR1;ZNF273;ZNF117;NFIA;ZNF462;RORA;AFF3;ZNF536;TRAF3;FGFR4;OR7D2;TGFBR1;BMP6;BMP7;ZNF827;PCBP3;ATXN1;ESRRG;ZNF205;AFF2;HEY1;EPHB2;TGFB2;SPIN2B;WWC1;ZNF628;RAB27A;BRCA2;ZNF407;TICAM1;SOX12;FGF10;PTBP3;CHD7;APOE;PTBP2;PRMT5;RBMS3;IGF1;FOXN3;PRDM5;ERMAP;CIAO3;HDAC1;HSPA1A;PCGF1;ZNF263;TRIM4;APLN;REL;IGF2BP3;NOVA1;PARP10;TRIM11;ANGPT1;ADAM19;ZNF678;POU3F1;NELL1;ZNF804A;EIF2AK3;RYBP;FASTK;CILP;KHSRP;ATXN1L;NOS1AP;LIMS1;MAPK8;PC;TRIM71;SNF8;DVL2;COQ7;SLC24A3;ZNF33A;GCNT2;TRIM44;NGF
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.5182758551029775,-0.9005023617636697,0.625,1.0,1.0,2/12,17.20%,MAP1LC3B;PEX5
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),0.5146455085242536,0.9004174321725968,0.5675675675675675,0.9896920351093166,1.0,3/12,6.85%,SERTAD2;ARID1B;ARID1A
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.3119516667034935,0.9003283541924701,0.8421052631578947,0.9893304839114435,1.0,27/227,11.91%,EPHA3;PID1;IRS1;PDE3A;PTPRK;EGFR;RORA;SLC26A3;FOS;TICAM1;PDGFRA;HCN1;AKR1C3;PRKCD;BRINP1;HMGB1;SSH1;AGAP3;PRKD1;ERCC6L2;MTR;KCNC2;LTK;MAPK8;FOXO1;NSMF;CIB2
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell cytokine production (GO:2000553),-0.6002661215626258,-0.9002695835327611,0.6451612903225806,1.0,1.0,3/5,36.94%,CD81;NLRP3;PRKCZ
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell cytokine production (GO:2000551),-0.6002661215626258,-0.9002695835327611,0.6451612903225806,1.0,1.0,3/5,36.94%,CD81;NLRP3;PRKCZ
prerank,GO_Biological_Process_2021__protein localization to site of double-strand break (GO:1990166),0.5407040247422621,0.9002677064225563,0.6590909090909091,0.9888568296479697,1.0,1/5,4.86%,XRCC4
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.46145818734300675,0.9001848532331639,0.5428571428571428,0.988375725153196,1.0,3/14,8.06%,MDK;PKDCC;SOX5
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.33334838678875756,0.8998374330859625,0.6666666666666666,0.9885937642138645,1.0,34/202,11.50%,HTR1F;HTR7;CHRNA10;UNC13C;PENK;GRIA4;GRIK4;HRH1;UNC13B;PTCHD1;GABRG3;KCND2;APBA1;GRIA2;GRM5;GRIN2A;HTR1E;GABRB1;GRIA1;NTSR1;GRIK1;NRXN1;NLGN1;GABRA3;HCRTR2;NOVA1;DLGAP1;CHRM3;SLC6A1;SYN2;CEL;CHRM5;HRH2;DRD4
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),0.5496315479969811,0.8997721157287534,0.5555555555555556,0.9881374873210057,1.0,1/6,2.22%,BCL2L11
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),-0.4640926914188317,-0.8993369912363398,0.6470588235294118,1.0,1.0,2/18,4.01%,CHAC2;CHAC1
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),-0.3785356009046033,-0.8992461127103806,0.6363636363636364,1.0,1.0,12/78,14.35%,LRPAP1;ACOX2;BNIP3;CHMP4B;CALCR;CIDEB;CHMP2A;CTSZ;CCL5;HTR2B;VPS35;CDKN1B
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),-0.5770679094610474,-0.8992068790035543,0.639344262295082,1.0,1.0,2/8,8.72%,CIITA;TAF7
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),0.5335045747313621,0.8991671484340825,0.6842105263157895,0.9889087457260977,1.0,4/7,17.09%,GRIN2A;GRIN2C;GRIN2B;GRIN1
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),-0.5581684123635785,-0.8989871276169099,0.6862745098039216,1.0,1.0,1/6,8.60%,STAT4
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),0.4506211585866967,0.8987058906557288,0.6,0.9893905333256288,1.0,2/13,4.59%,HORMAD1;MDK
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),0.47523609810471995,0.8986932138413157,0.575,0.9888224739434229,1.0,1/7,10.92%,NMNAT3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.48914044108948795,-0.8985272198963145,0.6481481481481481,1.0,1.0,2/14,5.33%,FGL1;IL4I1
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),-0.465532040132383,-0.8984224590730061,0.6029411764705882,1.0,1.0,5/17,24.11%,SPAG4;NUP155;VPS4A;SUN3;NEMP1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.44202882058649956,0.8983045198999846,0.5365853658536586,0.9890395689352379,1.0,3/19,9.82%,BCL2L11;HSPA1A;EIF2AK3
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),0.40720812455920746,0.8980596002957956,0.5675675675675675,0.9889924058227377,1.0,3/20,11.82%,CAMKMT;PRMT8;ETF1
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),-0.5542406958614896,-0.8979228788931544,0.6229508196721312,1.0,1.0,1/7,5.72%,CHMP4B
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),0.4368691269400051,0.8977220046818484,0.6666666666666666,0.9890732179650537,1.0,3/22,5.83%,COL15A1;F2RL1;PDE4D
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),0.6110312703593592,0.8976433469823308,0.6739130434782609,0.9886026255094162,1.0,2/5,18.71%,NRXN1;PTEN
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.40031034201124993,-0.8975722267509101,0.6285714285714286,1.0,1.0,1/65,0.05%,SLC28A2
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),-0.349218921208196,-0.8975518614343363,0.7183098591549296,1.0,1.0,29/170,19.81%,CD4;TERF2IP;CD74;P2RY1;CCND2;RAC1;TGFB1;PINK1;TBX1;RARRES2;FAM20A;AGER;GPER1;CALM3;SVIP;FLOT1;MUSK;TXN;NIBAN1;PLAUR;ADAM17;LYN;DAXX;ANKLE2;CDK2AP1;KAT5;FXR1;GPNMB;RAMP1
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.32346285320631396,-0.8975002292760947,0.7931034482758621,1.0,1.0,70/572,13.93%,CD44;HCK;PRLR;PNMA5;CYP1B1;WFS1;TNFSF18;PNMA2;BCL2L2;SFRP4;GADD45B;RABGGTB;AGT;CD74;ATF5;MOAP1;DDX20;CCND2;BNIP3;STAT1;RASGRF2;MTCH1;RASA1;PINK1;IL7;FLT3;BCL2L14;HSPA5;TP53I3;VAV3;CD27;ANXA5;CASP8;NCKAP1L;FIGNL1;KIF14;TFPT;CIDEB;PXT1;IFIT3;DAB2IP;REST;PPID;ZNF16;GPER1;KNG1;APH1B;PRAME;STK17A;FGD3;GSTP1;HIP1R;ITGB3BP;CTSH;MRE11;HRK;UFM1;SIX4;FADD;DNAJA1;PREX1;HTR2B;BAG4;RNPS1;BOK;SUDS3;IFI6;GADD45A;KLF11;LRP2
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),0.558164997864565,0.8974046669396055,0.5882352941176471,0.9885558168287565,1.0,4/7,15.84%,MRTFA;HEY1;MRTFB;MEF2C
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),-0.438739995178014,-0.8973838506826334,0.5909090909090909,1.0,1.0,3/17,11.48%,ERVFRD-1;ERVW-1;SIX4
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.33216764546774286,-0.8973457902139194,0.7228915662650602,1.0,1.0,36/306,17.19%,TICRR;RAD54L;POLQ;HIC1;POLE3;BCL2L2;CGAS;MOAP1;SUV39H1;SPDYA;RFC5;BACH1;RAD51AP1;VAV3;INIP;RECQL;FANCC;CIDEB;OTUB1;BRCA1;MRE11;APLF;NUDT1;BOK;SLF1;CBX5;GADD45A;YAP1;POLE2;DDX11;HPF1;PDS5B;ETAA1;LYN;CBX3;CHEK1
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),0.4646913020694933,0.8970895078257836,0.6363636363636364,0.9885968471180964,1.0,2/10,6.65%,F2RL1;PRKCD
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),0.3708324882483706,0.8968959263948967,0.6071428571428571,0.9884862971437952,1.0,2/46,0.61%,ACE2;PID1
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.380573313434843,-0.8965524971212084,0.6461538461538462,1.0,1.0,20/89,23.32%,FIP1L1;NXT1;SLU7;DDX39A;NCBP2;FYTTD1;SLBP;NCBP1;RNPS1;NUP85;ALYREF;CDC40;NUP155;UPF3B;THOC5;NUP188;GLE1;DHX38;SRSF5;CPSF4
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),0.5233996856473235,0.8964284636446016,0.5897435897435898,0.9890135134053194,1.0,2/7,22.02%,AK5;CTPS2
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.4905639800125174,-0.8963636939687629,0.5614035087719298,1.0,1.0,5/10,31.99%,TXN;STK26;GPR37L1;PARK7;LRRK2
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),-0.452390259817937,-0.8963490229648607,0.5806451612903226,1.0,1.0,9/22,22.84%,AMN;SLC52A2;CBLIF;SLC23A1;TCN2;SLC27A1;SLC52A1;TTPA;ABCG2
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.39948973168768154,0.89621146350112,0.6451612903225806,0.9887514990932739,1.0,5/37,11.51%,ZBED3;UNC13B;ZBTB20;IRS2;GCK
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.39225599382181403,-0.8960303979963741,0.6176470588235294,1.0,1.0,12/63,17.38%,GSTM5;GLRX2;ERAP2;G6PD;GSTP1;CPM;LVRN;PCSK5;ERAP1;RHD;NAALADL1;CPE
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.37620982314616774,0.8960096574772382,0.5862068965517241,0.9885614507445036,1.0,10/42,16.02%,CACNG3;GRM5;CACNG4;GRIK1;NRXN1;NLGN1;GRM8;SYT1;MEF2C;HOMER1
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.4056023116808406,0.8960093672230444,0.7096774193548387,0.9879579333753067,1.0,5/32,6.01%,KANK1;EPHB2;TGFB2;SPRY3;HEG1
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.4309524982934819,-0.8957681956245882,0.6307692307692307,1.0,1.0,5/25,12.30%,CCL5;SPI1;LBP;FADD;GBP5
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),0.428276984924764,0.8956979712072358,0.5833333333333334,0.9880627857337622,1.0,4/19,5.24%,WWTR1;TGFBR1;BMP6;TGFB3
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),-0.42436233665895995,-0.8956741252232515,0.5909090909090909,1.0,1.0,7/35,18.76%,ALDOB;ATP1B1;DNAJB1;TPM1;UHRF1;GABARAPL2;AHSA1
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),0.5377487110196889,0.895550149333528,0.6190476190476191,0.9872635689129174,1.0,4/5,27.40%,KMT5B;BEND3;SETD4;SMYD5
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),0.5377487110196889,0.895550149333528,0.6190476190476191,0.9872635689129174,1.0,4/5,27.40%,KMT5B;BEND3;SETD4;SMYD5
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),0.46712053846759505,0.8952561258676243,0.6521739130434783,0.9873130977156602,1.0,1/9,11.08%,GUCY1A1
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),0.32092510394110835,0.8951494083077471,0.7619047619047619,0.9869501241387545,1.0,52/275,17.03%,FHDC1;NEDD1;ARL13B;PCM1;PDE6D;CDC14B;DNAH5;CFAP70;TTC39C;CNGA4;RAB3IP;RPGRIP1L;UBXN10;PKHD1;JHY;CEP83;KIAA0586;TOGARAM1;CEP135;PIBF1;CDK5RAP2;CFAP43;EHD4;PTPN23;ABCC4;SCLT1;TMEM250;CFAP46;RFX2;MAPRE1;BBIP1;DYNLRB2;WDR35;SNAP29;EXOC7;FNBP1L;CFAP44;CFAP20;RILP;RSPH6A;DYNC1I2;ABLIM1;TRIP11;TTC36;BBS9;POC1B;ALMS1;PARVA;MACIR;IFT74;B9D1;RFX3
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),-0.5453071261618737,-0.8951429004064638,0.6290322580645161,1.0,1.0,1/8,4.17%,SUV39H1
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.45885347521458947,0.8948614733846341,0.5384615384615384,0.9870394171176805,1.0,2/10,7.04%,F2RL1;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),-0.4823911540585871,-0.8948301681571884,0.6440677966101694,1.0,1.0,4/11,23.91%,CHMP2B;CHMP2A;VPS4A;VPS37B
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.4129563865249158,0.8947209863764892,0.5641025641025641,0.9868988654077783,1.0,7/29,13.45%,ALG8;OSTC;B4GALNT2;DERL3;MAGT1;UGGT2;DPM3
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.5027557600480945,0.8946174945572485,0.6363636363636364,0.9865526392916438,1.0,1/8,2.36%,EGFR
prerank,MSigDB_Hallmark_2020__Androgen Response,0.33293283934611206,0.8945131660960945,0.6875,0.9862147459234919,1.0,19/95,18.85%,SGK1;HOMER2;IQGAP2;PMEPA1;CDC14B;ARID5B;TPD52;GUCY1A1;ABCC4;ANKH;ZBTB10;GNAI3;NDRG1;GPD1L;UBE2J1;ALDH1A3;ITGAV;PLPP1;HERC3
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),-0.5858119470068186,-0.8945028223158532,0.6825396825396826,1.0,1.0,1/6,14.66%,SLC36A1
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.42298145683567595,0.8942155603019644,0.5714285714285714,0.9864466036553399,1.0,5/25,10.39%,KDR;MCU;MARCHF5;RALA;INF2
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),-0.44520741533680563,-0.8941765002352061,0.640625,1.0,1.0,5/27,19.16%,IFIT1;PPID;CCL5;NR5A2;SRPK1
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),-0.5231718988799887,-0.8940496182554055,0.5892857142857143,1.0,1.0,3/8,31.91%,EEF1A1;SNRNP70;PLK3
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.4270840817360916,0.8939285609054816,0.6216216216216216,0.9864410986059122,1.0,2/25,3.07%,GPC4;SDC4
prerank,GO_Biological_Process_2021__epoxygenase P450 pathway (GO:0019373),0.5278093674117245,0.8937627701664645,0.6071428571428571,0.9862855395685378,1.0,1/6,0.56%,CYP1A2
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),-0.5455678836890805,-0.8937391193738041,0.5862068965517241,1.0,1.0,2/7,14.65%,TTLL4;METAP1D
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),-0.5393599937902539,-0.8936636671403576,0.6101694915254238,1.0,1.0,1/8,7.02%,GLRX
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),-0.5635889301971991,-0.8935531008594253,0.6721311475409836,1.0,1.0,2/7,13.03%,ADGRB1;FLOT1
prerank,GO_Biological_Process_2021__rRNA 5'-end processing (GO:0000967),-0.5688647623376863,-0.8933598511300198,0.6153846153846154,1.0,1.0,1/5,7.32%,ABT1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)",-0.5688647623376863,-0.8933598511300198,0.6153846153846154,1.0,1.0,1/5,7.32%,ABT1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)",-0.5688647623376863,-0.8933598511300198,0.6153846153846154,1.0,1.0,1/5,7.32%,ABT1
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),-0.5565896250632987,-0.8931025701516032,0.6031746031746031,1.0,1.0,2/7,20.07%,KCNJ11;CACNA1H
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),-0.5380279507524972,-0.892696856867861,0.660377358490566,1.0,1.0,2/10,5.83%,ZFPM1;NOTCH1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),0.4348999013720085,0.8924974637126382,0.5428571428571428,0.988884876853236,1.0,3/24,7.17%,CIDEA;IGF1;PTPN6
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.39957489543513103,-0.8924831332790517,0.7,1.0,1.0,7/61,10.27%,HCK;RAC1;VAV3;NCKAP1L;BRK1;PIK3CB;DOCK1
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.40227839295245205,0.8923281790096314,0.6,0.988712250123632,1.0,8/40,9.59%,RGS14;SPRED1;SPRED2;SPRED3;EPHB2;SPRY3;DUSP4;DUSP10
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),-0.4629768861282504,-0.8921249248832253,0.6911764705882353,1.0,1.0,3/24,8.12%,ABITRAM;RASA1;BRK1
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),-0.5999384621579923,-0.892088504636345,0.6607142857142857,1.0,1.0,3/5,25.45%,MSN;SPP1;AR
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),-0.5999384621579923,-0.892088504636345,0.6607142857142857,1.0,1.0,3/5,25.45%,MSN;SPP1;AR
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),-0.5574089628741379,-0.8918492896922162,0.6333333333333333,1.0,1.0,1/6,2.31%,CGAS
prerank,GO_Biological_Process_2021__negative regulation of SMAD protein signal transduction (GO:0060392),-0.6042152600913482,-0.8914517669065433,0.6612903225806451,1.0,1.0,2/5,17.05%,PBLD;CCN3
prerank,GO_Biological_Process_2021__regulation of hair cycle (GO:0042634),-0.5520105555275223,-0.8912633279425755,0.6415094339622641,1.0,1.0,3/6,28.59%,TRPV3;PER1;CDH3
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.5036914080227775,0.8911886805592713,0.6046511627906976,0.9905580327584935,1.0,4/13,14.74%,PCM1;CEP120;HOOK3;SUN2
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.2930690060091681,0.8908277531030615,0.8666666666666667,0.9909440000675364,1.0,25/243,8.13%,ELOVL6;PER2;IFI16;F2RL1;LEF1;WWTR1;OXTR;TGFBR1;ZBED3;SHLD1;S100A13;PLCB1;ESRRG;LEPR;MDK;TGFB2;PDGFC;TGFB3;EREG;ACVR1;MACROH2A2;APOE;NLGN1;SOX5;SMAD2
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.4104618605111424,-0.8906838257065857,0.6029411764705882,1.0,1.0,5/36,8.70%,TERF2IP;LRRC19;CD27;CD14;AGER
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.3546213367240414,-0.8904564036455317,0.6842105263157895,1.0,1.0,27/142,15.51%,CD4;BTN2A2;ITK;PTPRC;HHLA2;TXK;PSMB6;FYB1;HLA-DPB1;VAV3;BLNK;NCKAP1L;PSMB8;THEMIS;PIK3CB;SKP1;THEMIS2;PSMA3;HLA-A;TEC;PSMC3;PSMC6;PSMA5;PLCG2;WAS;SPG21;EIF2B5
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),-0.4619868514821664,-0.8900849405173105,0.5671641791044776,1.0,1.0,2/29,3.79%,KCNE2;DRD3
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.47295831099974545,-0.8899276708666869,0.5967741935483871,1.0,1.0,3/22,6.23%,SLCO2B1;SLC51A;STARD5
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.3817849225071596,-0.8898902697257774,0.6323529411764706,1.0,1.0,14/65,20.20%,POLR3K;CGAS;STAT1;IRF1;CD14;MRE11;FLOT1;TLR2;POLR2K;OAS3;STAT6;POLR1C;IRF3;HSPD1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.33293405323405556,0.8898897525133989,0.6666666666666666,0.9925421075303322,1.0,19/76,15.11%,UBASH3B;PTPRT;HSPB1;WWTR1;SPRED1;CEP85;PTPRB;TRIB2;PTPRO;SLC8A3;DUSP10;GNAQ;TAB1;SLC8A1;PRKRIP1;LRP6;SORL1;CHP1;PPM1E
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),-0.5679668295748146,-0.8898576684442523,0.6428571428571429,1.0,1.0,3/5,31.99%,ADAM9;D2HGDH;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),0.4352847327182105,0.8897373222547758,0.5882352941176471,0.9922496495934887,1.0,6/29,10.23%,EGFR;PLCB1;FGF10;FAM83D;LSM10;UBE2E2
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),0.4847678659021401,0.8897214817788143,0.627906976744186,0.9916822848893171,1.0,4/13,18.80%,AASS;TET1;CHTOP;NSD1
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,-0.3890596857572932,-0.8896750693137432,0.6233766233766234,1.0,1.0,10/76,7.89%,ENPP2;MYLK;ANKS4B;AGT;ANGPTL2;TRPA1;ALDOB;SLC38A11;SSTR1;TREH
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),-0.5211021252285163,-0.8896081282516984,0.7818181818181819,1.0,1.0,4/11,24.42%,VIL1;CFL1;TWF2;CFL2
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.3602295918740385,0.889250723444318,0.45454545454545453,0.9922238393832449,1.0,15/76,16.00%,TYSND1;ADAMTS3;PTCH1;PCSK2;ADAM19;TSPAN17;TASP1;SRGN;CASP2;ECE1;ADAMTS13;CPD;SORL1;TSPAN33;NCSTN
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),-0.5189936151337314,-0.889019851515296,0.6666666666666666,1.0,1.0,1/9,8.82%,CEP72
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),-0.45871965920729424,-0.8888618914420642,0.5692307692307692,1.0,1.0,4/18,24.09%,DGAT2L6;GPAM;DGAT1;PLA2G4A
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),-0.37051522770023615,-0.8887110775930693,0.6567164179104478,1.0,1.0,20/93,23.32%,FIP1L1;NXT1;SLU7;DDX39A;NCBP2;FYTTD1;SLBP;NCBP1;RNPS1;NUP85;ALYREF;CDC40;NUP155;UPF3B;THOC5;NUP188;GLE1;DHX38;SRSF5;CPSF4
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),-0.5620414207163948,-0.8886200757733435,0.65,1.0,1.0,2/7,16.15%,APH1B;ADAM17
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.5012939242270993,0.8880713606914381,0.6944444444444444,0.9943436128125385,1.0,2/10,8.47%,GABRG3;GABRA3
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),-0.49362618475453157,-0.8879005154014104,0.6363636363636364,1.0,1.0,2/11,11.34%,NCBP2;NCBP1
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),0.43692672013771,0.8878911631234043,0.6756756756756757,0.9941606792722009,1.0,1/16,0.59%,IFI16
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.34745596139754364,0.887673279087945,0.6551724137931034,0.9940564222544604,1.0,11/129,3.40%,FBXL7;NOX4;PDGFD;LAMB2;PRRX1;SVEP1;COL15A1;SGCD;PCDH18;FNDC1;LAMA4
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.37636698470543606,-0.8875700722773027,0.684931506849315,1.0,1.0,9/69,9.36%,MARVELD2;WFS1;NDUFB9;TMIE;KCNQ1;TBX1;EYA1;CEMIP;SLC26A4
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.5895913103400509,0.8870306027360639,0.5833333333333334,0.9948853583617373,1.0,4/8,18.71%,NLGN1;GRID2;WNT5A;PTEN
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.48323244129879966,0.8868722038517666,0.5945945945945946,0.9946710843044366,1.0,2/8,5.46%,TOX;RABL3
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.41107357433420605,0.8868274157512307,0.6756756756756757,0.9941359770840389,1.0,5/20,6.68%,SGCD;BMP7;SGCZ;CFLAR;SVIL
prerank,GO_Biological_Process_2021__regulation of excitatory synapse assembly (GO:1904889),0.5162472258015258,0.886734725773323,0.6666666666666666,0.9937423946209724,1.0,2/6,10.42%,VSTM5;LRFN4
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.38260439764738174,0.8867061707314972,0.5555555555555556,0.993255419697271,1.0,9/68,5.94%,ADAMTS2;LAMB2;SVEP1;COL15A1;EFS;FNDC1;SEMA5A;NYNRIN;PDGFRA
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),-0.46061888145322466,-0.8866625784416936,0.5892857142857143,1.0,1.0,3/18,8.66%,SLC12A7;ATP1B1;ATP1A1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.3299350915782087,0.8866599558277553,0.696969696969697,0.9927768464133675,1.0,12/70,15.84%,NTNG1;CTNNA2;PARD3;DSCAML1;CNTN4;RYK;SLITRK5;SPTBN4;PAK3;NRCAM;MAP6;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),-0.4891406086161758,-0.8866330160191385,0.5901639344262295,1.0,1.0,6/12,20.65%,HHLA2;AGER;IL18;FADD;TNFSF9;RPS3
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),0.4256569327822862,0.8865026370340252,0.675,0.9925722914603414,1.0,3/22,4.30%,KIT;KDR;CSF1R
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),0.3680438451782477,0.8861300645128166,0.7,0.9927583825796176,1.0,4/60,4.47%,ELOVL6;CYP1A2;ABHD1;DECR2
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.37244203298913486,0.8860356484406615,0.5666666666666667,0.9923121800093371,1.0,19/98,10.58%,FREM1;PTPRT;KCNIP1;EFS;KDR;SORCS1;ZNF536;NTM;MAPK4;RGS7BP;SLCO1C1;APOE;NRXN1;RCAN2;CNTN1;SLC6A1;CRTAC1;PCDH17;IL34
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),-0.5933554242569579,-0.8857112021593979,0.6666666666666666,1.0,1.0,1/5,4.15%,P2RY12
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.4305341123878965,-0.8855905351869358,0.6779661016949152,1.0,1.0,2/27,1.47%,ACOT4;PTGIS
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),-0.40514590383702265,-0.8855319531156809,0.6911764705882353,1.0,1.0,9/46,13.58%,PTPRC;ELANE;CD74;SERPINE1;CD14;TMSB4X;LBP;FADD;TLR2
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.35824563408426824,-0.885283504321607,0.6875,1.0,1.0,16/163,6.62%,CD44;HCK;LAMA2;CYP1B1;HHIP;FBLN2;TIMP3;ANGPTL2;GSTM5;PRG4;SPON2;MEOX1;FBLN5;COL6A1;RARRES2;CTHRC1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.429761308696285,-0.8852021364480543,0.6333333333333333,1.0,1.0,10/35,14.23%,ELANE;STAT1;NOX1;IGFBP5;PDGFRB;IL18;CCL5;OGN;APOD;NDRG4
prerank,GO_Biological_Process_2021__negative regulation of muscle cell differentiation (GO:0051148),0.575068839924597,0.885079806955781,0.6326530612244898,0.9939487573623309,1.0,3/5,19.36%,EREG;ID2;PTBP1
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),-0.5311372254866342,-0.8850273709168246,0.631578947368421,1.0,1.0,2/7,12.55%,SOX10;RHOXF1
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.4526729445776054,0.884824247039309,0.6578947368421053,0.9939856051625453,1.0,1/11,2.36%,EGFR
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.3456314294542991,0.8847280816387826,0.5217391304347826,0.99363294137856,1.0,14/113,6.27%,SLC12A3;KCNJ16;KCNH5;LRRC55;SLC12A1;KCNB2;KCNJ6;KCND2;KCNJ3;KCNN2;KCNJ2;KCNN3;KCNK7;HCN1
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.3855549741796988,0.8847234835096691,0.5384615384615384,0.9930471580107684,1.0,8/48,6.55%,KIT;ITGA4;TOX;HDAC9;LEPR;RABL3;GPR89B;CHD7
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),0.41532732867292016,0.8846199541680304,0.6296296296296297,0.9927343758346614,1.0,3/23,5.90%,F2RL1;RAB7B;TICAM1
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.4328976374153297,0.8845278648455579,0.6666666666666666,0.9923364374197141,1.0,3/23,4.15%,PID1;PTPRT;SELPLG
prerank,GO_Biological_Process_2021__glycolipid transport (GO:0046836),-0.5744329517539495,-0.8844949061843966,0.7049180327868853,1.0,1.0,2/6,22.72%,PSAP;CPTP
prerank,MSigDB_Hallmark_2020__Hypoxia,0.3266439316635517,0.8844793834361129,0.72,0.9918534951026686,1.0,27/165,13.02%,GPC4;SLC37A4;BCL2;EGFR;RORA;ATF3;EXT1;SDC4;VLDLR;B4GALNT2;TGFB3;FOS;MT1E;MXI1;PGM2;IRS2;TPD52;SLC25A1;BNIP3L;SCARB1;IER3;GCK;GCNT2;ZNF292;HS3ST1;NEDD4L;PFKFB3
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.4566568097260859,-0.884403013722896,0.6349206349206349,1.0,1.0,7/19,26.15%,TMEM35A;HSPD1;HSPA4;PSMG1;HSP90AB1;CCT2;HOPX
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),-0.5470108979152529,-0.8842038630209196,0.6612903225806451,1.0,1.0,1/7,9.83%,APH1B
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),0.5551250948156691,0.8841028627887149,0.625,0.9920234842010232,1.0,1/5,12.40%,RC3H1
prerank,GO_Biological_Process_2021__regulation of superoxide metabolic process (GO:0090322),0.5497194071433347,0.8838982893880588,0.5777777777777777,0.9919060947556471,1.0,2/6,3.79%,BMP7;GCH1
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.36877265358757017,-0.8838337715136494,0.68,1.0,1.0,5/75,8.70%,SLC28A2;SLCO2B1;ABCB1;SLC22A8;AGER
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.3652288514126907,0.8838012459693021,0.5714285714285714,0.9915328675227383,1.0,23/102,16.07%,KCNJ16;KCNH5;LRRC55;KCNB2;KCNJ6;KCND2;KCNJ3;KCNN2;KCNJ2;KCNN3;KCNK7;HCN1;KCNQ5;KCNC2;KCNS3;SLC24A3;KCNK12;KCNC3;CHP1;KCNJ14;KCNS2;KCNC1;KCNF1
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.4658145561944022,-0.883734759392155,0.65,1.0,1.0,3/20,11.34%,CELF3;NCBP2;NCBP1
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),0.43209836784417205,0.8834918233101524,0.6216216216216216,0.9915321938126382,1.0,1/25,0.36%,TBX6
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),-0.376876064953815,-0.8833802619666554,0.6842105263157895,1.0,1.0,13/94,14.35%,CCNE1;CDKN2D;CDKN3;CCND2;CCNG2;CDC6;DAB2IP;CALM3;MTCP1;CDC25A;CDK5R1;GADD45A;CDKN1B
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),-0.5735729515592599,-0.8831870280916164,0.6296296296296297,1.0,1.0,1/5,15.51%,EIF2B5
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),0.5159479564384878,0.8831605056848736,0.5405405405405406,0.9909888340238034,1.0,2/11,6.16%,SLC37A4;SLC20A2
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),0.5159479564384878,0.8831605056848736,0.5405405405405406,0.9909888340238034,1.0,2/11,6.16%,SLC37A4;SLC20A2
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.3422133767134387,-0.8825250141029342,0.7435897435897436,1.0,1.0,35/227,12.30%,CD4;ITK;POLR3K;CYP1B1;PTPRC;CGAS;ELANE;AGT;CD74;NODAL;ZFPM1;HHLA2;NOX1;IRF1;TGFB1;IL7;TXK;SERPINE1;HLA-DPB1;IL15;ZBTB7B;CD14;SCIMP;AGER;CD6;IL18;BRCA1;HLA-A;MRE11;NOX5;IL18R1;LBP;FADD;HTR2B;GBP5
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.4153077188473505,0.8824526955299188,0.6470588235294118,0.9918629316986206,1.0,4/17,12.84%,TNFRSF11A;DVL2;MAP3K10;MAP3K5
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.4447612988521238,-0.8823690993409832,0.6610169491525424,1.0,1.0,8/28,21.41%,CCNE1;CDC6;BACH1;KLF11;PCNA;CDK5;CDK15;CDK18
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),-0.45829763251861544,-0.8821861348164023,0.6615384615384615,1.0,1.0,5/23,20.14%,SOX10;TLR2;EIF2B5;MXRA8;EIF2B2
prerank,GO_Biological_Process_2021__deoxyribonucleotide metabolic process (GO:0009262),0.5776395779338304,0.8821119901738638,0.6590909090909091,0.9920940800309681,1.0,2/5,9.14%,SAMHD1;RRM2
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.4243996426891793,-0.8820921944372231,0.6764705882352942,1.0,1.0,5/31,11.42%,CGAS;B2M;ACOX2;IL15;ARG2
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),0.5301909388778007,0.8820349025153164,0.6363636363636364,0.9917220695110618,1.0,3/6,22.32%,ERCC2;ERCC3;CTNNB1
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),0.32414346211755346,0.8819971970833157,0.6923076923076923,0.9912346293916358,1.0,23/114,13.83%,PID1;LEF1;BCL2;AFF3;IL1RAPL1;GCH1;CSF1R;ALDH1A2;TNFRSF11A;PTPN9;PTPN6;IL1RL2;REL;IGBP1;PTPN12;KHSRP;PTPN23;MAPK8;PTPN13;IL1R1;KLHL20;NFAT5;CHI3L1
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.34734025580456457,-0.8819326312540416,0.7,1.0,1.0,21/69,15.65%,PTPRC;ZBTB32;RCSD1;TMC8;SP140;ARHGAP9;CD37;GMFG;ADAM28;IL7;CD27;NCKAP1L;CORO1A;TAGAP;MAP4K1;WDFY4;RHOH;HVCN1;GPR18;WAS;STAP1
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),0.4195508526709847,0.881496012346714,0.575,0.9917899846982211,1.0,1/21,1.19%,GDAP1
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),-0.5022544608968805,-0.8814428218424138,0.6956521739130435,1.0,1.0,2/16,3.99%,GOT1;SDS
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),-0.4049454604224656,-0.8813728359336396,0.6571428571428571,1.0,1.0,13/52,15.31%,BIK;MOAP1;BNIP3;PINK1;CIDEB;ZDHHC6;GPER1;HIP1R;HRK;BOK;VPS35;PDCD5;PLAUR
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.3210792554063353,-0.8811794322569882,0.8641975308641975,1.0,1.0,38/358,11.98%,CD44;HCK;PRLR;WFS1;TNFSF18;BCL2L2;CDKN2D;ITGA5;CD74;ATF5;CCND2;BNIP3;ALOX12;RASA1;NOTCH1;PINK1;IL7;TBX1;SOD2;HSPA5;CRLF1;CD27;ANXA5;NCKAP1L;PRKCH;FIGNL1;RNF213;KIF14;IFIT3;ZNF16;PRAME;GSTP1;CTSH;MRE11;UFM1;SIX4;DNAJA1;HTR2B
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),-0.3904520142786874,-0.8810526595374165,0.72,1.0,1.0,10/58,10.98%,EPHA1;HCK;PRLR;ITK;TXK;FLT3;IL15;EFEMP1;PDGFRB;TEC
prerank,GO_Biological_Process_2021__radial glial cell differentiation (GO:0060019),0.5589986428159149,0.8810021631158673,0.6136363636363636,0.9923292512670895,1.0,1/5,6.24%,FGF10
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.45303000988808617,-0.8807431681059897,0.6461538461538462,1.0,1.0,7/22,18.21%,ATP5IF1;PINK1;UBE3A;UCHL5;TMF1;USP14;NUDT15
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.4656802620022873,-0.8805174437112715,0.6363636363636364,1.0,1.0,2/18,5.98%,EPAS1;PINK1
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),0.5736332719883277,0.8802176279160016,0.6097560975609756,0.9934693373596841,1.0,2/5,26.62%,MTCL1;MAP2
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),0.4990432830180061,0.8802049402251234,0.717948717948718,0.9929049526250455,1.0,3/10,14.93%,F2RL1;SPHK2;WNT5A
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.32170921662546614,0.8797084884157362,0.7096774193548387,0.9935273247808025,1.0,13/111,11.58%,FHDC1;FBXW8;TMED3;VTI1A;PRMT5;GOLGA8H;GOLGA8M;PI4K2A;PRKD1;BET1;ATL2;UBXN2A;STX6
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.37579973813675993,-0.8796446543196987,0.696969696969697,1.0,1.0,21/79,25.18%,HLA-DMA;CD74;HLA-DPB1;DCTN1;HLA-DMB;KIF11;RACGAP1;KIF3A;ARF1;AP1M2;KIF22;DYNLL1;SEC23A;CANX;KIF5A;KLC1;CLTC;SPTBN2;CLTA;KIF4A;LGMN
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),0.5575913218831214,0.8796379926391348,0.7317073170731707,0.9931175191695867,1.0,2/7,19.33%,ZDHHC5;SLC15A4
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.3644745819009065,-0.8796126895165589,0.7222222222222222,1.0,1.0,15/98,17.52%,ITK;RAC1;PSMB6;VAV3;PSMB8;PIK3CB;SKP1;PSMA3;TEC;PSMC3;PSMC6;PSMA5;PLCG2;LYN;PSMA7
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.5143098281990363,-0.8795115773799953,0.5892857142857143,1.0,1.0,3/9,15.37%,CLDN1;CLDN20;CLDN10
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),-0.48770939438185507,-0.8795035382150646,0.676923076923077,1.0,1.0,2/12,8.66%,ATP1B1;ATP1A1
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),-0.5479247313433222,-0.8793236832372595,0.6031746031746031,1.0,1.0,2/8,11.98%,ACTA2;HTR2B
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.3854110358193295,-0.8792462683625577,0.6375,1.0,1.0,9/71,15.38%,B2M;GMNN;HIP1R;NCBP1;STMN1;FLOT1;TXN;PLAUR;DDX11
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),0.46026267203879484,0.8791223025269158,0.625,0.9935544041237236,1.0,6/13,21.36%,SAMSN1;RC3H1;ID2;ATM;BLK;TNFRSF21
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.5275924115807126,0.8789615699973553,0.6904761904761905,0.9934525960816479,1.0,2/10,7.92%,PID1;PLD6
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.45459888258404996,-0.8788741877958702,0.6825396825396826,1.0,1.0,4/24,15.35%,WFS1;HERPUD1;LPCAT3;SYVN1
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,0.3179465791214889,0.8788591737349801,0.8,0.9931280803089823,1.0,27/160,12.51%,F11;CYP1A2;CA2;ATOH8;PROS1;GCH1;TGFB2;PAPSS2;DHRS1;ALAS1;AKR1C3;HGFAC;APOE;CSAD;IGF1;HPRT1;SLC35B1;CROT;RBP4;DCXR;LCAT;CYB5A;LEAP2;PC;GCNT2;ABCD2;IL1R1
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),0.494392352459065,0.8786263304329931,0.47368421052631576,0.9930420018528165,1.0,3/6,36.06%,PRUNE1;PRUNE2;BNIPL
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),-0.5243405038730332,-0.8785896037972033,0.6666666666666666,1.0,1.0,1/11,5.15%,RPP38
prerank,GO_Biological_Process_2021__viral mRNA export from host cell nucleus (GO:0046784),-0.5471336193024381,-0.8783278651382367,0.6451612903225806,1.0,1.0,2/7,19.78%,ALYREF;THOC5
prerank,GO_Biological_Process_2021__translocation of molecules into host (GO:0044417),-0.5471336193024381,-0.8783278651382367,0.6451612903225806,1.0,1.0,2/7,19.78%,ALYREF;THOC5
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.3822015470934746,0.8781574696989793,0.7096774193548387,0.9934011554409625,1.0,5/37,10.35%,RFWD3;TIMELESS;EME2;PRIMPOL;SMARCAL1
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),0.5926407091749232,0.8781462552837271,0.6285714285714286,0.9928164578803734,1.0,1/5,0.81%,CA2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.377046300540544,0.8778166165990298,0.7105263157894737,0.9930833339581971,1.0,4/42,2.31%,IFI16;BCL2A1;BCL2L11;BCL2
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),0.43138350196032477,0.8777282260482508,0.5897435897435898,0.9926757167277646,1.0,3/27,2.70%,ITGB5;ITGA4;LAMB3
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),-0.5886533088808009,-0.8775614810452094,0.7142857142857143,1.0,1.0,2/7,11.98%,FABP3;HTR2B
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),0.4452392903035505,0.8774430351501273,0.6,0.9928351690789505,1.0,3/9,12.73%,CACNA2D1;NOS1AP;CACNB2
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),0.49700389022984803,0.8773140845826608,0.6060606060606061,0.9923975677408015,1.0,2/8,13.89%,TIMELESS;SPIDR
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.32481512470598956,-0.8771602526684562,0.8148148148148148,1.0,1.0,29/286,12.43%,CD44;HCK;PRLR;WFS1;TNFSF18;BCL2L2;CD74;ATF5;CCND2;BNIP3;RASA1;IL7;HSPA5;CD27;ANXA5;NCKAP1L;FIGNL1;KIF14;IFIT3;ZNF16;PRAME;GSTP1;CTSH;MRE11;UFM1;SIX4;DNAJA1;HTR2B;BAG4
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),0.45430405869251467,0.8771313174667449,0.5882352941176471,0.9922740333828076,1.0,4/13,16.85%,PLIN5;SCARB1;FITM2;NR1H3
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.38652286927161844,0.8770701492993541,0.7058823529411765,0.9918296313142639,1.0,4/28,14.73%,RAB7A;RNF128;KPTN;SORL1
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),-0.44090969955827686,-0.8769602939168188,0.6607142857142857,1.0,1.0,4/24,7.73%,PDCD1LG2;FGL1;IL4I1;NCKAP1L
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.38033324967526094,-0.8768663150287366,0.6388888888888888,1.0,1.0,9/66,11.53%,POLR3K;FIP1L1;CSTF2T;TBP;POLR1E;NCBP2;SLBP;NCBP1;POLR1H
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.44633634281266993,-0.8768607492184433,0.7014925373134329,1.0,1.0,3/19,12.77%,FKBP1B;CALM3;CASQ1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),0.4559944127330817,0.8767214906826143,0.7096774193548387,0.9919815670724331,1.0,2/16,7.13%,TRPC3;IGF1
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.3597404295752849,0.8766347449222462,0.6842105263157895,0.9915989306395133,1.0,9/54,15.48%,TGFBR1;ACVR1;PRKCD;SBK1;PRKD1;MAPK8;MAP3K10;CDC42BPB;DYRK3
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.3301856013416672,-0.8765553271873551,0.8352941176470589,1.0,1.0,81/338,22.88%,PAPPA;NOTUM;WFS1;MMP15;RABGGTB;CP;GPC3;PAPPA2;MANBA;PCMT1;RPL36;SERPINA10;ITIH2;PHEX;RPL15;RPL38;UBL5;RPS21;DAB2IP;IGFBP5;KNG1;APH1B;RPS7;L2HGDH;CTSH;PRSS23;WARS1;PIGH;RPL37A;ASMT;RPL9;RPL28;MRPS14;MFGE8;SPARCL1;RPLP2;MEPE;PCSK5;RCN1;RPL5;EEF1A1;RPL35A;RSL24D1;RPS20;RPLP1;ADAM17;SFTPD;RPL8;RPL4;RPL22;CPE;RPL27A;MRPS18C;COPS5;RPL24;PLOD2;TTF1;RPS15;ERO1A;MRPL51;RAB12;MXRA8;SPP1;MRPL43;RPL34;RPL3;RPS24;RPS4X;RPS3;ATG3;RPS6KB2;RPS29;FURIN;RPL13A;FN1;RPS8;HSP90B1;RPS27A;RPL27;RPL37;RPL7A
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),-0.4682400239647722,-0.8763274296412881,0.704225352112676,1.0,1.0,1/15,4.70%,BNIP3
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.3978311316772973,-0.8763117098728264,0.53125,1.0,1.0,9/52,16.43%,TRPV6;ZACN;AQP9;TTN;CALM3;HVCN1;SLC30A8;ADAM9;KHK
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),-0.481123364075116,-0.8762832095249665,0.6268656716417911,1.0,1.0,1/14,2.33%,HSD17B10
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),-0.3530899671441883,-0.8760515277446903,0.6875,1.0,1.0,10/91,11.05%,EPHA1;CD4;PTPRC;CAV3;SPDYA;TTN;TAF7;CAMK2N1;GSTP1;WARS1
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.5901698492645127,-0.8758848284783779,0.68,1.0,1.0,1/5,18.82%,PDHX
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),0.4221777375528007,0.8756887055508003,0.625,0.9931775835991953,1.0,3/20,8.98%,IFI16;TRAFD1;LYAR
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.4810988769306558,-0.8755309602697718,0.6610169491525424,1.0,1.0,4/12,10.27%,CYP1B1;RDH10;RDH12;RETSAT
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.39432918734301386,-0.8751705477709317,0.6176470588235294,1.0,1.0,20/79,18.07%,AHR;JUNB;B3GNT3;KLF5;SYNGR2;ZBTB7B;ANXA5;CD14;CTSZ;CTSH;MFGE8;TMBIM1;LTBR;TNFAIP2;RHBDF2;MARCKSL1;OAS3;NFKBIA;PGLYRP1;MVP
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),-0.5331959857627195,-0.8750940002875095,0.6964285714285714,1.0,1.0,1/10,1.39%,SCN4B
prerank,MSigDB_Hallmark_2020__Complement,-0.35939826386177565,-0.8750299903027918,0.7027027027027027,1.0,1.0,31/147,17.54%,C4BPB;F8;MMP15;CP;IRF1;TIMP2;PPP4C;SERPINE1;HSPA5;ANXA5;PHEX;F10;NOTCH4;ERAP2;L3MBTL4;CALM3;CCL5;CPM;CTSH;CDK5R1;PLA2G7;WAS;PLAUR;C1QA;ADAM9;HPCAL4;USP14;SERPING1;LYN;HNF4A;LAMP2
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),0.3771713301078393,0.8747999368957544,0.631578947368421,0.9947238880271623,1.0,4/35,5.34%,PENK;C5AR1;OR3A2;NTSR2
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),-0.5796906479704077,-0.8746831416880694,0.6666666666666666,1.0,1.0,2/6,11.83%,CAV3;MYOF
prerank,GO_Biological_Process_2021__negative regulation of cholesterol transport (GO:0032375),-0.5264403936713032,-0.874617819004592,0.7272727272727273,1.0,1.0,3/7,16.01%,ABCG5;PLA2G10;SHH
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),-0.47580896576064813,-0.874560660425309,0.6774193548387096,1.0,1.0,5/13,19.17%,ITGA5;NOTCH1;PTRH2;SNAI2;ZNF304
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.370183821938261,-0.8742556327193334,0.6578947368421053,1.0,1.0,15/82,16.69%,AGT;P2RY12;TGFB1;RARRES2;SERPINE1;IL15;SCIMP;PDGFRB;IL18;CCL5;GBP5;TLR2;PLA2G7;NFKBIA;ZCCHC3
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,-0.3763029582408552,-0.8738599898394644,0.7205882352941176,1.0,1.0,14/65,20.15%,ATF5;TMEM97;NSDHL;ANXA5;DHCR7;FADS2;FASN;NIBAN1;PLAUR;PNRC1;SQLE;AVPR1A;MAL2;ACTG1
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.5090958476792411,-0.8736208734179425,0.6557377049180327,1.0,1.0,2/13,5.95%,H1-0;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),-0.5307505328385378,-0.8736001601271225,0.6166666666666667,1.0,1.0,3/9,10.49%,NHEJ1;XRCC1;TMSB4X
prerank,GO_Biological_Process_2021__mature ribosome assembly (GO:0042256),-0.5788386905179741,-0.8733078923206894,0.6440677966101694,1.0,1.0,4/5,26.70%,C1QBP;EIF6;SBDS;DDX3X
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),-0.5555427886330665,-0.8733053343650282,0.6896551724137931,1.0,1.0,2/7,20.76%,PIK3CB;PIK3CD
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),0.2906867143457045,0.8730957483128496,0.875,0.9980364116413624,1.0,48/441,9.50%,NRG1;TBX6;PDGFD;IRS1;TRPC3;LEF1;KDR;WWTR1;BCL2;EGFR;KITLG;FGFR4;TGFBR1;S100A13;BMP6;GRK5;IL15RA;TGM1;FGFR3;CSF1R;PARD3;MDK;DBF4B;TGFB2;PTGFR;PDGFC;TGFB3;EREG;BTC;RAB27A;GREM1;MEIS1;TNFRSF11A;PDGFRA;FGF10;AKR1C3;PRKCD;IGF1;PTPN6;PKHD1;HDAC1;TET1;SHANK2;IRS2;FAF1;LYAR;ERBB4;SLC25A33
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),0.32794004693871526,0.8730693980103741,0.7333333333333333,0.9975064202177656,1.0,7/65,7.74%,SH3RF1;BCL2;TGFBR1;ACVR1;CFLAR;IGF1;HSPA1A
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),-0.39197304408437506,-0.8730563871492508,0.6617647058823529,1.0,1.0,6/53,10.78%,TRIML2;TRIM22;TRIM5;TRIM25;SLC26A4;BORA
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.35420777152345206,0.8724581372931219,0.6363636363636364,0.9982786839312874,1.0,6/59,7.33%,EPHA3;EPHA5;IQGAP2;PRKCD;EFNA5;PEAK3
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.36849825080253956,0.8722878592646651,0.6333333333333333,0.9982284400169509,1.0,13/80,11.40%,F11;ITGA4;EYA4;SGK2;AFF3;C6;RNF128;SPTSSB;RGN;RBP4;COL22A1;HRH2;ADAMTS6
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.43135927411905284,0.8721556612879194,0.6486486486486487,0.9979425609761693,1.0,3/14,17.36%,GCK;EP300;PPARA
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),0.559113548704384,0.8720604453453811,0.627906976744186,0.9976646139131005,1.0,1/6,9.37%,UBE2D4
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.4784913531464541,0.8719652957849134,0.6388888888888888,0.9973110491677311,1.0,1/12,1.51%,LEF1
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.3557015422437739,0.8719518020751045,0.6341463414634146,0.996737793800537,1.0,15/62,13.16%,NFIB;KANK1;GRIN3A;FGFR3;HEY1;MARCHF5;SPRY3;GREM1;VASH1;SFMBT1;ANP32B;PTPRS;ELAPOR2;RC3H1;SRGAP2C
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.40362130127762774,-0.8719221827676977,0.676923076923077,1.0,1.0,9/40,16.98%,CYP1B1;EPHX1;ALOX12;PTGR1;ALOXE3;GSTP1;FADS2;PLA2G10;ELOVL2
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),-0.5263059783638766,-0.8716881158563201,0.6666666666666666,1.0,1.0,3/8,16.15%,CCL5;CXCL13;ADAM17
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),-0.5263059783638766,-0.8716881158563201,0.6666666666666666,1.0,1.0,3/8,16.15%,CCL5;CXCL13;ADAM17
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),-0.4751960726908268,-0.8716370652768887,0.6666666666666666,1.0,1.0,2/18,9.24%,NODAL;REST
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),0.4412928527261256,0.8715359533797225,0.7027027027027027,0.9971361270385439,1.0,3/18,8.48%,CARD18;IGF1;SERPINB1
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.47342024170674146,0.8715168171315023,0.6410256410256411,0.9966167067607801,1.0,7/17,17.63%,HDAC9;MAML1;HDAC1;DMPK;ATP11A;HDAC3;HDAC5
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),-0.4027756664063932,-0.8713401720752842,0.6428571428571429,1.0,1.0,6/44,15.08%,ROPN1B;PLEKHG7;CELSR1;NTN1;RIPOR1;WAS
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.366302770347509,-0.8708618236041634,0.6944444444444444,1.0,1.0,5/77,8.70%,SLC28A2;SLCO2B1;ABCB1;SLC22A8;AGER
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),-0.4708622983906553,-0.8708425327393351,0.5964912280701754,1.0,1.0,1/14,4.14%,LDLRAP1
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.4537568956024173,-0.8706973842735154,0.6307692307692307,1.0,1.0,6/23,23.05%,NODAL;BRCA1;CRY2;KANK2;CALR;PER1
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),-0.4052292768940132,-0.870548288254992,0.6666666666666666,1.0,1.0,4/35,7.46%,TRPV6;PTPRC;SLC24A1;TRPV3
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.33726320216241046,0.8698323244219827,0.7272727272727273,0.9995603519419219,1.0,6/59,6.73%,F2RL1;NRP1;KANK1;GPR174;HEG1;APOE
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.5073382326837477,-0.8698183056758353,0.7123287671232876,1.0,1.0,4/13,20.54%,PHKG1;PHKA1;AGL;CALM1
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.3712125870424879,0.8697287637858927,0.6551724137931034,0.9991612802723959,1.0,7/40,15.78%,CROCC;SDC4;STX18;CEP120;PIP4K2A;NUMA1;ELAPOR1
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),-0.5099692576261752,-0.8696619797266367,0.6666666666666666,1.0,1.0,3/8,20.28%,BRK1;WASF1;CYFIP1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.4339266228194968,0.8695629200237995,0.6571428571428571,0.9989897031755753,1.0,4/19,9.34%,KDR;MCU;MARCHF5;RALA
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),-0.4941429156261907,-0.869477796514591,0.6617647058823529,1.0,1.0,2/13,7.55%,ERVFRD-1;ERVW-1
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.31130131061430094,0.8694457309918863,0.7586206896551724,0.9987502554466804,1.0,20/206,7.72%,TPD52L1;MAML3;IRS1;NRP1;SULF2;KANK1;TGFBR1;BMP6;KLK6;CRADD;ADAMTS3;MAML1;MN1;TGFB2;JAG1;IGF1;PRKCB;TEDC2;NRXN1;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.4450771084560345,0.8691776482026893,0.6410256410256411,0.9987378531970877,1.0,2/13,17.20%,TPR;DNMT1
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.3777919753197538,0.8689251756946383,0.6571428571428571,0.9986499199141887,1.0,5/43,6.57%,NRP1;IL1RAPL1;FBXW8;MDK;CASS4
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.44810387519914874,0.8688008252063606,0.55,0.9983582340859777,1.0,4/20,6.36%,NRP1;TGFBR1;TGFB2;JAG1
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.4391324860871652,0.8687965397906414,0.53125,0.9978103291066468,1.0,10/14,32.03%,PNPLA2;NR1H3;PPARA;ITGAV;NR1H2;PTPN2;ABCA1;PPARG;TTC39B;ABHD5
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.35664603107121123,0.868621494509049,0.6071428571428571,0.99759488100958,1.0,5/71,2.07%,RXFP2;HTR7;GLP1R;CYSLTR2;CD247
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.3731970984014868,-0.8685532279663478,0.7402597402597403,1.0,1.0,9/83,9.89%,MMP26;PTGIS;ELANE;DRD3;CARD8;SERPINE1;RNF26;GPER1;SIGIRR
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),-0.32633953492553114,-0.8682987225921724,0.810126582278481,1.0,1.0,35/253,13.89%,PNMA5;PTGIS;CYP1B1;PNMA2;SFRP4;GADD45B;MOAP1;DDX20;BNIP3;RASGRF2;MTCH1;VAV3;CASP8;TFPT;PXT1;DAB2IP;REST;PPID;GPER1;KNG1;APH1B;STK17A;FGD3;HIP1R;ITGB3BP;HRK;FADD;DNAJA1;PREX1;RNPS1;BOK;SUDS3;CDK5R1;GADD45A;KLF11
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),0.31777289511274504,0.868007089302741,0.6774193548387096,0.9985027046689026,1.0,15/94,15.86%,MRPL17;TSFM;MRPL33;MRPL58;MRPL39;MRPS27;RARS2;MRPS18A;MRPL21;MRPS7;LARS2;QRSL1;EARS2;MTRF1L;DAP3
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),0.5177172651070716,0.867820051075518,0.6304347826086957,0.9983548997937376,1.0,1/8,4.08%,CEP85
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),-0.5056094365736,-0.8674916304765252,0.671875,1.0,1.0,2/7,7.77%,GMFG;CORO1A
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.36723779034340753,0.8674556916508728,0.6857142857142857,0.9985460416984915,1.0,3/30,8.78%,ATP6V0D2;REP15;STEAP3
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.3506343810104218,0.8674233890258879,0.8518518518518519,0.9980598020695339,1.0,18/74,17.68%,KANK1;EPHB2;TGFB2;SPRY3;RABL3;FGF10;RASGRP1;IGF1;IRS2;STARD8;MMD2;NGF;DENND1A;RASGRF1;RAPGEF1;RALGPS1;ARHGAP44;JAK2
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),-0.4361922913590629,-0.8673845767654671,0.6,1.0,1.0,3/15,9.42%,AHR;IL4I1;THEMIS2
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),0.5104534745191857,0.8672671588519548,0.7222222222222222,0.9977771546154359,1.0,2/8,10.35%,TIMELESS;SMARCAL1
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.44441831989844927,-0.8672023086951137,0.6984126984126984,1.0,1.0,8/28,7.53%,TMEM184A;SMIM22;LIPH;PTGR1;B3GNT3;CBLC;ANXA10;GPX2
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.3543211052037144,0.8669962446305026,0.65625,0.9977578697474073,1.0,16/57,19.64%,PCBP3;AFF2;PTBP3;PTBP2;IGF2BP3;NOVA1;FASTK;RC3H1;RRP1B;CELF1;HNRNPL;HNRNPH1;SRRM4;SON;PTBP1;MBNL1
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),-0.48759319250609623,-0.8669918724509202,0.7272727272727273,1.0,1.0,2/13,8.66%,ATP1B1;ATP1A1
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.3562962470620554,0.8668833738733308,0.6666666666666666,0.9974757221360931,1.0,9/63,11.01%,ZBED3;SMPD4;UBE2J2;REEP1;STX18;SPTSSB;EIF2AK3;ATL2;CYB5A
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",0.5601467522773549,0.8667648056791621,0.6521739130434783,0.9972014062522664,1.0,2/6,10.20%,SH3RF1;TWSG1
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),0.5217369053686202,0.8667130870066495,0.7021276595744681,0.9967398474435026,1.0,4/6,29.72%,SRGN;F2R;ABCA1;DTNBP1
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),-0.5496070075090502,-0.8666758922329834,0.6666666666666666,1.0,1.0,3/8,30.23%,RIPK2;PTPN22;CHMP5
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),-0.36824762650949083,-0.8665837293694608,0.6417910447761194,1.0,1.0,12/88,16.75%,TRPV6;CPNE5;KCNMB1;TTN;NEUROD2;CALM3;SYT2;SYT4;MCOLN1;PLCG2;ADAM9;RASGRP2
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.49012831697287923,0.8665270562495334,0.5882352941176471,0.9966162313182299,1.0,5/18,13.19%,UBASH3B;CACNA2D1;CBARP;NOS1AP;FYN
prerank,PanglaoDB_Augmented_2021__Pericytes,-0.3628533934151911,-0.8663448298761488,0.7297297297297297,1.0,1.0,23/107,13.33%,ALPL;LAMA2;MSX1;FBLN2;STEAP4;TIMP3;ANGPTL2;ECM2;COL6A1;SLC38A11;RARRES2;P2RY14;ANGPT2;ADGRF5;IGFBP5;PDE5A;PDGFRB;ACTA2;RGS5;MFGE8;SPARCL1;PLSCR4;HSD11B1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.48307822045203963,-0.8661485695997957,0.7377049180327869,1.0,1.0,6/15,30.03%,HERPUD1;SYVN1;UFD1;HSP90B1;DERL1;SELENOS
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),-0.3693423749447138,-0.866026984043759,0.6949152542372882,1.0,1.0,19/95,16.85%,SLC12A7;CHRNB1;PLP2;TRPA1;CNGB3;SLC24A1;SLC26A4;SLC9A6;SLC24A5;KCNN4;SLC17A8;CNGB1;MCOLN1;SLC36A1;PIEZO2;VDAC1;SLC25A18;SLC24A4;HCN4
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.33660889130250743,0.8659991952101646,0.56,0.9972421296275646,1.0,15/105,7.60%,CDH6;SLC12A3;LAMB2;GEM;KDR;RNF182;SLC12A1;LRRC66;ARID5A;NEK6;PDGFRA;JAG1;IGF1;HTRA1;PXDC1
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.3892606744430028,0.865312282215511,0.6590909090909091,0.9984065464595688,1.0,8/27,21.96%,NRXN1;NLGN1;SLC8A3;GRIN1;TMEM108;PTEN;RELN;RIMS2
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.3905454290822401,-0.8652628090890409,0.6470588235294118,1.0,1.0,10/40,20.20%,HSPA5;PEX16;TOMM20;SEC62;DNAJC19;ROMO1;PEX5;RTN2;PEX1;HSPD1
prerank,GO_Biological_Process_2021__mesoderm morphogenesis (GO:0048332),-0.5342939871283724,-0.8652288068750358,0.6607142857142857,1.0,1.0,1/7,4.63%,TBX19
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),-0.5669106935037282,-0.8651780337363901,0.7142857142857143,1.0,1.0,2/5,35.95%,INPP5K;DMTN
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.35705834449036794,0.8651647979011463,0.6153846153846154,0.9981025432812644,1.0,5/72,2.07%,RXFP2;HTR7;GLP1R;CYSLTR2;CD247
prerank,PanglaoDB_Augmented_2021__Trichocytes,-0.41588371677826275,-0.8648103406532693,0.6818181818181818,1.0,1.0,5/37,7.40%,TMEM184A;B3GNT3;ALOXE3;KLF5;WNT7B
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),-0.49008678026832625,-0.8646170892293338,0.6851851851851852,1.0,1.0,1/13,3.68%,NODAL
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.4656750750741206,0.8642965149830809,0.625,0.9995269579215454,1.0,3/15,13.57%,HSPB1;MAPK7;SIRT1
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),0.5013784512313634,0.8642630475483102,0.6486486486486487,0.999028271105155,1.0,1/9,5.96%,DDAH1
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.437018655069331,-0.8641873991683525,0.7313432835820896,1.0,1.0,7/30,16.65%,TGFB1;APH1B;CTSH;MBTPS2;ADAM9;ADAM17;ERAP1
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.5020295699498042,-0.8640886206221392,0.6949152542372882,1.0,1.0,2/12,6.89%,STAT1;CRLF1
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),0.40776933724001324,0.8640398189676347,0.7857142857142857,0.9989710182404029,1.0,1/19,1.17%,ITGA4
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.5174270171759496,-0.8637430029870604,0.7076923076923077,1.0,1.0,1/11,4.13%,WIPI1
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),-0.4941412353622391,-0.8637344299140007,0.6415094339622641,1.0,1.0,1/10,3.68%,NODAL
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),-0.47754793130289197,-0.8636313068560679,0.6363636363636364,1.0,1.0,3/14,11.39%,PTPRC;P2RY12;NTN1
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),0.5621562973943269,0.8635987988600193,0.7419354838709677,0.9994963315842263,1.0,1/5,8.31%,HPRT1
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.36785676869444955,-0.8634180326223737,0.7142857142857143,1.0,1.0,11/90,8.77%,MYLK;CHRNB1;ACTC1;CAV3;MYBPC2;CHRNE;CHRNG;SMTN;MYOT;TTN;MYOM1
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.44096320880464784,-0.8632582155005412,0.6333333333333333,1.0,1.0,7/28,12.30%,GNLY;ITK;PTPRC;THEMIS;CD6;TAGAP;GBP5
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.41563697771720676,-0.862821704455613,0.676923076923077,1.0,1.0,1/21,5.83%,NOTCH1
prerank,GO_Biological_Process_2021__protein K29-linked ubiquitination (GO:0035519),0.5446024602563779,0.8626175060146177,0.6521739130434783,1.0,1.0,1/5,9.37%,UBE2D4
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.321042140111754,0.8626158697320196,0.7878787878787878,1.0,1.0,9/103,7.25%,NRG1;SGK1;DOCK10;EGFR;CSF1R;EREG;BTC;FGF10;NRG2
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),-0.4341508351501748,-0.8625706784932121,0.6571428571428571,1.0,1.0,9/25,21.47%,ODAD4;CCDC39;DNAH8;ODAD3;DRC1;DNAH17;DNAH7;DNAI3;TTC12
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.40558307895538204,-0.8625305387463645,0.6666666666666666,1.0,1.0,5/26,16.67%,CAMLG;UCHL5;SVIP;USP14;MAP1A
prerank,GO_Biological_Process_2021__tyrosine phosphorylation of STAT protein (GO:0007260),-0.557770520882214,-0.8623213662959909,0.6956521739130435,1.0,1.0,1/5,7.33%,IL15
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),0.37611979969697135,0.8622891323488651,0.7272727272727273,1.0,1.0,8/26,25.99%,PARP10;SIRT2;SIRT1;PARP6;SIRT3;ZC3HAV1;PARP3;TNKS
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),-0.508356535701234,-0.8622658553423332,0.6666666666666666,1.0,1.0,4/11,33.76%,LRRK2;USP7;DENND10;ATP9A
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),-0.562771596444078,-0.8620815428473785,0.7450980392156863,1.0,1.0,1/6,9.94%,CHMP2A
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),0.43437731880501185,0.8620019738901058,0.6451612903225806,1.0,1.0,3/16,8.29%,RAB27A;NLGN1;CACNA1I
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),-0.48380798368864447,-0.8619302253015768,0.696969696969697,1.0,1.0,4/11,23.29%,BRK1;WASF1;CYFIP1;WHAMM
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),-0.43645344701472466,-0.8619227420925588,0.75,1.0,1.0,6/29,11.81%,SEMA3D;ELANE;NOTCH1;ANGPT2;SEMA3F;SEMA3A
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.5131501876858249,-0.8614716183997491,0.7457627118644068,1.0,1.0,2/9,9.82%,DRD3;CALM3
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.4566950511768607,-0.861331386731755,0.5614035087719298,1.0,1.0,4/21,19.01%,SUB1;PSMC3;PSMC6;ESR1
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.4587407117770695,0.8611935931670648,0.7291666666666666,1.0,1.0,5/12,17.36%,IRS1;IRS2;PRKCE;AKT2;PPARA
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.3489850134333924,0.8611924650933485,0.7777777777777778,1.0,1.0,2/61,1.34%,ATP6V0D2;IRS1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.45121931346769156,-0.860927351358188,0.6612903225806451,1.0,1.0,3/16,12.20%,DAB2IP;GSTP1;TRIM32
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.40550241302543466,0.8608200181217492,0.6842105263157895,1.0,1.0,7/23,13.44%,KDR;SEMA5A;MDK;PKHD1;ANGPT1;PAK4;MAPK7
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.35432796036363373,-0.8606670882408156,0.7846153846153846,1.0,1.0,10/82,10.39%,HIC1;CYP1B1;BCL2L2;HINT1;MOAP1;CHAC1;BNIP3;CIDEB;DAB2IP;BRCA1
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.5209667567318288,-0.8606244437485197,0.71875,1.0,1.0,3/11,25.49%,ZWILCH;KNL1;CHAMP1
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),-0.5243864077132256,-0.8605246452134888,0.6825396825396826,1.0,1.0,2/10,5.83%,ZFPM1;NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),-0.5123318241596941,-0.8603033979836867,0.7230769230769231,1.0,1.0,3/9,16.15%,CCL5;CXCL13;ADAM17
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.3622667005147985,-0.86025189532056,0.6666666666666666,1.0,1.0,9/50,18.93%,TICRR;RPS27L;BRCA1;MRE11;DONSON;ABRAXAS1;CHEK1;NEK11;RAD9B
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.38860455161379276,-0.8601810537554712,0.6349206349206349,1.0,1.0,7/34,18.38%,PIGC;B3GNT5;MPPE1;PIGH;PIGO;PGAP4;PGAP3
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),0.3929796099492642,0.8601007135115721,0.6774193548387096,1.0,1.0,3/34,7.87%,TENT5A;ELAVL1;TENT5C
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.41666235847174304,0.8597593293932562,0.6097560975609756,1.0,1.0,2/25,6.89%,KLRD1;RASGRP1
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.38883654488870434,-0.8597186362553821,0.6617647058823529,1.0,1.0,3/40,11.01%,TERF2IP;RPA3;MRE11
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),-0.4294764220214464,-0.8596158925222666,0.7419354838709677,1.0,1.0,8/25,19.27%,NOTCH1;TGFB1;ANGPT2;DAB2IP;ADGRB1;GADD45A;ADAMTS9;RGCC
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.44642993313238405,0.8595142626834766,0.6486486486486487,1.0,1.0,1/19,0.98%,STAC
prerank,GO_Biological_Process_2021__negative regulation of calcium ion-dependent exocytosis (GO:0045955),-0.5425440288154693,-0.859172581275209,0.6,1.0,1.0,2/5,12.25%,REST;SYT4
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.37601769104228333,-0.8588953977530545,0.7352941176470589,1.0,1.0,12/74,10.35%,PTPRC;PEBP1;CAV3;TIMP3;AGT;FOXM1;CBLC;PIK3CB;DAB2IP;CAMK2N1;GPER1;GSTP1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),-0.504572449504425,-0.8588419929839765,0.609375,1.0,1.0,3/9,23.64%,RPS7;RPL5;RPL23
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),0.5230333227506783,0.858631601932577,0.6511627906976745,1.0,1.0,3/7,29.43%,SETD4;KMT2C;SETD1A
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),-0.37721401952213507,-0.8585084271080413,0.6785714285714286,1.0,1.0,2/64,4.66%,F8;LMAN1
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.4199442603558734,0.8583059495070995,0.6666666666666666,1.0,1.0,3/24,9.03%,PTPRK;FGF10;ANGPT1
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.3402216826056033,0.8581626263543095,0.7,1.0,1.0,4/52,4.20%,IRS1;FGFR4;MCU;LEPR
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),0.31552612899401516,0.8580859835059331,0.7407407407407407,1.0,1.0,45/199,18.42%,FHDC1;ARL13B;PCM1;PDE6D;CDC14B;DNAH5;CFAP70;TTC39C;CNGA4;RAB3IP;TTC17;UBXN10;PKHD1;CEP83;KIAA0586;FAM161B;PIBF1;CFAP43;EHD4;PTPN23;ABCC4;SCLT1;TMEM250;RFX2;BBIP1;WDR35;SNAP29;EXOC7;FNBP1L;CFAP44;CFAP20;RILP;ABLIM1;TTC36;BBS9;POC1B;PARVA;MACIR;IFT74;B9D1;RFX3;RILPL1;SPAG16;RPGR;RAB11FIP3
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.46448887898206664,-0.8580856491745761,0.6818181818181818,1.0,1.0,6/17,25.62%,WDR12;RRP15;EIF6;LAS1L;NSA2;MAK16
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid segregation (GO:0033047),0.5310901286938133,0.8580216566080664,0.6904761904761905,1.0,1.0,2/6,20.14%,CDK5RAP2;LCMT1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle checkpoint (GO:1903504),0.5310901286938133,0.8580216566080664,0.6904761904761905,1.0,1.0,2/6,20.14%,CDK5RAP2;LCMT1
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.375411183131678,0.8578085854026892,0.75,1.0,1.0,9/65,12.84%,ATP6V0D2;WDR24;EIF2S1;DAP;PRKD1;EIF2AK3;KPTN;MAPK8;MAP3K5
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),0.47144087273436985,0.8576546467765852,0.6458333333333334,1.0,1.0,3/9,10.56%,ENPP1;GREM1;SRGN
prerank,GO_Biological_Process_2021__lung epithelium development (GO:0060428),-0.5166655078427663,-0.8574488905296977,0.6984126984126984,1.0,1.0,2/7,10.29%,WNT7B;RCN3
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),-0.5619856930069784,-0.8571255511550493,0.7049180327868853,1.0,1.0,2/5,26.70%,OAS3;DDX3X
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),-0.5233172926277128,-0.8570943245431238,0.6470588235294118,1.0,1.0,2/9,12.19%,SDS;SERINC3
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.5182060257168994,-0.8570377023070526,0.6428571428571429,1.0,1.0,1/11,3.45%,COASY
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.5182060257168994,-0.8570377023070526,0.6428571428571429,1.0,1.0,1/11,3.45%,COASY
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),-0.5182060257168994,-0.8570377023070526,0.6428571428571429,1.0,1.0,1/11,3.45%,COASY
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),0.36172495867799814,0.8569867518387484,0.5588235294117647,1.0,1.0,2/43,3.18%,SOX13;BMP7
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.34856940253674124,0.8567858357230712,0.7058823529411765,1.0,1.0,1/57,0.22%,FBXL7
prerank,GO_Biological_Process_2021__G protein-coupled opioid receptor signaling pathway (GO:0038003),-0.5782327531477097,-0.8566122303479714,0.7096774193548387,1.0,1.0,2/5,20.21%,OPRD1;OPRK1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),-0.548647583217192,-0.8565871054713193,0.7333333333333333,1.0,1.0,2/7,10.26%,CALCR;PDGFRB
prerank,GO_Biological_Process_2021__pentose catabolic process (GO:0019323),0.5423629772617989,0.8564857525987378,0.6428571428571429,1.0,1.0,1/5,9.57%,RPEL1
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),-0.4275927370225511,-0.8564188104959218,0.7313432835820896,1.0,1.0,7/29,21.05%,TAF7;BRCA1;SPI1;CHEK1;SET;NOS1;CTBP1
prerank,GO_Biological_Process_2021__mucosal immune response (GO:0002385),-0.5401842768063345,-0.8562410220165753,0.6909090909090909,1.0,1.0,2/6,21.76%,IFNLR1;RAB17
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.37610576017089853,0.8561908455317345,0.7241379310344828,1.0,1.0,8/29,19.79%,SYNJ2;PLD2;NLGN1;CEL;SYT1;NLGN4Y;OPHN1;PIP5K1C
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.3155533401737459,0.8561618874905278,0.6956521739130435,1.0,1.0,37/218,14.33%,TRPC7;SLC12A3;KCNJ16;TRPC3;SLC39A11;KCNH5;SLC30A10;LRRC55;SLC12A1;KCNB2;KCND2;SLC6A11;KCNN2;KCNJ2;KCNN3;KCNK7;HCN1;SLC6A4;TRPC5;SCNN1B;KCNQ5;SLC8A3;SLC6A13;KCNC2;SLC6A1;SLC4A4;SLC25A27;KCNS3;SLC24A3;KCNK12;ANO6;SLC6A2;TRPC1;SLC8A1;KCNC3;TRPV2;SCNN1D
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.43050260190421274,-0.8560494092831181,0.6349206349206349,1.0,1.0,3/22,5.83%,CAV3;AGT;NOTCH1
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.40099581561122066,-0.8559676590961465,0.6865671641791045,1.0,1.0,4/42,9.16%,CDKN2D;RFC5;RPA3;TRIM25
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),-0.515727412621625,-0.8558582503369002,0.6140350877192983,1.0,1.0,1/8,7.99%,DPYS
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),0.44209068323644163,0.8557376308836572,0.7575757575757576,1.0,1.0,2/11,5.75%,TGFBR1;GREM1
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),-0.3751795825829434,-0.8557128725468006,0.6142857142857143,1.0,1.0,9/56,16.07%,AGT;SERPINE1;IL15;IL18;CCL5;GBP5;TLR2;PLA2G7;NFKBIA
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.38898971684213834,0.8556677460517739,0.6923076923076923,1.0,1.0,4/29,4.57%,PTPN3;FGF14;FGF13;UTRN
prerank,PanglaoDB_Augmented_2021__B Cells,-0.34817194609664465,-0.8554889890493685,0.7123287671232876,1.0,1.0,23/88,15.65%,PTPRC;RCSD1;CD74;TMC8;SP140;ARHGAP9;IL21R;CD37;GMFG;EBF1;CD27;BLNK;NCKAP1L;CORO1A;CD14;IFIT3;TAGAP;WDFY4;RHOH;HVCN1;CD5;WAS;STAP1
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),-0.5584412190804651,-0.8553157879749377,0.6851851851851852,1.0,1.0,3/6,30.24%,EXOSC6;RNF168;RNF8
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.39580519046784807,0.855046575841338,0.6444444444444445,1.0,1.0,11/26,16.40%,WWTR1;RORA;ENPP1;TRIB2;FOXO1;SIRT2;SIRT1;WNT5A;ANKRD26;LRP3;BBS12
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),-0.479713532549599,-0.8550365620677212,0.6984126984126984,1.0,1.0,1/14,0.50%,CD4
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.38654324792387695,-0.8548756467519112,0.7761194029850746,1.0,1.0,17/65,25.97%,DNASE2;NCBP2;PCBP1;NCBP1;POLR2J;POLR2K;DDX1;DDX54;DDX24;DNASE1L1;HNRNPA0;POLR2B;METTL3;RAD50;KPNA2;POLR2D;RAN
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),0.3740153067167514,0.8547289923775682,0.696969696969697,1.0,1.0,5/31,11.51%,MCU;IRS2;MYRIP;RBP4;GCK
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),0.4325372251759937,0.854481705475042,0.6111111111111112,1.0,1.0,3/10,19.65%,SLC25A33;TFB2M;FOXO3
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),-0.49236419673292703,-0.8544478362107165,0.6730769230769231,1.0,1.0,1/13,3.27%,ITGA5
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.3323776334048498,0.8542692651880391,0.7272727272727273,1.0,1.0,3/29,5.21%,NRP1;LEPR;WWC1
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.5100789172501791,-0.854160087180284,0.7258064516129032,1.0,1.0,3/13,30.24%,SUPT5H;RNF168;RNF8
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),-0.5470431050603037,-0.8541590611861389,0.6190476190476191,1.0,1.0,1/5,7.13%,PCMT1
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),-0.4550000887458323,-0.854083861774098,0.74,1.0,1.0,6/16,24.38%,MORF4L1;MORF4L2;MSL3;BRD8;ACTL6A;NAA40
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.35777497242154865,0.8537800644681612,0.75,1.0,1.0,11/57,14.74%,VWC2L;VWC2;CRIM1;GREM1;SMAD2;FBXL15;TWSG1;ELAPOR2;NUMA1;SORL1;LEMD2
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),0.3486572482657598,0.8536941302822502,0.7435897435897436,1.0,1.0,6/39,11.55%,TLR1;TRAF3;HMGB1;S100A1;TAB3;TAB1
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),0.31830152547408663,0.8535717760960463,0.7586206896551724,1.0,1.0,9/79,13.08%,MRPL17;TSFM;MRPL33;MRPL58;MRPL39;MRPS27;MRPS18A;MRPL21;MRPS7
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),0.42697838828444457,0.8535035253608583,0.6888888888888889,1.0,1.0,5/16,12.23%,BMP7;HEY1;CNTN4;DTX1;DISP3
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),-0.4386409790767642,-0.8534561503675324,0.7272727272727273,1.0,1.0,4/29,9.22%,AHR;KCNQ1;AQP9;IGFBP5
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.41817109668242464,-0.8534434099796575,0.6363636363636364,1.0,1.0,6/26,13.19%,ELANE;P2RY12;TGFB1;RARRES2;PDGFRB;GPR183
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,-0.3597155837129263,-0.8534377441663136,0.7714285714285715,1.0,1.0,12/92,12.48%,ENPP2;SCN4B;SLCO2B1;P2RY12;SSTR1;ALDH2;CD14;RASSF4;GALNT15;A2M;PLP1;SPARCL1
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.41636742948287897,-0.8534076732479787,0.6724137931034483,1.0,1.0,8/24,18.33%,AGT;GPER1;HIP1R;TGFA;PLAUR;SHKBP1;ADAM17;BCAR3
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),-0.5562140138559292,-0.8533963663915706,0.6833333333333333,1.0,1.0,2/8,13.03%,HTR2B;FLOT1
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.40289690417083446,0.8530655257161078,0.65625,1.0,1.0,2/18,9.61%,LATS1;TFAP4
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),-0.5262485688022019,-0.8527568740826467,0.696969696969697,1.0,1.0,2/9,24.25%,GFPT2;HK3
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.4031962376928062,0.8526752894081038,0.6470588235294118,1.0,1.0,4/21,10.10%,NFATC1;HEY1;JAG1;ROBO2
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.41373740407367415,0.8525366717430274,0.6829268292682927,1.0,1.0,9/22,30.52%,GCK;SIRT1;EP300;SIRT7;CRY1;ZNF692;PTPN2;DGKQ;GNMT
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),-0.5221124699725526,-0.852469273934471,0.6923076923076923,1.0,1.0,2/6,41.97%,RAB11FIP5;SELENOT
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),0.4872466214821333,0.8524218607243848,0.6444444444444445,1.0,1.0,3/12,13.52%,GCH1;NOXRED1;GPHN
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.4227629278616398,-0.8523569619198685,0.6851851851851852,1.0,1.0,3/22,9.82%,DRD3;FKBP1B;CALM3
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.40552924884270614,0.85214756098266,0.7142857142857143,1.0,1.0,2/15,3.85%,MTHFS;DGLUCY
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.43586722319400334,-0.8521225994145935,0.6811594202898551,1.0,1.0,15/27,36.86%,KCNN4;CD160;CEACAM1;TESPA1;RPS3;CD226;DUSP3;EZR;PTPN22;PHPT1;CD81;LAPTM5;IKBKG;PRNP;SLA2
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.5058434819868538,-0.8521201707336327,0.6785714285714286,1.0,1.0,8/12,36.97%,TXN;MET;GPR37L1;HGF;PARK7;LRRK2;RACK1;PDE8A
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),0.505941997200456,0.8520556711751115,0.6857142857142857,1.0,1.0,2/6,19.91%,ETF1;APEH
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.3522209058262789,-0.8519031485903479,0.6875,1.0,1.0,16/93,16.02%,HCK;BIK;TMC8;KIF9;TGFB1;PINK1;HSPA5;BRK1;DAB2IP;HRK;WARS1;SVIP;SLF1;ANKRA2;ULK1;OPRD1
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),0.4098368189747824,0.8517993061681706,0.6666666666666666,1.0,1.0,4/18,11.05%,PTBP3;PTBP2;SFSWAP;U2AF2
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),-0.5523980831483366,-0.8517337095084653,0.7058823529411765,1.0,1.0,1/6,15.05%,RBX1
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.36386517400714435,0.8513465831484941,0.5625,1.0,1.0,7/27,16.85%,APOE;PTCH1;NAXE;EEPD1;SIRT1;YJEFN3;NR1H3
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.3811700638184382,-0.851225876875772,0.75,1.0,1.0,11/51,18.26%,H1-2;H1-0;TBP;ATAD2;POLR1E;POLR1H;POLR2K;DEK;ELOF1;CHEK1;POLR1C
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.39391195092333336,0.8512179179029121,0.5405405405405406,1.0,1.0,6/21,20.27%,HEG1;NLGN1;BSN;FERMT2;PCLO;NPHS1
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),-0.4987696469172994,-0.851217580371408,0.7142857142857143,1.0,1.0,3/7,5.33%,PTPRC;AHR;IL4I1
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),-0.5658691073119492,-0.851095248501481,0.7166666666666667,1.0,1.0,1/6,1.76%,DOCK2
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.3581840049985949,-0.8507151005523035,0.7101449275362319,1.0,1.0,17/68,25.22%,FRRS1;CP;ATP6AP1;NUBP1;SKP1;SLC30A8;HEPH;ISCU;ARF1;SLC11A1;ATOX1;ABCG2;FTH1;SLC39A6;SLC39A12;ATP6V1G1;SLC31A1
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),-0.33269601090926687,-0.8505626479410724,0.8024691358024691,1.0,1.0,26/215,11.04%,ENPP2;EPHA1;MYLK;SEMA3D;ZNF703;TNFSF18;SMIM22;PTPRC;RREB1;NOTCH1;TGFB1;SOD2;HSPA5;CEMIP;RAB11A;NCKAP1L;SEMA3F;F10;CLDN1;DAB2IP;GPER1;PDGFRB;DOCK1;CCL5;CTSH;KIF20B
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),0.3198698332627447,0.8503571866077937,0.8,1.0,1.0,7/93,8.81%,NRG1;BCL2L11;UNC13B;GNL3L;ERCC2;FERMT1;FAF1
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),0.3977337341047406,0.8502777500183757,0.7272727272727273,1.0,1.0,1/25,0.55%,PER2
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.4220372818051992,-0.8500070332782678,0.6935483870967742,1.0,1.0,5/27,13.69%,CYP1B1;SPTLC3;NQO1;ARG2;CYB5R3
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.4766371234513875,-0.8499282418091518,0.711864406779661,1.0,1.0,5/14,23.63%,ATAD5;ZNF16;PLCG2;STXBP4;PAF1
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.5025489434628326,-0.8499149209613844,0.7457627118644068,1.0,1.0,2/9,14.23%,APOD;NDRG4
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),0.5053936572666416,0.8498436616911555,0.7142857142857143,1.0,1.0,1/5,5.30%,PAPSS2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),0.5053936572666416,0.8498436616911555,0.7142857142857143,1.0,1.0,1/5,5.30%,PAPSS2
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),-0.485822044253925,-0.8498215689534838,0.6896551724137931,1.0,1.0,4/11,32.96%,METAP1D;NAA40;NAA35;NAA16
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.574189900914733,0.8497495358494825,0.7857142857142857,1.0,1.0,2/6,23.45%,EIF3E;EIF4G1
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.3847956799115853,0.8497020565841379,0.7142857142857143,1.0,1.0,4/35,12.40%,RAB3C;OLFM2;STEAP3;SVBP
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.520156075207166,-0.8496676846596873,0.7424242424242424,1.0,1.0,1/10,5.35%,GPC3
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),0.35640563158383376,0.8493739138628998,0.6896551724137931,1.0,1.0,7/47,9.35%,SLC16A2;SLC16A12;SLC16A9;SLC6A11;SLC16A7;SLC7A1;SLC6A13
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.33273805240803267,0.8493053880678936,0.7241379310344828,1.0,1.0,11/93,10.06%,CREB5;TEX15;EGFR;GCNA;CREB3L4;MYO1D;DNAH6;CCDC30;UBE3D;FAM229A;OSBP2
prerank,GO_Biological_Process_2021__lung development (GO:0030324),-0.4169269458384541,-0.8489936639331914,0.671875,1.0,1.0,6/25,21.74%,CCDC39;WNT7B;RCN3;SHH;FGF1;FGF7
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.2923693303670498,0.8489069767806753,0.8571428571428571,1.0,1.0,42/284,13.72%,ROR2;NOX4;CDH13;PER2;PTPRK;SLC16A2;SMYD2;MINAR1;MN1;ALDH1A2;TGFB2;MCC;TGFB3;BTG2;EREG;GREM1;DDAH1;ADAMTS8;PTPN6;MYO16;HSPA1A;NACC2;P3H3;P3H2;PARP10;ZBTB17;ERBB4;DUSP10;TFAP4;NELL1;FRK;RBP4;PDPN;PBRM1;NGF;RERG;PEX2;CTBP2;ATP8A2;SIRT2;VGLL4;CELF1
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.38656082686022625,-0.8487366930342488,0.7323943661971831,1.0,1.0,14/44,24.77%,DEGS2;SPTLC3;ALOXE3;PNPLA1;ARG2;ASMT;PCSK5;RHD;FURIN;NANP;SLC25A15;ASAH1;ARG1;CPS1
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.3952668474086332,-0.8485935129483576,0.6376811594202898,1.0,1.0,5/35,11.05%,NARS1;PPA1;EPRS1;IARS2;WARS1
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.39127192378400083,-0.8483150949031755,0.6973684210526315,1.0,1.0,8/44,15.65%,PTPRC;CARD8;SIGIRR;GSTP1;PELI3;GPS2;OAS3;STAP1
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),0.45656060422534395,0.8483114397297575,0.5945945945945946,1.0,1.0,3/10,10.61%,APOE;SCARB1;LCAT
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),0.48928378122510985,0.8477113777456006,0.7073170731707317,1.0,1.0,4/9,12.62%,HRH1;GABRB1;DRD4;GABRB3
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.39891044555702065,0.8475430905733751,0.6444444444444445,1.0,1.0,5/25,15.47%,CDC26;UBE2D4;UBE2E2;CDC23;ANAPC7
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,-0.34461058295486807,-0.847172651014859,0.7857142857142857,1.0,1.0,11/104,9.22%,PRLR;SLC13A4;WFS1;MMP15;CLIC6;AGT;ATP1B1;RARRES2;CLDN1;DAB2IP;IGFBP5
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),-0.43715713497684167,-0.8468818547154959,0.7068965517241379,1.0,1.0,5/16,24.73%,AGT;SIX4;PIK3CD;GJA1;SMO
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),0.38907972712417793,0.846781667525956,0.6341463414634146,1.0,1.0,3/22,5.83%,FGF13;PKP2;PDE4D
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),-0.5312777996188924,-0.8466273768863041,0.76,1.0,1.0,1/8,5.65%,ATP6AP1
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),-0.45993173225418976,-0.8465755143149748,0.6417910447761194,1.0,1.0,2/13,10.38%,PIK3CB;HIP1R
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.39754523223019433,-0.8464838261424386,0.65625,1.0,1.0,3/36,9.08%,EPN1;CBLC;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.5935212769372018,-0.8463862568466843,0.7580645161290323,1.0,1.0,2/5,38.21%,NUCKS1;YTHDC2
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),0.5142918439362361,0.8463380848446295,0.717391304347826,1.0,1.0,4/6,14.50%,BMP7;IGF1;LRP6;BAG3
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),0.4088241024618078,0.8461499244809131,0.6666666666666666,1.0,1.0,3/16,14.90%,APOE;SCARB1;ABCG8
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.3699201073906272,-0.8460124067109278,0.7424242424242424,1.0,1.0,3/64,5.85%,EPHA1;F11R;RAC1
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),0.27913572636606493,0.8458548373110543,0.9230769230769231,1.0,1.0,54/379,15.99%,NRK;SGK1;MOB3B;ARHGAP31;F2RL1;HSPB1;RASSF2;PEX5L;EGFR;SRGAP1;TRAF3;SPRED1;SMYD2;WWC1;TAF2;PRMT5;PKHD1;SGMS1;NLGN1;HDAC1;SYDE2;TTI1;FAM83D;GNA12;RGN;PAK5;STARD8;TAF12;STYXL1;SPHK2;PIP4K2A;GNAI1;IER3;PTPN13;TIAM2;PIP4P1;TELO2;PAK4;ARHGAP39;TRAF1;KALRN;NTRK3;PAK3;EP300;CHEK2;CRK;WNT5A;TIAM1;FBXL2;NGEF;ARHGAP30;FSHR;ARHGEF17;DDIT4
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),-0.4891139713112961,-0.8455448321766639,0.7192982456140351,1.0,1.0,2/11,4.70%,MOAP1;BNIP3
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),-0.4756116942474712,-0.8454499591305598,0.7377049180327869,1.0,1.0,1/16,2.87%,CDKN2D
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),-0.46192214185514535,-0.8451911757275085,0.7192982456140351,1.0,1.0,2/10,15.55%,RND1;C1QA
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.48483339496385025,0.8448768716748535,0.7111111111111111,1.0,1.0,3/8,11.70%,RCE1;PTAR1;PGGT1B
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),-0.5041829455621554,-0.8448730151643083,0.696969696969697,1.0,1.0,3/11,19.20%,AKAP5;ISCU;NOS1
prerank,GO_Biological_Process_2021__sterol import (GO:0035376),-0.5325601559774273,-0.8448427629818003,0.7358490566037735,1.0,1.0,1/6,6.23%,STARD5
prerank,GO_Biological_Process_2021__cholesterol import (GO:0070508),-0.5325601559774273,-0.8448427629818003,0.7358490566037735,1.0,1.0,1/6,6.23%,STARD5
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),-0.5009007090283009,-0.844775121968974,0.6896551724137931,1.0,1.0,5/8,36.31%,TDG;SMUG1;OGG1;UNG;MBD4
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),0.38124645664836554,0.8447668435290961,0.65625,1.0,1.0,4/26,6.63%,KIT;KITLG;TGFB2;AKR1C3
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.38191184961247704,-0.8446073915001663,0.7272727272727273,1.0,1.0,6/58,7.62%,HCK;PTGES;CASP12;LRRC19;IRF1;CASP8
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.3781660518957289,-0.8445193919484405,0.7692307692307693,1.0,1.0,16/70,16.18%,RXFP1;CALCB;DRD3;GPR26;MC4R;PTGER3;ADRA1D;CALCR;GPER1;ADGRB1;TBXA2R;TSHR;ADRB1;CNR2;ADGRE1;ADGRG2
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.3831957926741798,-0.8443637700997896,0.7361111111111112,1.0,1.0,6/31,12.52%,STAT1;CARD8;CASP8;DAB2IP;GSTP1;RHOH
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.41357803634681806,0.8442280101487097,0.6842105263157895,1.0,1.0,11/29,23.51%,PARD3;LRRC7;LIN7A;PARD3B;DLG2;DLG3;MTCL1;OPHN1;MYO9A;MARK2;RAP2A
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),0.5304479536855219,0.8440571749144707,0.7674418604651163,1.0,1.0,2/5,13.54%,SNF8;VPS25
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),0.5304479536855219,0.8440571749144707,0.7674418604651163,1.0,1.0,2/5,13.54%,SNF8;VPS25
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.32574501470198497,-0.8439618452400305,0.8157894736842105,1.0,1.0,22/148,14.19%,CD44;FJX1;GADD45B;JUNB;IRF1;SOD2;SERPINE1;IFNGR2;ETS2;STAT5A;IL18;DRAM1;CCL5;GFPT2;CD83;INHBA;EIF1;GPR183;TLR2;GADD45A;TNFAIP2;TUBB2A
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",-0.4008380029295772,-0.8439122914921915,0.6964285714285714,1.0,1.0,5/27,14.24%,RAC1;DOCK1;ADGRB1;RHOH;ARHGAP12
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.31808893583277126,-0.8437368802313914,0.8831168831168831,1.0,1.0,35/266,18.43%,TICRR;RAD54L;FANCI;POLQ;CDKN2D;FAAP24;RFC5;EYA1;BACH1;FANCM;RPA3;RAD51AP1;INIP;RECQL;FANCC;MGME1;XRCC1;BRCA1;MRE11;APLF;NUDT1;TDG;GADD45A;DDX1;POLE2;HPF1;PCNA;PDS5B;ABRAXAS1;MPG;CHEK1;RAD51C;PMS2;RBBP8;KAT5
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),-0.5102976596902699,-0.8436917295502158,0.7333333333333333,1.0,1.0,3/10,21.39%,GNPDA1;ST6GAL1;NANP
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),-0.47236420834329523,-0.8436263955710129,0.6724137931034483,1.0,1.0,4/10,28.92%,LBP;HSPD1;CD226;TNIP2
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),0.39194396099296347,0.8431923273212858,0.5757575757575758,1.0,1.0,4/19,10.50%,F2RL1;TRIB2;HMGB1;PIBF1
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),-0.5177545438569943,-0.843186973836526,0.660377358490566,1.0,1.0,1/9,4.44%,AHR
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),-0.5177545438569943,-0.843186973836526,0.660377358490566,1.0,1.0,1/9,4.44%,AHR
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.3067566941083928,0.8428802525281862,0.8421052631578947,1.0,1.0,34/261,13.72%,RUNX1;ATOH8;CIDEA;KDR;SAMD4A;HDAC9;TGFB2;BTG2;MACROH2A2;PTBP3;APOE;PTBP2;RBMS3;IGF1;HDAC1;HSPA1A;APLN;REL;IGF2BP3;PARP10;EIF2AK3;TWSG1;CILP;SRGN;PC;TRIM71;SLC24A3;PNPT1;DHFR;LSM14A;PHF1;ID2;SIRT1;CELF1
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),0.39841431044690445,0.8428133791555615,0.6904761904761905,1.0,1.0,6/33,11.46%,PER2;SLC37A4;G6PC3;SLC25A1;RBP4;PC
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),-0.4565227090307048,-0.8427061613636309,0.7666666666666667,1.0,1.0,5/17,19.17%,ITGA5;NOTCH1;PTRH2;SNAI2;ZNF304
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),-0.4705710902427137,-0.8427053701244452,0.7090909090909091,1.0,1.0,2/8,12.25%,REST;SYT4
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),-0.48779994755838446,-0.8426480490084887,0.7352941176470589,1.0,1.0,4/14,20.54%,PHKG1;PHKA1;AGL;CALM1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.49068570945870543,0.842566964814611,0.6666666666666666,1.0,1.0,4/8,19.86%,PRKCE;HECW2;NEDD4L;NEDD4
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),0.48307796863135366,0.8425320128999777,0.6666666666666666,1.0,1.0,3/9,19.24%,TGFBR1;ID2;MYT1L
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),-0.4827243369963268,-0.8424661906882004,0.75,1.0,1.0,2/10,4.11%,FOXM1;ING2
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.3966101768800126,-0.8424619002631679,0.7424242424242424,1.0,1.0,9/46,22.97%,CHMP4B;CHMP2B;CHMP2A;NUP85;NUP155;ANKLE2;NUP188;VPS4A;CCNB2
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.3966101768800126,-0.8424619002631679,0.7424242424242424,1.0,1.0,9/46,22.97%,CHMP4B;CHMP2B;CHMP2A;NUP85;NUP155;ANKLE2;NUP188;VPS4A;CCNB2
prerank,GO_Biological_Process_2021__positive regulation of fibroblast growth factor receptor signaling pathway (GO:0045743),0.5329046724672706,0.8424599540280493,0.7209302325581395,1.0,1.0,2/5,22.54%,FGFBP3;SMOC2
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),-0.470670182886361,-0.8423686367738377,0.75,1.0,1.0,6/16,26.49%,TOMM20;DNAJC19;ROMO1;TIMM17B;TIMM17A;GRPEL2
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,0.3494757786451872,0.8420298536883639,0.6451612903225806,1.0,1.0,6/56,5.57%,RUNX1;LAMB3;FGFR4;CAPN13;ANKRD30A;BTC
prerank,GO_Biological_Process_2021__lactation (GO:0007595),-0.5300593332523887,-0.8419604652718954,0.6923076923076923,1.0,1.0,2/7,7.44%,PRLR;ZBTB7B
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.33181568245020315,0.8416191571984775,0.8275862068965517,1.0,1.0,7/64,8.41%,ACE2;ITPR2;TGFB2;PDE4D;S100A1;APLN;SLC8A3
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),-0.40893606002703303,-0.8412878249772869,0.7419354838709677,1.0,1.0,7/44,14.96%,FUT2;GM2A;B3GNT5;GBA3;PSAP;B3GALNT1;NEU1
prerank,"GO_Biological_Process_2021__regulation of phagocytosis, engulfment (GO:0060099)",0.4729760791987824,0.8412039612703075,0.6388888888888888,1.0,1.0,1/7,1.40%,F2RL1
prerank,GO_Biological_Process_2021__positive regulation of membrane invagination (GO:1905155),0.4729760791987824,0.8412039612703075,0.6388888888888888,1.0,1.0,1/7,1.40%,F2RL1
prerank,GO_Biological_Process_2021__negative regulation of B cell proliferation (GO:0030889),0.4814351714803502,0.8411314925141691,0.6136363636363636,1.0,1.0,4/5,21.36%,RC3H1;ATM;BLK;TNFRSF21
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.4753270030965271,-0.8410090779463141,0.6440677966101694,1.0,1.0,7/11,26.30%,COX4I1;CYCS;COX7A2L;COX6C;COX6B1;COX7C;COX7B
prerank,GO_Biological_Process_2021__positive regulation of vesicle fusion (GO:0031340),0.5228257715966786,0.8408575839806143,0.6578947368421053,1.0,1.0,2/5,26.14%,AKT2;SNCA
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),-0.33179280706352243,-0.8407609509642223,0.7530864197530864,1.0,1.0,15/169,12.13%,SPAG4;CAV3;LMAN1;SPTBN5;CHMP2B;ZFP69B;SYNGR2;ARL1;GOLGA8O;TLCD2;RNF26;OTOF;MYOF;GOLGA8B;TANGO2
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.5446029343559382,-0.8406060180814877,0.7083333333333334,1.0,1.0,3/5,29.88%,RTF1;PAF1;CTR9
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,-0.3714260470470705,-0.8405999432874673,0.6666666666666666,1.0,1.0,2/41,4.89%,GYPB;GMFG
prerank,GO_Biological_Process_2021__development of primary female sexual characteristics (GO:0046545),0.5178018730493732,0.8405885849718338,0.6326530612244898,1.0,1.0,1/6,0.37%,LHFPL2
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),-0.3657281180261233,-0.8404438593000516,0.7536231884057971,1.0,1.0,9/56,18.38%,PIGC;WIPI1;ZDHHC22;ZDHHC6;MPPE1;PIGH;PIGO;PGAP4;PGAP3
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),-0.47310999772855045,-0.840346688972758,0.7457627118644068,1.0,1.0,3/12,16.56%,LRRC8D;SLC25A11;SLC25A18
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),0.5308535298309878,0.840291254361599,0.725,1.0,1.0,2/6,11.62%,PGM2;GALE
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.3558922304165057,0.8400505770841495,0.6744186046511628,1.0,1.0,5/40,3.60%,GPR149;PENK;CYSLTR2;SORCS1;NXPH2
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.3511154057556767,-0.8399712211313822,0.7910447761194029,1.0,1.0,20/95,23.32%,FIP1L1;NXT1;SLU7;DDX39A;NCBP2;FYTTD1;SLBP;NCBP1;RNPS1;NUP85;ALYREF;CDC40;NUP155;UPF3B;THOC5;NUP188;GLE1;DHX38;SRSF5;CPSF4
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.3865463888583087,-0.8399488653814848,0.8028169014084507,1.0,1.0,9/51,10.86%,HSD17B10;LIPH;SDS;BAAT;ACOX2;LIPI;ACSM4;LIPC;ACSM6
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.3703174272189354,0.8397965969741679,0.6774193548387096,1.0,1.0,4/32,6.13%,SEMA6D;NRP1;SEMA5A;SEMA4C
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.34839345093781854,-0.839690696120598,0.7875,1.0,1.0,22/125,17.05%,MMP26;HCK;RXFP1;PTGIS;ELANE;CALCB;GPR83;MC4R;CALCR;GPER1;GSTP1;TSHR;ADRB1;GPS2;VPS35;LPCAT3;RHBDF2;PLCG2;ADAM17;LYN;CXCL17;CCN3
prerank,GO_Biological_Process_2021__negative regulation of nervous system process (GO:0031645),0.5335319052305643,0.839628968862923,0.7073170731707317,1.0,1.0,2/6,9.82%,JAM2;EIF2AK3
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),-0.41544705559642203,-0.8395666848456618,0.6714285714285714,1.0,1.0,7/25,17.28%,RAC1;PREX1;CATIP;DIAPH3;WASF1;WAS;VIL1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),0.4902992064609202,0.8394359629421653,0.6578947368421053,1.0,1.0,2/5,6.02%,GREM1;ENPP3
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.453407078017414,0.8394122272059154,0.5476190476190477,1.0,1.0,2/13,10.22%,UPP2;DUT
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.31423193047948655,-0.8393511330664027,0.8641975308641975,1.0,1.0,81/322,24.83%,FIP1L1;NXT1;DDX20;SLU7;DDX39A;ANGPT2;RPL36;RPL15;RPL38;RPS21;NCBP2;RPS7;FYTTD1;SLBP;WARS1;NCBP1;RPL37A;ASMT;RPL9;RPL28;MRPS14;RPLP2;RNPS1;NUP85;ALYREF;POLR2J;MRPL44;RPL5;POLR2K;CDC40;EEF1A1;RPL35A;RSL24D1;RPS20;DDX54;RPLP1;RPL8;RPL4;NUP155;RPL22;CREBL2;RPL27A;MRPS18C;COPS5;RPL24;RBM4;RPS15;MRPL51;UPF3B;MRPL43;THOC5;RPL34;RPL3;NUP188;HSPD1;RPS24;RPS4X;POLR2B;RPS3;RPS6KB2;GLE1;RPS29;M1AP;RPL13A;RPS8;TESC;RPS27A;RPL27;CLP1;RPL37;RPL7A;DHX38;SRSF5;CPSF4;RPL35;RPL23;RPL32;RPS13;MRPL27;NUP214;MRPL42
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),-0.4667029938633084,-0.8391856456558163,0.765625,1.0,1.0,3/14,10.98%,ITK;TXK;TEC
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",0.47216144883387956,0.8389526493875783,0.59375,1.0,1.0,1/8,1.40%,F2RL1
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),-0.5270860126934935,-0.8388630516320323,0.7333333333333333,1.0,1.0,1/8,3.37%,SLC7A7
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),0.32835514511881136,0.8385054085123739,0.7027027027027027,1.0,1.0,15/70,12.19%,EGFR;C5AR1;BMP6;TGFB2;MCC;EREG;FGF10;IGF1;PKHD1;SGPP2;ANGPT1;PRKD1;DUSP10;LIMS1;PEX2
prerank,GO_Biological_Process_2021__polyphosphate catabolic process (GO:0006798),0.496961057678211,0.8379634092177789,0.6052631578947368,1.0,1.0,3/5,36.06%,PRUNE1;PRUNE2;BNIPL
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),-0.4721784855741885,-0.8376471970139203,0.7123287671232876,1.0,1.0,6/16,16.41%,BNIP3;SLC25A5;HEBP2;SLC25A4;SLC25A31;NAIF1
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),-0.3865067989634956,-0.837569197123875,0.7419354838709677,1.0,1.0,8/53,16.89%,ARIH2;IFI27;UBE3A;KBTBD6;TRIM32;RBX1;SYVN1;RNF152
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),-0.4769274738573296,-0.8374289989975021,0.6984126984126984,1.0,1.0,4/14,26.13%,INTS5;SSB;PTCD1;INTS14
prerank,GO_Biological_Process_2021__regulation of cellular response to osmotic stress (GO:0106049),0.5394471731497064,0.83722201062161,0.6428571428571429,1.0,1.0,1/5,3.02%,MICU1
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.2915096231862467,0.8370480501979485,0.9166666666666666,1.0,1.0,25/212,12.09%,SOX13;WWTR1;ZEB2;EGFR;KANK1;ZBED3;SEMA5A;LATS1;CDK14;MDK;MCC;PRICKLE1;GREM1;FGF10;APOE;PTPRO;RBMS3;HDAC1;ANKRD6;PRDM15;GNAQ;UBAC2;TLE2;DVL2;LYPD6
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,0.2956680169329669,0.8370073748834236,0.8260869565217391,1.0,1.0,31/191,16.95%,NRG1;HOMER2;CLSTN2;FSTL5;KCTD1;PPP1R14C;MORN4;CNGA4;CNTN4;EFNA5;DUSP8;RNF128;LRRIQ1;CAP2;MARK1;CFAP43;SPOCK1;NAT14;ARHGAP39;SPTBN4;FGF12;NYAP1;EPN2;MAP6;DNER;IFT74;GNAL;B9D1;PRR36;KCNA5;FAM81A
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),0.45001007383798713,0.8368409464171167,0.6976744186046512,1.0,1.0,1/9,1.33%,PTPRT
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),-0.4916442013610912,-0.8367753949513856,0.6666666666666666,1.0,1.0,2/9,26.64%,TSC2;AKT1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.3679490247680759,0.8365822119767203,0.7105263157894737,1.0,1.0,6/33,6.33%,NRP1;IQGAP2;CSF1R;MDK;PDGFRA;ESAM
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.40521099465430793,-0.8360231524866331,0.6557377049180327,1.0,1.0,6/25,11.86%,GNLY;SPON2;TUBB;TUBA1B;CCL5;STMN1
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.3956701647621497,-0.8358762773194535,0.703125,1.0,1.0,6/39,12.06%,ARIH2;TRIM5;TRAF3IP2;MAGEL2;PELI3;PRPF19
prerank,GO_Biological_Process_2021__negative regulation of skeletal muscle cell differentiation (GO:2001015),-0.5368578184951369,-0.8356178331530829,0.7142857142857143,1.0,1.0,2/5,23.80%,SIX4;EPHB1
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),0.4943039772540898,0.8353955123804471,0.717948717948718,1.0,1.0,1/11,0.59%,IFI16
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),0.3440119983532505,0.8353695054469802,0.7931034482758621,1.0,1.0,7/53,6.73%,GPC4;CYP1A2;SDC4;CYP4V2;ALDH1A2;AKR1C3;APOE
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.3715500464444075,-0.8352645354243743,0.7313432835820896,1.0,1.0,11/59,21.76%,ABITRAM;RAC1;ODAD3;TBC1D13;WAS;PODXL;FXR1;TBC1D24;ATG3;TWF2;RAB17
prerank,GO_Biological_Process_2021__regulation of nuclease activity (GO:0032069),-0.5471378456018076,-0.8351966113111225,0.7321428571428571,1.0,1.0,1/5,15.36%,OAS3
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),0.45398019146111857,0.8350898966902148,0.6904761904761905,1.0,1.0,2/10,5.94%,TGFBR1;PDGFRA
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),-0.4236849129663728,-0.8350721401284966,0.6756756756756757,1.0,1.0,6/33,22.79%,CHMP4B;PINK1;PIP4K2C;PHF23;NUPR1;RAB1B
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),0.39776914463231483,0.8349952233993001,0.7555555555555555,1.0,1.0,1/24,0.55%,PER2
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),0.3336994694735955,0.8349951088408668,0.7741935483870968,1.0,1.0,8/60,14.68%,FARS2;CDKAL1;LCMT2;TRDMT1;WDR4;TRMT61A;CPSF1;ADAT2
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),0.321811369373166,0.8349700045299613,0.8235294117647058,1.0,1.0,7/87,4.78%,RUNX1;NFATC1;SULF2;KANK1;CBFB;CDK14;WWOX
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.49599676223429623,-0.834874732142011,0.6964285714285714,1.0,1.0,2/12,15.29%,MGME1;SLC25A4
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.3262027750856482,0.8348728928240776,0.8333333333333334,1.0,1.0,32/101,20.37%,ZNF536;MAPK4;LHFPL4;SLC35F1;UNC5D;GRIA2;LRRC4C;PCDH19;GALNT13;CADM2;CSRNP3;PAK5;MMD2;RHBDL3;PHF21B;CRABP1;NOL4;ELAVL3;SAG;MEGF10;SEMA5B;DPYSL5;MAP6;KCNC1;SNAP91;CLVS2;CACNA1B;LGR5;ID4;PHYHIPL;PCLO;WNK2
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),0.368599641082209,0.8347832805979047,0.6842105263157895,1.0,1.0,1/31,0.61%,CCNH
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.2970951283648746,0.8347690601980369,0.9032258064516129,1.0,1.0,23/136,13.52%,ELOVL6;GCH1;GSTO2;CEPT1;CHKA;ALAS1;APOE;LCMT2;SGMS1;HACD2;PLA2G4C;SGPP2;SPTSSB;PRKD1;SPTLC1;SPHK2;LCAT;GSTT2B;ST3GAL2;CHPT1;CERS4;CERS3;GPHN
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),-0.40638629154059436,-0.8345360730359864,0.6666666666666666,1.0,1.0,4/24,11.83%,CHRNB1;CAV3;TTN;MYOF
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.3468481538731441,0.8342640559600378,0.6956521739130435,1.0,1.0,23/111,14.09%,FLRT2;SGCD;PDLIM1;PKP2;TGFBR1;BMP7;SGCZ;HDAC9;TGFB2;ACVR1;HEG1;CHD7;SMG9;APLN;ERBB4;RBP4;DVL2;ECE1;FGF12;ID2;ALPK3;ADAP2;NTRK3
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.32629131508037096,0.8342283314224611,0.7916666666666666,1.0,1.0,8/91,5.31%,ACE2;IFI16;CIDEA;IFIH1;TRAF3;S100A13;HDAC9;EREG
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),-0.34842206148787963,-0.8340788700495342,0.7246376811594203,1.0,1.0,17/102,12.13%,CALB1;C3AR1;CAV3;CALCB;DRD3;P2RY1;FKBP1B;PTGER3;ADRA1D;CALCR;BCAP31;GPER1;KNG1;SCGN;TBXA2R;CHRNA9;TAC4
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),0.32207694897817873,0.8339813840360453,0.717948717948718,1.0,1.0,2/49,2.59%,IFI16;IFIH1
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),-0.5095457453666946,-0.8339518741284951,0.696969696969697,1.0,1.0,1/7,10.38%,HAT1
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),0.41077899306346144,0.8338409771908326,0.8484848484848485,1.0,1.0,4/27,6.73%,F11;KLKB1;PDGFRA;APOE
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.3702182036951338,0.8334390199964734,0.7894736842105263,1.0,1.0,9/66,12.84%,ATP6V0D2;WDR24;EIF2S1;DAP;PRKD1;EIF2AK3;KPTN;MAPK8;MAP3K5
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.49450937913481996,-0.8333626328900466,0.6842105263157895,1.0,1.0,1/9,5.92%,IFIT1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.33048938642062153,0.8332891122075413,0.7777777777777778,1.0,1.0,10/125,6.03%,CCNH;MAML3;TEAD2;WWTR1;RORA;ESRRG;HDAC9;MAML1;TAF2;NR3C2
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.5055269311344354,0.8332676001448658,0.6428571428571429,1.0,1.0,3/9,25.44%,TPR;NUP107;NUP98
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.47939402993246716,-0.8330745510006062,0.7,1.0,1.0,3/14,12.30%,DUOX1;STAT1;KCNJ11
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.43021890496489396,-0.8328018086087079,0.6774193548387096,1.0,1.0,7/25,19.27%,NOTCH1;TGFB1;ANGPT2;TBXA2R;GADD45A;MMRN2;RGCC
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.4174922187496257,-0.8325718932988062,0.6612903225806451,1.0,1.0,2/31,5.79%,ABITRAM;RASA1
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),0.5309914684767912,0.8323512880418906,0.6829268292682927,1.0,1.0,2/5,11.93%,VAMP3;VAMP8
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.41427510144522284,0.8321658764791436,0.7333333333333333,1.0,1.0,9/17,23.68%,TMTC2;CRPPA;DPM3;TMTC1;FKTN;DPM2;LARGE1;FKRP;DPM1
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),-0.42958136236921174,-0.8317577398547085,0.6865671641791045,1.0,1.0,2/21,5.95%,RAC1;TGFB1
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.38949369551399043,0.8316719305919311,0.6285714285714286,1.0,1.0,4/33,6.57%,NOX4;CSF1R;GRM5;CASS4
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),-0.5252281457321507,-0.8315127734475632,0.6981132075471698,1.0,1.0,1/6,15.73%,ULK1
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),0.31155224050647856,0.8314283421890968,0.8333333333333334,1.0,1.0,8/77,6.73%,UNC5B;BCL2;SLC30A10;TOX3;MDK;TGFB3;PM20D1;APOE
prerank,GO_Biological_Process_2021__nose development (GO:0043584),-0.5279037930427802,-0.8310882835871689,0.72,1.0,1.0,2/6,11.48%,GLI3;SIX4
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),-0.5337425661665042,-0.8307455334307337,0.7647058823529411,1.0,1.0,1/8,7.48%,RAB11A
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),0.5005664474560831,0.8307264403597476,0.717391304347826,1.0,1.0,4/8,22.97%,ST3GAL1;ST3GAL2;ST3GAL4;CHD1
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),-0.42635817948352694,-0.830710627610238,0.6721311475409836,1.0,1.0,4/17,17.98%,AMN;CBLIF;MMUT;TCN2
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),-0.42635817948352694,-0.830710627610238,0.6721311475409836,1.0,1.0,4/17,17.98%,AMN;CBLIF;MMUT;TCN2
prerank,GO_Biological_Process_2021__regulation of phospholipid transport (GO:2001138),-0.5320455625598524,-0.8307077079398907,0.6727272727272727,1.0,1.0,1/5,11.38%,ABCB4
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.45657953164809645,0.8306654764218022,0.7105263157894737,1.0,1.0,3/8,15.79%,VAMP3;VAMP8;UVRAG
prerank,GO_Biological_Process_2021__isopentenyl diphosphate biosynthetic process (GO:0009240),-0.5402683235159202,-0.8306375943250767,0.7678571428571429,1.0,1.0,2/5,35.42%,PMVK;IDI1
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.3113996548085154,0.8305446832333444,0.8636363636363636,1.0,1.0,11/187,5.86%,FBXL7;TPD52L1;CCNH;NEDD1;KDM8;PCM1;PLCB1;LATS1;CDK14;ACVR1;TAF2
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),-0.5318994577319812,-0.8303962236208705,0.7407407407407407,1.0,1.0,1/5,8.28%,GLI3
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),-0.3804111260547156,-0.8303054950283413,0.65625,1.0,1.0,9/37,23.43%,CAV3;RAC1;DCTN1;STMN1;CDK5R1;RPS3;MET;PSRC1;ANKRD53
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),-0.5297307129196401,-0.8301940400778688,0.75,1.0,1.0,1/6,12.22%,PLAAT5
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.4319045843431477,-0.8300917456472381,0.6721311475409836,1.0,1.0,4/28,8.91%,MYLK;DUOX1;SERPINE1;CLDN1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),0.4191816401582494,0.8299111547228933,0.6590909090909091,1.0,1.0,4/16,17.80%,LYAR;EIF2AK3;UBTF;SIRT7
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),0.3066972648715561,0.8295982199466779,0.7407407407407407,1.0,1.0,12/94,12.16%,PRELID2;PITPNC1;SLCO1C1;CHKA;APOE;ABCA13;ABCC11;SLC27A3;SCARB1;ABCC4;ABCA6;ABCD2
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),-0.48009409994702,-0.8294674386429681,0.6491228070175439,1.0,1.0,1/11,0.64%,CSRP3
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),0.3020564533959794,0.8293607003434161,0.7142857142857143,1.0,1.0,16/85,20.13%,MRPL17;MRPL33;MRPL58;MRPL39;MRPS27;MRPS18A;ETF1;MRPL21;MRPS7;MTRF1L;DAP3;MRPL4;AURKAIP1;MRPL41;APEH;MRPL48
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),-0.38565566370194637,-0.8292826385435443,0.746268656716418,1.0,1.0,7/34,19.54%,DRD3;RCN3;ERLEC1;SYVN1;CCDC47;GLRA3;GLRA1
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),-0.4771613325521268,-0.8292472664983149,0.7083333333333334,1.0,1.0,1/11,4.15%,P2RY12
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.2717619495548346,0.8290998106630427,0.9655172413793104,1.0,1.0,27/381,7.80%,POU6F2;TEAD2;SOX13;WWTR1;ZNF273;ZNF117;NFIA;RORA;ZNF536;OR7D2;TGFBR1;ATXN1;ESRRG;ZNF205;GRM5;SPIN2B;WWC1;ZNF628;RABL3;BRCA2;SOX12;CHD7;PRMT5;FOXN3;RBBP6;PCGF1;ZNF263
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.4460529967902133,0.8287867023068418,0.6521739130434783,1.0,1.0,3/10,14.50%,HSPA1A;SIRT2;BAG3
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),0.4588862843151795,0.828738633567731,0.7428571428571429,1.0,1.0,3/17,13.54%,DDAH1;NOS1AP;TMEM106A
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),-0.385328465863669,-0.828595652636685,0.7794117647058824,1.0,1.0,10/44,15.77%,ATP5IF1;PINK1;NKD2;CASP8;RCN3;CTSH;FADD;TRIM32;CCBE1;ADAM9
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),-0.4853112314506571,-0.8285145012217617,0.7192982456140351,1.0,1.0,1/7,11.04%,MDH1
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),0.40418767773655895,0.8283153352354691,0.696969696969697,1.0,1.0,2/22,2.71%,ITGA4;PKP2
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),0.3775372241167936,0.8282696668748203,0.7666666666666667,1.0,1.0,3/30,10.74%,MCTP1;SNCAIP;MCTP2
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.48601371546590977,-0.8281751254768517,0.7049180327868853,1.0,1.0,3/9,21.13%,DAB2IP;MMRN2;CNMD
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.41869558612486263,0.8274468506960105,0.6285714285714286,1.0,1.0,7/17,13.24%,TOX;SLC16A2;MDK;TAFA1;TRIM71;DISP3;ID2
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),-0.3899813409193602,-0.8271561759837704,0.7428571428571429,1.0,1.0,4/40,9.94%,SPAG4;CHMP4B;CHMP2B;CHMP2A
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.4142693526719355,0.8268034204757001,0.6744186046511628,1.0,1.0,1/15,0.89%,PTPN3
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.3538484988846816,0.8266720928171847,0.7037037037037037,1.0,1.0,6/48,7.04%,HSPB1;TLR1;IFIH1;EPHB2;RASGRP1;HMGB1
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),0.4503992832743188,0.8265644573065545,0.6285714285714286,1.0,1.0,2/13,9.97%,RNF128;KPTN
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell membrane repolarization (GO:0099624),0.48232723028652724,0.8263679137541,0.65,1.0,1.0,2/5,5.64%,KCNJ3;KCNN2
prerank,GO_Biological_Process_2021__membrane repolarization during atrial cardiac muscle cell action potential (GO:0098914),0.48232723028652724,0.8263679137541,0.65,1.0,1.0,2/5,5.64%,KCNJ3;KCNN2
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.33277067568631163,-0.8263440002267506,0.726027397260274,1.0,1.0,19/133,15.27%,CD4;TERF2IP;CD74;TRIML2;TRIM22;PINK1;CASP8;TRIM5;TRIM25;TRAF3IP2;CXXC5;FADD;ROR1;HTR2B;TRIM32;LTBR;IFIT5;DDX1;GOLT1B
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated protein folding (GO:1903644),-0.5573905047652251,-0.8261859932778082,0.6964285714285714,1.0,1.0,2/5,17.09%,PDCD5;SGTB
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.4553413748701962,0.8260211646295229,0.6410256410256411,1.0,1.0,4/13,17.91%,RAD21L1;SMC1A;DSCC1;POGZ
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.3738502711492888,-0.825629374435242,0.7205882352941176,1.0,1.0,1/39,0.14%,EPN1
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),0.3353926411328826,0.8256277416683918,0.7142857142857143,1.0,1.0,4/62,7.17%,RUNX1;CBFB;CFLAR;PTPN6
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.33353633888049805,0.825222581523726,0.8275862068965517,1.0,1.0,13/116,9.52%,FBXL7;SEMA6D;NTM;CACNA2D1;FIGN;PDZRN3;GUCY1A2;ADGRL2;PKDCC;HTRA1;GFRA1;CAP2;AMOTL2
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),-0.4245808628332727,-0.8251291985424771,0.6716417910447762,1.0,1.0,2/19,6.46%,RGPD3;RGPD1
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),-0.37207187149319737,-0.82504757345219,0.7205882352941176,1.0,1.0,8/66,10.55%,TICRR;EYA1;RAD51AP1;INIP;NHEJ1;FIGNL1;BRCA1;AEN
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.5003762927974265,-0.8249868990182724,0.7142857142857143,1.0,1.0,2/11,2.30%,HIC1;MSX1
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),-0.4927634778323723,-0.8248213104402013,0.7794117647058824,1.0,1.0,4/13,20.54%,PHKG1;PHKA1;AGL;CALM1
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),-0.5146773733425398,-0.8247295918880725,0.7540983606557377,1.0,1.0,2/8,15.80%,RFC5;PCNA
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),-0.5146773733425398,-0.8247295918880725,0.7540983606557377,1.0,1.0,2/8,15.80%,RFC5;PCNA
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),-0.5049136396438968,-0.8246142901529846,0.7017543859649122,1.0,1.0,4/9,28.34%,CACNA1H;AKR1B1;TSPOAP1;STAR
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.5012685203315419,0.8245060478955125,0.7037037037037037,1.0,1.0,3/6,39.53%,PPM1F;ADAR;CORO1C
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.4878547596726165,-0.8244951676638106,0.7761194029850746,1.0,1.0,7/12,33.20%,MYOF;SYTL4;DYSF;RAB3A;ANXA6;SMPD1;ARL8B
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.38572885654859124,-0.8244342096723459,0.734375,1.0,1.0,6/21,22.84%,SLC14A1;SLC14A2;SLC27A1;SLC38A5;CPTP;ABCG2
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.442234194150231,-0.8244010551410272,0.6428571428571429,1.0,1.0,2/14,5.85%,NOX1;RAC1
prerank,PanglaoDB_Augmented_2021__T Helper Cells,0.3918137740461581,0.8242725585000299,0.6666666666666666,1.0,1.0,6/46,4.40%,CD38;KLRD1;CD247;RORA;CD96;GPR174
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),0.48981499404715934,0.8238913981990087,0.6666666666666666,1.0,1.0,2/6,29.53%,YY1;POLH
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.3803330103920808,-0.8236702979476016,0.6923076923076923,1.0,1.0,8/37,20.80%,RPS27L;RPS7;NOB1;EMG1;ERAL1;RPS15;RPS24;SURF6
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),0.35506719707289447,0.823632128297983,0.7307692307692307,1.0,1.0,6/46,7.04%,HSPB1;TLR1;IFIH1;EPHB2;RASGRP1;HMGB1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),-0.4099645233277315,-0.8236195627853716,0.7833333333333333,1.0,1.0,4/28,11.83%,CTNNA1;CAV3;SPI1;DNAJA1
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.4358243679752964,-0.8235018214525953,0.7611940298507462,1.0,1.0,7/18,23.48%,CDKN2D;INHBA;CDKN1B;STAP1;ANKLE2;DYNLL1;INPP5K
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),-0.5110021368006534,-0.8230510972412833,0.7258064516129032,1.0,1.0,3/7,27.46%,AGO1;DDX3X;AGO4
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.42943045260178464,0.8230424384996259,0.696969696969697,1.0,1.0,3/10,8.90%,PCBP3;IGF2BP3;NOVA1
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),-0.555935548174763,-0.8230046896035107,0.7647058823529411,1.0,1.0,2/6,26.01%,SPI1;VCPIP1
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),-0.48468380318157955,-0.8229055408468202,0.6935483870967742,1.0,1.0,1/6,1.89%,ZNF703
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),-0.4852365297770347,-0.8226148304077064,0.7647058823529411,1.0,1.0,3/11,14.16%,HSPA5;EIF2AK1;HERPUD1
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),0.3102864957139503,0.8226119095786115,0.8620689655172413,1.0,1.0,10/47,11.13%,SLC16A2;SLC22A13;SLC16A12;SLC16A9;SLC6A11;SLCO1C1;SLC16A7;ABCC11;SLC6A13;ABCC4
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.31084560029119757,-0.8224457451783387,0.8860759493670886,1.0,1.0,56/233,28.66%,FIP1L1;CSTF2T;SLU7;SYF2;DDX39A;NONO;SNRPD2;UBL5;NCBP2;FRG1;PPWD1;PCBP1;NCBP1;PRPF19;ZMAT2;RNPS1;SNRNP48;ALYREF;USP39;POLR2J;POLR2K;CDC40;BUD13;RBM4B;HNRNPA0;CRNKL1;CWC25;RBM4;UPF3B;SF3B2;POLR2B;MFAP1;BUD31;CLP1;DHX38;SNW1;SRSF5;CPSF4;DHX16;METTL3;POLR2D;ZCCHC8;LSM4;HSPA8;SMU1;NUDT21;PRCC;WBP11;SNRNP70;ELAVL2;CSTF1;SRSF9;YTHDC1;SRSF8;PPIL3;DHX15
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.4271860973427648,0.8224332528402457,0.7142857142857143,1.0,1.0,2/12,8.91%,IWS1;TPR
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),0.3890602697161296,0.8223961409910253,0.7435897435897436,1.0,1.0,6/36,11.46%,PER2;SLC37A4;G6PC3;SLC25A1;RBP4;PC
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),-0.4504780610794338,-0.8223066707948699,0.7166666666666667,1.0,1.0,4/14,26.14%,CALCR;AKAP5;PJA2;AKAP7
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.42282476316548956,0.8221873967789609,0.5757575757575758,1.0,1.0,2/14,5.72%,PAPSS2;ENPP1
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),-0.38007504392601144,-0.8219844146235383,0.7647058823529411,1.0,1.0,12/35,27.59%,SLC13A4;SLC26A4;SLC25A11;TTYH1;RACGAP1;GLRA1;SLC11A1;SLC26A8;BEST1;SLC26A11;SLC5A5;CLCN4
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),-0.47374053277608363,-0.821908023153095,0.6949152542372882,1.0,1.0,3/11,19.23%,ROPN1L;CABYR;SPAG17
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),0.3957622092923273,0.821675223475078,0.7560975609756098,1.0,1.0,6/20,16.85%,RORA;APOE;SCARB1;SIRT1;FITM2;NR1H3
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.2975877883516888,0.8216723325732778,0.9259259259259259,1.0,1.0,21/98,15.39%,ARHGAP31;GRAP2;RRAS2;ARFIP2;RGS19;CNKSR1;SHC3;RASGRP1;IGF1;PLD2;RASL10A;PRKD1;RALA;RIN2;CCNA2;TIAM2;RERG;NUCB2;CHP1;TIAM1;ARHGAP30
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.4110539380012047,-0.8216063617335914,0.7333333333333333,1.0,1.0,7/23,28.20%,RAC1;WAS;VIL1;ACTG1;CDC42;SHANK3;RDX
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),-0.46335056899268545,-0.8215618619260906,0.7540983606557377,1.0,1.0,2/12,16.18%,HPF1;PARG
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.4128776291830276,-0.8213072702728128,0.7169811320754716,1.0,1.0,3/25,8.81%,IRF1;CASP8;TRIM5
prerank,GO_Biological_Process_2021__amino-acid betaine transport (GO:0015838),-0.5045513723517439,-0.8211722115761478,0.7115384615384616,1.0,1.0,2/5,22.45%,PDZK1;SLC22A4
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.3549247400136711,0.821161854709688,0.7142857142857143,1.0,1.0,4/36,8.83%,DGKB;PLPPR5;SGPP2;DGKH
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),0.46699300906703156,0.8211247603303562,0.6818181818181818,1.0,1.0,2/10,6.73%,PDGFRA;APOE
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.3997005719182182,0.8210716132356064,0.7441860465116279,1.0,1.0,2/18,2.31%,BCL2A1;BCL2
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.3800260192574872,-0.8209096614600294,0.7538461538461538,1.0,1.0,11/59,15.77%,TNFSF18;FBLN2;NODAL;P2RY12;ECM2;RAC1;NCKAP1L;CCL5;TPM1;RNASE10;ADAM9
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),0.3899674983695611,0.820855344410907,0.7142857142857143,1.0,1.0,2/12,13.29%,TPR;KLHL20
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),0.4098096380250719,0.8204914529002081,0.7878787878787878,1.0,1.0,4/21,6.32%,SPRED1;SPRED2;SPRED3;IL17RD
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),-0.5079770281631824,-0.8202329677490963,0.7966101694915254,1.0,1.0,1/8,2.85%,SFRP4
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),0.49168231908255966,0.8201963044839413,0.6595744680851063,1.0,1.0,1/5,10.23%,UBE2E2
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),-0.4970872734392169,-0.8200087185305123,0.7049180327868853,1.0,1.0,4/9,24.97%,LBP;PLCG2;GRN;DYSF
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.2850027873317542,0.8199853555302691,1.0,1.0,1.0,15/142,11.23%,ALK;SGK1;CIDEA;BCL2L11;FANK1;CRADD;TOX3;LGALS1;PTPN6;STEAP3;PERP;BNIP3L;MALT1;ANP32B;CASP2
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),-0.48313723465292224,-0.8199325794100516,0.7777777777777778,1.0,1.0,2/14,5.56%,IHO1;CDC6
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),-0.43744080148008935,-0.819748626578946,0.8253968253968254,1.0,1.0,3/13,15.07%,UFM1;APOD;RAB23
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),-0.5109173376279412,-0.8196037846741688,0.7777777777777778,1.0,1.0,3/9,17.05%,RIN3;STAP1;CCN3
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),-0.3670519666250814,-0.819457025160182,0.7727272727272727,1.0,1.0,14/75,15.80%,CCNE1;CDKN2D;CDKN3;SPDYA;CDC6;BACH1;CRLF3;INHBA;GPR132;CDC25A;KLF11;CDKN1B;CDK4;PCNA
prerank,GO_Biological_Process_2021__insulin metabolic process (GO:1901142),0.5228913677844151,0.8191553064114766,0.7142857142857143,1.0,1.0,2/5,15.35%,PCSK2;IDE
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),-0.4639492362663805,-0.8188863723285107,0.72,1.0,1.0,1/15,1.95%,WFS1
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),0.4461123821626583,0.818564532548498,0.717948717948718,1.0,1.0,5/11,24.25%,RYK;NR4A2;LRP6;CTNNB1;VEGFA
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.33518931330279084,-0.8184758012157529,0.8873239436619719,1.0,1.0,4/137,6.05%,CD44;NOTCH1;TGFB1;TBX1
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.37232101572704485,-0.8184500330704949,0.7027027027027027,1.0,1.0,3/44,10.66%,PTGIS;DAB2IP;CCL5
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.3212489412236683,0.8182832387988859,0.8518518518518519,1.0,1.0,16/92,14.12%,TRPC7;TRPC3;CACNG3;GRIN3A;MICU1;CACNA2D1;TRPC5;CACNA1I;SLC8A3;SLC24A3;CACNB2;FYN;ANO6;TRPC1;SLC8A1;TRPV2
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-0.4852760849212233,-0.8182388199087998,0.7017543859649122,1.0,1.0,4/9,30.07%,HSPA5;COPS5;BAX;BAK1
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.3282424902607471,-0.8179485815577896,0.8795180722891566,1.0,1.0,13/90,19.98%,MSX1;NXT1;RANBP6;SKP1;SPRN;SIX4;NUP85;TSC2;NUP155;RPF2;GCKR;CALR;NUP188
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.3063706471921362,0.8176591660842789,0.7741935483870968,1.0,1.0,13/65,18.73%,ZBTB20;NUP210;NUP42;IGF1;TPR;SLC4A4;GCK;NUP37;PFKFB3;EP300;PPARA;ZBTB7A;JMJD8
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.44731472827693625,0.8174855759276746,0.6744186046511628,1.0,1.0,4/15,8.13%,TGFBR1;OSBPL7;PTCH1;SMAD2
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),-0.3752152737111287,-0.8172584082551249,0.7536231884057971,1.0,1.0,7/53,14.98%,CAV3;TLCD2;OTOF;PLSCR5;MYOF;PLSCR4;SYTL4
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.40885399554946333,0.8172494922480196,0.7575757575757576,1.0,1.0,4/24,6.36%,PKP2;HEY1;TGFB2;JAG1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.46964881713891893,-0.8171035656567486,0.7543859649122807,1.0,1.0,1/10,5.83%,NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.49046302713728707,-0.8171009060268357,0.7377049180327869,1.0,1.0,2/11,6.00%,CD74;IL7
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),0.3846877556314878,0.8167308603983613,0.6,1.0,1.0,7/25,17.74%,TLR1;C5AR1;FER1L5;TMEM106A;CRTC3;JAK2;AZU1
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.3845630287997537,-0.8167095165249534,0.7058823529411765,1.0,1.0,8/39,17.20%,TMC8;HSPA5;KIF14;SVIP;ULK1;OPRD1;ANKRD27;PEX5
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),-0.38887640470882506,-0.8166363388391998,0.7017543859649122,1.0,1.0,10/27,26.79%,PIGC;MPPE1;PIGH;PIGO;PGAP4;PGAP3;PIGV;PIGX;GPAA1;PIGN
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),0.5034493149216553,0.8166116458198251,0.7368421052631579,1.0,1.0,3/7,18.75%,IRS2;BCL6;BLK
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),-0.3935679309120947,-0.8165137575535011,0.7222222222222222,1.0,1.0,6/33,15.14%,AGT;NOTCH1;PINK1;DAB2IP;MSN;ANKRA2
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,-0.35081184851221053,-0.8164349191822313,0.8108108108108109,1.0,1.0,18/74,13.93%,AMBP;ALPL;UPB1;ALDOB;SLC5A2;SLC22A8;DPYS;GBA3;UGT2B7;KNG1;LBP;PPIC;CRYL1;C3P1;HSD11B1;PDZK1;ABCC2;LRP2
prerank,GO_Biological_Process_2021__lymphocyte activation involved in immune response (GO:0002285),0.5208015094249712,0.8158703373602183,0.696969696969697,1.0,1.0,2/6,4.59%,F2RL1;MDK
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.3474444243174927,0.8156825389717592,0.7419354838709677,1.0,1.0,7/28,13.23%,KCNJ16;KCNJ6;KCNJ3;KCNJ2;CHRM3;NEDD4L;ANO6
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),-0.481551709251526,-0.8152177331457701,0.7678571428571429,1.0,1.0,5/11,24.52%,GAD1;ALDH4A1;NOS1;DAO;ARG1
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),0.4895681815294558,0.8152153031045666,0.7142857142857143,1.0,1.0,2/8,17.39%,LTC4S;CYP2C8
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.41226024623188695,0.8151331161029055,0.8378378378378378,1.0,1.0,5/13,18.06%,TGFB2;FGFR1;CELF1;RAI2;CELF4
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.4169775084847084,0.8148453709525509,0.75,1.0,1.0,4/18,10.10%,NFATC1;HEY1;JAG1;ROBO2
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),-0.3472892112913592,-0.8147915059646852,0.7971014492753623,1.0,1.0,9/86,15.68%,C4BPB;GPC3;DAB2IP;ADGRB1;TRIM32;CDKN1B;C4BPA;EEF1A1;AZIN1
prerank,GO_Biological_Process_2021__monoamine transport (GO:0015844),0.5286808737044619,0.8146651523109254,0.6944444444444444,1.0,1.0,3/6,13.33%,SLC22A3;SLC6A4;SLC6A2
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,-0.3454960963523569,-0.8145869944010103,0.7540983606557377,1.0,1.0,11/69,13.60%,MMP15;PRDX4;MBNL3;CCDC86;FKBP4;SLC52A2;TEAD4;HSD11B2;DHCR7;HMGB3;FASN
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.31052063277878367,-0.8145439773119199,0.8354430379746836,1.0,1.0,30/242,16.05%,ZNF703;SMIM22;PTPRC;CDKN2D;GADD45B;GMNN;FOXM1;CDKN3;JUNB;IRF1;NOTCH1;TGFB1;CRLF3;WDR6;FIGNL1;DAB2IP;CAMK2N1;GPER1;BRCA1;KIF20B;INHBA;TRIM32;CDC25A;LIN9;GADD45A;CDKN1B;TAF6;CDK4;TSC2;SPATA22
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.5066478005687978,0.8143869681742827,0.7317073170731707,1.0,1.0,1/5,8.00%,ZBTB1
prerank,GO_Biological_Process_2021__regulation of aldosterone biosynthetic process (GO:0032347),0.47711061844725766,0.8142585755984663,0.6739130434782609,1.0,1.0,1/6,3.13%,BMP6
prerank,GO_Biological_Process_2021__cGMP biosynthetic process (GO:0006182),0.4683829412547761,0.8141047182141622,0.7555555555555555,1.0,1.0,1/7,11.08%,GUCY1A1
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.31529058668512594,-0.8140721514399123,0.8552631578947368,1.0,1.0,38/196,23.88%,POLR3K;HSF2BP;GCM2;RREB1;TBPL2;TBP;ABT1;ZBTB7B;NFE2L3;TAF7;NCBP2;COPS2;TBPL1;NCBP1;RNPS1;POLR2J;POLR2K;DEK;TAF6;SUPT5H;RNMT;CREBL2;RTF1;POLR1C;TCEA2;TTF1;POLR2B;GTF3C6;BTF3;GTF3C3;CTDP1;GLIS3;TFAM;GTF3C4;PAF1;POLR3G;SNAPC2;TWNK
prerank,GO_Biological_Process_2021__positive regulation of secretion (GO:0051047),-0.5309941882708117,-0.8139493180343705,0.7818181818181819,1.0,1.0,3/6,33.28%,GPLD1;ABCB11;ACSL3
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),0.4783019065764068,0.8137626570579702,0.7560975609756098,1.0,1.0,1/5,19.09%,ABHD12
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.3648631630359777,0.813665338300766,0.8611111111111112,1.0,1.0,5/35,7.04%,F2RL1;CSF1R;MDK;MOSPD2;HMGB1
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),0.46692468751679017,0.8133124509021724,0.6666666666666666,1.0,1.0,1/7,2.59%,IFIH1
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),-0.3963414278529119,-0.8132066987829413,0.7636363636363637,1.0,1.0,6/24,18.38%,PIGC;MPPE1;PIGH;PIGO;PGAP4;PGAP3
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.44648340143277104,0.8131811964446317,0.7333333333333333,1.0,1.0,7/17,25.44%,TPR;ANO6;TSPAN33;NUP107;PLEKHA7;ADAM10;NUP98
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.38984333460029225,-0.8131554626712097,0.71875,1.0,1.0,4/31,10.23%,HSD17B10;DALRD3;WDR6;TRMO
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),0.48151526496579844,0.8131291026355375,0.6,1.0,1.0,1/6,3.13%,BMP6
prerank,GO_Biological_Process_2021__negative regulation of monocyte chemotaxis (GO:0090027),0.5072248135780819,0.8131037892983152,0.7857142857142857,1.0,1.0,1/5,5.75%,GREM1
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),0.44890308345303315,0.8130896792059288,0.7297297297297297,1.0,1.0,1/8,17.91%,POGZ
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),-0.46082298668433186,-0.812742286731155,0.6666666666666666,1.0,1.0,4/10,23.40%,LIPC;PCSK5;FURIN;ANGPTL3
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),-0.43305897215081157,-0.8127071690758468,0.7192982456140351,1.0,1.0,1/14,2.29%,PTPRC
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.3191335014843793,-0.8126888933643375,0.8625,1.0,1.0,32/140,24.67%,TPX2;ING2;RFC5;TBP;RPA3;TAF7;BRCA1;MRE11;CDK5R1;RPL5;RMI1;TAF6;RPS20;DAXX;CHEK1;RBBP8;KAT5;RPS15;RPF2;PRKAB2;RAD9B;CDK5;RAD1;RPL37;BLM;RNF34;RPL23;MAPKAPK5;PRDM1;CHD4;RAD50;RMI2
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),-0.40794820633398715,-0.81262549702997,0.6911764705882353,1.0,1.0,5/19,19.00%,PTPRC;HTR2B;PLCG2;ITPR1;ERO1A
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.36711186367141724,0.812381099559712,0.6578947368421053,1.0,1.0,4/33,5.94%,KIT;EGFR;C5AR1;PDGFRA
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.42279313004350794,0.8123752410214239,0.7209302325581395,1.0,1.0,2/9,14.73%,REP15;SORL1
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.3710030712875493,-0.8122401544722333,0.7702702702702703,1.0,1.0,3/61,2.71%,MMP26;PTGIS;ELANE
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.4814763957681631,-0.8122306473799095,0.6935483870967742,1.0,1.0,3/10,30.23%,RIPK2;PTPN22;CHMP5
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.4707910139761223,0.8120020316149715,0.7222222222222222,1.0,1.0,1/8,1.98%,NRP1
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.4707910139761223,0.8120020316149715,0.7222222222222222,1.0,1.0,1/8,1.98%,NRP1
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),0.5036502505028311,0.8119851380051165,0.7441860465116279,1.0,1.0,2/6,20.87%,TPR;PCID2
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),0.5036502505028311,0.8119851380051165,0.7441860465116279,1.0,1.0,2/6,20.87%,TPR;PCID2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),0.4026405261635915,0.8119775945226856,0.6666666666666666,1.0,1.0,2/13,5.65%,HOMER2;NAV3
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.4515726226334048,-0.8119223721592637,0.7272727272727273,1.0,1.0,2/12,6.05%,HCK;TBX1
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),-0.4554914810578834,-0.8114519301164362,0.7017543859649122,1.0,1.0,3/13,14.96%,GM2A;GBA3;NEU1
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.2727583989670868,0.8111090341604279,1.0,1.0,1.0,24/345,7.80%,POU6F2;TEAD2;SOX13;WWTR1;ZNF273;ZNF117;NFIA;RORA;ZNF536;OR7D2;TGFBR1;ATXN1;ESRRG;ZNF205;SPIN2B;WWC1;ZNF628;BRCA2;SOX12;CHD7;PRMT5;FOXN3;PCGF1;ZNF263
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),-0.5106120384917618,-0.8110498701971763,0.8035714285714286,1.0,1.0,2/6,18.19%,P4HA3;P4HTM
prerank,GO_Biological_Process_2021__coronary artery morphogenesis (GO:0060982),-0.5289005742420573,-0.810848128106218,0.8125,1.0,1.0,3/5,13.93%,NOTCH1;TBX1;LRP2
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.33609401101804653,0.8105818167979537,0.7741935483870968,1.0,1.0,9/58,13.23%,SLC12A3;SLC12A1;GABRG3;GABRB1;GABRA3;ANO5;SLC6A1;GABRB3;ANO6
prerank,GO_Biological_Process_2021__response to UV-B (GO:0010224),0.4130648427843476,0.8102713273568634,0.6764705882352942,1.0,1.0,2/8,24.43%,RELA;MME
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),-0.5326165728453427,-0.8101627529251575,0.734375,1.0,1.0,1/8,2.87%,GBP6
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),0.4124217392437184,0.809868141731864,0.7555555555555555,1.0,1.0,4/15,11.50%,GCH1;TGFB2;SNCAIP;DRD4
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),0.43856121200173603,0.8098675928894321,0.6923076923076923,1.0,1.0,2/6,5.24%,TGFB2;TGFB3
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),0.3349807563365654,0.8095131793653212,0.84375,1.0,1.0,1/52,0.22%,FBXL7
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.463932606486186,0.8093001210512785,0.6666666666666666,1.0,1.0,1/7,1.79%,KDR
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),-0.3680215522545821,-0.809181653494425,0.7323943661971831,1.0,1.0,10/47,11.98%,SEMA3D;PDXDC1;SOX10;GPC3;TBX1;FAT2;SEMA3F;AMOT;SEMA3A;HTR2B
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.34279943745320063,-0.8089969372127288,0.8,1.0,1.0,18/64,23.20%,SLU7;DDX39A;TST;NCBP2;SLBP;NCBP1;RNPS1;ALYREF;FLOT1;CDC40;NUP155;SIDT1;UPF3B;THOC5;NUP188;DHX38;RFTN1;SRSF5
prerank,GO_Biological_Process_2021__gastro-intestinal system smooth muscle contraction (GO:0014831),0.46757400589420123,0.8089470127697117,0.7105263157894737,1.0,1.0,1/5,2.21%,SULF2
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),-0.4156191294050827,-0.8088776004991555,0.7407407407407407,1.0,1.0,6/25,16.91%,MARVELD2;F11R;TJP3;MSN;MYADM;RAB1A
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.418059097687952,-0.8085832218180651,0.7121212121212122,1.0,1.0,4/16,16.69%,CGAS;IFIT1;FLOT1;ZCCHC3
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),-0.43906109232212887,-0.8085703765525132,0.6551724137931034,1.0,1.0,2/19,3.43%,CHRNB1;LRP4
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.49242378588104346,-0.8082389319292259,0.7666666666666667,1.0,1.0,3/7,19.01%,TGFB1;BCDIN3D;ESR1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.4673902642086083,-0.8080926636524477,0.7636363636363637,1.0,1.0,2/12,10.68%,GNPDA1;GFPT2
prerank,MSigDB_Hallmark_2020__Coagulation,-0.3400697118653221,-0.8079288540540347,0.7534246575342466,1.0,1.0,23/89,18.59%,F8;MMP15;TIMP3;ACOX2;P2RY1;RAC1;SERPINE1;BMP1;F10;CTSH;PRSS23;A2M;MASP2;CPB2;C1QA;ADAM9;CFD;SERPING1;HNF4A;ISCU;LAMP2;RABIF;VWF
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),0.43119101164256,0.8078556213407955,0.7428571428571429,1.0,1.0,3/11,10.61%,APOE;SCARB1;LCAT
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),-0.4434754338832596,-0.8077973916481495,0.7758620689655172,1.0,1.0,5/14,25.18%,DCTN1;MAP1A;ARF1;CHRNA7;LGMN
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.3682731754551425,-0.8077571813933555,0.7605633802816901,1.0,1.0,10/46,25.56%,LDLRAP1;TGFB1;RAB31;ACKR3;NSG1;RAMP1;ARFGEF2;CLTC;LGMN;CD9
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.3633714695968141,0.8075195105002535,0.7352941176470589,1.0,1.0,7/35,15.77%,UNC13B;ZBTB20;FOXO1;PIK3R1;GCK;SIRT1;FOXK1
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),0.4253620840973607,0.8074311615778909,0.7352941176470589,1.0,1.0,2/11,10.19%,RNFT1;USP25
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),-0.3484439014555848,-0.8070364159976952,0.8055555555555556,1.0,1.0,13/66,19.98%,NXT1;RANBP6;PINK1;RAB11A;SPRN;NEURL1B;NUP85;TSC2;LAMP1;NUP155;LAMP2;GCKR;NUP188
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),0.311318978979789,0.8069194444038778,0.8387096774193549,1.0,1.0,2/82,1.51%,GPC4;LEF1
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.3561933000623609,0.8066294645117669,0.7941176470588235,1.0,1.0,8/45,12.40%,PER2;MINAR1;HSPA1A;GNL3L;IVNS1ABP;U2AF2;BAG2;SVBP
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),-0.4596163039408091,-0.8062798133466537,0.676923076923077,1.0,1.0,2/8,15.19%,PBLD;MUC4
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,-0.35386669496248496,-0.8062793057263951,0.7808219178082192,1.0,1.0,12/65,12.99%,PPP1R1B;IL20RA;VWA2;B3GNT3;KCNQ1;TMC4;CBLC;ALDH2;HSD11B2;PLEKHG3;TJP3;TMEM45B
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.4317394320074916,0.8062602122119455,0.7105263157894737,1.0,1.0,5/21,13.16%,PARD3;JAM2;EIF2AK3;TENM4;SIRT2
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),0.3103791604603705,0.8062176029635658,0.88,1.0,1.0,6/109,5.61%,ROR2;LEF1;NFATC1;PLCB1;PRICKLE1;GNAO1
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),-0.5242547449358124,-0.8061927848510173,0.7719298245614035,1.0,1.0,1/7,11.08%,PAICS
prerank,GO_Biological_Process_2021__cellular response to gonadotropin stimulus (GO:0071371),-0.541111249750002,-0.805818782559965,0.7636363636363637,1.0,1.0,1/5,5.83%,NOTCH1
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),0.4760033969589752,0.8056676126569373,0.7111111111111111,1.0,1.0,3/8,11.71%,MID1;MID2;MAPRE1
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.40728589691290007,0.8056460541219436,0.7,1.0,1.0,4/15,13.00%,GCH1;SPTLC1;SPHK2;DHFR
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.4577445807649879,-0.8055473785599057,0.734375,1.0,1.0,4/13,9.16%,TRIML2;TRIM22;TRIM5;TRIM25
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.34045153566298275,-0.8054352212586371,0.8472222222222222,1.0,1.0,15/74,20.17%,POLR3K;CGAS;IRF1;CD14;TRIM25;RNF26;MRE11;TRIM32;POLR2K;STAT6;UFD1;POLR1C;IKBKE;IRF3;NLRC5
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.40956362146550507,-0.8053933258863005,0.7361111111111112,1.0,1.0,5/22,17.96%,H1-0;TGFB1;TXN;PLAUR;TWIST1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.3748890353498182,-0.8052512598723083,0.803030303030303,1.0,1.0,9/47,23.92%,TCP1;CCT6A;CCT8;DCP2;NAT10;CCT7;CCT2;PKIB;MAPKAPK5
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.43435237957718564,0.8052160750942097,0.625,1.0,1.0,3/11,21.89%,RAB27A;KIF5C;TMEM230
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.31488974645199463,-0.8051441396362045,0.8571428571428571,1.0,1.0,33/168,18.95%,SLC7A11;CD82;EPHX1;HINT1;H1-2;CCND2;GM2A;RPS27L;NOTCH1;TGFB1;PROCR;GPX2;RPL36;RETSAT;DRAM1;AEN;HSPA4L;BLCAP;CDK5R1;GADD45A;TGFA;RHBDF2;ANKRA2;PCNA;LDHB;CSRNP2;TNFSF9;ISCU;RAD51C;TCN2;NUDT15;ITGB4;MXD1
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.39535887021374205,-0.8050079739547603,0.7142857142857143,1.0,1.0,4/22,13.37%,ATP1B1;ABCB1;GLRX;PDZK1
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.46158114585562865,0.8049610453547056,0.75,1.0,1.0,1/11,3.47%,SEMA5A
prerank,GO_Biological_Process_2021__negative regulation of macrophage cytokine production (GO:0010936),0.45175231278677064,0.8048094664260262,0.6285714285714286,1.0,1.0,2/5,5.24%,TGFB2;TGFB3
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.4241510866390566,0.8044067687943662,0.75,1.0,1.0,2/13,11.51%,PEX7;TMEM86B
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),0.4514794168087342,0.804279837149673,0.7222222222222222,1.0,1.0,3/8,19.77%,ENPP1;CHP1;ERRFI1
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),0.5004447686696176,0.8042382709267111,0.7058823529411765,1.0,1.0,1/5,2.14%,TLR1
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),-0.4688224834812038,-0.8042079829195496,0.6727272727272727,1.0,1.0,4/8,31.99%,TXN;GPR37L1;PARK7;LRRK2
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.3644756420959269,-0.8037722949037802,0.7704918032786885,1.0,1.0,11/50,19.30%,ELANE;MANBA;DAB2IP;PRPF19;CLPX;NGLY1;SIAH1;ADAMTS9;LAMP2;CEACAM1;RAB12
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),-0.4331423461184378,-0.8035540919051757,0.76,1.0,1.0,1/21,5.69%,KCNQ1
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),-0.33205072436817445,-0.8035439962466809,0.7727272727272727,1.0,1.0,12/81,13.34%,TXNRD2;NOX1;PINK1;SOD2;GPX2;FANCC;G6PD;LRRC8D;GSTP1;NOX5;PRDX1;CYCS
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.3793145204502255,0.8033310146786572,0.7222222222222222,1.0,1.0,6/30,16.65%,EPM2A;MINAR1;KPTN;SIRT1;DDIT4;ATM
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),-0.47665213461328987,-0.8032878062519323,0.7377049180327869,1.0,1.0,3/9,25.63%,CELSR1;SHROOM3;MAL
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),0.33753637334030706,0.8030236106714965,0.75,1.0,1.0,10/56,14.01%,METTL8;THADA;MTERF4;LCMT2;TRDMT1;TYW3;FBLL1;TRMT61A;ZC3H13;TRMT61B
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),0.34106292034625774,0.802881033516421,0.75,1.0,1.0,10/39,13.32%,PER2;OSBPL7;OSBPL6;AKR1C3;CYP7B1;PNPO;SLC27A2;CYP39A1;OSBPL3;ACOT8
prerank,GO_Biological_Process_2021__regulation of translational elongation (GO:0006448),-0.5458986453344163,-0.8027521346349402,0.7547169811320755,1.0,1.0,1/5,3.91%,EIF5A2
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),-0.38659423506551077,-0.8027207822230662,0.8125,1.0,1.0,4/34,8.66%,SLC12A7;KCNE2;ATP1B1;ATP1A1
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),-0.491224522612466,-0.8026412472815528,0.7758620689655172,1.0,1.0,1/6,2.84%,CAV3
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.46108626539825637,-0.8025672575086816,0.8032786885245902,1.0,1.0,3/8,23.30%,TMSB4X;LAMTOR5;ZNF593
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.37591713184561926,0.8024932333002756,0.7608695652173914,1.0,1.0,11/26,21.96%,IL1RAPL1;LZTS3;ABHD17A;PPFIA2;SIPA1L1;WNT5A;HOMER1;ARHGAP44;ABHD17C;EPHA4;TANC2
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),0.33091319772874195,0.8020270539762099,0.8275862068965517,1.0,1.0,10/61,15.15%,THADA;CDKAL1;LCMT2;TRDMT1;WDR4;TYW3;TRMT61A;TRMT61B;ADAT2;PUSL1
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.3926575771797453,0.8016530304204259,0.717948717948718,1.0,1.0,8/18,20.93%,FAF1;FAM83D;SNF8;NEDD4L;ZDHHC2;CHEK2;ZDHHC7;ITGB1
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.34937554386764585,0.8013353219388453,0.8571428571428571,1.0,1.0,11/30,23.76%,LZTS3;NLGN1;PPFIA2;SIPA1L1;NGEF;ARHGAP44;PTEN;RELN;EPHA4;TANC2;CAPRIN1
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),-0.5164015779932537,-0.8012486737429739,0.7777777777777778,1.0,1.0,1/7,16.55%,IMPA2
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),-0.49932456199693387,-0.800909318718425,0.7818181818181819,1.0,1.0,3/9,25.97%,LPCAT3;MBTPS2;RAN
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),0.43868679918612974,0.8008830553360872,0.7837837837837838,1.0,1.0,3/10,16.85%,PLIN5;SCARB1;NR1H3
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),-0.36762345956069487,-0.8008255226053939,0.7424242424242424,1.0,1.0,4/44,10.22%,DEGS2;SPTLC3;ALOXE3;PNPLA1
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),-0.4337258083510135,-0.8005482282621437,0.7090909090909091,1.0,1.0,3/17,9.25%,SMIM22;HSD17B13;PPID
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),-0.39429326229014616,-0.8003471082450141,0.7936507936507936,1.0,1.0,6/29,12.27%,TIMP3;CHAC1;TIMP2;CAMK2N1;KNG1;TIMP4
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.4279895703295012,-0.8003466102158587,0.8095238095238095,1.0,1.0,10/24,30.51%,RFC5;RPA3;XRCC1;PCNA;RPS27A;UBC;LIG1;RPA1;POLD1;UBB
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),-0.3322449314468304,-0.7999391059191123,0.8387096774193549,1.0,1.0,5/87,3.68%,EPHA1;PTGIS;CYP1B1;ITGA5;NODAL
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),-0.48566493425218654,-0.7997893857923416,0.8103448275862069,1.0,1.0,2/10,16.67%,OR2M4;SLC24A4
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),-0.5151676914865055,-0.799767392241872,0.711864406779661,1.0,1.0,3/5,44.02%,RPS6KA4;FMR1;MAPK3
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.3429109938768283,0.7997361621691467,0.717948717948718,1.0,1.0,5/29,10.97%,DGKB;APOE;LYPLA2;DGKH;PNPLA2
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.32761875507215,-0.7996763270875911,0.8656716417910447,1.0,1.0,26/111,20.27%,SLC7A11;AMN;SLC7A7;SLC52A2;CHMP2B;AQP9;SLC48A1;SLC18A2;LRRC8D;CHMP2A;RCN3;CBLIF;TMEM30A;ABCC2;LRP2;SLC36A1;SLC23A1;SLC38A4;SNX4;TCN2;KIF3A;SLC3A1;SLC11A1;RAMP1;SLC52A1;TXNIP
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.3111218321722252,-0.7992578721542414,0.8648648648648649,1.0,1.0,38/166,24.65%,PATL2;RPS27L;ENC1;PAIP2B;EPRS1;IGFBP5;NCBP2;EIF1B;NCBP1;ZNF540;EIF1;RPL5;EEF2;ILF3;DDX1;NIBAN1;NAT10;RBM4B;EIF4A2;CSDE1;RBM4;EIF6;FXR1;UPF3B;CALR;RPS6KA1;EIF2B2;CYFIP1;RPS4X;RPS3;GLE1;RPL13A;YTHDF1;EIF5;EIF4H;MAPKAPK5;METTL3;MTIF2
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),-0.4657959971655982,-0.7992299738587558,0.7636363636363637,1.0,1.0,7/13,36.80%,ETFB;SLC25A18;ETFDH;NDUFA5;ETFA;ETFRF1;PPARGC1A
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.3508868778669509,0.7990700440011044,0.7647058823529411,1.0,1.0,4/31,8.59%,UNC5C;SEMA6D;SEMA4C;EPHA7
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),-0.4776968217924661,-0.798754096694184,0.75,1.0,1.0,3/10,11.46%,REST;CCL5;PSMC3
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.3131300492665109,-0.7985698803621845,0.8607594936708861,1.0,1.0,38/144,16.55%,HLA-DMA;GBP6;B2M;CD74;STAT1;FGL2;IRF1;CIITA;IFIT1;IL7;SOD2;IFI27;P2RY14;IL15;CASP8;PSMB8;RNF213;STAT4;ISG20;IFIT3;TRIM25;IL18BP;PSMA3;HLA-A;CCL5;WARS1;IFI44;CMPK2;CMTR1;EPSTI1;ZNFX1;TNFAIP2;GPR18;OAS3;XAF1;NFKBIA;SERPING1;NAMPT
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),0.5065565017988148,0.7983247175630362,0.7209302325581395,1.0,1.0,2/7,13.16%,PARD3;SIRT2
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),0.5065565017988148,0.7983247175630362,0.7209302325581395,1.0,1.0,2/7,13.16%,PARD3;SIRT2
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),-0.3710852933247088,-0.7982869841196911,0.734375,1.0,1.0,4/34,8.37%,ZNF703;NOTCH1;TGFB1;NOTCH4
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),-0.5059695944614183,-0.7980050333883112,0.7627118644067796,1.0,1.0,1/6,4.17%,SUV39H1
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.341366827943874,-0.7978869961017342,0.8311688311688312,1.0,1.0,37/108,30.51%,PTGIS;PSMB6;PSMB8;TOLLIP;DAB2IP;SKP1;PSMA3;CCL5;PELI3;PSMC3;PSMC6;PSMA5;RBX1;NFKBIA;PSMA7;PSMD12;PSME1;ADAMTS12;RPS27A;PSMB2;GBP2;UBC;RIPK2;MAPK13;PSMD2;PSMA8;PSMA1;MAP3K3;PSMC1;TNIP2;PSMD4;PSMD8;MAP3K8;PSMB4;PSMC4;IRAK4;UBB
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),-0.4170675805785827,-0.7976483048745376,0.7846153846153846,1.0,1.0,1/18,2.84%,CAV3
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.3831814558027121,-0.7975693197223104,0.7678571428571429,1.0,1.0,5/28,12.99%,ACOT4;ACOX2;ACSBG1;ACOT1;ACOT2
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),-0.4799394854764616,-0.7970471113789648,0.765625,1.0,1.0,3/10,16.93%,GPC1;NCMAP;CNTNAP1
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),0.3391132230361882,0.7967647289957718,0.7631578947368421,1.0,1.0,4/43,8.78%,ATP6V0D2;MELTF;REP15;STEAP3
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.3239356307654434,0.79668628025853,0.7692307692307693,1.0,1.0,10/32,14.12%,SEMA6D;NRP1;SEMA5A;SEMA4C;ERBB4;SEMA3C;RADIL;PHACTR4;SEMA5B;NRTN
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),-0.5358336073711774,-0.7964373974593566,0.75,1.0,1.0,1/5,9.25%,MGME1
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.45164598315872706,0.7962971283498197,0.7804878048780488,1.0,1.0,3/10,18.53%,B3GAT2;B3GAT3;B3GAT1
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.4712237312974489,0.7954303931906193,0.8,1.0,1.0,3/11,11.34%,BCL2L11;ATF6;PIK3R1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.2931584206433212,0.7952613523807185,1.0,1.0,1.0,10/153,6.03%,CCNH;MAML3;TEAD2;WWTR1;RORA;ESRRG;HDAC9;MAML1;TAF2;NR3C2
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.33219990191867355,0.7952525936593832,0.8260869565217391,1.0,1.0,7/99,2.49%,RXFP2;IFI16;HTR7;GLP1R;CYSLTR2;CD247;SAMSN1
prerank,GO_Biological_Process_2021__regulation of hormone secretion (GO:0046883),0.48525643364586724,0.7951483184226408,0.7619047619047619,1.0,1.0,2/7,11.48%,NMB;VAMP3
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.3283480919887041,-0.7950852243574419,0.8571428571428571,1.0,1.0,19/105,19.94%,WFS1;CHAC1;WIPI1;IFIT1;HSPA5;GEMIN4;DCP2;NFYB;DCTN1;XPOT;HERPUD1;TUBB2A;EEF2;EIF4A2;KDELR3;HSPA9;ERO1A;CALR;NABP1
prerank,GO_Biological_Process_2021__regulation of epithelial cell apoptotic process (GO:1904035),0.4562677090544719,0.794962075474462,0.7142857142857143,1.0,1.0,2/8,7.33%,MDK;PKHD1
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),0.4842836858355597,0.7949518671557002,0.7692307692307693,1.0,1.0,2/8,6.65%,F2RL1;PRKCD
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3340060875088135,0.7948688313209806,0.8125,1.0,1.0,8/48,16.65%,CRADD;BTG2;CASP2;EP300;CHEK2;TFDP1;TRIAP1;ATM
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),-0.46994293299765155,-0.7946134185194988,0.6923076923076923,1.0,1.0,2/10,11.83%,GSTP1;DNAJA1
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),0.30306505351583296,0.7945210695528013,0.8709677419354839,1.0,1.0,11/93,13.08%,MRPL17;TSFM;EEFSEC;MRPL33;MRPL58;EEF1D;MRPL39;MRPS27;MRPS18A;MRPL21;MRPS7
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.3101932505803911,0.7944934849979262,0.8888888888888888,1.0,1.0,12/105,9.80%,NPNT;UNC5B;LAMB2;SDC4;COBL;UNC13B;OGDH;MYO1D;TMEM117;RNF128;PERP;PARM1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.3197326005379203,-0.7938279589521163,0.8767123287671232,1.0,1.0,29/120,23.65%,DDX20;RPS27L;CELF3;ABT1;SNRPD2;RPL38;GEMIN4;NCBP1;PRPF19;USP39;RPL5;DDX1;RSL24D1;ERAL1;EIF2S2;CRNKL1;RPL24;EIF6;RPS15;RPF2;SRPK1;MCTS1;RPL3;TRAF7;CLP1;HSP90AB1;SRSF5;EIF5;EIF4H
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),0.3382434287736099,0.7937939125368051,0.8285714285714286,1.0,1.0,7/39,9.59%,RGS14;BMP7;SPRY3;PRKCD;APOE;STK38;DUSP10
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.49102978604652514,0.7937113586516228,0.75,1.0,1.0,3/6,26.42%,PARP10;TLK2;TLK1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),0.4257767317349571,0.7936166640732824,0.7111111111111111,1.0,1.0,2/7,25.70%,ANKRD2;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.43047527632912186,-0.7935845045634049,0.7857142857142857,1.0,1.0,3/21,9.82%,TGFB1;CEMIP;CALM3
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),-0.33253197586117117,-0.7934011196115507,0.90625,1.0,1.0,20/94,20.32%,AGT;RPS27L;TGFB1;CASP8;INHBA;FADD;TRIM32;MSN;VPS35;RPL5;EEF2;PLA2G10;NIBAN1;UHRF1;NFKBIA;NAT10;EIF6;FXR1;UPF3B;RPS4X
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),-0.47821245114571326,-0.7930405129367724,0.7580645161290323,1.0,1.0,2/8,15.04%,MTCH1;CNTN2
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.5005552469357355,-0.7928318052254661,0.847457627118644,1.0,1.0,5/10,15.36%,ELANE;SIGIRR;GSTP1;APOD;OAS3
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),-0.4545746627348236,-0.792805728866093,0.78125,1.0,1.0,3/10,19.23%,ROPN1L;CABYR;SPAG17
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),-0.3436738540596814,-0.7925784006467815,0.8918918918918919,1.0,1.0,9/91,13.23%,CELF3;SLU7;NONO;SNRPD2;NCBP2;NCBP1;RNPS1;SNRNP48;USP39
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),-0.40693429619420957,-0.7924796078909209,0.7192982456140351,1.0,1.0,3/16,7.73%,CD74;RAC1;NCKAP1L
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.28743675596431845,0.792346137939329,1.0,1.0,1.0,25/170,14.14%,GNG4;SGK1;BCL2;EGFR;SGK2;MELTF;TGFBR1;SERTAD2;MINAR1;TGFB2;ENPP1;KIF26A;HSPA1A;PAK5;SLC25A33;SPHK2;SPOCK1;RERG;SOCS2;BCL6;PAK4;CHPT1;SIRT1;VGLL4;NRG3
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.42500923801077367,-0.7922059227456747,0.765625,1.0,1.0,7/14,31.69%,NUDT1;NUDT15;ENTPD5;ENTPD2;NUDT18;NUDT9;ENTPD1
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),0.3594766052494182,0.7918232076534503,0.8333333333333334,1.0,1.0,1/29,0.61%,CCNH
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.33106973653168487,-0.7918196234453418,0.8589743589743589,1.0,1.0,16/91,15.45%,CASP12;NODAL;RPS27L;MTCH1;KHDC1;CARD8;CASP8;BCAP31;REST;GPER1;HIP1R;FADD;BOK;CYCS;PDCD5;ATP2A3
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),-0.3840543270167437,-0.7915347751949801,0.7285714285714285,1.0,1.0,5/39,15.01%,ATP5IF1;F11R;DAB2IP;GMIP;SH2D4A
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),0.49096310117637676,0.7915262962624233,0.6818181818181818,1.0,1.0,1/5,10.36%,SPHK2
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),-0.42281266651107463,-0.7914440014789872,0.8813559322033898,1.0,1.0,2/19,7.94%,TTLL4;AGBL5
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),0.5063276199603599,0.7913111246962078,0.7209302325581395,1.0,1.0,1/6,3.11%,ZBED3
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.4063685637124339,0.7912809934481959,0.7804878048780488,1.0,1.0,4/23,11.64%,CCDC63;JAM2;PLD6;RFX2
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.44755627609144144,0.7912786929050668,0.6585365853658537,1.0,1.0,2/11,6.63%,BCL2L11;AKR1C3
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.3514860524390613,0.7912590892804441,0.7222222222222222,1.0,1.0,4/25,7.33%,CSF1R;ACVR1;FGF10;PKHD1
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.3481255484696094,0.7911026047653971,0.7142857142857143,1.0,1.0,11/35,22.25%,ZDHHC14;NAT9;ZDHHC3;FOXO1;ZDHHC5;EP300;ZDHHC2;CREBBP;ZDHHC7;GTF2B;KAT6A
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.34072658636580144,0.7903477430257281,0.6842105263157895,1.0,1.0,3/23,11.55%,IFIH1;TAB3;TAB1
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,-0.35432105446238843,-0.7903206127863759,0.8181818181818182,1.0,1.0,7/49,7.53%,ALPL;SMIM22;B3GNT3;TMC4;MYO5B;CBLC;GPX2
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.42920365017905854,-0.7902612233611881,0.7761194029850746,1.0,1.0,10/18,37.57%,SYVN1;MAN1B1;RPS27A;MARCHF6;UBC;UBB;RNF139;UBA52;AMFR;RNF5
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),0.4477262837865574,0.7902335364606236,0.6578947368421053,1.0,1.0,1/8,1.52%,HOMER2
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.4171983353130761,-0.7902177588030455,0.7971014492753623,1.0,1.0,3/19,8.60%,STAT1;STAT5A;STAT4
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.36942061030074014,-0.79015565292866,0.7702702702702703,1.0,1.0,13/40,21.83%,STAT1;ZBTB7B;STAT5A;STAT4;IGFBP5;GPER1;EIF2B5;KHK;STAT6;EIF6;SLC27A1;EIF2B2;STAT2
prerank,GO_Biological_Process_2021__granulocyte activation (GO:0036230),0.48884997899633087,0.7899916363199715,0.7111111111111111,1.0,1.0,2/6,6.65%,F2RL1;PRKCD
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.3736623434182724,0.7899631105246259,0.7297297297297297,1.0,1.0,12/23,27.49%,PRKCD;ID2;SIRT1;NSMCE2;ECRG4;KAT6A;TERF2;HMGA2;PML;MAPK14;SMC6;ULK3
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),-0.41366018443923896,-0.7896927931088853,0.8035714285714286,1.0,1.0,3/18,15.72%,NCBP2;NCBP1;SUPT5H
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),-0.4794634557930625,-0.7895691736102639,0.8064516129032258,1.0,1.0,2/9,3.46%,TNFSF18;CD74
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),-0.49237004722309774,-0.7894316413520432,0.75,1.0,1.0,2/8,30.24%,GSTZ1;PDK4
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),-0.49237004722309774,-0.7894316413520432,0.75,1.0,1.0,2/8,30.24%,GSTZ1;PDK4
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),0.31347399900483525,0.7892892085538356,0.85,1.0,1.0,6/78,5.06%,PID1;WWTR1;ZBED3;BMP7;PRR5L;EPHB2
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),0.4347161090803309,0.7890380547604192,0.725,1.0,1.0,3/12,7.52%,GRIN3A;GRIN2A;SDF4
prerank,GO_Biological_Process_2021__positive regulation of type I interferon-mediated signaling pathway (GO:0060340),-0.5170523980127913,-0.7890165634581553,0.6785714285714286,1.0,1.0,2/5,20.17%,FADD;NLRC5
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),0.4995269686080829,0.788928206920568,0.8048780487804879,1.0,1.0,2/6,11.93%,SPHK2;VAMP8
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.38915246332516557,0.7880291061261167,0.8518518518518519,1.0,1.0,5/24,10.23%,EGFR;PLCB1;FGF10;LSM10;UBE2E2
prerank,GO_Biological_Process_2021__positive regulation of acrosome reaction (GO:2000344),0.4608792015931798,0.7879385829983461,0.7708333333333334,1.0,1.0,1/6,3.58%,PLCB1
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",-0.4883440589435116,-0.7876050251790961,0.7301587301587301,1.0,1.0,2/8,21.72%,ERI2;EXOSC8
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),-0.4883440589435116,-0.7876050251790961,0.7301587301587301,1.0,1.0,2/8,21.72%,ERI2;EXOSC8
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),-0.5203421489305033,-0.7875989191985009,0.7619047619047619,1.0,1.0,4/5,38.79%,DNM1L;ARMC1;LRRK2;CLUH
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),0.3479189643672064,0.7875702771858227,0.8157894736842105,1.0,1.0,6/33,17.07%,CCNH;ERCC2;TAF1B;TCOF1;UBTF;ERCC3
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),-0.439405558995335,-0.7874962509177094,0.7818181818181819,1.0,1.0,2/16,12.73%,LDLRAP1;ABCG5
prerank,MSigDB_Hallmark_2020__Angiogenesis,-0.39622495158884263,-0.7873836974069116,0.7627118644067796,1.0,1.0,3/24,4.60%,MSX1;LRPAP1;CCND2
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),-0.4486328867982406,-0.7873631888946617,0.7540983606557377,1.0,1.0,3/12,12.52%,RAC1;ADGRB1;RHOH
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),-0.4697801266499356,-0.7873522231857554,0.7758620689655172,1.0,1.0,1/10,11.36%,SESN3
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),-0.4697801266499356,-0.7873522231857554,0.7758620689655172,1.0,1.0,1/10,11.36%,SESN3
prerank,GO_Biological_Process_2021__regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),-0.5279068463821471,-0.787254267592155,0.7741935483870968,1.0,1.0,2/5,20.54%,CALM3;CALM1
prerank,GO_Biological_Process_2021__cellular response to nutrient (GO:0031670),0.4849221789883269,0.7872349559401964,0.7446808510638298,1.0,1.0,5/5,51.52%,LPL;CDKN2B;XBP1;USF1;PDK2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.3878965530636712,0.7872179427462384,0.7142857142857143,1.0,1.0,3/18,7.04%,PLCB1;MDK;HMGB1
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),0.40132459510589646,0.7871447102898459,0.75,1.0,1.0,4/14,21.27%,IGBP1;MTMR9;MTMR3;SMG6
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),0.39499908370261244,0.7871162638705012,0.7027027027027027,1.0,1.0,4/12,16.94%,KCNJ3;KCNN2;CACNB2;KCNA5
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.3812518473439034,-0.7869437250149991,0.7419354838709677,1.0,1.0,6/36,8.59%,ACTC1;ZFPM1;TBX19;NOTCH1;TBX1;TTN
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.3414925622908226,-0.7868176378625021,0.8115942028985508,1.0,1.0,12/92,11.72%,HCK;PTGES;PDE6B;CASP12;LRRC19;P2RY12;IRF1;CASP8;TRIM5;TMSB4X;NMT1;CNGB1
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.42401679289202193,-0.7859398360508407,0.7391304347826086,1.0,1.0,2/15,11.34%,CELF3;NCBP1
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),0.40448411380524174,0.7859266683126455,0.8444444444444444,1.0,1.0,5/20,11.48%,F2RL1;EPHB2;SPHK2;RBP4;VAMP3
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),-0.4055486958615816,-0.7859035985115692,0.7818181818181819,1.0,1.0,2/14,11.04%,BORA;KIF20B
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.3888413374742471,0.7858623961217742,0.7567567567567568,1.0,1.0,2/25,3.97%,KDR;HDAC9
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),-0.45541251057186405,-0.785824314692561,0.7166666666666667,1.0,1.0,1/7,5.95%,TGFB1
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),-0.3354539896457377,-0.7856447035661912,0.828125,1.0,1.0,6/70,14.33%,LMAN1;F11R;PINK1;MSN;VPS35;NEXN
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.40713940614567146,-0.7854600704130232,0.8225806451612904,1.0,1.0,3/26,13.60%,ALOX12;GGTA1;FASN
prerank,PanglaoDB_Augmented_2021__Sebocytes,0.3620738732939195,0.7852026979556969,0.8125,1.0,1.0,4/40,2.92%,GALNT3;F2RL1;LAMB3;HRH1
prerank,GO_Biological_Process_2021__maintenance of DNA repeat elements (GO:0043570),-0.5094403162059807,-0.785184947032346,0.8181818181818182,1.0,1.0,4/6,36.66%,AXIN2;RMI2;TCF7L2;MSH6
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.3343027550597859,-0.7848663073924741,0.8676470588235294,1.0,1.0,8/82,13.62%,RAB6C;LMAN1;ARL1;MAGEL2;DCTN1;STX16;PREPL;VPS35
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),0.3516838020544624,0.7848015337648803,0.7142857142857143,1.0,1.0,8/49,11.46%,PER2;SLC37A4;G6PC3;IRS2;SLC25A1;RBP4;DCXR;PC
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.4280577322554527,-0.784675007678895,0.75,1.0,1.0,4/18,17.01%,TXNDC15;UCHL5;SHH;PDCL
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),0.26901026192614347,0.784674046697365,1.0,1.0,1.0,18/286,7.03%,FBXL7;LAMB2;PENK;VCAN;LTBP1;SENP8;MELTF;DNAJC3;AFP;FBXW8;FEM1A;SOCS6;LGALS1;CCDC22;FBXO27;ERCC8;APOE;COMMD1
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.47148524123438307,-0.7846667627640315,0.8035714285714286,1.0,1.0,2/8,14.23%,APOD;NDRG4
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.4161008936908375,0.7845798254493463,0.8604651162790697,1.0,1.0,1/9,3.03%,LRRC55
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.4277657259487082,-0.7845702451585155,0.7843137254901961,1.0,1.0,6/13,18.95%,CIITA;GPER1;SLC18A2;GSTP1;ASXL3;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),-0.48964747806147246,-0.784222472005954,0.7627118644067796,1.0,1.0,1/6,10.32%,IL18
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),0.5287402268021429,0.7841997526252403,0.7567567567567568,1.0,1.0,1/5,5.83%,PDE4D
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),-0.4928054934314547,-0.7840547794011818,0.875,1.0,1.0,3/8,17.60%,DRC1;LAMP1;NEFH
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.4091307224973736,0.7838945595837092,0.8205128205128205,1.0,1.0,2/18,4.60%,RAD51B;DBF4B
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.4143087824769395,-0.7838267498496946,0.7741935483870968,1.0,1.0,1/16,0.42%,GNLY
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),-0.3640551830846041,-0.7838064795500364,0.8059701492537313,1.0,1.0,9/49,22.97%,CHMP4B;CHMP2B;CHMP2A;NUP85;NUP155;ANKLE2;NUP188;VPS4A;CCNB2
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.39203377123714567,0.7837480562868652,0.7142857142857143,1.0,1.0,6/14,23.85%,ST6GALNAC4;ST8SIA3;ST8SIA4;ST8SIA2;LARGE1;ST8SIA5
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.3064564689640119,0.7836636983684351,0.8260869565217391,1.0,1.0,7/134,6.15%,FBXL7;NEDD1;RAD51B;KCNH5;PCM1;DBF4B;HMMR
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.330135422253645,-0.7834410402909794,0.8461538461538461,1.0,1.0,20/92,23.32%,FIP1L1;NXT1;SLU7;DDX39A;NCBP2;FYTTD1;SLBP;NCBP1;RNPS1;NUP85;ALYREF;CDC40;NUP155;UPF3B;THOC5;NUP188;GLE1;DHX38;SRSF5;CPSF4
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.39206044436257914,-0.7833482329174734,0.7619047619047619,1.0,1.0,9/24,25.15%,CAV3;RAC1;DCTN1;CDK5R1;RPS3;MET;PSRC1;ANKRD53;TRPV4
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),-0.42012809356815844,-0.7832350987334953,0.7586206896551724,1.0,1.0,3/13,7.73%,CD74;RAC1;NCKAP1L
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.42012809356815844,-0.7832350987334953,0.7586206896551724,1.0,1.0,3/13,7.73%,CD74;RAC1;NCKAP1L
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.29554109425279457,0.7831556580739385,0.8387096774193549,1.0,1.0,19/83,18.60%,PTPRK;EGFR;ERCC8;PRKCD;SDF4;ZBTB1;ERCC2;EIF2S1;CASP9;PRIMPOL;RHBDD1;MAPK8;RUVBL2;EP300;TRIAP1;ERCC3;YY1;CREBBP;USP47
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.3325038153628444,-0.782918129300431,0.8181818181818182,1.0,1.0,14/57,18.95%,EPN1;AGT;CBLC;DAB2IP;GPER1;HIP1R;IFI6;TGFA;RHBDF2;PLAUR;SHKBP1;MVP;BCAR3;CEACAM1
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.35655771700283634,0.7828860609640378,0.9,1.0,1.0,5/35,9.35%,SLC22A2;SLC16A2;SLC19A1;SLC7A1;SLC6A13
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),0.339980276993645,0.7827705130215759,0.84375,1.0,1.0,4/62,8.76%,CCNH;ELP4;IWS1;ERCC2
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.30149090544960955,0.7827395885399264,0.90625,1.0,1.0,11/129,11.22%,ATP6V0D2;IFI16;WDR24;AKR1C3;EIF2S1;DAP;PRKD1;EIF2AK3;KPTN;MAPK8;FOXO1
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.32277252803491246,0.7822408300607956,0.8235294117647058,1.0,1.0,2/33,5.75%,TGFBR1;ACVR1
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),-0.3291996018892576,-0.7822004677142802,0.8307692307692308,1.0,1.0,10/68,14.51%,FUT2;B3GNT5;B3GNT3;GCNT1;B3GNT9;B3GALT1;XYLT1;B3GNT4;B3GALNT1;B3GALT4
prerank,GO_Biological_Process_2021__phenol-containing compound biosynthetic process (GO:0046189),0.5358671309246428,0.7819864087593558,0.8048780487804879,1.0,1.0,2/5,13.34%,TPH1;TRPC1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.33780596574258726,-0.7818596160527005,0.8,1.0,1.0,15/81,20.65%,PATL2;ENC1;PAIP2B;EPRS1;DAB2IP;IGFBP5;CAMK2N1;KNG1;ZNF540;ILF3;RBM4;FXR1;CALR;CDK5;RPS3
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),-0.39769996661534657,-0.7818060183532726,0.7868852459016393,1.0,1.0,5/21,21.91%,NUBP1;NFS1;ISCU;HSPA9;CIAO2A
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),-0.3589105131780432,-0.781803729876597,0.8666666666666667,1.0,1.0,11/41,19.30%,MANBA;ISG20;DAB2IP;NCBP1;NGLY1;SUPV3L1;DNASE1L1;ADAMTS9;RNASEH2C;RNASET2;RAB12
prerank,GO_Biological_Process_2021__negative regulation of hemostasis (GO:1900047),-0.487523891784169,-0.7817696025755313,0.765625,1.0,1.0,2/9,9.72%,SERPINE1;KNG1
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.395906810603598,-0.7811289535335025,0.6825396825396826,1.0,1.0,2/15,11.37%,PIGC;PIGH
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.3609610968053169,0.7810954958162784,0.8421052631578947,1.0,1.0,3/19,6.13%,SEMA6D;SEMA5A;SEMA4C
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.38053690763568837,0.7809879505410524,0.7027027027027027,1.0,1.0,4/18,18.49%,PPP1R8;CHP1;PPP1R35;ENSA
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),-0.4007509228685987,-0.7807711791791714,0.8181818181818182,1.0,1.0,5/20,19.00%,PTPRC;HTR2B;PLCG2;ITPR1;ERO1A
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.4324766451421532,0.7807685302530425,0.8611111111111112,1.0,1.0,2/11,6.85%,PMEPA1;ARID1A
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),-0.45915852872092505,-0.7804902566072288,0.8032786885245902,1.0,1.0,4/11,18.70%,TMIE;TBX1;TWIST1;ZIC1
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),-0.48916509142516573,-0.780488469244505,0.7843137254901961,1.0,1.0,3/6,23.18%,GTF3C6;GTF3C3;GTF3C4
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.3750190481836605,-0.7804544250063987,0.7358490566037735,1.0,1.0,6/21,30.24%,ATXN7L3;UHRF1;PAF1;UBE2B;CTR9;RNF8
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.35527906779892166,-0.7803706312200283,0.8472222222222222,1.0,1.0,7/43,13.49%,PTPRC;CD74;IL15;CCL5;FADD;GBP5;HLA-DMB
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.44331909793902696,0.7802943085583792,0.7222222222222222,1.0,1.0,1/9,3.81%,ACADVL
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.42936070689647743,0.7801832888676643,0.7575757575757576,1.0,1.0,3/9,18.42%,SIRT1;EP300;CREBBP
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),-0.34722009514631075,-0.7799217956449104,0.835820895522388,1.0,1.0,9/61,9.72%,CYP1B1;PTPRC;RND1;RASA1;NOTCH1;TGFB1;SERPINE1;DACT2;KNG1
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),0.3177587580235889,0.7795415017642289,0.9032258064516129,1.0,1.0,19/51,21.43%,F2RL1;GPR174;FGF10;RASGRP1;IGF1;IRS2;MMD2;AUTS2;NGF;P2RY10;RASGRF1;RTN4R;RAPGEF1;JAK2;ROBO1;MAP4K4;PRAG1;APOA1;GPR35
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),-0.39460253840743204,-0.7791232955037397,0.8103448275862069,1.0,1.0,6/19,21.50%,RAC1;NCKAP1L;RHOH;NEFH;CYFIP1;RHOU
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.37800668262048687,0.7790758359838137,0.6896551724137931,1.0,1.0,4/24,10.50%,SAMSN1;PRKCD;PTPN6;PIBF1
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.3163527485724335,-0.7790755723747861,0.8961038961038961,1.0,1.0,18/127,18.84%,ARIH2;TGFB1;PINK1;CEMIP;CASP8;UBL5;TOMM7;KIF20B;TMEM30A;NMT1;PDZK1;RIPOR1;YWHAG;AKAP5;YWHAB;YWHAH;ZIC1;TCAF2
prerank,MSigDB_Hallmark_2020__Pperoxisome,-0.33283249489484706,-0.7790744981476889,0.8714285714285714,1.0,1.0,20/95,19.64%,ABCB1;PEX11B;SOD2;ALDH1A1;ACSL5;HSD11B2;RETSAT;ECI2;ABCB4;PRDX1;SIAH1;SLC25A4;CRABP2;PEX5;YWHAH;HSD17B11;ESR2;MVP;DIO1;SLC25A19
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),-0.3937933998165252,-0.7786798461180591,0.796875,1.0,1.0,1/27,0.68%,KCNE2
prerank,GO_Biological_Process_2021__endothelin receptor signaling pathway (GO:0086100),-0.4942561220219629,-0.7786719922922397,0.7368421052631579,1.0,1.0,1/5,18.33%,BCAR3
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),0.47897385590696445,0.7783848145832,0.7,1.0,1.0,1/5,20.70%,BDP1
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),0.37835888426475395,0.7782380141598783,0.7906976744186046,1.0,1.0,1/19,0.70%,SOX13
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),-0.4109757513321599,-0.778195877097597,0.75,1.0,1.0,1/19,0.59%,SLC12A7
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.4126563084586813,-0.7780437848000303,0.7647058823529411,1.0,1.0,5/15,13.72%,CYP1B1;NOTCH1;CRLF3;CCL5;OCIAD2
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),0.469394478445172,0.7779164247032858,0.7435897435897436,1.0,1.0,1/8,1.98%,NRP1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),0.44231709757997506,0.7778173354744515,0.7631578947368421,1.0,1.0,1/12,0.95%,ATOH8
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.4459472327034961,-0.7777781599455241,0.8307692307692308,1.0,1.0,1/16,3.73%,WNT8A
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),0.4192010220797467,0.7777470162548497,0.71875,1.0,1.0,1/7,8.91%,TPR
prerank,GO_Biological_Process_2021__positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),-0.48468177596798057,-0.777708895251896,0.7419354838709677,1.0,1.0,3/6,13.97%,ADRA1D;ADRB1;TPM1
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),-0.5331366448837206,-0.7776676207221076,0.8,1.0,1.0,1/5,8.83%,BCAT2
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.3644146433467331,0.777598945257569,0.8148148148148148,1.0,1.0,11/47,15.53%,PER2;PID1;SDF4;FOXO1;OSBPL11;CTBP2;NR4A2;SIRT1;EP300;AKT2;BBS9
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),0.4784288187729025,0.7775857580565805,0.75,1.0,1.0,1/6,1.38%,DOK5
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),-0.3079619387115693,-0.7775330812669738,0.8947368421052632,1.0,1.0,13/143,12.80%,EPHA1;DOCK8;RGS10;RASIP1;ARHGAP15;ARHGAP9;F11R;VAV3;DAB2IP;FGD3;CCL5;ADRB1;GMIP
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),0.46567266566489973,0.7775296236659218,0.717391304347826,1.0,1.0,1/7,3.21%,GAL3ST1
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),0.2982658996389493,0.7774581237424336,0.8857142857142857,1.0,1.0,9/87,11.71%,NEDD1;PCM1;RAB3IP;RPGRIP1L;CEP83;CEP135;CDK5RAP2;SCLT1;MAPRE1
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),-0.35893495825169164,-0.7773689999521509,0.8591549295774648,1.0,1.0,8/43,16.01%,WFS1;LRP4;AGT;REN;CTSH;PCSK5;KANK2;SHH
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),-0.5052719685079158,-0.7773659708671038,0.7377049180327869,1.0,1.0,1/7,9.25%,MGME1
prerank,GO_Biological_Process_2021__beta-catenin destruction complex assembly (GO:1904885),-0.5148347167833877,-0.7773210665363796,0.7966101694915254,1.0,1.0,2/5,39.79%,CSNK1A1;AMER1
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),-0.4121191063136451,-0.7766653829517134,0.8076923076923077,1.0,1.0,3/20,8.33%,PXMP2;PEX11B;PEX16
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.2591795966292298,0.7764866283305139,1.0,1.0,1.0,36/268,14.51%,SLC22A2;PID1;LEF1;FGFR4;TGFBR1;BMP6;BMP7;HEY1;EPHB2;ANKRD31;RAB27A;GREM1;TICAM1;FGF10;RBMS3;IGF1;HSPA1A;ANGPT1;ADAM19;POU3F1;ZNF804A;EIF2AK3;NOS1AP;LIMS1;MAPK8;VAMP3;SNF8;SLC24A3;NGF;ECE1;ID2;MAPK7;CELF1;NTRK3;MAGI2;BRAF
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),0.4300303252629125,0.7764376260702475,0.7272727272727273,1.0,1.0,5/15,24.25%,TAFA1;DISC1;CTNNB1;SMARCD3;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),-0.4615260554344843,-0.7763213756352404,0.7551020408163265,1.0,1.0,1/9,16.42%,GNL3
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.31449498217836763,0.7763197235401574,0.8222222222222222,1.0,1.0,14/46,23.70%,MAP3K20;CLSPN;CASP9;CDC5L;NDRG1;CHEK2;TRIAP1;ATM;ATRIP;TP53BP1;ABL1;HUS1;HINFP;RAD9A
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),0.4957613859456089,0.7762163985585653,0.6976744186046512,1.0,1.0,2/6,7.04%,LEF1;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.3275719560402678,-0.7760226804265933,0.8676470588235294,1.0,1.0,4/73,7.73%,HCK;CAV3;RAC1;NCKAP1L
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.41378220737042665,0.7758902985177039,0.6842105263157895,1.0,1.0,3/15,5.75%,HEY1;TGFB2;ACVR1
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.32206460003132864,-0.7757208865952451,0.8767123287671232,1.0,1.0,15/116,13.58%,TERF2IP;TNFSF18;AGT;TRIML2;TRIM22;PRKCH;AGER;TRIM5;TRIM25;IL18;IL18R1;ROR1;TRIM32;FLOT1;TLR2
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.32845312584941266,0.7755900306266473,0.926829268292683,1.0,1.0,13/39,16.22%,TGFB2;MEIS1;CHD7;SMG9;ATF6;CHRDL1;RBP4;SMOC1;SIPA1L3;ECE1;PBX4;PBX1;MEIS2
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.3446604900478316,0.7755514899362338,0.75,1.0,1.0,1/35,0.59%,IFI16
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.34462501992239947,0.7753238970648499,0.8125,1.0,1.0,1/23,2.36%,EGFR
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),-0.31681651458881005,-0.7751002071141988,0.9375,1.0,1.0,13/125,10.78%,CD4;PTPRC;TPX2;AGT;DOK7;SPDYA;TOM1L1;STRADB;KIF14;DAB2IP;CALM3;CCL5;BORA
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.38776474302911906,-0.7748757660681678,0.8571428571428571,1.0,1.0,3/48,2.40%,AMBP;WFS1;HHIP
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.30443611226329625,0.7748220881930247,0.8620689655172413,1.0,1.0,11/65,14.10%,IRS1;FGFR4;MCU;LEPR;RBP4;FOXO1;PIK3R1;GCK;SIRT1;MBD5;BACE2
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),-0.30817676302097324,-0.7746281594629377,0.9436619718309859,1.0,1.0,18/122,20.28%,ROPN1B;PLEKHG7;RREB1;RAC1;CELSR1;BRK1;GPSM2;NTN1;RHOH;WASF1;RIPOR1;WAS;RASGRP2;RASGRP3;CFL1;ZNF304;MRAS;CYFIP1
prerank,GO_Biological_Process_2021__water homeostasis (GO:0030104),-0.498273122694206,-0.7745779023080762,0.7419354838709677,1.0,1.0,4/6,29.40%,AQP9;SCTR;AQP11;AQP4
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),0.400708445606863,0.7745761585963858,0.725,1.0,1.0,3/17,10.52%,VLDLR;SLC10A7;SCARB1
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),-0.48255650151606083,-0.7743591205336811,0.7936507936507936,1.0,1.0,1/8,5.56%,CDC6
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),0.430789857720217,0.7737472928188471,0.7837837837837838,1.0,1.0,2/11,6.73%,HS3ST5;APOE
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.3649915310435825,0.7735798369371205,0.75,1.0,1.0,5/20,13.24%,DSCAML1;ACVR1;PDGFRA;RBP4;ID2
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.2844111701869941,0.7734269631447759,0.9583333333333334,1.0,1.0,10/94,13.12%,TEAD2;CD247;PARD3;WIPF1;LIN7A;TPR;TFAP4;VAMP3;PPIH;TRAF1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.32899546530112833,0.7733575941747864,0.90625,1.0,1.0,5/38,9.30%,QRICH2;LATS1;CCDC22;COMMD1;GNA12
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3130631884279895,0.7733419313577735,0.8214285714285714,1.0,1.0,15/68,14.73%,RGS14;BMP7;LATS1;SPRY3;HEG1;PRKCD;APOE;SLC8A3;STK38;TFAP4;SLC8A1;SIRT1;LRP6;PKIA;SORL1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.2987101320722325,-0.7732849163886317,0.9705882352941176,1.0,1.0,9/154,10.91%,F8;LMAN1;SPTBN5;ARCN1;F10;BCAP31;MPPE1;CTSZ;DCTN1
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),-0.44946967688842343,-0.7732047431810974,0.7424242424242424,1.0,1.0,1/9,0.88%,NES
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.4501750228516963,-0.7731620591601371,0.8360655737704918,1.0,1.0,6/13,21.05%,TAF7;BRCA1;TWIST1;SET;JARID2;CTBP1
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.26824069499233755,0.7730341510509898,1.0,1.0,1.0,5/138,2.38%,EPHA3;PID1;IRS1;EGFR;RORA
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.30702496123699574,0.772970795473628,0.9375,1.0,1.0,7/64,8.98%,SGK1;SGK2;IL15RA;ZNF205;RAB27A;APOE;LYAR
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",-0.5375873531456102,-0.7728591281909212,0.7966101694915254,1.0,1.0,1/5,9.83%,APH1B
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.49253136895836913,-0.7726516800139639,0.8181818181818182,1.0,1.0,1/11,3.11%,LRPAP1
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),-0.4358958209833361,-0.7724858366544438,0.7868852459016393,1.0,1.0,4/14,17.96%,MSX1;GLI3;SHH;TWIST1
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),-0.40278819528241117,-0.7723411655262072,0.8448275862068966,1.0,1.0,1/19,0.88%,NES
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.3056430780430789,0.7722652352681421,0.9354838709677419,1.0,1.0,9/61,15.02%,SH3RF1;MARCHF5;SH3RF3;ERCC8;RNFT1;UBE3D;TRIM71;RNF19B;RNF208
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.3281504629600696,0.7719090541448703,0.8604651162790697,1.0,1.0,7/32,17.02%,SDC4;RAB7A;RAB27A;SNF8;TSG101;SMPD3;RAB27B
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),0.47266511571757547,0.7717526942574436,0.7941176470588235,1.0,1.0,4/11,22.59%,APOE;PC;IGF2R;ZNF502
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),-0.3636831776493477,-0.7716503278107377,0.8356164383561644,1.0,1.0,7/35,13.58%,ELANE;CD74;SERPINE1;CD14;LBP;FADD;TLR2
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),0.286987430750202,0.7716079418594247,0.8928571428571429,1.0,1.0,14/79,20.13%,MRPL17;MRPL33;MRPL58;MRPL39;MRPS27;MRPS18A;MRPL21;MRPS7;MTRF1L;DAP3;MRPL4;AURKAIP1;MRPL41;MRPL48
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),-0.5227874932828532,-0.7716074897780187,0.7741935483870968,1.0,1.0,3/6,21.12%,PDGFRB;CCN3;AAMP
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.3493413803182672,-0.7715150338580131,0.8108108108108109,1.0,1.0,10/46,17.28%,CHMP4B;RAC1;CHMP2A;PREX1;CATIP;CASQ1;DIAPH3;WASF1;WAS;VIL1
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.42843789109320507,0.7713935222890134,0.6923076923076923,1.0,1.0,2/9,14.73%,EIPR1;SORL1
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.3355084682222595,0.77123186645624,0.8709677419354839,1.0,1.0,6/29,13.78%,SEMA6D;SEMA5A;SEMA4C;SEMA3C;PTPRS;SEMA5B
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),0.4045577862011684,0.7711371791702741,0.7027027027027027,1.0,1.0,1/16,0.42%,KIT
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),-0.39610712350646116,-0.7710061999868764,0.796875,1.0,1.0,3/28,5.83%,NOTUM;LRP4;NOTCH1
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),0.3592623304895899,0.770784707736271,0.8095238095238095,1.0,1.0,1/30,0.61%,CCNH
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),0.3592623304895899,0.770784707736271,0.8095238095238095,1.0,1.0,1/30,0.61%,CCNH
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.3283224223371407,0.7707811395431075,0.8787878787878788,1.0,1.0,12/50,14.52%,PTPRK;EGFR;FOS;PDGFRA;AKR1C3;APOE;AGAP3;ERCC6L2;MAPK8;FYN;SIRT1;FER
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.36111425917459494,-0.7706719129331456,0.8688524590163934,1.0,1.0,3/46,11.01%,TERF2IP;RPA3;MRE11
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.3189700948610594,-0.7706057455029567,0.8656716417910447,1.0,1.0,14/66,24.58%,DRD3;CDC6;RAB11A;KIF14;CALM3;KIF20B;PLK4;RACGAP1;CALM1;VPS4A;CDC14A;CCP110;ANKRD53;CETN2
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),-0.5017174545837296,-0.7705298031911547,0.7910447761194029,1.0,1.0,2/7,12.31%,OTUB1;GPS2
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),-0.4390391692922469,-0.7704356247932589,0.734375,1.0,1.0,4/11,29.59%,DPYS;ALDH6A1;CRMP1;CTPS1
prerank,GO_Biological_Process_2021__regulation of protein kinase C activity (GO:1900019),0.5049080881106072,0.7703874148600864,0.7105263157894737,1.0,1.0,1/5,2.36%,EGFR
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C activity (GO:1900020),0.5049080881106072,0.7703874148600864,0.7105263157894737,1.0,1.0,1/5,2.36%,EGFR
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),0.3707616720088298,0.770373699066909,0.7619047619047619,1.0,1.0,1/15,2.42%,C5AR1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),0.44666189123999006,0.7702303038798198,0.868421052631579,1.0,1.0,4/10,17.81%,ACADVL;PIBF1;SIRT1;ERLIN2
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),0.36484520666414655,0.7697847946708145,0.7777777777777778,1.0,1.0,1/16,1.96%,TEX15
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.3266892821822458,0.7695614156658085,0.9,1.0,1.0,8/46,14.37%,RUBCNL;NUP210;NUP42;TPR;GCK;NUP37;PNPT1;EP300
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.3429899446511836,0.7694784812140942,0.8333333333333334,1.0,1.0,8/40,17.08%,ARID1B;ARID1A;HDAC1;PBRM1;SMARCAD1;DMAP1;SMARCB1;SMARCA4
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),-0.36190124240962435,-0.7694377749110622,0.8813559322033898,1.0,1.0,3/33,9.58%,DRD3;PIK3CB;GPER1
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.40622034623791997,0.7694192066230051,0.7692307692307693,1.0,1.0,1/10,1.98%,NRP1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),0.42855999880214135,0.7693429296423292,0.8108108108108109,1.0,1.0,2/16,10.87%,DDAH1;NOS1AP
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),-0.40422017474287064,-0.7691967586409757,0.7457627118644068,1.0,1.0,5/17,18.23%,P2RY12;RARRES2;CCL5;CXCL17;CMKLR1
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.39106355664136894,-0.7690017023554696,0.8153846153846154,1.0,1.0,9/24,21.83%,STAT1;STAT5A;CALCR;STAT4;AGER;EIF2B5;STAT6;EIF2B2;STAT2
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),-0.34391274147541,-0.7689493473900577,0.8,1.0,1.0,8/44,16.59%,AGT;TGFB1;INHBA;VPS35;PLA2G10;UHRF1;NFKBIA;RBM4B
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.4412941860023828,0.7689473548921696,0.7297297297297297,1.0,1.0,1/11,2.22%,BCL2L11
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),0.4433043447325715,0.7688813725196513,0.7096774193548387,1.0,1.0,3/8,18.75%,SPHK2;FER;BLK
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.42478366454707833,-0.7686465539308713,0.7586206896551724,1.0,1.0,3/17,6.89%,PINK1;SOD2;NONO
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),-0.373616690721961,-0.7685046514292256,0.9180327868852459,1.0,1.0,10/56,15.56%,CCNE1;CDKN2D;CDKN3;SPDYA;CRLF3;INHBA;GPR132;CDC25A;CDKN1B;CDK4
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),-0.47301218168015075,-0.7681201724899085,0.7758620689655172,1.0,1.0,1/5,13.42%,SLF1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),-0.47301218168015075,-0.7681201724899085,0.7758620689655172,1.0,1.0,1/5,13.42%,SLF1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),-0.47301218168015075,-0.7681201724899085,0.7758620689655172,1.0,1.0,1/5,13.42%,SLF1
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),-0.3839769428096107,-0.7680098053272454,0.7368421052631579,1.0,1.0,1/27,1.77%,CYP1B1
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),-0.42949113034957165,-0.7675020227337993,0.7627118644067796,1.0,1.0,4/14,13.58%,B2M;NOTCH1;REST;TLR2
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),0.363101431284347,0.7673622288156736,0.7741935483870968,1.0,1.0,3/25,5.24%,CATSPER2;TGFB2;TGFB3
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.3542431040901575,-0.7670184749403764,0.835820895522388,1.0,1.0,9/52,13.26%,AGT;TMC8;BCL2L14;CASP8;GPER1;GSTP1;PELI3;FADD;LTBR
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.361503047812366,0.7669211990776501,0.75,1.0,1.0,5/24,19.75%,KDM8;HR;KDM3B;JMJD1C;KDM4C
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),0.383011597112457,0.7668646249993749,0.8372093023255814,1.0,1.0,4/16,10.56%,HEY1;ENPP1;GREM1;SRGN
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),-0.27898789814944275,-0.7667853409442907,0.9886363636363636,1.0,1.0,66/433,17.93%,BTN2A2;CYP1B1;WFS1;MSX1;SFRP4;CDKN2D;LRPAP1;TCHP;ATF5;GMNN;FOXM1;RND1;CDKN3;BNIP3;IRF1;CDC6;CHMP4B;RASA1;NOTCH1;TGFB1;TDRD9;TBX1;SOD2;CRLF3;SSTR1;WDR6;FABP3;NOTCH4;BTBD18;IFIT3;DAB2IP;REST;DACT2;CAMK2N1;TP53TG5;GPER1;KNG1;PRAME;CHMP2A;ADGRB1;IFNLR1;WARS1;INHBA;HTR2B;TLR2;VPS35;KLF11;CLMN;CDKN1B;LPCAT3;TAF6;PDCD5;KANK2;TSC2;PDS5B;SHH;PODXL;NAIF1;INCA1;LYN;CCN3;HNF4A;TPTE2;WNT9A;OSGIN2;ESR2
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),-0.3306933622964461,-0.766741168328532,0.8852459016393442,1.0,1.0,13/69,16.85%,SCN4B;ATP1B1;SLC5A2;SCN7A;SLC24A1;ATP1A1;SLC9A6;SCN9A;SLC6A16;SLC6A7;ATP12A;SLC24A4;HCN4
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),-0.47011755919818876,-0.7665786046176983,0.7894736842105263,1.0,1.0,1/8,8.39%,STAT5A
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),-0.47011755919818876,-0.7665786046176983,0.7894736842105263,1.0,1.0,1/8,8.39%,STAT5A
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.26978162594411864,0.7665503382787966,1.0,1.0,1.0,24/285,8.76%,CCNH;MAML3;TEAD2;PRRX1;INTS11;WWTR1;RORA;C5AR1;CBFB;ESRRG;HDAC9;MAML1;TAF2;NR3C2;NFIX;ELP4;IWS1;CPSF7;HDAC1;ZBTB1;SOX5;GTF2I;TFCP2;ERCC2
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.40182515981045674,-0.7662122148958255,0.796875,1.0,1.0,2/26,6.22%,CELF3;SLU7
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),-0.48645820907621273,-0.7660153349677609,0.7692307692307693,1.0,1.0,4/7,36.77%,CDC42;PPT1;ANKFY1;APPL1
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),0.44362966909855917,0.7656676796092182,0.7142857142857143,1.0,1.0,4/9,24.25%,AZU1;CXCL12;VEGFD;VEGFA
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),-0.38727936558422027,-0.7656605902452129,0.85,1.0,1.0,5/22,21.91%,NUBP1;NFS1;ISCU;HSPA9;CIAO2A
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.3967478968406981,0.76537364193878,0.8108108108108109,1.0,1.0,4/9,32.65%,SIRT1;MYOCD;PRKAA2;DIP2B
prerank,GO_Biological_Process_2021__positive regulation of DNA ligation (GO:0051106),-0.5060858139312512,-0.7650691765992976,0.7619047619047619,1.0,1.0,2/5,12.07%,XRCC1;APLF
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.3204988588394581,0.7647409561620728,0.896551724137931,1.0,1.0,4/45,9.34%,RAB3C;IL1RAPL1;RAB27A;RALA
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.3495995837436834,0.7646293830945358,0.8108108108108109,1.0,1.0,4/17,9.95%,CTNNA2;ARFIP2;WASF2;ARFIP1
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.3203105498988803,0.7644050769496765,0.8125,1.0,1.0,9/61,11.07%,PLCB1;PIGQ;CSF1R;SMPD4;GDE1;PLA2G4C;DGKH;LCAT;PIGP
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.44991160044494466,0.764402212059274,0.7272727272727273,1.0,1.0,1/11,6.73%,APOE
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),-0.45066190478261836,-0.7638297206394676,0.8135593220338984,1.0,1.0,4/12,25.01%,CELSR1;ACTG1;FUZ;AHI1
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.4836278673882666,-0.7637928529811522,0.7878787878787878,1.0,1.0,1/8,5.85%,RAC1
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),-0.45593842198759793,-0.7637278498988204,0.7333333333333333,1.0,1.0,4/16,15.77%,GOT1;CALCR;REST;ADAM9
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.30803227859449733,0.763697726901974,0.8333333333333334,1.0,1.0,4/43,7.36%,EPHA5;WWC1;EFNA5;TRIM67
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.3859553359718374,-0.763689354980482,0.8,1.0,1.0,5/25,21.74%,CCDC39;WNT7B;SHH;FGF1;FGF7
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.34043204922864917,-0.7636050029595981,0.8904109589041096,1.0,1.0,13/52,26.64%,PRDX4;NKIRAS1;CD14;DAB2IP;TLR2;NFKBIA;RPS27A;NFKBIL1;UBC;RIPK2;TIFA;TBK1;AKT1
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),-0.4377552525906508,-0.7635554651756975,0.8387096774193549,1.0,1.0,3/14,17.67%,CCL5;CXCL13;ACKR3
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",-0.4746408787312422,-0.7635226263970485,0.765625,1.0,1.0,2/7,13.62%,RAB11A;VPS35
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.30268448229391476,-0.763520010434654,0.9,1.0,1.0,25/174,15.27%,CD4;TERF2IP;CD74;TRIML2;TRIM22;STAT1;PINK1;CARD8;CASP8;TRIM5;DAB2IP;TRIM25;TRAF3IP2;GSTP1;CXXC5;FADD;ROR1;HTR2B;TRIM32;RHOH;LTBR;IFIT5;DDX1;PLCG2;GOLT1B
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),-0.36647859613796196,-0.7631943807111479,0.8793103448275862,1.0,1.0,9/39,16.56%,SLC7A11;SLC7A7;SLC38A11;SFXN3;LRRC8D;SLC38A8;SLC36A1;SLC38A4;SLC25A18
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.38525219963877455,-0.7628919955755117,0.803030303030303,1.0,1.0,8/29,10.66%,TNFSF18;CTF1;FLT3;CRLF1;IL15;IL18;STAP2;CCL5
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.41479333026909204,0.762502041485043,0.7714285714285715,1.0,1.0,2/14,4.66%,SLC30A10;MARCHF5
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.33980053646383535,0.7623800110622867,0.7941176470588235,1.0,1.0,6/41,9.25%,TRAF3;FGFR4;DNAJC1;CLN6;TM4SF20;PERP
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.31481177286491735,0.7620261680619649,0.9142857142857143,1.0,1.0,6/50,10.37%,MYLIP;VLDLR;RAB7A;CTSC;BNIP3L;MALT1
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),0.4056904427596581,0.7619574059595032,0.7435897435897436,1.0,1.0,1/11,1.98%,NRP1
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),-0.4113969867904103,-0.761919465032757,0.8412698412698413,1.0,1.0,3/14,13.18%,PTPRC;FLT3;MSN
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.3219860272839532,-0.7616151070737953,0.8767123287671232,1.0,1.0,9/72,9.36%,MARVELD2;WFS1;NDUFB9;TMIE;KCNQ1;TBX1;EYA1;CEMIP;SLC26A4
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),-0.4435979909499098,-0.7612879042063705,0.7857142857142857,1.0,1.0,1/8,2.84%,CAV3
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.4045924826782965,-0.7612098587364476,0.84375,1.0,1.0,3/18,7.73%,CD74;RAC1;NCKAP1L
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.42282047153118185,0.7611915775267202,0.8333333333333334,1.0,1.0,3/12,12.13%,IRS1;IRS2;SOCS2
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.42282047153118185,0.7611915775267202,0.8333333333333334,1.0,1.0,3/12,12.13%,IRS1;IRS2;SOCS2
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.3194375741272718,0.7610135150805734,0.8636363636363636,1.0,1.0,12/72,14.80%,IRS1;ZBED3;HDAC9;ENPP1;IRS2;SLC25A33;FOXO1;PIK3R1;GCK;SIRT1;FER;AKT2
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.41285010320942495,-0.7609767390995417,0.8,1.0,1.0,3/20,6.80%,WNT8A;TBX1;ATP6AP2
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,-0.3246434319256053,-0.7608416254307874,0.9,1.0,1.0,12/91,14.34%,NES;CYP19A1;FJX1;LRP4;TEAD4;DAB2IP;PPIC;BOK;SRPX;GPC1;SMARCA1;YAP1
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),-0.3157477049978116,-0.7606904917295962,0.9552238805970149,1.0,1.0,9/92,11.66%,CTNNA1;P2RY12;AHR;P2RY1;KCNQ1;AQP9;IGFBP5;BRCA1;TSHR
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),-0.3216073848636788,-0.7605232125954878,0.8656716417910447,1.0,1.0,8/112,9.22%,EPHA1;CYP1B1;CD74;NODAL;RAC1;SERPINE1;DAB2IP;IGFBP5
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),-0.3303736751346408,-0.7604604955278643,0.90625,1.0,1.0,7/56,11.05%,EPHA1;PTPRC;CAV3;TAF7;CAMK2N1;GSTP1;WARS1
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),-0.43617185633709454,-0.760257181321719,0.7164179104477612,1.0,1.0,2/14,3.93%,ODAD4;DNAH8
prerank,GO_Biological_Process_2021__glial cell migration (GO:0008347),-0.49551821080783953,-0.7599242546391428,0.7894736842105263,1.0,1.0,1/5,4.15%,P2RY12
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.4397372633299278,0.7597775348572129,0.8095238095238095,1.0,1.0,3/8,16.15%,HSPA1A;SORL1;DNAJB2
prerank,GO_Biological_Process_2021__synapse pruning (GO:0098883),-0.5022572411661662,-0.7597517605774082,0.8412698412698413,1.0,1.0,1/6,15.55%,C1QA
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),0.33330004835814164,0.7595781772866773,0.7037037037037037,1.0,1.0,8/37,11.90%,NPNT;RSU1;PTPRO;PKHD1;LIMS1;PDPN;GCNT2;SPOCK1
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),0.46675376772894916,0.7592569595667382,0.6875,1.0,1.0,1/6,3.21%,GAL3ST1
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),0.46675376772894916,0.7592569595667382,0.6875,1.0,1.0,1/6,3.21%,GAL3ST1
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.361189137536006,0.7592062121237114,0.8947368421052632,1.0,1.0,6/35,10.37%,RGS14;BACH2;ATXN1;RITA1;GEMIN8;MALT1
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),-0.42019330970444346,-0.7590384116892335,0.8363636363636363,1.0,1.0,2/13,11.78%,PIK3CB;KBTBD6
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),-0.4429980189178815,-0.7590002365523164,0.7540983606557377,1.0,1.0,1/7,5.26%,ALOX12
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),-0.5033315312204107,-0.7589093871037514,0.7894736842105263,1.0,1.0,1/5,5.83%,NOTCH1
prerank,GO_Biological_Process_2021__aromatic compound biosynthetic process (GO:0019438),0.45750723479916816,0.7588677176095632,0.6666666666666666,1.0,1.0,2/6,10.31%,GCH1;PNPO
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),-0.45090034512768384,-0.7588298859872198,0.6666666666666666,1.0,1.0,2/9,17.95%,RNF26;C1QBP
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),0.3106564126657511,0.7587054958038207,0.8214285714285714,1.0,1.0,8/77,6.52%,ADAMTS2;COL15A1;LAMB3;TGFBR1;ADAMTS3;TGFB2;GREM1;COL11A2
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),-0.38436109197480167,-0.7584499490569631,0.8153846153846154,1.0,1.0,3/22,6.12%,HHIP;SFRP4;RFLNA
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.288709993802449,0.7584042516355184,0.9615384615384616,1.0,1.0,10/111,10.79%,GDAP1;CACNG3;PARD3;ZDHHC14;ZDHHC11B;RAB3IP;AP4E1;NLGN1;SRPRB;ZDHHC3
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.41934785145284903,0.7582396522709715,0.75,1.0,1.0,1/12,1.98%,NRP1
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),-0.48473087594657305,-0.7581114766402635,0.859375,1.0,1.0,2/8,16.27%,DAB2IP;PIP4K2C
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.32484882175617447,0.7580586380020096,0.75,1.0,1.0,6/51,9.51%,CDH6;CDH20;PKP2;CDHR3;CLDN12;DCHS1
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,-0.30217361898796186,-0.7576348105322714,0.9583333333333334,1.0,1.0,18/94,19.23%,CCDC60;TEX26;TMEM212;ANGPTL2;RARRES2;CFAP126;ARMC3;CFAP77;CATIP;DRC1;APOBEC4;FAM81B;CXCL17;CFAP54;SNTN;DNAH7;DNAH9;SPAG17
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.3761457438149327,-0.7575903960998588,0.8059701492537313,1.0,1.0,4/21,20.54%,FKBP1B;CALM3;NOS1;CALM1
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),-0.32351619586934327,-0.7575377570279799,0.9032258064516129,1.0,1.0,4/76,3.68%,EPHA1;PTGIS;CYP1B1;NODAL
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.3867814314166764,-0.7569161130900668,0.7924528301886793,1.0,1.0,2/19,7.73%,HLA-DPB1;NCKAP1L
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.40730417779686157,0.7566573483252298,0.7142857142857143,1.0,1.0,4/11,18.39%,PARD3;DGKH;AZU1;PLPP1
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.3605991303340517,0.7560773517701731,0.7647058823529411,1.0,1.0,8/20,17.94%,HMGB1;XKR6;XKR4;SCARB1;MEGF10;RHOBTB1;NR1H3;ITGAV
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),-0.3687610862142644,-0.7560560658193983,0.8333333333333334,1.0,1.0,8/25,23.43%,CAV3;RAC1;DCTN1;CDK5R1;RPS3;MET;PSRC1;ANKRD53
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.28156963328216145,0.7553286289135611,0.9629629629629629,1.0,1.0,9/109,6.05%,HSPB1;NRP1;EGFR;BMP7;DSCAM;NUP210;GRM5;EREG;NUP42
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),-0.38142903268103145,-0.7552241169463014,0.7580645161290323,1.0,1.0,2/21,2.84%,SCN4B;CAV3
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.32136911244716293,0.7549141302215502,0.875,1.0,1.0,5/36,13.34%,UBASH3B;PDE4D;SELENON;JSRP1;TRPC1
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),0.4226452230086264,0.754622432762427,0.7804878048780488,1.0,1.0,1/11,3.68%,SMYD2
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),0.30830039102139917,0.7546095461556187,0.9428571428571428,1.0,1.0,5/48,9.56%,IFI16;IFIH1;PARP10;TRIM11;MID2
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),-0.38757532639064585,-0.7545805874333231,0.84375,1.0,1.0,8/19,33.11%,UQCRB;UQCR10;UQCRH;OXA1L;MTFR1L;MTFR1;SDHC;UQCRC1
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),-0.4165384643704069,-0.7545654573555192,0.7692307692307693,1.0,1.0,2/10,8.59%,NOTCH1;TTN
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.4122499332629381,0.7542791866351026,0.7692307692307693,1.0,1.0,4/14,10.10%,BMP7;FGF10;PTCH1;ROBO2
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.26070354963499154,0.7542090667815442,1.0,1.0,1.0,43/296,16.15%,FBXL7;RNF126;FEM1A;CDC26;DNAJB12;UBE2J2;FBXO27;ERCC8;PTTG1;ANAPC16;ZNRF1;UBE3D;FAF1;PELI1;AGAP3;RHBDD2;FBXL15;DMAC2;CDC23;RNF103-CHMP3;FOXRED2;DERL3;UBXN2A;TRIM71;TMUB2;RNF216;KCTD5;HECW2;NEDD4L;KLHL42;SIRT2;KLHL20;WWP1;SIRT1;BTRC;RNF175;UBE2U;FBXL17;FBXL2;ANAPC7;FBXO45;PSMD13;DNAJB2
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.3410821610244385,-0.7538315759553414,0.8970588235294118,1.0,1.0,8/50,10.85%,AMBP;TMEM184A;B3GNT3;MYO5B;CBLC;GPX2;CLDN1;CTSH
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.34660944546390493,0.7536866986890389,0.75,1.0,1.0,2/30,2.71%,NKAIN3;PKP2
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.33911386481154987,0.7536468443937806,0.8604651162790697,1.0,1.0,8/25,17.89%,EREG;BTC;IGF1;CDC23;ESPL1;NSMCE2;ANAPC7;PDGFB
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),0.46236783807316195,0.7535878841721932,0.7857142857142857,1.0,1.0,1/6,4.91%,APBA1
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),-0.45115523763994886,-0.7534596496221353,0.7833333333333333,1.0,1.0,5/8,20.07%,SERPINA10;SPINK13;PLA2G10;GLRA1;CACNA1H
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),-0.4045542985766092,-0.7531756404106286,0.75,1.0,1.0,4/15,12.89%,PTPRC;IL21R;CASP8;PRDX1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.40460642911637995,0.7527483086197032,0.7837837837837838,1.0,1.0,1/12,1.98%,NRP1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),-0.27579584385326295,-0.7523848672751303,1.0,1.0,1.0,24/347,12.24%,TRIM58;ARIH2;EPAS1;TRIM54;RNF212B;TRIML2;TRIM22;ENC1;PINK1;EYA1;CBLC;RNF39;RNF213;NEUROD2;TRIM5;SKP1;RNF26;C10ORF90;BRCA1;HLA-A;UFM1;HIF3A;TRIM32;RNF181
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.3279250510916638,-0.7523577145012955,0.9333333333333333,1.0,1.0,6/64,10.98%,HCK;ITGA5;TXK;FYB1;DOCK1;TEC
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.39701586450691073,0.7523132268739073,0.7407407407407407,1.0,1.0,2/11,6.99%,KLK6;PRMT5
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.2944335788779775,0.7522945359466169,1.0,1.0,1.0,13/91,9.52%,EYA4;CACNA2D1;FIGN;ADAMTS3;ADGRL2;DDAH1;IL17RD;MID1;ZFHX4;GNG12;PRTG;CAP2;AMOTL2
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),-0.44079474225464355,-0.7522896835465562,0.76,1.0,1.0,3/11,21.33%,CHAF1A;CHAF1B;M1AP
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),0.47696031012882634,0.7521076600832833,0.7317073170731707,1.0,1.0,2/6,9.21%,PRKCD;PRKD1
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),-0.5046114821614606,-0.7518925221912699,0.8166666666666667,1.0,1.0,2/6,7.60%,RBP2;RLBP1
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,-0.2973276920093964,-0.751632687736626,0.9710144927536232,1.0,1.0,15/134,13.60%,UROD;HSD17B10;EPHX1;SERINC1;IL4I1;NSDHL;NCAPH2;ALDH1A1;ACSL5;RETSAT;MDH1;ECI2;ENO2;ACOT2;FASN
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),-0.396003221823267,-0.7514851614004403,0.8333333333333334,1.0,1.0,3/19,10.30%,HSD17B10;BCAT2;SLC25A44
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),-0.396003221823267,-0.7514851614004403,0.8333333333333334,1.0,1.0,3/19,10.30%,HSD17B10;BCAT2;SLC25A44
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),0.34325067981048046,0.7514533012347456,0.8387096774193549,1.0,1.0,6/24,16.85%,APOE;ABCA13;PTCH1;EEPD1;SIRT1;NR1H3
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),0.32470546810276685,0.7510638614984397,0.8571428571428571,1.0,1.0,7/36,15.48%,KIT;ALAS1;LYAR;CDIN1;ID2;ABCB10;DYRK3
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),-0.30741684208271275,-0.7510325821048036,0.9333333333333333,1.0,1.0,15/136,13.33%,PRLR;ANKS4B;TMEM35A;EID2;CCDC39;TCP1;CHMP4B;TGFB1;RPL38;CHMP2A;HIP1R;CASQ1;DRC1;VBP1;STXBP6
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),-0.45473864710051615,-0.7506499123553393,0.8732394366197183,1.0,1.0,2/9,10.26%,NOTCH4;PDGFRB
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),-0.4733268861874465,-0.7506240496157524,0.8275862068965517,1.0,1.0,1/7,1.19%,C17ORF99
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),-0.42780485778369404,-0.7504848204946626,0.8032786885245902,1.0,1.0,2/12,5.92%,ATP5IF1;IFIT1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.34137700168127144,-0.7504172696463094,0.8970588235294118,1.0,1.0,4/68,9.77%,ARIH2;CAV3;NKD2;DDA1
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),0.471408769286904,0.7503369578304264,0.7209302325581395,1.0,1.0,1/5,3.92%,VLDLR
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),-0.4863873352922171,-0.7495649138690688,0.8095238095238095,1.0,1.0,1/6,5.87%,CIITA
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),-0.4283990462603653,-0.7495449690688278,0.828125,1.0,1.0,1/11,1.47%,PTGIS
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),0.35648742011920287,0.7492894330618237,0.7948717948717948,1.0,1.0,4/17,16.54%,RNF2;PCGF1;RYBP;RING1
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),-0.32454225920234825,-0.7492422159260635,0.9027777777777778,1.0,1.0,6/75,15.84%,EPHA1;GRTP1;ARHGAP22;GMIP;TBC1D13;CXCL13
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),-0.47946234046755626,-0.7491406963843014,0.7636363636363637,1.0,1.0,2/5,16.93%,CNTN2;CNTNAP1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),-0.37987522455600037,-0.7489652231656804,0.803030303030303,1.0,1.0,8/18,25.64%,PDCD1LG2;IL4I1;SFTPD;LYN;GPNMB;ARG1;SOX11;CD80
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),0.36543716209315574,0.7489316658349261,0.7666666666666667,1.0,1.0,10/30,14.32%,EGFR;GCH1;GLA;DDAH1;APOE;S100A1;SCARB1;NOS1AP;DHFR;CYGB
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),0.3120077712245582,0.7488148918769706,0.84,1.0,1.0,8/39,19.78%,EGFR;APOE;SIRT2;RILP;NFKB1;ITGAV;BANP;IRAK3
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.3407963269141003,0.7486979427532527,0.8604651162790697,1.0,1.0,7/28,21.23%,CEPT1;CHKA;LCAT;CHPT1;PCYT1B;GPAT4;APOA1
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),-0.40824897843495156,-0.748638885808261,0.8490566037735849,1.0,1.0,4/12,32.35%,SLC30A8;CAMK2G;PARK7;RAB11FIP5
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.4502992626292917,-0.7483180600478699,0.8,1.0,1.0,6/10,36.44%,GPLD1;C2CD2L;BAIAP3;PLA2G6;CFTR;TRPM4
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),0.44977805794370584,0.7482929844620655,0.7692307692307693,1.0,1.0,3/8,8.00%,TGFBR1;FGF10;ZBTB1
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),0.42307100137002207,0.7477054391873046,0.7884615384615384,1.0,1.0,1/9,2.36%,EGFR
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),-0.4662131312353942,-0.7477029856459052,0.8387096774193549,1.0,1.0,1/7,10.91%,DCTN1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),-0.4690424393113344,-0.7473374288445157,0.7818181818181819,1.0,1.0,2/5,13.34%,BOK;CYCS
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),0.34615226235401403,0.7472883210540612,0.9032258064516129,1.0,1.0,4/26,11.71%,KANK1;PRKCD;SSH1;MAPRE1
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.394902641592227,-0.7472194107776129,0.7647058823529411,1.0,1.0,4/15,11.58%,PTPRC;AGER;HLA-A;FADD
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.3593961513654327,-0.7470363190645612,0.7971014492753623,1.0,1.0,8/41,8.21%,HSPG2;RDH10;GPC3;RARRES2;RBP2;ALDH1A1;RLBP1;RDH12
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),0.36683356540141654,0.7469552078803007,0.7777777777777778,1.0,1.0,3/13,13.63%,PTCH1;IGF1;MBD5
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),-0.45085442021060795,-0.7469332926492982,0.7678571428571429,1.0,1.0,3/8,20.76%,PIK3CB;LYN;PIK3CD
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.3235661313290513,-0.7468602259810433,0.8985507246376812,1.0,1.0,24/72,30.51%,PSMB6;PSMB8;PSMA3;PSMC3;PSMC6;PSMA5;PSMA7;BUB1B;PSMD12;PSME1;RPS27A;PSMB2;UBC;PSMD2;ANAPC2;UBE2S;PSMA8;PSMA1;PSMC1;PSMD4;PSMD8;PSMB4;PSMC4;UBB
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),-0.42694346328817756,-0.7468323351669783,0.7692307692307693,1.0,1.0,3/11,17.32%,TBX1;PDGFRB;ADAMTS9
prerank,GO_Biological_Process_2021__cellular nitrogen compound catabolic process (GO:0044270),-0.47494813554424153,-0.7468320318308027,0.8363636363636363,1.0,1.0,1/7,6.55%,TST
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),0.3564397806488416,0.746719590754128,0.8857142857142857,1.0,1.0,1/26,0.81%,CA2
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),-0.3785755289766103,-0.7466903018068665,0.8524590163934426,1.0,1.0,9/30,21.10%,ALDOB;CHST1;KCNJ11;APOD;KHK;ADPGK;GALM;AKR1A1;GHRL
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),0.3725927289162771,0.7465756921954302,0.7777777777777778,1.0,1.0,5/16,16.82%,APOE;SLC27A3;SLC27A6;SLC22A9;SLC5A8
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.37618367042124495,-0.7464625878643073,0.8615384615384616,1.0,1.0,8/35,10.66%,TNFSF18;CTF1;FLT3;CRLF1;IL15;IL18;STAP2;CCL5
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.36464714762317313,-0.7463066520290225,0.746268656716418,1.0,1.0,11/28,26.94%,IRF1;FLOT1;TLR2;OAS3;IRF3;ISG15;POLR3G;RIPK2;TBK1;DDX3X;PTPN11
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.3555845781550795,-0.746186433499093,0.8,1.0,1.0,2/33,3.44%,NPY;AGT
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.38905645145166373,-0.7461265638944893,0.9076923076923077,1.0,1.0,5/16,27.57%,COA5;SCO2;FASTKD3;COX18;OXA1L
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.4407170034520602,-0.7460731973446821,0.7288135593220338,1.0,1.0,3/10,26.57%,STX19;STX1B;STX3
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.39890250231603874,-0.7460333585956845,0.8,1.0,1.0,3/15,18.03%,ZCCHC3;C1QBP;UFD1
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),0.2829718329489055,0.7458579021093472,0.9285714285714286,1.0,1.0,15/86,18.70%,RFWD3;GEM;LATS1;LRWD1;HDAC1;HMGN4;PHF1;SIRT1;HDAC10;SMARCA4;HDAC3;HDAC5;ZBTB7A;CUL4A;BAHD1
prerank,GO_Biological_Process_2021__riboflavin metabolic process (GO:0006771),-0.5195327288745062,-0.7457993932068999,0.8275862068965517,1.0,1.0,3/5,20.12%,SLC52A2;RFK;SLC52A1
prerank,GO_Biological_Process_2021__flavin-containing compound metabolic process (GO:0042726),-0.5195327288745062,-0.7457993932068999,0.8275862068965517,1.0,1.0,3/5,20.12%,SLC52A2;RFK;SLC52A1
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),-0.39693147562904213,-0.7457000244096784,0.7777777777777778,1.0,1.0,2/17,7.12%,MYO5B;MYO1F
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.29467990740346534,0.7456972429758718,0.868421052631579,1.0,1.0,14/64,17.28%,WWTR1;RORA;ENPP1;TRIB2;FOXO1;SIRT2;ID2;SIRT1;WNT5A;ANKRD26;CREB1;LRP3;BBS12;FTO
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),0.36693258394937084,0.7454639832741465,0.8292682926829268,1.0,1.0,2/18,7.40%,BCL2;TRPC5
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),-0.43212022120569105,-0.7454457146883353,0.7758620689655172,1.0,1.0,1/10,1.10%,IRAG1
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.3473971816740871,-0.745417293500657,0.8115942028985508,1.0,1.0,10/34,19.01%,UBE3A;GPER1;TMF1;RHOXF1;KDM3A;YAP1;DDX54;DAXX;ESR2;ESR1
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.30639218050422157,0.7452898405032218,0.8787878787878788,1.0,1.0,18/87,14.09%,PDLIM1;PKP2;TGFBR1;HDAC9;HEY1;TGFB2;ACVR1;HEG1;SMG9;ERBB4;RBP4;DVL2;ECE1;FGF12;ID2;ALPK3;ADAP2;NTRK3
prerank,GO_Biological_Process_2021__fluid transport (GO:0042044),-0.4815409471300227,-0.7450202836567185,0.7627118644067796,1.0,1.0,1/7,7.64%,AQP9
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.4079620708290876,0.7447309414009616,0.8484848484848485,1.0,1.0,2/14,6.36%,BACH2;JAG1
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.35321819983781555,-0.744724828149512,0.8571428571428571,1.0,1.0,4/37,12.73%,LDLRAP1;STARD5;LIPC;ABCG5
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.4118718186952146,-0.7447242371046365,0.8412698412698413,1.0,1.0,4/18,9.16%,TRIML2;TRIM22;TRIM5;TRIM25
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.2937550388738497,-0.7445485484549406,0.9285714285714286,1.0,1.0,23/126,18.17%,TNFSF18;YBX3;STAT1;PSMB6;CD27;PSMB8;DAB2IP;GPER1;BRCA1;PSMA3;TMSB4X;CCL5;PSMC3;BAG4;TXNDC17;LTBR;PSMC6;PSMA5;NFKBIA;ADAM17;TNFSF9;PSMA7;TNFRSF11B
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.3575423476928471,-0.7445197368952263,0.8484848484848485,1.0,1.0,14/33,32.27%,MLC1;LAMP1;GAS1;NEFH;RBM4;NDEL1;LCP1;NUP214;REEP5;ANTKMT;INPP5F;RINT1;LRRK2;RNF139
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.34543485688743797,-0.7444741880298507,0.8615384615384616,1.0,1.0,9/46,18.70%,HHIP;GPC3;GLI3;TXNDC15;UCHL5;SHH;GAS1;PDCL;ZIC1
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:0001844),0.45812297913221806,0.7444650343890514,0.7777777777777778,1.0,1.0,1/5,2.22%,BCL2L11
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.3562996052324306,0.7441851408486747,0.8888888888888888,1.0,1.0,5/23,7.09%,UNC13C;UNC13B;PDZRN3;ZC4H2;PPFIBP1
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),-0.3224645295575646,-0.7441735638001928,0.9027777777777778,1.0,1.0,6/70,11.37%,MMP15;RABGGTB;MANBA;PHEX;UBL5;PIGH
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.39421740843116804,-0.7439637364806648,0.7846153846153846,1.0,1.0,1/17,1.39%,SCN4B
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),0.3362075453439846,0.7436973671994292,0.7894736842105263,1.0,1.0,2/25,3.30%,GDAP1;PEX7
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.45895660349120415,-0.7435024679962482,0.8214285714285714,1.0,1.0,5/11,27.46%,NOTCH4;RBM4;EIF6;AGO1;AGO4
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),-0.45895660349120415,-0.7435024679962482,0.8214285714285714,1.0,1.0,5/11,27.46%,NOTCH4;RBM4;EIF6;AGO1;AGO4
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.25917334397770575,0.7433560561303101,1.0,1.0,1.0,15/163,8.36%,PDE3A;BCL2;RORA;PDE10A;SPRED1;BMP7;EPM2A;MINAR1;WWC1;SPRY3;CCDC22;PDE4D;CD22;PKHD1;SHANK2
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.4121757304236886,-0.7430215401941439,0.8095238095238095,1.0,1.0,1/14,1.47%,PTGIS
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),-0.4690581964649717,-0.7429114487044729,0.8571428571428571,1.0,1.0,1/7,15.73%,ULK1
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),-0.4690581964649717,-0.7429114487044729,0.8571428571428571,1.0,1.0,1/7,15.73%,ULK1
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,-0.33209753264848507,-0.7427444040763447,0.8461538461538461,1.0,1.0,10/66,13.50%,DNAJC5G;COL9A1;CTAGE14P;GCM2;C14ORF180;CTNNA3;L2HGDH;HIF3A;KCNJ11;TMEM266
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.30656135983221805,0.7421976079967049,0.9117647058823529,1.0,1.0,9/55,14.91%,HSPB1;KDR;NRP1;WASF2;PRKD1;PIK3R1;FYN;ELMO1;CRK
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.36686054439649685,-0.7417008876352968,0.8571428571428571,1.0,1.0,4/25,11.58%,CD300LF;CASP8;CD14;FADD
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.36686054439649685,-0.7417008876352968,0.8571428571428571,1.0,1.0,4/25,11.58%,CD300LF;CASP8;CD14;FADD
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.2870009583969613,-0.7414234581754087,0.9285714285714286,1.0,1.0,13/146,11.05%,EPHA1;PTGIS;HSPG2;CYP1B1;NODAL;STAT1;SERPINE1;DAB2IP;AMOT;BRCA1;ADGRB1;CTSH;WARS1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),-0.40972251021797523,-0.7414223745657619,0.7903225806451613,1.0,1.0,1/12,4.16%,YBX3
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),0.3136951906225478,0.7411575414328385,0.7575757575757576,1.0,1.0,5/38,12.56%,IFIH1;TRAF3;REL;PTPRS;RNF216
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),0.3278376525541953,0.7410747714077045,0.8529411764705882,1.0,1.0,9/36,15.99%,TGFB2;FOS;EPHA7;EIF2S1;MAP3K5;FYN;WNT5A;GRIN2B;DDIT4
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),-0.3891620542566278,-0.7408669271739468,0.85,1.0,1.0,4/16,13.93%,RBP2;RLBP1;CYP2R1;LRP2
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.31501177358478205,-0.7407990790190385,0.8767123287671232,1.0,1.0,12/80,20.65%,PATL2;ENC1;PAIP2B;EPRS1;IGFBP5;ZNF540;ILF3;RBM4;RTN2;FXR1;CALR;RPS3
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.3532673391304145,0.7407659509670242,0.8717948717948718,1.0,1.0,2/24,3.47%,NRP1;SEMA5A
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.4032165673007774,-0.7406296460445212,0.8269230769230769,1.0,1.0,3/17,9.01%,PTPRC;FKBP1B;BCAP31
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.3357922940826222,-0.7403412933680924,0.863013698630137,1.0,1.0,6/66,15.05%,ARIH2;NKD2;BCAP31;DDA1;HERPUD1;RBX1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.39451214627817677,-0.7401489419768766,0.8,1.0,1.0,6/20,22.91%,CCND2;SPDYA;ADAM17;RGCC;PSRC1;HSP90AB1
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),-0.43186741278846363,-0.7401342498090201,0.7636363636363637,1.0,1.0,2/9,15.19%,PBLD;MUC4
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.3977483868213171,0.74012924068733,0.7727272727272727,1.0,1.0,1/11,3.73%,LATS1
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.32556980429094234,-0.7396520271278222,0.92,1.0,1.0,9/63,16.88%,IHO1;RFC5;RPA3;ISG20;MRE11;DDX1;RBX1;PCNA;DNASE1L1
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),-0.4576549271061864,-0.7395542676136847,0.8727272727272727,1.0,1.0,2/8,9.08%,NEUROD2;DAB2IP
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),0.4274218453056429,0.7394696544920786,0.7857142857142857,1.0,1.0,1/7,5.75%,ACVR1
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),-0.3404324831556211,-0.739134621760428,0.8909090909090909,1.0,1.0,5/43,14.39%,AMN;RAB31;PREPL;STXBP6;STEAP2
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),-0.3715136092953533,-0.7391179959652495,0.9230769230769231,1.0,1.0,11/27,26.20%,HSPA5;DNAJB1;SDF2L1;ST13;HSPA9;ERO1A;ENTPD5;HSPA1L;CCT2;GAK;HSPA8
prerank,GO_Biological_Process_2021__regulation of animal organ morphogenesis (GO:2000027),-0.4697535424298736,-0.7390601402384054,0.8,1.0,1.0,2/6,16.01%,TBX1;SHH
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.3741643316004105,0.7390582990768324,0.8529411764705882,1.0,1.0,3/25,7.01%,CRIM1;GREM1;PTCH1
prerank,GO_Biological_Process_2021__negative regulation of B cell differentiation (GO:0045578),-0.4893869262483941,-0.7389748950038264,0.8035714285714286,1.0,1.0,1/5,11.24%,INHBA
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),0.41893685032720374,0.7389391371083123,0.8,1.0,1.0,4/12,11.79%,SLC16A12;SLC19A1;SLC6A13;PDPN
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),-0.31777749771874964,-0.7388972785342447,0.9,1.0,1.0,12/76,17.20%,PXMP2;PEX11B;CHMP4B;ZDHHC22;PEX16;ZDHHC6;SEC62;SRP14;NACA;ZDHHC24;SGTB;PEX5
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.38439517250663274,0.738856869671111,0.8648648648648649,1.0,1.0,4/16,14.92%,BMP7;AKR1C3;NR3C1;TFPI
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),0.3388031158677228,0.7388456303937143,0.8709677419354839,1.0,1.0,7/24,19.88%,PRKCD;TPR;PIK3R1;BAG3;DMAP1;HDAC3;CDH1
prerank,GO_Biological_Process_2021__positive regulation of protein maturation (GO:1903319),-0.448587920795979,-0.7386445254121854,0.8035714285714286,1.0,1.0,2/9,15.34%,NKD2;CCBE1
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),-0.4802240389456892,-0.7383815185578312,0.8333333333333334,1.0,1.0,2/6,25.95%,NDUFS2;NDUFB6
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),0.46411719188912626,0.738306735621049,0.8333333333333334,1.0,1.0,6/8,27.46%,MAPK12;CHEK2;ATM;ABL1;MAP2K6;CRY1
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.3769188199543708,-0.7382756381343379,0.8142857142857143,1.0,1.0,5/27,14.81%,DRD3;NOTCH1;SYT4;STXBP6;RHBDF2
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.39707351210143965,-0.7379697605164769,0.7377049180327869,1.0,1.0,4/13,14.35%,SOD2;GPER1;TPM1;CDKN1B
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),0.3882517826557801,0.7378601522004291,0.825,1.0,1.0,2/9,14.28%,ACVR1;MAGI2
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.370038500641691,-0.7377952230877599,0.84375,1.0,1.0,2/27,8.71%,ABT1;RPS21
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.28452150998623826,0.7376398366976159,0.9642857142857143,1.0,1.0,4/71,5.66%,SEM1;RFWD3;RAD51B;BRCA2
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.38761031724492856,-0.7374169624715776,0.859375,1.0,1.0,13/25,32.06%,WDR12;RRP15;EIF6;RPF2;RPL7A;LAS1L;NSA2;RPL35;MAK16;RPL7L1;DDX18;SNU13;FTSJ3
prerank,GO_Biological_Process_2021__tRNA thio-modification (GO:0034227),0.4519563337656722,0.7373303119073102,0.7906976744186046,1.0,1.0,5/5,54.82%,CTU1;MOCS3;CTU2;URM1;TRMU
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.3480347241507657,0.737233478341308,0.7380952380952381,1.0,1.0,7/24,12.86%,RORA;SGCZ;MRTFA;SEMA4C;NEBL;MRTFB;MEGF10
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),-0.33247474335032234,-0.7370839076882306,0.8955223880597015,1.0,1.0,10/59,12.95%,BCL2L2;MOAP1;TGFB1;IFI27;CD27;CASP8;DAB2IP;INHBA;FADD;BOK
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),0.4372075745941486,0.7370510070673675,0.7560975609756098,1.0,1.0,1/9,5.71%,MT1E
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),-0.39462228530292387,-0.7366439179918867,0.7666666666666667,1.0,1.0,3/13,21.72%,DIS3L;EXOSC6;EXOSC8
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),0.30007655415272044,0.7364565211062404,0.8918918918918919,1.0,1.0,10/41,19.88%,PRKCD;TPR;ANP32B;PIK3R1;BAG3;DMAP1;HDAC3;EMD;NEDD4;CDH1
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.4655741610701091,-0.735722905253476,0.8923076923076924,1.0,1.0,5/9,34.46%,RPS27A;ISG15;UBC;UBB;UBA52
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),0.41491785257951774,0.7356752540326721,0.7894736842105263,1.0,1.0,5/11,26.73%,MALT1;CHI3L1;CARD10;TRAF6;MAP3K7
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.3768499618926848,0.7356704947061399,0.8421052631578947,1.0,1.0,5/14,25.43%,CEL;ACOT8;NUDT19;ACAA1;LPIN3
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.2772272141405934,-0.735551952783507,1.0,1.0,1.0,34/256,19.55%,FIP1L1;DDX20;CSTF2T;SLU7;SYF2;DDX39A;NONO;SNRPD2;UBL5;NCBP2;FRG1;GEMIN4;PPWD1;PCBP1;NCBP1;PRPF19;ZMAT2;RNPS1;SNRNP48;ALYREF;USP39;POLR2J;POLR2K;DDX1;CDC40;BUD13;RBM4B;HNRNPA0;CRNKL1;CWC25;RBM4;SRPK1;UPF3B;SF3B2
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),0.45640115843429657,0.7354790543345138,0.7777777777777778,1.0,1.0,2/6,29.43%,SETD4;SETD1A
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,-0.3123242690651204,-0.7353704668465169,0.9090909090909091,1.0,1.0,11/90,12.56%,SLC12A7;MMP15;ARVCF;CELF3;F10;DACT2;SLC18A2;SCGN;SHD;SYT4;TMEM179
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),0.29342178394044227,0.7353180648671417,0.9354838709677419,1.0,1.0,15/75,13.59%,CDC14B;DBF4B;EREG;ANKRD31;BTC;MAP3K20;SVIL;IGF1;TPR;CEP120;MAP10;PRKCE;SIRT2;NUMA1;PKP4
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),-0.3404877286437477,-0.735189471636431,0.9538461538461539,1.0,1.0,5/47,7.40%,HSD17B2;CDKN2D;WNT8A;TBX1;WNT7B
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),0.43082385048502175,0.735056492875047,0.851063829787234,1.0,1.0,3/9,11.01%,GSTO2;RGN;CYB5A
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.2682999000232498,0.735044819855569,1.0,1.0,1.0,10/97,9.03%,CDH13;SEMA5A;DSCAM;RSU1;MDK;EPHB2;EFNA5;PKHD1;EPHA7;ANGPT1
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.296029508601924,-0.7350250524781949,0.9305555555555556,1.0,1.0,19/105,19.29%,ACOT4;SLC16A8;BAAT;ACOT12;ALOX12;PTGR1;CKB;ACOT1;ALDH4A1;ACOT2;FASN;VDAC1;LDHB;SLC16A1;PDZD11;ACOT6;PDHX;SLC16A3;BTD
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),0.36800284506630865,0.7350027613699956,0.8888888888888888,1.0,1.0,3/25,6.73%,ATOH8;VASH1;APOE
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),-0.47483787623374896,-0.7349886212481209,0.8571428571428571,1.0,1.0,1/6,5.83%,NOTCH1
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.34824620864099187,0.7347758718028522,0.9117647058823529,1.0,1.0,11/30,16.22%,TGFB2;MEIS1;SMG9;ATF6;CHRDL1;RBP4;SMOC1;SIPA1L3;PBX4;PBX1;MEIS2
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),0.4890255374683766,0.734460512107093,0.8333333333333334,1.0,1.0,2/5,22.18%,TCF4;SETD2
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),-0.43932017725735995,-0.7342479716416379,0.8333333333333334,1.0,1.0,1/9,5.83%,NOTCH1
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.3672087261595694,-0.7339064335759309,0.835820895522388,1.0,1.0,3/24,9.52%,B3GNT5;GCNT1;G6PD
prerank,MSigDB_Hallmark_2020__DNA Repair,0.26821937366502396,0.7338904055167929,1.0,1.0,1.0,11/136,10.22%,PNP;ZNF707;ADA;POLD3;ERCC8;APRT;HPRT1;ERCC2;RALA;TAF12;DUT
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),0.38260758711232973,0.7338255296564452,0.7857142857142857,1.0,1.0,5/20,11.51%,H6PD;PGM2;G6PC3;RPEL1;GCK
prerank,GO_Biological_Process_2021__skin development (GO:0043588),-0.35069620116403577,-0.7338255165121463,0.8448275862068966,1.0,1.0,12/51,21.29%,ALOX12;ALOXE3;CLDN1;DACT2;TMEM79;STMN1;ADAM9;HRNR;OPN3;ITGB4;TXNIP;MET
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),-0.3620104935812827,-0.7336568493096551,0.8450704225352113,1.0,1.0,6/27,22.91%,TGFB1;CALM3;PDGFRB;ANKLE2;CALM1;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),-0.47786928150421115,-0.7335740459400824,0.8225806451612904,1.0,1.0,3/7,20.45%,PRKCH;STAP1;NFAM1
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.3377191350084445,-0.733473573437818,0.875,1.0,1.0,13/43,26.64%,PINK1;TOMM20;BCAP31;TOMM7;TOMM22;DNAJC19;ROMO1;HSPD1;TIMM17B;TIMM17A;TIMM22;GRPEL2;AKT1
prerank,GO_Biological_Process_2021__positive regulation of skeletal muscle tissue development (GO:0048643),-0.46707246735866986,-0.7331212721982058,0.8333333333333334,1.0,1.0,1/5,13.03%,FLOT1
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),-0.3841590921188779,-0.7327469156593379,0.8524590163934426,1.0,1.0,3/22,11.24%,MSX1;TBX1;INHBA
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.30378866932399323,0.7324613879358165,0.95,1.0,1.0,19/72,17.09%,EPHA3;EPHA5;EPHB2;EFNA5;ARPC3;EPHA7;FYN;SIPA1L1;KALRN;EPHA8;PAK3;ANKS1B;CRK;TIAM1;NGEF;GRIN2B;NCSTN;ANKS1A;GRIN1
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),0.35586925336215064,0.7324318016754353,0.8421052631578947,1.0,1.0,2/17,7.13%,KDR;IGF1
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),-0.35584315008269224,-0.7321952975771395,0.8805970149253731,1.0,1.0,7/31,13.93%,CYP19A1;BIK;ADAM21;INHBA;SIX4;ADAM29;LRP2
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.31611689792772707,0.7321742105457233,0.9,1.0,1.0,3/44,7.95%,IFI16;MAP3K20;EEF1D
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),-0.3034135700885398,-0.731979813217516,0.9857142857142858,1.0,1.0,15/76,20.38%,TRIML2;BNIP3;TRIM22;PINK1;PIK3CB;TRIM5;SESN3;SVIP;TSC2;SUPT5H;ULK1;RNF152;KAT5;TRIM14;SCOC
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),-0.33187080653548195,-0.7318577503451514,0.9041095890410958,1.0,1.0,7/36,21.59%,ATP1B1;SFXN3;KCNJ11;TRPM6;SLC25A19;CACNA1H;SLC38A5
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.38521043892446083,-0.7316242067858155,0.9032258064516129,1.0,1.0,4/21,10.27%,CYP1B1;RDH10;RDH12;RETSAT
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),-0.43216328816909005,-0.731597515013543,0.875,1.0,1.0,2/11,10.58%,GOT1;L2HGDH
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.3316183659000714,0.7313308702928848,0.7857142857142857,1.0,1.0,10/28,23.70%,MAP3K20;CLSPN;CDC5L;CHEK2;ATM;ATRIP;TP53BP1;HUS1;HINFP;RAD9A
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.39457364262224015,-0.7311235974488859,0.896551724137931,1.0,1.0,4/15,21.25%,CAV3;TCAF2;HECW1;PLN
prerank,PanglaoDB_Augmented_2021__Reticulocytes,0.29486580481124214,0.7310674712597359,1.0,1.0,1.0,5/96,4.33%,RFWD3;ITGA4;URB2;CEP85;TIMELESS
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),-0.493934939374846,-0.7310476120290932,0.875,1.0,1.0,1/6,4.10%,ZFPM1
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),-0.29544254396537994,-0.7308280913518361,0.9871794871794872,1.0,1.0,10/149,9.24%,ENPP2;ZNF703;RREB1;BNIP3;PINK1;BMP1;NEUROD2;DAB2IP;ZDHHC6;REST
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),-0.4521910039535343,-0.7307677860102872,0.8363636363636363,1.0,1.0,1/7,5.83%,NOTCH1
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),-0.4104440802510514,-0.7307265442483314,0.8405797101449275,1.0,1.0,6/13,25.44%,HLA-A;CTSH;EMP2;GNL1;CD8A;BTN3A3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),-0.43422039436760124,-0.7306437383795308,0.7647058823529411,1.0,1.0,2/7,8.70%,NCKAP1L;AGER
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.39461735627983974,-0.7299780308510695,0.8769230769230769,1.0,1.0,1/19,1.66%,NOSTRIN
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),0.4191190890988392,0.7299272396246721,0.6739130434782609,1.0,1.0,1/7,10.01%,CHRM3
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.33002325504609864,0.7298565016410401,0.8888888888888888,1.0,1.0,2/31,3.47%,NRP1;SEMA5A
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),-0.4575881143309905,-0.7297970397240445,0.8545454545454545,1.0,1.0,2/9,9.08%,NEUROD2;DAB2IP
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),-0.4041256472353681,-0.7297282364857517,0.847457627118644,1.0,1.0,4/14,21.79%,TBX19;ITGB4;KDM6B;MESP1
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.2954624320663394,0.7291444473516688,0.9459459459459459,1.0,1.0,9/42,14.29%,GAL3ST1;KLK6;AMIGO1;PARD3;SLC8A3;SBF2;ABCD2;SIRT2;MBP
prerank,GO_Biological_Process_2021__exocrine system development (GO:0035272),0.45670078828493743,0.7284905370758896,0.8181818181818182,1.0,1.0,1/5,6.24%,FGF10
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.29012445014820176,0.7284805110035943,0.967741935483871,1.0,1.0,34/118,23.72%,LRWD1;ARID1A;BAZ2B;HDAC1;ZBTB1;SUV39H2;HMGN4;PBRM1;RUVBL2;PHF1;SIRT1;SMARCAD1;HDAC10;SMARCB1;MYB;BPTF;SMARCA4;HDAC3;HDAC5;ZBTB7A;HP1BP3;BAZ1B;TADA2A;KDM4C;MECOM;HIRIP3;HMGN1;CDAN1;HCFC1;SETD2;CHD1;KDM5D;BRDT;SMARCD3
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),-0.39151047120899146,-0.7284397870675238,0.875,1.0,1.0,4/18,26.13%,INTS5;EXOSC6;EXOSC8;INTS14
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),-0.42861252108318837,-0.7283352326828122,0.8541666666666666,1.0,1.0,1/10,3.79%,DRD3
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),-0.33483610722284884,-0.7281327752779829,0.9428571428571428,1.0,1.0,14/59,26.70%,IFIT1;PPID;CCL5;POLR2J;POLR2K;SUPT5H;NR5A2;SRPK1;POLR2B;VPS4A;CTDP1;KPNA2;POLR2D;DDX3X
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.3998442214795394,-0.7275879520015379,0.8461538461538461,1.0,1.0,2/17,5.43%,CCND2;SPDYA
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.27441040385702464,0.7274869230320289,1.0,1.0,1.0,9/86,13.03%,BCL2;EGFR;TGFBR1;TGFB2;IGF1;SLC25A33;NGF;NEDD4L;SYT1
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),-0.3479004839753636,-0.7274704524999989,0.8333333333333334,1.0,1.0,4/36,10.22%,DEGS2;SPTLC3;ALOXE3;PNPLA1
prerank,PanglaoDB_Augmented_2021__Neurons,-0.2742344055656033,-0.7271916416867893,0.9759036144578314,1.0,1.0,22/265,13.11%,NPY;CALB1;PPP1R1B;FBLN2;PDE1A;BEX1;CELF3;NDN;ZDHHC22;GRM3;ZCCHC12;GAD1;IFIT3;PNMA8A;CAMK2N1;SCRG1;MAGEE1;NMT1;SYT4;TMEM179;ENO2;NRN1
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.30863605115323967,0.7268388612080858,0.9655172413793104,1.0,1.0,5/66,5.94%,ADAMTS2;PCDH18;FNDC1;LAMA4;PDGFRA
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),0.3547948638234756,0.726529826002618,0.8297872340425532,1.0,1.0,2/19,4.59%,F2RL1;MDK
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.41305471423443973,0.7264889467471822,0.8604651162790697,1.0,1.0,2/9,10.27%,B4GALNT2;ST3GAL1
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),0.3823720778768885,0.7263888020107675,0.8,1.0,1.0,2/12,9.56%,TRIM11;MID2
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.42203359631573334,-0.7262055476059146,0.828125,1.0,1.0,4/8,36.47%,ENTPD5;ENTPD2;ENTPD1;ENTPD7
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),-0.42740185072580145,-0.7258617429124411,0.8490566037735849,1.0,1.0,1/8,8.70%,AGER
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),-0.43276915168906394,-0.7254908461157752,0.8490566037735849,1.0,1.0,2/8,16.67%,DCTN1;MAP1A
prerank,GO_Biological_Process_2021__receptor guanylyl cyclase signaling pathway (GO:0007168),-0.45944960794332523,-0.725412829000254,0.8245614035087719,1.0,1.0,4/6,40.20%,NPPC;GUCY2F;NPR2;GUCY2D
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),-0.4171381051375468,-0.725370352838062,0.8035714285714286,1.0,1.0,4/13,15.29%,ABCC6;LRRC8D;SLC25A5;SLC25A4
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.38769634791785884,0.7250887461709228,0.7894736842105263,1.0,1.0,3/10,20.08%,FGF10;PTEN;MAP4K4
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.39767869636253206,-0.7249760809169805,0.8431372549019608,1.0,1.0,4/10,36.54%,PAF1;CTR9;RNF8;WAC
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.2449018485009286,0.7249182139148883,1.0,1.0,1.0,63/454,15.17%,FBXL7;RFWD3;MYLIP;PELI2;RNF182;RNF126;SH3RF1;BCL2;TRIM36;CBFB;FBXW8;PDZRN3;MARCHF1;RNF217;MARCHF5;CCDC22;UBE2QL1;UBE2J2;FBXO27;SH3RF3;ERCC8;COMMD1;RBBP6;TRIM4;RNFT1;ANAPC16;ZNRF1;UBE3D;THOP1;TRIM11;PELI1;MARCHF3;UBE2D4;TSPAN17;FBXL15;MARCHF8;UBE2E2;CDC23;RNF103-CHMP3;DTX1;TRIM71;KLHL25;RNF25;TRIM44;TRIM47;PEX2;RC3H1;HECW2;NEDD4L;KLHL42;KLHL20;ASB9;WWP1;SIRT1;BTRC;EIPR1;RNF19B;HERC2;UBE2U;FBXL17;UBE2R2;RNF208;FBXL2
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),-0.37143000979508295,-0.7248771214306876,0.8484848484848485,1.0,1.0,1/25,0.44%,CA12
prerank,PanglaoDB_Augmented_2021__Melanocytes,-0.2987450371046081,-0.7247464072339125,0.961038961038961,1.0,1.0,9/112,5.91%,HSPG2;EPAS1;SYNC;TIMP3;ANGPTL2;OSMR;AHR;COL6A1;FILIP1L
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.31554197665145606,0.7246027151459823,0.9166666666666666,1.0,1.0,4/33,12.26%,NUP210;NUP42;TPR;NUP37
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),0.31554197665145606,0.7246027151459823,0.9166666666666666,1.0,1.0,4/33,12.26%,NUP210;NUP42;TPR;NUP37
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),0.3765059233307715,0.7245919015435021,0.868421052631579,1.0,1.0,4/10,16.97%,SRR;PSPH;SEPHS1;CTH
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),0.3833079297057007,0.7244868426617572,0.8636363636363636,1.0,1.0,3/15,10.52%,RORA;APOE;SCARB1
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.41741210401896517,0.7241303885355539,0.8292682926829268,1.0,1.0,2/7,13.57%,ERCC8;SIRT1
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),-0.4058824252845709,-0.7240423350469801,0.9166666666666666,1.0,1.0,4/13,21.70%,PINK1;COX7A2L;COX7A2;AK4
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.3834567759658238,0.7240356120770272,0.7567567567567568,1.0,1.0,2/15,6.63%,ITGA4;AKR1C3
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.42592171026320125,-0.7239997323264241,0.8939393939393939,1.0,1.0,2/13,13.58%,CD300LF;TLR2
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.32139865098861636,-0.7238333515583368,0.9420289855072463,1.0,1.0,10/48,14.97%,NODAL;CARD8;CASP8;CIDEB;BCAP31;REST;GPER1;FADD;CYCS;PDCD5
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),-0.38736487572893374,-0.7237801115642404,0.8461538461538461,1.0,1.0,1/12,5.24%,SPTLC3
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),-0.38736487572893374,-0.7237801115642404,0.8461538461538461,1.0,1.0,1/12,5.24%,SPTLC3
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),-0.3458926157653564,-0.7236642703827184,0.8888888888888888,1.0,1.0,7/37,22.58%,CYP1B1;GLRX2;ADAM9;PRDX3;RPS3;ZNF580;ANKZF1
prerank,GO_Biological_Process_2021__meiotic DNA double-strand break formation (GO:0042138),0.4298739575539768,0.7228175374624506,0.7674418604651163,1.0,1.0,2/5,5.52%,HORMAD1;ANKRD31
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),-0.5000224015935891,-0.7226919403078086,0.8852459016393442,1.0,1.0,1/6,16.79%,NUP155
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.40781394291587686,-0.7226832897452872,0.8461538461538461,1.0,1.0,1/13,2.84%,CAV3
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),0.27529522433439924,0.7226455569482737,1.0,1.0,1.0,16/62,22.16%,ARID5A;AKR1C3;ROBO2;GCK;NSMF;SOCS2;THRB;NR3C1;TFPI;MEF2C;AKR1C1;GAS2L1;TRIM24;STAT3;URI1;UBE2L3
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),0.385149968089241,0.7225551912947376,0.8095238095238095,1.0,1.0,8/14,32.89%,DMC1;NSMCE2;TPRKB;SMC6;MSH3;RAD51;SMC5;XRCC3
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),-0.39118078640281906,-0.7225288814361595,0.8333333333333334,1.0,1.0,4/18,20.95%,PPA1;TPST2;DAO;SULT2A1
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),-0.4630850122056844,-0.7224565717056974,0.8367346938775511,1.0,1.0,2/6,35.63%,SLC7A5;SLC6A15
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),-0.3785932070274414,-0.7221475391277717,0.8333333333333334,1.0,1.0,1/23,1.68%,NOTUM
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),0.2694069643111164,0.7220456636889487,1.0,1.0,1.0,7/98,8.76%,CCNH;GTF2H2C;POLD3;BRCA2;ERCC8;COMMD1;ERCC2
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),0.32740622679050185,0.7220111452780809,0.85,1.0,1.0,2/23,4.40%,F2RL1;GPR174
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),-0.28223489749341457,-0.7219950593261114,0.9733333333333334,1.0,1.0,21/154,17.54%,WFS1;MSX1;TCP1;ATP1B1;PINK1;CAMLG;CCT6A;GBA3;CCT8;C10ORF90;RPS7;HIP1R;CDC37L1;BAG4;FLOT1;RPL5;SYVN1;LAMP1;A1CF;CREBL2;LAMP2
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.368902225249526,-0.7219340807654918,0.8484848484848485,1.0,1.0,4/23,14.49%,ABCB1;ABCB4;TMEM30A;ATP10B
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.3599515435514601,0.7218504024076741,0.8125,1.0,1.0,6/31,6.55%,KIT;SOX13;LEPR;RABL3;GPR89B;CHD7
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),0.40417178068277004,0.7214926280713108,0.8421052631578947,1.0,1.0,2/10,8.00%,TICAM1;ZBTB1
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),-0.46829949733317683,-0.7212950498346528,0.8245614035087719,1.0,1.0,1/5,11.57%,TMEM30A
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),0.4440184125377393,0.7209992729314189,0.8378378378378378,1.0,1.0,2/10,16.52%,FNBP1L;PACSIN2
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),-0.37946850694888223,-0.720739038000724,0.8615384615384616,1.0,1.0,2/25,5.95%,NOTCH1;TGFB1
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.4064203189984363,0.7205783719870764,0.8723404255319149,1.0,1.0,6/11,26.47%,SPHK2;WNT5A;GPD1L;ADRA1A;VEGFA;DGKD
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),-0.4369790807018656,-0.7205345895848877,0.7659574468085106,1.0,1.0,2/6,18.77%,BRCA1;KDM1A
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),0.29801302074827335,0.7205295302690559,0.9428571428571428,1.0,1.0,12/55,23.26%,ARL13B;RAB7A;WDR81;DYNC1I2;ATM;LGALS8;AUP1;DYNC1I1;ATG2B;PCNT;KLHL3;CALCOCO2
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),-0.36960394806084806,-0.7202229453865937,0.8421052631578947,1.0,1.0,7/25,26.53%,F11R;STMN1;WAS;MET;INPP5K;ARHGAP28;SHANK3
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.4162665854413416,0.7200780360750832,0.7941176470588235,1.0,1.0,6/10,20.73%,IL1RAPL1;NLGN1;CEL;NLGN4Y;PTEN;PTPRD
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.3264879759407619,-0.7199499364345612,0.9154929577464789,1.0,1.0,7/40,15.31%,BCL2L2;PINK1;BCAP31;BOK;HERPUD1;SIAH1;PLAUR
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle remodeling (GO:0034372),0.4463160081462579,0.7197474106004745,0.84,1.0,1.0,2/5,10.61%,APOE;LCAT
prerank,GO_Biological_Process_2021__triglyceride-rich lipoprotein particle remodeling (GO:0034370),0.4463160081462579,0.7197474106004745,0.84,1.0,1.0,2/5,10.61%,APOE;LCAT
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),-0.3183659166194049,-0.7190005865205349,0.890625,1.0,1.0,11/60,22.94%,CPNE5;NEUROD2;SYT2;SYT4;MCOLN1;PLCG2;RASGRP2;SYT9;GPLD1;RYR3;SYT13
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),-0.2706225604644712,-0.7189368738637099,1.0,1.0,1.0,16/217,9.58%,CD4;ROPN1B;TERF2IP;CD74;P2RY1;CCND2;RAC1;TGFB1;PINK1;TBX1;RARRES2;FAM20A;TTN;AGER;DAB2IP;GPER1
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),-0.4347804637761225,-0.7186234657228615,0.8181818181818182,1.0,1.0,2/6,22.72%,TTPA;CPTP
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),-0.37208558612703324,-0.7181216217191404,0.8805970149253731,1.0,1.0,1/21,1.47%,PTGIS
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),0.40795678186737916,0.718060409695665,0.7555555555555555,1.0,1.0,1/6,10.97%,PNPLA2
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.2933712355238829,0.7179709650529077,0.9375,1.0,1.0,12/97,12.05%,PLCB1;CSF1R;SYNJ2;MTMR8;PIK3R6;PLA2G4C;PI4K2A;MTMR9;PIP4K2A;PIK3R1;PTPN13;PIP4P1
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",-0.3352877433785438,-0.7179322587409487,0.8793103448275862,1.0,1.0,5/27,20.98%,AEBP2;SPI1;H3-3A;SUZ12;JARID2
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),-0.4311042696130347,-0.7177919399447465,0.8636363636363636,1.0,1.0,1/9,3.43%,LRP4
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),0.3919959926013914,0.7177585673632086,0.8809523809523809,1.0,1.0,2/9,5.24%,TGFB2;TGFB3
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.37857072057650376,0.7170976677784027,0.8222222222222222,1.0,1.0,2/13,5.07%,NFIB;TGFB2
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.44584420637207256,0.7168289548546043,0.8958333333333334,1.0,1.0,4/8,30.76%,GABPA;ABL1;PRKN;DRD1
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.44584420637207256,0.7168289548546043,0.8958333333333334,1.0,1.0,4/8,30.76%,GABPA;ABL1;PRKN;DRD1
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),-0.33732609540099995,-0.7167474606745428,0.8636363636363636,1.0,1.0,2/46,2.83%,ACOT4;GOT1
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.4098896889029072,-0.7165423118540497,0.8166666666666667,1.0,1.0,2/18,2.30%,HIC1;MSX1
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),-0.3315808915997437,-0.716482954495842,0.8970588235294118,1.0,1.0,13/44,24.42%,RAC1;PREX1;CATIP;DIAPH3;WASF1;WAS;VIL1;CFL1;GHRL;TWF2;VILL;GAS7;CFL2
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.4319466444869663,-0.7162161487191219,0.8113207547169812,1.0,1.0,7/10,33.38%,GBP5;CPTP;USP50;DDX3X;NLRC3;CD36;NLRP2B
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),0.40260426403277855,0.7161415047229269,0.8085106382978723,1.0,1.0,3/12,9.57%,H6PD;PGM2;RPEL1
prerank,GO_Biological_Process_2021__eye development (GO:0001654),-0.3454589899021471,-0.7160760415757889,0.8387096774193549,1.0,1.0,5/39,10.79%,SALL2;LAMA1;ADAMTS18;EFEMP1;SCO2
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),-0.41318366282471836,-0.7160136174973286,0.8928571428571429,1.0,1.0,1/13,1.41%,CHRNB1
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.2698987853021723,-0.715804200398201,1.0,1.0,1.0,29/272,17.66%,RAB6C;CSRP3;CD74;WIPI1;FBLN5;ARCN1;RAB19;SLU7;CELSR1;SEPTIN14;ARL1;GRTP1;AMOT;DUOXA1;STX19;SEPTIN1;PRPF19;STX16;RAB31;VPS35;TBC1D13;CNTN2;RAB23;LAMTOR2;RAB1A;CNTNAP1;CPE;EMP2;YWHAH
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),-0.445135558919901,-0.715644580585599,0.7936507936507936,1.0,1.0,4/9,11.12%,DUOX1;NOX1;ALOX12;NOX5
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.34700194652765076,-0.7155472370544278,0.8923076923076924,1.0,1.0,6/38,15.56%,AGT;CD74;DAB2IP;GSTP1;TRIM32;CDK4
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.39505110464369464,0.7154229814732734,0.7857142857142857,1.0,1.0,2/9,19.73%,IP6K1;IP6K2
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),-0.3047905355307001,-0.7153463498668289,0.96,1.0,1.0,19/68,26.64%,RGPD3;NXT1;RANBP6;RGPD1;SPRN;NUP85;TSC2;NUP155;GCKR;NUP188;RPL23;NUP214;KPNA2;KPNA5;IPO11;RAN;TNPO1;RGPD4;AKT1
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.3319730678483376,0.7153025610198017,0.8571428571428571,1.0,1.0,4/29,11.03%,GREM1;NAF1;PARM1;PNKP
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),0.33240573881824736,0.7151152223354902,0.8,1.0,1.0,2/32,5.07%,KIT;TGFB2
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),-0.4324859506160419,-0.7150856578245437,0.8428571428571429,1.0,1.0,2/8,14.16%,HSPA5;HERPUD1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.3871819403119747,0.7150475180182383,0.8235294117647058,1.0,1.0,1/9,6.24%,FGF10
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.3967692588817315,-0.7147894516144092,0.8305084745762712,1.0,1.0,3/12,20.07%,SYT4;CACNA1G;CACNA1H
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.3357265939305106,0.7145107204559418,0.8484848484848485,1.0,1.0,2/27,3.30%,GDAP1;PEX7
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.2829545993954442,-0.7138852362407212,0.9743589743589743,1.0,1.0,47/189,25.14%,RPL36;RPL15;RPL38;RPS7;RPL37A;RPL9;INTS5;RPL28;RPLP2;NOB1;MRPL44;RPL5;RPL35A;EMG1;EXOSC6;DDX54;RPLP1;RPL8;RPL4;RPL22;RPL27A;WDR12;RPL24;THG1L;RPS15;KRR1;RPL34;RPL3;RPS24;SBDS;UTP11;EXOSC8;RPL13A;RPL27;RPL37;RPL7A;LAS1L;NOP56;RPL35;WDR55;RPL23;RPL32;IMP4;METTL3;UTP15;SSB;AGO1
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),-0.43617519184267856,-0.7137446744314802,0.7758620689655172,1.0,1.0,5/10,34.58%,GOLGA2;VCPIP1;PLK5;PLK3;PDCD10
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),-0.4238374127617125,-0.7137379343771365,0.8507462686567164,1.0,1.0,6/10,32.07%,BRCA1;MDM1;CCNF;CENATAC;KAT2A;TRIM37
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.4517172098822435,-0.7134551132648659,0.8363636363636363,1.0,1.0,4/8,20.04%,PKP1;SLIRP;PHAX;ZCCHC17
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),-0.30489385489497445,-0.7132538573555305,0.9493670886075949,1.0,1.0,18/84,23.97%,WFS1;HSPA5;TRIM25;RCN3;ERLEC1;HERPUD1;PSMC6;MAN1A1;SYVN1;SEL1L2;CCDC47;SGTB;UFD1;MAN1B1;HSP90B1;ANKZF1;TMUB1;MARCHF6
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.42448733848887465,0.7132438329111705,0.8222222222222222,1.0,1.0,2/6,17.84%,SLC16A10;SLC25A29
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.3667044626169965,-0.7132108478185121,0.875,1.0,1.0,1/18,2.85%,SFRP4
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),-0.40972358262100206,-0.7131084589081755,0.8548387096774194,1.0,1.0,1/12,6.87%,SERPINE1
prerank,PanglaoDB_Augmented_2021__Paneth Cells,-0.36202197010734527,-0.7128141063196579,0.8524590163934426,1.0,1.0,6/22,18.95%,GPX2;ACSL5;KCNN4;TMEM45B;CFD;CEACAM1
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.35108818729617153,0.712581055843976,0.8292682926829268,1.0,1.0,6/21,17.42%,NGF;NTRK3;MAGI2;RAPGEF1;RAP1A;TMEM108
prerank,GO_Biological_Process_2021__negative regulation of phospholipase activity (GO:0010519),0.46685943935444923,0.7122360635210396,0.8205128205128205,1.0,1.0,2/5,21.06%,BICD1;ABL1
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.29326544128889515,-0.7121365067377596,0.9583333333333334,1.0,1.0,15/98,17.52%,ITK;RAC1;PSMB6;VAV3;PSMB8;PIK3CB;SKP1;PSMA3;TEC;PSMC3;PSMC6;PSMA5;PLCG2;LYN;PSMA7
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),0.4403946061884013,0.7117693204430461,0.7567567567567568,1.0,1.0,1/5,5.46%,RABL3
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),0.4334492722534984,0.7117418872102105,0.851063829787234,1.0,1.0,2/6,8.06%,PDGFRA;SOX5
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.2997576974495677,0.7117012813877241,0.9696969696969697,1.0,1.0,15/49,19.33%,AMIGO1;LRRC4C;CHODL;ROBO2;TIAM2;NGF;SIPA1L1;PAK3;TIAM1;MAP6;RTN4R;PLXNA2;PTEN;ROBO1;PLXNC1
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),0.4486189032602555,0.7116589079308859,0.8378378378378378,1.0,1.0,4/6,32.52%,MTG2;NLGN3;ATP1A2;NLGN2
prerank,GO_Biological_Process_2021__SA node cell action potential (GO:0086015),-0.45052456761873766,-0.7115163792294865,0.8181818181818182,1.0,1.0,2/7,16.85%,CACNA1G;HCN4
prerank,GO_Biological_Process_2021__protein import (GO:0017038),-0.2970735788864824,-0.7113985264816421,0.9857142857142858,1.0,1.0,14/77,19.98%,PXMP2;NXT1;RANBP6;PEX11B;PEX16;SPRN;NUP85;TOMM22;TSC2;NUP155;PEX5;LAMP2;GCKR;NUP188
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),-0.25934078041838643,-0.7113819946417907,1.0,1.0,1.0,45/352,15.04%,ITK;ACTC1;SFRP4;RHOXF2;AGT;CD74;HHLA2;RPS27L;TBP;NOTCH1;TGFB1;TXK;IL15;ZBTB7B;CALCR;TTN;PIK3CB;MYOM1;POLR1E;CAMK2N1;GPER1;RPS7;BRCA1;CTSH;WARS1;NOX5;INHBA;ACTA2;POLR1H;HTR2B;RHOXF1;FLOT1;MSN;TLR2;VPS35;MUSK;PKP1;RPL5;YAP1;EEF2;POLR2K;DEK;PDCD5;NIBAN1;PLCG2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.42819325200139574,0.7112554940680611,0.8604651162790697,1.0,1.0,3/11,15.12%,ATF3;ATF6;CREB3L1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),0.3209016883307704,0.7112513993444753,0.8055555555555556,1.0,1.0,2/21,2.71%,FGF13;PKP2
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.2569726774439268,0.7108791896931772,1.0,1.0,1.0,26/168,13.02%,ALK;DUSP5;PLCB1;EPHB2;PLPPR5;ENPP1;ENPP3;GDE1;PTPRB;G6PC3;DUSP8;PLA2G4C;DUSP4;INPP1;EPHA7;DUSP12;DUSP10;SPHK2;LCAT;PNKP;PIP4K2A;GCK;PIP4P1;PANK3;PSPH;PFKFB3
prerank,GO_Biological_Process_2021__drug transport (GO:0015893),0.42722580783165176,0.7106285439915035,0.8723404255319149,1.0,1.0,1/5,6.69%,SLC19A1
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),-0.3823101331837959,-0.7106249347015188,0.85,1.0,1.0,6/22,26.37%,F11R;STMN1;WAS;MET;INPP5K;ARHGAP28
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),-0.40173764797847095,-0.7104885757816956,0.9122807017543859,1.0,1.0,5/14,22.91%,CALM3;PDGFRB;CALM1;GPLD1;HSP90AB1
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),-0.47767347374803526,-0.7101831100255345,0.8823529411764706,1.0,1.0,3/6,22.64%,MOCS2;NFS1;MOCOS
prerank,PanglaoDB_Augmented_2021__Parietal Cells,-0.3096524144148514,-0.7098999772808477,0.9305555555555556,1.0,1.0,7/98,6.45%,PPP1R1B;KCNE2;RAPGEF5;CP;KCNQ1;PAIP2B;MYO5B
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.40951378244490305,-0.7095789250767127,0.8448275862068966,1.0,1.0,7/14,33.11%,CMPK2;ENTPD5;AK4;ENTPD2;ENTPD1;AK8;AK1
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),-0.4118781171520658,-0.7095019473444021,0.8688524590163934,1.0,1.0,2/11,11.55%,KCNN4;KCNK10
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),-0.3543942050763187,-0.7093849276880955,0.859375,1.0,1.0,6/29,14.49%,ABCB1;ABCB4;TMEM30A;PLSCR5;PLSCR4;ATP10B
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),-0.34769814737269517,-0.7093447308717781,0.90625,1.0,1.0,11/28,27.47%,PEX16;TOMM20;DNAJC19;ROMO1;PEX5;PEX1;HSPD1;TIMM17B;TIMM17A;GRPEL2;PEX10
prerank,GO_Biological_Process_2021__water transport (GO:0006833),-0.46420902124739405,-0.7092762477000755,0.8833333333333333,1.0,1.0,1/7,7.64%,AQP9
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.30442933675850886,-0.7088618058618602,0.9855072463768116,1.0,1.0,5/71,5.92%,NES;LRPAP1;TMC8;ZFPM1;IFIT1
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.2922097200604883,-0.7085552043589635,0.9571428571428572,1.0,1.0,11/88,18.41%,IHO1;ATF5;RAB11A;GPER1;CALM3;BORA;KIF20B;PLK4;CHEK1;KIF11;RACGAP1
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.31138693691882635,-0.7085450793191888,0.8918918918918919,1.0,1.0,6/61,10.83%,PTGIS;CYP1B1;CARD8;DAB2IP;TMSB4X;SPI1
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),-0.42797386849582086,-0.7084927906267638,0.8490566037735849,1.0,1.0,3/8,23.18%,GTF3C6;GTF3C3;GTF3C4
prerank,GO_Biological_Process_2021__intermediate filament bundle assembly (GO:0045110),0.4291063936892604,0.7082896874514748,0.7727272727272727,1.0,1.0,1/5,2.71%,PKP2
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),0.28945727715862335,0.7081922670023996,0.9696969696969697,1.0,1.0,6/38,13.89%,SHLD1;TIMELESS;MGMT;PNKP;KMT5B;SPIDR
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),-0.48129487115042435,-0.7081384264329634,0.8695652173913043,1.0,1.0,2/5,13.19%,CCL5;GPR183
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),-0.33698171863597937,-0.7069713131703607,0.8648648648648649,1.0,1.0,2/32,2.84%,SCN4B;CAV3
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.3213808782763448,-0.7069074044620035,0.9047619047619048,1.0,1.0,11/55,17.05%,TERF2IP;LRRC19;CD27;CD14;AGER;TMSB4X;SPI1;TLR2;NFKBIA;C1QTNF4;CCN3
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),0.34788533306704134,0.7068773843425642,0.8571428571428571,1.0,1.0,2/16,6.73%,PTPN3;APOE
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),-0.4804331100300899,-0.706862797292734,0.8979591836734694,1.0,1.0,1/5,11.34%,NCBP1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),-0.4331750699100073,-0.7068326954894296,0.873015873015873,1.0,1.0,1/7,6.48%,SOD2
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),0.46098641937630397,0.706339556924381,0.8536585365853658,1.0,1.0,1/5,13.93%,SMC1A
prerank,GO_Biological_Process_2021__regulation of leukocyte mediated cytotoxicity (GO:0001910),-0.44633015693908773,-0.70630922647321,0.8727272727272727,1.0,1.0,1/6,8.70%,AGER
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),0.3530045277823511,0.7060990693948827,0.8863636363636364,1.0,1.0,8/17,19.36%,SLC30A10;PLIN5;ABCD2;SIRT2;TRAP1;AATF;PPARA;ABCD1
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.4135456748475177,-0.7059685379864236,0.8524590163934426,1.0,1.0,4/12,16.51%,CD74;TGFB1;PLCG2;CUEDC2
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),0.4231551002375733,0.705781484650637,0.8478260869565217,1.0,1.0,3/7,12.65%,NEK6;CDC23;HECW2
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.355678290616527,-0.7057750480005145,0.875,1.0,1.0,9/31,21.56%,DRD3;CDC6;KIF14;KIF20B;HTR2B;SHH;RACGAP1;FGF1;CDC14A
prerank,GO_Biological_Process_2021__carnitine biosynthetic process (GO:0045329),-0.48134344548719166,-0.7055768343783724,0.8135593220338984,1.0,1.0,3/5,43.36%,TMLHE;BBOX1;SHMT1
prerank,GO_Biological_Process_2021__amino-acid betaine biosynthetic process (GO:0006578),-0.48134344548719166,-0.7055768343783724,0.8135593220338984,1.0,1.0,3/5,43.36%,TMLHE;BBOX1;SHMT1
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.4144631441225013,0.7054823149554054,0.8604651162790697,1.0,1.0,2/8,7.77%,ATOH8;ZEB1
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.3428701742143644,0.7052390736433242,0.8285714285714286,1.0,1.0,6/27,15.84%,CTNNA2;HDAC9;MEGF10;ID2;MAPK12;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.32989730692292124,-0.7050358458247434,0.9552238805970149,1.0,1.0,15/53,22.90%,HSPG2;STAT1;DAB2IP;AMOT;ADGRB1;SERPINF1;STAB1;CD160;RGCC;GHRL;CNMD;FOXO4;SPARC;PGK1;SPINK5
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),0.4166387801889541,0.7048953731292646,0.8333333333333334,1.0,1.0,1/6,13.16%,SIRT2
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.31366976343888237,0.7048935950020493,0.8648648648648649,1.0,1.0,7/30,19.34%,ZDHHC14;ZDHHC11B;ZDHHC3;ZDHHC5;ZDHHC2;ZDHHC11;ZDHHC7
prerank,MSigDB_Hallmark_2020__Apical Junction,0.28331795277885535,0.7045783411963834,1.0,1.0,1.0,15/158,9.92%,CDH6;IRS1;VCAN;EGFR;LAMB3;NECTIN3;AMIGO1;RSU1;MPZL1;MDK;MAP3K20;CADM2;CNTN1;ITGA10;CDK8
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.328484019391172,0.7044715673952987,0.9354838709677419,1.0,1.0,2/31,6.31%,IFI16;FHIT
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.45133701906472573,0.7042211323137084,0.9393939393939394,1.0,1.0,1/7,10.50%,PIBF1
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.33811479012044077,0.7041475985617384,0.8928571428571429,1.0,1.0,3/39,7.73%,SVEP1;LAMB3;HDAC1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),-0.38608743055292266,-0.7038888367848938,0.8363636363636363,1.0,1.0,3/12,17.05%,NOTCH1;SOX6;CCN3
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.3558667325381267,-0.7038652638095114,0.8615384615384616,1.0,1.0,5/23,11.58%,MOAP1;CASP8;DAB2IP;SPI1;FADD
prerank,GO_Biological_Process_2021__positive regulation of vasoconstriction (GO:0045907),-0.4290377381875894,-0.7035744324169168,0.8,1.0,1.0,3/9,11.60%,SMTNL1;ADRA1D;TBXA2R
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),-0.34986805898729656,-0.7035247447386566,0.8928571428571429,1.0,1.0,4/24,14.30%,PINK1;SOD2;REST;TXN
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),-0.4163980728587075,-0.7033907472472234,0.7254901960784313,1.0,1.0,1/7,8.35%,RNF213
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),0.2585230133929616,0.7030664362158037,1.0,1.0,1.0,23/147,18.05%,PTPN3;CDC26;BTG2;NEK6;BRINP1;PRMT5;EIF4EBP1;ANAPC16;ERCC2;HECA;TFAP4;CDC23;RCC1;SIRT1;BTRC;BRINP2;ANAPC7;PSMD13;MEIS2;ERCC3;TMEM8B;TTC28;TTL
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),-0.3108590102109013,-0.7029872477738376,0.95,1.0,1.0,13/66,23.10%,POLE3;MORF4L1;HAT1;SPI1;MORF4L2;TAF6;WDR5;MSL3;KAT5;TADA1;BRD8;PER1;ACTL6A
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),0.2695408217125321,0.7029531313518348,0.9523809523809523,1.0,1.0,10/135,8.31%,HSPB1;TENT5A;SAMD4A;ELAVL1;PRKCD;MEX3D;EXOSC1;HSPA1A;TENT5C;IGF2BP3
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.29643589943003057,-0.7029358272548559,0.9444444444444444,1.0,1.0,26/120,20.17%,BTN2A2;PTPRC;ELANE;PDCD1LG2;ZFPM1;RAC1;NCKAP1L;AGER;TRIM25;SIGIRR;TMSB4X;INHBA;APOD;SFTPD;CUEDC2;C1QBP;UFD1;CMKLR1;KAT5;CEACAM1;RGCC;IKBKE;SLC11A1;GPNMB;IRF3;NLRC5
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),-0.36921343566028136,-0.7028400243568655,0.9104477611940298,1.0,1.0,4/20,14.99%,LDLRAP1;FMO5;LPCAT3;MBTPS2
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),-0.40847724938091434,-0.7027502079862931,0.8833333333333333,1.0,1.0,3/12,12.16%,ACOX2;PINK1;HEBP2
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),0.3971645170183329,0.7026642615739153,0.8947368421052632,1.0,1.0,3/12,21.29%,MT1E;ATP7B;HSF1
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.45134912271897415,0.7023355520493458,0.8048780487804879,1.0,1.0,1/5,17.64%,TANK
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),0.43184846773024077,0.7022420999581217,0.8648648648648649,1.0,1.0,1/7,10.36%,SPHK2
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),0.37861422331303884,0.7019929126551826,0.8372093023255814,1.0,1.0,1/11,1.96%,TEX15
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),-0.4437064407207103,-0.7017659629638127,0.86,1.0,1.0,3/7,23.18%,GTF3C6;GTF3C3;GTF3C4
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.27562874921131475,-0.7013319456510848,0.9859154929577465,1.0,1.0,19/133,18.12%,SFRP4;DEPDC1B;GPC3;TGFB1;PSMB6;ATP6AP2;PSMB8;RSPO3;RSPO2;PSMA3;PSMC3;RSPO4;TLR2;PSMC6;PSMA5;DAAM2;PLEKHA4;PSMA7;ATP6V1C2
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),-0.3923270252638252,-0.701315070552592,0.8852459016393442,1.0,1.0,6/14,28.17%,MANBA;NGLY1;ADAMTS9;ADAMTS12;OGA;FBXO6
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.421230595391088,0.7011824852312658,0.803921568627451,1.0,1.0,3/9,14.18%,OSBPL7;PTCH1;LRP6
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),-0.48402907787722926,-0.7011823843810184,0.8979591836734694,1.0,1.0,3/5,31.97%,PODXL;RAP1GAP;ATP8B1
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.2925060796894011,0.7010628866601065,0.90625,1.0,1.0,9/40,22.32%,GREM1;NAF1;PARM1;PNKP;TERF1;ATM;NVL;SMG6;CTNNB1
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),0.4437550689577943,0.7010173023092072,0.8378378378378378,1.0,1.0,3/7,14.73%,EIPR1;ZDHHC2;SORL1
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),0.3737854103498097,0.7009477009738403,0.8823529411764706,1.0,1.0,1/9,6.73%,APOE
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.2686328771460906,0.7008111043228107,1.0,1.0,1.0,13/97,13.66%,GNG4;FGF13;SERTAD2;MINAR1;TGFB2;ENPP1;HSPA1A;SPHK2;RERG;PTPRS;BCL6;SIRT1;VGLL4
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),0.3552862656081918,0.6999539813314924,0.8857142857142857,1.0,1.0,4/20,16.18%,FGF13;MAP7D3;TPPP3;ZNF207
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),-0.4324697396227895,-0.6998338655505218,0.8709677419354839,1.0,1.0,1/5,15.58%,UHRF1
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),-0.4324697396227895,-0.6998338655505218,0.8709677419354839,1.0,1.0,1/5,15.58%,UHRF1
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.332696884469452,0.6994539196608854,0.8333333333333334,1.0,1.0,6/21,21.95%,PPP6R1;MTMR9;CHP1;PPP1R35;BMP2;URI1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.35856603581448676,0.6992208905808902,0.8333333333333334,1.0,1.0,2/16,5.56%,ADAMTS3;TSPAN12
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.2519967730593614,0.6991499374381891,1.0,1.0,1.0,22/85,22.10%,PCBP3;EREG;SF3B4;HSPA1A;LSM10;U2AF2;PNPT1;SNRPG;CELF1;LSM6;PCF11;SRRM4;SNRPE;SF3A2;SON;AURKAIP1;PTBP1;SCAF11;HSF1;SNRPB;ZFP36L2;DIS3L2
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.25617833079718433,0.6991497361013971,1.0,1.0,1.0,58/358,16.13%,FHDC1;ARL13B;TMOD4;PCM1;PDE6D;RAB32;CDC14B;DNAH5;CFAP70;TTC39C;RAB7A;CNGA4;RAB3IP;NEK6;GOLGA8H;GOLGA8M;UBXN10;PKHD1;PLA2G4C;CEP83;KIAA0586;PATL1;EIF2S1;PIBF1;CFAP43;EHD4;PTPN23;ABCC4;SCLT1;TMEM250;UBXN2A;SNF8;RFX2;MAPRE1;BBIP1;BICD1;WDR35;RC3H1;TSG101;SNAP29;RCC1;EXOC7;LSM14A;FNBP1L;CFAP44;VPS25;CFAP20;RILP;ABLIM1;FITM2;TTC36;BBS9;POC1B;EMC6;ELAPOR1;WDR45;PARVA;MACIR
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.2880718292409249,-0.699127418751733,0.9154929577464789,1.0,1.0,22/105,22.99%,DOCK8;RGS10;F11R;PINK1;GBA3;CALM3;RCN3;CCL5;CTSH;ADRB1;PSAP;MMUT;RASGRP2;ZC3H15;BCAR3;DOCK11;CALM1;RPS3;RGS1;RAP1GAP;NDEL1;NTRK1
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,-0.3445694716109712,-0.6990339884494643,0.9076923076923077,1.0,1.0,6/28,13.66%,SCGN;MAFB;SRP9;SRP14;PKLR;NKX2-2
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),-0.3647071450086099,-0.6990054328696967,0.873015873015873,1.0,1.0,5/19,30.21%,WDR5;MSL3;KANSL2;KANSL1;MSL1
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),-0.44842419917259313,-0.6987374813567795,0.9166666666666666,1.0,1.0,3/8,29.80%,LRRC8D;TWNK;LETM1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.3097225731765207,0.6986579226918109,0.9444444444444444,1.0,1.0,12/30,25.98%,EXOSC1;PATL1;EXOSC5;LSM6;DCPS;DCP1B;DIS3;DIS3L2;EXOSC7;DCP1A;POLR2G;EXOSC9
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.38832716386908656,-0.6985944976095148,0.8524590163934426,1.0,1.0,2/21,3.46%,AGT;CD74
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.36183040062034666,0.6984635706873975,0.8604651162790697,1.0,1.0,3/14,5.94%,TGFB2;PKDCC;PDGFRA
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),-0.361510298727852,-0.698309216973939,0.9,1.0,1.0,3/19,19.84%,USP21;ATXN7L3;EPOP
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.3102759331446872,-0.698054435873759,0.90625,1.0,1.0,21/44,33.30%,ATP5F1E;GHITM;ATP5F1C;MICOS10;ROMO1;ATP5MC3;HSPA9;ATP5PD;ATP5F1A;ATP5ME;ATP5PB;TIMM8A;TIMM22;SPG7;MICOS13;LETM1;TIMM8B;APOO;MTX2;AFG3L2;ATP5MC1
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),0.32821636640517193,0.6978937383920686,0.8387096774193549,1.0,1.0,2/35,2.36%,PTPN3;EGFR
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),-0.3636390292356046,-0.697880468321268,0.9076923076923077,1.0,1.0,9/25,26.61%,SLC18A2;OTOF;SLC17A8;CDK5;SLC32A1;WNT7A;CPLX1;DNAJC5;RAB3A
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),-0.4494383189681879,-0.6978411386915212,0.8947368421052632,1.0,1.0,2/8,10.83%,TAF7;SPI1
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),0.3612045973108366,0.697400555056626,0.8048780487804879,1.0,1.0,2/20,5.71%,SLC30A10;MT1E
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),-0.4782893058021248,-0.6969667260521597,0.9,1.0,1.0,1/5,3.17%,TIMP3
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),-0.43012503652575906,-0.6968395054619329,0.835820895522388,1.0,1.0,2/6,18.58%,GPSM2;EPB41L2
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),-0.38935588407863425,-0.6962182722249117,0.875,1.0,1.0,2/13,7.40%,ZNF703;WNT7B
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),-0.31070148555887506,-0.6959515626371204,0.8783783783783784,1.0,1.0,15/52,25.66%,BNIP3;TOMM20;BCAP31;TOMM7;SLC25A5;TOMM22;DNAJC19;SLC25A4;SLC25A31;TMEM14C;TMEM14A;TIMM17B;TIMM17A;TIMM22;COX18
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),0.3145655366248774,0.6958598291866188,0.9090909090909091,1.0,1.0,3/23,8.97%,KANK1;PRKCD;SSH1
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),-0.3195239961311616,-0.695738996901922,0.9295774647887324,1.0,1.0,3/38,4.86%,LIPH;DDHD2;LIPI
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.3265061115771122,-0.6956491163484434,0.9154929577464789,1.0,1.0,8/38,25.48%,TRIM32;POLR2J;POLR2K;SUPT5H;TRIM14;POLR2B;CTDP1;POLR2D
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),0.3883034408471487,0.6953465827654576,0.8541666666666666,1.0,1.0,6/10,32.89%,NSMCE2;TPRKB;SMC6;RAD51;SMC5;XRCC3
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.3592995704740102,-0.6951528980111827,0.9298245614035088,1.0,1.0,4/26,11.04%,DRD3;CDC6;KIF14;KIF20B
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),-0.397288752443401,-0.6951317334757979,0.8507462686567164,1.0,1.0,5/16,14.23%,SERPINE1;IGFBP5;PDGFRB;CCL5;NDRG4
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.27819703407270613,0.6949614640553692,0.9705882352941176,1.0,1.0,8/62,12.56%,HSPB1;ATF3;DNAJC3;EIF4EBP1;TPR;EIF2AK3;KLHL25;EIF3E
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),0.38826331322643726,0.6949095419113057,0.8205128205128205,1.0,1.0,2/9,10.36%,SLC25A33;SPHK2
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),-0.37522380110016357,-0.6948638446193683,0.875,1.0,1.0,7/17,19.73%,SERPINE1;AGER;CCL5;PLA2G7;CXCL17;C1QBP;CALR
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.2884131331074413,-0.6947257238437965,0.9384615384615385,1.0,1.0,12/62,21.68%,TPX2;RAB11A;GOLGA8O;STARD9;GOLGA8B;TUBGCP4;ABRAXAS1;MZT1;KIF11;RPS3;HAUS6;TUBGCP2
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),0.37965896507162117,0.6946531476838894,0.8611111111111112,1.0,1.0,2/12,11.74%,SHLD1;KMT5B
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.4016105397864852,0.6940133919247982,0.875,1.0,1.0,2/9,14.73%,STX18;SORL1
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),-0.4504758185836917,-0.6939458069488323,0.8275862068965517,1.0,1.0,5/6,38.40%,C1QA;CD81;C1S;C1QB;ZP3
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",0.3036338750917307,0.6938178056362886,0.9333333333333333,1.0,1.0,4/64,8.76%,CCNH;ELP4;IWS1;ERCC2
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),-0.2794540867925599,-0.6933612967424715,0.96,1.0,1.0,15/149,18.33%,EPHA1;DOCK8;RGS10;F11R;GRTP1;ARHGAP22;CCL5;ADRB1;GMIP;TBC1D13;MMUT;CXCL13;RASGRP2;ZC3H15;BCAR3
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.3832843146161795,-0.6933537172177394,0.819672131147541,1.0,1.0,2/10,8.37%,NOTCH1;NOTCH4
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.3916667429537707,0.6932640348379636,0.8536585365853658,1.0,1.0,4/13,11.08%,DDAH1;APOE;KCNC2;GUCY1A1
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),-0.3720782465566993,-0.6931031563246448,0.8153846153846154,1.0,1.0,4/12,28.20%,CTSH;BRD8;KLF9;RDX
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.306493694619477,-0.6929890617031723,0.9868421052631579,1.0,1.0,10/62,13.34%,CASP12;RPS27L;MTCH1;KHDC1;CARD8;CASP8;HIP1R;FADD;BOK;CYCS
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),-0.4493769541634467,-0.6927523309416418,0.8253968253968254,1.0,1.0,3/6,32.20%,SLC27A1;GPAM;PLA2G6
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.4040615680190234,-0.692556393055328,0.8095238095238095,1.0,1.0,2/10,12.18%,SVIP;ERLEC1
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.3548568468561441,0.6924006813371524,0.84375,1.0,1.0,9/25,22.25%,NAT9;FOXO1;SIRT1;EP300;DSCC1;CREBBP;GTF2B;NAA15;KAT6A
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.3081192371679587,-0.6921911357766447,0.9583333333333334,1.0,1.0,17/61,27.31%,CHMP4B;CASP8;CTSZ;CTSH;PRPF19;CLPX;NGLY1;VPS4A;ADAMTS12;CTSK;RPS27A;ISG15;MARCHF6;UBC;LGMN;PSMA8;RNF41
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),0.3906936450911075,0.6921343526851905,0.8780487804878049,1.0,1.0,1/10,1.40%,F2RL1
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),0.3136656060339643,0.6921133895168807,0.95,1.0,1.0,5/25,15.85%,AK6;RRM2;DUT;AK5;AK9
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.38733549024317365,-0.6918545939199681,0.8305084745762712,1.0,1.0,3/10,19.01%,PSMC3;PSMC6;ESR1
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.3165193098629092,-0.6917423823634107,0.9142857142857143,1.0,1.0,10/41,25.41%,RFC5;RPA3;TRIM25;POLE2;PCNA;UFD1;RPS27A;ISG15;UBC;RCHY1
prerank,GO_Biological_Process_2021__regulation of glucokinase activity (GO:0033131),0.45190549826548254,0.6917412644491765,0.8181818181818182,1.0,1.0,1/5,8.67%,DUSP12
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),-0.2750017247953745,-0.6917320514042613,0.9871794871794872,1.0,1.0,9/123,7.48%,CAV3;P2RY1;ATP1B1;F11R;NKD2;FYB1;ZDHHC22;MRAP;RAB11A
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.26884218914481994,0.6913870019531055,1.0,1.0,1.0,21/149,14.96%,SEM1;RFWD3;RAD51B;DCLRE1B;PAXX;XRCC4;BRCA2;HMGB1;EME2;SAMHD1;BABAM2;SMARCAL1;MAPK8;NSMCE1;EYA3;BRCC3;SPIDR;SMARCAD1;HERC2;CHEK2;NSMCE2
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),-0.356727215015151,-0.6913698436764422,0.8656716417910447,1.0,1.0,7/29,18.95%,HSD17B13;GPER1;ASXL3;CREBL2;EIF6;PRKAB2;CEACAM1
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",0.4191072336901338,0.691228979323238,0.8125,1.0,1.0,1/6,2.26%,SH3RF1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.3323711117138233,-0.6911460523590249,0.8840579710144928,1.0,1.0,5/25,19.00%,CHAC1;DAB2IP;ATP2A3;ITPR1;ERO1A
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.32654046069110787,-0.6909142721189402,0.953125,1.0,1.0,3/39,9.37%,CHMP2B;CORO1A;RNF26
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",-0.41465474743535824,-0.6905411907830621,0.8571428571428571,1.0,1.0,2/9,12.18%,SVIP;ERLEC1
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),-0.398772685142363,-0.6898988207019997,0.873015873015873,1.0,1.0,5/15,24.69%,HIP1R;NSG1;CALY;CLTC;CLTA
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.40116090692372774,0.6898804871184541,0.7446808510638298,1.0,1.0,4/7,23.58%,STAT3;TNRC6B;EIF4G1;AGO2
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.40116090692372774,0.6898804871184541,0.7446808510638298,1.0,1.0,4/7,23.58%,STAT3;TNRC6B;EIF4G1;AGO2
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),-0.3784877294128149,-0.6896928820371547,0.828125,1.0,1.0,4/11,28.20%,CTSH;BRD8;KLF9;RDX
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),-0.27657175044067994,-0.6895744006535751,1.0,1.0,1.0,9/120,7.48%,CAV3;P2RY1;ATP1B1;F11R;NKD2;FYB1;ZDHHC22;MRAP;RAB11A
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),-0.2838490229868718,-0.6895365422210183,1.0,1.0,1.0,15/89,19.68%,PDCD1LG2;SERPINE1;CD14;CD6;DAB2IP;GSTP1;LBP;STAP1;ADAM9;CXCL13;ADAM17;HNRNPA0;PRDX3;NOS1;SLC11A1
prerank,GO_Biological_Process_2021__protein side chain deglutamylation (GO:0035610),-0.4738728523023318,-0.6894980469859754,0.8688524590163934,1.0,1.0,2/5,20.06%,AGBL2;AGBL3
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.402878885397184,0.689462274374497,0.8285714285714286,1.0,1.0,1/11,10.50%,PIBF1
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.29713568070610147,0.6892556939173597,0.9743589743589743,1.0,1.0,9/58,10.59%,PTPN3;BCL2;LEPR;MTMR8;PLIN5;DAP;NELL1;TAB3;MTMR9
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),-0.38589797793770675,-0.6891215593334863,0.8181818181818182,1.0,1.0,4/12,19.91%,MSX1;CACNA1G;HCN4;NOTCH2
prerank,GO_Biological_Process_2021__regulation of response to reactive oxygen species (GO:1901031),0.4629377592020544,0.6889624812662787,0.868421052631579,1.0,1.0,2/6,3.79%,BMP7;GCH1
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),-0.41264812740353574,-0.6889568049267523,0.8939393939393939,1.0,1.0,2/12,14.16%,BCAP31;HERPUD1
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),0.4160155352781024,0.688737339003219,0.8181818181818182,1.0,1.0,2/6,5.75%,TGFB2;ACVR1
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),-0.36610386734274925,-0.6885130257940956,0.8888888888888888,1.0,1.0,1/18,9.27%,SKP1
prerank,GO_Biological_Process_2021__lipid transport across blood-brain barrier (GO:1990379),-0.4475597243363235,-0.6883494748804594,0.847457627118644,1.0,1.0,3/5,35.69%,SLC27A1;CD36;MFSD2A
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.37091296431571585,0.6877463999866361,0.7692307692307693,1.0,1.0,5/11,27.13%,UVRAG;TBC1D25;RUBCN;CALCOCO2;CLN3
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),-0.4435110236616784,-0.6874169009739355,0.8181818181818182,1.0,1.0,1/5,17.99%,PHF23
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),0.39623804286010933,0.6872751652354896,0.8571428571428571,1.0,1.0,2/10,13.33%,MDK;RIPOR2
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.3577337488000383,-0.6870902423419848,0.864406779661017,1.0,1.0,1/18,2.03%,RGS10
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol biosynthetic process (GO:0010511),-0.4597242396312363,-0.6865032217083362,0.8947368421052632,1.0,1.0,1/5,11.98%,HTR2B
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),-0.300389280865568,-0.6864951674127427,0.9705882352941176,1.0,1.0,11/66,19.98%,NXT1;DDX20;RANBP6;SNRPD2;GEMIN4;SPRN;NUP85;TSC2;NUP155;GCKR;NUP188
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),-0.40442947216921327,-0.6862419735548339,0.9027777777777778,1.0,1.0,1/14,3.45%,COASY
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.2787133561269616,-0.6861274508559145,0.9863013698630136,1.0,1.0,13/108,13.93%,SLC22A25;AMN;SLCO2B1;GM2A;CHMP2B;AQP9;SLC48A1;SLC18A2;CHMP2A;RCN3;CBLIF;ABCG5;LRP2
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),-0.43582238436897075,-0.6858059709495022,0.8846153846153846,1.0,1.0,4/7,29.56%,SLC24A1;ARF1;SLC24A2;PRRT1
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,0.28675589055723816,0.6857559819344978,1.0,1.0,1.0,21/97,18.52%,ADGRA1;GRIA2;GRM5;BRINP1;NGB;MMD2;FBLL1;ELAVL3;ARHGAP39;NXPH1;NYAP1;PPFIA3;MAP6;DNER;KCNC1;SNAP91;PRR36;GRIN1;BSN;CNIH2;CLVS2
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.38424912508720704,-0.6857241501627339,0.890625,1.0,1.0,1/14,6.22%,SLU7
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),0.3891172090508931,0.6853491980474109,0.8108108108108109,1.0,1.0,3/8,28.85%,ZFP36;MAPKAPK2;FOXP1
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),-0.3201174343062339,-0.6852225654103868,0.9322033898305084,1.0,1.0,5/42,10.81%,CTNNA1;AHR;MLC1;BRCA1;MAP4K1
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.3720472701833748,0.6852020744754037,0.9302325581395349,1.0,1.0,2/12,6.03%,BMP7;NR3C2
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),0.4057595137860993,0.6851417841939523,0.8863636363636364,1.0,1.0,1/7,1.44%,DOCK10
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),-0.4432903267910831,-0.6851273048892034,0.8679245283018868,1.0,1.0,1/5,14.23%,WASF1
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),-0.27675499060618297,-0.6850022670620177,0.9594594594594594,1.0,1.0,11/120,10.38%,ANGPTL7;AGT;ATF5;TMC8;TMEM97;PINK1;PAPPA2;NUBP1;KIF14;DAB2IP;HIP1R
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),-0.320793791954302,-0.6849453928284236,0.9076923076923077,1.0,1.0,7/35,22.56%,MYO5B;MYO1F;SYT4;RAB1A;MYO15A;MYO7B;NDEL1
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),0.3955439290092308,0.6847092836418338,0.7555555555555555,1.0,1.0,3/7,12.22%,SOX12;DUSP10;BCL6
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.28877477225300124,0.6847045170930105,0.9615384615384616,1.0,1.0,4/47,12.40%,RAB3C;OLFM2;STEAP3;SVBP
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.3062474041477172,0.6846071946283626,0.9302325581395349,1.0,1.0,14/36,25.77%,RNF126;UBE3D;UBE2R2;KLHL12;OBI1;MGRN1;CDC73;NEURL1;KLHL22;UBE2O;CUL3;RAD18;PRKN;ZNF598
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.4640234678492494,-0.6842028396801517,0.8813559322033898,1.0,1.0,2/6,16.41%,SVIP;USP14
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),-0.31719333445928055,-0.6838920058923137,0.9444444444444444,1.0,1.0,3/39,4.86%,LIPH;DDHD2;LIPI
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),-0.41254836999881594,-0.6837649634311685,0.9074074074074074,1.0,1.0,2/13,19.42%,ULK1;SCTR
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.27574857041685885,0.6837483789993386,0.9736842105263158,1.0,1.0,20/92,19.75%,ARID1B;ARID1A;BAZ2B;HDAC1;ZBTB1;SUV39H2;PBRM1;RUVBL2;SIRT1;SMARCAD1;SMARCB1;MYB;BPTF;SMARCA4;HDAC5;ZBTB7A;BAZ1B;BAHD1;TADA2A;KDM4C
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),0.36629236377544905,0.6834207383306176,0.8974358974358975,1.0,1.0,4/10,18.71%,CDC14B;BTRC;GORASP1;PTEN
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),-0.2549978896506176,-0.6834121836008854,1.0,1.0,1.0,29/360,14.25%,ROPN1B;NDP;HSD17B10;HSD17B13;KIF9;LMAN1;SPTBN5;PEX11B;CHMP4B;PINK1;CFAP126;CHMP2B;ZFP69B;ARL1;GOLGA8O;PEX16;PPID;CHMP2A;FGD3;ZMYM3;GOLGA8B;TANGO2;CATIP;RAB31;MCOLN1;CYCS;DIAPH3;TPM1;SPRYD3
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),0.34385513300593723,0.6831229928296703,0.8461538461538461,1.0,1.0,1/12,2.59%,IFIH1
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.30302839994269837,0.6830480753050565,0.868421052631579,1.0,1.0,3/28,9.19%,SMYD2;PRDM5;SUV39H2
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.41893080145175055,0.682703271275016,0.8333333333333334,1.0,1.0,2/7,5.62%,ZNF205;RAB27A
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",-0.3469176761387612,-0.6826429008823096,0.8888888888888888,1.0,1.0,6/23,24.54%,MAN1A1;SYVN1;MAN1B1;RPS27A;MARCHF6;UBC
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),-0.2879023500164672,-0.6826282280306053,0.9583333333333334,1.0,1.0,5/88,9.22%,EPHA1;CYP1B1;CD74;SERPINE1;IGFBP5
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.2620026813594397,0.6825309195184187,1.0,1.0,1.0,9/108,11.51%,ATP6V0D2;IRS1;HDAC9;ENPP1;IRS2;SLC25A33;FOXO1;PIK3R1;GCK
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.3812832650258004,-0.6822751254582394,0.927536231884058,1.0,1.0,2/15,14.20%,RPS7;RPL5
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),0.46321834695797015,0.6820478721080211,0.8292682926829268,1.0,1.0,3/5,16.59%,SLC19A1;ABCC4;ABCC5
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.31248513794520266,0.6820128482982939,0.975,1.0,1.0,8/36,16.21%,WWTR1;LATS1;TPR;BYSL;EIF2AK3;SIN3A;OTUD7B;CARD10
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.31223728323019695,0.6817037220377956,0.9428571428571428,1.0,1.0,2/26,7.55%,SLC7A2;SLC7A1
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),-0.3552709830282267,-0.6814848187387144,0.8833333333333333,1.0,1.0,1/18,2.03%,RGS10
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-0.37319551604359014,-0.6812159639104137,0.8507462686567164,1.0,1.0,2/9,29.46%,INPP5K;TOP2B
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),-0.44427715266119305,-0.6811933145055866,0.927536231884058,1.0,1.0,1/6,7.92%,PRKCH
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),0.4581337497260888,0.681069314245801,0.9047619047619048,1.0,1.0,3/5,31.06%,BAG3;PRKN;MAPT
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),-0.40944722645804155,-0.6809547208048137,0.8888888888888888,1.0,1.0,1/11,3.79%,DRD3
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.28627337511076767,-0.6807797589434005,0.9696969696969697,1.0,1.0,9/75,14.78%,TPX2;ATF5;ATAD5;TUBB;KIF14;CEP72;DCTN1;PLK4;YWHAG
prerank,PanglaoDB_Augmented_2021__Spermatocytes,-0.36201793409243976,-0.680468463127209,0.921875,1.0,1.0,9/19,27.93%,CAPN1;TTC6;TDRD5;SLC25A31;NOTCH3;PRSS54;SYCP2;WDR87;SYCP3
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),-0.43399006982745014,-0.6801887101576978,0.8823529411764706,1.0,1.0,1/5,8.00%,GBA3
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.39101478470365536,0.6799892069008823,0.8363636363636363,1.0,1.0,3/7,24.09%,SLC27A2;SLC25A17;PEX13
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),0.42612207511500066,0.6798278453001035,0.8333333333333334,1.0,1.0,3/5,15.20%,AUTS2;SIRT1;SMARCB1
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),0.4082414322585026,0.6794285057796331,0.8666666666666667,1.0,1.0,2/6,12.95%,SRR;PSPH
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),-0.39096392667413715,-0.6791685825555207,0.8596491228070176,1.0,1.0,2/13,12.93%,GMNN;DONSON
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),0.34753430909375255,0.6791024386602695,0.8571428571428571,1.0,1.0,1/13,2.22%,BCL2L11
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",-0.4301497552974609,-0.67904229748879,0.8709677419354839,1.0,1.0,2/7,10.44%,IRF1;HLA-A
prerank,GO_Biological_Process_2021__venous blood vessel development (GO:0060841),-0.4520760705592195,-0.678967172081011,0.8387096774193549,1.0,1.0,2/5,23.91%,CCBE1;ACVR2B
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),0.34165377817309023,0.6787726362490935,0.8541666666666666,1.0,1.0,1/15,3.56%,SLC22A13
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),0.231245249279308,0.678732362862528,1.0,1.0,1.0,4/159,3.16%,PID1;IMMP2L;GDAP1;RAB32
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),-0.3106563772995049,-0.678004900865389,0.9298245614035088,1.0,1.0,6/37,18.41%,TPX2;RAB11A;ABRAXAS1;MZT1;KIF11;RACGAP1
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.25434802230126236,0.6779854950173606,1.0,1.0,1.0,20/206,11.22%,ATP6V0D2;IFI16;HSPB1;BCL2;LEPR;WDR24;OSBPL7;TICAM1;MTMR8;HMGB1;VPS26B;DAP;PRKD1;ATF6;MID2;TAB3;MTMR9;PIP4K2A;MAPK8;FOXO1
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),0.459541276346591,0.6777615751477549,0.7272727272727273,1.0,1.0,1/5,4.86%,XRCC4
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),-0.43581206732547983,-0.6775823530532666,0.9056603773584906,1.0,1.0,3/6,12.27%,TIMP3;TIMP2;TIMP4
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),0.35806992588987674,0.677400130963968,0.8372093023255814,1.0,1.0,2/13,5.36%,CSF1R;ARFIP2
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),-0.3828416955462258,-0.6770897246726015,0.828125,1.0,1.0,1/14,10.25%,DCP2
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),-0.3304681301745169,-0.6769432173754218,0.9272727272727272,1.0,1.0,4/35,11.48%,GCM2;CHAC1;WDR62;SIX4
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),-0.283282671063142,-0.6768605719716396,0.96875,1.0,1.0,9/96,11.83%,FANCI;WFS1;PINK1;CAMLG;UBE3A;BRCA1;TSPYL5;ADGRB1;DNAJA1
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),-0.30506019349580926,-0.6767754731338982,0.9295774647887324,1.0,1.0,6/53,11.38%,EIF5A2;ACOX2;AQP9;TLCD2;PNPLA1;ABCB4
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),0.365379147815957,0.6767685679771722,0.8372093023255814,1.0,1.0,2/12,7.95%,TGFB2;APLN
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.3116581946372718,-0.6766565214519498,0.9240506329113924,1.0,1.0,3/46,13.03%,B2M;HIP1R;FLOT1
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),0.3874280883314044,0.6766171654308376,0.8888888888888888,1.0,1.0,3/10,8.31%,UCK2;UPP2;HPRT1
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.41188505156661304,0.6765171918645658,0.7777777777777778,1.0,1.0,3/7,29.74%,CTNNB1;RBPJ;STARD13
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),-0.4423100745327164,-0.6763685097884763,0.9137931034482759,1.0,1.0,1/7,10.02%,EFEMP1
prerank,GO_Biological_Process_2021__alditol metabolic process (GO:0019400),0.4287192591073821,0.6757937166135197,0.8372093023255814,1.0,1.0,1/5,10.49%,COQ2
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.2454044183563273,0.6757297827471324,1.0,1.0,1.0,17/231,10.03%,FBXL7;TEAD2;LEF1;CD247;MCU;PARD3;DNAJB12;ZNHIT6;WIPF1;GRIA1;LIN7A;HDAC1;CTSC;TRAPPC1;TFAP4;BET1;PPP6R1
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.39726265291260976,-0.6756990273893898,0.8688524590163934,1.0,1.0,1/10,11.57%,TMEM30A
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.2888445650544315,0.6756828438934496,1.0,1.0,1.0,6/29,15.60%,STAMBPL1;BABAM2;USP25;BRCC3;OTUD7B;OTUD7A
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),-0.43015724702105973,-0.6756765061483809,0.8787878787878788,1.0,1.0,2/5,18.58%,GPSM2;EPB41L2
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.2881924235340786,-0.6755948056390934,0.9863013698630136,1.0,1.0,13/85,17.52%,CLEC4C;PSMB6;PSMB8;SKP1;PSMA3;MUCL1;PSMC3;PSMC6;PSMA5;PLCG2;MUC4;LYN;PSMA7
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.2881924235340786,-0.6755948056390934,0.9863013698630136,1.0,1.0,13/85,17.52%,CLEC4C;PSMB6;PSMB8;SKP1;PSMA3;MUCL1;PSMC3;PSMC6;PSMA5;PLCG2;MUC4;LYN;PSMA7
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),-0.2881924235340786,-0.6755948056390934,0.9863013698630136,1.0,1.0,13/85,17.52%,CLEC4C;PSMB6;PSMB8;SKP1;PSMA3;MUCL1;PSMC3;PSMC6;PSMA5;PLCG2;MUC4;LYN;PSMA7
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860),-0.4439095145260547,-0.6755759290918081,0.8412698412698413,1.0,1.0,1/5,24.63%,CD226
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857),-0.4439095145260547,-0.6755759290918081,0.8412698412698413,1.0,1.0,1/5,24.63%,CD226
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.27481923943338704,0.6750699684886022,1.0,1.0,1.0,11/71,13.45%,TRPC3;CACNG3;GRIN3A;CACNA2D1;TRPC5;SLC8A3;MAGT1;NIPAL2;FYN;TRPC1;SLC8A1
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),-0.4137772983194201,-0.6750680044904911,0.7959183673469388,1.0,1.0,1/6,10.91%,DCTN1
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.35428343579417837,0.6749916165964907,0.875,1.0,1.0,6/15,19.64%,TGFB2;PTCH1;MYH3;LRP6;FBXW4;MBNL1
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),-0.42947974209924433,-0.6749832349554007,0.8333333333333334,1.0,1.0,2/7,13.19%,CCL5;GPR183
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.28059362052432835,-0.6747082786323675,0.9605263157894737,1.0,1.0,5/87,9.77%,ARIH2;NKD2;CAMLG;UCHL5;DDA1
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),-0.2733126055760778,-0.6745209881974725,1.0,1.0,1.0,12/109,17.65%,RAB6C;ARL1;MAGEL2;DCTN1;STX16;PREPL;VPS35;LAMP1;HOOK2;VPS52;ANKRD27;EMP2
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.31009011530346986,0.6744918431014065,0.95,1.0,1.0,7/28,17.08%,LEF1;HDAC1;TFAP4;RRP1B;EP300;SMARCB1;SMARCA4
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),0.4251553856297383,0.674300869020494,0.8837209302325582,1.0,1.0,2/5,20.05%,PTPN23;PTPRR
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.3028995842352734,-0.6741564323362744,0.971830985915493,1.0,1.0,4/43,10.39%,RFC5;RPA3;TRIM25;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.4023385281238989,-0.6739599069252861,0.890625,1.0,1.0,2/9,12.30%,CD6;GBP5
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.31619851989709097,-0.6739288366356438,0.9142857142857143,1.0,1.0,12/49,23.01%,ACOX2;BNIP3;CALCR;CIDEB;HEBP2;CDKN1B;C1QA;DAXX;PRR7;ZNF746;NTRK1;AXIN2
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.29028624267102415,-0.6738955256615841,0.9705882352941176,1.0,1.0,17/76,21.78%,NDUFB9;TMEM126B;NDUFA2;COA5;SCO2;NDUFB3;NDUFC1;NDUFB2;NDUFS2;NDUFB4;DMAC1;NDUFAB1;NDUFA1;FASTKD3;NDUFB11;NDUFS5;NDUFB10
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.3498557001658447,-0.673790545969703,0.8787878787878788,1.0,1.0,8/28,17.96%,CD74;IL7;AGER;IL18;TLR2;OAS3;ADAM17;TWIST1
prerank,GO_Biological_Process_2021__limb development (GO:0060173),-0.3542402459522692,-0.6737443040227641,0.9242424242424242,1.0,1.0,5/23,13.80%,LRP4;GLI3;RSPO2;KREMEN1;PCSK5
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),0.29309045917193904,0.6736971201652228,0.975,1.0,1.0,5/27,17.94%,MAP3K20;MAPK8;MAP3K5;BTRC;NFKB1
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),0.3519053583435707,0.6736054215540676,0.8717948717948718,1.0,1.0,2/13,17.80%,SPIN1;SIRT7
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),-0.2520788790400012,-0.6735620025370421,1.0,1.0,1.0,43/298,20.27%,RAB6C;AMN;CD74;ATP6V1B2;ATP6AP1;ARCN1;RAB19;SLU7;CHMP2B;ATP6V1E1;ARL1;UNC119B;ATP6V1D;GRTP1;CHMP2A;RCN3;STX19;TANGO2;STX16;NEURL1B;RAB31;MCOLN1;PREPL;VPS35;LRP2;TBC1D13;RAB23;ATP6V1C1;ATP6V1E2;RAB1A;SNX4;LAMP2;YWHAH;ATP6V1C2;ARF3;KIF3A;ARF1;RAB12;ARL4C;RAMP1;RUNDC1;ARL6;TXNIP
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),-0.33679780708324414,-0.6726017555879212,0.8870967741935484,1.0,1.0,5/34,13.03%,LRP4;CHMP4B;TLCD2;CHMP2A;FLOT1
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",-0.4336929063939871,-0.6722499212763168,0.9180327868852459,1.0,1.0,1/6,7.48%,RAB11A
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),0.345094808249,0.6720781194380194,0.8387096774193549,1.0,1.0,1/8,11.82%,ETF1
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.27779270436777703,-0.6718764764414465,0.9714285714285714,1.0,1.0,9/105,10.83%,PTGIS;CYP1B1;WFS1;SFRP4;CARD8;DAB2IP;SIGIRR;TMSB4X;SPI1
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.3015219501100971,-0.6716638951298339,0.971830985915493,1.0,1.0,13/54,24.77%,TCP1;RFC5;CCT6A;CCT8;PDGFRB;PCNA;RGCC;CCT7;HSP90AB1;CCT2;PKIB;MAPKAPK5;CHTF18
prerank,GO_Biological_Process_2021__prepulse inhibition (GO:0060134),-0.4252284287076983,-0.67153319869869,0.9375,1.0,1.0,1/6,3.79%,DRD3
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),-0.30296889362127055,-0.6715238233647187,0.8955223880597015,1.0,1.0,7/33,20.02%,PTGIS;BRCA1;ACMSD;SNAI2;OPN3;CEACAM1;SLC27A1
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.255949416104011,0.6714643459373505,1.0,1.0,1.0,11/103,14.01%,ATP6V0D2;KDR;EPM2A;MTMR8;VPS26B;BNIP3L;MAPK8;EXOC7;NRBP2;SIRT1;GNAI3
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),0.2751345868894016,0.6714264029573243,0.9666666666666667,1.0,1.0,2/32,6.73%,IRS1;APOE
prerank,GO_Biological_Process_2021__DNA deamination (GO:0045006),-0.4531950436205071,-0.6713957043963728,0.9090909090909091,1.0,1.0,1/5,15.75%,EXOSC6
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.36804881122884103,-0.6713816389594496,0.9692307692307692,1.0,1.0,6/16,30.14%,NEFL;MAP1A;KIF5A;KIF1C;KIF1A;SOD1
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.31631209473693345,0.67120347047433,0.90625,1.0,1.0,1/14,3.56%,SLC22A13
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),0.3663072826112546,0.6706915034616857,0.9148936170212766,1.0,1.0,1/10,5.93%,LRRC17
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),-0.37377822309630215,-0.6706562244235786,0.9206349206349206,1.0,1.0,3/14,22.84%,PCK2;GPAM;DGAT1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.3878803573361005,-0.670414798104613,0.8985507246376812,1.0,1.0,4/13,12.31%,CARD8;GSTP1;PELI3;GPS2
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),-0.37051062349832375,-0.6698926468117283,0.9305555555555556,1.0,1.0,2/13,10.46%,GAR1;TRUB1
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.2686732891572834,0.6698668407799626,1.0,1.0,1.0,14/93,13.66%,GNG4;SERTAD2;FGFR3;MINAR1;TGFB2;MT1E;ENPP1;HSPA1A;SPHK2;RERG;BCL6;PNPT1;SIRT1;VGLL4
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),-0.3007948856541003,-0.669809413516789,0.9848484848484849,1.0,1.0,6/77,9.94%,UPB1;POLQ;RNF213;CLDN1;LRRC8D;CHMP2A
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),-0.3498510637491211,-0.6697901179873085,0.890625,1.0,1.0,2/21,8.12%,RAC1;BRK1
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),-0.45427232233580594,-0.6695489405241601,0.8936170212765957,1.0,1.0,2/5,20.76%,PIK3CB;PIK3CD
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),-0.3851948338572537,-0.6695282091483171,0.8852459016393442,1.0,1.0,2/14,5.86%,ALOX12;ADAMTS18
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",0.40739652852651254,0.6694831923718161,0.8837209302325582,1.0,1.0,1/7,1.98%,NRP1
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.2697195224975769,0.6689672689128064,1.0,1.0,1.0,6/56,11.46%,CROCC;CDKL1;TBC1D10B;TBC1D2;CEP120;TBC1D16
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.3519929264508296,-0.6689664606779901,0.859375,1.0,1.0,6/19,18.23%,RARRES2;CCL5;MSN;LYN;CXCL17;CMKLR1
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.3405183950915192,0.6686694809985434,0.7804878048780488,1.0,1.0,8/18,26.15%,NRXN1;NLGN1;GRIN1;PTEN;RELN;RIMS2;SHANK1;NLGN3
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.3386396086223977,-0.6686615172452611,0.9411764705882353,1.0,1.0,4/23,20.69%,CEMIP;PDZK1;TCAF2;MIEF1
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.36446901027639,0.6682641068962257,0.8,1.0,1.0,3/11,10.54%,IL1RAPL1;NLGN1;CEL
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.3507645271483359,-0.6679482355563373,0.9206349206349206,1.0,1.0,8/41,15.65%,B2M;LDLRAP1;GPC3;SERPINE1;NCKAP1L;RAB31;FLOT1;STAP1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.3851136606475283,-0.6678534722265306,0.8947368421052632,1.0,1.0,4/9,18.87%,CCL5;CXCL13;PODXL;SKAP1
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),0.2959443532081497,0.6678059731885583,0.9666666666666667,1.0,1.0,8/34,19.36%,PPP1R8;PRKCD;PPP6R1;NSMF;SPPL3;PPP1R7;ENSA;PTBP1
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),-0.4455011897634923,-0.6675791018798183,0.8947368421052632,1.0,1.0,2/6,19.03%,BRCA1;MDM1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.38100023462946553,0.6675765515679831,0.8653846153846154,1.0,1.0,2/7,28.51%,VEGFA;PPP1R16B
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),-0.2779340329174751,-0.6675702306959073,1.0,1.0,1.0,20/131,18.37%,ACTC1;RND1;RAC1;RFLNA;MYO5B;MYO1F;CORO1A;TTN;HIP1R;RHOH;INPPL1;TPM1;ARHGAP12;WAS;MARCKSL1;VIL1;SHROOM3;EMP2;TLE6;MYO15A
prerank,GO_Biological_Process_2021__polyol transport (GO:0015791),-0.43004671791093896,-0.6675256199095657,0.8888888888888888,1.0,1.0,4/6,30.37%,AQP9;SLC5A11;AQP11;AQP7
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.3081625416518437,-0.6673487661672034,0.8870967741935484,1.0,1.0,4/36,15.80%,RFC5;RPA3;RBX1;PCNA
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),-0.3146961317846997,-0.6671839892575797,0.9836065573770492,1.0,1.0,7/31,28.05%,LAMTOR2;GLRA3;GLRA1;LAMTOR5;RRAGA;SPAAR;LAMTOR3
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),-0.34991567698040765,-0.6670203167505508,0.9354838709677419,1.0,1.0,9/22,26.20%,HSPA5;DNAJB1;SDF2L1;ST13;HSPA9;ERO1A;HSPA1L;GAK;HSPA8
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),-0.34043624934698646,-0.6668360754534653,0.8382352941176471,1.0,1.0,6/21,25.01%,SOX10;LIN7C;ARHGAP12;ACTG1;PRKX;AHI1
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.3182741455257331,0.6667994446200447,0.9230769230769231,1.0,1.0,9/23,22.32%,TET1;AUTS2;PHF1;SIRT1;MYB;DNMT1;CHTOP;DNMT3B;CTNNB1
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),0.39990745151189866,0.6666393076383185,0.9473684210526315,1.0,1.0,1/8,4.89%,JAM2
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),-0.4498574727512613,-0.6665937292325851,0.9428571428571428,1.0,1.0,1/5,7.92%,PRKCH
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),0.3265982968606018,0.6665636873336611,0.9047619047619048,1.0,1.0,2/18,8.59%,TGFB2;EPHA7
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.24526438080514948,0.6664733247193554,1.0,1.0,1.0,34/158,21.25%,DGKB;SYNJ2;CEPT1;MTMR8;CHKA;PIK3R6;PLD2;PLD6;PLA2G4C;DGKH;PI4K2A;MTMR9;LCAT;AGPAT5;PIP4K2A;PIK3R1;PTPN13;CHPT1;ABHD8;LCLAT1;GPD1L;PCYT1B;PIK3C2B;ABHD4;PCYT2;PTEN;MTMR6;PIP5K1C;PITPNM1;GPAT4;MTM1;MTMR3;APOA1;PGS1
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),-0.29924785273138343,-0.6663837503567793,1.0,1.0,1.0,7/47,17.16%,WFS1;WIPI1;HSPA5;DCTN1;SYVN1;DDX11;KDELR3
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),0.3785563730730354,0.6661407740740314,0.7555555555555555,1.0,1.0,3/7,22.32%,CDH1;CBL;CTNNB1
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),0.320060460913364,0.6660996076895076,0.9210526315789473,1.0,1.0,2/18,7.49%,COX10;COX19
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),-0.3616985975269706,-0.6658404319869065,0.8688524590163934,1.0,1.0,2/19,7.12%,MYO5B;MYO1F
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.2572868758733547,0.6657605801639556,0.967741935483871,1.0,1.0,10/75,16.02%,ROR2;PRICKLE1;RYK;FZD1;DVL2;MAGI2;WNT5A;TIAM1;PRICKLE2;PSMD13
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,0.2528794493530051,0.6654822818342236,1.0,1.0,1.0,20/88,18.94%,KCNB2;IGDCC3;PLPPR5;LIN28B;CACNG4;RHBDL3;GRM8;PHF21B;CRABP1;FBLL1;MEX3A;NYAP1;EPHA8;PPM1E;DPYSL5;SNAP91;ST8SIA2;CLVS2;C2CD4C;CACNA1B
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),-0.2831888898057903,-0.6654778679818301,0.9736842105263158,1.0,1.0,31/82,30.51%,PSMB6;PSMB8;TOLLIP;SKP1;PSMA3;PELI3;PSMC3;PSMC6;PSMA5;RBX1;NFKBIA;PSMA7;PSMD12;PSME1;RPS27A;PSMB2;UBC;RIPK2;PSMD2;PSMA8;PSMA1;MAP3K3;PSMC1;TNIP2;PSMD4;PSMD8;MAP3K8;PSMB4;PSMC4;IRAK4;UBB
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell differentiation (GO:2000727),-0.45007038247102676,-0.6654390202527869,0.8947368421052632,1.0,1.0,1/5,5.95%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),0.3189381811136643,0.6653718115731909,0.9642857142857143,1.0,1.0,4/33,12.56%,IFIH1;REL;PTPRS;RNF216
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),-0.39705759869089047,-0.6652145425220416,0.9107142857142857,1.0,1.0,3/9,21.25%,FKBP1B;VDAC1;PLN
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.2595887211643555,0.665058519107117,0.9565217391304348,1.0,1.0,5/116,5.51%,ADARB2;PPP1R8;PCBP3;ATXN1;RBMS1
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),-0.39184834396299256,-0.6650229107325543,0.8909090909090909,1.0,1.0,2/9,17.05%,NOTCH1;CCN3
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),0.34929020298935437,0.6648146422325959,0.8571428571428571,1.0,1.0,3/14,10.58%,CSF1R;MDK;IL34
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.31767067344446176,0.6647639830713509,0.9459459459459459,1.0,1.0,5/17,13.66%,APOE;RNF128;CTSC;FAF1;VGLL4
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),-0.29317006053428746,-0.6645072454172524,0.9863013698630136,1.0,1.0,15/71,23.97%,WFS1;HSPA5;TRIM25;HERPUD1;PSMC6;MAN1A1;SYVN1;SEL1L2;SGTB;UFD1;MAN1B1;HSP90B1;ANKZF1;TMUB1;MARCHF6
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.31445555265297326,-0.6644426628826456,0.9180327868852459,1.0,1.0,4/34,15.80%,RFC5;RPA3;RBX1;PCNA
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),-0.4364850001512729,-0.6642315663145099,0.9482758620689655,1.0,1.0,1/6,15.75%,EXOSC6
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.23242348588062603,0.6638079263414782,1.0,1.0,1.0,19/219,11.48%,TEAD2;LRRTM3;HORMAD1;CD247;PKP2;QRICH2;PARD3;RAD21L1;WIPF1;LIN7A;NLGN1;JHY;FSCN3;TOGARAM1;TFAP4;FZD1;LIMS1;CFAP46;VAMP3
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),-0.39182865710658904,-0.6636260552319,0.8823529411764706,1.0,1.0,1/11,7.19%,TTLL4
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),0.30076504363621004,0.6633738307365517,0.8666666666666667,1.0,1.0,6/30,12.05%,IDH2;APOE;CLN6;LCAT;SCAP;PIP4P1
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),-0.35647557889182474,-0.6621113167746825,0.8571428571428571,1.0,1.0,8/12,39.22%,VPS4A;OSBPL2;STAR;SERAC1;ARV1;NPC2;NPC1;STARD4
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.28250397781822895,-0.6620963528870669,0.9861111111111112,1.0,1.0,10/55,18.14%,CAV3;LDLRAP1;TMEM97;FABP3;LIPC;IL18;ABCG5;PLA2G10;HNF4A;ACSM3
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.24618961608188167,-0.6617743273151047,1.0,1.0,1.0,61/276,28.66%,FIP1L1;CSTF2T;SLU7;SYF2;DDX39A;NONO;SNRPD2;UBL5;NCBP2;FRG1;PPWD1;PCBP1;NCBP1;PRPF19;ZMAT2;RNPS1;SNRNP48;ALYREF;USP39;CMTR1;POLR2J;POLR2K;CDC40;SUPT5H;BUD13;RNMT;RBM4B;HNRNPA0;CRNKL1;CWC25;RBM4;UPF3B;SF3B2;THOC5;POLR2B;MFAP1;BUD31;CLP1;DHX38;SNW1;SRSF5;CPSF4;DHX16;METTL3;POLR2D;ZCCHC8;LSM4;ALKBH5;HSPA8;SMU1;NUDT21;PRCC;WBP11;SNRNP70;ELAVL2;CSTF1;SRSF9;YTHDC1;SRSF8;PPIL3;DHX15
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),-0.4203258719274542,-0.6617464736124082,0.8852459016393442,1.0,1.0,1/6,11.27%,ACTA2
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.2991312050809262,0.6616259276396818,0.9333333333333333,1.0,1.0,2/19,7.72%,KANK1;NLGN1
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),0.3948529398360975,0.6615678836094226,0.8958333333333334,1.0,1.0,2/6,16.08%,DLG2;CARF
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),0.3948529398360975,0.6615678836094226,0.8958333333333334,1.0,1.0,2/6,16.08%,DLG2;CARF
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),-0.41448358460003903,-0.6615326554395333,0.8936170212765957,1.0,1.0,1/6,15.58%,UHRF1
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),-0.3998857986462367,-0.6615015989814101,0.8666666666666667,1.0,1.0,1/8,2.29%,PTPRC
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),0.3896638094517788,0.6612690158233574,0.9047619047619048,1.0,1.0,3/7,23.59%,ATM;SMG6;TERF2
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),-0.3746795896544574,-0.6609718704609301,0.92,1.0,1.0,2/15,5.83%,LRP4;NOTCH1
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",-0.35692819918087476,-0.6606428284454056,0.9047619047619048,1.0,1.0,6/17,30.03%,HERPUD1;SYVN1;UFD1;HSP90B1;DERL1;SELENOS
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.29373162242286327,0.6604125614685956,1.0,1.0,1.0,9/28,23.69%,EXOSC1;PATL1;EXOSC5;LSM6;DCPS;DCP1B;DIS3;EXOSC7;DCP1A
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.360826156679218,-0.6601820704336842,0.8135593220338984,1.0,1.0,4/18,12.77%,CEMIP;CALCR;GPER1;CASQ1
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.3240930554017759,-0.6600812592687191,0.9285714285714286,1.0,1.0,5/27,23.48%,CEMIP;PDZK1;TCAF2;MIEF1;INPP5K
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.2851259836933672,-0.6595312703366654,0.9859154929577465,1.0,1.0,25/60,30.26%,B2M;PSMB6;PSMB8;PSMA3;HLA-A;PSMC3;PSMC6;PSMA5;PSMA7;PSMD12;CALR;HLA-C;PSME1;NCF2;PSMB2;HLA-F;PSMD2;PSMA8;PSMA1;PSMC1;PSMD4;PSMD8;CD36;PSMB4;PSMC4
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),-0.355092836895102,-0.6594663530934116,0.9215686274509803,1.0,1.0,2/13,5.33%,FGL1;IL4I1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.29730558444816985,-0.6589617797021068,0.9852941176470589,1.0,1.0,6/46,12.31%,CARD8;CASP8;GSTP1;PELI3;FADD;GPS2
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),0.2946905069769677,0.658945996994651,0.9142857142857143,1.0,1.0,5/29,12.57%,LIX1;RUBCNL;VAMP8;TSG101;SNAP29
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.28647407003988246,-0.6589233256014978,0.958904109589041,1.0,1.0,1/51,1.20%,PATL2
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),0.30137367831676176,0.6589158977894055,0.967741935483871,1.0,1.0,6/32,18.40%,SGMS1;SPHK2;AGPAT5;FITM2;SGMS2;PCYT2
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.4038600827457537,-0.6589072325088796,0.890625,1.0,1.0,2/9,11.57%,ABCB4;TMEM30A
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),-0.4243017023698408,-0.6587590401544274,0.8767123287671232,1.0,1.0,1/6,5.98%,PINK1
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),0.36199556924350795,0.65856641280278,0.8648648648648649,1.0,1.0,1/10,3.31%,GSDMB
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.24464421754134805,0.6585132355235763,1.0,1.0,1.0,6/114,6.24%,ZEB2;EGFR;KANK1;ZBED3;SEMA5A;FGF10
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),-0.3743362610466903,-0.6583999629866839,0.85,1.0,1.0,1/12,3.10%,TK2
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.3150171121611529,0.6582069534995675,0.975,1.0,1.0,3/23,11.55%,TLR1;TAB3;TAB1
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),-0.332159018643908,-0.6581753046265337,0.9666666666666667,1.0,1.0,8/25,26.20%,HSPA5;DAB2IP;DAXX;HSPA9;HSPD1;HSPA1L;BAX;HSPA8
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),0.25285741819990815,0.6576374201669913,1.0,1.0,1.0,15/134,11.60%,SOX13;WWTR1;LATS1;MDK;MCC;PRICKLE1;GREM1;APOE;PTPRO;RBMS3;HDAC1;ANKRD6;UBAC2;TLE2;DVL2
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.2904708465612524,0.6575587365264716,0.8837209302325582,1.0,1.0,13/32,23.70%,TIMELESS;MAP3K20;CLSPN;CDC5L;CHEK2;ATM;ATRIP;SETMAR;TP53BP1;HUS1;TIPIN;HINFP;RAD9A
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.3171987368754443,0.6572213934898294,0.9411764705882353,1.0,1.0,6/22,19.34%,ZDHHC14;ZDHHC11B;ZDHHC3;ZDHHC2;ZDHHC11;ZDHHC7
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.3171987368754443,0.6572213934898294,0.9411764705882353,1.0,1.0,6/22,19.34%,ZDHHC14;ZDHHC11B;ZDHHC3;ZDHHC2;ZDHHC11;ZDHHC7
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),0.26182580828215707,0.6572060948668753,1.0,1.0,1.0,7/66,11.55%,TLR1;TRAF3;TICAM1;HMGB1;S100A1;TAB3;TAB1
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.3501744062585682,-0.6569156967094691,0.847457627118644,1.0,1.0,1/18,10.02%,EFEMP1
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),0.2716356388332676,0.6565865458262397,1.0,1.0,1.0,5/50,12.26%,IFIH1;NUP210;NUP42;TPR;NUP37
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),-0.41246344459757006,-0.6564179609254933,0.92,1.0,1.0,3/8,16.27%,GBA3;B3GALT1;B4GALT3
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.2784491724322891,-0.6563846906798859,0.9722222222222222,1.0,1.0,10/56,18.14%,CAV3;LDLRAP1;TMEM97;FABP3;LIPC;IL18;ABCG5;PLA2G10;HNF4A;ACSM3
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.3508055648448507,-0.6560954630035667,0.8769230769230769,1.0,1.0,3/17,13.62%,DAB2IP;MSN;VPS35
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),-0.4314728059529144,-0.6560609011052212,0.8833333333333333,1.0,1.0,1/6,13.37%,PDZK1
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),-0.3963905040428505,-0.6560282635908631,0.890625,1.0,1.0,6/10,19.53%,CYP19A1;HSD11B1;YWHAH;HSD17B11;HSD17B6;SPP1
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.2578051399077613,-0.6559339290126912,1.0,1.0,1.0,21/153,17.79%,NOTUM;HIC1;SFRP4;LRP4;NKD2;PSMB6;PSMB8;GLI3;RNF213;DAB2IP;PSMA3;KREMEN1;PSMC3;PSMC6;PSMA5;RBX1;TSC2;WIF1;SNAI2;PSMA7;TLE6
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.358639517832248,0.6554719623481631,0.9722222222222222,1.0,1.0,4/10,22.57%,SMAD2;SRRT;PUS10;DGCR8
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.30630732312281506,0.6553873103657264,0.9354838709677419,1.0,1.0,2/19,9.61%,LATS1;TFAP4
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),0.42486022675263646,0.6553828459852974,0.8,1.0,1.0,3/5,27.57%,PTPN1;NCK1;PPP1R15B
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),0.4187969518456465,0.65534206871454,0.7631578947368421,1.0,1.0,6/6,58.13%,TGFBR3;GNG2;ADCY6;GNB1;TNFSF4;SFRP1
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),0.3289422075824848,0.6550575603117185,0.9354838709677419,1.0,1.0,2/13,5.75%,TGFBR1;GREM1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.2850858476796748,-0.6549716814258674,1.0,1.0,1.0,25/62,30.26%,B2M;PSMB6;PSMB8;PSMA3;HLA-A;PSMC3;PSMC6;PSMA5;PSMA7;PSMD12;CALR;HLA-C;PSME1;NCF2;PSMB2;HLA-F;PSMD2;PSMA8;PSMA1;PSMC1;PSMD4;PSMD8;CD36;PSMB4;PSMC4
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),0.23725920209429965,0.6547639162954142,1.0,1.0,1.0,23/166,16.03%,NEDD1;KCNH5;PCM1;CDC14B;CDC26;NEK6;HMMR;PTPN6;ANAPC16;ERCC2;CEP135;TFAP4;CDC23;CDK5RAP2;MAPRE1;HECW2;SIRT2;ID2;BTRC;DYNC1I2;ANAPC7;PSMD13;ALMS1
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),0.2909259174706589,0.6543263373843854,0.967741935483871,1.0,1.0,7/25,19.88%,PRKCD;TPR;PIK3R1;BAG3;DMAP1;HDAC3;CDH1
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.2613812582679714,0.6539930705074865,1.0,1.0,1.0,11/41,26.87%,NBDY;HSPA1A;RC3H1;PNPT1;LSM6;ZFP36L2;DIS3L2;DDX5;ZFP36;EXOSC9;METTL16
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.29558213511766174,-0.6539301676188353,0.9811320754716981,1.0,1.0,9/40,19.27%,DRD3;TOM1L1;PDGFRB;BORA;KIF20B;TGFA;CHEK1;NME6;RGCC
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.4335328757119639,-0.6535588409328713,0.92,1.0,1.0,1/6,15.41%,EMG1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),0.25925969488342365,0.6533137898919817,1.0,1.0,1.0,9/57,16.21%,WWTR1;CROCC;GNL3L;EIF2AK3;BICD1;FYN;NUMA1;GPD1L;CARD10
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.33165495059957945,0.65325927927992,0.9024390243902439,1.0,1.0,4/14,13.32%,DECR2;EHHADH;CROT;ACOT8
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.3636078596936102,0.652931536595932,0.8536585365853658,1.0,1.0,4/11,27.63%,ARID5B;SPTLC2;SH3PXD2B;ZNF516
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.3734752200630265,-0.652833976389804,0.8857142857142857,1.0,1.0,6/17,27.56%,PAICS;GMPR2;AK4;AMPD2;AMPD3;IMPDH2
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.37565011171950724,-0.6525958702451754,0.9130434782608695,1.0,1.0,5/15,24.40%,OAS3;NLRC5;STAT2;ISG15;METTL3
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.41075872645920136,0.6525171971575007,0.8913043478260869,1.0,1.0,4/7,39.33%,CPEB2;CPEB4;UNK;CPEB3
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.4149231885741276,0.6515141444972505,0.9210526315789473,1.0,1.0,2/7,6.36%,HEY1;JAG1
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),0.41023562472978803,0.651444016006994,0.8936170212765957,1.0,1.0,5/5,58.99%,PML;ETS1;HIPK2;SERBP1;HABP4
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),-0.3161685688800684,-0.6512287341103258,0.9558823529411765,1.0,1.0,5/39,11.34%,NOTCH1;ALDH1A1;IL15;ACOT13;IL18R1
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.36842743541152434,-0.6510935306042066,0.8939393939393939,1.0,1.0,2/9,18.03%,C1QBP;UFD1
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.3496651063976379,0.6510072215398244,0.9090909090909091,1.0,1.0,2/10,12.83%,SLC25A20;CPT1A
prerank,GO_Biological_Process_2021__liver development (GO:0001889),-0.33859630915911665,-0.6508610984234356,0.9577464788732394,1.0,1.0,2/22,9.61%,CCDC39;GFER
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),-0.39697373112369355,-0.6506076782965885,0.8870967741935484,1.0,1.0,2/9,9.52%,NCKAP1L;G6PD
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.4245278412107124,0.6505138660370672,0.9130434782608695,1.0,1.0,1/5,15.37%,PLEKHM1
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.3739867810530242,0.6504544058565649,0.8611111111111112,1.0,1.0,3/12,6.36%,HEY1;ACVR1;JAG1
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.39450662804248937,0.650359043029495,0.8108108108108109,1.0,1.0,2/5,8.00%,HMGB1;ZBTB1
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544),-0.44323572360349883,-0.6497819416630707,0.8928571428571429,1.0,1.0,2/5,21.00%,CXCL13;FGF1
prerank,GO_Biological_Process_2021__negative regulation of anion transmembrane transport (GO:1903960),-0.40691106268185073,-0.6497130589763033,0.88,1.0,1.0,2/5,26.72%,TCAF2;ARL6IP5
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),0.2939827686237358,0.6495820220744691,0.975,1.0,1.0,10/30,26.86%,GRM5;PRKCD;TCOF1;NANOS3;FOXO3;GEMIN5;PUM3;NR1H4;SAMD8;METTL18
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),0.3958750534631483,0.6495171272409754,0.875,1.0,1.0,1/6,10.74%,DDX60
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.34643925933710495,-0.6491204883989931,0.921875,1.0,1.0,4/18,16.24%,WFS1;BCAP31;HERPUD1;CCDC47
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.3302326313835957,0.6491077285399257,0.9761904761904762,1.0,1.0,6/17,12.82%,ST3GAL3;B4GALNT2;MPDU1;FUT9;ABO;ST3GAL2
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.36338157803873067,-0.648818612743775,0.9846153846153847,1.0,1.0,7/21,19.41%,DUOX1;NTN1;TRIM32;ADAM17;LYN;TWIST1;TUBB2B
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),-0.33883060580143604,-0.6486253342952989,0.9402985074626866,1.0,1.0,3/28,13.68%,RASA1;SERPINE1;APOD
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.32838276795337445,0.6485435434327251,0.9117647058823529,1.0,1.0,1/18,2.10%,ZEB2
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.32838276795337445,0.6485435434327251,0.9117647058823529,1.0,1.0,1/18,2.10%,ZEB2
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),-0.3663099154523969,-0.6484242412127809,0.9365079365079365,1.0,1.0,2/12,5.95%,NOTCH1;TGFB1
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),-0.40292928368536074,-0.6482659784609479,0.88,1.0,1.0,1/6,5.13%,ABCB1
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.3072969192635669,-0.6479595784514741,0.9841269841269841,1.0,1.0,9/33,20.63%,ISG20;NCBP1;NUDT1;SUPV3L1;DNASE1L1;RNASEH2C;RNASET2;NUDT15;ENTPD5
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.3861419158340951,0.647686079229111,0.8636363636363636,1.0,1.0,1/6,7.74%,HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.2885257157453744,0.6474449996355663,0.972972972972973,1.0,1.0,4/32,10.33%,BCL2L11;BCL2;NACC2;STYXL1
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),-0.40214820168302556,-0.6472967896834014,0.873015873015873,1.0,1.0,1/6,4.89%,GMFG
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),-0.2575408825099227,-0.6472840550843096,1.0,1.0,1.0,9/92,18.43%,LOXL4;RNF212B;EYA1;EEF1AKMT2;NUP85;NUP155;NDUFAB1;PLOD2;KAT5
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),0.3939594794520505,0.6472834666850166,0.8863636363636364,1.0,1.0,4/6,28.39%,NR1H3;NR1H2;PTPN2;PPARG
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),0.3939594794520505,0.6472834666850166,0.8863636363636364,1.0,1.0,4/6,28.39%,NR1H3;NR1H2;PTPN2;PPARG
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.40339721144817714,-0.647096208941278,0.9038461538461539,1.0,1.0,1/7,2.84%,CAV3
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),0.34399107632091874,0.6469226957909929,0.8285714285714286,1.0,1.0,2/12,8.81%,CCDC22;FAF1
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),0.25148041363166107,0.6468088520996991,1.0,1.0,1.0,9/76,16.02%,ROR2;PRICKLE1;PKHD1;FZD1;DVL2;WNT5A;TIAM1;PRICKLE2;PSMD13
prerank,"GO_Biological_Process_2021__pentose-phosphate shunt, non-oxidative branch (GO:0009052)",0.4334563521369852,0.6460842598631322,0.8809523809523809,1.0,1.0,1/5,9.57%,RPEL1
prerank,GO_Biological_Process_2021__negative regulation of intracellular transport (GO:0032387),-0.3982920091468747,-0.6460778865765998,0.8703703703703703,1.0,1.0,1/5,21.25%,PLN
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),-0.40537868909345587,-0.6455057419660328,0.9137931034482759,1.0,1.0,1/6,8.00%,GBA3
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),-0.40537868909345587,-0.6455057419660328,0.9137931034482759,1.0,1.0,1/6,8.00%,GBA3
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),-0.3944451010724758,-0.6454538200653387,0.896551724137931,1.0,1.0,2/8,9.58%,TGFB1;GPER1
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.33997882746667185,-0.6452826316445839,0.8771929824561403,1.0,1.0,2/14,13.74%,PGAM1;SRPX2
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.36171492463811405,-0.6451384992576682,0.890625,1.0,1.0,2/10,10.66%,MSMP;CCL5
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),0.30270606665103666,0.6447917974482252,1.0,1.0,1.0,2/26,9.76%,EGFR;PTPN12
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.3828541783811838,-0.6444466751099416,0.8688524590163934,1.0,1.0,2/10,16.78%,GSTP1;LYN
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),-0.39504523272135006,-0.644283737915483,0.8793103448275862,1.0,1.0,1/7,11.49%,TMEM79
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.2817470756160505,-0.6442530806050196,1.0,1.0,1.0,13/83,22.85%,PATL2;ENC1;PAIP2B;EPRS1;IGFBP5;ZNF540;ILF3;RBM4;FXR1;CALR;RPS3;RPL13A;YTHDF1
prerank,GO_Biological_Process_2021__regulation of lymphocyte apoptotic process (GO:0070228),-0.3978016911889938,-0.6440921273924727,0.8,1.0,1.0,2/5,29.80%,LYN;JAK3
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.3001810296311924,0.6428236466241999,0.9444444444444444,1.0,1.0,7/28,19.70%,SF3B4;HSPA1A;U2AF2;PIK3R1;TRA2A;CELF4;SETX
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.3309943030030718,-0.6427499594154882,0.9245283018867925,1.0,1.0,3/13,18.93%,MRE11;NEK11;RAD9B
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),-0.3829483795396751,-0.6426458119910365,0.8888888888888888,1.0,1.0,4/7,29.29%,SYT4;KIF5A;KIF1C;KIF1A
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.4053185340193927,-0.6423912663630292,0.90625,1.0,1.0,1/8,6.80%,ATP6AP2
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.28828708940380615,-0.6422816866297999,0.95,1.0,1.0,5/33,16.67%,CAMLG;UCHL5;RPS7;RPL5;MAP1A
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.31969200412706594,-0.6421855707927933,0.9130434782608695,1.0,1.0,8/31,20.55%,B3GNT3;KLF5;CBLC;DUOXA1;PKP1;ITGB4;IRF3;IL13RA1
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.28481373879120364,0.6421804296673891,0.9629629629629629,1.0,1.0,5/27,12.84%,TNFRSF11A;DUSP10;DVL2;MAP3K10;MAP3K5
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),0.379498151890961,0.6421239792101548,0.8205128205128205,1.0,1.0,2/6,28.80%,TANK;VCP
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),0.3783909354623218,0.6417416017015938,0.9523809523809523,1.0,1.0,4/13,21.42%,EPHB2;ZDHHC2;ADCY8;RELN
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),-0.29234694239495174,-0.6416398895791339,0.9552238805970149,1.0,1.0,8/42,24.19%,PLCD3;PLCH1;INPPL1;PLCG2;IMPA2;CALM1;IPMK;PLCD1
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.35748617323416526,-0.641530581728246,0.9836065573770492,1.0,1.0,2/18,10.21%,SUV39H1;EEF1AKMT2
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.34319401906670327,0.6411890388975059,0.967741935483871,1.0,1.0,1/13,2.86%,TRAF3
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),0.39652267777523137,0.640536241657102,0.9117647058823529,1.0,1.0,2/7,8.81%,CCDC22;FAF1
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),-0.3295363120576496,-0.6401926062976182,0.9473684210526315,1.0,1.0,2/22,9.72%,USP20;OTUB1
prerank,GO_Biological_Process_2021__histidine catabolic process (GO:0006548),-0.42234616039607853,-0.6400254593016959,0.8620689655172413,1.0,1.0,1/5,15.86%,AMDHD1
prerank,GO_Biological_Process_2021__histidine metabolic process (GO:0006547),-0.42234616039607853,-0.6400254593016959,0.8620689655172413,1.0,1.0,1/5,15.86%,AMDHD1
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.2615852601150618,0.6397675200263987,1.0,1.0,1.0,1/81,0.22%,FBXL7
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),0.32196439465790994,0.639726442858168,0.9487179487179487,1.0,1.0,2/21,4.60%,RAD51B;DBF4B
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.34195502396895927,-0.6397050812004921,0.8771929824561403,1.0,1.0,2/18,15.05%,RPA3;RBX1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.34195502396895927,-0.6397050812004921,0.8771929824561403,1.0,1.0,2/18,15.05%,RPA3;RBX1
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),-0.2947387005425191,-0.6394218369981638,0.9696969696969697,1.0,1.0,6/51,18.64%,HENMT1;TRUB1;NAT10;BCDIN3D;THG1L;DTWD2
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),-0.41878268869873814,-0.6393849576988921,0.9,1.0,1.0,2/5,22.69%,CHMP2A;CCP110
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.27239517340346514,-0.6393407331334776,0.9848484848484849,1.0,1.0,27/82,30.26%,PSMB6;PSMB8;SKP1;ZNF16;PSMA3;PSMC3;CDKN1B;PSMC6;PSMA5;PSMA7;BUB1B;NEK11;PSMD12;PSME1;PSMB2;PSMD2;ANAPC2;NEK10;UBE2S;PSMA8;PSMA1;PSMC1;DBF4;PSMD4;PSMD8;PSMB4;PSMC4
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.30733243603326027,0.6392982577067893,0.9411764705882353,1.0,1.0,4/28,10.50%,PLCB1;MDK;HMGB1;PIBF1
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),-0.28074988826020825,-0.6390674116599124,0.971830985915493,1.0,1.0,10/60,16.53%,ATP6AP1;TGFB1;TTN;MYOM1;PPID;GPER1;SYTL4;PLA2G10;ADAM9;EXPH5
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),0.35877093500846297,0.6390388749906196,0.9069767441860465,1.0,1.0,3/10,14.73%,PTPN23;EIPR1;SORL1
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),0.4111814879229851,0.6389477059792524,0.9024390243902439,1.0,1.0,1/7,8.40%,P3H3
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.32185523232618024,-0.6389227749337374,0.8955223880597015,1.0,1.0,7/24,21.47%,CCDC39;RP1;DRC1;RP1L1;SPAG17;RSPH9;TTC12
prerank,GO_Biological_Process_2021__negative regulation of hematopoietic progenitor cell differentiation (GO:1901533),0.42060545688455375,0.6384199682575731,0.8888888888888888,1.0,1.0,1/5,16.57%,MYB
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),-0.2826954200956343,-0.6383414015418231,0.984375,1.0,1.0,13/43,22.91%,HSPA5;DAB2IP;HSPA4L;DNAJA1;DNAJB1;HERPUD1;HSPH1;DAXX;HSPA9;HSPD1;HSPA4;HSPA1L;HSP90AB1
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),-0.3885916558120852,-0.638001862333301,0.9230769230769231,1.0,1.0,1/8,8.48%,UNC119B
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),-0.3941683214686582,-0.6376066405646238,0.9032258064516129,1.0,1.0,3/8,22.21%,TGFB1;ESR1;DND1
prerank,GO_Biological_Process_2021__cellular response to prostaglandin E stimulus (GO:0071380),0.4187743190661479,0.6375627382140692,0.775,1.0,1.0,5/5,58.13%,GNG2;ADCY6;GNB1;TNFSF4;SFRP1
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),0.39931179907220193,0.6374838055512873,0.8444444444444444,1.0,1.0,1/6,9.59%,DUSP10
prerank,GO_Biological_Process_2021__aldehyde biosynthetic process (GO:0046184),-0.43313381583125776,-0.6374772034782833,0.9375,1.0,1.0,3/5,25.14%,KDM3A;CACNA1H;TKT
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),-0.38607945532512966,-0.6373135288003939,0.855072463768116,1.0,1.0,4/10,16.85%,SERPINE1;CCL5;PLA2G7;CXCL17
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.2470212817543321,-0.6373089829131475,1.0,1.0,1.0,35/190,20.65%,TERF2IP;TNFSF18;AGT;TRIML2;NODAL;TRIM22;BEX1;PRKCH;NEUROD2;AGER;TRIM5;TRIM25;IL18;IL18R1;ROR1;TRIM32;FLOT1;TLR2;MBTPS2;PLCG2;SHH;OPRD1;NFKBIA;COPS5;ESR2;PRDX3;KDM1A;RHEBL1;ESR1;RGCC;IKBKE;TRIM14;LAMTOR5;NFAM1;RPS3
prerank,GO_Biological_Process_2021__regulation of glucagon secretion (GO:0070092),0.4169909208819715,0.6370229717022604,0.8636363636363636,1.0,1.0,5/5,58.31%,PASK;SYT7;CRH;FFAR4;AIMP1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.34526804344179163,-0.6364519668883177,0.9365079365079365,1.0,1.0,7/15,30.10%,NCKAP1L;GHRL;NLRP12;NLRC3;CD200;SELENOS;PTPN22
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by RNA (GO:0060967),-0.4175195987389283,-0.635801359996773,0.8688524590163934,1.0,1.0,1/5,5.95%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of posttranscriptional gene silencing (GO:0060149),-0.4175195987389283,-0.635801359996773,0.8688524590163934,1.0,1.0,1/5,5.95%,TGFB1
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.35537262483305476,0.6356625924852686,0.8620689655172413,1.0,1.0,3/13,25.44%,TPR;NUP107;NUP98
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),0.30838984922223694,0.6354549250302466,0.9473684210526315,1.0,1.0,7/19,26.87%,MTERF4;FBLL1;TFB2M;METTL15;MRM1;NSUN4;METTL16
prerank,GO_Biological_Process_2021__negative regulation of ceramide biosynthetic process (GO:1900060),0.39153696498054463,0.6353976117899908,0.8837209302325582,1.0,1.0,5/5,60.86%,ORMDL1;SPHK1;ORMDL2;PRKAA1;ORMDL3
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),0.2592489924055185,0.6352929971709129,0.9615384615384616,1.0,1.0,4/32,12.54%,CLVS1;CLN6;ARSB;HOOK3
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),0.3791100328132178,0.6352910153475897,0.9047619047619048,1.0,1.0,1/8,7.04%,HMGB1
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.33092101622695125,-0.6351546352227503,0.9538461538461539,1.0,1.0,8/21,25.93%,MOAP1;TOMM22;ROMO1;HSPA4;TIMM8A;TIMM22;COX18;BAX
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.3049368989743499,0.6348205644909821,0.9615384615384616,1.0,1.0,2/14,13.69%,MLYCD;NUDT7
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),-0.36192600684026366,-0.6346999929718039,0.9107142857142857,1.0,1.0,2/11,12.20%,TRIM5;TRIM32
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),0.390027640154023,0.6345821306534604,0.8974358974358975,1.0,1.0,2/7,12.22%,IRS2;BCL6
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),0.35490849867155205,0.6340247936141408,0.9285714285714286,1.0,1.0,2/9,10.79%,PRKCB;ZDHHC3
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.33199392664037614,-0.6337176605320536,0.9298245614035088,1.0,1.0,5/19,24.22%,CASP8;FLOT1;SPATA2;NUPR1;ASAH1
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.24090257243255572,0.6337147282489054,1.0,1.0,1.0,22/98,19.88%,MDK;APOE;PLD2;BIN1;FMNL2;PAK5;MAST4;MARK1;SIPA1L3;PAK4;KLHL20;CDC42BPB;RHOBTB1;FITM2;MAST2;PDZD8;MICAL3;PACSIN2;SEMA6A;FMNL3;RND3;PCLO
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),0.3245364751890297,0.6336214270512767,0.9444444444444444,1.0,1.0,2/24,6.53%,CEPT1;CHKA
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.4096270785151952,0.6335507784883928,0.875,1.0,1.0,1/5,9.88%,KIF13A
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),0.4231027718205403,0.6333672418329752,0.8863636363636364,1.0,1.0,1/6,4.82%,RAD21L1
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),0.2773309283671868,0.6331959001332779,0.9166666666666666,1.0,1.0,2/23,6.99%,PRR5L;EIF4EBP1
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),0.392179463484582,0.6331405320916711,0.85,1.0,1.0,2/5,12.04%,PARP10;TRIM44
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),-0.37537236694272313,-0.6330019502342086,0.9375,1.0,1.0,1/11,3.43%,LRP4
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",-0.26881942834898676,-0.6328281729807224,0.96875,1.0,1.0,14/74,21.95%,TBP;POLR1E;AEBP2;CGGBP1;SPI1;POLR1H;TDG;POLR2K;DEK;POLR1C;H3-3A;SUZ12;JARID2;POLR1F
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.3540316236597533,-0.632763991227203,0.9148936170212766,1.0,1.0,2/11,17.19%,BRCA1;CHEK1
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),-0.31514345841959845,-0.632202897082154,0.984375,1.0,1.0,2/28,6.68%,MTCH1;GLRX2
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),0.3406874372959934,0.6319514603608514,0.875,1.0,1.0,3/18,10.58%,CSF1R;MDK;IL34
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),-0.39223341856729005,-0.6319275305664157,0.8947368421052632,1.0,1.0,3/8,35.37%,KDM1A;RIOX1;KDM5C
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.2930568570816538,0.6319104832704059,1.0,1.0,1.0,7/26,14.92%,NUP42;RANBP17;TPR;RANBP3;XPO7;CHP1;RANBP3L
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.36278121624916815,-0.6317626148752845,0.8870967741935484,1.0,1.0,3/12,14.98%,LPCAT4;LPCAT3;PLA2G10
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.3782620699771636,0.6312327812095662,0.9024390243902439,1.0,1.0,3/6,21.23%,MAPK7;MBP;APOA1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.3782620699771636,0.6312327812095662,0.9024390243902439,1.0,1.0,3/6,21.23%,MAPK7;MBP;APOA1
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.24792445671492574,0.6307956537586762,0.967741935483871,1.0,1.0,10/35,24.54%,APOE;PTPRS;NRCAM;SIN3A;MAP3K13;RTN4R;LIMK1;ABL1;GOLGA4;L1CAM
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.3339833059282247,0.6306155907476466,1.0,1.0,1.0,6/16,12.82%,ST3GAL3;B4GALNT2;MPDU1;FUT9;ABO;ST3GAL2
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.34054354102328016,0.6305304863845034,0.8536585365853658,1.0,1.0,4/12,26.60%,RAP1A;MAP4K4;RAP2A;RAP2B
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.34054354102328016,0.6305304863845034,0.8536585365853658,1.0,1.0,4/12,26.60%,RAP1A;MAP4K4;RAP2A;RAP2B
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.2818493033217077,-0.6298150501762336,0.9848484848484849,1.0,1.0,11/53,21.70%,ATP5IF1;PINK1;PGAM1;NUP85;NUP155;COX7A2L;COX7A2;EIF6;GCKR;NUP188;AK4
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.30556222798725713,0.6297829102173795,0.918918918918919,1.0,1.0,3/24,8.41%,NFIB;FGF10;SLC8A3
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.31560291433265875,-0.6296829368862292,0.9333333333333333,1.0,1.0,4/30,11.24%,STAT1;NCKAP1L;ZNF16;INHBA
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),-0.2923602600676254,-0.6296764352926657,0.953125,1.0,1.0,8/41,24.19%,PLCD3;PLCH1;INPPL1;PLCG2;IMPA2;CALM1;IPMK;PLCD1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),-0.28834552973454924,-0.6293610298072326,0.9692307692307692,1.0,1.0,4/49,11.28%,HSD17B10;ACOX2;ETFB;ECI2
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.2898885478480876,-0.6292236842088773,0.9696969696969697,1.0,1.0,4/55,11.82%,LDLRAP1;NSDHL;G6PD;DHCR7
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.3772441416464856,-0.6285475346117644,0.8870967741935484,1.0,1.0,3/12,36.88%,RNF168;RNF8;NELFCD
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.34013451599399935,0.6281610884008746,0.9512195121951219,1.0,1.0,6/13,30.73%,PPP3CA;PPP5C;NCK1;PPM1F;PPP1R15B;PPP1CA
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),0.29640259552426296,0.6281432886134045,0.972972972972973,1.0,1.0,5/15,16.97%,GLYAT;SRR;PSPH;THNSL2;CTH
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),0.3524564701724156,0.6280364460610456,0.9318181818181818,1.0,1.0,1/10,6.08%,MACROH2A2
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),-0.39114933613016073,-0.6279458253453454,0.9074074074074074,1.0,1.0,2/9,5.98%,FBLN5;PINK1
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),0.21700452397500083,0.6279444596814623,1.0,1.0,1.0,24/231,16.02%,RCE1;INO80D;SENP8;IFIH1;TRAF3;TGFBR1;DESI2;RNF128;SMAD2;STAMBPL1;CLSPN;USP31;BABAM2;USP25;CCNA2;TAB1;BRCC3;OTUD3;MBD5;EP300;OTUD7B;OTUD7A;FOXK1;PSMD13
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),0.30190050816196284,0.6271320552055123,0.9166666666666666,1.0,1.0,9/18,26.00%,SGPP2;SPTLC1;SPHK2;PLPP1;SPTLC2;ACER1;ABCA2;PLPP3;ACER3
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.33841428440283683,-0.6268583003047165,0.9482758620689655,1.0,1.0,1/16,4.14%,LDLRAP1
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),-0.35521868392212436,-0.6266703662242399,0.9464285714285714,1.0,1.0,3/12,15.29%,ABCC6;LRRC8D;SLC25A4
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),-0.30999992356108874,-0.6265828018259642,0.9552238805970149,1.0,1.0,8/28,28.14%,RAC1;BRK1;WAS;CYFIP1;TWF2;CDC42;ACTR2;ABI3
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),0.2790762112649997,0.6263383408660417,0.9696969696969697,1.0,1.0,10/42,19.80%,SRPK3;TXNL4A;CELF2;SNRPG;CELF1;CELF4;SNRPE;SF3A2;SETX;SCAF11
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.3368263415534418,0.6260989706511176,0.9210526315789473,1.0,1.0,6/11,26.80%,AGBL1;TTL;LCMT1;ICMT;ATG7;AGBL4
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),0.3315325784342802,0.625470088370915,0.9230769230769231,1.0,1.0,4/18,12.16%,GCH1;SGPP2;SPHK2;PRKG2
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),0.3863763030786791,0.6250684823779951,0.9487179487179487,1.0,1.0,2/7,12.57%,VAMP8;SNAP29
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),0.3500121834177805,0.6244435573354983,0.925,1.0,1.0,2/11,16.60%,FBLL1;EXOSC5
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),-0.27469597107871213,-0.6237039718438581,1.0,1.0,1.0,8/84,16.14%,HCK;PTPRC;RAB11A;HIP1R;SEPTIN1;SLC30A8;TSC2;GAS1
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),-0.29560413209122,-0.6232821772400915,0.9692307692307692,1.0,1.0,6/33,24.19%,SESN3;LAMTOR2;GLRA1;LAMTOR5;RRAGA;SPAAR
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),-0.2666552051471096,-0.6230670376006868,1.0,1.0,1.0,12/58,22.31%,SLC13A4;SFXN3;LRRC8D;SLC25A5;SLC25A4;SLC23A1;SLC25A11;SLC25A18;SLC25A19;SLC27A1;SLC38A5;PRAF2
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.36582800360135376,-0.6229880689738941,0.9482758620689655,1.0,1.0,2/11,15.53%,CBLC;GPRC5A
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.2736569596045155,-0.6228711050213213,1.0,1.0,1.0,11/57,20.80%,RPL38;RPS7;RPL5;RPL26L1;RPL35A;EMG1;WDR12;RPS15;RPF2;RPS24;SURF6
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),-0.36256826071793447,-0.6227253720185447,0.927536231884058,1.0,1.0,2/12,16.15%,APH1B;ADAM17
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),0.3535986092656245,0.6227239179022479,0.9117647058823529,1.0,1.0,5/9,21.71%,APOE;SCAP;ERLIN2;NFKB1;BMP2
prerank,GO_Biological_Process_2021__positive regulation of catecholamine secretion (GO:0033605),0.3748378728923475,0.6225789238053412,0.8863636363636364,1.0,1.0,5/5,62.53%,GRK2;STX1A;VIP;KCNB1;CHRNB2
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),0.23197628593643146,0.6221708761293898,1.0,1.0,1.0,11/112,12.74%,HSPB1;SAMD4A;PRR5L;ELAVL1;PRKCD;EXOSC1;HSPA1A;IGF2BP3;KHSRP;RC3H1;PNPT1
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),-0.36082548411956994,-0.6220135361647494,0.9827586206896551,1.0,1.0,3/15,13.07%,SFRP4;TMEM204;LRIT3
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),0.34038457254598325,0.6216960551458884,0.9285714285714286,1.0,1.0,2/10,9.92%,NAF1;RPUSD1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.3148460548716851,-0.6215528769973399,0.9523809523809523,1.0,1.0,7/27,17.66%,CASP8;HIP1R;NMT1;BOK;YWHAG;YWHAB;YWHAH
prerank,GO_Biological_Process_2021__membrane depolarization during AV node cell action potential (GO:0086045),-0.4194714104810342,-0.6215395592866976,0.9107142857142857,1.0,1.0,1/5,13.00%,CACNA1G
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),-0.29092734249342056,-0.6214770463110209,0.9710144927536232,1.0,1.0,3/43,7.26%,GMNN;CDC6;ATAD5
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),-0.35302570201801625,-0.6211825785391158,0.9473684210526315,1.0,1.0,6/11,44.13%,SLC7A5;NLRP3;PRKCZ;ZP3;HLA-E;TNFSF4
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),0.38431419800138245,0.6209398633216197,0.9166666666666666,1.0,1.0,1/5,7.90%,RNF128
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),-0.3778140025305981,-0.6209139888180714,0.9285714285714286,1.0,1.0,1/9,3.10%,TK2
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),-0.3778140025305981,-0.6209139888180714,0.9285714285714286,1.0,1.0,1/9,3.10%,TK2
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),0.32096545806840787,0.6207258946215005,0.9736842105263158,1.0,1.0,5/15,27.52%,PIP4P1;TELO2;GPR137C;KLHL22;SIK3
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),-0.43117039709746124,-0.6206648450730988,0.896551724137931,1.0,1.0,2/5,18.93%,CRYL1;AKR1A1
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),-0.43117039709746124,-0.6206648450730988,0.896551724137931,1.0,1.0,2/5,18.93%,CRYL1;AKR1A1
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),-0.43117039709746124,-0.6206648450730988,0.896551724137931,1.0,1.0,2/5,18.93%,CRYL1;AKR1A1
prerank,GO_Biological_Process_2021__lysosomal lumen acidification (GO:0007042),-0.4270726322403039,-0.6204798994107157,0.967741935483871,1.0,1.0,1/6,6.80%,ATP6AP2
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.2673144483948499,0.6200404948372727,0.975,1.0,1.0,7/23,23.59%,FGFR4;DACH1;ATM;PDGFB;SMG6;SMOC2;TERF2
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),0.29632725327546733,0.6200020204121984,1.0,1.0,1.0,2/19,8.48%,ZBED3;IRS2
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.2628766282723421,0.619568622179149,1.0,1.0,1.0,3/38,10.14%,LEF1;BRCA2;TAF12
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.21793004890619605,0.6195622519839721,1.0,1.0,1.0,27/162,19.80%,ADARB2;ATXN1;RBMS1;LIN28B;SF3B4;IVNS1ABP;NOVA1;KHSRP;U2AF2;BICD1;SRRM1;CELF2;SNRPG;CELF1;MAGOHB;HNRNPL;SNRPN;LSM6;HNRNPH1;SRRM4;SF3A2;SON;AURKAIP1;PTBP1;MBNL1;SETX;SCAF11
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),0.27309782019107165,0.6193514363344009,1.0,1.0,1.0,17/58,20.56%,DCLRE1B;PAXX;XRCC4;ERCC8;HMGB1;BABAM2;SMARCAL1;BRCC3;HERC2;NSMCE2;UVRAG;ATM;ZBTB7A;SETMAR;UIMC1;TP53BP1;POLL
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),-0.3320048331028602,-0.6193415815773935,0.9107142857142857,1.0,1.0,2/15,13.68%,P2RY12;APOD
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.3310978447879577,-0.6187915758758127,0.9242424242424242,1.0,1.0,2/18,19.20%,BRCA1;NOS1
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.2636346835903876,0.6181171084475239,1.0,1.0,1.0,8/41,18.73%,NUP210;NUP42;TPR;GCK;NUP37;EP300;ZBTB7A;JMJD8
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),-0.38258985778590293,-0.6179008509631676,0.9166666666666666,1.0,1.0,2/7,13.58%,ABCC6;ABCC2
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),-0.3575638705167984,-0.6177220708917167,0.9523809523809523,1.0,1.0,3/15,12.30%,P2RY12;P2RY1;KCNJ11
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),-0.38687750991026987,-0.6174478717088115,0.8615384615384616,1.0,1.0,4/6,27.95%,GPER1;BAIAP3;STX1B;SLC4A8
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),-0.3601421588086322,-0.6173446422846988,0.8387096774193549,1.0,1.0,2/9,27.08%,CUX2;DBN1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.31879129965987896,-0.6171386444234356,0.9824561403508771,1.0,1.0,2/19,17.96%,SUB1;TWIST1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),-0.4037782578695306,-0.6170518871715667,0.9215686274509803,1.0,1.0,1/5,10.39%,BRCA1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),-0.3699404658795676,-0.6168989867308557,0.9508196721311475,1.0,1.0,3/10,20.98%,BRCA1;KDM1A;JARID2
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.3382442849678213,0.6168150143464789,0.8536585365853658,1.0,1.0,6/9,28.39%,NR1H3;PPARA;ITGAV;NR1H2;ABCA1;PPARG
prerank,GO_Biological_Process_2021__succinate transmembrane transport (GO:0071422),-0.3918113189836604,-0.6165775513484462,0.9107142857142857,1.0,1.0,4/5,37.85%,SLC25A11;SLC25A10;SLC13A3;SLC25A14
prerank,GO_Biological_Process_2021__succinate transport (GO:0015744),-0.3918113189836604,-0.6165775513484462,0.9107142857142857,1.0,1.0,4/5,37.85%,SLC25A11;SLC25A10;SLC13A3;SLC25A14
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),-0.33024103029064744,-0.6164094085441759,0.9523809523809523,1.0,1.0,5/19,18.23%,RARRES2;CCL5;STAP1;CXCL17;CMKLR1
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),0.3286514193912671,0.616155673380989,0.8974358974358975,1.0,1.0,2/14,6.95%,PTBP3;PTBP2
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),-0.23203517144691227,-0.6152693668542182,1.0,1.0,1.0,35/282,20.24%,RAB6C;CD74;NXT1;LMAN1;RANBP6;TGFB1;ARCN1;RAB19;SLU7;ARL1;STRADB;GRTP1;SPRN;STX19;STX16;NUP85;RAB31;VPS35;TBC1D13;STRADA;RAB23;TSC2;NUP155;RAB1A;LAMP2;YWHAH;ARF3;RTN2;ARF1;ARL4C;GCKR;CALR;RUNDC1;NUP188;ARL6
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",-0.3685771314335084,-0.6151903104996467,0.9047619047619048,1.0,1.0,2/7,21.72%,EXOSC6;EXOSC8
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),-0.3685771314335084,-0.6151903104996467,0.9047619047619048,1.0,1.0,2/7,21.72%,EXOSC6;EXOSC8
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),-0.31764170437811556,-0.6151704522864639,0.9672131147540983,1.0,1.0,9/21,31.31%,TUBB;TUBA1B;HOOK2;KIF5A;KIF1C;KIF1A;CCDC186;TUBA1A;CCDC88C
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),-0.30970601249211044,-0.6147402203054617,0.95,1.0,1.0,3/17,14.06%,DRD3;PDGFRB;TGFA
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),-0.4121441146484687,-0.6146334058966225,0.9482758620689655,1.0,1.0,1/5,13.04%,CMPK2
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),-0.35550387852533094,-0.6146317981026862,0.8983050847457628,1.0,1.0,2/10,19.59%,HAT1;H3-3A
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),-0.37490635818300433,-0.6142939276249627,0.9122807017543859,1.0,1.0,4/10,28.70%,ISG20;DNASE1L1;DFFB;REXO4
prerank,GO_Biological_Process_2021__regulation of DNA methylation (GO:0044030),-0.390964901750643,-0.6138609511438832,0.9074074074074074,1.0,1.0,2/5,43.46%,GRHL2;KDM1B
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),-0.36910793268520786,-0.6135352737856835,0.9649122807017544,1.0,1.0,1/8,10.39%,BRCA1
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),0.3729455214208023,0.6133756120756837,0.851063829787234,1.0,1.0,3/5,26.11%,ATM;NIPBL;XRCC6
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),0.3702312006329788,0.6126608901784277,0.9487179487179487,1.0,1.0,1/7,14.80%,AKT2
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),-0.3137956078133698,-0.6125345370691346,0.9848484848484849,1.0,1.0,4/20,18.89%,MPV17L2;RCC1L;C1QBP;FASTKD3
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.2594919094409012,0.6121770150229319,1.0,1.0,1.0,13/60,18.60%,PTPRK;PRKCD;ZBTB1;EIF2S1;CASP9;RHBDD1;RUVBL2;SIRT1;EP300;TRIAP1;YY1;CREBBP;USP47
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),0.40949957926031955,0.612126232800503,1.0,1.0,1.0,3/6,33.10%,PTEN;MTMR2;CBLN1
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),0.3121445630002896,0.6118345871839367,0.96875,1.0,1.0,2/31,2.31%,CHCHD6;BCL2
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),0.23983074645945449,0.6116550623040083,1.0,1.0,1.0,4/70,8.76%,CCNH;POLD3;ERCC8;ERCC2
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),0.2607679506067619,0.6114363151715357,0.972972972972973,1.0,1.0,4/35,12.26%,NUP210;NUP42;TPR;NUP37
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.2910940770927295,0.6110919802126188,1.0,1.0,1.0,5/21,15.09%,EREG;BTC;TSG101;VPS25;CBLB
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),0.3512600588162698,0.6110379163705588,0.8979591836734694,1.0,1.0,3/10,21.90%,PTPRS;RTN4R;EPHA4
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),-0.37148255411249587,-0.6105071920503324,0.9180327868852459,1.0,1.0,3/7,14.24%,NOTCH1;LIN7C;ARHGAP12
prerank,GO_Biological_Process_2021__endochondral ossification (GO:0001958),0.382313408630535,0.6099208865047948,0.9230769230769231,1.0,1.0,1/6,4.03%,FGFR3
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),-0.3808355631917718,-0.6094705423172366,0.9402985074626866,1.0,1.0,1/9,7.80%,BMP1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),-0.27587582426747925,-0.6092758580871868,1.0,1.0,1.0,15/54,22.69%,TOM1L1;DAB2IP;GPER1;CHMP2A;BRCA1;CBX5;CBX3;CHEK1;NME6;RBBP8;SUZ12;VPS4A;L3MBTL2;FOXO4;CCP110
prerank,MSigDB_Hallmark_2020__Notch Signaling,-0.29100382773860817,-0.6089798128233556,0.9850746268656716,1.0,1.0,5/26,22.07%,NOTCH1;SKP1;RBX1;NOTCH2;NOTCH3
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),-0.4020188705317977,-0.6089453563686918,0.9347826086956522,1.0,1.0,4/6,29.83%,GBP5;USP50;DDX3X;CD36
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.3318579600976471,-0.6089347921550423,0.9508196721311475,1.0,1.0,3/17,13.03%,NOTCH1;NOTCH4;FLOT1
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),-0.3382726685946786,-0.608764613552118,0.9482758620689655,1.0,1.0,1/17,2.53%,HSD17B13
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.24195035106883053,0.6080233288055042,1.0,1.0,1.0,34/111,23.99%,PIGQ;SOCS6;SYNJ2;MTMR8;PIK3R6;PI4K2A;MTMR9;PIP4K2A;PIGP;PIK3R1;PTPN13;SOCS2;DPM3;IP6K1;PIGA;PIK3C2B;PTEN;MTMR6;IP6K2;PIP5K1C;PITPNM1;MTM1;DPM2;MTMR3;PLEKHA1;EFR3B;PI4K2B;SMG1;PIGU;PIP5K1B;DPM1;INPP5J;PI4KA;SOCS4
prerank,GO_Biological_Process_2021__negative regulation of sphingolipid biosynthetic process (GO:0090155),0.39153696498054497,0.6079218379314564,0.9347826086956522,1.0,1.0,5/5,60.86%,ABCA2;ORMDL1;SPHK1;ORMDL2;ORMDL3
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.22147028708255592,0.607874602429176,1.0,1.0,1.0,42/187,23.51%,BCL2L11;PCM1;LATS1;ARFIP2;BRCA2;MID1;WASF2;RASA2;BIN1;KPTN;CDK5RAP2;ESPL1;MAPRE1;RASAL2;HOOK3;NUMA1;SMC1A;ACTN4;SUN2;TIAM1;ALMS1;CNTROB;PXN;LMNB1;VCL;PLEKHG2;OPHN1;FARP1;KIF23;MYO1E;ATG4B;ABL1;ARHGEF11;CDC42BPA;KATNB1;PCNT;CCDC88A;STK38L;MYO9B;SSH2;DST;CNTRL
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.26047854005463633,0.6075295422491561,1.0,1.0,1.0,6/39,11.68%,SMPD4;GLA;CLN6;GLB1;ST8SIA3;NEU3
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.34967834955236454,-0.6073715592554741,0.9607843137254902,1.0,1.0,3/9,27.04%,PDZD11;BTD;PCCB
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.33234727403635866,0.6073390960736671,0.9473684210526315,1.0,1.0,4/13,26.55%,EP300;CREBBP;NAA15;NAA20
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),-0.35348234863871414,-0.6071822077904372,0.9130434782608695,1.0,1.0,1/10,11.83%,DNAJA1
prerank,GO_Biological_Process_2021__anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),-0.3821159896856418,-0.6071115099368262,0.896551724137931,1.0,1.0,2/5,23.00%,KIF17;KIF5A
prerank,GO_Biological_Process_2021__anterograde dendritic transport (GO:0098937),-0.3821159896856418,-0.6071115099368262,0.896551724137931,1.0,1.0,2/5,23.00%,KIF17;KIF5A
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),-0.29085342960125166,-0.6067850499248503,0.9482758620689655,1.0,1.0,3/31,13.32%,AMN;RAB31;PREPL
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),0.2580702036452647,0.6067039092596335,0.9375,1.0,1.0,9/45,15.79%,LIX1;RUBCNL;FZD1;DVL2;VAMP8;TSG101;SNAP29;LRP6;UVRAG
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.32187316453238046,-0.6065396951744177,0.95,1.0,1.0,5/20,17.66%,CASP8;NMT1;YWHAG;YWHAB;YWHAH
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.32187316453238046,-0.6065396951744177,0.95,1.0,1.0,5/20,17.66%,CASP8;NMT1;YWHAG;YWHAB;YWHAH
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),-0.27001761592505436,-0.6060309571783052,0.9848484848484849,1.0,1.0,16/68,26.41%,TBP;NCBP2;NCBP1;INTS5;POLR2J;POLR2K;TAF6;PHAX;NABP1;POLR2B;SNAPC2;POLR2D;TAF5;INTS14;GTF2A2;ELL2
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.24954945870881626,-0.6055340930343197,1.0,1.0,1.0,18/102,22.94%,CPNE5;B2M;BNIP3;NEUROD2;SYT2;SYT4;MCOLN1;HVCN1;CDKN1B;PLCG2;RASGRP2;DAXX;GLRA1;SYT9;CACNA1H;GPLD1;RYR3;SYT13
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.2982641180597445,-0.6054591802484989,0.9655172413793104,1.0,1.0,12/27,36.84%,RFLNA;PAWR;LCP1;EPS8;CORO1B;EZR;RFLNB;BAIAP2L2;MYO1B;CALD1;DMTN;PLS1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),-0.36415872732976196,-0.6050415854255118,0.9473684210526315,1.0,1.0,2/8,15.26%,TGFB1;SOX6
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.2704311456831958,-0.6049752200898469,0.9841269841269841,1.0,1.0,6/56,17.53%,SFRP4;WNT8A;WNT7B;TCF7;TCF7L1;WNT9A
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),-0.3203910480040085,-0.6046027359620502,0.9661016949152542,1.0,1.0,2/23,10.21%,SUV39H1;EEF1AKMT2
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.36069010251545364,0.6044923220239943,0.8787878787878788,1.0,1.0,2/9,16.81%,ENPP1;SULT2B1
prerank,GO_Biological_Process_2021__positive regulation of necrotic cell death (GO:0010940),-0.4071958184998011,-0.6044714418592269,0.9682539682539683,1.0,1.0,1/5,12.16%,HEBP2
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.30576576835927227,0.6043001629265796,0.95,1.0,1.0,2/13,7.74%,ZNF205;HSPA1A
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),-0.26767792610280294,-0.6042852236947539,0.9848484848484849,1.0,1.0,16/69,26.41%,TBP;NCBP2;NCBP1;INTS5;POLR2J;POLR2K;TAF6;PHAX;NABP1;POLR2B;SNAPC2;POLR2D;TAF5;INTS14;GTF2A2;ELL2
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.2822299235954516,-0.6041553685339616,0.9705882352941176,1.0,1.0,5/31,18.70%,TGFB1;UFM1;APOD;RAB23;ZIC1
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),0.2914798906415609,0.6039104242931075,0.9411764705882353,1.0,1.0,3/24,13.39%,IFIH1;POU2F2;RRP1B
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),0.3256864630051488,0.6034481729192456,0.9,1.0,1.0,2/8,21.06%,ABL2;ABL1
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.2893509496884105,-0.6034468739443032,0.974025974025974,1.0,1.0,4/46,12.25%,CPNE5;NTN1;SYT2;SYT4
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),0.24367071179472571,0.6034261257098994,0.9615384615384616,1.0,1.0,15/71,15.99%,RRAS2;PM20D1;FOS;EIF2S1;EGLN3;GRID2;NSMF;MAP3K5;FYN;SORL1;CHP1;WNT5A;GRIN2B;MEF2C;DDIT4
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),0.22251340414750473,0.60285193154626,1.0,1.0,1.0,24/223,16.02%,RCE1;INO80D;SENP8;IFIH1;TRAF3;TGFBR1;DESI2;RNF128;SMAD2;STAMBPL1;CLSPN;USP31;BABAM2;USP25;CCNA2;TAB1;BRCC3;OTUD3;MBD5;EP300;OTUD7B;OTUD7A;FOXK1;PSMD13
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),-0.27328564775235664,-0.6027972773886096,0.9855072463768116,1.0,1.0,6/53,11.38%,ACOX2;FABP3;TLCD2;PNPLA1;RCN3;ABCB4
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),-0.3591312253627035,-0.6025965441442034,0.9230769230769231,1.0,1.0,2/9,16.78%,AGER;LYN
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),-0.29494417309944165,-0.6025615925401299,0.9661016949152542,1.0,1.0,1/26,3.68%,NODAL
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.3140625019946559,-0.6024711891267744,0.967741935483871,1.0,1.0,4/17,23.17%,BRCA1;WDR5;KDM1A;SNW1
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),0.3089426780909142,0.6020709131593108,0.9444444444444444,1.0,1.0,1/12,6.73%,APOE
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.23879552112998884,0.6019378776735798,1.0,1.0,1.0,20/79,19.64%,SF3B4;KHDRBS3;NOVA1;RBFOX1;SFSWAP;NSRP1;U2AF2;KHDRBS2;CELF2;CELF1;HNRNPL;TRA2A;RBFOX2;QKI;ZBTB7A;CELF4;SRRM4;SON;PTBP1;MBNL1
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.4229493312966055,0.6018770686837174,0.8780487804878049,1.0,1.0,3/5,26.62%,ABL1;MARK2;MAP2
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),-0.37900641381222383,-0.6017231558636572,0.9032258064516129,1.0,1.0,2/8,24.09%,GGTA1;PLA2G4A
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),-0.3938023343058926,-0.6013667848708643,0.9076923076923077,1.0,1.0,2/5,21.28%,MAN1A1;MAN1B1
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),-0.3938023343058926,-0.6013667848708643,0.9076923076923077,1.0,1.0,2/5,21.28%,MAN1A1;MAN1B1
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),-0.3938023343058926,-0.6013667848708643,0.9076923076923077,1.0,1.0,2/5,21.28%,MAN1A1;MAN1B1
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.3476495875201435,-0.6013143844534274,0.9571428571428572,1.0,1.0,6/16,17.05%,SERPINE1;CCL5;PLA2G7;LYN;CXCL17;CCN3
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.2523833303646185,0.6012595189953522,1.0,1.0,1.0,4/57,6.99%,EGFR;TGM1;TGFB2;EIF4EBP1
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),-0.40173859572221654,-0.6012504962109787,0.9433962264150944,1.0,1.0,1/5,9.43%,SLC9A6
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),-0.31140867766792474,-0.6009419531544736,0.9821428571428571,1.0,1.0,3/15,12.55%,SOX10;SEMA3A;RHOXF1
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.34796872864781986,0.600693164041246,0.9117647058823529,1.0,1.0,5/8,31.72%,CPNE1;CLN3;CPNE7;AGK;CPNE6
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),0.3652095439053449,0.6000333073383469,0.926829268292683,1.0,1.0,1/7,10.99%,LIMS1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),0.28758553477456805,0.5999984838418905,1.0,1.0,1.0,4/24,13.42%,PKHD1;CDK5RAP2;ESPL1;NUMA1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.3085483034192945,-0.5999692865622054,1.0,1.0,1.0,2/23,6.88%,NOTCH1;HSPA5
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),-0.2380443363649448,-0.5999529947235864,1.0,1.0,1.0,18/114,19.35%,PSMB6;PSMB8;NQO1;PSMA3;NFYB;PSMC3;DHCR7;GPS2;FASN;PSAP;PSMC6;PSMA5;AZIN1;HNF4A;PSMA7;SQLE;PRKAB2;PSMD12
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.23436799088704924,0.5998365145155106,1.0,1.0,1.0,17/68,23.29%,MID1;CBARP;FOXO6;PHF21B;LYPD6;ARHGAP39;MEX3A;EPHA8;RBFOX2;DLX2;C2CD4C;MEIS3;KIF7;TMEM198;NR2F1;EFNA2;MSI1
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.297127298095456,0.5989250758175243,0.9736842105263158,1.0,1.0,3/19,13.09%,EIF2S1;BICD1;LSM14A
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.2505533590833365,0.598461330654433,1.0,1.0,1.0,8/41,18.73%,NUP210;NUP42;TPR;GCK;NUP37;EP300;ZBTB7A;JMJD8
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.28717507911983964,-0.5983684718676819,0.9836065573770492,1.0,1.0,6/30,19.73%,RREB1;RAC1;DOCK1;MYADM;C1QBP;CALR
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),-0.3111907774976528,-0.598195017615736,0.9672131147540983,1.0,1.0,7/30,29.09%,NOTCH4;RBM4;EIF6;AGO1;RAN;AGO4;LIMD1
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),-0.36870682047565106,-0.5981424834315955,0.9193548387096774,1.0,1.0,3/9,27.46%,CLP1;AGO1;AGO4
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),-0.3254219711332946,-0.5977417882020535,0.9672131147540983,1.0,1.0,2/16,13.19%,OSCAR;GPR183
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.3073349779171107,0.5974743707048717,0.9428571428571428,1.0,1.0,3/13,16.68%,SLC8A1;SPIDR;CASP7
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.33380949571712654,-0.5974715938094992,0.9545454545454546,1.0,1.0,3/18,11.72%,PDE6B;NMT1;CNGB1
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),-0.2676661007921843,-0.5974395053431387,1.0,1.0,1.0,16/73,19.98%,TGFB1;SLU7;DDX39A;STRADB;NCBP2;NCBP1;RNPS1;ALYREF;CDC40;STRADA;NUP155;PHAX;UPF3B;CALR;THOC5;NUP188
prerank,GO_Biological_Process_2021__positive regulation of deoxyribonuclease activity (GO:0032077),-0.3843920315201174,-0.5974351655256511,0.8870967741935484,1.0,1.0,4/5,26.64%,DDX11;PCNA;RPS3;AKT1
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),-0.3564168415294298,-0.5973666426139883,0.9516129032258065,1.0,1.0,4/9,26.57%,RAB11A;RAB8A;STX1B;STX3
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),0.30445730340112875,0.5973524474765445,0.9333333333333333,1.0,1.0,1/15,2.59%,IFIH1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),0.3136967740118927,0.5966772053265265,0.9142857142857143,1.0,1.0,1/12,2.71%,PKP2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),0.3777557471703231,0.5964273727743705,0.85,1.0,1.0,1/6,18.07%,CXCL12
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),0.2959548281085499,0.5963141373170354,1.0,1.0,1.0,2/17,6.63%,ACADVL;AKR1C3
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),-0.32279417113870856,-0.5955229782103358,0.9821428571428571,1.0,1.0,5/14,27.56%,RAB23;GTPBP1;AK4;RAN;IMPDH2
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),-0.3879865637027361,-0.59451403254157,0.9411764705882353,1.0,1.0,1/6,10.39%,BRCA1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),-0.3662601994810791,-0.5944227520744781,0.9552238805970149,1.0,1.0,3/9,25.74%,DAB2IP;FURIN;ATRAID
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.28305035146162383,-0.5943363460555585,1.0,1.0,1.0,13/37,33.11%,ETFB;UQCRB;CYCS;UQCR10;UQCRH;OXA1L;MTFR1L;ETFDH;MTFR1;NDUFA5;SDHC;ETFA;UQCRC1
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),0.32771466344337624,0.5938152807817048,0.92,1.0,1.0,1/9,4.03%,FGFR3
prerank,GO_Biological_Process_2021__intestinal lipid absorption (GO:0098856),0.34764550689477314,0.5938101913922113,0.926829268292683,1.0,1.0,3/8,18.41%,CEL;ABCG8;AKR1C1
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),0.31327623504212065,0.5936682565336224,0.9047619047619048,1.0,1.0,2/13,14.91%,PKHD1;CRK
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.26966317589194455,-0.5936381866338585,0.971830985915493,1.0,1.0,7/47,20.02%,MBNL3;CELF3;REST;RNPS1;RBM4;FXR1;SAP18
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),-0.3012035259333735,-0.5931949563026397,0.9841269841269841,1.0,1.0,1/27,4.17%,SUV39H1
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.34334706303904267,0.5921199109094388,0.9565217391304348,1.0,1.0,1/6,13.57%,SIRT1
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.30931104921955105,-0.5919321055433274,0.9642857142857143,1.0,1.0,3/20,16.75%,GAR1;NAT10;DIMT1
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),0.2828894440868989,0.5917565194661553,1.0,1.0,1.0,4/26,13.24%,MN1;PTPN6;FAM83D;ID2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),-0.3308589909621111,-0.591754413330516,0.9811320754716981,1.0,1.0,1/13,5.83%,NOTCH1
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.2911775169499228,0.5909435799542394,1.0,1.0,1.0,5/24,20.80%,DNAJC1;ARFIP1;CHP1;P3H1;WWP2
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.2504884709731787,0.5908555416293265,1.0,1.0,1.0,5/25,17.68%,FGFR4;NOS1AP;SIRT1;FITM2;JAK2
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),-0.27134110235634284,-0.590832500363752,1.0,1.0,1.0,9/48,16.27%,BNIP3;PINK1;SESN3;SLC25A5;SLC25A4;TSC2;SUPT5H;VDAC1;PIP4K2C
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),0.38711845942827,0.5908046511399109,0.9285714285714286,1.0,1.0,1/6,9.88%,KIF13A
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),0.2396144156944805,0.5906010149442147,1.0,1.0,1.0,7/53,15.19%,PCM1;FIGN;MAP10;HOOK3;NUMA1;CHP1;SPAST
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),-0.3331538582041382,-0.5905368135666597,0.9344262295081968,1.0,1.0,2/9,21.72%,EXOSC6;EXOSC8
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.30783062720196847,-0.5904405755461011,1.0,1.0,1.0,2/20,10.91%,GPSM2;DCTN1
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.34658073574457743,0.5901052663177864,0.9333333333333333,1.0,1.0,3/8,30.20%,ICE1;SNAPC3;ICE2
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),-0.3802552567891705,-0.5896228501023602,0.9384615384615385,1.0,1.0,1/6,15.93%,AKAP5
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),-0.33147510972321953,-0.5892436494250521,0.9538461538461539,1.0,1.0,1/8,23.48%,INPP5K
prerank,GO_Biological_Process_2021__chylomicron assembly (GO:0034378),0.3910849700624146,0.5886870904824321,0.9047619047619048,1.0,1.0,1/5,6.73%,APOE
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),0.25361333199809827,0.5885855007658378,1.0,1.0,1.0,9/33,19.91%,PTGFR;AKR1C3;SPHK2;ADCY2;GNAI1;NR3C1;DCPS;LARP1;ADCY8
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.3047123517457542,-0.5885315181197827,1.0,1.0,1.0,4/22,20.54%,TGFB1;CALM3;ANKLE2;CALM1
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),-0.2678887547659677,-0.5884092591146921,1.0,1.0,1.0,4/50,11.84%,HSD17B10;ALOX12;ECI2;ADH5
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.2538637335224155,0.5882482459525167,1.0,1.0,1.0,5/46,14.63%,LEF1;BRCA2;RUVBL2;EP300;DMAP1
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.34988444816066644,-0.5879868809179707,0.9298245614035088,1.0,1.0,5/9,34.15%,PCSK5;FURIN;SPCS1;SPCS3;SEC11C
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.32888668563551027,0.5875336763045351,0.85,1.0,1.0,3/8,23.61%,PLXNA2;PLXNC1;PLXNA1
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),-0.3122509105664899,-0.5874511102061712,0.9090909090909091,1.0,1.0,4/15,19.28%,MEST;PLA2G10;NFKBIA;IKBKE
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.22656201378638968,0.5868371658169568,1.0,1.0,1.0,16/112,15.48%,ATF3;NUP210;NEK6;VASH1;NUP42;HSPA1A;TPR;CASP9;IER3;BAG2;NUP37;PNPT1;SIRT1;EP300;BAG3;DYRK3
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.31081852572926955,-0.586556401595579,0.972972972972973,1.0,1.0,10/17,36.86%,GPS2;CD160;CEACAM1;DUSP3;EZR;PTPN22;PHPT1;LAPTM5;PRNP;SLA2
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),0.26881202567716317,0.5865363869270459,0.9714285714285714,1.0,1.0,3/29,10.74%,BMP6;EREG;DDX60
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),-0.3804746350230546,-0.585823777267174,0.9642857142857143,1.0,1.0,1/5,17.95%,C1QBP
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),-0.25055745899762344,-0.5845457317192708,1.0,1.0,1.0,8/54,18.77%,COPS9;PDE6B;CNGB1;CDC25A;OPN1SW;PCNA;OPN3;KDM1A
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),-0.3271190772115216,-0.5843740396661403,0.9655172413793104,1.0,1.0,2/12,16.30%,NIPAL3;NIPAL4
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),-0.3725792809815834,-0.5840939812226559,0.9310344827586207,1.0,1.0,1/7,8.70%,AGER
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),-0.33414094791889,-0.5835902467814594,0.9482758620689655,1.0,1.0,3/12,21.83%,FADS2;ELOVL2;ACOX1
prerank,GO_Biological_Process_2021__regulation of receptor catabolic process (GO:2000644),0.34646562905317757,0.5832991300050488,0.9302325581395349,1.0,1.0,5/5,65.36%,PTPN1;MTMR2;DTX3L;ITCH;LAPTM5
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),0.3395094348672156,0.5831661881786607,0.9523809523809523,1.0,1.0,4/9,20.54%,ABCD2;PTEN;ABCD1;MYRF
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),0.33224708553144394,0.5831232674495365,0.9459459459459459,1.0,1.0,3/7,30.29%,CTPS2;PRPS1;TPK1
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),0.28971732539576633,0.5831095336972933,1.0,1.0,1.0,1/25,1.86%,CHCHD6
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),-0.32441702134874806,-0.5822087004871583,0.9710144927536232,1.0,1.0,2/13,13.47%,HAT1;HMGB3
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),0.22318229866711828,0.5816949111213983,1.0,1.0,1.0,1/61,0.93%,CDK2AP2
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),-0.37523948907072163,-0.5815740731487099,0.9454545454545454,1.0,1.0,3/6,43.46%,DIRAS3;PRMT7;KDM1B
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.32983478149959683,0.5812410145109993,0.9411764705882353,1.0,1.0,1/13,6.20%,LIN28B
prerank,GO_Biological_Process_2021__intestinal cholesterol absorption (GO:0030299),0.3494898104117134,0.5807778680544787,0.9318181818181818,1.0,1.0,3/7,18.41%,CEL;ABCG8;AKR1C1
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",0.3896454820579335,0.5804860349561861,0.9148936170212766,1.0,1.0,5/5,61.05%,XRN1;TOE1;PARN;PDE12;TRIR
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),-0.3213331906396148,-0.580214098402532,0.9552238805970149,1.0,1.0,3/16,16.78%,TXK;TEC;LYN
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.25067340815699524,-0.5789298400227131,1.0,1.0,1.0,8/65,19.27%,FOXM1;RPS27L;GADD45A;CDKN1B;PCNA;CNOT11;KAT5;RGCC
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.3192354774320244,-0.5787530541737681,0.9508196721311475,1.0,1.0,1/13,5.72%,CHMP4B
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),0.35787774336360756,0.5782339890784847,0.918918918918919,1.0,1.0,4/7,29.16%,DYRK3;DHX8;VCP;KIF5B
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.3437429788403412,0.5779502354615083,0.8974358974358975,1.0,1.0,3/11,16.76%,STX18;ATL2;VAPB
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,-0.24427732863109067,-0.5779259221716834,1.0,1.0,1.0,16/91,20.10%,PXMP2;ALDH1A1;AQP9;PEX16;ACSL5;RETSAT;FADS2;TFCP2L1;SLC23A1;PIPOX;HSD17B11;HSD17B6;BCAR3;PECR;DIO1;PEX1
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.3179434080463065,-0.5775799602233597,0.9538461538461539,1.0,1.0,6/17,31.90%,SRP14;MAN1A1;RAB3GAP2;SPCS1;SRP54;SPCS3
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.3062095106309962,-0.5767511551111228,0.9827586206896551,1.0,1.0,4/12,20.98%,BRCA1;WDR5;KDM1A;JARID2
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.3250833813176386,0.5763620691891074,0.9285714285714286,1.0,1.0,3/13,17.08%,ARID1A;SMARCB1;SMARCA4
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.3250833813176386,0.5763620691891074,0.9285714285714286,1.0,1.0,3/13,17.08%,ARID1A;SMARCB1;SMARCA4
prerank,GO_Biological_Process_2021__regulation of transmission of nerve impulse (GO:0051969),0.3653815274237199,0.5763435057157815,0.9318181818181818,1.0,1.0,2/5,19.21%,FGF12;HCRT
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.29253268314783465,-0.5756813250050227,1.0,1.0,1.0,2/23,8.33%,PEX11B;PEX16
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.28232396103667823,-0.5755574933380304,0.9577464788732394,1.0,1.0,4/28,16.51%,CD6;GBP5;APOD;CUEDC2
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),-0.3430164084852514,-0.5754648477827193,0.9836065573770492,1.0,1.0,1/9,6.26%,CHST1
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),0.3488434932987462,0.5746699513537349,0.8695652173913043,1.0,1.0,5/5,65.13%,HMGCLL1;MCCC2;MCCC1;IVD;HMGCL
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),0.29250803016850757,0.5746560614285752,0.9767441860465116,1.0,1.0,7/13,28.41%,BACE2;IDE;NCSTN;APEH;MME;PSEN1;MGAT3
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.360258082015418,0.5741825001971531,0.9459459459459459,1.0,1.0,1/6,13.57%,SIRT1
prerank,GO_Biological_Process_2021__plasma membrane phospholipid scrambling (GO:0017121),0.33869424638354273,0.5733661833744473,0.9772727272727273,1.0,1.0,2/7,13.23%,PLSCR2;ANO6
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),-0.3552839492488874,-0.5732342156553637,0.9583333333333334,1.0,1.0,1/6,14.30%,TXN
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),-0.3223719761413446,-0.5726403844820164,0.9473684210526315,1.0,1.0,2/9,18.19%,P4HA3;P4HTM
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.2587646387031045,-0.5725096712075587,1.0,1.0,1.0,4/57,9.10%,TCP1;TGFB1;CCT6A;CCT8
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),-0.3499688165655366,-0.5723162570125675,0.9672131147540983,1.0,1.0,6/9,32.58%,AK4;AMPD2;AMPD3;NT5C1A;NT5E;ADSS2
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.30761028402697355,-0.5721598880572054,0.96875,1.0,1.0,2/14,15.08%,RAD51AP1;WAS
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.26833525470663344,0.5714477470531651,0.95,1.0,1.0,9/25,29.43%,TET2;SETMAR;WDR82;BEND3;TET3;SETD4;PAXIP1;KMT2C;SETD1A
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.3197931543111869,0.5714317248616722,0.9473684210526315,1.0,1.0,3/7,27.27%,CXCL12;FERMT2;FERMT3
prerank,MSigDB_Hallmark_2020__Protein Secretion,-0.23663408082533882,-0.5713784666593834,1.0,1.0,1.0,22/91,28.07%,LMAN1;BNIP3;ARCN1;TOM1L1;ATP1A1;STX16;LAMP2;CLCN3;ARF1;ARFGEF2;ANP32E;M6PR;CLTC;CLTA;DNM1L;NAPG;SCAMP1;TMED10;NAPA;COPB1;PPT1;ERGIC3
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.26611969065112906,-0.5710834388523357,1.0,1.0,1.0,9/33,26.76%,G6PD;MOCS2;NFS1;GPAM;MOCOS;IPMK;CPS1;TKT;GK5
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.33334905890486677,-0.5707087666579937,0.9836065573770492,1.0,1.0,3/13,11.81%,DAB2IP;KIF20B;SEMA3A
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),-0.36819933409301087,-0.5689383356607378,0.9508196721311475,1.0,1.0,4/7,30.10%,GPS2;PLAA;DDX3X;PTPN22
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),0.3360536129276331,0.5682777110891943,0.9454545454545454,1.0,1.0,6/6,66.41%,TRPM7;CNNM4;SLC7A8;ATP13A2;UNC80;COX11
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),-0.2777623467115717,-0.5680487985769241,0.9705882352941176,1.0,1.0,2/28,8.13%,HSD17B13;FABP3
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),-0.28003263090434727,-0.5674068185045555,0.9672131147540983,1.0,1.0,7/23,28.49%,SLC30A8;SLC4A9;HCN4;SLC30A4;SLC4A8;FHL1;CAMK2D
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),-0.3299062888166072,-0.5670319613123903,0.9803921568627451,1.0,1.0,1/9,10.91%,DCTN1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),-0.3003443494201882,-0.5670316169428666,0.9508196721311475,1.0,1.0,2/18,16.36%,DCP2;NAT10
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),-0.2717422201947436,-0.5670242059271815,1.0,1.0,1.0,1/25,3.34%,CENPK
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),-0.38053345626769225,-0.5669470901807389,0.9833333333333333,1.0,1.0,3/6,31.91%,GOLGA2;PLK5;PLK3
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),-0.2163547487136898,-0.5668818277834621,1.0,1.0,1.0,51/189,30.52%,ENC1;PSMB6;IFI27;PSMB8;KIF14;PRAME;RCN3;PSMA3;PSMC3;KBTBD6;PRPF19;ERLEC1;PSMC6;PSMA5;RBX1;SIAH1;SYVN1;CCDC47;PSMA7;KAT5;SPSB1;KCTD2;PSMD12;HECW1;RNF187;TNFAIP1;CRBN;PSME1;PSMB2;RNF34;MARCHF6;PLAA;RNF122;PSMD2;PSMA8;FEM1C;SPSB3;UCHL1;RNF41;PSMA1;FEM1B;PSMC1;UBE2B;DERL1;PSMD4;PSMD8;PSMB4;PCBP2;RAD23B;PSMC4;SPSB2
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),-0.2849012353894459,-0.5666003364591825,1.0,1.0,1.0,6/28,28.05%,LAMTOR2;GLRA1;LAMTOR5;RRAGA;SPAAR;LAMTOR3
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),-0.3094576946438123,-0.5663175608606373,0.9722222222222222,1.0,1.0,2/13,21.76%,FGD3;RAB17
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.26929876247186135,0.5658941168625775,0.9714285714285714,1.0,1.0,4/19,19.02%,SPHK2;RUVBL2;SMARCB1;TADA2A
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),-0.2649136711503353,-0.5652994677664683,1.0,1.0,1.0,10/49,23.52%,MANBA;GCNT1;NGLY1;MAN1A1;MGAT4B;ADAMTS9;CNMD;MAN1B1;AGA;MGAT4A
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),-0.3369528971228965,-0.5651368128536309,0.9574468085106383,1.0,1.0,3/12,24.19%,SESN3;RNF152;SPAAR
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.27637058997094394,-0.5650652638472607,0.9857142857142858,1.0,1.0,4/28,14.27%,TGFB1;IFI27;KIF20B;RIPOR1
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),0.34799762200724205,0.5647836325212245,0.9047619047619048,1.0,1.0,6/6,65.21%,SENP1;SENP6;SENP2;SENP5;USPL1;SENP7
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),-0.34991930366793367,-0.5645308502319364,0.9508196721311475,1.0,1.0,2/8,13.03%,ADGRB1;FLOT1
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.24572106942481617,0.5640683108053621,1.0,1.0,1.0,8/54,13.16%,BCL2;LEPR;MTMR8;DAP;TAB3;MTMR9;NRBP2;SIRT2
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),-0.3175473746640458,-0.5640302228740729,0.9848484848484849,1.0,1.0,3/13,18.13%,PAIP2B;EIF2AK1;RBM4
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.29771858634445003,-0.5622827128281087,0.9850746268656716,1.0,1.0,6/23,24.89%,CASP8;LACC1;AAMP;RPS27A;UBC;RIPK2
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),0.3034054054054054,0.5621879303880056,0.9166666666666666,1.0,1.0,9/9,69.67%,TERF1;PARP3;TP53;PINX1;POT1;SRC;ERCC4;PIF1;MEN1
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),0.24367301086447518,0.5620514592238516,1.0,1.0,1.0,4/37,12.26%,NUP210;NUP42;TPR;NUP37
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),-0.3165933977630382,-0.5618490590631185,1.0,1.0,1.0,3/16,17.32%,MANBA;NGLY1;ADAMTS9
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),0.3556710794912129,0.5613943762842887,0.9361702127659575,1.0,1.0,1/6,14.80%,AKT2
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.30396323115821233,-0.5613471743909009,0.9852941176470589,1.0,1.0,6/21,24.89%,CASP8;AAMP;RPS27A;RNF34;UBC;RIPK2
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),-0.37116497903198975,-0.56100906615642,0.9807692307692307,1.0,1.0,1/6,8.87%,ACSL5
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),-0.33496686621049776,-0.5605342859121518,0.9365079365079365,1.0,1.0,3/8,29.52%,MSN;RDX;EZR
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),-0.33496686621049776,-0.5605342859121518,0.9365079365079365,1.0,1.0,3/8,29.52%,MSN;RDX;EZR
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),-0.33496686621049776,-0.5605342859121518,0.9365079365079365,1.0,1.0,3/8,29.52%,MSN;RDX;EZR
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),-0.3485445257149742,-0.5605111677271556,0.9672131147540983,1.0,1.0,1/8,11.08%,PAICS
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.31556369621084607,-0.5604954085799815,0.9649122807017544,1.0,1.0,4/12,25.97%,RAB23;GTPBP1;AK4;RAN
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.28123247076401736,-0.5604922405783412,0.9841269841269841,1.0,1.0,2/25,10.91%,GPSM2;DCTN1
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.3500036981129772,-0.5604787819273146,0.896551724137931,1.0,1.0,1/7,14.00%,GPC1
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),-0.3008102592124768,-0.5601404463546718,0.9672131147540983,1.0,1.0,3/16,18.77%,TSPYL5;YAP1;KDM1A
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),-0.3970555796321792,-0.5592946313403404,0.9622641509433962,1.0,1.0,2/5,27.46%,AGO1;AGO4
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),0.33169546403004047,0.5587517701939374,0.9791666666666666,1.0,1.0,2/8,10.93%,BMP7;TOM1L2
prerank,GO_Biological_Process_2021__kynurenine metabolic process (GO:0070189),-0.36491329209587736,-0.5579204949439008,1.0,1.0,1.0,4/8,33.44%,IDO1;KMO;TDO2;AFMID
prerank,GO_Biological_Process_2021__positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.35562252841196845,0.5572788408970833,0.9302325581395349,1.0,1.0,1/5,6.89%,RASGRP1
prerank,GO_Biological_Process_2021__regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.35562252841196845,0.5572788408970833,0.9302325581395349,1.0,1.0,1/5,6.89%,RASGRP1
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.23323557962981056,0.5571019731756807,1.0,1.0,1.0,5/51,12.26%,NUP210;NUP42;TPR;TRIM71;NUP37
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.23323557962981056,0.5571019731756807,1.0,1.0,1.0,5/51,12.26%,NUP210;NUP42;TPR;TRIM71;NUP37
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.28852925470878865,-0.5570953341305623,0.9848484848484849,1.0,1.0,7/19,25.61%,SKP1;RPS7;RPL5;RAB1A;RPL23;GOLGA2;UBE2S
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.28731745200295256,-0.5563538648244057,0.96875,1.0,1.0,4/24,22.94%,SYT2;SYT4;SYT9;SYT13
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.3092417905061286,0.5563229158213296,0.9655172413793104,1.0,1.0,2/13,10.40%,IGF1;CILP
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.24470195762247104,0.556116564953043,0.96875,1.0,1.0,12/30,32.69%,BICD1;BORCS5;TRAK2;DYNC1I1;BICDL1;TRAK1;CLN3;UXT;KIF5B;MAPT;NDE1;RAB6A
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),-0.31538153821839304,-0.5558591440097901,0.9838709677419355,1.0,1.0,3/17,13.09%,GINS2;MRE11;GINS1
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),-0.33648074648676096,-0.5553664311108846,0.9833333333333333,1.0,1.0,1/8,8.00%,GBA3
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),-0.3117024642045205,-0.5553373486390764,0.967741935483871,1.0,1.0,4/13,25.96%,RAB11A;ARL6;RAB17;BBS7
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),-0.3117024642045205,-0.5553373486390764,0.967741935483871,1.0,1.0,4/13,25.96%,RAB11A;ARL6;RAB17;BBS7
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.29861881982843136,0.5551502216213018,0.9428571428571428,1.0,1.0,3/9,21.76%,PIP4K2A;ELAPOR1;SH3GLB1
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-0.36242621156497434,-0.5549456420042069,0.8928571428571429,1.0,1.0,1/5,22.37%,CTDP1
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),-0.3245763563796445,-0.5548631419221942,1.0,1.0,1.0,3/9,29.52%,MSN;CDC42;EZR
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),0.2982648645275888,0.5547615773857411,1.0,1.0,1.0,2/16,10.48%,BCL2;GGCT
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),0.2672935476617864,0.5543800859931234,0.9534883720930233,1.0,1.0,5/22,19.38%,TPR;ANP32B;BAG3;SIRT7;EMD
prerank,GO_Biological_Process_2021__glycerol ether metabolic process (GO:0006662),-0.3583640192648969,-0.5542062643164201,0.9622641509433962,1.0,1.0,1/5,14.24%,NCEH1
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),-0.2902084872972008,-0.5541732249064164,0.9661016949152542,1.0,1.0,3/15,28.43%,WDR5;KANSL2;KANSL1
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),-0.2902084872972008,-0.5541732249064164,0.9661016949152542,1.0,1.0,3/15,28.43%,WDR5;KANSL2;KANSL1
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.24917560418901136,0.5541594836535265,1.0,1.0,1.0,9/40,19.91%,PAPSS2;ADCY2;GUCY1A1;PANK3;PANK1;AK5;ADCY9;PPCDC;ADCY8
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.27389412618518666,-0.5534211674579084,0.9692307692307692,1.0,1.0,4/23,21.55%,AGER;APH1B;LYN;PSME1
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),-0.2683145000789781,-0.5533866623239339,0.9846153846153847,1.0,1.0,1/28,2.77%,TPX2
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.28094725291838873,0.5532003173403549,0.972972972972973,1.0,1.0,4/19,13.42%,SMAD2;FBXL15;ELAPOR2;NUMA1
prerank,GO_Biological_Process_2021__brown fat cell differentiation (GO:0050873),-0.3539105320568398,-0.5530340641615019,0.9344262295081968,1.0,1.0,4/6,40.69%,PRDM16;PPARGC1A;METRNL;UCP1
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),0.3441324530038452,0.552691383629326,0.9795918367346939,1.0,1.0,2/7,10.93%,BMP7;TOM1L2
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),0.3102459631426331,0.551867472719749,0.972972972972973,1.0,1.0,2/11,16.18%,MT1E;ZNF658
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),-0.3361036709322763,-0.5516097300443958,0.9180327868852459,1.0,1.0,6/7,34.65%,SPI1;DLEC1;ABI3;PLK5;DAPK1;LAPTM5
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),-0.30657019638746086,-0.5515271242700656,0.9850746268656716,1.0,1.0,4/16,18.27%,LDLRAP1;APH1B;ADAM17;NSG1
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),0.30034055894913203,0.5514233526380934,0.9024390243902439,1.0,1.0,10/10,69.98%,SIRT7;ZNF692;DGKQ;GNMT;OGT;FBP1;PDK2;USP7;SDHAF3;SELENOS
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),-0.3086847959224107,-0.551285504251011,1.0,1.0,1.0,2/20,9.72%,SERPINE1;KNG1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.26578920990068444,-0.5502717393430592,1.0,1.0,1.0,9/32,28.95%,CAMLG;UCHL5;GABARAPL2;MAP1A;HSP90AB1;LAMP3;PRKCG;AQP11;GIPC1
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),0.21135754283971694,0.5498001907678388,1.0,1.0,1.0,6/62,12.26%,NUP210;ELAVL1;NUP42;TPR;TRIM71;NUP37
prerank,GO_Biological_Process_2021__arginine catabolic process (GO:0006527),-0.34132842788560647,-0.5496952801219516,0.9491525423728814,1.0,1.0,3/7,24.52%,ARG2;NOS1;ARG1
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),-0.3332973449480119,-0.5481572287582469,0.9259259259259259,1.0,1.0,3/8,25.51%,HLA-A;PGLYRP1;NLRC4
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.2666612928413718,-0.5479667419926961,1.0,1.0,1.0,8/29,27.13%,OTOF;MYOF;RABIF;GCA;DNM1L;DYSF;NAPG;NAPA
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),0.29444565468784484,0.5477980012620184,0.9142857142857143,1.0,1.0,1/8,8.40%,TNNC2
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),-0.24998460186704252,-0.5475126167500709,1.0,1.0,1.0,7/49,21.76%,DENND1C;VPS35;VPS52;ANKRD27;SNX4;ARL4C;RAB17
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),-0.3166377821389368,-0.5472348339081458,0.9682539682539683,1.0,1.0,1/10,10.32%,IL18
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.2805390990647353,0.5466351772228257,1.0,1.0,1.0,1/13,3.97%,HDAC9
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),0.33896692965692726,0.5453071685416893,0.8918918918918919,1.0,1.0,2/6,14.93%,CHD7;WNT5A
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),-0.305911651472197,-0.5450396957203418,0.9710144927536232,1.0,1.0,3/16,14.96%,GM2A;B3GALT4;NEU1
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),0.269586325015545,0.544359744753229,0.9487179487179487,1.0,1.0,7/19,28.31%,PNKP;ATM;SMG6;TERF2;TNKS;PRKCQ;HNRNPD
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),-0.30197561196510414,-0.5435152276961273,0.9852941176470589,1.0,1.0,2/16,11.86%,RASIP1;STMN1
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),-0.37989730595843785,-0.5431347143534352,0.9508196721311475,1.0,1.0,1/5,10.38%,HIP1R
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),-0.34052645956195193,-0.5427656756306022,0.9433962264150944,1.0,1.0,1/8,15.05%,RBX1
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),-0.34190022813210535,-0.542646003442467,0.9310344827586207,1.0,1.0,1/6,10.83%,SPI1
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),0.2935568758931462,0.5422230625563952,1.0,1.0,1.0,2/17,13.89%,TIMELESS;SPIDR
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),0.3243568777665502,0.5419707843814322,0.9722222222222222,1.0,1.0,2/6,18.75%,FER;BLK
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.2300781561342779,0.5417876274642653,1.0,1.0,1.0,6/39,14.09%,LIN7A;NRXN1;SYN3;SYN2;SYT1;PPFIA3
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),-0.26486559394220455,-0.5416169747183376,0.9859154929577465,1.0,1.0,1/25,5.98%,PINK1
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),0.3398154479639898,0.5410102173709739,0.8837209302325582,1.0,1.0,1/5,14.43%,LCLAT1
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.3023674567026087,-0.5409793374701041,1.0,1.0,1.0,3/11,30.27%,SHANK3;RAB5A;DLG4
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),0.33257052414361865,0.5399421876863738,0.9375,1.0,1.0,3/9,30.20%,ICE1;RPTOR;ICE2
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.22400601041307422,0.5399005609691857,1.0,1.0,1.0,6/40,14.09%,LIN7A;NRXN1;SYN3;SYN2;SYT1;PPFIA3
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),0.3470179684147406,0.5397063871640464,0.9777777777777777,1.0,1.0,1/7,10.74%,DDX60
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.27550047983530346,-0.5396080046092375,1.0,1.0,1.0,5/24,19.78%,ALYREF;HTATSF1;SUPT5H;TCEA2;THOC5
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),-0.33131339017631545,-0.5395115279700321,0.9803921568627451,1.0,1.0,1/7,15.73%,ULK1
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.285950817690747,-0.5382877881104942,0.9833333333333333,1.0,1.0,4/19,20.76%,NCKAP1L;CCL5;CXCL13;PIK3CD
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),0.2633026319018365,0.537984765247181,0.9487179487179487,1.0,1.0,9/18,28.55%,ADAM19;BACE2;NCSTN;SPPL3;DAG1;ADAM10;PSEN1;PRKCQ;RBMX
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.25029403471958905,0.5379441810349541,0.96875,1.0,1.0,3/24,14.77%,GNL3L;DACH1;TERF1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.265311626687953,-0.5378338544114389,0.9508196721311475,1.0,1.0,2/25,9.27%,PINK1;SKP1
prerank,GO_Biological_Process_2021__mitotic spindle elongation (GO:0000022),0.3490297590045017,0.5373103638139711,0.95,1.0,1.0,3/6,20.36%,MAP10;AURKC;KIF23
prerank,GO_Biological_Process_2021__mitotic spindle midzone assembly (GO:0051256),0.3490297590045017,0.5373103638139711,0.95,1.0,1.0,3/6,20.36%,MAP10;AURKC;KIF23
prerank,GO_Biological_Process_2021__negative regulation of steroid biosynthetic process (GO:0010894),0.3378535387290004,0.5371140501520435,0.8571428571428571,1.0,1.0,4/5,26.38%,NFKB1;PROX1;BMP2;WNT4
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.30425749942019387,-0.5370904072616612,0.9846153846153847,1.0,1.0,2/12,11.83%,PINK1;DNAJA1
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),0.3005273323557445,0.5369459283352833,0.9761904761904762,1.0,1.0,4/11,24.25%,DISC1;CTNNB1;SMARCD3;VEGFA
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),-0.25041682507616647,-0.5361643050556285,1.0,1.0,1.0,5/54,17.54%,WIPI1;MAP1LC3B;RIPOR1;ULK1;LAMP2
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),-0.2584339860413624,-0.5357139130514398,1.0,1.0,1.0,9/35,22.21%,DAB2IP;BRCA1;CBX5;CBX3;CHEK1;RBBP8;SUZ12;L3MBTL2;FOXO4
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.2672860630226853,0.5353471905867744,0.972972972972973,1.0,1.0,2/14,14.51%,PRKCB;BRAF
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),-0.23660297010841974,-0.5350165913598344,0.9841269841269841,1.0,1.0,8/43,19.68%,CD14;CD6;LBP;ADAM17;HNRNPA0;PRDX3;NOS1;SLC11A1
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),-0.29291041225536707,-0.5349943042784356,0.9846153846153847,1.0,1.0,1/11,19.17%,ZNF304
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.32658624631400834,-0.5349265726266782,0.9850746268656716,1.0,1.0,1/8,6.83%,IFI27
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.29638235012956055,-0.534765809087434,1.0,1.0,1.0,1/20,3.79%,DRD3
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),-0.31124461708485,-0.5343375822216876,0.9649122807017544,1.0,1.0,2/9,13.58%,ABCC6;ABCC2
prerank,GO_Biological_Process_2021__ribosome localization (GO:0033750),-0.3337109112495331,-0.5342384219708375,0.9482758620689655,1.0,1.0,2/5,25.97%,EIF6;RAN
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),-0.35550448000672963,-0.533622076910383,0.967741935483871,1.0,1.0,2/6,24.22%,HEBP2;ASAH1
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),-0.2997439210131921,-0.5333432231019138,0.96875,1.0,1.0,1/11,11.86%,STMN1
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),0.33206427105003555,0.5321861553091355,0.9347826086956522,1.0,1.0,4/6,32.04%,DENND1A;DENND4B;DENND4A;DENND3
prerank,GO_Biological_Process_2021__cellular response to UV-B (GO:0071493),0.31955252918287946,0.5319261980154215,0.9230769230769231,1.0,1.0,5/5,68.05%,MME;HYAL2;HYAL3;STK11;HYAL1
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),-0.3286423871662954,-0.531445572220002,0.9818181818181818,1.0,1.0,3/7,29.52%,MSN;RDX;EZR
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),0.3442854582529626,0.5313253579571038,0.9090909090909091,1.0,1.0,1/6,5.06%,EPHB2
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),0.3130072959489725,0.531048474681203,0.975,1.0,1.0,2/7,17.04%,FYN;DOCK3
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),0.239707939535169,0.5302282540412933,1.0,1.0,1.0,2/17,10.70%,APOE;SCAP
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),-0.3139770414868226,-0.5299722008126196,0.9285714285714286,1.0,1.0,2/8,18.40%,LIN7C;PDZD11
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),-0.3139770414868226,-0.5299722008126196,0.9285714285714286,1.0,1.0,2/8,18.40%,LIN7C;PDZD11
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.2533300607934447,0.529921074426565,1.0,1.0,1.0,11/24,30.50%,LIN28B;EXOSC5;DIS3;DIS3L2;MTREX;EXOSC7;EXOSC9;POP1;TENT4B;XRN1;EXOSC4
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),-0.24392805466784118,-0.5295072690082198,1.0,1.0,1.0,9/43,25.47%,CHMP4B;RASA1;STMN1;RACGAP1;MITD1;EFHC2;KIF4A;KLHDC8B;CKAP2
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),-0.32585280659339855,-0.529471706700878,0.953125,1.0,1.0,1/8,9.25%,MGME1
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),-0.32666113494995086,-0.5294159281323827,0.9682539682539683,1.0,1.0,2/8,21.70%,CMPK2;AK4
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),0.2849189189189191,0.5289816346655958,1.0,1.0,1.0,9/9,71.52%,HMGCLL1;SLC27A5;OXCT1;BDH1;ACSS3;BDH2;AACS;HMGCL;ACAT1
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),-0.25438376388360406,-0.5286949632593363,1.0,1.0,1.0,9/37,22.21%,DAB2IP;BRCA1;CBX5;CBX3;CHEK1;RBBP8;SUZ12;L3MBTL2;FOXO4
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),-0.33374770295103234,-0.5286145307699414,0.9836065573770492,1.0,1.0,7/7,66.64%,DIRAS3;PRMT7;KDM1B;PCGF3;MECP2;PCGF5;DNMT3A
prerank,GO_Biological_Process_2021__positive regulation of Golgi to plasma membrane protein transport (GO:0042998),0.33273886727194135,0.5282104372614878,0.9428571428571428,1.0,1.0,5/5,66.74%,CLN3;ATP2C1;CNST;RACK1;ACSL3
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),-0.30880625337134326,-0.5278372439712588,0.9583333333333334,1.0,1.0,1/9,14.65%,METAP1D
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),-0.29577616044687294,-0.5275267709504777,0.9838709677419355,1.0,1.0,4/14,25.96%,RAB11A;ARL6;RAB17;BBS7
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),-0.29577616044687294,-0.5275267709504777,0.9838709677419355,1.0,1.0,4/14,25.96%,RAB11A;ARL6;RAB17;BBS7
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.306310240640995,0.5275188753722618,0.9722222222222222,1.0,1.0,2/11,13.16%,PARD3;SIRT2
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),0.3423057727051343,0.5262998297881345,0.9487179487179487,1.0,1.0,1/5,13.45%,SLC8A1
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),0.3423057727051343,0.5262998297881345,0.9487179487179487,1.0,1.0,1/5,13.45%,SLC8A1
prerank,MSigDB_Hallmark_2020__Myc Targets V2,-0.2450126081109672,-0.5261292752824263,1.0,1.0,1.0,21/52,31.55%,TMEM97;MAP3K6;PLK4;CDK4;GNL3;SUPV3L1;CBX3;HSPD1;GRWD1;LAS1L;NOP56;IMP4;NIP7;PA2G4;MCM4;RABEPK;DDX18;PPRC1;AIMP2;NDUFAF4;MRTO4
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),-0.26146411067573494,-0.5253865807513297,1.0,1.0,1.0,2/21,14.24%,DOCK1;ARHGAP12
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.3514860364359196,0.5242116151500792,0.9302325581395349,1.0,1.0,2/5,26.19%,TRIP11;TBC1D23
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),-0.25720111700793225,-0.5239708599614076,1.0,1.0,1.0,6/39,18.07%,ISG20;DCP2;NCBP1;SUPV3L1;RNASEH2C;RNASET2
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.26809295728081844,0.5239016724903997,0.9411764705882353,1.0,1.0,1/17,3.18%,BMP7
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.24287178179666782,-0.5230054726889042,0.9841269841269841,1.0,1.0,6/31,25.48%,SLU7;DAXX;FGF1;HSP90AB1;TRPV4;POLR2D
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.23535989744777866,0.5225602915526928,1.0,1.0,1.0,3/20,19.86%,RAB7A;SORL1;NEDD4
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),-0.26107385858143733,-0.5220466003692762,1.0,1.0,1.0,4/17,23.18%,POLR1E;GTF3C6;GTF3C3;GTF3C4
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.27072032488811043,-0.5218586719936086,0.9841269841269841,1.0,1.0,4/21,20.76%,NCKAP1L;CCL5;CXCL13;PIK3CD
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),0.2674143629618514,0.5218479429342534,1.0,1.0,1.0,7/20,30.20%,ICE1;ZNF345;RPTOR;BRF2;POLR3F;POLR3C;ICE2
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),0.25057641034828343,0.5218442048976419,1.0,1.0,1.0,3/24,10.28%,RNF2;PCGF1;RYBP
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),0.3149219159975566,0.5214203407724467,0.95,1.0,1.0,2/6,17.04%,FYN;DOCK3
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.31694941235207785,-0.5214090251755407,1.0,1.0,1.0,1/11,7.88%,CD14
prerank,GO_Biological_Process_2021__regulation of potassium ion export across plasma membrane (GO:1903764),0.30375174067974553,0.5211876940117581,0.926829268292683,1.0,1.0,1/5,13.23%,ANO6
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),0.3271296802312152,0.5203515878232573,0.9285714285714286,1.0,1.0,2/8,13.00%,MTR;DHFR
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.2784049156499956,-0.5202411334067243,1.0,1.0,1.0,4/21,20.76%,NCKAP1L;CCL5;CXCL13;PIK3CD
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),-0.333339954989017,-0.5200344049650549,0.9795918367346939,1.0,1.0,3/8,32.36%,VPS4A;ANKFY1;VPS39
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),-0.22265312601615622,-0.5199306829548437,1.0,1.0,1.0,13/75,24.76%,FKBP4;RPA3;BAG4;DNAJC2;NUP85;DNAJB1;HSPH1;NUP155;NUP188;HSPA1L;HSP90AB1;CAMK2G;NUP214
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),0.30330430377107487,0.5195469863262747,0.9736842105263158,1.0,1.0,2/7,18.75%,FER;BLK
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),-0.32163683697503553,-0.5191464979872242,0.9814814814814815,1.0,1.0,2/6,21.24%,REST;DKK3
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.3031921349829511,0.5191113995461869,0.9354838709677419,1.0,1.0,2/8,13.45%,PDE4D;SLC8A1
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),0.32103284703449986,0.5175980947848104,0.9696969696969697,1.0,1.0,2/8,14.10%,ACOT8;BACE2
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),0.2864760614151919,0.5173524120280156,1.0,1.0,1.0,2/8,15.25%,MEGF10;PLAT
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.2733403265839288,-0.5172838225981625,1.0,1.0,1.0,1/26,8.77%,BTBD18
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),0.29190326808321654,0.5170213730984721,0.9761904761904762,1.0,1.0,2/10,12.77%,TPH1;SRM
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),0.31402153978481945,0.5162451720565296,0.9117647058823529,1.0,1.0,4/8,27.33%,PROM2;NR1H3;CLN3;NR1H2
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),-0.237957887893449,-0.5155826652087072,1.0,1.0,1.0,5/36,21.67%,CHMP2B;RNF26;HOOK2;CLCN3;ARFGEF2
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),-0.245108700642961,-0.515322333492308,0.9838709677419355,1.0,1.0,7/29,26.20%,HSPA5;DAB2IP;DAXX;HSPA9;HSPA1L;BAX;HSPA8
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),0.28918918918918934,0.5150691089692643,0.9534883720930233,1.0,1.0,9/9,71.10%,IRAK2;TRAF6;PIK3AP1;EPG5;PIK3C3;PIK3R4;IRAK1;IRAK4;TNIP2
prerank,GO_Biological_Process_2021__lymphatic endothelial cell differentiation (GO:0060836),0.3225379989668822,0.5149191917156996,0.918918918918919,1.0,1.0,3/5,26.99%,PDPN;PROX1;BMPR2
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),-0.2703260860270805,-0.5148285583448183,1.0,1.0,1.0,3/21,18.77%,TSPYL5;YAP1;KDM1A
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),0.23918075432992342,0.5144002521733686,1.0,1.0,1.0,4/32,17.42%,BLOC1S4;AP3B2;SPAST;TMEM108
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),-0.321979214710635,-0.5139963083424279,0.9682539682539683,1.0,1.0,1/5,25.77%,EFEMP2
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",0.3137699956766106,0.5139658584280227,0.9565217391304348,1.0,1.0,5/5,68.63%,SEC61A2;ZFAND2B;SEC61A1;SEC61B;SRP54
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),-0.2949768977095707,-0.5125970100622211,0.9818181818181818,1.0,1.0,4/11,23.29%,CORO1A;VIL1;ARF1;WHAMM
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.24286911801434957,0.5111079600646966,1.0,1.0,1.0,9/37,24.11%,WDR24;PIP4P1;TELO2;WDR59;HDAC3;GPR137C;RPTOR;LAMTOR4;KLHL22
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),0.2655410631138749,0.5110774377948187,0.9736842105263158,1.0,1.0,1/9,13.07%,MLYCD
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.3246358569171789,0.5103287966748279,0.9696969696969697,1.0,1.0,1/6,5.83%,PDE4D
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),0.28614338274086876,0.5101151194289705,0.9782608695652174,1.0,1.0,4/10,21.61%,RIPOR2;LRCH1;MIA3;CD200R1
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.25156704099552996,-0.5099234142779918,1.0,1.0,1.0,3/22,15.65%,TCHP;YAP1;STAP1
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),-0.28336809505614624,-0.5097151707209442,0.9571428571428572,1.0,1.0,1/13,14.88%,NEFL
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.3105611288615753,-0.5095313518602372,1.0,1.0,1.0,3/10,24.44%,TLR2;ZCCHC3;TLR5
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),-0.268267696141142,-0.509225878669217,0.9841269841269841,1.0,1.0,2/13,23.13%,CYP2R1;IPMK
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),-0.27851541169054794,-0.5089719025314139,1.0,1.0,1.0,4/17,33.46%,MSN;RDX;EZR;DENND10
prerank,GO_Biological_Process_2021__regulation of blood-brain barrier permeability (GO:1905603),-0.3154558513047132,-0.5086759803141184,0.9807692307692307,1.0,1.0,1/6,12.59%,TJP3
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.29178197036908604,0.5078310431252255,0.9302325581395349,1.0,1.0,2/9,14.43%,PLA2G4C;LCLAT1
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.29593328144991793,0.5071322719372667,0.9523809523809523,1.0,1.0,1/10,6.73%,APOE
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),-0.2754025500881424,-0.5070434129925929,0.984375,1.0,1.0,2/10,21.72%,EXOSC6;EXOSC8
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.2300907016275045,-0.5065944832924969,1.0,1.0,1.0,5/36,20.62%,RNPS1;POLR2J;POLR2K;CREBL2;POLR2B
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.27363298396309643,0.5061511755777245,0.967741935483871,1.0,1.0,1/14,5.95%,ZNHIT6
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.25770412063842585,0.506111644037774,0.9545454545454546,1.0,1.0,1/14,8.44%,GNL3L
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.2952328729785144,-0.5059453167222381,1.0,1.0,1.0,1/13,7.88%,CD14
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.22890105012583495,0.5057337957459271,0.9743589743589743,1.0,1.0,6/32,20.06%,KPTN;PIP4P1;TELO2;DYRK3;ATM;GPR137C
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),-0.321655141404442,-0.5053345548010217,0.9818181818181818,1.0,1.0,2/5,29.20%,VCPIP1;TRAIP
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),-0.3336640429644745,-0.5050747390941837,0.9629629629629629,1.0,1.0,2/5,22.45%,PDZK1;SLC22A4
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),0.2869666866327715,0.5047482310930734,1.0,1.0,1.0,2/8,13.46%,PNKP;AK5
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.29793252155609434,-0.5043007246771141,0.9846153846153847,1.0,1.0,6/13,34.97%,CIAO2A;MAGEF1;ISCA2;CISD3;GLRX3;MMS19
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),-0.2942118272770155,-0.5035337043047452,0.9833333333333333,1.0,1.0,2/7,25.97%,EIF6;RAN
prerank,GO_Biological_Process_2021__positive regulation of sterol transport (GO:0032373),0.336869989841562,0.5030381757598087,1.0,1.0,1.0,2/5,16.85%,ABCA13;NR1H3
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.29167162155828197,-0.5026497306384374,0.9661016949152542,1.0,1.0,2/8,23.01%,DDX11;AXIN2
prerank,GO_Biological_Process_2021__stress granule disassembly (GO:0035617),0.3303181512650864,0.5022192432866144,0.9459459459459459,1.0,1.0,3/5,29.16%,DYRK3;VCP;KIF5B
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),0.2849035187287174,0.5012574285561127,0.9743589743589743,1.0,1.0,8/8,71.52%,HMGCLL1;SLC27A5;BDH1;ACSS3;BDH2;AACS;HMGCL;ACAT1
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.24552411993337675,-0.5002543930079076,1.0,1.0,1.0,9/27,30.81%,TRIM25;BRCA1;ESR1;GHRL;AR;PELP1;CD24;LOC400499;GHRHR
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),-0.26005934679814313,-0.5002218986596775,0.9848484848484849,1.0,1.0,3/17,23.00%,RAB11A;CDK5;KIF5A
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.23800865943361849,0.5001077098757806,1.0,1.0,1.0,1/23,3.81%,ACADVL
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),-0.31383082929735384,-0.49986844704396394,0.9661016949152542,1.0,1.0,1/7,13.03%,FLOT1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),0.29588197146562895,0.49945908647781495,0.9473684210526315,1.0,1.0,5/5,70.42%,CTPS2;UMPS;CAD;DHODH;CTPS1
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),-0.3190668763922887,-0.4987165596483893,0.9836065573770492,1.0,1.0,1/5,21.72%,EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),-0.3190668763922887,-0.4987165596483893,0.9836065573770492,1.0,1.0,1/5,21.72%,EXOSC8
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),-0.3190668763922887,-0.4987165596483893,0.9836065573770492,1.0,1.0,1/5,21.72%,EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),-0.3190668763922887,-0.4987165596483893,0.9836065573770492,1.0,1.0,1/5,21.72%,EXOSC8
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.2848251845289551,0.4980390097058225,0.975609756097561,1.0,1.0,3/14,17.08%,ARID1A;SMARCB1;SMARCA4
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),0.2906712787806722,0.49725082082882077,0.975609756097561,1.0,1.0,7/7,70.94%,HSF1;HMGA2;NUDT16L1;ERCC6;TFIP11;AUNIP;CYREN
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),0.31732602420520833,0.497109006538776,0.9545454545454546,1.0,1.0,3/5,21.61%,RIPOR2;LRCH1;CD200R1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.2607585578366815,-0.49681236646688404,1.0,1.0,1.0,7/23,25.98%,RPS7;RPL5;GABARAPL2;HSP90AB1;RPL23;LAMP3;PRKCG
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.32955036748811073,0.49610406843170163,0.9411764705882353,1.0,1.0,5/5,67.05%,NAA15;NAA20;NAA30;NAA25;NAA16
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.2585373997164486,-0.4960677683222735,1.0,1.0,1.0,8/26,26.94%,FADD;OAS3;NLRC5;STAT2;HSP90AB1;ISG15;METTL3;PTPN11
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),-0.3480877144628497,-0.4957262293993367,1.0,1.0,1.0,3/5,38.74%,MTRES1;RACK1;LTN1
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.27341765848952787,-0.49552562103481573,1.0,1.0,1.0,3/12,25.97%,EIF6;RPS15;RAN
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.27462952488507814,-0.49510190415281097,0.9852941176470589,1.0,1.0,1/15,9.45%,NCBP2
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),-0.31516630732369866,-0.4943528627833301,1.0,1.0,1.0,1/5,16.76%,SUPV3L1
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.2990236659494298,0.4943262633370012,0.9795918367346939,1.0,1.0,2/5,24.81%,PIGU;PGAP1
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),-0.29035577939790735,-0.4919621501688595,0.953125,1.0,1.0,2/8,14.98%,PLA2G7;PLA2G10
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),0.26663246244150185,0.4914143291530194,1.0,1.0,1.0,2/10,21.09%,MTMR9;MTMR3
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),-0.2892396295008385,-0.49140911574268603,0.9852941176470589,1.0,1.0,2/8,29.06%,NUPR1;CBFA2T3
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),-0.2892396295008385,-0.49140911574268603,0.9852941176470589,1.0,1.0,2/8,29.06%,NUPR1;CBFA2T3
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.24616806832728294,0.4913759552072242,1.0,1.0,1.0,5/19,18.13%,ST8SIA3;ST8SIA4;GANC;PRKCSH;ST8SIA2
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.2983743600028692,0.4913011558610809,0.9714285714285714,1.0,1.0,2/8,16.90%,SIRT2;RCC2
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),-0.2785572260600684,-0.4906477557157114,1.0,1.0,1.0,2/12,14.99%,LPCAT3;MBTPS2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),-0.3134909252562809,-0.49037458979560605,0.9692307692307692,1.0,1.0,2/6,18.23%,C1QBP;CMKLR1
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.2698960820633887,0.49000590437002495,0.9761904761904762,1.0,1.0,4/11,25.70%,SPAST;TRAK2;TRAK1;HIF1A
prerank,GO_Biological_Process_2021__histone-serine phosphorylation (GO:0035404),0.31139213143104194,0.4895522509399557,0.9523809523809523,1.0,1.0,5/5,68.87%,HMGA2;VRK1;MST1;RPS6KA5;RPS6KA4
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),-0.29912872096538773,-0.48939963189507546,0.9672131147540983,1.0,1.0,2/8,21.70%,CMPK2;AK4
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),-0.25964376338772654,-0.48867386879697966,1.0,1.0,1.0,2/22,13.68%,TLR2;APOD
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.25865787814239766,-0.48852914874957337,0.9852941176470589,1.0,1.0,3/13,20.02%,RNPS1;C1QBP;SAP18
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),-0.2584160239082436,-0.4883882838333209,0.984375,1.0,1.0,3/14,20.02%,RNPS1;C1QBP;SAP18
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),-0.3160496976315855,-0.4870753409449086,1.0,1.0,1.0,1/5,19.17%,ZNF304
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),-0.32880880740690954,-0.48576134309671065,0.9833333333333333,1.0,1.0,1/5,19.68%,SLC11A1
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",0.30508566178457547,0.48567742168423833,1.0,1.0,1.0,6/6,69.50%,UXT;LRPPRC;MAP1S;RHOT2;RHOT1;UBB
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 methylation (GO:0051574),0.3055711427169975,0.4855816977744597,0.9473684210526315,1.0,1.0,2/5,16.57%,SIRT1;MYB
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),0.28308922877371245,0.48447369271975355,0.9787234042553191,1.0,1.0,6/6,71.70%,METTL16;MEPCE;NHP2;DKC1;METTL4;NOP10
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),-0.26859765951346204,-0.4841851443693563,0.9846153846153847,1.0,1.0,3/10,23.89%,KDM3A;KDM1A;KDM7A
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),-0.30726654528328207,-0.4839026014812484,0.9827586206896551,1.0,1.0,2/7,27.07%,RYR3;D2HGDH
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.2424840404569124,0.4838511318789551,1.0,1.0,1.0,7/18,27.48%,ABCD2;SLC25A20;CPT1A;ABCD1;ACACA;SLC27A5;ACACB
prerank,GO_Biological_Process_2021__inner ear auditory receptor cell differentiation (GO:0042491),-0.3184779143614801,-0.48302740700969277,0.9827586206896551,1.0,1.0,2/5,25.39%,PDZD7;LRTOMT
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),-0.26465040030256237,-0.4827701947148016,1.0,1.0,1.0,1/12,6.92%,EPHB6
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),-0.3138740947434374,-0.4827584417184924,0.9852941176470589,1.0,1.0,1/6,25.97%,RAN
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),0.2932008596510928,0.48225444234406234,1.0,1.0,1.0,1/6,16.84%,PTHLH
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),-0.31052824708892507,-0.48158471453923174,1.0,1.0,1.0,2/9,20.46%,IL18;NUPR1
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),-0.30468504043206696,-0.48067158722674946,0.9833333333333333,1.0,1.0,1/7,15.58%,UHRF1
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),-0.2979832591351673,-0.47997938834473264,0.9821428571428571,1.0,1.0,2/7,20.49%,ITGB4;KDM6B
prerank,GO_Biological_Process_2021__regulation of norepinephrine secretion (GO:0014061),0.31231085170773887,0.4793663139881015,1.0,1.0,1.0,5/5,68.78%,HRH3;STX1A;KCNB1;ADRA2C;ADRA2A
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.25562016922131203,-0.4787827455425545,1.0,1.0,1.0,2/14,15.35%,HERPUD1;SYVN1
prerank,GO_Biological_Process_2021__detection of stimulus involved in sensory perception of pain (GO:0062149),0.3139905256433635,0.47791796423570493,0.9375,1.0,1.0,1/5,15.65%,MMP24
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),0.2855058365758753,0.4774684968530985,1.0,1.0,1.0,5/5,71.46%,PPP5C;PPP1CA;MAPT;PLSCR1;PPP2CB
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),0.2988002594033724,0.47700738078359195,0.9444444444444444,1.0,1.0,5/5,70.13%,WDR70;RNF40;CDK9;RNF20;CTR9
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),-0.3186378304494504,-0.47593528987382205,0.9807692307692307,1.0,1.0,3/6,24.58%,LIN7C;PDZD11;AP4M1
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),-0.27633671151758055,-0.47579759760072243,0.9841269841269841,1.0,1.0,4/9,36.16%,PKD1L3;LGMN;RAB11FIP5;IMPACT
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),-0.29113657341208704,-0.47455588968622525,1.0,1.0,1.0,2/8,19.28%,PLA2G10;IKBKE
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),0.27568502405015394,0.47317261384915593,0.9772727272727273,1.0,1.0,6/6,72.44%,PRKN;SNCA;MT3;HDAC6;ETFBKMT;OXA1L
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),-0.3081524253189408,-0.47287176988836493,0.9607843137254902,1.0,1.0,1/6,16.78%,LYN
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),-0.2723074409929924,-0.47124486083785694,0.9836065573770492,1.0,1.0,1/15,13.68%,APOD
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),-0.2723074409929924,-0.47124486083785694,0.9836065573770492,1.0,1.0,1/15,13.68%,APOD
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.2630182109299636,-0.4707996553072462,0.9814814814814815,1.0,1.0,3/13,23.17%,BRCA1;WDR5;SNW1
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),0.2918445657460953,0.470747504795048,1.0,1.0,1.0,6/6,70.83%,MTSS2;SYAP1;HAS1;MARS1;HYAL1;CORO1B
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),-0.2718170612743198,-0.46997542351476296,0.9818181818181818,1.0,1.0,2/10,24.67%,DIMT1;UTP15
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),-0.2977569962068227,-0.4698372050230302,1.0,1.0,1.0,2/5,25.24%,RAMP1;GOLGA2
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.24361353789138201,-0.46836045430122725,1.0,1.0,1.0,2/23,16.36%,DCP2;NAT10
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),-0.29280332017576516,-0.46778873205459953,0.9649122807017544,1.0,1.0,2/7,25.97%,RPS15;RAN
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),-0.30823520358803513,-0.4666789891885567,1.0,1.0,1.0,1/5,19.73%,CALR
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.23198429904167386,0.4649783936316611,1.0,1.0,1.0,1/16,5.78%,MEIS1
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.2496621073687626,0.46436856771585433,1.0,1.0,1.0,12/12,75.05%,TRAK2;MTM1;TRAK1;MAPT;MEF2A;HAP1;ATCAY;CLUH;MSTO1;LRRK2;ARMC1;DNM1L
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.22415192338906026,0.46372496844944905,1.0,1.0,1.0,26/26,77.62%,FSCN3;AIF1L;FSCN1;SHROOM2;DPYSL3;SHROOM1;MICAL1;FAM107A;PLS3;ADD2;BAIAP2;ADD1;LIMA1;NEDD9;BAIAP2L1;PLS1;DMTN;CALD1;MYO1B;BAIAP2L2;EZR;CORO1B;EPS8;LCP1;PAWR;HSP90B1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.26246606710880105,-0.4602486158736383,1.0,1.0,1.0,2/13,16.51%,APOD;CUEDC2
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),-0.31005467319488234,-0.459929958511779,1.0,1.0,1.0,3/5,33.04%,CLCN3;SHANK3;KCNMA1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),0.21394651303061973,0.45803251577594895,1.0,1.0,1.0,4/27,18.26%,NAF1;PNKP;ATM;PPP1R10
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.2750124871598288,0.4571358624535249,1.0,1.0,1.0,3/11,16.40%,AKR1C3;CTBP2;DHRS3
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),-0.2283993199111236,-0.45675230077160384,1.0,1.0,1.0,7/22,31.54%,MAP1A;CHRNA7;EFEMP2;HSPA8;CAMSAP1;GPX1;PARK7
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.25174896943928304,-0.45612411226033434,1.0,1.0,1.0,5/19,24.09%,LPCAT4;LPCAT3;PLA2G10;MBOAT7;PLA2G4A
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),-0.27920535712842315,-0.45599987418421967,0.9285714285714286,1.0,1.0,1/7,17.99%,PHF23
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),0.261895142933187,0.4548488240928571,1.0,1.0,1.0,1/9,10.08%,SLC6A1
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),0.27752256390855545,0.45342868815049875,1.0,1.0,1.0,6/6,72.26%,ANK2;RYR1;NOL3;TRDN;RYR2;ATP2A2
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),0.2849405858652891,0.4528741309115453,1.0,1.0,1.0,4/5,27.96%,NR1H3;ITGAV;NR1H2;PTPN2
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),0.23572664359861573,0.4524248797812339,1.0,1.0,1.0,13/13,76.44%,PNKP;TNKS;PRKCQ;HNRNPD;NABP2;MAPK1;MAP2K7;MAP3K4;MAPK3;NEK7;TNKS2;MAPKAPK5;PKIB
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.21996232596455131,-0.4519636977320715,1.0,1.0,1.0,9/35,26.78%,IARS2;MRPS14;MRPL51;MRPL16;MRPS34;TFAM;TWNK;GFM2;GATC
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),-0.2846770633823017,-0.45175140961067073,1.0,1.0,1.0,3/10,26.72%,SLC25A18;PRAF2;ARL6IP5
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),-0.26919392167571216,-0.4514979831442584,0.9787234042553191,1.0,1.0,2/7,30.10%,DDX3X;PTPN22
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.22842584704107016,0.45044826427803936,1.0,1.0,1.0,4/19,21.96%,NLGN1;RAP1A;VPS18;RIMS2
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),-0.2760272802257986,-0.4493480877207212,1.0,1.0,1.0,3/7,26.53%,INHBA;LHX6;SHANK3
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),-0.2425945458469997,-0.4483850352003372,1.0,1.0,1.0,3/12,29.52%,MSN;CDC42;EZR
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),-0.26645719841454263,-0.4476946018418958,1.0,1.0,1.0,2/12,19.20%,AKAP5;NOS1
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),-0.2876951363264375,-0.4448088065403477,1.0,1.0,1.0,3/6,34.78%,NUP155;LDB1;NUP133
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.2660390544844824,-0.44459897659092873,1.0,1.0,1.0,3/10,33.36%,CENPH;NUF2;CENPW
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.1970040833351975,0.44457747175328133,1.0,1.0,1.0,4/23,20.13%,UGGT2;ZER1;FBXL17;AUP1
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),-0.22768575297024773,-0.4444630331932387,1.0,1.0,1.0,6/22,29.29%,RAB1A;KIF3A;NDEL1;KIF5A;KIF1C;KIF1A
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),-0.2199569809415945,-0.4402994159302994,1.0,1.0,1.0,8/27,33.67%,CDKN1B;EIF4A2;PRDX3;INPP5K;MEN1;PIF1;PARK7;PHPT1
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.2514322775916118,0.439683160550377,0.9767441860465116,1.0,1.0,7/7,74.87%,TARBP2;AGO2;ADAR;AGO3;DICER1;AGO4;AGO1
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.26193497570496105,-0.4371151187397855,0.9830508474576272,1.0,1.0,2/10,26.99%,DDX11;PWP1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),0.2778191551550019,0.4359701823584915,1.0,1.0,1.0,1/5,13.24%,PHF1
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),0.22852219156131293,0.43481109270320617,0.9705882352941176,1.0,1.0,4/10,24.36%,FER1L5;AZU1;CSF1;ADAM10
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),-0.24570070788782333,-0.4301918836746679,0.9830508474576272,1.0,1.0,6/16,28.95%,LRRC8D;SLC25A18;PRAF2;GJA1;ARL6IP5;GIPC1
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.2669693039342844,0.4283184614300856,1.0,1.0,1.0,5/5,73.31%,EIF4G1;NCK1;EIF2AK4;IMPACT;DDX3X
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),0.26828081932659575,0.42630159019655867,0.9736842105263158,1.0,1.0,6/6,73.18%,GBF1;TMED9;TMED2;ARFGAP2;ARFGAP3;TMED10
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),0.26828081932659575,0.42630159019655867,0.9736842105263158,1.0,1.0,6/6,73.18%,GBF1;TMED9;TMED2;ARFGAP2;ARFGAP3;TMED10
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),0.26828081932659575,0.42630159019655867,0.9736842105263158,1.0,1.0,6/6,73.18%,GBF1;TMED9;TMED2;ARFGAP2;ARFGAP3;TMED10
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),-0.23662819010238656,-0.425582833138202,1.0,1.0,1.0,4/14,25.45%,DDX54;ESR2;ESR1;AR
prerank,GO_Biological_Process_2021__negative regulation of amino acid transport (GO:0051956),0.26713143104193693,0.42417712351827275,1.0,1.0,1.0,5/5,73.29%,GRM7;HRH3;SLC43A1;SLC43A2;ARL6IP5
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),-0.22606579848828257,-0.42381144571269885,1.0,1.0,1.0,6/17,28.40%,VIL1;TWF2;VILL;EPS8;TRIOBP;FLII
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),-0.22606579848828257,-0.42381144571269885,1.0,1.0,1.0,6/17,28.40%,VIL1;TWF2;VILL;EPS8;TRIOBP;FLII
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.222319266975792,-0.42083768248808884,1.0,1.0,1.0,8/14,36.05%,GHITM;AKT1;GPX1;CLU;HGF;PSMD10;BCL2L1;PRELID1
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),0.23360899410842662,0.4201932045562627,1.0,1.0,1.0,8/8,76.65%,TERF1;TERF2;XRCC3;WRN;POT1;SLX4;RECQL4;BLM
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),-0.2374613637070086,-0.4195212695361395,1.0,1.0,1.0,8/14,35.01%,FASN;PPCS;PPT1;ACAT1;CBR4;SCD;SCD5;ACLY
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),0.25614629403871525,0.41870886304876376,0.9782608695652174,1.0,1.0,3/7,24.60%,CHP1;FKTN;ABCA2
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.22178521702201753,0.416551175939311,1.0,1.0,1.0,3/11,21.76%,PIP4K2A;ELAPOR1;SH3GLB1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to synapse (GO:1902474),0.2615687030819793,0.41647828021372085,1.0,1.0,1.0,1/5,14.93%,WNT5A
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),-0.2407250218133783,-0.4163628205842208,1.0,1.0,1.0,5/10,33.82%,PSMG1;POMP;ADRM1;PSMD4;PSMD10
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.2251273061544196,0.41490034769587625,1.0,1.0,1.0,2/11,20.13%,UGGT2;AUP1
prerank,GO_Biological_Process_2021__negative regulation of hormone secretion (GO:0046888),0.2451902291396456,0.41152494213886276,0.9777777777777777,1.0,1.0,5/5,75.49%,RAB11FIP3;RAB11FIP1;IL11;RAB11FIP5;GJA1
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),0.23359636796022054,0.4073200925113604,1.0,1.0,1.0,7/7,76.65%,TERF1;TERF2;WRN;POT1;SLX4;RECQL4;BLM
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),-0.2550117430099047,-0.40376912376873986,0.9811320754716981,1.0,1.0,3/6,37.98%,USP1;USP7;ATXN3
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),0.24660601428287676,0.4037077518385967,1.0,1.0,1.0,2/7,19.14%,PNPT1;TRMT10C
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),-0.2577835537903723,-0.40290186724969523,1.0,1.0,1.0,2/6,27.75%,CALM1;ATP2A2
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),0.2199960143488476,0.4027028632588515,1.0,0.9997970512361433,1.0,3/14,15.35%,PNPT1;TRAP1;IDE
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.25018170814500196,-0.40221726938813246,1.0,1.0,1.0,3/7,30.86%,DNM1L;MIEF2;DNM1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.25018170814500196,-0.40221726938813246,1.0,1.0,1.0,3/7,30.86%,DNM1L;MIEF2;DNM1
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.1961364345800843,0.40198770817592616,1.0,0.999479259959997,1.0,6/19,28.62%,MOV10L1;CELF1;TNRC6B;AGO2;TNRC6A;CNOT6
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),-0.21114791889574852,-0.4010625419977423,1.0,1.0,1.0,1/20,8.13%,FABP3
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),-0.2066457739670984,-0.40075529054132397,1.0,1.0,1.0,8/23,28.95%,ABCC2;SLC25A18;PRAF2;SLC26A8;GJA1;SLC1A7;ARL6IP5;GIPC1
prerank,GO_Biological_Process_2021__protein localization to ciliary transition zone (GO:1904491),-0.28122217981791076,-0.3971873016905153,1.0,1.0,1.0,2/5,31.87%,NPHP4;TMEM107
prerank,GO_Biological_Process_2021__benzene-containing compound metabolic process (GO:0042537),-0.2420716494785745,-0.3951815758838397,1.0,1.0,1.0,2/8,25.03%,CYP2E1;KMO
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.20732608541758107,0.3923762302057844,1.0,0.9996476315344681,1.0,3/14,22.34%,SCAP;MIA3;SEC23B
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.20257733942809925,-0.386225886231454,1.0,1.0,1.0,11/24,35.98%,RBX1;RPS27A;UBC;CETN2;RNF111;RAD23B;UBB;XPC;UBA52;ERCC4;CUL4B
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.18727747062267133,-0.3831557014323816,1.0,1.0,1.0,13/33,36.07%,NOB1;NAT10;RPS8;NGDN;TSR2;HELB;SNU13;TSR3;RPS28;RPS16;RPS14;RPS19;UTP6
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),-0.21116055403530237,-0.3787629025487166,1.0,1.0,1.0,3/12,29.52%,MSN;CDC42;EZR
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.20011035647368192,0.3636884969180702,1.0,1.0,1.0,3/11,24.60%,BACE2;AGO2;ABCA2
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),-0.19925921075644618,-0.36040953882972965,1.0,1.0,1.0,8/17,35.01%,FASN;DGAT1;PPT1;CBR4;SCD;ACSL3;SCD5;ACLY
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.1953718703871951,0.35716426171470395,1.0,1.0,1.0,3/10,24.67%,XPO5;STAT3;ZFP36
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.19241212957518547,-0.3531912734762407,1.0,1.0,1.0,2/16,24.67%,DIMT1;UTP15
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.21831703674811637,-0.3525207213155889,1.0,1.0,1.0,2/9,24.09%,SLC27A1;PLA2G4A
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),0.20442802294768245,0.3422625845336837,1.0,0.9998774305521508,1.0,1/5,14.70%,FITM2
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),-0.2272418465865678,-0.3421142917320431,1.0,1.0,1.0,1/6,17.53%,ITM2C
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.17587426362258274,-0.3221687283148623,1.0,0.9999883630947186,1.0,9/20,35.98%,RBX1;RPS27A;UBC;CETN2;RAD23B;UBB;XPC;UBA52;CUL4B
